{"meta":{"query_hash":"bbb242f1805f","filters":{"topic":"Pharmacovigilance and Adverse Drug Reactions"},"cohort_total":622,"direct_labels_cover":2,"predictions_cover":622,"exported":622,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/bbb242f1805f","api":"https://metacan.xera.ac/api/v1/cohort?topic=Pharmacovigilance+and+Adverse+Drug+Reactions"},"results":[{"id":"W112499095","doi":"","title":"Objective psychological measurement and clinical assessment of anxiety in adverse drug reactions.","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anxiety; Medicine; Depression (economics); Psychogenic disease; Checklist; Psychiatry; Adverse effect; Drug; Clinical psychology; Internal medicine; Psychology","score_opus":0.20335444508226927,"score_gpt":0.48474935993006546,"score_spread":0.2813949148477962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W112499095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95798093,0.0053883954,0.004826245,0.0011389797,0.00017818448,0.0042672106,0.0031521455,0.00011796766,0.022950042],"genre_scores_gemma":[0.9872459,0.001328917,0.0067241504,0.00053914817,0.00010756527,0.0018222728,0.0012775392,0.000006402256,0.00094804284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99254006,0.004420104,0.0009920747,0.00029141392,0.0015164529,0.00023984593],"domain_scores_gemma":[0.98673326,0.004096545,0.0062530176,0.00030527666,0.0018615819,0.0007503778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055706543,0.00049960794,0.00043025,0.0013101858,0.00033084466,0.00057323376,0.00049035467,0.000484419,0.0015032078],"category_scores_gemma":[0.016645921,0.00015438031,0.0005545885,0.0009907117,0.000479755,0.0005464572,0.0010109947,0.0010505769,0.0003741992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011490427,0.0015782156,0.89768255,0.0008249845,0.00035372557,0.000355883,0.00065989984,0.00041262724,0.0027236503,0.00026853674,0.0021647376,0.09182608],"study_design_scores_gemma":[0.00008281804,0.0021815975,0.99361104,0.000066987166,0.000058122692,0.0011763024,0.00034010617,0.00041398223,0.00041759497,0.00010322316,0.0015328281,0.000015433783],"about_ca_topic_score_codex":0.000700992,"about_ca_topic_score_gemma":0.0015042087,"teacher_disagreement_score":0.0055706543,"about_ca_system_score_codex":0.00049962435,"about_ca_system_score_gemma":0.00069378456,"threshold_uncertainty_score":0.029460788},"labels":[],"label_agreement":null},{"id":"W1138417772","doi":"10.3233/jrs-2010-0490","title":"Drug safety and Health Canada","year":2010,"lang":"en","type":"article","venue":"International Journal of Risk & Safety in Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; University of Toronto; University Health Network","funders":"Health Canada","keywords":"Drug; Medicine; Pharmacology","score_opus":0.046136341851427336,"score_gpt":0.44834727469708463,"score_spread":0.4022109328456573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1138417772","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019099682,0.032458354,0.0010417297,0.32294074,0.0055829985,0.00022204427,0.0033376894,0.00034437657,0.6321621],"genre_scores_gemma":[0.12517552,0.05629385,0.0056398925,0.28980926,0.0036921098,0.00031482588,0.0050112084,0.0002600445,0.51380324],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9732289,0.0022255543,0.000885163,0.0014871701,0.018528072,0.0036451244],"domain_scores_gemma":[0.94590306,0.0061171525,0.0018024393,0.0015428576,0.033592258,0.011042222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008765869,0.00071241177,0.0010142308,0.004011606,0.0076585,0.010686299,0.0027370565,0.00946151,0.055160675],"category_scores_gemma":[0.036449663,0.0006355064,0.0012101699,0.0044264277,0.0057356907,0.0027328143,0.0036000297,0.008696154,0.007820401],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008286085,0.00007094024,0.0029416883,0.0004283294,0.000040778443,0.00026256352,0.00021213813,0.00032207454,0.00017520544,0.14933781,0.7505571,0.09556848],"study_design_scores_gemma":[0.000041227664,0.000036219433,0.004441187,0.00041085543,0.00002071437,0.00013554409,0.00012407021,0.00018948872,0.000101628066,0.0073143477,0.987148,0.000036746434],"about_ca_topic_score_codex":0.93184143,"about_ca_topic_score_gemma":0.9284162,"teacher_disagreement_score":0.9123241,"about_ca_system_score_codex":0.08767591,"about_ca_system_score_gemma":0.33031246,"threshold_uncertainty_score":0.6361362},"labels":[],"label_agreement":null},{"id":"W1163370901","doi":"10.1016/j.pharma.2015.07.001","title":"Perception de la pharmacovigilance par les pharmaciens hospitaliers québécois","year":2015,"lang":"fr","type":"article","venue":"Annales Pharmaceutiques Françaises","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacovigilance; Adverse drug reaction; Medicine; Family medicine; Pharmacist; Drug reaction; Pharmacy; Perception; Medical emergency; Nursing; Adverse effect; Psychology; Drug; Pharmacology","score_opus":0.12516539605000998,"score_gpt":0.45656581634285476,"score_spread":0.3314004202928448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1163370901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92636526,0.007348646,0.0007880023,0.046052277,0.0001578104,0.00004747342,0.00067291764,0.000045583478,0.018522143],"genre_scores_gemma":[0.9906645,0.002033286,0.0003181007,0.00332416,0.000048608865,0.000012055164,0.000114576986,0.0000093662675,0.0034752912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997721,0.00071031763,0.0001594548,0.00015996702,0.00088441017,0.00036480773],"domain_scores_gemma":[0.9869069,0.0035499888,0.0023013733,0.00010641798,0.0046098614,0.0025256018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002317653,0.00026777547,0.0003145783,0.00086803065,0.002117491,0.0031503488,0.00042724496,0.0013584367,0.0048915525],"category_scores_gemma":[0.010434101,0.00023465899,0.00046885,0.0012503362,0.00083159754,0.00093983364,0.00057272176,0.0019597823,0.00028112397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008507459,0.00027365054,0.8418881,0.00037459514,0.00035458297,0.004111985,0.032322966,0.0014877314,0.0043416726,0.0035722614,0.024586655,0.08583503],"study_design_scores_gemma":[0.00006365168,0.00028676508,0.92336106,0.0005960179,0.00011036648,0.0013663312,0.025399905,0.0017814372,0.0004353999,0.00022346368,0.046263997,0.00011164062],"about_ca_topic_score_codex":0.9230366,"about_ca_topic_score_gemma":0.9158677,"teacher_disagreement_score":0.076963425,"about_ca_system_score_codex":0.022434343,"about_ca_system_score_gemma":0.014859851,"threshold_uncertainty_score":0.16277331},"labels":[],"label_agreement":null},{"id":"W1239449858","doi":"10.2165/11599720-000000000-00000","title":"Impact of Regulatory Guidances and Drug Regulation on Risk Minimization Interventions in Drug Safety","year":2012,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Patient Safety Institute; Golden Key International Honour Society","keywords":"Medicine; Psychological intervention; Drug; Agency (philosophy); MEDLINE; Pharmacovigilance; Population; Adverse effect; Regulatory science; Intensive care medicine; Pharmacology; Environmental health; Psychiatry","score_opus":0.13580833739695367,"score_gpt":0.4777817785596545,"score_spread":0.3419734411627008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1239449858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041185235,0.9965978,0.00034304667,0.0010176226,0.00011653562,0.0000131192755,0.000024338924,0.0000083215855,0.0014673099],"genre_scores_gemma":[0.0061751883,0.9908573,0.0012393747,0.0011837729,0.00018967164,0.000017779801,0.000035688106,0.0000030016522,0.00029819456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969132,0.001075847,0.00043092933,0.00032618886,0.001130441,0.0001234223],"domain_scores_gemma":[0.9881464,0.009066525,0.0015286847,0.00017015118,0.00096302934,0.00012525191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073553384,0.0010848633,0.0027303838,0.002866431,0.00023596025,0.0016063688,0.0014950664,0.0023820105,0.003674153],"category_scores_gemma":[0.01028468,0.00044170493,0.0020341421,0.0022303998,0.00075041945,0.0014677325,0.0008276346,0.0023749808,0.00044637325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017228285,0.0001441293,0.00040129092,0.029533083,0.00052769855,0.00009860902,0.00006569278,0.0009303043,0.00042235496,0.005836366,0.0057418197,0.95612633],"study_design_scores_gemma":[0.0005491856,0.0009759054,0.012080512,0.12014287,0.0060747205,0.0016736584,0.00028120982,0.0014883223,0.002756921,0.013211111,0.840626,0.00013959529],"about_ca_topic_score_codex":0.0034393312,"about_ca_topic_score_gemma":0.00527762,"teacher_disagreement_score":0.0073553384,"about_ca_system_score_codex":0.0016598089,"about_ca_system_score_gemma":0.004255583,"threshold_uncertainty_score":0.038899183},"labels":[],"label_agreement":null},{"id":"W147912069","doi":"10.2165/00002018-200427110-00001","title":"Quantifying Adverse Drug Events","year":2004,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Health Sciences Centre; Sunnybrook Health Science Centre; Toronto Public Health; Children's & Women's Health Centre of British Columbia; Public Health Ontario; University of British Columbia; University of Toronto; Royal Victoria Hospital","funders":"","keywords":"Medicine; Systematic review; Terminology; Clinical trial; MEDLINE; Psychological intervention; Alternative medicine; Adverse effect; Intensive care medicine; Pharmacology; Pathology","score_opus":0.22090137391587814,"score_gpt":0.5039366087313554,"score_spread":0.2830352348154772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W147912069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054150578,0.9512601,0.0253188,0.0012099682,0.00076899986,0.00047909672,0.0023333179,0.0004285132,0.012786143],"genre_scores_gemma":[0.05307437,0.8858298,0.044056423,0.0017927705,0.0010881218,0.00040578484,0.003388502,0.000058479225,0.010305741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540085,0.0011182474,0.00075859553,0.00048108664,0.002157615,0.00008359394],"domain_scores_gemma":[0.9928469,0.0028373264,0.0022357116,0.000248124,0.0017137364,0.000118263146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046672025,0.0024082311,0.003372201,0.0066241035,0.00022734057,0.0019893954,0.0017046187,0.0008259266,0.004936006],"category_scores_gemma":[0.009122521,0.00035914176,0.0023426674,0.004113573,0.00046783546,0.0014175491,0.0009447041,0.0011543873,0.0016382484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001040272,0.00006534125,0.004163128,0.0074566,0.00048394097,0.000075734315,0.000032656997,0.00062275934,0.0009773709,0.0012038933,0.006925042,0.9778895],"study_design_scores_gemma":[0.00038366247,0.0024129276,0.092614725,0.028772347,0.008142272,0.010753834,0.0004892468,0.0077222628,0.018101074,0.021126084,0.8091501,0.00033151833],"about_ca_topic_score_codex":0.0017618388,"about_ca_topic_score_gemma":0.0026871457,"teacher_disagreement_score":0.0066241035,"about_ca_system_score_codex":0.00091987837,"about_ca_system_score_gemma":0.0015864357,"threshold_uncertainty_score":0.02468282},"labels":[],"label_agreement":null},{"id":"W1484238088","doi":"","title":"COX-2 inhibitors in the treatment of cardiovascular disease.","year":2002,"lang":"en","type":"letter","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Table (database); Disease; Adverse effect; Medicine; Computer science; Intensive care medicine; Data science; Pharmacology; Internal medicine; Data mining","score_opus":0.15367228819975262,"score_gpt":0.3598925404401693,"score_spread":0.20622025224041665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1484238088","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023577565,0.059248846,0.00039793213,0.8372784,0.041650895,0.00008676245,0.00034255214,0.0001114037,0.05852547],"genre_scores_gemma":[0.028279932,0.039684825,0.00078516884,0.7385592,0.14058352,0.0000822356,0.00027527555,0.000054641307,0.05169516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983146,0.00029370873,0.00014161681,0.0001257377,0.00092712237,0.00019724331],"domain_scores_gemma":[0.99700123,0.0014362218,0.0003388664,0.000068262954,0.0007113744,0.0004440924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011829596,0.00069573254,0.0010461679,0.00093792833,0.001342771,0.0012661458,0.00095475453,0.009901976,0.0062066396],"category_scores_gemma":[0.0055005914,0.00029041877,0.00065839145,0.0009066979,0.0007678296,0.000899458,0.0004548266,0.010256625,0.006013275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020198236,0.00004080885,0.0011954552,0.00016552792,0.000017384398,0.0045471285,0.000052825588,0.00005813653,0.00035379027,0.0018592133,0.9522147,0.039293192],"study_design_scores_gemma":[0.0002429183,0.00019454974,0.0056914254,0.00043443422,0.000055297758,0.0104821725,0.00012571384,0.00021882015,0.00049900915,0.002339285,0.9796862,0.000030275945],"about_ca_topic_score_codex":0.012295707,"about_ca_topic_score_gemma":0.064844556,"teacher_disagreement_score":0.012295707,"about_ca_system_score_codex":0.0027585563,"about_ca_system_score_gemma":0.0028502296,"threshold_uncertainty_score":0.024448276},"labels":[],"label_agreement":null},{"id":"W1489821983","doi":"10.1111/bcp.12552","title":"Post‐market safety warnings for drugs approved in <scp>C</scp>anada under the <scp>N</scp>otice of <scp>C</scp>ompliance with conditions policy","year":2014,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"","keywords":"Notice; Medicine; Patient safety; Pharmacology; Health care","score_opus":0.06732101278913186,"score_gpt":0.4405504065969612,"score_spread":0.3732293938078294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1489821983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39645407,0.22464931,0.018023439,0.15642458,0.008451224,0.015499419,0.060486175,0.0013128234,0.118698984],"genre_scores_gemma":[0.8496185,0.054965466,0.035198502,0.02988707,0.0024234464,0.004198486,0.012002354,0.00017768194,0.011528475],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8511978,0.05419349,0.041395467,0.004489337,0.04607947,0.0026444648],"domain_scores_gemma":[0.29462492,0.34023437,0.2617538,0.011600502,0.08399023,0.0077961576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09869534,0.0003907016,0.0010662159,0.007813774,0.001262288,0.0035824927,0.0011328992,0.0025211591,0.0052798814],"category_scores_gemma":[0.34397003,0.0006246447,0.0029090398,0.006564178,0.0013623189,0.002491381,0.00184505,0.0019518436,0.0007686122],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010523939,0.0005386024,0.24676692,0.07881163,0.0054773022,0.0013104344,0.002938483,0.0016481972,0.0062283366,0.010434879,0.22090319,0.41441804],"study_design_scores_gemma":[0.0023377687,0.0041329167,0.5505548,0.032485463,0.005638344,0.0024473122,0.0015626223,0.0032704666,0.0113515835,0.0046728,0.38114128,0.00040462147],"about_ca_topic_score_codex":0.022229766,"about_ca_topic_score_gemma":0.0630167,"teacher_disagreement_score":0.9900586,"about_ca_system_score_codex":0.009941402,"about_ca_system_score_gemma":0.03978309,"threshold_uncertainty_score":0.52195704},"labels":[],"label_agreement":null},{"id":"W1502985427","doi":"10.1007/s40264-015-0305-9","title":"Electronic Health Data for Postmarket Surveillance: A Vision Not Realized","year":2015,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Ottawa","keywords":"Medicine; Observational study; Terminology; Clinical trial; Adverse effect; MEDLINE; Medical emergency; Risk analysis (engineering); Pharmacology; Pathology","score_opus":0.2873736372829309,"score_gpt":0.5676336977194099,"score_spread":0.28026006043647894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502985427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021071141,0.98352724,0.0015355385,0.011429991,0.0011273747,0.000021705675,0.00023549728,0.000058061807,0.0018539255],"genre_scores_gemma":[0.0035038888,0.9786592,0.004238683,0.009217803,0.0027072805,0.000038702747,0.00046266115,0.00002275994,0.0011489285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963075,0.0016163654,0.0004120743,0.00043043942,0.0010725245,0.00016110121],"domain_scores_gemma":[0.9615223,0.028266124,0.0029277462,0.0013919377,0.0046903593,0.0012014494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010966304,0.0014388381,0.0034560154,0.0044653732,0.00043955454,0.0044005495,0.0037279108,0.0046514506,0.008023895],"category_scores_gemma":[0.017109687,0.00052829174,0.0022492807,0.004761611,0.0022209794,0.009888105,0.002940498,0.007807089,0.0026533913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007912943,0.000078173834,0.0007018402,0.01377259,0.0002968929,0.000098903954,0.00012473977,0.00023294392,0.00033746933,0.014923824,0.06665219,0.90270126],"study_design_scores_gemma":[0.00005658984,0.00010459701,0.0017220267,0.02749957,0.0004776857,0.00078859046,0.00033403677,0.00039181765,0.0004406547,0.014694845,0.953421,0.00006860673],"about_ca_topic_score_codex":0.0020938064,"about_ca_topic_score_gemma":0.0033841997,"teacher_disagreement_score":0.010966304,"about_ca_system_score_codex":0.0018087347,"about_ca_system_score_gemma":0.004670546,"threshold_uncertainty_score":0.057996035},"labels":[],"label_agreement":null},{"id":"W1511436002","doi":"10.1609/aimag.v35i1.2500","title":"An Antimicrobial Prescription Surveillance System That Learns from Experience","year":2014,"lang":"en","type":"article","venue":"AI Magazine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medical prescription; Software deployment; Antimicrobial; Process (computing); Computer science; Health care; Medicine; Point (geometry); Artificial intelligence; Risk analysis (engineering); Medical emergency; Machine learning; Nursing; Software engineering","score_opus":0.06974765745576511,"score_gpt":0.40202591352379763,"score_spread":0.3322782560680325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1511436002","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35877317,0.0013160742,0.5014672,0.002436726,0.00035173367,0.0013986997,0.006685537,0.10591791,0.021652853],"genre_scores_gemma":[0.7490556,0.0004348689,0.23697282,0.0007643496,0.00016090304,0.00037006522,0.0056860633,0.00039908173,0.006156127],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999172,0.00013783666,0.00010182589,0.00029963136,0.00024676917,0.00004190164],"domain_scores_gemma":[0.99531317,0.0023420358,0.00045470337,0.000657798,0.0010157595,0.00021652153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011518822,0.0006290606,0.0007139045,0.0014600147,0.00033494373,0.0010029309,0.0013240271,0.00082291313,0.0021368605],"category_scores_gemma":[0.00805766,0.0004048964,0.0003708505,0.0007949769,0.00018607028,0.0017315997,0.0006432257,0.0007669529,0.0012500945],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070519885,0.001515962,0.048957497,0.00029149244,0.00022162637,0.0007191097,0.0003412476,0.021694824,0.01762884,0.0014745158,0.02225727,0.8841926],"study_design_scores_gemma":[0.00013795089,0.00051241776,0.022673286,0.00006226775,0.00014982611,0.0007383933,0.0001302488,0.9270988,0.028125277,0.0034563253,0.016808607,0.00010656135],"about_ca_topic_score_codex":0.004426953,"about_ca_topic_score_gemma":0.0047160923,"teacher_disagreement_score":0.004426953,"about_ca_system_score_codex":0.00057923264,"about_ca_system_score_gemma":0.0009732108,"threshold_uncertainty_score":0.008802354},"labels":[],"label_agreement":null},{"id":"W1514986028","doi":"10.2147/dhps.s91046","title":"The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram","year":2015,"lang":"en","type":"article","venue":"Drug Healthcare and Patient Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Citalopram; Medical prescription; Medicine; Population; Antidepressant; Emergency medicine; Drug; Pharmacology; Long QT syndrome; Confidence interval; QT interval; Internal medicine; Environmental health","score_opus":0.18473789568779286,"score_gpt":0.41677435711872,"score_spread":0.23203646143092715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514986028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88821304,0.010373003,0.012180359,0.03362855,0.00076753524,0.00094577996,0.0010894574,0.00013513875,0.052667122],"genre_scores_gemma":[0.9917926,0.00092809653,0.0044534043,0.001839566,0.00028208975,0.00016126838,0.0001235647,0.000019486648,0.0003998414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.854317,0.0917278,0.008673696,0.004838191,0.038484905,0.0019583942],"domain_scores_gemma":[0.1895043,0.6253974,0.1340165,0.016172297,0.032541737,0.0023677738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16650712,0.0004771158,0.00080314634,0.0017316731,0.0014504173,0.0057764496,0.0029047567,0.0030581963,0.003558405],"category_scores_gemma":[0.6034912,0.0006562049,0.0020908187,0.00180879,0.0042310026,0.005357993,0.002001879,0.004322565,0.00031629787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080337245,0.0018835204,0.6102828,0.0030423068,0.001603385,0.0004429499,0.01274359,0.010900085,0.0020596618,0.03768635,0.0076929387,0.3036287],"study_design_scores_gemma":[0.000608747,0.0036358768,0.92610765,0.0037088536,0.0013797791,0.00040693406,0.0052917865,0.024499737,0.0023538808,0.011686308,0.020046331,0.00027410834],"about_ca_topic_score_codex":0.030144196,"about_ca_topic_score_gemma":0.017857686,"teacher_disagreement_score":0.16650712,"about_ca_system_score_codex":0.008563284,"about_ca_system_score_gemma":0.012593265,"threshold_uncertainty_score":0.88058436},"labels":[],"label_agreement":null},{"id":"W1518655779","doi":"10.1002/pds.3306","title":"Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs)","year":2012,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Liverpool John Moores University","keywords":"Medicine; Community pharmacist; Community pharmacy; Pharmacy; Family medicine; Pharmacoepidemiology; Quarter (Canadian coin); Drug reaction; Health professionals; Alternative medicine; Adverse drug reaction; Drug; Nursing; Health care; Medical prescription; Pharmacology","score_opus":0.20070617287615844,"score_gpt":0.4694679563140662,"score_spread":0.26876178343790774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1518655779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992285,0.0009814473,0.000121309975,0.0025563703,0.000018755134,0.000031458196,0.00017120472,0.0000092216715,0.003825152],"genre_scores_gemma":[0.9972805,0.0009580809,0.00018884418,0.0009988856,0.00002765167,0.000021810614,0.00008202746,0.0000028344243,0.00043936048],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9892582,0.0061915102,0.00069550145,0.00027456207,0.0030606093,0.00051961135],"domain_scores_gemma":[0.9638475,0.01266881,0.01467299,0.0007139406,0.0052773547,0.0028193546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004206478,0.0001581983,0.00030874193,0.00073066313,0.00085045304,0.0011465285,0.00038091154,0.0009657863,0.002708226],"category_scores_gemma":[0.032100264,0.00030712815,0.0001780367,0.0009850444,0.00061488437,0.0005769108,0.000900932,0.00082709495,0.00038287803],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006969269,0.00022355045,0.89121413,0.0005972698,0.00013123792,0.0010907417,0.018718958,0.00012255863,0.0024854746,0.0000886063,0.0046745352,0.07995607],"study_design_scores_gemma":[0.000048230282,0.0007739907,0.9727802,0.00023615854,0.000031547286,0.002145274,0.016787259,0.00021179029,0.00028366686,0.000049361224,0.006609232,0.00004325421],"about_ca_topic_score_codex":0.04335216,"about_ca_topic_score_gemma":0.05021456,"teacher_disagreement_score":0.04335216,"about_ca_system_score_codex":0.0010653356,"about_ca_system_score_gemma":0.0016277651,"threshold_uncertainty_score":0.08619964},"labels":[],"label_agreement":null},{"id":"W1526057606","doi":"10.1111/j.1553-2712.2012.01379.x","title":"Clinical Decision Rules to Improve the Detection of Adverse Drug Events in Emergency Department Patients","year":2012,"lang":"en","type":"article","venue":"Academic Emergency Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; St. Paul's Hospital; Vernon Jubilee Hospital; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"Michael Smith Health Research BC","keywords":"Medicine; Emergency department; Observational study; Emergency medicine; Confidence interval; Medical prescription; Pharmacist; Prospective cohort study; Clinical pharmacy; Adverse effect; Internal medicine; Pharmacy; Family medicine; Psychiatry","score_opus":0.09916300085317392,"score_gpt":0.49029036620779104,"score_spread":0.3911273653546171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526057606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76848525,0.0047778753,0.20161226,0.004392333,0.0005279931,0.002733009,0.0044824397,0.0019493025,0.011039606],"genre_scores_gemma":[0.815612,0.00061112846,0.17928953,0.0007005382,0.00017440005,0.00050020637,0.002730956,0.00003871912,0.00034249976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98960435,0.0058393804,0.0016939524,0.0010150657,0.0015608575,0.00028644048],"domain_scores_gemma":[0.89684474,0.08372294,0.007270675,0.0015877724,0.009458737,0.0011151213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011393628,0.0008951225,0.0013654364,0.0035984789,0.0005921436,0.0024223882,0.001199043,0.00089695596,0.001551304],"category_scores_gemma":[0.10365063,0.00040934244,0.00088627136,0.0019268693,0.00034028705,0.0011685059,0.0010730962,0.0012954521,0.0004437744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002576198,0.0016112351,0.4504461,0.0009453634,0.0007520997,0.0008319079,0.0008698276,0.075552955,0.0012810787,0.002166463,0.011983142,0.45098364],"study_design_scores_gemma":[0.0012401692,0.0013817879,0.16808373,0.001186818,0.0009214027,0.001868354,0.00092485285,0.795488,0.0045832754,0.015572012,0.008570414,0.00017916015],"about_ca_topic_score_codex":0.009068315,"about_ca_topic_score_gemma":0.008801798,"teacher_disagreement_score":0.011393628,"about_ca_system_score_codex":0.001128589,"about_ca_system_score_gemma":0.003232162,"threshold_uncertainty_score":0.060255945},"labels":[],"label_agreement":null},{"id":"W1544759846","doi":"10.1111/jpc.12684","title":"Characteristics of adverse medication events in a children's hospital","year":2014,"lang":"en","type":"article","venue":"Journal of Paediatrics and Child Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Children's Health Foundation; Child Health Foundation","keywords":"Medicine; Psychological intervention; Harm; Pharmacist; Adverse effect; Coding (social sciences); Medical record; Incident report; Family medicine; Pediatrics; Emergency medicine; Medical emergency; Psychiatry; Internal medicine; Pharmacy","score_opus":0.02232357744756475,"score_gpt":0.37234906638827414,"score_spread":0.3500254889407094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1544759846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946008,0.00051645207,0.00009458026,0.00018514722,0.000019982783,0.000039258903,0.0035910024,0.000016027,0.0009366926],"genre_scores_gemma":[0.9972019,0.00031596367,0.00016578608,0.00004848968,0.000015976742,0.000033812503,0.0021040323,0.0000056051817,0.000108557426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778986,0.00021570125,0.00053843175,0.0003275866,0.0008225943,0.000305691],"domain_scores_gemma":[0.98633504,0.0015826572,0.009688685,0.00021695136,0.0011330424,0.0010435536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009379628,0.0002836077,0.00050413696,0.0027072784,0.00044288274,0.0008245741,0.00042014424,0.0004932292,0.0022449605],"category_scores_gemma":[0.00948153,0.00024733023,0.00083366834,0.003264714,0.00035900125,0.0007384676,0.00078502536,0.0007513286,0.000244846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028187053,0.0000073157576,0.99902165,0.000015933312,0.00001672589,0.00008726943,0.000061634084,0.00003152865,0.000026777392,0.000008176867,0.00012892063,0.0005657519],"study_design_scores_gemma":[0.0000020420791,0.000047140853,0.998931,0.000018007911,0.0000066543607,0.0005072435,0.00023576924,0.000039594837,0.00003193377,0.000004843667,0.0001721861,0.0000035925875],"about_ca_topic_score_codex":0.009924744,"about_ca_topic_score_gemma":0.008428756,"teacher_disagreement_score":0.009924744,"about_ca_system_score_codex":0.0011945023,"about_ca_system_score_gemma":0.0011765077,"threshold_uncertainty_score":0.019733965},"labels":[],"label_agreement":null},{"id":"W1559324176","doi":"","title":"How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Pimozide; Nephrogenic diabetes insipidus; Medicine; Adverse effect; Lithium (medication); Ziprasidone; Antipsychotic; Psychotropic drug; Intensive care medicine; Drug; Pharmacology; Psychiatry; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Diabetes insipidus; Haloperidol; Dopamine","score_opus":0.051016733256919945,"score_gpt":0.3416993187562017,"score_spread":0.2906825854992817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1559324176","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062676067,0.98292494,0.0013635098,0.0052603194,0.00066079025,0.000037595844,0.000085255415,0.00005075805,0.003349067],"genre_scores_gemma":[0.06623536,0.9200261,0.002258627,0.006225958,0.0021776163,0.00006189179,0.00012222516,0.000017484626,0.0028747986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993,0.00023220992,0.0001322633,0.00006496425,0.00021029357,0.000060288687],"domain_scores_gemma":[0.996566,0.0017164935,0.001160932,0.00005978354,0.00041710073,0.00007976427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013689963,0.00066458853,0.0011704162,0.0011850315,0.00032048154,0.0014228229,0.00052388356,0.0017180364,0.003571958],"category_scores_gemma":[0.0037031693,0.00023534306,0.00090484106,0.0008674812,0.0006034749,0.00182911,0.00042045818,0.0009747818,0.0013244301],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054244616,0.00022532613,0.032809228,0.024922738,0.0012373895,0.014265729,0.00074700394,0.00071063574,0.0142414095,0.005634763,0.04575328,0.8589101],"study_design_scores_gemma":[0.0003024527,0.0021986337,0.13417864,0.016831962,0.0030252081,0.19403301,0.0026225888,0.00145028,0.021222413,0.017669939,0.60622054,0.0002442947],"about_ca_topic_score_codex":0.00079547707,"about_ca_topic_score_gemma":0.001007932,"teacher_disagreement_score":0.003571958,"about_ca_system_score_codex":0.0005999471,"about_ca_system_score_gemma":0.0008657768,"threshold_uncertainty_score":0.01194936},"labels":[],"label_agreement":null},{"id":"W1561057973","doi":"10.1002/pds.2330","title":"When should case‐only designs be used for safety monitoring of medical products?","year":2012,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ministry of Health","funders":"U.S. Department of Health and Human Services","keywords":"Confounding; Medicine; Observational study; Crossover study; Causality (physics); Selection bias; Pharmacoepidemiology; Crossover; Cohort study; Residual; Outcome (game theory); Cohort; Statistics; Econometrics; Computer science; Algorithm; Artificial intelligence; Internal medicine; Pathology; Mathematics","score_opus":0.3282102323380323,"score_gpt":0.5101522614093926,"score_spread":0.1819420290713603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1561057973","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038143165,0.09105983,0.74401253,0.020254113,0.020599568,0.07403665,0.0035427734,0.0009863066,0.007365109],"genre_scores_gemma":[0.17124636,0.008379593,0.6630296,0.015384477,0.0031181786,0.1364678,0.0012035345,0.00023366533,0.00093682844],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.15075926,0.7659526,0.046109386,0.011658537,0.024442976,0.0010771947],"domain_scores_gemma":[0.11654364,0.71282715,0.06843933,0.07174104,0.02887722,0.0015717441],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6523675,0.0023515217,0.00696782,0.004549112,0.0024417334,0.0067766667,0.007897938,0.009095466,0.00860973],"category_scores_gemma":[0.8185966,0.0023070418,0.009775721,0.0051422473,0.0057053934,0.009533934,0.0047437204,0.0050844634,0.0013901931],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028813876,0.0020779988,0.0680555,0.08229511,0.04326627,0.0008228522,0.007859851,0.0063457787,0.001963056,0.17454611,0.03270367,0.5512499],"study_design_scores_gemma":[0.02863447,0.03843538,0.05906116,0.11843202,0.031472076,0.0019388199,0.0039068065,0.03923383,0.007535643,0.35336483,0.31674987,0.0012351398],"about_ca_topic_score_codex":0.001099223,"about_ca_topic_score_gemma":0.0011505943,"teacher_disagreement_score":0.34763253,"about_ca_system_score_codex":0.0043701576,"about_ca_system_score_gemma":0.008563722,"threshold_uncertainty_score":0.42869282},"labels":[],"label_agreement":null},{"id":"W1564717582","doi":"10.1002/pds.3596","title":"Methodological gaps in the assessment of risk minimization interventions: a systematic review","year":2014,"lang":"en","type":"review","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; AstraZeneca (Canada); Université de Montréal","funders":"Canadian Institutes of Health Research; AstraZeneca Canada","keywords":"Medicine; Psychological intervention; Pharmacoepidemiology; Systematic review; Risk assessment; MEDLINE; Risk analysis (engineering); Pharmacology; Psychiatry","score_opus":0.4155061355617425,"score_gpt":0.6069063975078771,"score_spread":0.19140026194613463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564717582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007946221,0.9940065,0.0014918565,0.0021077439,0.00031007515,0.0007253711,0.0002544537,0.000012885393,0.00029642932],"genre_scores_gemma":[0.045374613,0.9305076,0.012314214,0.004261165,0.0005979679,0.0062898993,0.0005099996,0.000030753283,0.0001138074],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7069408,0.15945405,0.09359627,0.008775059,0.0295304,0.0017033528],"domain_scores_gemma":[0.30884835,0.6069244,0.05491273,0.0071699247,0.02100128,0.0011432806],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19841409,0.0026737244,0.014660424,0.019368036,0.0017234734,0.007999111,0.005375081,0.005388584,0.0041807666],"category_scores_gemma":[0.50014347,0.003325668,0.01076662,0.017089177,0.0039749686,0.008864138,0.00419516,0.0031555523,0.0004959142],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024052717,0.00002691464,0.001310051,0.9348056,0.009364347,0.000082460414,0.0005210342,0.00020403526,0.00007846742,0.0011374557,0.0013496123,0.05087945],"study_design_scores_gemma":[0.00023019643,0.00013157514,0.0023303567,0.9600951,0.025630333,0.00019350147,0.00049513206,0.00019251488,0.00013882206,0.0018901299,0.00863165,0.00004071599],"about_ca_topic_score_codex":0.0064904736,"about_ca_topic_score_gemma":0.012465862,"teacher_disagreement_score":0.9853396,"about_ca_system_score_codex":0.011265808,"about_ca_system_score_gemma":0.036861688,"threshold_uncertainty_score":0.98849815},"labels":[],"label_agreement":null},{"id":"W1580628800","doi":"10.4212/cjhp.v61i4.65","title":"Possible Enhancement of the Effect of Warfarin Secondary to Oral Prednisone Therapy","year":2008,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine","funders":"","keywords":"Warfarin; Medicine; Prednisone; Methylprednisolone; Drug; Intensive care medicine; Internal medicine; Pharmacology; Atrial fibrillation","score_opus":0.06633274358531101,"score_gpt":0.3869438200712935,"score_spread":0.3206110764859825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1580628800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8419241,0.068657435,0.0084555615,0.013325446,0.00088110525,0.0005841742,0.00046367018,0.00067851174,0.06503005],"genre_scores_gemma":[0.99182045,0.004052365,0.00047010096,0.0013737315,0.00066738145,0.000017154243,0.00007676218,0.000011049154,0.0015110348],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99850106,0.0003849599,0.00021895792,0.00016100478,0.0004622154,0.00027172628],"domain_scores_gemma":[0.9959209,0.0018790909,0.001313998,0.000295925,0.00033416747,0.00025583766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010113347,0.00073035026,0.00089334045,0.0013124576,0.0008106696,0.0011583759,0.0007596184,0.002442693,0.0075124362],"category_scores_gemma":[0.007647158,0.0002902112,0.0012575939,0.0011480969,0.0009663306,0.0005540364,0.0004833153,0.0017784704,0.0010149655],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002214043,0.00034162166,0.20804124,0.00097164034,0.00038846754,0.722458,0.0006601841,0.00024257683,0.012415186,0.0018264034,0.0027059508,0.04773473],"study_design_scores_gemma":[0.00032396405,0.0014504516,0.17878634,0.00031966376,0.0005576811,0.7953162,0.0003083503,0.0009898175,0.009571681,0.0011130814,0.01122538,0.00003737378],"about_ca_topic_score_codex":0.0059410497,"about_ca_topic_score_gemma":0.0031848198,"teacher_disagreement_score":0.0075124362,"about_ca_system_score_codex":0.001247873,"about_ca_system_score_gemma":0.00096477964,"threshold_uncertainty_score":0.025131643},"labels":[],"label_agreement":null},{"id":"W1600992313","doi":"10.1002/pds.2320","title":"Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini‐Sentinel pilot","year":2012,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation; U.S. Department of Health and Human Services","keywords":"Medicine; Statistic; Missing data; Data mining; Test statistic; Statistical hypothesis testing; Statistics; Computer science; Machine learning","score_opus":0.4609065369429212,"score_gpt":0.47574029364495934,"score_spread":0.014833756702038126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600992313","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009514657,0.0011286744,0.9857547,0.0009891584,0.00011673304,0.0010847029,0.0002100135,0.00053838216,0.0006629884],"genre_scores_gemma":[0.13624233,0.0012570034,0.8556979,0.00063236663,0.00032784857,0.0048944307,0.00042640607,0.00020270277,0.00031912376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.75180227,0.21680146,0.006839185,0.005255036,0.018794887,0.00050715223],"domain_scores_gemma":[0.42506757,0.4901765,0.026987422,0.04052776,0.016088514,0.0011522471],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20678669,0.0010214628,0.001968312,0.0029537894,0.0005220305,0.0019807129,0.0035735876,0.0010710648,0.003813581],"category_scores_gemma":[0.38508594,0.0009144154,0.0018633318,0.004051287,0.0033434378,0.0026685556,0.0030137629,0.0027333302,0.00049537397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001038848,0.00041041884,0.031987358,0.0019736604,0.0012463966,0.00013296613,0.0018992784,0.013728562,0.0010718481,0.044476133,0.005579618,0.8964549],"study_design_scores_gemma":[0.002300865,0.012808687,0.07128458,0.0034121417,0.0012598331,0.0012666658,0.001869316,0.49608466,0.006664429,0.34940705,0.053118516,0.0005232389],"about_ca_topic_score_codex":0.002080831,"about_ca_topic_score_gemma":0.0017412382,"teacher_disagreement_score":0.20678669,"about_ca_system_score_codex":0.0010973362,"about_ca_system_score_gemma":0.0042421957,"threshold_uncertainty_score":0.97817326},"labels":[],"label_agreement":null},{"id":"W164951198","doi":"","title":"Reporting of fatal adverse drug reactions.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baycrest Hospital","funders":"","keywords":"Medicine; Drug; Drug reaction; Causality (physics); Concomitant; Adverse drug reaction; Adverse effect; Medical history; Medical record; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.16906940350968921,"score_gpt":0.4212467434343544,"score_spread":0.2521773399246652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W164951198","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2861978,0.5796318,0.015297105,0.0090677915,0.0024402034,0.002150136,0.043194123,0.00095361774,0.061067455],"genre_scores_gemma":[0.8529972,0.11614563,0.006850472,0.003249778,0.001126135,0.00037701463,0.016310865,0.000058700985,0.002884151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98946244,0.0019674888,0.0030891267,0.00059701235,0.0046214173,0.00026262147],"domain_scores_gemma":[0.9488252,0.008742578,0.03178369,0.0017505478,0.008436466,0.00046158434],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0056159156,0.00046499938,0.000392637,0.0033178488,0.00038776064,0.0011368028,0.00074494706,0.00044044608,0.0025008246],"category_scores_gemma":[0.04110228,0.00017419335,0.00038812732,0.0021856553,0.0006734713,0.0008530429,0.0007627299,0.00030327396,0.0006491158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063833816,0.000047553902,0.61067533,0.015356214,0.00037594474,0.0037687288,0.0010811045,0.00039956428,0.0020573458,0.0011226473,0.036137003,0.32834014],"study_design_scores_gemma":[0.00008583447,0.00045133953,0.7504331,0.0111098625,0.0005191276,0.035091385,0.0012497344,0.0006002894,0.0026618442,0.00094673777,0.19678453,0.00006612847],"about_ca_topic_score_codex":0.01353746,"about_ca_topic_score_gemma":0.013569609,"teacher_disagreement_score":0.9943841,"about_ca_system_score_codex":0.001234388,"about_ca_system_score_gemma":0.0018269924,"threshold_uncertainty_score":0.02970016},"labels":[],"label_agreement":null},{"id":"W1800693533","doi":"10.14740/jocmr2328w","title":"Japanese Physicians’ Views on Drug Post-Marketing Surveillance","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"University of Tokushima","keywords":"Medicine; Postmarketing surveillance; Drug; Family medicine; Marketing; Pharmacology; Business","score_opus":0.6157843015154445,"score_gpt":0.6604246725410025,"score_spread":0.04464037102555796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1800693533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579806,0.0013552861,0.00037245225,0.008279903,0.000056721146,0.00003088661,0.00007467553,0.000008257693,0.0040238043],"genre_scores_gemma":[0.9974571,0.00076191826,0.00027420925,0.001136621,0.00009215278,0.000013413336,0.00003906589,0.0000014847996,0.00022400123],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9863849,0.0077317045,0.0016506441,0.00057556934,0.002812199,0.00084491225],"domain_scores_gemma":[0.9083808,0.029812945,0.040854793,0.0023706355,0.011461608,0.0071192123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012791307,0.00012623373,0.00016159817,0.000900378,0.0012077822,0.0012867245,0.0004737265,0.00095013774,0.0012543155],"category_scores_gemma":[0.04145781,0.0001963082,0.00026991678,0.00093005376,0.0012803065,0.00089252973,0.0009989081,0.0006383452,0.00015768911],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001885905,0.000079273625,0.9368516,0.0002591992,0.000054621934,0.0013196663,0.022709817,0.00013705551,0.0019110303,0.000459845,0.0031239835,0.032905266],"study_design_scores_gemma":[0.000024405701,0.00035051024,0.9478818,0.00026840987,0.00006016833,0.002003734,0.033881947,0.0006489325,0.0009554322,0.00019440292,0.013677479,0.00005273522],"about_ca_topic_score_codex":0.005827043,"about_ca_topic_score_gemma":0.0060206386,"teacher_disagreement_score":0.012791307,"about_ca_system_score_codex":0.0018058076,"about_ca_system_score_gemma":0.0022730906,"threshold_uncertainty_score":0.067647696},"labels":[],"label_agreement":null},{"id":"W1841827866","doi":"10.2196/publichealth.4488","title":"Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter","year":2015,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Internet privacy; Adverse effect; Human immunodeficiency virus (HIV); Drug; Medicine; Public health; Psychology; Intensive care medicine; Computer science; Psychiatry; Pharmacology; Family medicine","score_opus":0.18768353590364126,"score_gpt":0.4635258085651492,"score_spread":0.27584227266150796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1841827866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88209826,0.002230136,0.008292898,0.003335927,0.000480993,0.0004923177,0.08693089,0.00039188078,0.01574679],"genre_scores_gemma":[0.9433706,0.0010173811,0.009610616,0.00056813244,0.0004901507,0.00038779163,0.041656826,0.000035969864,0.0028624285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989343,0.00036970136,0.00013512175,0.00021194377,0.00026015608,0.00008870946],"domain_scores_gemma":[0.9957111,0.0022250435,0.0012112948,0.0002681199,0.00041604243,0.00016845646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010088601,0.0005128073,0.00032732237,0.0022699179,0.00050143874,0.00092148234,0.00027596313,0.0005392367,0.0019215414],"category_scores_gemma":[0.0052828044,0.00011921179,0.000594184,0.0013855663,0.00024819458,0.0009231283,0.00101134,0.0004986939,0.0008715014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010467694,0.0003416621,0.73909146,0.0017862904,0.00034200112,0.0011381451,0.0029054962,0.004849599,0.015682226,0.0014947912,0.0393381,0.1919835],"study_design_scores_gemma":[0.000051549825,0.00038479298,0.85955447,0.00048655146,0.00025588262,0.000734975,0.0047864383,0.059145417,0.008695621,0.003709268,0.06207667,0.00011833884],"about_ca_topic_score_codex":0.0036311997,"about_ca_topic_score_gemma":0.0066333544,"teacher_disagreement_score":0.0036311997,"about_ca_system_score_codex":0.0004968186,"about_ca_system_score_gemma":0.000363488,"threshold_uncertainty_score":0.007220149},"labels":[],"label_agreement":null},{"id":"W1858946267","doi":"10.1186/s13104-015-1448-6","title":"Rosiglitazone use and associated adverse event rates in Canada: an updated analysis","year":2015,"lang":"en","type":"article","venue":"BMC Research Notes","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Rosiglitazone; Medicine; Adverse effect; Event (particle physics); MEDLINE; Data science; Computer science; Internal medicine; Political science","score_opus":0.46484652452903585,"score_gpt":0.5398291698473829,"score_spread":0.07498264531834709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858946267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8102322,0.019365212,0.0005759024,0.0021416673,0.00010587401,0.00028016098,0.15576531,0.00016415487,0.011369505],"genre_scores_gemma":[0.9473635,0.0118955355,0.00094837346,0.0006497502,0.000073781644,0.000091249814,0.037377868,0.000031587166,0.0015684806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980477,0.00007717713,0.00019159578,0.0001932337,0.0012152123,0.00027512884],"domain_scores_gemma":[0.99240065,0.0003121543,0.0017323871,0.00014096408,0.004700408,0.0007134028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093875214,0.00042774642,0.0006085763,0.004350628,0.0011178316,0.0013169434,0.0010373327,0.00037712525,0.0019842053],"category_scores_gemma":[0.004173729,0.00030357597,0.0013972258,0.01259617,0.00027613525,0.0004171712,0.000558825,0.0007741909,0.0002303582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015815295,0.000033020442,0.97822464,0.00029245522,0.0003985222,0.00010293369,0.00015412808,0.00045620065,0.00009777665,0.00009762989,0.0067223534,0.013262238],"study_design_scores_gemma":[0.000014537297,0.000017037628,0.9957415,0.00007968277,0.00016777539,0.00007167249,0.00012569512,0.0005640659,0.000056226345,0.000014433056,0.0031333722,0.000013972344],"about_ca_topic_score_codex":0.992675,"about_ca_topic_score_gemma":0.9927718,"teacher_disagreement_score":0.027870353,"about_ca_system_score_codex":0.027870353,"about_ca_system_score_gemma":0.039551612,"threshold_uncertainty_score":0.20221454},"labels":[],"label_agreement":null},{"id":"W1865013153","doi":"10.2215/cjn.11271114","title":"Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI","year":2015,"lang":"en","type":"review","venue":"Clinical Journal of the American Society of Nephrology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; Government of Alberta","keywords":"Medicine; Norepinephrine; Reuptake inhibitor; Serotonin; Serotonin Uptake Inhibitors; Pharmacology; Internal medicine; Dopamine; Fluoxetine","score_opus":0.21474775833949886,"score_gpt":0.5257736998425371,"score_spread":0.3110259415030382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1865013153","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50998026,0.4796476,0.003492315,0.0021072002,0.00028289476,0.00013713243,0.0019859832,0.000045523164,0.002321172],"genre_scores_gemma":[0.95780164,0.039312255,0.0016013156,0.00036774538,0.0001869832,0.00005410087,0.0005026855,0.0000052490072,0.00016792442],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953023,0.0023317842,0.00080074026,0.0006454317,0.00076194183,0.0001577124],"domain_scores_gemma":[0.9804648,0.011641895,0.0057240142,0.0006065107,0.0013107879,0.00025197963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058418517,0.00042879357,0.0011980821,0.0012898663,0.00021614532,0.0011691377,0.00059361703,0.0007517515,0.0008251325],"category_scores_gemma":[0.016966522,0.00040908516,0.0041550775,0.0013714462,0.00035281782,0.00039414255,0.00037353646,0.00093977555,0.000065849825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040546064,0.00008871468,0.8534897,0.0073824483,0.10274171,0.00031669837,0.000092021095,0.0028315666,0.0005625397,0.00046774393,0.00080489385,0.027167385],"study_design_scores_gemma":[0.0009621404,0.0010059796,0.8566764,0.003257399,0.12535879,0.0016054679,0.00013741262,0.005621883,0.001142254,0.0013853394,0.0027808547,0.000066099194],"about_ca_topic_score_codex":0.0128840115,"about_ca_topic_score_gemma":0.012063664,"teacher_disagreement_score":0.0128840115,"about_ca_system_score_codex":0.0011002226,"about_ca_system_score_gemma":0.0014117849,"threshold_uncertainty_score":0.030895054},"labels":[],"label_agreement":null},{"id":"W1870462077","doi":"10.14236/jhi.v18i2.762","title":"Automated processing of electronic medical records is a reliablemethod of determining aspirin use in populations at risk forcardiovascular events","year":2010,"lang":"en","type":"article","venue":"Journal of Innovation in Health Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"","keywords":"Medicine; Aspirin; Contraindication; Medical record; Electronic medical record; MEDLINE; Internal medicine; Emergency medicine; Alternative medicine; Pathology","score_opus":0.13853696419299655,"score_gpt":0.4956134548808074,"score_spread":0.35707649068781083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1870462077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73089117,0.015706366,0.17899825,0.0060542566,0.00079107523,0.007250525,0.038959388,0.0037785578,0.017570471],"genre_scores_gemma":[0.7771356,0.0053672562,0.18430822,0.0019134111,0.0011350162,0.0024341946,0.025839016,0.00018216945,0.00168509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.93952644,0.031352125,0.010927524,0.0051494436,0.012333045,0.0007113826],"domain_scores_gemma":[0.7237112,0.1390144,0.06737384,0.03096508,0.038142767,0.00079268025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0325791,0.0011506326,0.0016082106,0.011752452,0.0007389572,0.002623504,0.001717315,0.0012902349,0.0030470195],"category_scores_gemma":[0.15239945,0.00072797656,0.0011156736,0.0067925532,0.0009612293,0.002547004,0.001821985,0.00075104216,0.0023676709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009598471,0.00057953276,0.6090084,0.004597766,0.0006795984,0.00046180878,0.0015768994,0.0011912521,0.012106466,0.0005868592,0.012399935,0.35585168],"study_design_scores_gemma":[0.00028653117,0.0008787476,0.9491326,0.0016604249,0.0005791794,0.001687489,0.000892825,0.012290081,0.010499443,0.0020230033,0.01991391,0.00015575475],"about_ca_topic_score_codex":0.0038608687,"about_ca_topic_score_gemma":0.0044728434,"teacher_disagreement_score":0.0325791,"about_ca_system_score_codex":0.0007302128,"about_ca_system_score_gemma":0.0024828552,"threshold_uncertainty_score":0.17229688},"labels":[],"label_agreement":null},{"id":"W1876913242","doi":"10.1111/j.2042-7174.2011.00150.x","title":"Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?","year":2011,"lang":"en","type":"article","venue":"International Journal of Pharmacy Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacovigilance; Medicine; Pharmacy; Pharmacist; Drug reaction; Health professionals; Family medicine; Patient safety; Adverse effect; Health care; Clinical pharmacy; Perception; Nursing; Drug; Pharmacology; Psychology","score_opus":0.2653520298433582,"score_gpt":0.5406550540435104,"score_spread":0.27530302420015224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1876913242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8520077,0.0057281163,0.004069159,0.11944558,0.00020463367,0.00015486252,0.00013827112,0.00006819298,0.018183442],"genre_scores_gemma":[0.9929838,0.0016261643,0.0007214275,0.0039039021,0.000061708815,0.000017125285,0.000017029179,0.000004790606,0.00066413434],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.97298354,0.016985338,0.0015512477,0.0010398036,0.0059323423,0.0015076812],"domain_scores_gemma":[0.9150784,0.046145465,0.026336666,0.0015722307,0.007245336,0.0036218166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015741128,0.00010236699,0.00023595149,0.00047861537,0.0021199558,0.0027374849,0.0010492431,0.0016315449,0.0020082358],"category_scores_gemma":[0.06678168,0.00021686927,0.000180506,0.0007416189,0.0049544084,0.0026331462,0.0022669218,0.0016150913,0.00031353394],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001749834,0.00014445998,0.2463128,0.0022463654,0.00007945879,0.0067079435,0.5805646,0.00020819454,0.003026657,0.003286988,0.010585851,0.14666164],"study_design_scores_gemma":[0.00003485658,0.00035630286,0.14770728,0.002023233,0.00006266154,0.009279871,0.78975075,0.0004148464,0.0016901254,0.0017507528,0.046831593,0.000097761156],"about_ca_topic_score_codex":0.038635597,"about_ca_topic_score_gemma":0.031339075,"teacher_disagreement_score":0.038635597,"about_ca_system_score_codex":0.004723128,"about_ca_system_score_gemma":0.011067854,"threshold_uncertainty_score":0.08324802},"labels":[],"label_agreement":null},{"id":"W1883456152","doi":"10.1007/s40290-015-0106-6","title":"Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Food and Drug Administration; Hamilton Health Sciences Foundation","keywords":"Pharmacovigilance; Outreach; Adverse effect; Medicine; Event (particle physics); Adverse drug event; Medical emergency; Medical physics; Internal medicine","score_opus":0.4049343292784165,"score_gpt":0.5660667458406965,"score_spread":0.16113241656228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1883456152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975842,0.00021155966,0.0002841221,0.0004678504,0.0000054841435,0.00016311466,0.0004155425,0.000012644525,0.000855569],"genre_scores_gemma":[0.99760324,0.00032727432,0.0005976494,0.00036141727,0.000013662241,0.000226897,0.00048529654,0.00001623555,0.00036840257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99091774,0.00450872,0.0010356418,0.00060033874,0.0018949057,0.0010427813],"domain_scores_gemma":[0.9727471,0.012054022,0.00879157,0.00106915,0.0030862151,0.0022519834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075654355,0.0003425159,0.00041427586,0.002893447,0.0011533771,0.0017552385,0.00083549944,0.0008664758,0.002219715],"category_scores_gemma":[0.034783084,0.0003750848,0.0011951204,0.0034125228,0.0007454473,0.0022327057,0.0031692204,0.0014620424,0.00032784362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005302458,0.0007478419,0.9534995,0.00019550789,0.00017856131,0.00020665824,0.010617959,0.00013480059,0.00022357958,0.00019446136,0.0012474944,0.03222333],"study_design_scores_gemma":[0.000031709227,0.00054138893,0.9860875,0.00013331216,0.0000741938,0.0001828522,0.0103790155,0.0009465549,0.00012636905,0.000089574474,0.0013838279,0.00002363641],"about_ca_topic_score_codex":0.019388318,"about_ca_topic_score_gemma":0.022965336,"teacher_disagreement_score":0.019388318,"about_ca_system_score_codex":0.0016749008,"about_ca_system_score_gemma":0.0038558086,"threshold_uncertainty_score":0.040010333},"labels":[],"label_agreement":null},{"id":"W1912594775","doi":"10.1002/pds.3401","title":"Agreement between patients' self‐report and medical records for vaccination: the PGRx database","year":2013,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Concordance; Vaccination; Pharmacoepidemiology; Medical record; Medical prescription; Medical diagnosis; Database; Family medicine; Pediatrics; Internal medicine; Immunology","score_opus":0.08151379411289221,"score_gpt":0.4410830521257261,"score_spread":0.3595692580128339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1912594775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95768774,0.0014853233,0.004872615,0.0005127881,0.000038751576,0.00090277806,0.030169433,0.00018611047,0.0041445657],"genre_scores_gemma":[0.9695435,0.0005090495,0.00554466,0.00026959874,0.00008238159,0.0011208679,0.022201056,0.000030113666,0.0006987309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9568969,0.027462458,0.0054350346,0.004534794,0.0051799277,0.0004908531],"domain_scores_gemma":[0.9190317,0.03805971,0.024600478,0.01153828,0.0058373897,0.00093235244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019861644,0.00043280039,0.0011967807,0.004122302,0.0003676025,0.0020010152,0.0015170159,0.00073795515,0.00194416],"category_scores_gemma":[0.061688393,0.00045241287,0.00061341544,0.0047733076,0.0004847331,0.0010829355,0.0024793774,0.00053338794,0.00083345466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046665972,0.00007253098,0.9776154,0.00029441828,0.00035260178,0.000061717954,0.00087070017,0.00026198418,0.00018907734,0.00012252631,0.0017895584,0.017902857],"study_design_scores_gemma":[0.00012218255,0.00016320763,0.9941315,0.00011080145,0.00015131047,0.00029761135,0.0003296589,0.0014036442,0.00032662967,0.00008605763,0.0028602055,0.000017051821],"about_ca_topic_score_codex":0.0076098475,"about_ca_topic_score_gemma":0.0037470153,"teacher_disagreement_score":0.019861644,"about_ca_system_score_codex":0.0009164874,"about_ca_system_score_gemma":0.0011568641,"threshold_uncertainty_score":0.105039656},"labels":[],"label_agreement":null},{"id":"W1915143997","doi":"10.1046/j.1365-2125.2003.01968.x","title":"Application of data mining techniques in pharmacovigilance","year":2003,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacovigilance; Data mining; Association rule learning; Knowledge extraction; Computer science; Practolol; Data pre-processing; Database; Medicine; Adverse effect; Pharmacology","score_opus":0.4674098703697274,"score_gpt":0.6320227834884029,"score_spread":0.16461291311867549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1915143997","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03772524,0.07457512,0.8506227,0.017280368,0.0007132786,0.0021234113,0.0050425455,0.0019068404,0.010010532],"genre_scores_gemma":[0.21687354,0.033126056,0.74231464,0.0022287995,0.00059456786,0.0013437113,0.0027272883,0.00008637111,0.0007051049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97666526,0.012433048,0.003708297,0.0017280619,0.0052097845,0.00025549525],"domain_scores_gemma":[0.91387314,0.07172182,0.0049510407,0.0032838224,0.005759725,0.00041031497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026738597,0.0012078189,0.0020178028,0.015248579,0.00074001675,0.005650355,0.0021404997,0.0020071808,0.0012583919],"category_scores_gemma":[0.054232664,0.00078464503,0.002795646,0.0147319,0.0011638287,0.0031746272,0.002065814,0.0022446346,0.0005403063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043339253,0.00046622645,0.05874039,0.016136887,0.003743981,0.0015571204,0.0013833039,0.044327945,0.0048349425,0.033956144,0.008905112,0.82551455],"study_design_scores_gemma":[0.000498304,0.0013924967,0.059499912,0.019694395,0.002910694,0.0066305525,0.0037740532,0.39935467,0.02388242,0.30886385,0.17291717,0.0005814591],"about_ca_topic_score_codex":0.0025578008,"about_ca_topic_score_gemma":0.0014981898,"teacher_disagreement_score":0.026738597,"about_ca_system_score_codex":0.0017853685,"about_ca_system_score_gemma":0.0029276016,"threshold_uncertainty_score":0.14140892},"labels":[],"label_agreement":null},{"id":"W1916981799","doi":"10.4212/cjhp.v57i1.345","title":"Analysis of Spontaneous Reports of Hypoglycemia and Hyperglycemia Associated with Marketed Systemic Fluoroquinolones Made to the Canadian Adverse Drug Reaction Monitoring Program","year":2004,"lang":"en","type":"article","venue":"Murdoch Research Repository (Murdoch University)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Gatifloxacin; Hypoglycemia; Moxifloxacin; Medicine; Levofloxacin; Adverse effect; Ciprofloxacin; Adverse drug reaction; Drug reaction; Intensive care medicine; Drug; Internal medicine; Antibiotics; Pharmacology; Insulin; Microbiology","score_opus":0.07127619811759546,"score_gpt":0.37672223410032557,"score_spread":0.3054460359827301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1916981799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842896,0.008890004,0.00055400265,0.00012611315,0.000039603114,0.00025567753,0.00141982,0.000046527628,0.004378693],"genre_scores_gemma":[0.99094206,0.0058975844,0.0006347065,0.00015664831,0.00004782085,0.00007447308,0.001837885,0.000010134062,0.0003986614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968616,0.00037709373,0.00055199163,0.00019846295,0.001733858,0.00027713765],"domain_scores_gemma":[0.99166554,0.0017081164,0.002910954,0.000352382,0.0028306076,0.0005324855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013009055,0.0004004774,0.00032394752,0.0059189145,0.0008428503,0.000696528,0.00075369753,0.0002947488,0.0011872946],"category_scores_gemma":[0.007862768,0.0002403496,0.00058477727,0.0036671513,0.0006415359,0.00033826294,0.0006139582,0.0002738869,0.00027011192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033918457,0.000084123974,0.949777,0.00049562054,0.00020761736,0.019315043,0.00091022794,0.00010853787,0.0015964147,0.00013769089,0.0011373147,0.025891336],"study_design_scores_gemma":[0.00003463359,0.00027895422,0.94657403,0.0001715633,0.0001249673,0.04646063,0.0010795968,0.00029678497,0.0014166458,0.00004393698,0.0034909425,0.000027371781],"about_ca_topic_score_codex":0.1045355,"about_ca_topic_score_gemma":0.10063162,"teacher_disagreement_score":0.8954645,"about_ca_system_score_codex":0.002408519,"about_ca_system_score_gemma":0.003286569,"threshold_uncertainty_score":0.20785403},"labels":[],"label_agreement":null},{"id":"W1918668148","doi":"10.1111/bcp.12708","title":"Reply to ‘Indication bias or protopathic bias?’","year":2015,"lang":"en","type":"letter","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medical prescription; Medicine; Reporting bias; Selection bias; Abortion; Response bias; MEDLINE; Gynecology; Pregnancy; Psychology; Pharmacology; Social psychology; Pathology","score_opus":0.48358018471809944,"score_gpt":0.5630341033915762,"score_spread":0.07945391867347679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918668148","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019666408,0.001137235,0.000121020465,0.9848096,0.013226819,0.000008678526,0.000032729684,0.000026062618,0.00044115915],"genre_scores_gemma":[0.0016035025,0.00030140704,0.00016083676,0.9813292,0.01591377,0.00001943503,0.000010923649,0.000010759566,0.00065012],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98194444,0.008983739,0.002746617,0.0019027318,0.0033466148,0.0010758676],"domain_scores_gemma":[0.9385472,0.043621242,0.0048268377,0.0017027183,0.008922755,0.0023792684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02042363,0.0010403091,0.0019675451,0.0011086246,0.0034986923,0.004639269,0.00327492,0.07337579,0.0056280075],"category_scores_gemma":[0.14005505,0.00094151916,0.0015862369,0.0012382133,0.0070526474,0.0074360166,0.002728193,0.04837405,0.006299106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004948033,0.000012677618,0.0007854532,0.00010286518,0.000025663941,0.0011783646,0.00036863162,0.00003694332,0.00009306185,0.0025134226,0.9894639,0.0053695235],"study_design_scores_gemma":[0.00016046179,0.000100952326,0.0024017252,0.0012239434,0.000073856114,0.008057199,0.0015918354,0.00065416424,0.00046329777,0.018458817,0.96658474,0.0002290592],"about_ca_topic_score_codex":0.0033917136,"about_ca_topic_score_gemma":0.0039490084,"teacher_disagreement_score":0.07337579,"about_ca_system_score_codex":0.005191126,"about_ca_system_score_gemma":0.0043764967,"threshold_uncertainty_score":0.10801178},"labels":[],"label_agreement":null},{"id":"W1937322069","doi":"10.1093/ajhp/61.14.1466","title":"Pharmacist surveillance of adverse drug events","year":2004,"lang":"en","type":"article","venue":"American Journal of Health-System Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Drug; Pharmacist; Adverse effect; Medicine; Medical emergency; Pharmacology; Pharmacy; Family medicine","score_opus":0.08525990566797091,"score_gpt":0.45568843073665544,"score_spread":0.3704285250686845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937322069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96267813,0.003972441,0.0032821572,0.00085952383,0.00008704339,0.00093684846,0.009345757,0.0003081333,0.018530149],"genre_scores_gemma":[0.9923558,0.0013685381,0.0021053706,0.0003414121,0.00014705489,0.00022568372,0.002532408,0.000013813851,0.00090997387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933275,0.0020867032,0.00124043,0.0008048611,0.0022413505,0.00029918662],"domain_scores_gemma":[0.97495395,0.0033051977,0.015375185,0.0006187961,0.004627505,0.0011192866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004029478,0.0004414069,0.0006192922,0.0021455584,0.00036555534,0.000814478,0.00058371783,0.00030854775,0.0012579592],"category_scores_gemma":[0.011306577,0.00017056303,0.0003779583,0.0021157607,0.00028318298,0.00048366646,0.0004689202,0.00051969604,0.00040299952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003795428,0.000114393486,0.97011954,0.00022102705,0.00010330757,0.00012380544,0.00013391132,0.00018895099,0.00046044425,0.00003125695,0.0012204597,0.026903339],"study_design_scores_gemma":[0.00006181867,0.0007258345,0.993718,0.000084128566,0.00007883131,0.00069467485,0.00010194547,0.00079090777,0.0009104117,0.00003197106,0.0027841902,0.000017121398],"about_ca_topic_score_codex":0.01735729,"about_ca_topic_score_gemma":0.017415563,"teacher_disagreement_score":0.01735729,"about_ca_system_score_codex":0.0013963286,"about_ca_system_score_gemma":0.0021845377,"threshold_uncertainty_score":0.03451252},"labels":[],"label_agreement":null},{"id":"W1951380831","doi":"10.1136/amiajnl-2013-002116","title":"ICD-10 codes used to identify adverse drug events in administrative data: a systematic review","year":2013,"lang":"en","type":"review","venue":"Journal of the American Medical Informatics Association","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Coding (social sciences); Medicine; Adverse effect; Diagnosis code; MEDLINE; Set (abstract data type); Computer science; Information retrieval; Data mining; Statistics; Pharmacology","score_opus":0.1934403541551048,"score_gpt":0.5454114426251365,"score_spread":0.3519710884700317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951380831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002700051,0.990204,0.000833836,0.00087536604,0.00027213147,0.002532469,0.0020159618,0.00002026517,0.00054599077],"genre_scores_gemma":[0.04124942,0.9404615,0.0063380725,0.0015945489,0.00024351405,0.0080758305,0.0018461554,0.000021619142,0.00016933325],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9109506,0.033299405,0.03708651,0.0038812119,0.013604399,0.0011778624],"domain_scores_gemma":[0.68272334,0.25055397,0.043407228,0.00373903,0.018528286,0.0010480575],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05452134,0.0019424036,0.008491202,0.035172604,0.0013829594,0.0043609035,0.0030751256,0.0024936502,0.0035459895],"category_scores_gemma":[0.22532117,0.0014343262,0.0066052917,0.028740175,0.0019490914,0.004770097,0.0034068709,0.001772999,0.00045013704],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100014775,0.000016130747,0.0021513766,0.9685154,0.0037392187,0.00007947847,0.0004623258,0.000084111154,0.000085451684,0.00035195262,0.0015737948,0.022840742],"study_design_scores_gemma":[0.00013425454,0.000090954985,0.0051689055,0.9666666,0.015984623,0.00017710096,0.00057862554,0.00008844949,0.0001263627,0.00038072228,0.010566462,0.000036838333],"about_ca_topic_score_codex":0.0097979065,"about_ca_topic_score_gemma":0.026941115,"teacher_disagreement_score":0.9454787,"about_ca_system_score_codex":0.0094992975,"about_ca_system_score_gemma":0.030206336,"threshold_uncertainty_score":0.28833985},"labels":[],"label_agreement":null},{"id":"W1963723557","doi":"10.1211/0022357055821","title":"An introduction to adverse drug reaction reporting systems in different countries","year":2005,"lang":"en","type":"article","venue":"International Journal of Pharmacy Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacovigilance; Family medicine; Adverse drug reaction; MEDLINE; Community pharmacist; Health care; Drug reaction; Alternative medicine; Pharmacist; Pharmacy; Adverse effect; Drug; Pharmacology","score_opus":0.08956307172593693,"score_gpt":0.5010796680933411,"score_spread":0.41151659636740423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963723557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00448922,0.95445406,0.010875825,0.016014237,0.005546364,0.0007897288,0.002278475,0.0004564945,0.0050955666],"genre_scores_gemma":[0.040743258,0.8642288,0.067934744,0.01198088,0.006061603,0.0024848753,0.004595069,0.00021516382,0.0017556363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9409705,0.026946517,0.0229816,0.003072118,0.005048703,0.0009806935],"domain_scores_gemma":[0.8435322,0.09311595,0.03161255,0.0031982732,0.027174462,0.0013665286],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.048914246,0.0018786356,0.0027541548,0.04212906,0.0010552121,0.0077669537,0.0025396852,0.0024243814,0.0036744599],"category_scores_gemma":[0.078604266,0.0017318183,0.005521784,0.04422408,0.002057683,0.014240201,0.0034035149,0.0043712533,0.0011855813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044445656,0.0001953863,0.012086663,0.071351625,0.0010275481,0.0005248325,0.0019267997,0.001816511,0.001442827,0.014048121,0.062360227,0.83277506],"study_design_scores_gemma":[0.00022197184,0.0012554174,0.07181406,0.13664767,0.0014408765,0.0027914343,0.0028047673,0.0013528214,0.0010606307,0.005858482,0.77444744,0.00030440293],"about_ca_topic_score_codex":0.006558431,"about_ca_topic_score_gemma":0.0048384913,"teacher_disagreement_score":0.95108575,"about_ca_system_score_codex":0.006792672,"about_ca_system_score_gemma":0.006114473,"threshold_uncertainty_score":0.2586863},"labels":[],"label_agreement":null},{"id":"W1964484586","doi":"10.4212/cjhp.v63i2.890","title":"A Tribute to Charlie Bayliff","year":2010,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Tribute; Political science; Library science; Humanities; Art; Computer science; Law","score_opus":0.07041915630285266,"score_gpt":0.4163575345024462,"score_spread":0.34593837819959355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964484586","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023598653,0.0048402334,0.00016499152,0.84749055,0.1278545,0.000030830925,0.00008804811,0.000115936346,0.019178882],"genre_scores_gemma":[0.0028464599,0.002085101,0.0003074637,0.83468664,0.03249555,0.00006878763,0.00007583067,0.00011701583,0.12731715],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9809514,0.0017472269,0.0010054362,0.0025022882,0.010157699,0.0036358475],"domain_scores_gemma":[0.9428026,0.0068904674,0.0017314012,0.002007439,0.022036389,0.024531716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010213966,0.001341321,0.0030906808,0.0026095319,0.012216071,0.012541005,0.0037070343,0.04305939,0.047662787],"category_scores_gemma":[0.067493014,0.0013433408,0.0023534468,0.0013642444,0.0056016445,0.0044499342,0.00576865,0.05237236,0.036973905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010253103,0.000009762367,0.000063585205,0.000007213587,0.000005444634,0.00005980551,0.000011354423,0.000008484425,0.000011347094,0.00072063925,0.99614525,0.0029468045],"study_design_scores_gemma":[0.00006672181,0.000034109413,0.00046975786,0.00020669364,0.000014460793,0.00028983603,0.0001287649,0.00007609399,0.00003640432,0.0016395628,0.9969902,0.000047401456],"about_ca_topic_score_codex":0.05582073,"about_ca_topic_score_gemma":0.097029865,"teacher_disagreement_score":0.05582073,"about_ca_system_score_codex":0.008227584,"about_ca_system_score_gemma":0.033500824,"threshold_uncertainty_score":0.15944791},"labels":[],"label_agreement":null},{"id":"W1970223156","doi":"10.1186/1472-6963-13-473","title":"Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study","year":2013,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Adverse effect; Emergency medicine; Pharmacovigilance; Emergency department; Prospective cohort study; Adverse drug event; Adverse drug reaction; Medical emergency; Drug; Internal medicine; Pharmacology; Psychiatry","score_opus":0.6460804674699029,"score_gpt":0.6823669608815858,"score_spread":0.036286493411682885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970223156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289686,0.00049332244,0.0074167256,0.0001596822,0.000051490057,0.0036004249,0.004075305,0.000060025934,0.0012460555],"genre_scores_gemma":[0.977235,0.00025596193,0.0074676694,0.00026112585,0.000071719405,0.0022602642,0.012242704,0.00003780648,0.0001677615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.86561656,0.0828431,0.014322145,0.009695521,0.024510588,0.0030119526],"domain_scores_gemma":[0.599704,0.19630606,0.08704442,0.05838603,0.054552708,0.0040067844],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.121030286,0.0014465896,0.0013129403,0.0047485065,0.0012398857,0.0022601665,0.004267112,0.0017121622,0.000907232],"category_scores_gemma":[0.26176268,0.00094226986,0.0029403276,0.0059261853,0.0023108919,0.0018537191,0.0032072072,0.0016884917,0.00049211265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006813921,0.0004481029,0.99120903,0.00017138595,0.00049731386,0.00006829262,0.0005639465,0.00059268076,0.00020893074,0.00010216867,0.00037788352,0.005078754],"study_design_scores_gemma":[0.00032338846,0.0009284806,0.99197406,0.00013523562,0.00027812505,0.0002749359,0.00039664368,0.0036181028,0.00053412735,0.00010988456,0.0013890367,0.00003796267],"about_ca_topic_score_codex":0.028140211,"about_ca_topic_score_gemma":0.016252276,"teacher_disagreement_score":0.8789697,"about_ca_system_score_codex":0.0034883705,"about_ca_system_score_gemma":0.0067726085,"threshold_uncertainty_score":0.640077},"labels":[],"label_agreement":null},{"id":"W1976536802","doi":"10.1001/archdermatol.2009.188","title":"The Misperception That Clinical Trial Data Reflect Long-term Drug Safety","year":2009,"lang":"en","type":"article","venue":"Archives of Dermatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry","score_opus":0.30732504133453364,"score_gpt":0.5440625227769148,"score_spread":0.23673748144238116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976536802","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015844906,0.058219507,0.1217256,0.69879514,0.054516613,0.0010496805,0.0032634803,0.0012094119,0.04537568],"genre_scores_gemma":[0.34573364,0.023948804,0.065491654,0.5014577,0.054177456,0.0014064986,0.00087587425,0.0006883988,0.0062200543],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.45769548,0.37713242,0.059261266,0.018721832,0.085055076,0.0021339366],"domain_scores_gemma":[0.112277426,0.70747423,0.05675848,0.060276013,0.059123334,0.004090497],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5449651,0.0011041326,0.0026376594,0.007431189,0.0019171769,0.013884166,0.004906167,0.0063033663,0.005122582],"category_scores_gemma":[0.8229624,0.0014088235,0.0021244506,0.0059911506,0.024291707,0.016515763,0.00468672,0.018848423,0.0043026065],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022132094,0.00030490337,0.041853663,0.008193519,0.00420294,0.00057059195,0.0067060515,0.0016173519,0.00093845715,0.14665712,0.4389096,0.3478326],"study_design_scores_gemma":[0.00092525006,0.0013072704,0.024052938,0.016955594,0.0026697416,0.0052240803,0.0051819705,0.0065090572,0.0035834708,0.46887413,0.46422157,0.0004948725],"about_ca_topic_score_codex":0.0022506027,"about_ca_topic_score_gemma":0.0023051086,"teacher_disagreement_score":0.4550349,"about_ca_system_score_codex":0.0054707043,"about_ca_system_score_gemma":0.0076762266,"threshold_uncertainty_score":0.5611391},"labels":[],"label_agreement":null},{"id":"W1978862538","doi":"10.1111/j.1525-1497.2005.30390.x","title":"Adverse drug events occurring following hospital discharge","year":2005,"lang":"en","type":"article","venue":"Journal of General Internal Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":499,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Medical prescription; Psychological intervention; Emergency medicine; Incidence (geometry); Prospective cohort study; Adverse effect; Confidence interval; Cohort study; Pediatrics; Internal medicine; Psychiatry","score_opus":0.05485544478574611,"score_gpt":0.439605952497824,"score_spread":0.3847505077120779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978862538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816551,0.0040750485,0.00087780575,0.00046835776,0.00018054467,0.00041727675,0.0021323196,0.00010254175,0.010090989],"genre_scores_gemma":[0.9946485,0.00093903666,0.00053979165,0.0010005288,0.00009930115,0.00013111376,0.0015175539,0.000008886135,0.0011152804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981108,0.0004318659,0.00053332234,0.0001511263,0.00048384262,0.000289202],"domain_scores_gemma":[0.9943303,0.0013398721,0.0025096287,0.00022651609,0.0009051687,0.0006885714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010695761,0.00030031873,0.0010266982,0.00090475957,0.0008086047,0.0008580217,0.00027298127,0.00069108495,0.0027961326],"category_scores_gemma":[0.006761516,0.00011354557,0.001104978,0.0008881912,0.00018380229,0.0003863178,0.00065142184,0.0015039135,0.00043616016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004157344,0.0004062431,0.9379694,0.00076722226,0.00067260937,0.009439686,0.0006599985,0.00031400644,0.0026330694,0.00025591557,0.002440271,0.040284175],"study_design_scores_gemma":[0.00019376838,0.0026596864,0.9787619,0.0002376814,0.00032119398,0.008376261,0.0006987917,0.00051904045,0.0016182099,0.00024329973,0.0063241115,0.000045984452],"about_ca_topic_score_codex":0.0017162315,"about_ca_topic_score_gemma":0.0025756694,"teacher_disagreement_score":0.0027961326,"about_ca_system_score_codex":0.0006156206,"about_ca_system_score_gemma":0.000740884,"threshold_uncertainty_score":0.009354055},"labels":[],"label_agreement":null},{"id":"W1979446181","doi":"10.1016/j.jval.2012.05.007","title":"Costs of Adverse Drug Events in German Hospitals—A Microcosting Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Helmholtz Zentrum München","keywords":"Medicine; Concomitant; Propensity score matching; Emergency medicine; Adverse effect; Resource use; Medical record; Drug reaction; Drug; Surgery; Internal medicine","score_opus":0.11483599506774046,"score_gpt":0.47773021674634986,"score_spread":0.3628942216786094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979446181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978137,0.0005090183,0.000090019596,0.00009172865,0.0000048587895,0.0000165232,0.0010539091,0.0000036727379,0.00041655338],"genre_scores_gemma":[0.99884725,0.00019051998,0.0000601111,0.00004136836,0.000009099364,0.000011643749,0.0007087224,0.0000022939425,0.00012897732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981341,0.0007069373,0.00018228014,0.00030043256,0.0003035878,0.00037271317],"domain_scores_gemma":[0.9945675,0.0015494678,0.0024352383,0.0003242788,0.00038507645,0.00073838845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090223167,0.00064428436,0.0004885894,0.0028711504,0.00043283505,0.0012526333,0.0007045241,0.0008915658,0.0016730934],"category_scores_gemma":[0.0042179907,0.0004529298,0.0013344657,0.0035661568,0.00058185065,0.00095368025,0.00082227506,0.0007259328,0.00021952303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013628997,0.00042825117,0.9880006,0.00008776435,0.0006561957,0.0003793858,0.00024376293,0.0021203072,0.00016286809,0.00029784083,0.00079190894,0.0054682093],"study_design_scores_gemma":[0.000061754225,0.0003146132,0.9968526,0.000018209585,0.00022123182,0.00021225295,0.0003240347,0.0015218459,0.0000944805,0.000053496507,0.00030718162,0.000018357796],"about_ca_topic_score_codex":0.053500243,"about_ca_topic_score_gemma":0.03755288,"teacher_disagreement_score":0.053500243,"about_ca_system_score_codex":0.0050602625,"about_ca_system_score_gemma":0.0010405122,"threshold_uncertainty_score":0.10637766},"labels":[],"label_agreement":null},{"id":"W1986040212","doi":"10.2165/11319000-000000000-00000","title":"Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System","year":2010,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Adverse Event Reporting System; Adverse effect; Event (particle physics); MEDLINE; Intensive care medicine; Pharmacology","score_opus":0.10990941038024392,"score_gpt":0.4324854646658608,"score_spread":0.32257605428561686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986040212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495579,0.0020008143,0.002983588,0.00034543237,0.000029370483,0.00017759336,0.043660134,0.00018428682,0.0010609931],"genre_scores_gemma":[0.9227735,0.00068038213,0.007518069,0.00014444372,0.000031026873,0.0001505614,0.06828819,0.00002599274,0.00038782132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946903,0.0008929679,0.0015039676,0.0009818212,0.0016490537,0.00028186553],"domain_scores_gemma":[0.9680944,0.014705527,0.0107253045,0.0022448765,0.003467707,0.0007620586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041429666,0.00054897246,0.0009256609,0.0062934943,0.00046810092,0.0018649003,0.0008608872,0.0011031344,0.0008806478],"category_scores_gemma":[0.016628377,0.00034780905,0.0011168725,0.0067091268,0.00030870162,0.0010342273,0.00071681343,0.00080874143,0.0005223585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011086753,0.00039972152,0.95605576,0.00039024718,0.0005229171,0.0007911351,0.00013355033,0.0030532277,0.002743502,0.00030039373,0.0026262873,0.031874493],"study_design_scores_gemma":[0.00013677683,0.00060452917,0.9474039,0.0001800825,0.00087685266,0.002295255,0.0003511507,0.029141862,0.010021724,0.00051458844,0.00840479,0.00006854712],"about_ca_topic_score_codex":0.00778364,"about_ca_topic_score_gemma":0.0064892746,"teacher_disagreement_score":0.00778364,"about_ca_system_score_codex":0.0007191964,"about_ca_system_score_gemma":0.001593655,"threshold_uncertainty_score":0.02191037},"labels":[],"label_agreement":null},{"id":"W1986997842","doi":"10.1002/1099-1557(200007/08)9:4<305::aid-pds513>3.0.co;2-o","title":"Repeat prescribing: which diagnoses, which drugs?","year":2000,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pharmacoepidemiology; Medical diagnosis; Intensive care medicine; Pharmacology; Medical prescription; Radiology","score_opus":0.07935571727589702,"score_gpt":0.4222835152377598,"score_spread":0.3429277979618628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986997842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321932,0.020753557,0.0011510218,0.032833207,0.000253686,0.00006892662,0.00085722096,0.000045097688,0.011844008],"genre_scores_gemma":[0.9900355,0.005600866,0.00080270175,0.0023585868,0.00024376789,0.000021947544,0.00022414865,0.000009117774,0.0007034449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654996,0.001161543,0.00056223106,0.0004350945,0.0010207257,0.00027039243],"domain_scores_gemma":[0.98357177,0.0064891526,0.007199334,0.0004781877,0.0011649725,0.0010965373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002701089,0.0001724528,0.0005205431,0.0008276248,0.00055278285,0.0013589822,0.00048793782,0.0008312046,0.0041163964],"category_scores_gemma":[0.024231523,0.00013907744,0.0003332788,0.001858243,0.0013232493,0.0012292321,0.00081805285,0.00079692993,0.00060858415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045741277,0.00008164563,0.8271677,0.0008244666,0.000063455984,0.0009394419,0.0020400276,0.00015652947,0.00044583567,0.00060528354,0.005800634,0.1614175],"study_design_scores_gemma":[0.000027988372,0.00027144252,0.9726217,0.0013656154,0.000081855775,0.006984247,0.007503107,0.0008141979,0.0003557398,0.0020528801,0.007883856,0.000037369984],"about_ca_topic_score_codex":0.013363244,"about_ca_topic_score_gemma":0.021618802,"teacher_disagreement_score":0.013363244,"about_ca_system_score_codex":0.002091333,"about_ca_system_score_gemma":0.0018208564,"threshold_uncertainty_score":0.026570916},"labels":[],"label_agreement":null},{"id":"W1989389124","doi":"10.1016/j.socscimed.2011.11.046","title":"Pharmacovigilance in Europe and North America: Divergent approaches","year":2012,"lang":"en","type":"article","venue":"Social Science & Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; York University","funders":"Canadian Institutes of Health Research; U.S. Food and Drug Administration; Industry Canada; Canadian Patient Safety Institute","keywords":"Pharmacovigilance; European union; Postmarketing surveillance; Medicine; Corporate governance; Political science; Business; Adverse effect; Pharmacology; International trade; Finance","score_opus":0.2155040513677413,"score_gpt":0.4459365709639678,"score_spread":0.23043251959622651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989389124","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5836619,0.22769237,0.013391552,0.09832148,0.001076142,0.0002399135,0.0011115657,0.00006980043,0.074435316],"genre_scores_gemma":[0.96125907,0.020508934,0.003321946,0.013353072,0.00038514356,0.00012344315,0.00031575328,0.000029235936,0.00070351246],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98421854,0.008919291,0.0015552975,0.0017160751,0.0022066785,0.0013840387],"domain_scores_gemma":[0.9582192,0.025284018,0.0045963293,0.0013616525,0.00838767,0.0021511202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033041388,0.00050894765,0.0012994071,0.007895879,0.0016909385,0.005644571,0.0016027701,0.002298838,0.0016459925],"category_scores_gemma":[0.03912498,0.00041326333,0.0013009897,0.011486216,0.0042477683,0.0038111415,0.0053508743,0.0026965777,0.00010548659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010045855,0.00046620588,0.4453558,0.0024988458,0.0032345306,0.0006935042,0.02918571,0.0024917307,0.00083098136,0.1455241,0.011692381,0.35702157],"study_design_scores_gemma":[0.00016461365,0.00028271964,0.8419207,0.00803275,0.0016097354,0.0008571057,0.063279666,0.0025150822,0.00084402796,0.032621197,0.04771056,0.0001618146],"about_ca_topic_score_codex":0.110981114,"about_ca_topic_score_gemma":0.13382308,"teacher_disagreement_score":0.110981114,"about_ca_system_score_codex":0.010622972,"about_ca_system_score_gemma":0.009910328,"threshold_uncertainty_score":0.22067022},"labels":[],"label_agreement":null},{"id":"W1990042182","doi":"10.2174/157488611797579258","title":"Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review","year":2011,"lang":"en","type":"review","venue":"Current Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary","funders":"","keywords":"Pharmacovigilance; Medicine; Yellow fever vaccine; Adverse effect; MedDRA; Database; Pediatrics; Yellow fever; Internal medicine; Immunology","score_opus":0.39540252105469176,"score_gpt":0.5510976044093795,"score_spread":0.15569508335468774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990042182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003350218,0.99143827,0.0006476744,0.0003940418,0.00013286546,0.00055657054,0.003079214,0.000024059387,0.00037701204],"genre_scores_gemma":[0.0615001,0.9297981,0.002301226,0.0011659815,0.00017754451,0.0019364511,0.0029707644,0.000031337928,0.000118439],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9308398,0.0210448,0.034960587,0.0037387032,0.008680941,0.0007351773],"domain_scores_gemma":[0.74791497,0.16654387,0.06140797,0.0042233746,0.019133212,0.0007767073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041548397,0.0015108127,0.009589654,0.020285396,0.0005566327,0.003961301,0.0029058605,0.0021018332,0.0032582763],"category_scores_gemma":[0.1902763,0.0015330936,0.0114843175,0.020469582,0.0012403883,0.003936897,0.0026291758,0.0012950974,0.00036248518],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024729577,0.00001289497,0.0037859045,0.949371,0.02017396,0.000056453377,0.00022099755,0.00009896619,0.00010135215,0.00015088829,0.0012374675,0.024542829],"study_design_scores_gemma":[0.00033836666,0.00020869757,0.012837281,0.8540105,0.118670516,0.00043211627,0.00043230213,0.00015682074,0.00033486597,0.00029604905,0.0122148255,0.00006774778],"about_ca_topic_score_codex":0.009879016,"about_ca_topic_score_gemma":0.013807385,"teacher_disagreement_score":0.041548397,"about_ca_system_score_codex":0.0040929145,"about_ca_system_score_gemma":0.0118361255,"threshold_uncertainty_score":0.21973157},"labels":[],"label_agreement":null},{"id":"W1990359398","doi":"10.1016/j.vaccine.2007.12.033","title":"Improving global monitoring of vaccine safety: A quantitative analysis of adverse event reports in the WHO Adverse Reactions Database","year":2008,"lang":"en","type":"article","venue":"Vaccine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; McMaster University; University of Ottawa","funders":"","keywords":"Adverse effect; Vaccine safety; Pharmacovigilance; Medicine; Database; Adverse Event Reporting System; Immunization; Environmental health; Medical emergency; Pharmacology; Computer science; Immunology","score_opus":0.08829943032615872,"score_gpt":0.43465117686346605,"score_spread":0.3463517465373073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990359398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8993176,0.0027008164,0.016245764,0.0011886635,0.000034889566,0.00055628584,0.07780814,0.00047750204,0.0016704235],"genre_scores_gemma":[0.91911286,0.00068485516,0.01966657,0.00019278964,0.000059407612,0.0003072103,0.05974282,0.00004780054,0.00018570678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9770727,0.009644091,0.005048809,0.0030441321,0.004607377,0.0005829953],"domain_scores_gemma":[0.8812745,0.066368274,0.033179004,0.008228038,0.009662637,0.0012875261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023230659,0.0006523352,0.0014530795,0.010956967,0.00028019573,0.0022207366,0.0011321957,0.0008039924,0.0007094486],"category_scores_gemma":[0.052966654,0.00037306707,0.001973235,0.010623202,0.00028643594,0.0022927218,0.001534191,0.00087315013,0.0002382728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058293587,0.0001444616,0.945023,0.00037904986,0.0014193963,0.00007285986,0.00014519184,0.0035995145,0.0011097419,0.0002931574,0.001961974,0.04526867],"study_design_scores_gemma":[0.000095982876,0.00037152806,0.97765905,0.000074016905,0.0008702542,0.00025006427,0.00018123,0.016704451,0.0013638183,0.00037852605,0.0020125965,0.000038388847],"about_ca_topic_score_codex":0.009976003,"about_ca_topic_score_gemma":0.008105966,"teacher_disagreement_score":0.023230659,"about_ca_system_score_codex":0.001086777,"about_ca_system_score_gemma":0.0021078766,"threshold_uncertainty_score":0.122856915},"labels":[],"label_agreement":null},{"id":"W1992505090","doi":"10.1310/hpj4401-47","title":"Quarter Watch: 2008 Quarter 1 : QUARTER WATCH PROJECT TEAM","year":2009,"lang":"en","type":"article","venue":"Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; History","score_opus":0.06940550408291904,"score_gpt":0.42719093860783786,"score_spread":0.35778543452491884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992505090","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004684334,0.003201871,0.0027217139,0.06272421,0.043869402,0.0019965002,0.05786101,0.00979809,0.8131429],"genre_scores_gemma":[0.0053130626,0.0016532803,0.0009967029,0.0058602868,0.0048179366,0.0005741824,0.023950152,0.0013618877,0.9554726],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987521,0.00014343605,0.00006851392,0.0001819361,0.00061269314,0.00024137768],"domain_scores_gemma":[0.99231225,0.0003391685,0.00050132285,0.0004951137,0.0037190206,0.002633074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027800961,0.0010134107,0.00046516673,0.0018128874,0.0011590708,0.0057617403,0.0016754247,0.0021683995,0.47931227],"category_scores_gemma":[0.0056568664,0.00053173513,0.0003900472,0.0013701231,0.0002669239,0.0025583801,0.0017912714,0.0015484293,0.30675954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002250716,0.000018418345,0.00014874458,0.00002764204,5.642289e-7,0.000004945737,0.0000054055363,0.000007962138,0.00004150741,0.00011434625,0.9879287,0.011679329],"study_design_scores_gemma":[0.000021674048,0.000036322304,0.0018596293,0.00005717642,0.0000014640472,0.000009325804,0.000054919157,0.00006703427,0.00007718549,0.00011113066,0.9976998,0.0000041955354],"about_ca_topic_score_codex":0.0042957193,"about_ca_topic_score_gemma":0.00509555,"teacher_disagreement_score":0.47931227,"about_ca_system_score_codex":0.0011950965,"about_ca_system_score_gemma":0.003888028,"threshold_uncertainty_score":0.74269783},"labels":[],"label_agreement":null},{"id":"W1992770459","doi":"10.1007/s40261-014-0187-0","title":"Availability of Data on Adverse Reactions to Antiretroviral Drugs in Medical Charts According to the Naranjo Algorithm: An Example of a Brazilian Historical Cohort","year":2014,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Adverse effect; Medical record; Cohort; Medical prescription; Dyslipidemia; Lipodystrophy; Referral; Pharmacy; Human immunodeficiency virus (HIV); Antiretroviral therapy; Family medicine; Internal medicine; Viral load; Disease; Pharmacology","score_opus":0.2423668398692314,"score_gpt":0.48011020635694857,"score_spread":0.23774336648771716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992770459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94982874,0.0018155685,0.0042936555,0.0013480951,0.0000761108,0.0004132093,0.025037602,0.00009269997,0.017094333],"genre_scores_gemma":[0.98439515,0.0013552824,0.00398541,0.00019903271,0.000039481438,0.0001697291,0.008854745,0.000059839105,0.00094135234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765575,0.0006327086,0.00032269766,0.00049363397,0.0005929062,0.0003023063],"domain_scores_gemma":[0.9873976,0.0026939681,0.0040493603,0.0018470822,0.0033232183,0.00068874774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038996413,0.00029486857,0.0006401034,0.0034929481,0.0009832863,0.0010020813,0.0006046209,0.00034635927,0.002399229],"category_scores_gemma":[0.018421222,0.00028017838,0.0006282512,0.0042986837,0.00040973988,0.0004922872,0.000758296,0.0005843313,0.00026901605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014553776,0.000055837296,0.97983325,0.00014168292,0.0001232178,0.00060743035,0.0014182655,0.00018714188,0.00055272155,0.0011098961,0.0019979568,0.013827142],"study_design_scores_gemma":[0.000017935841,0.000062026986,0.9850182,0.0001962641,0.00012406254,0.0015874085,0.0010342948,0.00080399774,0.0003151342,0.0004440135,0.010365661,0.00003099952],"about_ca_topic_score_codex":0.14665234,"about_ca_topic_score_gemma":0.11786822,"teacher_disagreement_score":0.14665234,"about_ca_system_score_codex":0.0013316681,"about_ca_system_score_gemma":0.0029793312,"threshold_uncertainty_score":0.2915975},"labels":[],"label_agreement":null},{"id":"W1995160040","doi":"10.1080/10543406.2014.901338","title":"Statistical Methods for Active Pharmacovigilance, With Applications to Diabetes Drugs","year":2014,"lang":"en","type":"article","venue":"Journal of Biopharmaceutical Statistics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Pharmacovigilance; Polypharmacy; Medicine; Adverse effect; Drug reaction; Adverse drug reaction; Drug; Pharmacoepidemiology; Intensive care medicine; Pharmacology; Medical prescription","score_opus":0.09100574465620725,"score_gpt":0.5203279639654611,"score_spread":0.42932221930925385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995160040","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010729049,0.0007369345,0.9943112,0.0009107711,0.0003241303,0.00053933973,0.00060796033,0.0010877106,0.00040906208],"genre_scores_gemma":[0.029653033,0.0006707048,0.96093524,0.00073103386,0.00077337,0.0053497255,0.00065147114,0.0004976724,0.000737807],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.830196,0.1472478,0.00713335,0.0046637277,0.01013201,0.0006270435],"domain_scores_gemma":[0.39653504,0.55611265,0.013221465,0.024480728,0.008462613,0.0011874634],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11935729,0.0023566352,0.003293333,0.006865901,0.0015290057,0.0030859238,0.0037652545,0.0028463318,0.008653058],"category_scores_gemma":[0.37709555,0.0015138612,0.0049324823,0.00853362,0.004289047,0.003347056,0.003491201,0.008493219,0.0019326038],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010405559,0.0005398549,0.022801897,0.004134097,0.006910657,0.00090972945,0.0015955488,0.032241393,0.0020881975,0.3519184,0.06309802,0.51272166],"study_design_scores_gemma":[0.0006775978,0.0010380647,0.010299481,0.0012965096,0.0009289059,0.0010859772,0.00045742217,0.3302363,0.0017634903,0.5770584,0.07490099,0.000256928],"about_ca_topic_score_codex":0.0027117867,"about_ca_topic_score_gemma":0.0021538772,"teacher_disagreement_score":0.8806427,"about_ca_system_score_codex":0.0015098461,"about_ca_system_score_gemma":0.0052011455,"threshold_uncertainty_score":0.6312292},"labels":[],"label_agreement":null},{"id":"W1998780470","doi":"10.1111/j.1445-5994.2007.01588.x","title":"Provision of information on regulatory authorities’ websites","year":2008,"lang":"en","type":"article","venue":"Internal Medicine Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Agency (philosophy); Medicine; Regulatory agency; European union; Pharmacovigilance; Secrecy; Legislation; Data Protection Act 1998; Freedom of information; Regulatory affairs; Business; Public relations; Public administration; Political science; Drug; Pharmacology; Law","score_opus":0.10587881533375063,"score_gpt":0.4437865156783385,"score_spread":0.33790770034458784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998780470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84551126,0.005565354,0.0052853213,0.020877708,0.00022659225,0.00091497996,0.005777477,0.0005278932,0.11531343],"genre_scores_gemma":[0.988118,0.00192335,0.0033773216,0.0021468769,0.00019576603,0.00024212063,0.0015463618,0.000060136997,0.0023900757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9384092,0.03186427,0.008980273,0.0019237715,0.017009351,0.0018131546],"domain_scores_gemma":[0.45348907,0.30220535,0.16201021,0.017477978,0.054776676,0.010040765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039436214,0.00025907968,0.000428165,0.0075776065,0.0016971817,0.003892182,0.001344309,0.0015357067,0.008154243],"category_scores_gemma":[0.17011793,0.0003806879,0.0003172737,0.0077304523,0.002235262,0.0048868754,0.0026745521,0.0011474956,0.0018470989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004554265,0.00032422267,0.66825014,0.0042259423,0.00013434101,0.0016676666,0.053946868,0.0006004167,0.0023639454,0.005121091,0.042767,0.22014299],"study_design_scores_gemma":[0.000077639466,0.00048760168,0.6282499,0.005858823,0.00017668161,0.0031641792,0.046831843,0.0012380508,0.00252618,0.002363241,0.30881462,0.00021122025],"about_ca_topic_score_codex":0.0072057648,"about_ca_topic_score_gemma":0.005911806,"teacher_disagreement_score":0.039436214,"about_ca_system_score_codex":0.0034366257,"about_ca_system_score_gemma":0.0076103266,"threshold_uncertainty_score":0.20856106},"labels":[],"label_agreement":null},{"id":"W1999859711","doi":"10.2165/00002018-200427080-00009","title":"Current Requirements and Emerging Trends for Labelling as a Tool for Communicating Pharmacovigilance Findings","year":2004,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacovigilance; Labelling; Medicine; CLARITY; Risk analysis (engineering); Medical prescription; Confusion; Product (mathematics); Patient safety; Health care; Pharmacology; Drug","score_opus":0.2112922528361526,"score_gpt":0.5332601897570727,"score_spread":0.3219679369209201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999859711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036962726,0.98366284,0.004317745,0.005430703,0.00077639444,0.00003193247,0.000108790606,0.000087037384,0.005214913],"genre_scores_gemma":[0.0037438949,0.977749,0.0119584445,0.0031816368,0.0006873636,0.00006065043,0.0002583297,0.000031283587,0.0023295016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99268323,0.00233194,0.0012608452,0.0008082371,0.002666195,0.00024947483],"domain_scores_gemma":[0.96449715,0.023770597,0.0036846492,0.0007259055,0.006665691,0.0006560108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020612577,0.0015319064,0.0037160215,0.005358282,0.0007849419,0.0060197967,0.004123369,0.0049041654,0.0058558593],"category_scores_gemma":[0.020688735,0.00078600965,0.0014475894,0.0073823035,0.0025948356,0.0064726854,0.0016572878,0.0052062008,0.0037997335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009269478,0.00007593183,0.0005149123,0.019106189,0.00006685232,0.00029641794,0.00024394678,0.0003709901,0.00115525,0.011647455,0.024758361,0.941671],"study_design_scores_gemma":[0.000048327573,0.0001580073,0.0018465854,0.022875039,0.0003275074,0.0024574937,0.00046129778,0.0005538338,0.0014681281,0.008178676,0.96154886,0.000076263925],"about_ca_topic_score_codex":0.0067590605,"about_ca_topic_score_gemma":0.007389512,"teacher_disagreement_score":0.020612577,"about_ca_system_score_codex":0.004074133,"about_ca_system_score_gemma":0.008437975,"threshold_uncertainty_score":0.109011054},"labels":[],"label_agreement":null},{"id":"W2002872131","doi":"10.1016/j.sapharm.2006.01.001","title":"Demystifying medication safety: Making sense of the terminology","year":2006,"lang":"en","type":"article","venue":"Research in Social and Administrative Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"World Health Organization","keywords":"Terminology; Confusion; Computer science; Risk analysis (engineering); Medicine; Psychology; Linguistics","score_opus":0.5501401394290011,"score_gpt":0.6171737590772695,"score_spread":0.06703361964826837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002872131","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027666489,0.081137024,0.24506764,0.602209,0.013066228,0.0002826468,0.00046605864,0.0006740565,0.029430987],"genre_scores_gemma":[0.50075674,0.041278567,0.34881148,0.095972165,0.009102552,0.00064870215,0.00042371207,0.00081773725,0.0021883752],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.8601069,0.09958724,0.016181609,0.0049314066,0.01707098,0.0021218052],"domain_scores_gemma":[0.69768405,0.19946302,0.03396471,0.026166094,0.037560485,0.005161633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12210192,0.0018487093,0.0033680915,0.015358561,0.005110465,0.022504894,0.007522811,0.008945523,0.001564984],"category_scores_gemma":[0.2569881,0.0012778918,0.0025662624,0.008167254,0.05187295,0.045925397,0.0133367125,0.02116871,0.0006800493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041126003,0.00015944404,0.013774929,0.0037568398,0.0003587187,0.0010930978,0.06738258,0.0013507956,0.0024845076,0.62481374,0.04491587,0.23949812],"study_design_scores_gemma":[0.00007951139,0.0001615154,0.004178203,0.007666397,0.0003471673,0.0023725259,0.03018404,0.0023768807,0.0014226258,0.8056644,0.14528582,0.00026089908],"about_ca_topic_score_codex":0.006777868,"about_ca_topic_score_gemma":0.008003536,"teacher_disagreement_score":0.12210192,"about_ca_system_score_codex":0.009901068,"about_ca_system_score_gemma":0.024655445,"threshold_uncertainty_score":0.6457444},"labels":[],"label_agreement":null},{"id":"W2004340555","doi":"10.1371/journal.pone.0092632","title":"The Logic of Surveillance Guidelines: An Analysis of Vaccine Adverse Event Reports from an Ontological Perspective","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Fraser Health Authority; Public Health Agency; Public Health Agency of Canada; Michael Smith Health Research BC; Child and Family Research Institute","keywords":"Pharmacovigilance; Ontology; Adverse effect; Event (particle physics); Adverse Event Reporting System; Computer science; Risk analysis (engineering); Process (computing); Medicine; Data science","score_opus":0.1961389239183493,"score_gpt":0.4619415176389816,"score_spread":0.2658025937206323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004340555","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16739827,0.001514803,0.76356953,0.012864662,0.00028168858,0.0026782816,0.016025973,0.0034907518,0.03217595],"genre_scores_gemma":[0.351615,0.00091962254,0.6301188,0.0008440251,0.00008026542,0.0006451473,0.0135590695,0.000288697,0.0019293983],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98261654,0.0068914187,0.0028533305,0.0012101133,0.005878891,0.0005496852],"domain_scores_gemma":[0.918084,0.05306536,0.008388557,0.0059164185,0.013619304,0.0009263444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01896083,0.00052066165,0.00044508942,0.010907774,0.0017580305,0.006650906,0.0020367526,0.0013285214,0.002551643],"category_scores_gemma":[0.075785905,0.0004356258,0.001849578,0.009002493,0.0021021592,0.008643226,0.002859767,0.0015700168,0.000457595],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005266295,0.0005696314,0.099009074,0.0029125586,0.00043525154,0.0057877176,0.022457657,0.031765826,0.010432234,0.45164278,0.026055912,0.3484047],"study_design_scores_gemma":[0.00014136822,0.00031082227,0.05800787,0.003670462,0.0009549493,0.0035744288,0.024290383,0.32372433,0.01665377,0.2935307,0.274814,0.0003269024],"about_ca_topic_score_codex":0.028825881,"about_ca_topic_score_gemma":0.023256797,"teacher_disagreement_score":0.028825881,"about_ca_system_score_codex":0.004939288,"about_ca_system_score_gemma":0.007846659,"threshold_uncertainty_score":0.100275695},"labels":[],"label_agreement":null},{"id":"W200501671","doi":"10.1155/2000/123046","title":"Hospitalization due to Adverse Drug Reactions and Drug Interactions before and after HAART","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Infectious Diseases and Medical Microbiology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Wellesley Institute; University of Toronto; St. Michael's Hospital","funders":"Abbott Laboratories","keywords":"Medicine; Drug; Retrospective cohort study; Internal medicine; Adverse effect; Human immunodeficiency virus (HIV); Adverse drug reaction; Drug reaction; Population; Pharmacovigilance; Pediatrics; Pharmacology; Immunology","score_opus":0.00955488179032295,"score_gpt":0.3180035463615621,"score_spread":0.30844866457123915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W200501671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767727,0.0007795394,0.00008916158,0.000036719364,0.000013443091,0.000061843115,0.00072525674,0.000008224952,0.00060862757],"genre_scores_gemma":[0.9983022,0.00039680506,0.00011133147,0.000047077323,0.000040721086,0.000029489494,0.00094778964,0.000002213324,0.00012239351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980059,0.000495002,0.00035565498,0.0002776895,0.0004769176,0.00038877153],"domain_scores_gemma":[0.9923469,0.0016058547,0.0044535245,0.00013560124,0.00053947064,0.00091874663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092581304,0.00029672502,0.00061345234,0.0015606112,0.0005287414,0.0006431334,0.0003151219,0.00052937755,0.0018437858],"category_scores_gemma":[0.0046604644,0.00022505039,0.00072908873,0.0011496465,0.00034366085,0.00055332,0.00046710917,0.0006841391,0.00018507779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002847372,0.00004568739,0.99684876,0.000036529073,0.0000603398,0.00045344626,0.000051800525,0.0000350413,0.00013079593,0.000007274563,0.000065211585,0.0019802677],"study_design_scores_gemma":[0.000007829433,0.00036717905,0.99819297,0.000016051476,0.00001730064,0.0010577436,0.00011068339,0.00005073669,0.00007540124,0.000004446546,0.00009538293,0.000004177809],"about_ca_topic_score_codex":0.003313084,"about_ca_topic_score_gemma":0.0041691493,"teacher_disagreement_score":0.003313084,"about_ca_system_score_codex":0.0006779511,"about_ca_system_score_gemma":0.0006784736,"threshold_uncertainty_score":0.0065876245},"labels":[],"label_agreement":null},{"id":"W2005766236","doi":"10.1002/1099-1557(200007/08)9:4<337::aid-pds524>3.0.co;2-b","title":"Where is the epidemiology in pharmacovigilance?","year":2000,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Pharmacovigilance; Medicine; Library science; Citation; Pharmacoepidemiology; Family medicine; Nursing; Pharmacology; Drug; Medical prescription; Computer science","score_opus":0.1199651830942512,"score_gpt":0.4646092983783394,"score_spread":0.3446441152840882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005766236","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049721473,0.40310326,0.013477688,0.56678426,0.007041789,0.00003842404,0.00033831756,0.00008313789,0.0041609425],"genre_scores_gemma":[0.19728772,0.5463531,0.019539334,0.16611665,0.068051174,0.00025544278,0.00043261502,0.00016566843,0.0017982753],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.96359235,0.022272864,0.0056301006,0.0037972245,0.0035069436,0.0012005097],"domain_scores_gemma":[0.6517254,0.27573127,0.022566477,0.0096919155,0.03442276,0.005862153],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06896579,0.0015938272,0.0054859957,0.010517279,0.003378298,0.017142715,0.0032164217,0.014492196,0.007614955],"category_scores_gemma":[0.19581795,0.0027113508,0.0026557117,0.01423199,0.01676416,0.05648167,0.0069463965,0.018471807,0.0016488887],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007186981,0.000659229,0.15676674,0.013236138,0.0023842833,0.0015487649,0.0049671317,0.0028391806,0.0006569044,0.29255858,0.11857931,0.40508497],"study_design_scores_gemma":[0.00032109316,0.0005760247,0.09477706,0.04355201,0.0019690888,0.006111852,0.020687964,0.0061330996,0.00043869988,0.56012446,0.26438728,0.00092128146],"about_ca_topic_score_codex":0.033625722,"about_ca_topic_score_gemma":0.030515755,"teacher_disagreement_score":0.9310342,"about_ca_system_score_codex":0.0076539465,"about_ca_system_score_gemma":0.014788707,"threshold_uncertainty_score":0.36473036},"labels":[],"label_agreement":null},{"id":"W2010725925","doi":"10.1007/s40264-014-0194-3","title":"A Comparison of Active Adverse Event Surveillance Systems Worldwide","year":2014,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sun Yat-sen University; Johns Hopkins University","keywords":"Pharmacovigilance; Medicine; Postmarketing surveillance; Adverse Event Reporting System; Pharmacoepidemiology; General partnership; Medical emergency; Adverse effect; Pharmacology; Business; Medical prescription","score_opus":0.13697062891435727,"score_gpt":0.505399370736806,"score_spread":0.36842874182244867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010725925","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022793,0.00964017,0.013811765,0.00455672,0.00040325048,0.00089918333,0.025862494,0.0009843323,0.04156269],"genre_scores_gemma":[0.9666372,0.0020455765,0.006063117,0.0004884336,0.00019017475,0.0003143733,0.02264136,0.0001411661,0.0014786824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97534776,0.006441704,0.005717349,0.004636585,0.0064615463,0.0013950493],"domain_scores_gemma":[0.8536531,0.04049335,0.027615665,0.011979375,0.06187347,0.004385111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027216787,0.00070686114,0.0008420368,0.015018852,0.0007115798,0.0041679796,0.0013590377,0.00089742534,0.0032138021],"category_scores_gemma":[0.07556843,0.000408127,0.0013195014,0.0136094885,0.00089277123,0.0065146275,0.003069421,0.00093960634,0.00075008697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061197265,0.0001669661,0.8266929,0.0010380521,0.0011258702,0.00023390916,0.003334908,0.0033036582,0.001005824,0.0076654833,0.00950152,0.14531891],"study_design_scores_gemma":[0.00012859251,0.0005794599,0.9456895,0.00082491495,0.00045258028,0.00071564637,0.006236802,0.007154502,0.0015004704,0.0020541472,0.03455411,0.00010925585],"about_ca_topic_score_codex":0.010131004,"about_ca_topic_score_gemma":0.0070031458,"teacher_disagreement_score":0.027216787,"about_ca_system_score_codex":0.0023098972,"about_ca_system_score_gemma":0.0021409222,"threshold_uncertainty_score":0.14393789},"labels":[],"label_agreement":null},{"id":"W2012012763","doi":"10.7202/1021110ar","title":"Le système de pharmacovigilance Canadien en quête d’une réforme en profondeur ?","year":2013,"lang":"fr","type":"article","venue":"Lex Electronica","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Humanities; Political science; Pharmacovigilance; Philosophy; Medicine","score_opus":0.02329593657699976,"score_gpt":0.3608312819548259,"score_spread":0.33753534537782615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012012763","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00931567,0.030184967,0.010024811,0.8937664,0.004905564,0.0002493183,0.0005699893,0.0005198408,0.050463375],"genre_scores_gemma":[0.5181548,0.065997675,0.056785427,0.25636914,0.009675306,0.000888981,0.0022421747,0.0005967639,0.08928969],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.96263784,0.019385366,0.0019468613,0.0035076467,0.008402675,0.0041196933],"domain_scores_gemma":[0.9465978,0.012470007,0.0042061717,0.0063419756,0.021353563,0.009030491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047932614,0.0009280784,0.0014137122,0.0036181684,0.0048560943,0.022800319,0.0034751347,0.007327286,0.015625736],"category_scores_gemma":[0.070175454,0.0007453685,0.0015987783,0.0052345446,0.00944556,0.013708381,0.005980979,0.008553707,0.0043438915],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048397458,0.00028346034,0.021158768,0.0014646734,0.00035661008,0.00031011098,0.004068838,0.0024348483,0.00090810604,0.450848,0.21880287,0.29887974],"study_design_scores_gemma":[0.00019403904,0.0003590363,0.0145699205,0.0022942303,0.00020509447,0.0002625734,0.0022909397,0.0018106595,0.00081345433,0.06060596,0.91641057,0.00018336678],"about_ca_topic_score_codex":0.2179001,"about_ca_topic_score_gemma":0.1334275,"teacher_disagreement_score":0.96298283,"about_ca_system_score_codex":0.037017155,"about_ca_system_score_gemma":0.10896299,"threshold_uncertainty_score":0.43326354},"labels":[],"label_agreement":null},{"id":"W2013068307","doi":"10.1002/pds.1399","title":"Guidelines for submitting adverse event reports for publication","year":2007,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacovigilance; Alternative medicine; Pharmacy; Adverse effect; Warrant; Postmarketing surveillance; Pharmacoepidemiology; Medical education; Family medicine; Pharmacology; Pathology; Medical prescription","score_opus":0.23339066436070172,"score_gpt":0.5346572447626472,"score_spread":0.3012665804019455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013068307","genre_codex":"protocol","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034784211,0.0356838,0.15238367,0.15575029,0.07257134,0.378623,0.048717827,0.016502028,0.13628961],"genre_scores_gemma":[0.015356017,0.04066952,0.33584502,0.04620991,0.027641049,0.43682417,0.037387554,0.0046191043,0.055447698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.50021297,0.20274197,0.23632228,0.008800125,0.047028717,0.0048939637],"domain_scores_gemma":[0.17714529,0.30445746,0.094071485,0.072766274,0.34006554,0.011493945],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.31624487,0.0033944212,0.0075134933,0.03477433,0.0065092104,0.021944497,0.011909505,0.023772247,0.086403884],"category_scores_gemma":[0.5899866,0.005842348,0.0087430775,0.01919884,0.0069512106,0.014824828,0.009219047,0.01691206,0.10593431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008903028,0.00040042808,0.0013216692,0.031432126,0.00018216184,0.002036511,0.0038180177,0.000591964,0.001773032,0.009547561,0.7826724,0.1653337],"study_design_scores_gemma":[0.0008026869,0.00033144627,0.0022679237,0.047135357,0.0001477141,0.0016908208,0.0017512116,0.0007320392,0.0009086405,0.0109517975,0.9329986,0.00028177793],"about_ca_topic_score_codex":0.0023707615,"about_ca_topic_score_gemma":0.005456821,"teacher_disagreement_score":0.68375516,"about_ca_system_score_codex":0.004936751,"about_ca_system_score_gemma":0.048147924,"threshold_uncertainty_score":0.8431918},"labels":[],"label_agreement":null},{"id":"W2013330307","doi":"10.3899/jrheum.140203","title":"Trying to Improve Care: The Morbidity and Mortality Conference in a Division of Rheumatology","year":2014,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute for Work & Health; Hospital for Sick Children; McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; MEDLINE; Intensive care medicine; Family medicine","score_opus":0.08089900234336923,"score_gpt":0.4180280643722801,"score_spread":0.33712906202891085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013330307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92829394,0.030161584,0.0014979189,0.021025447,0.0006638903,0.0005635783,0.0029959162,0.00009891744,0.014698763],"genre_scores_gemma":[0.9843152,0.007956098,0.0022734615,0.002374313,0.00036311123,0.0001981046,0.0015455313,0.000015185463,0.000958921],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9850311,0.0052825874,0.0028061122,0.00056066044,0.0052239643,0.001095532],"domain_scores_gemma":[0.95490867,0.007179057,0.028660722,0.000914186,0.0051940754,0.0031431424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066214716,0.00021627065,0.00028697064,0.0022195103,0.0016706622,0.0017717826,0.00088493177,0.0013155983,0.001516776],"category_scores_gemma":[0.033862874,0.00023550108,0.00045877844,0.0029642053,0.00070396136,0.002039245,0.0017987861,0.0014930712,0.00026610037],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018901583,0.000091758346,0.9264681,0.00089976663,0.000078753634,0.0018143791,0.00530585,0.0002241316,0.00026978535,0.0002606668,0.014287055,0.050110746],"study_design_scores_gemma":[0.000017741484,0.0002057949,0.9713476,0.0010928081,0.00004851411,0.0036475465,0.008331107,0.0002602437,0.00020750554,0.00006593484,0.014744365,0.00003095215],"about_ca_topic_score_codex":0.028429857,"about_ca_topic_score_gemma":0.048389684,"teacher_disagreement_score":0.028429857,"about_ca_system_score_codex":0.0036085697,"about_ca_system_score_gemma":0.005017466,"threshold_uncertainty_score":0.056528747},"labels":[],"label_agreement":null},{"id":"W2017601550","doi":"10.4021//jmc.v3i6.799","title":"A Rare Complication of Antibiotic (Piperacillin/Tazobactam) Therapy: Resistant Hypokalemia","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hypokalemia; Medicine; Piperacillin/tazobactam; Tazobactam; Piperacillin; Antibiotics; Beta-Lactamase Inhibitors; Intensive care medicine; Complication; Internal medicine; Microbiology; Antibiotic resistance; Bacteria","score_opus":0.18238847465530916,"score_gpt":0.46730113718900834,"score_spread":0.2849126625336992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017601550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707473,0.009423696,0.0062385635,0.0030287185,0.00020796056,0.00013527645,0.00014399456,0.00034352354,0.009731005],"genre_scores_gemma":[0.9974498,0.00082240725,0.0005283386,0.0005586135,0.0001777807,0.000009648542,0.00003549143,0.000010331984,0.00040762927],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99929774,0.00019890962,0.00010199111,0.00010054692,0.00011198306,0.0001888899],"domain_scores_gemma":[0.9975145,0.0007178967,0.0010882788,0.00020227395,0.00013183987,0.0003452303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039734397,0.00084483763,0.0008630974,0.0009799597,0.00093127124,0.0009925687,0.0005366768,0.0026022927,0.0019206244],"category_scores_gemma":[0.004426787,0.00039099818,0.0006763529,0.0007146631,0.00074020855,0.0009901824,0.0007755273,0.0018933195,0.00044916171],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117792035,0.00006143565,0.029295234,0.00008645615,0.000028272163,0.96341914,0.00015168275,0.00009283551,0.0022488541,0.00029319458,0.00039671702,0.0038084157],"study_design_scores_gemma":[0.000014449984,0.000077184224,0.0068648094,0.000015312582,0.00002038929,0.9914746,0.00005709735,0.00020669482,0.0006130134,0.00013800355,0.0005125987,0.000005764423],"about_ca_topic_score_codex":0.0007317871,"about_ca_topic_score_gemma":0.0006315253,"teacher_disagreement_score":0.0026022927,"about_ca_system_score_codex":0.00044722378,"about_ca_system_score_gemma":0.00050383987,"threshold_uncertainty_score":0.0064250827},"labels":[],"label_agreement":null},{"id":"W2020037446","doi":"10.1002/phar.1496","title":"Evaluation of the Reproducibility of the Naranjo Adverse Drug Reaction Probability Scale Score in Published Case Reports","year":2014,"lang":"en","type":"article","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Schwartz/Reisman Emergency Medicine Institute; Mount Sinai Hospital","funders":"International Society for Pharmacoepidemiology","keywords":"Reproducibility; Scale (ratio); Adverse drug reaction; Drug; Medicine; Medical physics; Computer science; Statistics; Mathematics; Pharmacology; Cartography; Geography","score_opus":0.10240877232914693,"score_gpt":0.4249091301807329,"score_spread":0.322500357851586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020037446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9203194,0.011468231,0.053868085,0.0007287496,0.0010130596,0.003217299,0.0020737192,0.000523863,0.006787672],"genre_scores_gemma":[0.97727466,0.00085803744,0.018418305,0.00017028113,0.00036300387,0.0014272217,0.0010407115,0.00012791871,0.0003198229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.62716377,0.18529879,0.09888209,0.017687175,0.06917481,0.0017933684],"domain_scores_gemma":[0.21229914,0.43789998,0.16634926,0.069637105,0.11181589,0.0019986245],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27812502,0.00094376673,0.0020020495,0.008821276,0.0009227611,0.0030866254,0.0027369396,0.001255329,0.0012774877],"category_scores_gemma":[0.56199217,0.0007224938,0.0027282473,0.004599748,0.0028132068,0.0021709867,0.0035925526,0.00069083343,0.00064082036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017466662,0.00019894351,0.9250137,0.002634666,0.0033193922,0.0006196729,0.0052869096,0.0011075741,0.0022700408,0.00049089396,0.0013933968,0.055918224],"study_design_scores_gemma":[0.00042219818,0.0026054222,0.9492669,0.0022578284,0.003667632,0.0053859563,0.0025847424,0.011607788,0.01072473,0.0016166145,0.009590826,0.00026950025],"about_ca_topic_score_codex":0.0007177722,"about_ca_topic_score_gemma":0.0009542256,"teacher_disagreement_score":0.99799794,"about_ca_system_score_codex":0.0012869635,"about_ca_system_score_gemma":0.0014491237,"threshold_uncertainty_score":0.8902004},"labels":[],"label_agreement":null},{"id":"W2020715522","doi":"10.2165/11534580-000000000-00000","title":"Enhancing Pharmacosurveillance with Systematic Collection of Treatment Indication in Electronic Prescribing","year":2010,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Electronic prescribing; Medical prescription; Electronic data; Medical record; Off-label use; Electronic medical record; Gold standard (test); MEDLINE; Clinical decision support system; Documentation; Intensive care medicine; Drug Utilization Review; Emergency medicine; Decision support system; Surgery; Internal medicine; Database; Data mining","score_opus":0.03130026216337235,"score_gpt":0.36825298916125243,"score_spread":0.3369527269978801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020715522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5844381,0.006413833,0.32298824,0.02020237,0.0010834823,0.014772954,0.007059012,0.007759177,0.035282787],"genre_scores_gemma":[0.7116262,0.0023405696,0.2720466,0.0041899337,0.0013144038,0.0028989862,0.0033967998,0.00023275733,0.0019538053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.90593934,0.06371825,0.016549349,0.00304178,0.009959108,0.00079216424],"domain_scores_gemma":[0.5787111,0.274308,0.055412427,0.035667296,0.05240306,0.0034981929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06499743,0.0011785581,0.002310095,0.008533399,0.000990648,0.003927628,0.0015628397,0.0015557277,0.0020629202],"category_scores_gemma":[0.2740506,0.0010221092,0.0011444417,0.006404431,0.00055887876,0.0053789294,0.0039463853,0.0015491503,0.0012664727],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019385263,0.0016846241,0.38570818,0.0024738708,0.0009857063,0.00030321136,0.0030597472,0.0051189424,0.0042186594,0.001196846,0.013294254,0.5800174],"study_design_scores_gemma":[0.0014442785,0.0051349676,0.7213547,0.004498736,0.0036966407,0.0021208334,0.0051716077,0.14311495,0.041031737,0.011715566,0.06001448,0.0007015992],"about_ca_topic_score_codex":0.0061283056,"about_ca_topic_score_gemma":0.008619019,"teacher_disagreement_score":0.06499743,"about_ca_system_score_codex":0.0016357765,"about_ca_system_score_gemma":0.0067523825,"threshold_uncertainty_score":0.34374338},"labels":[],"label_agreement":null},{"id":"W2021002927","doi":"10.1016/j.annepidem.2010.09.001","title":"An Introduction to Pharmacovigilance by Patrick Waller","year":2010,"lang":"en","type":"article","venue":"Annals of Epidemiology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pharmacovigilance; Medicine; Identification (biology); SIGNAL (programming language); Process (computing); Triage; Process management; Risk analysis (engineering); Computer science; Medical emergency; Business; Psychiatry","score_opus":0.24853596701695008,"score_gpt":0.5510556403233725,"score_spread":0.30251967330642243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021002927","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003355169,0.16923772,0.02456798,0.6324368,0.15083669,0.0001090895,0.00031946867,0.00082470226,0.021332081],"genre_scores_gemma":[0.0064310124,0.19240588,0.022151627,0.38276234,0.27265608,0.00029342377,0.00032080154,0.0010221186,0.12195668],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99503833,0.0017757099,0.00058593566,0.000683955,0.0016734215,0.00024256948],"domain_scores_gemma":[0.9798576,0.011363928,0.0011630266,0.00057733024,0.004509662,0.002528486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009261435,0.0025655266,0.0021497265,0.0041045053,0.0009968446,0.0049644914,0.0016714854,0.007002343,0.016929716],"category_scores_gemma":[0.02799946,0.0011885251,0.0010610729,0.0019925751,0.0022135444,0.009046634,0.0037406443,0.01695068,0.014156112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032271128,0.000028685296,0.0001382067,0.00021323943,0.000011677645,0.00018019209,0.00010109692,0.0001611133,0.00014980178,0.004247265,0.918103,0.07663346],"study_design_scores_gemma":[0.00002788739,0.000045131215,0.0003653426,0.00084596506,0.000015834314,0.0008757342,0.00008798112,0.00036993585,0.00011156509,0.010235339,0.98697287,0.000046448604],"about_ca_topic_score_codex":0.0026981027,"about_ca_topic_score_gemma":0.0034315127,"teacher_disagreement_score":0.016929716,"about_ca_system_score_codex":0.0014844899,"about_ca_system_score_gemma":0.0027150125,"threshold_uncertainty_score":0.05663556},"labels":[],"label_agreement":null},{"id":"W2030289873","doi":"10.1007/s40264-014-0216-1","title":"Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum","year":2014,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacovigilance; Medicine; Curriculum; The Internet; Multidisciplinary approach; Public relations; Alternative medicine; Health care; Globalization; Medical education; Pharmacology; Adverse effect; Law; Political science","score_opus":0.07154550662978594,"score_gpt":0.42545354338143304,"score_spread":0.3539080367516471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030289873","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11693062,0.007726382,0.2954329,0.2156076,0.009572152,0.0075516016,0.0016579885,0.009193688,0.3363271],"genre_scores_gemma":[0.25008565,0.009582955,0.59691536,0.04025234,0.0037588961,0.004103315,0.0019508441,0.00092591846,0.09242464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655235,0.00088013674,0.00027458568,0.00028774273,0.0013735621,0.000631713],"domain_scores_gemma":[0.98197097,0.0023847094,0.0011887724,0.0009600045,0.003212595,0.01028295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007538364,0.0009536385,0.00070997246,0.0017687996,0.0013138677,0.0032850385,0.002430344,0.0020134316,0.016024228],"category_scores_gemma":[0.014012268,0.00056667934,0.00093435385,0.00096674514,0.0009285719,0.0020650516,0.007666093,0.0039134254,0.0060794204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108168075,0.0032669727,0.010053856,0.0009246544,0.000033646826,0.000510583,0.002078313,0.0030427715,0.003531476,0.014552458,0.21281652,0.7490806],"study_design_scores_gemma":[0.00025988068,0.0013483597,0.06493002,0.005215295,0.00011328579,0.0035059212,0.0039478308,0.008630992,0.008276645,0.09257683,0.8110345,0.00016037238],"about_ca_topic_score_codex":0.0030191492,"about_ca_topic_score_gemma":0.00997923,"teacher_disagreement_score":0.016024228,"about_ca_system_score_codex":0.0041748905,"about_ca_system_score_gemma":0.03219493,"threshold_uncertainty_score":0.05360639},"labels":[],"label_agreement":null},{"id":"W2032355944","doi":"10.1371/journal.pone.0045196","title":"Study of Natural Health Product Adverse Reactions (SONAR): Active Surveillance of Adverse Events Following Concurrent Natural Health Product and Prescription Drug Use in Community Pharmacies","year":2012,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Health Canada; Women and Children’s Health Research Institute; University of Ottawa; University of Toronto; University of Alberta","funders":"Canadian Institutes of Health Research; Health Canada; Alberta Innovates; Alberta Heritage Foundation for Medical Research; Canadian Patient Safety Institute","keywords":"Medical prescription; Medicine; Adverse effect; Pharmacy; Pharmacist; Family medicine; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.2093658946244799,"score_gpt":0.4358863962264267,"score_spread":0.2265205016019468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032355944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986534,0.00022329733,0.00018531924,0.00002795795,0.000003194925,0.0001736443,0.00022828202,0.0000061555315,0.00049874716],"genre_scores_gemma":[0.99893445,0.00012901293,0.00039460717,0.000052700012,0.000014616912,0.000067503795,0.0002397807,0.0000017562681,0.00016552009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972121,0.0012606073,0.00035428855,0.00031712672,0.0007005341,0.00015535232],"domain_scores_gemma":[0.98669887,0.001936122,0.008818819,0.0004533216,0.0011564398,0.0009363268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029940568,0.0002739577,0.0004034127,0.001534918,0.00033937473,0.0005753768,0.00057082175,0.0005280398,0.0012543962],"category_scores_gemma":[0.0075480016,0.00026834084,0.0004486619,0.0009128872,0.00030170457,0.0005382174,0.00076629315,0.0005543816,0.00024832692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003007662,0.00025931105,0.9924568,0.00007328273,0.000068118105,0.00014336366,0.00026739016,0.000023650327,0.00045481548,0.000010373906,0.00008023473,0.0058619506],"study_design_scores_gemma":[0.0000210931,0.0011458041,0.9973236,0.000012991909,0.000028819713,0.0006798427,0.0002520593,0.00015054597,0.00019582552,0.00000769208,0.00017648863,0.0000052994806],"about_ca_topic_score_codex":0.003695415,"about_ca_topic_score_gemma":0.0038398341,"teacher_disagreement_score":0.003695415,"about_ca_system_score_codex":0.00036104716,"about_ca_system_score_gemma":0.00057554845,"threshold_uncertainty_score":0.015834272},"labels":[],"label_agreement":null},{"id":"W2034704010","doi":"","title":"Adverse events related to medications identified by a Canadian poison centre.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Adverse effect; Medical emergency; Nova scotia; Emergency medicine; Retrospective cohort study; Injury prevention; Occupational safety and health; Drug; Poison control; Family medicine; Pharmacology; Internal medicine","score_opus":0.09987295555454184,"score_gpt":0.3693361806867988,"score_spread":0.26946322513225696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034704010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92574257,0.0035454435,0.0005526081,0.0026864032,0.00008514295,0.0014853367,0.032619536,0.00013512986,0.033147763],"genre_scores_gemma":[0.99024427,0.0014067818,0.00080975937,0.0008524893,0.000035852365,0.0001567126,0.004308163,0.000015116641,0.0021709162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971506,0.00022505167,0.0002926833,0.0003182044,0.0016673498,0.000346073],"domain_scores_gemma":[0.98879075,0.0010670286,0.0050335345,0.00030134228,0.0039116903,0.000895671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010904564,0.000287312,0.0002832653,0.0020060712,0.0019721705,0.0013507162,0.0010280493,0.0004273568,0.004266607],"category_scores_gemma":[0.009560424,0.0002626081,0.00026571853,0.0035681245,0.00054686045,0.00041707794,0.0010490987,0.00077629735,0.00062498386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011521576,0.000059228292,0.97737426,0.0003084386,0.00003905168,0.0004677698,0.0009477512,0.00011516006,0.00025839033,0.0000722399,0.005495305,0.014747237],"study_design_scores_gemma":[0.000010530932,0.00005342141,0.9945498,0.00007727904,0.000017769364,0.00033692538,0.00065752986,0.00014292575,0.00012339819,0.000013854086,0.004002382,0.0000141514165],"about_ca_topic_score_codex":0.9388611,"about_ca_topic_score_gemma":0.9398774,"teacher_disagreement_score":0.061138928,"about_ca_system_score_codex":0.015310653,"about_ca_system_score_gemma":0.020016557,"threshold_uncertainty_score":0.12299794},"labels":[],"label_agreement":null},{"id":"W2038210354","doi":"10.3821/1913-701x(2007)140[286:nsatip]2.0.co;2","title":"New study aims to increase pharmacist reporting of adverse events in natural health products","year":2007,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacist; Adverse effect; Natural (archaeology); Medicine; Business; Pharmacy; Family medicine; Pharmacology; History","score_opus":0.12509996914890492,"score_gpt":0.43509723643146736,"score_spread":0.30999726728256244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038210354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85517496,0.0075950287,0.005107169,0.04386809,0.0032202355,0.012035196,0.01811443,0.0005836579,0.054301202],"genre_scores_gemma":[0.9367349,0.0034314282,0.022411484,0.015024586,0.0020299174,0.0058255526,0.0041863616,0.00006184085,0.010293917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9872521,0.006493745,0.0011530818,0.0012567443,0.0033844754,0.0004597442],"domain_scores_gemma":[0.93491864,0.030298669,0.012382279,0.0026422406,0.013925164,0.005833052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014137067,0.0005328442,0.0007108279,0.0012180709,0.00086724106,0.0019947174,0.0012103919,0.001735294,0.009270194],"category_scores_gemma":[0.041883696,0.00037208534,0.0013475843,0.0008558999,0.00064425456,0.0022973751,0.00090961874,0.0011203623,0.0012174189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024767932,0.014060446,0.5533708,0.004918426,0.0013929866,0.00029942422,0.0007810169,0.00047462052,0.003640833,0.0012351314,0.0390622,0.3559962],"study_design_scores_gemma":[0.006732866,0.01809927,0.9208959,0.0007124805,0.0015470189,0.00038096713,0.0006457282,0.0018884628,0.005389946,0.0007420349,0.04288997,0.00007529145],"about_ca_topic_score_codex":0.027071757,"about_ca_topic_score_gemma":0.050268758,"teacher_disagreement_score":0.9729282,"about_ca_system_score_codex":0.0034198882,"about_ca_system_score_gemma":0.010721251,"threshold_uncertainty_score":0.07476491},"labels":[],"label_agreement":null},{"id":"W2038688076","doi":"10.1016/j.ijmedinf.2014.03.003","title":"The effectiveness of computerized drug-lab alerts: A systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"International Journal of Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St Joseph's Health Care; Kingston Health Sciences Centre; Queen's University","funders":"National Institute on Aging","keywords":"Medicine; MEDLINE; CINAHL; Meta-analysis; Confidence interval; Systematic review; Randomized controlled trial; Adverse effect; Emergency medicine; Intensive care medicine; Internal medicine; Psychological intervention","score_opus":0.15040197239308142,"score_gpt":0.5177754002083219,"score_spread":0.3673734278152405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038688076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010479747,0.9883118,0.00038324585,0.00012070135,0.00013033129,0.00015578854,0.0002458424,0.000017523254,0.00015504097],"genre_scores_gemma":[0.30242023,0.6919433,0.0029712636,0.0010855155,0.00030499318,0.00043012618,0.00050849485,0.00003270566,0.0003033438],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9903895,0.0037731736,0.0031187993,0.0012180109,0.0011999157,0.00030067115],"domain_scores_gemma":[0.9742493,0.019571153,0.0041333153,0.0006697165,0.0011317142,0.0002448851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011601861,0.0025301254,0.01705202,0.004161086,0.00057439983,0.0027437964,0.0022948638,0.0027055677,0.0038722814],"category_scores_gemma":[0.029463572,0.0015893521,0.030585274,0.0047082943,0.00090374507,0.0026520528,0.0015870777,0.0023269288,0.00026913485],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005606579,0.00010271721,0.0056067626,0.29628143,0.6737832,0.00012621992,0.00011884479,0.00039466412,0.00025062886,0.00008475701,0.00044395996,0.017200314],"study_design_scores_gemma":[0.0016173476,0.0005012625,0.004665021,0.012904129,0.97881615,0.00009076859,0.0000739207,0.0001664087,0.0001209818,0.000112865135,0.00089937256,0.000031836316],"about_ca_topic_score_codex":0.0046289973,"about_ca_topic_score_gemma":0.013370129,"teacher_disagreement_score":0.01705202,"about_ca_system_score_codex":0.0021002106,"about_ca_system_score_gemma":0.002395239,"threshold_uncertainty_score":0.06135726},"labels":[],"label_agreement":null},{"id":"W2041187947","doi":"10.2165/11539300-000000000-00000","title":"Case Series in Drug Safety","year":2010,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pharmacovigilance; Drug reaction; Drug; Adverse effect; Adverse drug reaction; Pediatrics; Pharmacology","score_opus":0.1231651913550462,"score_gpt":0.4639343263772994,"score_spread":0.34076913502225326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041187947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12801714,0.64059144,0.021281023,0.018947478,0.008673459,0.00032393524,0.0009435387,0.0011805138,0.18004146],"genre_scores_gemma":[0.6719537,0.26241964,0.008133066,0.010685525,0.014006678,0.00012424422,0.0008232173,0.00018748888,0.031666454],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.999067,0.00016849682,0.00015582694,0.00018383958,0.00023408687,0.00019088],"domain_scores_gemma":[0.9973525,0.00086863566,0.0009001708,0.00021747436,0.00023369807,0.00042755032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005507512,0.0023953686,0.0010609521,0.0052894186,0.0012798852,0.0018266687,0.0015568971,0.004684803,0.013021777],"category_scores_gemma":[0.005201691,0.00061764405,0.0012429726,0.0029461798,0.0014028029,0.0023776258,0.0020712318,0.0034063514,0.0042092255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028900107,0.00007486251,0.0053479327,0.0004882294,0.00005201181,0.9309287,0.00022406137,0.00019852971,0.0004737631,0.0011381488,0.010595878,0.050448984],"study_design_scores_gemma":[0.0000067830997,0.000010329064,0.0007372787,0.00024056331,0.000029605415,0.98639107,0.00008740798,0.00007594498,0.00019779765,0.0005422737,0.011671909,0.000008997861],"about_ca_topic_score_codex":0.0008353219,"about_ca_topic_score_gemma":0.0012667672,"teacher_disagreement_score":0.013021777,"about_ca_system_score_codex":0.00073098036,"about_ca_system_score_gemma":0.00095072004,"threshold_uncertainty_score":0.043562174},"labels":[],"label_agreement":null},{"id":"W2046112541","doi":"10.1186/s12916-015-0270-2","title":"Why are there deadly drugs?","year":2015,"lang":"en","type":"letter","venue":"BMC Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; York University; University of Toronto","funders":"","keywords":"Medicine; Drug; Food and drug administration; Harm; Clinical trial; Intensive care medicine; Risk analysis (engineering); Drug reaction; Number needed to harm; Pharmacology; Alternative medicine; Number needed to treat; Internal medicine; Pathology","score_opus":0.21683319706207668,"score_gpt":0.45800743237025343,"score_spread":0.24117423530817675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046112541","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013074714,0.00316873,0.000112722686,0.99088204,0.0046232548,0.000005116805,0.000008800634,0.000014588658,0.0010539638],"genre_scores_gemma":[0.0015941088,0.0021951755,0.00021954413,0.98281604,0.0116401585,0.000008796484,0.0000064206993,0.000010934484,0.0015088026],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906922,0.0028981753,0.0010496039,0.0012239207,0.0034878396,0.00064829027],"domain_scores_gemma":[0.976454,0.014582625,0.002215014,0.00071097526,0.0037007723,0.002336609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0088908095,0.0009592715,0.0014856891,0.001007826,0.0052087996,0.0051986,0.0024248462,0.055784445,0.006184822],"category_scores_gemma":[0.048199665,0.00067990576,0.0018192165,0.0010435977,0.008590024,0.012667841,0.0028144899,0.048924297,0.0061520096],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007091438,0.000054975415,0.0009038247,0.00028810994,0.000039586885,0.004426455,0.0006851977,0.000080286736,0.0004603138,0.014316782,0.933426,0.045247488],"study_design_scores_gemma":[0.00005797207,0.00007470252,0.00054277596,0.0005697535,0.00002868972,0.0042032152,0.000830534,0.00015116826,0.00024230522,0.020610867,0.972629,0.000059143098],"about_ca_topic_score_codex":0.0054439204,"about_ca_topic_score_gemma":0.010875919,"teacher_disagreement_score":0.055784445,"about_ca_system_score_codex":0.007066642,"about_ca_system_score_gemma":0.005880065,"threshold_uncertainty_score":0.051272273},"labels":[],"label_agreement":null},{"id":"W2047539181","doi":"10.1038/sj.tpj.6500370","title":"Pharmacovigilance in a genomic era","year":2006,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Pharmacovigilance; Medicine; Business; Pharmacology; Drug","score_opus":0.08580772195881785,"score_gpt":0.4241182426508137,"score_spread":0.33831052069199585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047539181","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1434305,0.10772579,0.0581103,0.63885313,0.0039959154,0.00006717154,0.0017319525,0.0013239267,0.04476135],"genre_scores_gemma":[0.86047596,0.027025614,0.020830298,0.079375654,0.009363235,0.000039336774,0.00061302003,0.00011077437,0.0021661115],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9968624,0.001807197,0.00022142312,0.00047352622,0.00049561675,0.00013988306],"domain_scores_gemma":[0.9629218,0.026938006,0.0032168375,0.0017658211,0.003343365,0.0018141329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007922354,0.0003027837,0.00068345905,0.0022310396,0.00047725093,0.0027897365,0.00074557343,0.0027390267,0.004098],"category_scores_gemma":[0.028073149,0.00021258593,0.0004612465,0.0024412225,0.0019075713,0.0039093606,0.001243288,0.0021703194,0.00036680995],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001060626,0.00036144914,0.14049682,0.0011859919,0.00053693046,0.0040894505,0.002311022,0.004155942,0.0067330017,0.1390741,0.057170413,0.6428243],"study_design_scores_gemma":[0.00034550493,0.0007122724,0.25412765,0.001564335,0.00090668566,0.009571337,0.0030267895,0.011363846,0.004402427,0.39355746,0.32018352,0.0002383001],"about_ca_topic_score_codex":0.0033217382,"about_ca_topic_score_gemma":0.0023629342,"teacher_disagreement_score":0.007922354,"about_ca_system_score_codex":0.0022261124,"about_ca_system_score_gemma":0.0021796362,"threshold_uncertainty_score":0.041897893},"labels":[],"label_agreement":null},{"id":"W2051152621","doi":"10.4103/0976-500x.99417","title":"Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmacology and Pharmacotherapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Adverse drug reaction; Drug reaction; Medicine; Protocol (science); Drug; Pharmacology; Data mining; Computer science; Alternative medicine; Pathology","score_opus":0.2168935148296222,"score_gpt":0.49858612306712974,"score_spread":0.2816926082375075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051152621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8165815,0.069116235,0.02586023,0.0014952809,0.001138907,0.01818178,0.041117392,0.0007351812,0.025773462],"genre_scores_gemma":[0.91673607,0.014748583,0.028702749,0.000710201,0.0002469128,0.015509546,0.021297395,0.00018281648,0.0018657971],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.82705116,0.08760537,0.05007546,0.0076095294,0.02666476,0.0009937099],"domain_scores_gemma":[0.5995539,0.2544175,0.089480765,0.0154606495,0.03973046,0.0013566803],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.100101806,0.0008118176,0.0019929544,0.0067761764,0.0004745199,0.0024191006,0.001375308,0.00090861216,0.0042534196],"category_scores_gemma":[0.26496133,0.00044248035,0.006533255,0.0074727684,0.00090483075,0.0030163843,0.0015905449,0.0011384859,0.0010685908],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061486576,0.0012967046,0.4124204,0.043693755,0.021328311,0.00036664004,0.0054247524,0.0017463034,0.0030009085,0.0043811933,0.010833833,0.4340206],"study_design_scores_gemma":[0.0046434235,0.017718378,0.8873294,0.007654656,0.018528942,0.001730548,0.0043875496,0.0032211097,0.004976078,0.0017901337,0.04758269,0.00043701584],"about_ca_topic_score_codex":0.00090649835,"about_ca_topic_score_gemma":0.0012616172,"teacher_disagreement_score":0.8998982,"about_ca_system_score_codex":0.0018750108,"about_ca_system_score_gemma":0.0025193095,"threshold_uncertainty_score":0.5293953},"labels":[],"label_agreement":null},{"id":"W2051434441","doi":"10.1177/1715163513481325","title":"Increased bruising with the combination of long-chain omega-3 fatty acids, flaxseed oil and clopidogrel","year":2013,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Alberta; University of Ottawa","funders":"","keywords":"Medicine; Adverse effect; Clopidogrel; Pharmacist; Pharmacy; Medical prescription; Omega 3 fatty acid; Family medicine; Emergency medicine; Internal medicine; Fatty acid; Pharmacology; Docosahexaenoic acid","score_opus":0.04625423919066619,"score_gpt":0.3194660778189023,"score_spread":0.2732118386282361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051434441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538886,0.010862692,0.0011126711,0.005296394,0.00010194958,0.00028502624,0.000820912,0.000111474066,0.027520182],"genre_scores_gemma":[0.9946791,0.0023197671,0.0006692422,0.0008398424,0.00011349064,0.000014427492,0.00018544667,0.000009152481,0.0011695847],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.998552,0.00027556493,0.00010710721,0.00013959466,0.00069098535,0.00023463229],"domain_scores_gemma":[0.9980989,0.00035884965,0.00089060835,0.00006106255,0.00036511247,0.00022543526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006402737,0.00033969842,0.00037728134,0.001121005,0.0011870323,0.0007655669,0.0003573312,0.000599257,0.0038301342],"category_scores_gemma":[0.0036788934,0.00020777747,0.0004156481,0.0015005956,0.00049707084,0.00030496024,0.00033929967,0.0007267469,0.0002263301],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083880546,0.00024557253,0.93634,0.00021205845,0.00018926113,0.022065923,0.0007216722,0.00011203282,0.0026594258,0.00024950254,0.003535267,0.032830637],"study_design_scores_gemma":[0.000025339908,0.00020866762,0.9647789,0.0001250473,0.00012039957,0.03066207,0.00044097888,0.00026968753,0.00048901653,0.00010168834,0.0027603006,0.000018021541],"about_ca_topic_score_codex":0.26497877,"about_ca_topic_score_gemma":0.2917745,"teacher_disagreement_score":0.26497877,"about_ca_system_score_codex":0.0024180652,"about_ca_system_score_gemma":0.0029555636,"threshold_uncertainty_score":0.5268729},"labels":[],"label_agreement":null},{"id":"W2051908585","doi":"10.1177/1078155209354135","title":"Look-alike, sound-alike drugs in oncology","year":2010,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Formulary; Bigram; Levenshtein distance; Drug; Internal medicine; Oncology; Emergency medicine; Medical emergency; Family medicine; Algorithm; Pharmacology; Artificial intelligence","score_opus":0.1372158935252119,"score_gpt":0.5370151428571186,"score_spread":0.3997992493319067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051908585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87832916,0.017301362,0.056573384,0.016564453,0.0005962535,0.0011967669,0.000823472,0.0014352425,0.027179837],"genre_scores_gemma":[0.91126084,0.0033093942,0.081134394,0.0021137001,0.00017308859,0.00009373331,0.00036003714,0.00007048073,0.001484303],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880322,0.004254233,0.0014030377,0.0009104357,0.005154286,0.00024578552],"domain_scores_gemma":[0.9370153,0.028024746,0.020644002,0.0025656933,0.0093731545,0.0023770437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007880087,0.00046551225,0.0005059728,0.005764577,0.0014964865,0.0024964393,0.0013120288,0.00088688004,0.0026089647],"category_scores_gemma":[0.055980552,0.00027750185,0.0004570207,0.0038285856,0.001388971,0.0019258086,0.0030145396,0.0010484343,0.0006447432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004238925,0.0003130547,0.5453779,0.0013013541,0.00015662401,0.0013329455,0.0031926949,0.0015571107,0.0033223603,0.0020778016,0.0068318276,0.4341124],"study_design_scores_gemma":[0.00010676292,0.002308734,0.8261527,0.0021511293,0.00062988565,0.023332229,0.010897116,0.025458183,0.01794182,0.01870812,0.072066955,0.0002464752],"about_ca_topic_score_codex":0.008573285,"about_ca_topic_score_gemma":0.023435343,"teacher_disagreement_score":0.008573285,"about_ca_system_score_codex":0.0028745953,"about_ca_system_score_gemma":0.006421911,"threshold_uncertainty_score":0.041674435},"labels":[],"label_agreement":null},{"id":"W2052084025","doi":"10.1007/bf03261973","title":"Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Toronto Rehabilitation Institute; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Polypharmacy; Incidence (geometry); Emergency department; Emergency medicine; Pharmacy; Population; Retrospective cohort study; Logistic regression; Diagnosis code; Health care; Pediatrics; Family medicine; Environmental health; Internal medicine","score_opus":0.03744386741267191,"score_gpt":0.3582969599565819,"score_spread":0.32085309254391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052084025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380857,0.00091680523,0.000042999556,0.0006306764,0.000010915844,0.000035561774,0.0023276585,0.0000050353647,0.002221759],"genre_scores_gemma":[0.9977041,0.00087711704,0.0000880285,0.00008609058,0.000018298442,0.000012720238,0.0009553454,0.0000013544452,0.00025689648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900717,0.00011578122,0.00009370162,0.000083880404,0.0004778231,0.00022165691],"domain_scores_gemma":[0.99694973,0.00016605979,0.0017163947,0.000057605157,0.00059728447,0.0005129848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042288,0.00020391168,0.0002366075,0.0010872496,0.00076906354,0.0007549101,0.00049213733,0.00025838034,0.0017874873],"category_scores_gemma":[0.0031532373,0.00023969325,0.00045326154,0.0017779929,0.00038223213,0.00028803744,0.00075722585,0.00039760466,0.00011156294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033778757,0.000015188761,0.9966551,0.000026224336,0.00003712791,0.00012957428,0.00010206656,0.000076954144,0.000048832015,0.000034441106,0.00059147755,0.002249186],"study_design_scores_gemma":[0.0000031599986,0.000010374803,0.99939466,0.0000135094,0.000008058572,0.000073705836,0.00012236479,0.00010161613,0.0000049860237,0.000008107785,0.00025756695,0.000001833257],"about_ca_topic_score_codex":0.7715653,"about_ca_topic_score_gemma":0.83815724,"teacher_disagreement_score":0.22843468,"about_ca_system_score_codex":0.010934569,"about_ca_system_score_gemma":0.007308027,"threshold_uncertainty_score":0.45955992},"labels":[],"label_agreement":null},{"id":"W2052653315","doi":"10.1186/1472-6882-12-s1-p321","title":"P04.51. Study of natural health product adverse reactions (SONAR): active surveillance in community pharmacies","year":2012,"lang":"en","type":"article","venue":"BMC Complementary and Alternative Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa; University of Toronto; McGill University Health Centre; University of Alberta","funders":"","keywords":"Medicine; Medical prescription; Pharmacy; Pharmacist; Family medicine; Telephone interview; Alternative medicine; Adverse effect; Medical emergency; Pharmacology","score_opus":0.27061340390680655,"score_gpt":0.514346079592455,"score_spread":0.2437326756856485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052653315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645212,0.0020455378,0.0013484749,0.0010481371,0.00013037155,0.00092110183,0.009467075,0.000112729744,0.02040531],"genre_scores_gemma":[0.9945281,0.00030415115,0.0007096551,0.00041657782,0.0001229238,0.0003186638,0.0014695983,0.000014978398,0.00211537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974921,0.001570341,0.00020529212,0.00017578148,0.00042162195,0.00013487172],"domain_scores_gemma":[0.9891298,0.0037448795,0.0036974964,0.0007549974,0.0016706724,0.0010020268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00316218,0.00017955125,0.0002044568,0.0009545098,0.00043971965,0.00063170656,0.0005406845,0.0006445202,0.011494228],"category_scores_gemma":[0.010645437,0.00015541093,0.0002924429,0.0015267398,0.00027061303,0.0004914421,0.0003658792,0.00038329797,0.0013965041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013031316,0.00043536755,0.96522254,0.00017984399,0.00009457141,0.00027963455,0.00016135247,0.000034488476,0.00041828462,0.00010343697,0.0039951233,0.027772378],"study_design_scores_gemma":[0.00015963904,0.0012159195,0.99553776,0.00006776608,0.000033774624,0.0006697071,0.00011452711,0.00019223796,0.00015396175,0.00003394493,0.0018169117,0.000003841477],"about_ca_topic_score_codex":0.004023315,"about_ca_topic_score_gemma":0.0025067125,"teacher_disagreement_score":0.011494228,"about_ca_system_score_codex":0.00026063086,"about_ca_system_score_gemma":0.00076885364,"threshold_uncertainty_score":0.03845197},"labels":[],"label_agreement":null},{"id":"W2053064174","doi":"10.1055/s-2009-1216427","title":"The Anatomy of Spontaneously Reported Dietary Supplement Adverse Events and a Standardized Process to Score and Interpret Collected Events","year":2009,"lang":"en","type":"article","venue":"Planta Medica","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Drug Abuse; Agricultural Research Service; University of British Columbia; University of Illinois at Urbana-Champaign; Chinese Academy of Sciences; Kurukshetra University; University of Illinois at Chicago; National Oceanic and Atmospheric Administration; U.S. Food and Drug Administration; National Science Foundation of Sri Lanka; University of Colombo; U.S. Department of Agriculture; Western Carolina University; International Science Council; National Center for Complementary and Alternative Medicine; China Academy of Traditional Chinese Medicine; National Institutes of Health; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Hong Kong Polytechnic University; National Science Foundation; Deutsche Krebshilfe; National Natural Science Foundation of China; Tata Trusts; University Grants Commission; Wake Forest University","keywords":"Medicine; Pharmacovigilance; Adverse effect; Pharmacology","score_opus":0.04879143433801929,"score_gpt":0.42812949658474087,"score_spread":0.37933806224672156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053064174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32023263,0.009301949,0.23007841,0.0039705634,0.0017333903,0.31713048,0.039723363,0.0032223137,0.0746069],"genre_scores_gemma":[0.48120445,0.00703481,0.2465318,0.0021010947,0.0009898761,0.22836258,0.015124925,0.00045282007,0.018197633],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9696595,0.01493659,0.0067960024,0.0015065437,0.0064777997,0.00062353595],"domain_scores_gemma":[0.95588696,0.011138012,0.014082406,0.0052402206,0.012392635,0.0012598336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022766247,0.0009992665,0.0017912434,0.0032237188,0.000875499,0.0018423015,0.0010106271,0.0009867925,0.0077199074],"category_scores_gemma":[0.03104406,0.0005113883,0.0016193498,0.002575902,0.0012811017,0.0009868109,0.0016021582,0.0019262157,0.002177761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033643756,0.004584432,0.15268834,0.011787456,0.0011808063,0.0016252021,0.004271979,0.0030989067,0.023226282,0.013128351,0.027702047,0.7230624],"study_design_scores_gemma":[0.0056931227,0.04386309,0.7511004,0.0024551498,0.0009316121,0.0036627392,0.0021985439,0.009785947,0.021882908,0.008552243,0.1493948,0.00047940557],"about_ca_topic_score_codex":0.00075637735,"about_ca_topic_score_gemma":0.0019915986,"teacher_disagreement_score":0.022766247,"about_ca_system_score_codex":0.0011236623,"about_ca_system_score_gemma":0.0028726235,"threshold_uncertainty_score":0.120400846},"labels":[],"label_agreement":null},{"id":"W2054211381","doi":"10.1503/cmaj.109-4487","title":"Drug reporting may be mandatory for doctors","year":2013,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Drug reaction; Drug; Veterans Affairs; Medicine; Adverse drug reaction; Mandatory reporting; Family medicine; Health care; Medical emergency; Political science; Pharmacology; Law; Internal medicine","score_opus":0.07544929570416595,"score_gpt":0.420179958445288,"score_spread":0.3447306627411221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054211381","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09454637,0.005940433,0.0154698575,0.41771343,0.018195715,0.0028103364,0.012142685,0.006400134,0.42678106],"genre_scores_gemma":[0.40558037,0.0047280453,0.02493625,0.3649774,0.014529962,0.002502954,0.01134197,0.00070837606,0.17069475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.94971657,0.014630841,0.0077058133,0.004826327,0.016501227,0.006619175],"domain_scores_gemma":[0.68862617,0.12933916,0.055888046,0.053042177,0.057726126,0.0153783215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050108448,0.000587978,0.0010728713,0.0031404735,0.0042034355,0.0048626545,0.0048866114,0.013597683,0.025344834],"category_scores_gemma":[0.15546198,0.0014501226,0.0018199941,0.0023558617,0.0021793758,0.00471926,0.003445274,0.006305344,0.01164122],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012206315,0.00069899176,0.04319763,0.0012657974,0.00014333238,0.002260363,0.0016442921,0.00045536432,0.00931468,0.026187213,0.76752293,0.14608869],"study_design_scores_gemma":[0.0006148861,0.00079403695,0.0953513,0.0021935117,0.0002223779,0.0019194714,0.00068798993,0.0013247593,0.008082896,0.007267786,0.8812493,0.00029155854],"about_ca_topic_score_codex":0.016689155,"about_ca_topic_score_gemma":0.019300774,"teacher_disagreement_score":0.050108448,"about_ca_system_score_codex":0.0030062203,"about_ca_system_score_gemma":0.016227106,"threshold_uncertainty_score":0.26500195},"labels":[],"label_agreement":null},{"id":"W2055017324","doi":"10.1517/14740338.2011.584531","title":"Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Adverse effect; Drug; Adverse drug reaction; Pediatrics; Adverse drug event; Intensive care medicine; Pharmacology","score_opus":0.14124959565047093,"score_gpt":0.4633750617566379,"score_spread":0.322125466106167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055017324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023752027,0.9984127,0.00015551681,0.00044859207,0.00007899117,0.000005311682,0.000026966689,0.000008454548,0.0006258906],"genre_scores_gemma":[0.002220549,0.9966509,0.00041425636,0.0002709384,0.00012954658,0.0000072937764,0.000048630256,0.0000013711502,0.00025654354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932325,0.00016740523,0.00013281673,0.00008790915,0.00025259578,0.0000361328],"domain_scores_gemma":[0.9985434,0.00064651284,0.00043523576,0.000019549081,0.00030325618,0.000052056163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012916108,0.00074375496,0.0016280628,0.0017412356,0.00016228408,0.0008890379,0.0007347416,0.0010146484,0.0022119493],"category_scores_gemma":[0.0021952896,0.00019142729,0.0008646544,0.0017859438,0.00024079182,0.00078023697,0.00042458338,0.0011237373,0.00088145665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009401265,0.000031696254,0.001458603,0.016763555,0.00021625351,0.0003942138,0.00006202276,0.00020137851,0.0005687777,0.0008364366,0.012263298,0.9671098],"study_design_scores_gemma":[0.00013281037,0.0004039353,0.021491177,0.04211142,0.0019024527,0.018315298,0.00041619377,0.000637809,0.0018085643,0.0039016532,0.90879434,0.00008430396],"about_ca_topic_score_codex":0.0025793654,"about_ca_topic_score_gemma":0.0032369997,"teacher_disagreement_score":0.0025793654,"about_ca_system_score_codex":0.0005680074,"about_ca_system_score_gemma":0.0016915301,"threshold_uncertainty_score":0.007399738},"labels":[],"label_agreement":null},{"id":"W2055370690","doi":"10.1002/pds.674","title":"ISPE as a balanced forum. Summary of the president's address at the International Conference of Pharmacoepidemiology, Toronto, 2001","year":2001,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacoepidemiology; Pharmacy; Library science; Medicine; Family medicine; Pharmacology; Computer science; Medical prescription","score_opus":0.12351555279408909,"score_gpt":0.4478919985483185,"score_spread":0.3243764457542294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055370690","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001423665,0.024034647,0.0015379336,0.25877142,0.3665794,0.0005869933,0.0030048816,0.0006351522,0.3434259],"genre_scores_gemma":[0.00802649,0.0135043245,0.00097631797,0.0316963,0.039298438,0.00022329678,0.0036807253,0.00021350231,0.90238065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987702,0.00016826419,0.000064456355,0.00010159758,0.0006209407,0.00027464406],"domain_scores_gemma":[0.9916711,0.00038557543,0.00025300414,0.00014387476,0.00349045,0.0040560868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003132104,0.0015052353,0.0008317647,0.0012059301,0.0027202596,0.006601385,0.0008506196,0.006583173,0.18773808],"category_scores_gemma":[0.0045510214,0.0006489534,0.0006208216,0.0020123073,0.0005557463,0.0031648807,0.0023100444,0.005822841,0.10982585],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018133685,0.0000098559085,0.0000691905,0.00002673672,0.000001314487,0.00002148401,0.000010666966,0.000012787109,0.00003113632,0.00021009952,0.9937509,0.0058377483],"study_design_scores_gemma":[0.000016178405,0.00002051972,0.0011470551,0.000071419585,0.000004137165,0.00003779301,0.00008593847,0.000044126224,0.00002958889,0.00014983004,0.9983882,0.0000052473424],"about_ca_topic_score_codex":0.011433296,"about_ca_topic_score_gemma":0.031565323,"teacher_disagreement_score":0.18773808,"about_ca_system_score_codex":0.0016161313,"about_ca_system_score_gemma":0.008492588,"threshold_uncertainty_score":0.6280464},"labels":[],"label_agreement":null},{"id":"W2056650104","doi":"10.1186/1472-6947-13-114","title":"Evaluating the risk of patient re-identification from adverse drug event reports","year":2013,"lang":"en","type":"article","venue":"BMC Medical Informatics and Decision Making","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Natural Resources Canada; Canadian Institutes of Health Research; Vanderbilt University","keywords":"Identification (biology); Adversary; Matching (statistics); Computer science; Event (particle physics); Computer security; Risk analysis (engineering); Data science; Medicine; Statistics; Mathematics","score_opus":0.11252360912583993,"score_gpt":0.47880279918932156,"score_spread":0.36627919006348164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056650104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72323513,0.0005008152,0.26256463,0.0020407806,0.00008145202,0.0007741429,0.0013948086,0.0003101781,0.009098024],"genre_scores_gemma":[0.9840859,0.00013152407,0.013494852,0.000091779635,0.000015305566,0.0001687537,0.00025052507,0.000018750967,0.0017426825],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99558467,0.0023557732,0.00019276216,0.0007039243,0.0005022796,0.00066063524],"domain_scores_gemma":[0.9596073,0.031432986,0.0052606035,0.0013009203,0.0015020045,0.0008961671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010158369,0.0011890823,0.0011706331,0.0010713526,0.00058506185,0.002308009,0.0028177584,0.0028550893,0.0031876082],"category_scores_gemma":[0.033430193,0.000665046,0.0010320172,0.00071687327,0.0017845834,0.0023007188,0.0019047617,0.0018108487,0.00027522113],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013943121,0.00006407964,0.009504613,0.00003027118,0.00004443198,0.00007395291,0.000051828185,0.98381054,0.00020990334,0.0036569675,0.0002187217,0.002195247],"study_design_scores_gemma":[0.000021097003,0.000121288445,0.0013393151,0.000009604909,0.000020097714,0.00004538555,0.000038525086,0.99569476,0.000171526,0.0023417622,0.0001830973,0.000013488915],"about_ca_topic_score_codex":0.02230831,"about_ca_topic_score_gemma":0.007275898,"teacher_disagreement_score":0.02230831,"about_ca_system_score_codex":0.0039878474,"about_ca_system_score_gemma":0.0029467146,"threshold_uncertainty_score":0.053723276},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2057896244","doi":"10.1177/1715163514536523","title":"Adverse drug reactions","year":2014,"lang":"en","type":"review","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"University of Alberta; Alberta Health Services","keywords":"Drug reaction; Medicine; Drug; Computer science; Intensive care medicine; Pharmacology","score_opus":0.15863814677048754,"score_gpt":0.43288740145924376,"score_spread":0.2742492546887562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057896244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046977177,0.87895054,0.005973076,0.007691717,0.0022891625,0.00084279187,0.0030544545,0.00036626527,0.096134275],"genre_scores_gemma":[0.11835449,0.7761525,0.009132376,0.02556545,0.002282637,0.0006632964,0.0033508798,0.00010046955,0.06439793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993418,0.0016650656,0.00112333,0.000548575,0.0029810437,0.00026401653],"domain_scores_gemma":[0.99352527,0.0021138878,0.0020399473,0.00039755102,0.0017147996,0.00020852874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026760586,0.00094404235,0.0014182647,0.0013158463,0.00067406107,0.0018012782,0.0010468344,0.0020180044,0.017997663],"category_scores_gemma":[0.007903047,0.00022444419,0.0015919753,0.0017675532,0.00083342125,0.00085405627,0.0011123826,0.0024123278,0.005397034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040195638,0.00021252413,0.005016787,0.025476346,0.00070164574,0.003781815,0.0004258311,0.00044931626,0.006074497,0.0117937075,0.14167364,0.8039919],"study_design_scores_gemma":[0.00013631019,0.0003362814,0.0073304838,0.0067622648,0.0004083622,0.014846156,0.00023605287,0.00012549473,0.0028023329,0.003446994,0.96352404,0.000045212113],"about_ca_topic_score_codex":0.003845845,"about_ca_topic_score_gemma":0.005846207,"teacher_disagreement_score":0.017997663,"about_ca_system_score_codex":0.0013332703,"about_ca_system_score_gemma":0.0019070494,"threshold_uncertainty_score":0.06020814},"labels":[],"label_agreement":null},{"id":"W2061863162","doi":"10.4103/0253-7613.56068","title":"Therapeutic class-specific signal detection of bradycardia associated with propranolol hydrochloride","year":2009,"lang":"en","type":"article","venue":"Indian Journal of Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bradycardia; Propranolol; Class (philosophy); SIGNAL (programming language); Propranolol Hydrochloride; Pharmacology; Chemistry; Medicine; Anesthesia; Internal medicine; Computer science; Heart rate; Artificial intelligence","score_opus":0.05546527684431484,"score_gpt":0.3729392223970642,"score_spread":0.3174739455527493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061863162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96910334,0.0022563613,0.017876493,0.00019652459,0.000051318602,0.00078302884,0.002362551,0.00023305246,0.0071373344],"genre_scores_gemma":[0.99036086,0.00057532935,0.0068990323,0.00011363652,0.000026082811,0.00012330315,0.0014680541,0.000013123319,0.00042069983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944114,0.001413507,0.0010337022,0.0004666785,0.0024670912,0.00020760066],"domain_scores_gemma":[0.98733586,0.003954889,0.005135696,0.0006906512,0.0027021954,0.00018072048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004088885,0.00023434129,0.0002856418,0.0014059612,0.00019306142,0.0003842232,0.00032076705,0.00022268329,0.0012141811],"category_scores_gemma":[0.010818147,0.000064439875,0.00044298594,0.00093168346,0.00027143603,0.0001800292,0.0003044951,0.00025820453,0.00022249378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013711838,0.00013850756,0.8479478,0.00087152794,0.00023070631,0.0009825784,0.00039132268,0.00046993035,0.018177992,0.00024045823,0.0013121708,0.12786591],"study_design_scores_gemma":[0.00003743395,0.0010346111,0.96951395,0.00007048911,0.00023961625,0.0045472104,0.0002189881,0.0028723662,0.018057844,0.00017452845,0.003209843,0.000023019495],"about_ca_topic_score_codex":0.0035155537,"about_ca_topic_score_gemma":0.004592037,"teacher_disagreement_score":0.004088885,"about_ca_system_score_codex":0.0003554798,"about_ca_system_score_gemma":0.0007600714,"threshold_uncertainty_score":0.021624327},"labels":[],"label_agreement":null},{"id":"W2064115956","doi":"10.2165/00002018-200831020-00006","title":"A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Western University","funders":"","keywords":"Medicine; Adverse Event Reporting System; Adverse effect; Drug; Incidence (geometry); Exact test; Adverse drug reaction; Drug reaction; Pharmacology; Internal medicine","score_opus":0.07724585836498933,"score_gpt":0.4216054189303475,"score_spread":0.34435956056535816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064115956","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4032075,0.0055164276,0.5587427,0.0013398357,0.00053891324,0.0016236225,0.005478854,0.007741299,0.015810871],"genre_scores_gemma":[0.6670055,0.0010573342,0.32318836,0.000627227,0.0002058204,0.0008335345,0.0018940056,0.00010264325,0.005085539],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99770314,0.0006280326,0.00031047026,0.00040188874,0.00087347085,0.000083106555],"domain_scores_gemma":[0.98656195,0.0060137915,0.0019223964,0.0012076804,0.003910928,0.00038322748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037380687,0.0005631885,0.00075886055,0.0041182074,0.0003691412,0.0009913845,0.00072329736,0.00079414743,0.0024000714],"category_scores_gemma":[0.011696758,0.00026411645,0.00046033814,0.0013970694,0.0001498064,0.00082809257,0.0006379788,0.0006575283,0.0011146638],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011519593,0.00045598167,0.18258002,0.00028795065,0.00015529567,0.00046274954,0.00026740236,0.00082917215,0.039548814,0.0012026103,0.0072251717,0.76583296],"study_design_scores_gemma":[0.0006977736,0.0053896504,0.53241223,0.0005816172,0.0015550165,0.026363593,0.00072345126,0.1779261,0.2006823,0.004538354,0.04869832,0.00043163422],"about_ca_topic_score_codex":0.0012701015,"about_ca_topic_score_gemma":0.0015024644,"teacher_disagreement_score":0.0041182074,"about_ca_system_score_codex":0.0002858039,"about_ca_system_score_gemma":0.00095112546,"threshold_uncertainty_score":0.019769073},"labels":[],"label_agreement":null},{"id":"W2066369361","doi":"10.1371/journal.pone.0123974","title":"Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda","year":2015,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institutes of Health; African Population and Health Research Center; Health Resources and Services Administration; Fogarty International Center; International Development Research Centre; Wellcome Trust","keywords":"Medicine; Referral; Family medicine; Health care; Drug class; Health professionals; Public health; Adverse drug reaction; Drug reaction; Medical emergency; Pediatrics; Emergency medicine; Drug; Nursing; Psychiatry","score_opus":0.22516385034961595,"score_gpt":0.4217278853766619,"score_spread":0.19656403502704595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066369361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990263,0.00035828567,0.000041445277,0.000106360174,0.0000022198567,0.000018704062,0.000115520605,0.0000019740387,0.000329183],"genre_scores_gemma":[0.9990502,0.0005238703,0.00018362622,0.00007456253,0.0000046687433,0.000018727178,0.00007402181,5.677966e-7,0.000069821326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982577,0.00075207587,0.00033193,0.00017823683,0.00024195564,0.000238105],"domain_scores_gemma":[0.99609596,0.00086733076,0.0021947299,0.000107323125,0.00036846357,0.00036618306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011306469,0.00022868562,0.00024920114,0.0010625427,0.00059323525,0.0005199981,0.00031053383,0.0004230558,0.001118913],"category_scores_gemma":[0.0056730355,0.0003765275,0.00012985984,0.00083268626,0.0005486693,0.0005122686,0.0011711273,0.0003047812,0.00016218291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073771604,0.00003270606,0.9733054,0.00025389614,0.000012574591,0.0007312303,0.012776768,0.00003487975,0.00083658384,0.000026037149,0.00042256343,0.011493577],"study_design_scores_gemma":[0.000007369738,0.00023908884,0.9722014,0.00026492373,0.000010173002,0.0023764037,0.02315134,0.00012238325,0.00016878647,0.000033993707,0.0014108233,0.00001322744],"about_ca_topic_score_codex":0.008582377,"about_ca_topic_score_gemma":0.011221369,"teacher_disagreement_score":0.008582377,"about_ca_system_score_codex":0.0006475272,"about_ca_system_score_gemma":0.0011614758,"threshold_uncertainty_score":0.01706487},"labels":[],"label_agreement":null},{"id":"W2067182354","doi":"10.1186/1472-6882-10-8","title":"Consumers of natural health products: natural-born pharmacovigilantes?","year":2010,"lang":"en","type":"article","venue":"BMC Complementary and Alternative Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pharmacovigilance; Medicine; Health care; Family medicine; Alternative medicine; Qualitative research; Nursing; Drug; Pharmacology","score_opus":0.14714538792134918,"score_gpt":0.4886181913291714,"score_spread":0.3414728034078222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067182354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89673555,0.021068523,0.0021998596,0.05337567,0.0002248355,0.00006898852,0.00009378609,0.000037600592,0.02619518],"genre_scores_gemma":[0.9890598,0.0037064385,0.00066324824,0.005336322,0.00009992077,0.00001787414,0.00003043003,0.0000054000384,0.0010806274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977755,0.0013272723,0.000099013145,0.00015750472,0.00051011867,0.00013065996],"domain_scores_gemma":[0.9937431,0.0037750436,0.0016211504,0.00016191904,0.0005175567,0.0001811475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038964732,0.00013108953,0.0001933477,0.00026661664,0.00078583433,0.001922449,0.00025943638,0.0013965047,0.0034305525],"category_scores_gemma":[0.010594863,0.00013727974,0.00022336225,0.00034654868,0.0017188558,0.002093663,0.0009185904,0.0008533615,0.00020853961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012262871,0.0004659155,0.3561293,0.00331209,0.00022237952,0.0079753855,0.25567728,0.00013265896,0.010009699,0.027039362,0.014248862,0.3235609],"study_design_scores_gemma":[0.00017900375,0.0013852522,0.20882812,0.0042801676,0.00055953476,0.026790636,0.40303516,0.0012837184,0.00915275,0.020573372,0.32374498,0.00018728685],"about_ca_topic_score_codex":0.0017944801,"about_ca_topic_score_gemma":0.0014690799,"teacher_disagreement_score":0.0038964732,"about_ca_system_score_codex":0.0009720882,"about_ca_system_score_gemma":0.0006790047,"threshold_uncertainty_score":0.020606756},"labels":[],"label_agreement":null},{"id":"W2067735578","doi":"10.6000/1927-5951.2013.03.02.6","title":"A Prospective Study on Adverse Drug Reactions in an Indian Hospital","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmacy and Nutrition Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug reaction; Drug; Medicine; Intensive care medicine; Pharmacology","score_opus":0.09872469842230013,"score_gpt":0.4652697571489333,"score_spread":0.3665450587266332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067735578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847966,0.00021328723,0.00006077433,0.00003599397,0.000008084432,0.00009426702,0.0004879096,0.0000032539945,0.0006166537],"genre_scores_gemma":[0.9986065,0.0002895312,0.00013642537,0.0001040468,0.00002397135,0.00009146334,0.00055239524,0.0000018648718,0.00019391802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988531,0.00029390695,0.00019656475,0.00017647346,0.00026623273,0.00021370748],"domain_scores_gemma":[0.9975078,0.00028404966,0.0012634024,0.00021063894,0.0002977059,0.00043631298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009927342,0.00041721854,0.0004391787,0.0013253102,0.0010328359,0.00084478845,0.0004254356,0.00043594025,0.0020271025],"category_scores_gemma":[0.002046842,0.0005993345,0.0006614919,0.0021762457,0.00034119273,0.00066829304,0.00068652723,0.000841851,0.00048516877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007742296,0.00013516784,0.99875677,0.000023679127,0.000022947817,0.0001200662,0.00015651464,0.000006656507,0.000091485046,0.0000061888563,0.000061007773,0.0005421163],"study_design_scores_gemma":[0.000012349302,0.00039220988,0.99833566,0.000010762687,0.000019454394,0.00044859786,0.00052817963,0.00003106912,0.000031646425,0.000006488376,0.00017706832,0.0000065595405],"about_ca_topic_score_codex":0.006439408,"about_ca_topic_score_gemma":0.0065147355,"teacher_disagreement_score":0.006439408,"about_ca_system_score_codex":0.00054632284,"about_ca_system_score_gemma":0.0009088927,"threshold_uncertainty_score":0.012803853},"labels":[],"label_agreement":null},{"id":"W2068181643","doi":"10.1310/hct0805-311","title":"An Estimate of the Proportion of Symptoms Reported in Self-Administered Questionnaires That Are Captured as Adverse Drug Events in an Observational Database","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"Ontario HIV Treatment Network","keywords":"Medicine; Interquartile range; Diarrhea; Nausea; Adverse effect; Cohort; Observational study; Cohort study; Pediatrics; Internal medicine","score_opus":0.5661113770237269,"score_gpt":0.6173921826787941,"score_spread":0.05128080565506721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068181643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494499,0.0026069116,0.018055366,0.0004957124,0.00008951508,0.0005865609,0.025882067,0.00009482444,0.0027391156],"genre_scores_gemma":[0.98165095,0.0006185413,0.0045432583,0.00032339516,0.00009760627,0.0005394694,0.01189385,0.000016153928,0.00031672785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96946824,0.01616062,0.0047435914,0.0035857873,0.005327022,0.00071475876],"domain_scores_gemma":[0.90238994,0.042032916,0.036892403,0.0075962325,0.010189588,0.00089898525],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02488728,0.00049252703,0.0007700682,0.0037715328,0.00046853456,0.0014874176,0.0011708696,0.0009274769,0.00094742],"category_scores_gemma":[0.08048438,0.00049900915,0.0012809163,0.0039469176,0.00039126683,0.001537338,0.00116045,0.0006853143,0.00040501222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073085146,0.000016916156,0.9968982,0.00007551926,0.0003354557,0.000014403621,0.000065529784,0.00010476135,0.00008539021,0.000042226013,0.00024332832,0.0020452016],"study_design_scores_gemma":[0.000016690801,0.00009372067,0.99610955,0.000064735854,0.00017598638,0.0002788366,0.00013995137,0.001951386,0.00014913184,0.00005143846,0.0009573681,0.000011120582],"about_ca_topic_score_codex":0.01460376,"about_ca_topic_score_gemma":0.00844197,"teacher_disagreement_score":0.97511274,"about_ca_system_score_codex":0.0013216202,"about_ca_system_score_gemma":0.0009234692,"threshold_uncertainty_score":0.13161808},"labels":[],"label_agreement":null},{"id":"W2069936810","doi":"10.1136/bmj.g5511","title":"Reporting guidelines for pharmacoepidemiological studies are urgently needed","year":2014,"lang":"en","type":"letter","venue":"BMJ","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Medicine; Pharmacoepidemiology; Consolidated Standards of Reporting Trials; Alternative medicine; Systematic review; MEDLINE; Drug trial; Clinical trial; Family medicine; Pharmacology; Internal medicine; Political science; Pathology","score_opus":0.769180508856146,"score_gpt":0.6382721915857102,"score_spread":0.13090831727043573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069936810","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014934933,0.00556431,0.009039459,0.9497398,0.030937353,0.00086323457,0.00049678754,0.0004106686,0.002799092],"genre_scores_gemma":[0.0031944134,0.0089599285,0.10020338,0.8456742,0.031189663,0.004379858,0.0018649489,0.0004509313,0.0040826597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.32111308,0.32661492,0.24972396,0.008400358,0.088358864,0.005788766],"domain_scores_gemma":[0.05721692,0.52957267,0.107907936,0.058695257,0.23687817,0.009729046],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.47635713,0.0024051357,0.0066087246,0.013423833,0.0058297655,0.015163683,0.017852217,0.051909614,0.01644111],"category_scores_gemma":[0.7517865,0.0044982685,0.011725505,0.012804911,0.012351092,0.036332782,0.01030278,0.057943773,0.021063277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011675408,0.00014284205,0.0010246994,0.0048786774,0.0001447203,0.00029146444,0.0006919145,0.00021184905,0.0004072592,0.010741181,0.92159486,0.05975383],"study_design_scores_gemma":[0.0006693569,0.00026261635,0.0021522006,0.034014087,0.00037715313,0.0010816047,0.0017827044,0.0017997063,0.00075802265,0.043510217,0.91310304,0.00048931985],"about_ca_topic_score_codex":0.011087145,"about_ca_topic_score_gemma":0.012717277,"teacher_disagreement_score":0.5236429,"about_ca_system_score_codex":0.01347519,"about_ca_system_score_gemma":0.045258038,"threshold_uncertainty_score":0.6457449},"labels":[],"label_agreement":null},{"id":"W2077130682","doi":"10.1016/j.annemergmed.2011.01.003","title":"Outcomes of Emergency Department Patients Presenting With Adverse Drug Events","year":2011,"lang":"en","type":"article","venue":"Annals of Emergency Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Centre for Advancing Health Outcomes; Vancouver General Hospital; Capital District Health Authority; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Emergency department; Medical emergency; Emergency medicine; Drug; Adverse drug event; Adverse effect; Internal medicine; Pharmacology; Psychiatry","score_opus":0.29546995966851086,"score_gpt":0.4886975129156439,"score_spread":0.19322755324713303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077130682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724257,0.00038173853,0.00006898927,0.00023788602,0.000027283793,0.000021994972,0.00047607927,0.000005180268,0.0015382273],"genre_scores_gemma":[0.9990258,0.00013947242,0.000038108043,0.00008063527,0.00003415836,0.000010072677,0.0005695855,0.0000017293381,0.000100393765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987392,0.00026163604,0.00023882266,0.00015291646,0.0001951546,0.0004123071],"domain_scores_gemma":[0.99360883,0.0011077082,0.003106985,0.00017696104,0.00071972585,0.0012798408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076029665,0.00033115767,0.0008459533,0.000882844,0.0008423212,0.001346647,0.0004038804,0.00085504923,0.003313827],"category_scores_gemma":[0.00873952,0.00025269628,0.001247407,0.0010052209,0.00035959814,0.0011588217,0.0011517851,0.0015454767,0.00034911928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004032485,0.000085775166,0.9970975,0.000019318131,0.00007506629,0.00051811966,0.00008403506,0.000064559856,0.000064644075,0.000039660958,0.00021741855,0.001330722],"study_design_scores_gemma":[0.00003856357,0.0005309479,0.9957688,0.000029499273,0.000087847446,0.0019070028,0.0009276986,0.00025583367,0.000060744038,0.00016282542,0.00021018571,0.000020012965],"about_ca_topic_score_codex":0.0019654338,"about_ca_topic_score_gemma":0.001765962,"teacher_disagreement_score":0.003313827,"about_ca_system_score_codex":0.00074533117,"about_ca_system_score_gemma":0.0007480989,"threshold_uncertainty_score":0.011085868},"labels":[],"label_agreement":null},{"id":"W2077713383","doi":"10.1016/j.vaccine.2012.05.045","title":"Capacity for a global vaccine safety system: The perspective of national regulatory authorities","year":2012,"lang":"en","type":"article","venue":"Vaccine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Economic and Social Research Council; Dalhousie University; Canada Research Chairs; World Health Organization","keywords":"Pharmacovigilance; Developing country; Business; Blueprint; Immunization; Public health; Medicine; Environmental health; Public relations; Economic growth; Adverse effect; Political science; Economics; Immunology","score_opus":0.10840432566016618,"score_gpt":0.42968594356128054,"score_spread":0.32128161790111437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077713383","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013532442,0.0028743278,0.0048143095,0.93885684,0.0013835273,0.00010186567,0.00013391011,0.000119643555,0.038183123],"genre_scores_gemma":[0.7156086,0.0046644425,0.010030911,0.2524912,0.0038329195,0.00039433272,0.0002813201,0.00012017869,0.012576052],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.95966417,0.019912817,0.0020937144,0.0032256052,0.0075675254,0.0075360714],"domain_scores_gemma":[0.79316694,0.10119181,0.017257486,0.01061422,0.03983705,0.037932567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10734613,0.0010677649,0.0015063868,0.002655103,0.005654479,0.025742017,0.0058357627,0.022580259,0.01891661],"category_scores_gemma":[0.11180326,0.00090724835,0.0017440402,0.0016168846,0.017172702,0.02268287,0.017874528,0.025217762,0.0017322898],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002824564,0.0006550589,0.014088605,0.00081292505,0.00036600887,0.0010016881,0.004529185,0.008445657,0.0016222852,0.79820174,0.102069095,0.06792527],"study_design_scores_gemma":[0.000394515,0.0006612978,0.010801956,0.0028184836,0.00023476435,0.0009086085,0.007919052,0.00734409,0.0016175946,0.5995107,0.3673985,0.00039037043],"about_ca_topic_score_codex":0.014330616,"about_ca_topic_score_gemma":0.009870284,"teacher_disagreement_score":0.10734613,"about_ca_system_score_codex":0.011524619,"about_ca_system_score_gemma":0.096802056,"threshold_uncertainty_score":0.5677074},"labels":[],"label_agreement":null},{"id":"W2082711644","doi":"10.1016/j.annemergmed.2009.10.008","title":"Do Emergency Physicians Attribute Drug-Related Emergency Department Visits to Medication-Related Problems?","year":2009,"lang":"en","type":"article","venue":"Annals of Emergency Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Vancouver General Hospital; Capital District Health Authority; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Emergency department; Emergency medicine; Adverse effect; Clinical pharmacy; Pharmacist; Observational study; Adverse drug event; Drug; Confidence interval; Adverse drug reaction; Prospective cohort study; Family medicine; Internal medicine; Pharmacy; Psychiatry","score_opus":0.18727030081598034,"score_gpt":0.4936912970980648,"score_spread":0.30642099628208447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082711644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94972193,0.0051642274,0.0012590674,0.02353032,0.0005603628,0.00007293326,0.0013012993,0.00007608622,0.018313648],"genre_scores_gemma":[0.9952938,0.0011934192,0.0005126219,0.002113391,0.00030473154,0.00001034209,0.00033764017,0.0000074279874,0.00022670337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99595875,0.0012476431,0.0008940086,0.00037948234,0.0009774464,0.0005425765],"domain_scores_gemma":[0.9659888,0.0120329065,0.01633923,0.0013141774,0.0030148018,0.001310158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030093417,0.0002801821,0.0005538883,0.0020082472,0.0005244711,0.0016653126,0.00060498813,0.0025765048,0.0042950665],"category_scores_gemma":[0.067154914,0.00032478897,0.0006982367,0.0020465537,0.0004884278,0.0022976801,0.00070732477,0.0014263564,0.0008690892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007848584,0.000087157234,0.98699677,0.000052581363,0.00006492145,0.00050597586,0.00028406244,0.000059496808,0.00006524706,0.00012860444,0.0020134556,0.0096633155],"study_design_scores_gemma":[0.000032266023,0.00007931913,0.9848173,0.0002903474,0.000110690286,0.0068990793,0.0025197857,0.0011000609,0.0002411991,0.000726125,0.0031632797,0.000020565507],"about_ca_topic_score_codex":0.0044068927,"about_ca_topic_score_gemma":0.003892452,"teacher_disagreement_score":0.0044068927,"about_ca_system_score_codex":0.0005373747,"about_ca_system_score_gemma":0.0009527599,"threshold_uncertainty_score":0.015915096},"labels":[],"label_agreement":null},{"id":"W2083496267","doi":"10.4212/cjhp.v62i6.846","title":"Survey of Canadian Pharmacists’ Responses to Warnings of Potential Interactions Between Ceftriaxone and Calcium in IV Solutions","year":2009,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Island Health","funders":"","keywords":"Notice; Pharmacy; Medicine; Family medicine; Health care; Political science; Law","score_opus":0.18880971547702144,"score_gpt":0.4365043303887252,"score_spread":0.24769461491170378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083496267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881919,0.00018556447,0.00014561816,0.0011583995,0.000019147872,0.00025700644,0.003055882,0.000016901375,0.0069694673],"genre_scores_gemma":[0.9944771,0.0005476719,0.00052762125,0.0011901468,0.000021599712,0.000155936,0.0012748876,0.000005185142,0.001799897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676836,0.00049040286,0.00027643837,0.00023585188,0.0016650823,0.0005639864],"domain_scores_gemma":[0.99148566,0.0009766124,0.0023568203,0.00017433568,0.003783666,0.0012229261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024327647,0.0002633352,0.0002528592,0.0012910259,0.0017750182,0.0007085807,0.00076318684,0.00070518407,0.0034121904],"category_scores_gemma":[0.011430391,0.00030433608,0.00032088204,0.002685632,0.00053017435,0.0003200068,0.0008696736,0.0006166941,0.00064578064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002444536,0.00019684761,0.95050246,0.0003359353,0.000042034124,0.0003730278,0.008897093,0.00010227729,0.0012080041,0.00012857228,0.01254019,0.02542901],"study_design_scores_gemma":[0.000023682924,0.00014314239,0.9854956,0.00006915625,0.000011142802,0.00018766217,0.006546319,0.00028451576,0.00022076376,0.000013834166,0.0069808154,0.000023248633],"about_ca_topic_score_codex":0.8391147,"about_ca_topic_score_gemma":0.8554122,"teacher_disagreement_score":0.16088527,"about_ca_system_score_codex":0.0073660207,"about_ca_system_score_gemma":0.012601557,"threshold_uncertainty_score":0.3236655},"labels":[],"label_agreement":null},{"id":"W2083990413","doi":"10.1002/pds.1675","title":"A distributed research network model for post‐marketing safety studies: the Meningococcal Vaccine Study","year":2008,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi Pasteur","keywords":"Medicine; Adjudication; Vaccination; Quarter (Canadian coin); Vaccine safety; Medical record; Population; Family medicine; Pediatrics; Medical emergency; Environmental health; Immunization; Surgery","score_opus":0.36500882723418443,"score_gpt":0.5447052066106878,"score_spread":0.17969637937650335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083990413","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06383112,0.002224337,0.8596166,0.01820418,0.0010953274,0.018828718,0.004937247,0.0021820762,0.029080475],"genre_scores_gemma":[0.40539628,0.001859506,0.53749263,0.0030710278,0.00080167456,0.035806566,0.0037995474,0.0002985281,0.011474216],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.8832596,0.103193596,0.0026780157,0.0060537583,0.0039549773,0.00086004625],"domain_scores_gemma":[0.8990365,0.066554315,0.006942486,0.016205966,0.007419785,0.0038408134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.120851606,0.0013970627,0.001505613,0.0028483232,0.0017506384,0.0058772448,0.0058336104,0.0035663722,0.014874174],"category_scores_gemma":[0.09453631,0.0012099105,0.002255069,0.0040410953,0.002540971,0.0061871056,0.005747946,0.00331049,0.003684156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009059612,0.003960691,0.12501955,0.0022645337,0.0021621608,0.0017498344,0.0035023615,0.23050658,0.001292086,0.31856388,0.037169255,0.2647495],"study_design_scores_gemma":[0.008063419,0.0043470203,0.013781855,0.00097266684,0.0010071433,0.00091266824,0.0013248455,0.6849323,0.00080851984,0.20091952,0.08266147,0.00026860353],"about_ca_topic_score_codex":0.005459857,"about_ca_topic_score_gemma":0.0060748616,"teacher_disagreement_score":0.120851606,"about_ca_system_score_codex":0.0044150446,"about_ca_system_score_gemma":0.010193123,"threshold_uncertainty_score":0.639132},"labels":[],"label_agreement":null},{"id":"W2086049425","doi":"10.1111/j.1365-2125.2011.04037.x","title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database","year":2011,"lang":"en","type":"letter","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":495,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Drug; Clinical trial; Identification (biology); Adverse drug reaction; Clinical pharmacology; Intensive care medicine; Database; Pharmacology; Internal medicine; Computer science","score_opus":0.17106071522282634,"score_gpt":0.49237423642532124,"score_spread":0.3213135212024949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086049425","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.122439235,0.016867787,0.69311243,0.04801429,0.002711888,0.006138811,0.08467547,0.0050068954,0.02103318],"genre_scores_gemma":[0.4704452,0.0032822455,0.47936136,0.005411932,0.0045377696,0.0034641132,0.03190037,0.0005287825,0.0010682713],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.79794574,0.13469304,0.026646711,0.012511556,0.026839798,0.0013632304],"domain_scores_gemma":[0.4921236,0.3417137,0.038564097,0.07234961,0.049407087,0.005841905],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13421819,0.0014980735,0.0030374639,0.01356788,0.001097848,0.0071318243,0.0034374488,0.0027653754,0.0040803775],"category_scores_gemma":[0.3747281,0.0009096369,0.0038951098,0.012014627,0.00086314225,0.006406704,0.0073356354,0.002979824,0.0018022336],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004824693,0.0007049254,0.47079614,0.004237474,0.008531693,0.0010302424,0.00093185046,0.007574396,0.0015266731,0.018973064,0.053834956,0.42703384],"study_design_scores_gemma":[0.0033302756,0.0030588582,0.43180737,0.00805775,0.01402804,0.009517606,0.001635884,0.20813635,0.0067930818,0.11237392,0.20013656,0.001124347],"about_ca_topic_score_codex":0.0035843486,"about_ca_topic_score_gemma":0.0019864703,"teacher_disagreement_score":0.8657818,"about_ca_system_score_codex":0.0014621023,"about_ca_system_score_gemma":0.00481554,"threshold_uncertainty_score":0.70982206},"labels":[],"label_agreement":null},{"id":"W2088967801","doi":"10.1002/pds.1845","title":"Confounder summary scores when comparing the effects of multiple drug exposures","year":2009,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging; Canadian Institutes of Health Research","keywords":"Medicine; Confounding; Cohort; Proportional hazards model; Pharmacoepidemiology; Logistic regression; Hazard ratio; Cohort study; Propensity score matching; Internal medicine; Statistics; Confidence interval; Pharmacology; Medical prescription; Mathematics","score_opus":0.07804785339417342,"score_gpt":0.4101140904959519,"score_spread":0.33206623710177846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088967801","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37413234,0.056009986,0.5111766,0.004976897,0.0029304652,0.0038759909,0.03714254,0.0018309521,0.007924244],"genre_scores_gemma":[0.85629416,0.0033311052,0.12540545,0.0014992147,0.0011236098,0.0031249207,0.008050381,0.00022092083,0.0009502009],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8586075,0.11347254,0.009166675,0.0075875665,0.010452464,0.0007131565],"domain_scores_gemma":[0.60953057,0.32543176,0.033152226,0.025341608,0.005680712,0.0008631915],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10155947,0.0013286474,0.0030925456,0.0048160725,0.00038810258,0.00219137,0.0018306229,0.0012144552,0.003918965],"category_scores_gemma":[0.2731644,0.00045388195,0.0057696863,0.004119453,0.00097077806,0.0015507163,0.0018252383,0.0016078707,0.00036839873],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009046859,0.00027275388,0.5669123,0.0073197144,0.13077304,0.0004380037,0.00074653607,0.013190887,0.0012990227,0.010458701,0.011264078,0.24827811],"study_design_scores_gemma":[0.0035551647,0.010948418,0.7468292,0.0023669545,0.064604305,0.0020151054,0.0006261982,0.047868364,0.0056787618,0.054045938,0.06088673,0.00057484664],"about_ca_topic_score_codex":0.0010580034,"about_ca_topic_score_gemma":0.0010463514,"teacher_disagreement_score":0.89844054,"about_ca_system_score_codex":0.0007392738,"about_ca_system_score_gemma":0.0010006946,"threshold_uncertainty_score":0.53710425},"labels":[],"label_agreement":null},{"id":"W2089079482","doi":"10.1503/cmaj.070652","title":"The effect of publication on Internet-based solicitation of personal-injury litigants","year":2007,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Plaintiff; Harm; Internet privacy; Personal injury; Action (physics); Gatifloxacin; The Internet; Medicine; World Wide Web; Computer science; Law; Political science","score_opus":0.032493517683587436,"score_gpt":0.3904608340991732,"score_spread":0.35796731641558577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089079482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91451657,0.0033290666,0.00051603036,0.03630573,0.0007275206,0.00044739438,0.0021472576,0.00015051693,0.04185983],"genre_scores_gemma":[0.9866595,0.001248158,0.00065091543,0.0074297055,0.00090876507,0.00011501536,0.00034743856,0.0000209712,0.0026194819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97531134,0.011577966,0.0023765152,0.0011185821,0.0080192555,0.0015964226],"domain_scores_gemma":[0.6616164,0.21522628,0.08941851,0.007215567,0.01688059,0.009642632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010749539,0.000348334,0.0003590346,0.0052101687,0.0022151384,0.0035652304,0.000815589,0.0036510278,0.008639406],"category_scores_gemma":[0.11650334,0.00025493008,0.00051426794,0.0035747543,0.0012942418,0.0013938679,0.0013402796,0.0022026089,0.0018032308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022584407,0.00092915574,0.8783549,0.0004441488,0.00019556668,0.00744328,0.0023282387,0.00020230644,0.0020795425,0.0010623356,0.029026309,0.07567576],"study_design_scores_gemma":[0.00014762158,0.0015432283,0.9585789,0.00041931533,0.00017982814,0.011573722,0.004324652,0.0015412155,0.0028518527,0.00062559126,0.018117364,0.00009674697],"about_ca_topic_score_codex":0.009318853,"about_ca_topic_score_gemma":0.011678591,"teacher_disagreement_score":0.010749539,"about_ca_system_score_codex":0.0027271565,"about_ca_system_score_gemma":0.0018765301,"threshold_uncertainty_score":0.05684966},"labels":[],"label_agreement":null},{"id":"W2094409037","doi":"10.1177/0091270005283285","title":"Challenges and Opportunities for Pharmacoepidemiology in Drug‐Therapy Decision Making","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University; Centre for Advancing Health Outcomes; Royal Victoria Hospital","funders":"","keywords":"Pharmacoepidemiology; Medicine; Adverse effect; Drug; Intensive care medicine; Population; Drug reaction; MEDLINE; Alternative medicine; Randomized controlled trial; Clinical study design; Adverse drug reaction; Clinical trial; Pharmacology; Internal medicine; Pathology; Environmental health","score_opus":0.5675048479289339,"score_gpt":0.5966121160322262,"score_spread":0.02910726810329234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094409037","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011115726,0.024916997,0.014581711,0.9531541,0.0029968473,0.00012354387,0.000042670956,0.000057355464,0.003015202],"genre_scores_gemma":[0.2433124,0.08997658,0.19290659,0.4092492,0.059515443,0.0025985674,0.00022413721,0.0002571496,0.0019600214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6286149,0.32080024,0.014431663,0.007273151,0.025092503,0.00378748],"domain_scores_gemma":[0.25486612,0.6738004,0.015339829,0.009643279,0.029960135,0.016390314],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5048445,0.002075168,0.0076322677,0.009047634,0.0073760827,0.028020907,0.011972819,0.027463863,0.00754718],"category_scores_gemma":[0.5005136,0.0025388796,0.0036501673,0.004723762,0.041407786,0.038583737,0.020073162,0.047277186,0.002330374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093178486,0.00078061305,0.011462449,0.00490805,0.0012515747,0.00198938,0.009066395,0.008886344,0.00029782602,0.329189,0.1748352,0.45640147],"study_design_scores_gemma":[0.000613325,0.00028079867,0.0029150308,0.009587574,0.0001998868,0.001158198,0.008998343,0.01008921,0.00013828743,0.86305916,0.10254743,0.00041279293],"about_ca_topic_score_codex":0.007883723,"about_ca_topic_score_gemma":0.0082963165,"teacher_disagreement_score":0.5048445,"about_ca_system_score_codex":0.014677391,"about_ca_system_score_gemma":0.044010904,"threshold_uncertainty_score":0.6106149},"labels":[],"label_agreement":null},{"id":"W2095347020","doi":"10.1016/j.sapharm.2013.06.002","title":"Reflections on the role of the pharmacy regulatory authority in enhancing quality related event reporting in community pharmacies","year":2013,"lang":"en","type":"article","venue":"Research in Social and Administrative Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Hospital; St. Francis Xavier University","funders":"Canadian Institutes of Health Research; Research Nova Scotia","keywords":"Pharmacy; Thematic analysis; Focus group; Quality (philosophy); Public relations; Pharmacy practice; Best practice; Standardization; Nonprobability sampling; Business; Psychology; Medical education; Qualitative research; Political science; Medicine; Nursing; Marketing; Sociology; Environmental health; Law","score_opus":0.6391652690005799,"score_gpt":0.6524494190056166,"score_spread":0.013284150005036688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095347020","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012081118,0.00065590005,0.00030638918,0.99528,0.0011888996,0.000013003316,0.000010326296,0.0000120463255,0.0013252116],"genre_scores_gemma":[0.09023025,0.002341941,0.003926933,0.8941939,0.0062972317,0.0001234982,0.000023955381,0.00008007974,0.0027822114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.6921698,0.18399653,0.028651165,0.014518171,0.051528636,0.029135646],"domain_scores_gemma":[0.18840683,0.63796157,0.027723571,0.013136391,0.09054478,0.042226892],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.30903795,0.0011635392,0.0018446345,0.0029344636,0.0131393755,0.034015607,0.014701955,0.08751589,0.018068582],"category_scores_gemma":[0.52894974,0.002468468,0.004319047,0.0026023437,0.03430381,0.040580787,0.016764028,0.09022552,0.0020481397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067083543,0.0009891733,0.017477835,0.0022946387,0.00041435505,0.0029538895,0.044106327,0.0028565712,0.0014847474,0.13486828,0.6856475,0.106235854],"study_design_scores_gemma":[0.0011094689,0.0010295962,0.02781686,0.013742963,0.0005496783,0.0018824543,0.13281283,0.0035222482,0.0029462536,0.07759666,0.7358646,0.0011264444],"about_ca_topic_score_codex":0.074791044,"about_ca_topic_score_gemma":0.09079719,"teacher_disagreement_score":0.30903795,"about_ca_system_score_codex":0.022063592,"about_ca_system_score_gemma":0.12633629,"threshold_uncertainty_score":0.8520792},"labels":[],"label_agreement":null},{"id":"W2096644138","doi":"10.1177/009286151104500613","title":"Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec","year":2011,"lang":"en","type":"article","venue":"Drug Information Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Jewish General Hospital","funders":"","keywords":"Medicine; Adverse drug reaction; Family medicine; Pharmacy; Pharmacovigilance; Adverse effect; Drug; Psychiatry; Pharmacology","score_opus":0.2042651310587935,"score_gpt":0.48682183950446795,"score_spread":0.2825567084456745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096644138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414295,0.0004630613,0.00015091014,0.0022524577,0.000018290026,0.00013260463,0.00016855229,0.0000055725177,0.0026655789],"genre_scores_gemma":[0.9965264,0.000416135,0.00022493889,0.0013303461,0.000008032946,0.000084720356,0.00006347713,0.0000059788545,0.0013399147],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9926703,0.0040533086,0.00034610124,0.00041499265,0.0010596673,0.0014555538],"domain_scores_gemma":[0.96923864,0.014993903,0.004154032,0.000392582,0.006914961,0.0043059415],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007284472,0.00029661783,0.0006938947,0.0017691448,0.0121073695,0.0048677474,0.0018970916,0.0020243234,0.004067734],"category_scores_gemma":[0.019557882,0.0006617429,0.00043692335,0.002931698,0.0028495195,0.002091782,0.002940143,0.0023902887,0.00021600894],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007257363,0.0002649701,0.07646268,0.00018135822,0.000027595117,0.0009574331,0.9145324,0.000043699078,0.00080928387,0.00032118932,0.0012674623,0.005059301],"study_design_scores_gemma":[0.000012323459,0.00009865355,0.05205927,0.00018923561,0.00001342042,0.00014765582,0.942569,0.00017461421,0.00013757459,0.000038213104,0.0045299213,0.00003019488],"about_ca_topic_score_codex":0.87553364,"about_ca_topic_score_gemma":0.935237,"teacher_disagreement_score":0.99271554,"about_ca_system_score_codex":0.033691473,"about_ca_system_score_gemma":0.04161023,"threshold_uncertainty_score":0.2503987},"labels":[],"label_agreement":null},{"id":"W2101827593","doi":"10.1345/aph.1q529","title":"Adverse Drug Reactions in Elderly Hospitalized Patients: A 12-Year Population-Based Retrospective Cohort Study","year":2012,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Incidence (geometry); Retrospective cohort study; Cohort; Internal medicine; Comorbidity; Population; Cohort study; Charlson comorbidity index; Pharmacoepidemiology; Pediatrics; Emergency medicine; Medical prescription; Pharmacology; Environmental health","score_opus":0.08293428222576218,"score_gpt":0.4465516808341864,"score_spread":0.36361739860842424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101827593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816775,0.00018829395,0.00014708903,0.00003893945,0.000008457158,0.000066174405,0.0011878797,0.0000051471275,0.00019031268],"genre_scores_gemma":[0.99786747,0.00025259782,0.0002772089,0.00008693491,0.000016273958,0.00006947672,0.0012974273,0.0000039795336,0.00012864463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861634,0.0002701427,0.00017416557,0.00042241506,0.00027823562,0.00023866941],"domain_scores_gemma":[0.9974642,0.00030141004,0.00094298006,0.0003718254,0.0004570163,0.00046264118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020593149,0.00063468656,0.00090207864,0.0016425264,0.0011852814,0.0011725175,0.00088188384,0.00077709893,0.001165375],"category_scores_gemma":[0.0028414705,0.00095393293,0.0010874894,0.0027151494,0.00044885892,0.0010102513,0.0008876015,0.0011964719,0.00033946923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078934056,0.000059478425,0.9991037,0.000007911503,0.00009079719,0.00009599236,0.00008161829,0.000017633743,0.000054832624,0.000006484847,0.00009536413,0.00030725932],"study_design_scores_gemma":[0.00003257373,0.00021484972,0.9984622,0.000014206137,0.00010892915,0.00038654756,0.0003299662,0.00020269197,0.000026392398,0.0000102203785,0.00020057046,0.000010897834],"about_ca_topic_score_codex":0.06159339,"about_ca_topic_score_gemma":0.058370482,"teacher_disagreement_score":0.06159339,"about_ca_system_score_codex":0.0013560667,"about_ca_system_score_gemma":0.0016761683,"threshold_uncertainty_score":0.12246972},"labels":[],"label_agreement":null},{"id":"W2101887300","doi":"10.1093/neuonc/not176","title":"EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacology; Clinical pharmacology; Systems pharmacology; Medicine; Drug","score_opus":0.11912994090894631,"score_gpt":0.45912819782955216,"score_spread":0.33999825692060587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101887300","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02897108,0.21477862,0.04485842,0.07403547,0.011049784,0.0008138568,0.0023101547,0.00096046686,0.6222221],"genre_scores_gemma":[0.40290192,0.26067215,0.036829457,0.02767099,0.014863718,0.0016333514,0.0019891246,0.00020635477,0.253233],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856734,0.00046274622,0.00009423988,0.0002377894,0.0005264395,0.00011139928],"domain_scores_gemma":[0.9983376,0.00045790267,0.00016460617,0.00056332716,0.00030303092,0.00017349803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022870242,0.0007545811,0.0006861479,0.0014635099,0.00081480487,0.0025263545,0.0010917551,0.0016601424,0.033675734],"category_scores_gemma":[0.0024579722,0.00029960892,0.00051629887,0.00087860523,0.0038974318,0.0020985145,0.0021308854,0.0029799885,0.008007451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004647719,0.00083703554,0.0020229535,0.0021407835,0.00008410693,0.0003818043,0.00045921787,0.000434814,0.03640243,0.5316744,0.06046382,0.3646339],"study_design_scores_gemma":[0.00013023852,0.00082643406,0.0036447693,0.0005984773,0.00007123997,0.000948798,0.00030544618,0.00042593095,0.0152231585,0.13561864,0.842177,0.000030015683],"about_ca_topic_score_codex":0.00079619105,"about_ca_topic_score_gemma":0.0007771253,"teacher_disagreement_score":0.033675734,"about_ca_system_score_codex":0.0018663558,"about_ca_system_score_gemma":0.0030845192,"threshold_uncertainty_score":0.11265653},"labels":[],"label_agreement":null},{"id":"W2110012204","doi":"10.1002/pds.1900","title":"Adverse drug events among children presenting to a hospital emergency department in Newfoundland and Labrador, Canada","year":2009,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Emergency department; Family medicine; Emergency medicine; Pediatrics; Medical emergency; Psychiatry","score_opus":0.02628509623281426,"score_gpt":0.3726905478130456,"score_spread":0.34640545158023134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110012204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410385,0.0009445925,0.00006833997,0.0003331137,0.000013439213,0.00006138341,0.0023890366,0.000007843085,0.0020784305],"genre_scores_gemma":[0.99668056,0.0007356041,0.00021770207,0.00019648903,0.000011345117,0.00003124289,0.0013595873,0.0000036085169,0.0007640247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987464,0.00011950007,0.00011894386,0.0001599106,0.00045922128,0.0003960117],"domain_scores_gemma":[0.9962213,0.00024871787,0.0013527574,0.00005892786,0.0013109293,0.0008072397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054033234,0.00027394047,0.0003468126,0.0016112514,0.0012954781,0.00086265994,0.0008496026,0.00033915625,0.0021691807],"category_scores_gemma":[0.0021396514,0.00031217354,0.00048005144,0.002435443,0.00059696287,0.0003483727,0.0007081608,0.00067466,0.00018155984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008648047,0.00001173311,0.99844897,0.000011550324,0.000009773778,0.00009126335,0.00016089645,0.000017982735,0.000029152494,0.000011400875,0.00029147897,0.000907081],"study_design_scores_gemma":[0.000001743472,0.00000951022,0.9990546,0.000015935022,0.00000461873,0.000098831566,0.000526161,0.000030476498,0.000015475478,0.0000015046247,0.00023907743,0.0000021750257],"about_ca_topic_score_codex":0.96285737,"about_ca_topic_score_gemma":0.98641545,"teacher_disagreement_score":0.037142634,"about_ca_system_score_codex":0.015979098,"about_ca_system_score_gemma":0.014365178,"threshold_uncertainty_score":0.115936995},"labels":[],"label_agreement":null},{"id":"W2111652281","doi":"10.1197/j.aem.2004.08.056","title":"Emergency Physician Recognition of Adverse Drug-related Events in Elder Patients Presenting to an Emergency Department","year":2005,"lang":"en","type":"article","venue":"Academic Emergency Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Vancouver General Hospital","funders":"","keywords":"Medicine; Emergency department; Emergency physician; Confidence interval; Scoring system; Emergency medicine; Internal medicine; Nursing","score_opus":0.1012943575018064,"score_gpt":0.45347678113973017,"score_spread":0.35218242363792374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111652281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991553,0.00026866276,0.00006777955,0.0000754586,0.000008519075,0.000012329714,0.00008359893,0.0000021349076,0.00032606153],"genre_scores_gemma":[0.9995592,0.00009959717,0.00010139548,0.000060853043,0.00002016735,0.0000056276613,0.00009893507,5.1842443e-7,0.00005378021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906725,0.00033991304,0.00018042869,0.00010537609,0.00018332736,0.00012377501],"domain_scores_gemma":[0.9935423,0.0018454135,0.003151018,0.00014215786,0.00077560876,0.0005434959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014648297,0.00021452353,0.00036161643,0.00058399333,0.00021570885,0.00042615624,0.00016166308,0.00037568202,0.0010402184],"category_scores_gemma":[0.011332261,0.00015738628,0.0002852162,0.00036571917,0.00017319617,0.00061052514,0.0004053388,0.00048149892,0.00022078458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008448282,0.000045426703,0.99766076,0.0000147943065,0.000014580188,0.0000776156,0.00008281188,0.00003256777,0.000061323386,0.0000032008481,0.000075691576,0.00184683],"study_design_scores_gemma":[0.00001716,0.00036390033,0.99838734,0.000019933761,0.000014656186,0.00050897273,0.0002343427,0.00024988843,0.000056283778,0.000008584105,0.00013552501,0.0000034406614],"about_ca_topic_score_codex":0.0016658375,"about_ca_topic_score_gemma":0.0017571746,"teacher_disagreement_score":0.0016658375,"about_ca_system_score_codex":0.0001718081,"about_ca_system_score_gemma":0.00027881778,"threshold_uncertainty_score":0.0077468753},"labels":[],"label_agreement":null},{"id":"W2113753800","doi":"10.2196/medinform.3022","title":"Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives","year":2014,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Adverse Event Reporting System; Pharmacovigilance; Computer science; Adverse effect; Narrative; Medical prescription; Annotation; Event (particle physics); Information retrieval; Medicine; F1 score; Natural language processing; Artificial intelligence; Internal medicine; Pharmacology","score_opus":0.04696299010168346,"score_gpt":0.39996653007321126,"score_spread":0.3530035399715278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113753800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69102216,0.004509527,0.18162194,0.0058781947,0.0007751078,0.0024065976,0.0830601,0.011223982,0.019502431],"genre_scores_gemma":[0.56068015,0.001834728,0.31616992,0.0010289226,0.00024146985,0.0010643663,0.1130646,0.00051887543,0.0053968946],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99668616,0.0013522126,0.00065564824,0.00052931695,0.00067012646,0.00010661994],"domain_scores_gemma":[0.97078943,0.018314052,0.0040344284,0.002158818,0.0043228995,0.00038030103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004220986,0.0006024896,0.00032559413,0.0038558617,0.00064078916,0.0012941683,0.0008108067,0.0010359924,0.0018787099],"category_scores_gemma":[0.021438902,0.00035050022,0.00048403683,0.0016247922,0.00043802554,0.002330579,0.00122228,0.0008211436,0.0014002909],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018129632,0.0008717182,0.13400777,0.005538239,0.00031900624,0.009126695,0.013061243,0.01969855,0.11430444,0.010011885,0.10140575,0.5898418],"study_design_scores_gemma":[0.00022823576,0.0006093052,0.14436957,0.0017523441,0.00046571638,0.0045432956,0.006609807,0.19341817,0.16225217,0.008565488,0.47686225,0.00032357365],"about_ca_topic_score_codex":0.006032887,"about_ca_topic_score_gemma":0.0078219,"teacher_disagreement_score":0.006032887,"about_ca_system_score_codex":0.0015299582,"about_ca_system_score_gemma":0.0023839897,"threshold_uncertainty_score":0.022323012},"labels":[],"label_agreement":null},{"id":"W2120242446","doi":"10.1007/s40264-015-0297-5","title":"A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance","year":2015,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Humana; Pfizer","keywords":"Observational study; Medicine; Analytics; Usability; Computer science; Data mining; Outcome (game theory); Data science; Internal medicine","score_opus":0.4922250256428415,"score_gpt":0.5517772702141691,"score_spread":0.05955224457132763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120242446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9199868,0.0024298348,0.053884283,0.005194788,0.0003989125,0.0015800174,0.009423659,0.00038177834,0.006719997],"genre_scores_gemma":[0.9754742,0.00037682278,0.018082941,0.0005425482,0.00008689542,0.0005661121,0.0043057012,0.00008924159,0.0004755069],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.82984024,0.14400741,0.006302822,0.0070345625,0.0109784035,0.001836593],"domain_scores_gemma":[0.418806,0.5046348,0.024319315,0.025258804,0.022080513,0.0049006077],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23568685,0.0010052397,0.0014826913,0.0027729825,0.00076044776,0.0047845836,0.0039072484,0.0016718579,0.0033243848],"category_scores_gemma":[0.39278364,0.00061762135,0.0042474275,0.0031166375,0.0016357765,0.009581945,0.0055931597,0.002326049,0.00050494325],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024323303,0.0026116318,0.84944826,0.0014467008,0.009038793,0.00009898509,0.0025886637,0.018273924,0.00049574126,0.017773764,0.004797639,0.0691027],"study_design_scores_gemma":[0.0029295755,0.023861669,0.684107,0.0014461462,0.008244203,0.00067656476,0.010009975,0.2301504,0.002110072,0.024059301,0.012071952,0.0003331574],"about_ca_topic_score_codex":0.010905881,"about_ca_topic_score_gemma":0.0090370765,"teacher_disagreement_score":0.76431316,"about_ca_system_score_codex":0.0030749985,"about_ca_system_score_gemma":0.005472598,"threshold_uncertainty_score":0.9425342},"labels":[],"label_agreement":null},{"id":"W2120424561","doi":"10.1016/j.artmed.2005.07.005","title":"Automatic identification of confusable drug names","year":2005,"lang":"en","type":"article","venue":"Artificial Intelligence in Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Computer science; Identification (biology); Artificial intelligence; Natural language processing; Information retrieval","score_opus":0.16278233115110774,"score_gpt":0.49468689344254807,"score_spread":0.33190456229144033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120424561","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5649685,0.014716085,0.35884136,0.0031800848,0.0014298282,0.0005716709,0.015067621,0.02062493,0.020599917],"genre_scores_gemma":[0.8368577,0.0017500933,0.14470641,0.0005388395,0.00046085933,0.00012928886,0.0116031915,0.00030546542,0.0036480417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560827,0.0008199969,0.00064972346,0.00068922434,0.0020141674,0.0002185619],"domain_scores_gemma":[0.97389764,0.013224217,0.004480644,0.0018720723,0.005954326,0.0005711113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021696442,0.0010173711,0.001147647,0.010350421,0.0010559493,0.0027078295,0.0013667289,0.00193258,0.0020432684],"category_scores_gemma":[0.01605284,0.00035034405,0.00083209533,0.0039190263,0.0006745938,0.002246158,0.0019240378,0.001196085,0.0019291689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028321238,0.00048593918,0.07488903,0.0015432686,0.00043150026,0.004535196,0.0006739916,0.008582701,0.060784213,0.009414272,0.031113777,0.8047139],"study_design_scores_gemma":[0.00020137292,0.0005387981,0.04544216,0.00054092595,0.0008515253,0.012678105,0.00075141905,0.7198714,0.13920318,0.020444572,0.05922934,0.00024723107],"about_ca_topic_score_codex":0.0028422812,"about_ca_topic_score_gemma":0.0038099762,"teacher_disagreement_score":0.010350421,"about_ca_system_score_codex":0.0008091535,"about_ca_system_score_gemma":0.0022084487,"threshold_uncertainty_score":0.011474311},"labels":[],"label_agreement":null},{"id":"W2122067803","doi":"10.1136/amiajnl-2011-000454","title":"A systematic review to evaluate the accuracy of electronic adverse drug event detection","year":2011,"lang":"en","type":"review","venue":"Journal of the American Medical Informatics Association","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Adverse drug event; Adverse effect; Medicine; Systematic review; Computer science; MEDLINE; Internal medicine","score_opus":0.062090071315468634,"score_gpt":0.4695414874542294,"score_spread":0.4074514161387608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122067803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035558364,0.98885554,0.0010646714,0.0007428513,0.00029989897,0.0025620048,0.0019546726,0.000033074906,0.00093140575],"genre_scores_gemma":[0.08141508,0.8994438,0.0082390765,0.002234152,0.00030554394,0.00627847,0.0017586562,0.000030817082,0.00029431353],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9512745,0.016132446,0.022748595,0.001980391,0.007314236,0.0005497948],"domain_scores_gemma":[0.79824793,0.1479186,0.031628557,0.003358437,0.01795816,0.0008883506],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.035283446,0.0021058975,0.009886892,0.022696976,0.0010243127,0.004208576,0.0028380626,0.0022810998,0.004495506],"category_scores_gemma":[0.19563347,0.0014773948,0.008742334,0.016442623,0.0013860664,0.004607647,0.0022422415,0.0012986821,0.0004704323],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018524664,0.0000152033435,0.002213052,0.9560139,0.019678509,0.00009472867,0.00016477717,0.00011067945,0.00012919503,0.00021433581,0.0009344423,0.020246048],"study_design_scores_gemma":[0.00029387386,0.00019018745,0.0047306917,0.89234513,0.09240744,0.00031658527,0.00017715826,0.00018243601,0.00021316526,0.00034046173,0.008767854,0.000034986344],"about_ca_topic_score_codex":0.007415,"about_ca_topic_score_gemma":0.021433564,"teacher_disagreement_score":0.96471655,"about_ca_system_score_codex":0.006446994,"about_ca_system_score_gemma":0.018008264,"threshold_uncertainty_score":0.18659896},"labels":[],"label_agreement":null},{"id":"W2122920328","doi":"10.1136/qshc.2010.040378","title":"Use of an electronic information system to identify adverse events resulting in an emergency department visit","year":2010,"lang":"en","type":"article","venue":"BMJ Quality & Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; Canadian Patient Safety Institute","keywords":"Medicine; Emergency department; Medical emergency; Emergency medicine; Electronic medical record; Nursing","score_opus":0.1364366037891726,"score_gpt":0.5159405080969817,"score_spread":0.37950390430780906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122920328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778552,0.0009606445,0.0018005216,0.0006103728,0.00006765282,0.0010323962,0.008642402,0.00011266554,0.008918232],"genre_scores_gemma":[0.9934443,0.00045392168,0.0024016579,0.00030367196,0.000040682233,0.00025292198,0.002456522,0.0000063238845,0.00063999597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957034,0.001143418,0.0009959707,0.0004040064,0.0014287424,0.00032437185],"domain_scores_gemma":[0.9792392,0.0048511177,0.010004402,0.0007132358,0.0044847927,0.0007071717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029263617,0.0003214298,0.0003261695,0.0025201603,0.00040250825,0.0008299818,0.00057616783,0.0002948573,0.0014671212],"category_scores_gemma":[0.015575419,0.0001832659,0.0003236953,0.0025470885,0.0003275946,0.00038969188,0.0007150191,0.0004469316,0.00029801982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012629207,0.00006828174,0.9803874,0.00017664077,0.000047435467,0.0001157662,0.00028873855,0.00015363202,0.00028371284,0.000036749516,0.0012932314,0.017022112],"study_design_scores_gemma":[0.00001916816,0.00016823712,0.9965431,0.00014511553,0.000023119934,0.00023531403,0.00031833068,0.0005262519,0.00037120262,0.000016655014,0.0016226042,0.000010694317],"about_ca_topic_score_codex":0.07623198,"about_ca_topic_score_gemma":0.088203475,"teacher_disagreement_score":0.07623198,"about_ca_system_score_codex":0.0019959374,"about_ca_system_score_gemma":0.0026800958,"threshold_uncertainty_score":0.15157652},"labels":[],"label_agreement":null},{"id":"W2129685732","doi":"10.1345/aph.1h052","title":"Contribution of Latin America to Pharmacovigilance","year":2006,"lang":"en","type":"review","venue":"Annals of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacovigilance; Latin Americans; Medicine; Observational study; Family medicine; MEDLINE; Drug reaction; Clinical trial; Library science; Adverse effect; Political science; Pharmacology; Drug; Pathology","score_opus":0.33557868919055583,"score_gpt":0.5675893032948994,"score_spread":0.2320106141043436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129685732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015251642,0.9373586,0.0014735402,0.027594417,0.0008587075,0.00008660645,0.0010742251,0.000053308977,0.016248943],"genre_scores_gemma":[0.20130306,0.7726515,0.0047313278,0.017229715,0.0016465161,0.00031434096,0.0011291819,0.000065772605,0.0009285041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9833645,0.009916158,0.0027346185,0.0012084201,0.0022951127,0.00048115198],"domain_scores_gemma":[0.91646683,0.053152807,0.018196855,0.0016302245,0.009723506,0.00082975655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021259658,0.0008398424,0.0014731761,0.0087041445,0.0008347827,0.00639325,0.0013934075,0.0013389356,0.0061494093],"category_scores_gemma":[0.053355806,0.00044738024,0.0016174605,0.02266404,0.001833381,0.002675392,0.0023371242,0.0013735329,0.00038232762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009099056,0.00012676972,0.17071816,0.104733884,0.0048103286,0.0033103146,0.007869338,0.0011278666,0.00084039953,0.019615581,0.034043267,0.65189415],"study_design_scores_gemma":[0.00059427955,0.0002796423,0.16758484,0.2464773,0.009148264,0.0042518643,0.009457006,0.0006213728,0.0011202763,0.014679462,0.5456405,0.00014508994],"about_ca_topic_score_codex":0.03018901,"about_ca_topic_score_gemma":0.019486418,"teacher_disagreement_score":0.03018901,"about_ca_system_score_codex":0.0060696406,"about_ca_system_score_gemma":0.012067739,"threshold_uncertainty_score":0.112433136},"labels":[],"label_agreement":null},{"id":"W2130075738","doi":"10.2165/00002018-200730050-00001","title":"Guidelines for Submitting Adverse Event Reports for Publication","year":2007,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacovigilance; Alternative medicine; Pharmacy; Adverse effect; Warrant; Credence; Medical education; Family medicine; Pharmacology; Pathology","score_opus":0.18196448700324783,"score_gpt":0.5093983329817617,"score_spread":0.3274338459785139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130075738","genre_codex":"protocol","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006378707,0.01751729,0.17773631,0.12046046,0.06392987,0.28648683,0.087273255,0.020838369,0.21937895],"genre_scores_gemma":[0.015503328,0.01565591,0.3758985,0.03924894,0.020372747,0.27568382,0.07787892,0.0039407476,0.17581716],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.770004,0.092869855,0.09929188,0.0036190269,0.030384546,0.0038306543],"domain_scores_gemma":[0.3673778,0.16090733,0.07130591,0.05229955,0.33727673,0.010832748],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14017133,0.0032946044,0.0061946716,0.027500248,0.004818802,0.012897136,0.009493866,0.020718966,0.12902254],"category_scores_gemma":[0.3836766,0.005767348,0.0105917,0.011489846,0.0028698316,0.006689504,0.0061269957,0.01406487,0.13229518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009369759,0.0007278604,0.0016046095,0.006512147,0.00023494019,0.00090940786,0.0006880038,0.000560147,0.0017428512,0.0024147797,0.8555262,0.12814201],"study_design_scores_gemma":[0.0018240759,0.0006339393,0.0082697505,0.015080204,0.00041696968,0.0018704508,0.00071490865,0.0017950248,0.0021455267,0.006067452,0.96088934,0.0002924297],"about_ca_topic_score_codex":0.0036448748,"about_ca_topic_score_gemma":0.009727901,"teacher_disagreement_score":0.85982865,"about_ca_system_score_codex":0.002418132,"about_ca_system_score_gemma":0.02585275,"threshold_uncertainty_score":0.7413057},"labels":[],"label_agreement":null},{"id":"W2131656019","doi":"10.1345/aph.1a262","title":"Cross-Sensitivity between Paroxetine and Sertraline","year":2002,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Sertraline; Paroxetine; Medicine; Pharmacology; Psychiatry; Antidepressant","score_opus":0.37437364980309606,"score_gpt":0.5377415882912158,"score_spread":0.1633679384881197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131656019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799295,0.005364567,0.0019747477,0.0010949424,0.00014699754,0.00006315595,0.00005875761,0.00012670155,0.011240727],"genre_scores_gemma":[0.9970686,0.0006232706,0.0006042553,0.0006941806,0.00017873442,0.000009181688,0.000036100955,0.000010498585,0.0007751511],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9989436,0.0002466728,0.00013863348,0.00022956019,0.0002082648,0.00023322638],"domain_scores_gemma":[0.9962709,0.0017581969,0.001121159,0.00037989355,0.00023837831,0.00023148837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008021902,0.001304936,0.000590499,0.000954186,0.0008162849,0.0010607848,0.0008052556,0.0031096467,0.004343058],"category_scores_gemma":[0.0064634006,0.0006429979,0.0009433347,0.0004726933,0.0008323685,0.0013696162,0.000985204,0.0018593727,0.0016340845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013575018,0.00011389644,0.03004123,0.00007820824,0.000049959755,0.95842785,0.00040030843,0.00008401113,0.0048216535,0.00023851225,0.0005392252,0.0050694514],"study_design_scores_gemma":[0.000012542025,0.00011932554,0.005033593,0.000013302316,0.00003053931,0.992183,0.000072311814,0.00015192656,0.0015899924,0.000056199377,0.0007329795,0.000004223927],"about_ca_topic_score_codex":0.0011427413,"about_ca_topic_score_gemma":0.00061746215,"teacher_disagreement_score":0.004343058,"about_ca_system_score_codex":0.0005533274,"about_ca_system_score_gemma":0.00024051052,"threshold_uncertainty_score":0.01452899},"labels":[],"label_agreement":null},{"id":"W2132829345","doi":"10.1345/aph.1m416","title":"Adverse Drug Events in Adult Patients Leading to Emergency Department Visits","year":2010,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Emergency department; Drug; Adverse effect; Emergency medicine; Medical emergency; Intensive care medicine; Pharmacology; Psychiatry","score_opus":0.09170929211075933,"score_gpt":0.47938369928944624,"score_spread":0.3876744071786869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132829345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966364,0.0012295072,0.00007114186,0.0001752848,0.000014486173,0.00006420687,0.0007589518,0.000008330427,0.0010416129],"genre_scores_gemma":[0.9986318,0.0004561335,0.00013069778,0.00011696539,0.0000263923,0.000026263944,0.0005291966,8.7361326e-7,0.00008170502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905914,0.0001922824,0.00016361478,0.00012342355,0.00029285083,0.00016866671],"domain_scores_gemma":[0.994163,0.0008310182,0.003439879,0.00006945526,0.00076293945,0.000733704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006050074,0.00016931903,0.00038760304,0.00077826466,0.00046978905,0.00047422506,0.00025523335,0.0003120117,0.0012725106],"category_scores_gemma":[0.0049184435,0.00013699205,0.00022755221,0.0012067271,0.00026264918,0.00026512993,0.00029219597,0.00042727878,0.00011116271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003277437,0.000014925974,0.9982241,0.00002440346,0.000009211574,0.00013713319,0.000044771456,0.000014261043,0.000021579048,0.0000049282075,0.00020359844,0.0012683298],"study_design_scores_gemma":[0.0000059521713,0.000055522334,0.99908686,0.00002037133,0.000006655831,0.00046838043,0.00009329944,0.000043687967,0.000017265871,0.0000050433446,0.00019548896,0.0000016001346],"about_ca_topic_score_codex":0.025077036,"about_ca_topic_score_gemma":0.031208778,"teacher_disagreement_score":0.025077036,"about_ca_system_score_codex":0.0008868132,"about_ca_system_score_gemma":0.0011272416,"threshold_uncertainty_score":0.049862146},"labels":[],"label_agreement":null},{"id":"W2133678665","doi":"10.1002/pds.2137","title":"A descriptive study evaluating Health Canada's risk communications","year":2011,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Health Canada; National Institutes of Health; National Center for Complementary and Integrative Health; Alberta Heritage Foundation for Medical Research","keywords":"Medicine; Harm; Seriousness; Product (mathematics); Environmental health; Family medicine; Psychology","score_opus":0.3762968323706418,"score_gpt":0.5146248936638196,"score_spread":0.13832806129317776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133678665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667827,0.002123952,0.0013241044,0.00055714266,0.000038838523,0.0024127902,0.020438304,0.00005605402,0.0062660924],"genre_scores_gemma":[0.9883206,0.0009767786,0.001555378,0.0006904173,0.000058262154,0.0022697058,0.005095819,0.000025756073,0.0010071881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.958816,0.0070691565,0.011176495,0.0024348432,0.018426586,0.0020770126],"domain_scores_gemma":[0.74375635,0.10069629,0.08617615,0.005725791,0.060309,0.0033364247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017956505,0.00040840896,0.00087129173,0.013075123,0.0024302746,0.002306019,0.0012148526,0.00073696487,0.0029478592],"category_scores_gemma":[0.09737957,0.0005572089,0.0009912901,0.018193772,0.0022527194,0.0015391529,0.0013148817,0.00067151425,0.00032477442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065730483,0.00020229505,0.97755903,0.0010938438,0.00014310365,0.00027028847,0.0063005225,0.00008127436,0.00022898539,0.00039324941,0.002467353,0.010602773],"study_design_scores_gemma":[0.00006404974,0.00066843635,0.97341,0.00052294554,0.00013607416,0.00060483784,0.014962893,0.0003306889,0.0006986209,0.00009138925,0.00843737,0.00007267344],"about_ca_topic_score_codex":0.35431877,"about_ca_topic_score_gemma":0.27177793,"teacher_disagreement_score":0.98168474,"about_ca_system_score_codex":0.01831525,"about_ca_system_score_gemma":0.028771846,"threshold_uncertainty_score":0.70451283},"labels":[],"label_agreement":null},{"id":"W2135462674","doi":"10.4212/cjhp.v62i4.812","title":"Evaluating the Risk of Re-identification of Patients from Hospital Prescription Records","year":2009,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Agricultural Research Institute of Ontario","funders":"Memorial University of Newfoundland; University of Alberta; Queen's University; McMaster University; Ontario Centres of Excellence; McGill University; Dalhousie University; Hamilton Health Sciences; University of British Columbia; Vanderbilt University","keywords":"Medical prescription; Audit; Identification (biology); Medicine; Medical record; Medical emergency; Pharmacy; Quality (philosophy); Family medicine; Business; Accounting; Surgery; Nursing","score_opus":0.09151234482635487,"score_gpt":0.42408005065571475,"score_spread":0.3325677058293599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135462674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982024,0.0012806845,0.009274014,0.0016822829,0.00006641499,0.0010536346,0.0009504436,0.000094026014,0.0035744556],"genre_scores_gemma":[0.9915029,0.00030249206,0.0069826925,0.00020402233,0.000030194256,0.00016695577,0.00048272166,0.000013212762,0.00031492853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9092909,0.051036283,0.0137119675,0.003975427,0.02044402,0.001541411],"domain_scores_gemma":[0.3909915,0.46153086,0.09899834,0.018456655,0.026404325,0.0036182413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.084699355,0.0005177791,0.00079135277,0.0027029007,0.0009325818,0.0020390733,0.0018833929,0.0018139577,0.0015046141],"category_scores_gemma":[0.3505665,0.0003996169,0.0019829783,0.002121939,0.0009248904,0.002455977,0.0022044007,0.001704535,0.00036767736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002135908,0.00032198234,0.9363942,0.0003528388,0.00054209033,0.00034165336,0.001101376,0.0064663156,0.00028686275,0.0005285908,0.0010662026,0.050461996],"study_design_scores_gemma":[0.00028904498,0.009491509,0.8333338,0.0012682213,0.0019613602,0.005164104,0.0048788255,0.1263095,0.0069065103,0.0029093595,0.0071791965,0.0003086069],"about_ca_topic_score_codex":0.0064095305,"about_ca_topic_score_gemma":0.004794407,"teacher_disagreement_score":0.084699355,"about_ca_system_score_codex":0.0023973421,"about_ca_system_score_gemma":0.0029375665,"threshold_uncertainty_score":0.44793838},"labels":[],"label_agreement":null},{"id":"W2137759263","doi":"","title":"Can current electronic systems meet drug safety and effectiveness requirements?","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Record linkage; Jurisdiction; Computer science; Reimbursement; Internet privacy; Medicine; Business; Health care; Environmental health","score_opus":0.07923790634487136,"score_gpt":0.3951636659419959,"score_spread":0.31592575959712454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137759263","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1948066,0.020258049,0.13933292,0.46259698,0.002097876,0.002712524,0.006313713,0.0015699348,0.17031138],"genre_scores_gemma":[0.82855636,0.006693402,0.09699135,0.057515725,0.002211434,0.0019361296,0.0031048155,0.00023855944,0.0027523108],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.78388596,0.117183015,0.026498077,0.008475051,0.059074055,0.004883904],"domain_scores_gemma":[0.34729844,0.46799636,0.044075664,0.06734935,0.069825724,0.003454481],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19885933,0.0006101014,0.0016485967,0.0045578135,0.0021184173,0.014989501,0.004274781,0.007207304,0.011976582],"category_scores_gemma":[0.50655794,0.0006878806,0.0015997979,0.0040140487,0.006627311,0.030036492,0.0038941603,0.003046802,0.004183692],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014136904,0.00076714036,0.08759386,0.0054057,0.00063651724,0.00047191526,0.0035708754,0.008203435,0.0020655685,0.21472612,0.045550123,0.62959504],"study_design_scores_gemma":[0.0009172646,0.0038737427,0.121993735,0.012399078,0.00094473147,0.0031698896,0.013861871,0.021933828,0.011842607,0.34416756,0.46444547,0.00045029697],"about_ca_topic_score_codex":0.0033791247,"about_ca_topic_score_gemma":0.0020804596,"teacher_disagreement_score":0.80114067,"about_ca_system_score_codex":0.005188049,"about_ca_system_score_gemma":0.011638302,"threshold_uncertainty_score":0.9879491},"labels":[],"label_agreement":null},{"id":"W2139514741","doi":"10.4212/cjhp.v59i3.248","title":"Monitoring and Reporting Adverse Drug Reactions in India: Initiatives and Contributions from Pharmacists","year":2006,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Pharmacy; Clinical pharmacy; Pharmacist; Government (linguistics); Pharmaceutical care; Medicine; Health care; Family medicine; Drug reaction; Nursing; Drug; Pharmacology; Political science","score_opus":0.0615837165016143,"score_gpt":0.41005386450295234,"score_spread":0.348470148001338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139514741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4835339,0.03374231,0.004510716,0.3986608,0.0017216316,0.0012270984,0.00075019314,0.00074380083,0.07510952],"genre_scores_gemma":[0.9352061,0.02309172,0.0069116433,0.028703693,0.0013784288,0.00018888687,0.00036163928,0.00005671099,0.004101239],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98710376,0.005098607,0.0011894247,0.00080033817,0.0042540943,0.0015538571],"domain_scores_gemma":[0.9307005,0.016353471,0.0101692965,0.0023418397,0.018879559,0.021555396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014836094,0.00053611974,0.00025325269,0.0038893283,0.0022408147,0.003342575,0.0027080046,0.0020279093,0.0016009652],"category_scores_gemma":[0.024772462,0.0005385767,0.00048525154,0.002817784,0.0019019056,0.0016904661,0.005548399,0.0037899558,0.00021108986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023300815,0.0011498721,0.30862042,0.0017327805,0.00014685329,0.003914049,0.016928816,0.00054424716,0.00348372,0.0035502592,0.029206622,0.63048947],"study_design_scores_gemma":[0.00012431157,0.0010181511,0.811518,0.0013552569,0.0002079095,0.0074503273,0.02306552,0.0009479226,0.0034680115,0.0010911573,0.14954522,0.00020821746],"about_ca_topic_score_codex":0.04885037,"about_ca_topic_score_gemma":0.037507612,"teacher_disagreement_score":0.04885037,"about_ca_system_score_codex":0.0063467203,"about_ca_system_score_gemma":0.04012699,"threshold_uncertainty_score":0.09713203},"labels":[],"label_agreement":null},{"id":"W2142384667","doi":"10.1111/j.1542-4758.2010.00460.x","title":"Psoas abscess formation after acupuncture in a hemodialysis patient","year":2010,"lang":"en","type":"letter","venue":"Hemodialysis International","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Acupuncture; Hemodialysis; Internal medicine; Alternative medicine; Pathology","score_opus":0.04915638689170597,"score_gpt":0.38269416099312986,"score_spread":0.3335377741014239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142384667","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9167802,0.0049661603,0.0016546047,0.043788705,0.001719006,0.00022016288,0.000249482,0.0002177804,0.030403877],"genre_scores_gemma":[0.9842614,0.0013934567,0.0008721963,0.007980892,0.0024503167,0.000019496914,0.000068138,0.000019694387,0.0029344903],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994466,0.00009988765,0.00008534381,0.00010712498,0.000106762,0.00015430822],"domain_scores_gemma":[0.9979194,0.00089685025,0.00042386435,0.00012476048,0.00013626389,0.0004989235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040813413,0.0009655709,0.0010472124,0.0013267158,0.0024278944,0.0014691302,0.0010879138,0.009990566,0.0042483737],"category_scores_gemma":[0.004577504,0.00076337013,0.0014165322,0.00076524814,0.0010943058,0.0016524013,0.0007441325,0.005063161,0.00093146425],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000718113,0.000059209953,0.004601466,0.000022247097,0.000009192687,0.99327636,0.00017225649,0.000025104184,0.00028484623,0.000111101275,0.00055691286,0.0008095944],"study_design_scores_gemma":[0.000064127504,0.00036792576,0.014564228,0.000038104314,0.000051679817,0.9813255,0.0006282695,0.00056734803,0.0006012694,0.00034683273,0.0014234408,0.000021259395],"about_ca_topic_score_codex":0.0030085251,"about_ca_topic_score_gemma":0.004602766,"teacher_disagreement_score":0.009990566,"about_ca_system_score_codex":0.002292897,"about_ca_system_score_gemma":0.001196114,"threshold_uncertainty_score":0.016636252},"labels":[],"label_agreement":null},{"id":"W2143346814","doi":"10.2165/00002018-200932070-00004","title":"Risk Perception and Reasons for Noncompliance in Pharmacovigilance","year":2009,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacovigilance; Medicine; Patient safety; Adverse effect; Health care; Postmarketing surveillance; Perception; Health professionals; Adverse drug reaction; Scope (computer science); Under-reporting; Family medicine; Pharmacology; Drug; Psychology","score_opus":0.06591350728348887,"score_gpt":0.43933007991107614,"score_spread":0.37341657262758726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143346814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466634,0.0008186342,0.0005366753,0.0018811498,0.000026799684,0.000074180716,0.0001361125,0.00002310599,0.0018370334],"genre_scores_gemma":[0.99894446,0.00008775322,0.0004887152,0.00023570184,0.000018517632,0.000011804529,0.00006412637,0.000004715851,0.00014419602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9812991,0.00756786,0.0035316858,0.0008220685,0.005912211,0.000867087],"domain_scores_gemma":[0.8667995,0.06864607,0.04825399,0.0034959656,0.008649739,0.0041547823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019015897,0.0002568984,0.0006328609,0.0018937702,0.00088102295,0.001796415,0.00059407693,0.0015723058,0.002311446],"category_scores_gemma":[0.112870395,0.0003843771,0.0019305595,0.0012973023,0.0005191052,0.0015946606,0.0009408618,0.0025781363,0.00021993493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036388825,0.00035021867,0.9896771,0.00003681336,0.00014047952,0.00018352097,0.0010535512,0.00011958531,0.00013902201,0.00010747104,0.00027682472,0.0075516594],"study_design_scores_gemma":[0.000056904308,0.00072255323,0.9907013,0.00010631977,0.00018539684,0.0016199456,0.0023813022,0.0024756286,0.00030864825,0.00037072913,0.0010137699,0.000057450136],"about_ca_topic_score_codex":0.0059486832,"about_ca_topic_score_gemma":0.004031507,"teacher_disagreement_score":0.019015897,"about_ca_system_score_codex":0.0014444436,"about_ca_system_score_gemma":0.0020559682,"threshold_uncertainty_score":0.100566864},"labels":[],"label_agreement":null},{"id":"W2143378126","doi":"10.1136/bmjopen-2014-005869","title":"Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants","year":2014,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institutes of Health; Health Resources and Services Administration; African Population and Health Research Center; Fogarty International Center; International Development Research Centre; Wellcome Trust; Johns Hopkins University","keywords":"Medicine; Health professionals; Health care; Pharmacovigilance; Family medicine; Drug reaction; Alternative medicine; Public health; Adverse drug reaction; Drug; Nursing; Pharmacology; Pathology","score_opus":0.30643574692604736,"score_gpt":0.550254683815609,"score_spread":0.2438189368895617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143378126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939704,0.00020149324,0.000024828294,0.00009757897,0.0000022105592,0.0000063634875,0.000073946656,9.0051924e-7,0.00019560485],"genre_scores_gemma":[0.9997118,0.00013920276,0.000042628857,0.000022766526,0.000002924829,0.0000053534254,0.000034533332,2.9880232e-7,0.000040398932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986835,0.0005485487,0.00019606561,0.00015218956,0.00018511429,0.0002344974],"domain_scores_gemma":[0.99553156,0.0012547773,0.0023824244,0.00007898905,0.00030644526,0.00044577153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011954545,0.0002250386,0.00023805755,0.0008196375,0.00040936665,0.0005804451,0.00035865576,0.00049485883,0.0014180865],"category_scores_gemma":[0.007974139,0.000406477,0.0001938169,0.0009973429,0.00046623367,0.0005430153,0.0010288414,0.00045949794,0.0001975224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017013412,0.00001384309,0.9983094,0.000021892956,0.0000061078363,0.000072235554,0.00045957798,0.000014272099,0.000036989222,0.000004815963,0.000058411562,0.0009854086],"study_design_scores_gemma":[0.000002861958,0.00007271707,0.9976683,0.000040130042,0.0000042435863,0.00030407854,0.0016527987,0.000096700634,0.000017555241,0.00000815733,0.00012972779,0.000002756513],"about_ca_topic_score_codex":0.011144486,"about_ca_topic_score_gemma":0.010300822,"teacher_disagreement_score":0.011144486,"about_ca_system_score_codex":0.00046084987,"about_ca_system_score_gemma":0.00059329916,"threshold_uncertainty_score":0.022159219},"labels":[],"label_agreement":null},{"id":"W2145104696","doi":"10.1186/1472-6963-6-33","title":"Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study","year":2006,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Medical prescription; Retrospective cohort study; Health administration; Emergency medicine; Family medicine; Public health; Internal medicine; Nursing","score_opus":0.2828509305925518,"score_gpt":0.5951993198010004,"score_spread":0.3123483892084486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145104696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717927,0.00005177112,0.0004397856,0.00006425618,0.00003229531,0.0017073834,0.000073803465,0.000010470114,0.0004410084],"genre_scores_gemma":[0.9875442,0.00009421053,0.0034638264,0.00016844634,0.000104649276,0.007543142,0.00009924364,0.000007499298,0.0009748247],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.962932,0.027041774,0.0021995332,0.0028866336,0.0032629585,0.0016772357],"domain_scores_gemma":[0.8964134,0.06381401,0.024083573,0.007620809,0.003138137,0.0049300403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022589855,0.0009301392,0.0013352317,0.0008295434,0.0014630397,0.0013681737,0.0017595943,0.0014179386,0.0046226084],"category_scores_gemma":[0.040704794,0.001105317,0.0013347797,0.00060604047,0.0024402926,0.0013426355,0.0014787631,0.0015649787,0.00044260285],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21539901,0.63108504,0.07884373,0.0014226065,0.0010826398,0.00026200985,0.0077273855,0.0021492622,0.009043224,0.0010689609,0.00070803845,0.051208038],"study_design_scores_gemma":[0.04462279,0.80892545,0.13181946,0.0001170188,0.0006019927,0.00007276333,0.0016949626,0.0048983665,0.004924329,0.0005980763,0.0015886617,0.0001360678],"about_ca_topic_score_codex":0.0044992636,"about_ca_topic_score_gemma":0.0041950447,"teacher_disagreement_score":0.022589855,"about_ca_system_score_codex":0.0034931407,"about_ca_system_score_gemma":0.0050161877,"threshold_uncertainty_score":0.11946797},"labels":[],"label_agreement":null},{"id":"W2146681306","doi":"10.1136/bmjqs-2012-001704","title":"Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs","year":2013,"lang":"en","type":"article","venue":"BMJ Quality & Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources; Agency for Healthcare Research and Quality; European Commission","keywords":"Medicine; Medical prescription; Patient safety; Medical emergency; Medical education; Family medicine; Internet privacy; Nursing; Health care","score_opus":0.104538094003399,"score_gpt":0.46798897818116275,"score_spread":0.3634508841777637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146681306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873975,0.0017898025,0.0005690392,0.0015392966,0.000052884643,0.000027205915,0.00092365325,0.000018128838,0.007682583],"genre_scores_gemma":[0.9981723,0.0005707226,0.00031264906,0.00025178544,0.000021851738,0.00000950658,0.00031759468,0.000019173953,0.000324382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99445975,0.0023752858,0.00073802966,0.0009152741,0.0011175844,0.00039410862],"domain_scores_gemma":[0.9599152,0.019922337,0.013569408,0.0015065799,0.004064798,0.0010216376],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006262094,0.0001101926,0.00024579538,0.0022936095,0.00039109084,0.001523378,0.00046966143,0.00035704466,0.004134567],"category_scores_gemma":[0.031096013,0.00013936525,0.0002942746,0.0035237065,0.0012753942,0.0011510629,0.0010811697,0.0005204188,0.00041060307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035148158,0.00005518537,0.8702204,0.0004650716,0.00017905638,0.00060809334,0.04999189,0.00019238253,0.0021300605,0.0016009777,0.0030207266,0.07118461],"study_design_scores_gemma":[0.0000045800466,0.000028438548,0.9875657,0.000128894,0.000027249553,0.00035653284,0.008236426,0.00013288905,0.0002383907,0.00014452703,0.0031200207,0.000016440708],"about_ca_topic_score_codex":0.026386108,"about_ca_topic_score_gemma":0.025193136,"teacher_disagreement_score":0.99373794,"about_ca_system_score_codex":0.0009997374,"about_ca_system_score_gemma":0.000825652,"threshold_uncertainty_score":0.05246508},"labels":[],"label_agreement":null},{"id":"W2151160448","doi":"10.1503/cmaj.050971","title":"Is there still a role for spontaneous reporting of adverse drug reactions?","year":2006,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Drug reaction; Adverse effect; Adverse drug reaction; Drug; Medicine; Intensive care medicine; Computer science; Pharmacology","score_opus":0.04073053288807508,"score_gpt":0.3787673391761428,"score_spread":0.3380368062880677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151160448","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017303402,0.08857155,0.17457068,0.6646364,0.018708315,0.0029526278,0.0081185885,0.005755212,0.019383254],"genre_scores_gemma":[0.28750178,0.06977969,0.3289057,0.23705404,0.04041315,0.008026831,0.018332291,0.0024738351,0.007512688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.3048917,0.45432207,0.1328852,0.024247311,0.079677574,0.003976172],"domain_scores_gemma":[0.035194602,0.5816408,0.11719325,0.1286996,0.1291221,0.0081497],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6525808,0.0019759764,0.0065567596,0.01745562,0.0036141258,0.028956762,0.016365724,0.008072251,0.0063175424],"category_scores_gemma":[0.77726346,0.0029610672,0.004740948,0.019445743,0.010727074,0.042078435,0.013811878,0.014622202,0.004239288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001555392,0.00072628283,0.1487405,0.014035677,0.0026321502,0.00038655137,0.0074774427,0.0020159448,0.0017183108,0.07937755,0.15375958,0.58757466],"study_design_scores_gemma":[0.0012782441,0.0026730758,0.103877924,0.04013848,0.0030721175,0.0028478021,0.0091806445,0.01727069,0.00691663,0.1067796,0.70388305,0.0020817865],"about_ca_topic_score_codex":0.019074399,"about_ca_topic_score_gemma":0.008821798,"teacher_disagreement_score":0.3474192,"about_ca_system_score_codex":0.011128324,"about_ca_system_score_gemma":0.044582278,"threshold_uncertainty_score":0.42842978},"labels":[],"label_agreement":null},{"id":"W2151288094","doi":"10.1136/flgastro-2011-100030","title":"Premedications for infliximab infusions do not impact the risk of acute adverse drug reactions","year":2011,"lang":"en","type":"article","venue":"Frontline Gastroenterology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Infliximab; Premedication; Rheumatoid arthritis; Adverse effect; Retrospective cohort study; Adverse drug reaction; Drug; Internal medicine; Rheumatology; Anesthesia; Pediatrics; Disease; Pharmacology","score_opus":0.07375118469511072,"score_gpt":0.405817328536058,"score_spread":0.3320661438409473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151288094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966846,0.0021219645,0.00014727288,0.00016394259,0.00001293002,0.000012426522,0.00012349676,0.00000693104,0.0007264191],"genre_scores_gemma":[0.99936277,0.00026349744,0.0001611714,0.000041314546,0.000021177024,0.0000040405994,0.000072380084,0.0000016972579,0.00007194528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979824,0.00060438935,0.0003133205,0.00027370892,0.00067134236,0.0001548086],"domain_scores_gemma":[0.9789023,0.00453759,0.014648098,0.00039201666,0.00083863153,0.00068141747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009887796,0.00014315377,0.00027416152,0.00036765687,0.00022909328,0.0005375994,0.00021161784,0.0003887726,0.002014829],"category_scores_gemma":[0.015350776,0.00011543797,0.00038714125,0.0005313308,0.00024976727,0.00032969538,0.00020276837,0.00037978136,0.00017882478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034551887,0.000028432652,0.9911772,0.000030967607,0.000057615427,0.00009971767,0.00003618702,0.000033007942,0.0003842723,0.000007008374,0.00006679396,0.007733368],"study_design_scores_gemma":[0.00001258666,0.00026083787,0.9985203,0.000019712888,0.000037570342,0.0006912208,0.000035221914,0.00007142794,0.0001026763,0.000005707974,0.00024035035,0.000002446574],"about_ca_topic_score_codex":0.0034800244,"about_ca_topic_score_gemma":0.005723098,"teacher_disagreement_score":0.0034800244,"about_ca_system_score_codex":0.0004592492,"about_ca_system_score_gemma":0.00060047023,"threshold_uncertainty_score":0.006919503},"labels":[],"label_agreement":null},{"id":"W2151619175","doi":"10.1136/qshc.2005.014159","title":"Multiplicity of medication safety terms, definitions and functional meanings: when is enough enough?","year":2005,"lang":"en","type":"article","venue":"BMJ Quality & Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"VA National Center for Patient Safety; Agency for Healthcare Research and Quality; Monash University; Royal College of Physicians and Surgeons of Canada","keywords":"Meaning (existential); Medicine; Adverse effect; Psychology; Pharmacology","score_opus":0.2546376462465491,"score_gpt":0.4757967192736666,"score_spread":0.22115907302711751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151619175","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7106824,0.02274256,0.20453864,0.035496294,0.0013460751,0.001277277,0.0007656675,0.00040176476,0.022749234],"genre_scores_gemma":[0.9205316,0.0024507341,0.07395331,0.001331912,0.0002744082,0.0006168299,0.00038612477,0.0001001051,0.00035498533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8350336,0.10849115,0.021321861,0.007368298,0.025717316,0.002067738],"domain_scores_gemma":[0.57847506,0.32942203,0.03802546,0.022693105,0.026031809,0.0053525884],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09936293,0.0010359787,0.0026450786,0.0141030075,0.004885123,0.011785305,0.003534467,0.0030534703,0.0025170266],"category_scores_gemma":[0.3373693,0.0011193473,0.0012986585,0.009576792,0.012574264,0.03702796,0.012956432,0.0037120425,0.00044014974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017595818,0.00028937843,0.25761166,0.007160328,0.0006566758,0.0026903455,0.24627504,0.0016803975,0.007981455,0.099646725,0.005207106,0.36904132],"study_design_scores_gemma":[0.00015950546,0.0010126401,0.14890692,0.012584122,0.0007013316,0.0109690875,0.417602,0.010996993,0.0042945016,0.31520683,0.076699644,0.000866473],"about_ca_topic_score_codex":0.002593931,"about_ca_topic_score_gemma":0.0024725806,"teacher_disagreement_score":0.9006371,"about_ca_system_score_codex":0.005139333,"about_ca_system_score_gemma":0.00566139,"threshold_uncertainty_score":0.52548766},"labels":[],"label_agreement":null},{"id":"W2154935252","doi":"10.1002/pds.3508","title":"Case‐crossover study design in pharmacoepidemiology: systematic review and recommendations","year":2013,"lang":"en","type":"review","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Women's College Hospital; University of Toronto","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research","keywords":"Pharmacoepidemiology; Medicine; Clinical study design; MEDLINE; Crossover study; Research design; Odds; Odds ratio; Alternative medicine; Statistics; Internal medicine; Pharmacology; Clinical trial; Logistic regression; Pathology","score_opus":0.30807246059747123,"score_gpt":0.5375527075414992,"score_spread":0.22948024694402797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154935252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007717114,0.98896056,0.0019317984,0.0034951686,0.0012951583,0.0028898253,0.00022005796,0.000019708126,0.0004159539],"genre_scores_gemma":[0.017696202,0.9509921,0.015819263,0.0061819204,0.0012829358,0.0073616486,0.00037935647,0.000017891423,0.00026872364],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8381143,0.09162483,0.04720563,0.0053890804,0.016566174,0.0011000042],"domain_scores_gemma":[0.5819919,0.34642678,0.04198458,0.00487734,0.023616469,0.0011028392],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15002377,0.0022174446,0.010440257,0.014211647,0.0012003697,0.0059502143,0.00503329,0.0061982716,0.0058543854],"category_scores_gemma":[0.34293973,0.0022873092,0.010095637,0.011953042,0.0022027504,0.010386903,0.0021061932,0.0028839535,0.0009858256],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005112221,0.00008047697,0.0020266224,0.89755285,0.009380794,0.00013308812,0.00036423097,0.00021522793,0.00018929278,0.0011581553,0.005259492,0.08312843],"study_design_scores_gemma":[0.0013203768,0.00031157472,0.00269998,0.9348528,0.035443477,0.0002881153,0.000508624,0.000454399,0.00023802528,0.002206524,0.021610713,0.00006536813],"about_ca_topic_score_codex":0.0070698718,"about_ca_topic_score_gemma":0.017193444,"teacher_disagreement_score":0.84997624,"about_ca_system_score_codex":0.0074192826,"about_ca_system_score_gemma":0.026068367,"threshold_uncertainty_score":0.793411},"labels":[],"label_agreement":null},{"id":"W2158718916","doi":"10.1136/amiajnl-2011-000735","title":"A secure distributed logistic regression protocol for the detection of rare adverse drug events","year":2012,"lang":"en","type":"article","venue":"Journal of the American Medical Informatics Association","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; McGill University; Memorial University of Newfoundland; Agricultural Research Institute of Ontario; University of Ottawa","funders":"U.S. National Library of Medicine; Canadian Institutes of Health Research; Canada Research Chairs; Ontario Institute for Cancer Research; National Institutes of Health; National Science Foundation","keywords":"Computer science; Pooling; Protocol (science); Logistic regression; Data mining; Population; False positive paradox; Artificial intelligence; Machine learning; Medicine","score_opus":0.07351165846192852,"score_gpt":0.45950530468421863,"score_spread":0.3859936462222901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158718916","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008553476,0.00008713959,0.98671037,0.0006991744,0.00007353392,0.00062063895,0.0001779622,0.0015652922,0.001512385],"genre_scores_gemma":[0.5868473,0.00029838248,0.40174088,0.0006975416,0.00018195696,0.004284038,0.0009313269,0.00024035126,0.0047783265],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9857972,0.0067628315,0.0014155321,0.0018682858,0.0033726285,0.0007835817],"domain_scores_gemma":[0.97675294,0.011775142,0.002418802,0.005794811,0.0027268974,0.0005314738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014341484,0.0008973222,0.00112076,0.0010632079,0.0014634577,0.0024524366,0.002743028,0.0018575037,0.004595312],"category_scores_gemma":[0.034372266,0.00068998267,0.0011116762,0.0008100202,0.0019030718,0.004305555,0.006597193,0.0027350632,0.0016716699],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040407726,0.00070413074,0.008674922,0.0009817407,0.0004335013,0.0036842301,0.0023727398,0.19819447,0.04825136,0.397833,0.026882524,0.30794662],"study_design_scores_gemma":[0.00064460066,0.00047656504,0.0007010379,0.00010662575,0.000095189,0.0010523804,0.00020684158,0.8541173,0.020379057,0.10533648,0.016756019,0.00012786184],"about_ca_topic_score_codex":0.00087177305,"about_ca_topic_score_gemma":0.00053835724,"teacher_disagreement_score":0.014341484,"about_ca_system_score_codex":0.0015024408,"about_ca_system_score_gemma":0.0048495685,"threshold_uncertainty_score":0.07584596},"labels":[],"label_agreement":null},{"id":"W2161338851","doi":"10.1016/s0002-8703(03)00250-3","title":"Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials","year":2003,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Palpitations; Atrial fibrillation; Placebo; Chest pain; Anesthesia; Atrial flutter; Cardiology; Heart rate; Internal medicine; Randomized controlled trial; Blood pressure","score_opus":0.0868776728199737,"score_gpt":0.4284647431511539,"score_spread":0.3415870703311802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161338851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427311,0.05326896,0.00056594773,0.00075454335,0.00043382702,0.00045003707,0.00054424116,0.000044632812,0.0012067691],"genre_scores_gemma":[0.9875279,0.009794593,0.0005756598,0.0006629321,0.00045546432,0.0002791597,0.0004611185,0.0000087336675,0.00023436217],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99770606,0.0012650435,0.00034890257,0.00032464383,0.00019554373,0.00015973077],"domain_scores_gemma":[0.99325114,0.003734515,0.0020789283,0.0002913425,0.00021582315,0.0004281369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003251508,0.0009601352,0.0042528603,0.00063695415,0.00040625193,0.0010572402,0.00073383993,0.0022975982,0.0022715416],"category_scores_gemma":[0.0065659815,0.0005996747,0.0049713817,0.00091203395,0.0011670536,0.0010808484,0.00034763367,0.0021423397,0.0001920628],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92133737,0.0015945557,0.01997411,0.0038548585,0.018008303,0.00012299682,0.000089595065,0.000412431,0.0017985912,0.00012697343,0.0005161532,0.032164082],"study_design_scores_gemma":[0.8508593,0.060858086,0.054032564,0.00043912756,0.03069757,0.00028536122,0.00009485097,0.00060542737,0.00081023056,0.00029832195,0.00095510465,0.000064053966],"about_ca_topic_score_codex":0.0009580285,"about_ca_topic_score_gemma":0.0015921231,"teacher_disagreement_score":0.0042528603,"about_ca_system_score_codex":0.00050469686,"about_ca_system_score_gemma":0.0006508581,"threshold_uncertainty_score":0.01719582},"labels":[],"label_agreement":null},{"id":"W2161475157","doi":"10.1177/2042098611424178","title":"Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Australia; Norwegian Institute of Public Health; Institute for Clinical Evaluative Sciences; U.S. Department of Veterans Affairs","keywords":"Pharmacoepidemiology; Medicine; Drug; Pharmacovigilance; Drug reaction; Pharmacology; Medical emergency; Intensive care medicine","score_opus":0.0853446839540162,"score_gpt":0.4357289746764908,"score_spread":0.35038429072247457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161475157","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008259313,0.12277784,0.023024803,0.45357573,0.11913755,0.0019468867,0.013385033,0.0033723584,0.25452054],"genre_scores_gemma":[0.06849704,0.22645777,0.030712167,0.072826095,0.15900202,0.0014680347,0.04368327,0.0014332758,0.39592025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943699,0.0011552874,0.00052256254,0.00025523122,0.0033444944,0.00035244157],"domain_scores_gemma":[0.98163337,0.0026289402,0.002004081,0.00035741122,0.010478201,0.0028980132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00894038,0.0012523929,0.0013112681,0.0037034785,0.0008393287,0.0052150595,0.0011352911,0.0033919134,0.051501464],"category_scores_gemma":[0.018452667,0.0004806327,0.0010923129,0.0018164936,0.00038596883,0.0018842017,0.0017093502,0.0049060853,0.021892056],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015701063,0.000061805884,0.00089041266,0.00028155276,0.000038759215,0.00013632399,0.000031139007,0.00012660018,0.00056660076,0.0005011419,0.8660696,0.13113904],"study_design_scores_gemma":[0.00006961432,0.00012395428,0.0067775855,0.0006222285,0.000074963704,0.00040759414,0.00005474277,0.00041384384,0.0011011739,0.0009924265,0.9893126,0.00004926335],"about_ca_topic_score_codex":0.0021552313,"about_ca_topic_score_gemma":0.0049904315,"teacher_disagreement_score":0.051501464,"about_ca_system_score_codex":0.0016753195,"about_ca_system_score_gemma":0.0032962223,"threshold_uncertainty_score":0.17228955},"labels":[],"label_agreement":null},{"id":"W2164718117","doi":"10.4212/cjhp.v67i6.1404","title":"Measuring Adverse Drug Events on Hospital Medicine Units with the Institute for Healthcare Improvement Trigger Tool: A Chart Review","year":2014,"lang":"en","type":"review","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Adverse effect; Medical prescription; Emergency medicine; Incidence (geometry); Health care; Pharmacy; Psychological intervention; Intensive care medicine; Medical emergency; Internal medicine; Family medicine; Pharmacology","score_opus":0.19572150080192585,"score_gpt":0.43963887299040366,"score_spread":0.2439173721884778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164718117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77946407,0.022357823,0.01849918,0.0043941545,0.0009365238,0.047248922,0.081730716,0.0022380925,0.043130472],"genre_scores_gemma":[0.8848121,0.015110758,0.0446393,0.0010822489,0.0004008723,0.013046435,0.035972875,0.00013192954,0.004803442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9889065,0.0026924787,0.0034975866,0.00074515154,0.0036518842,0.00050638296],"domain_scores_gemma":[0.95456594,0.0049461243,0.012672967,0.0015134843,0.024846422,0.0014551706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073703066,0.00058776,0.0010426715,0.010330371,0.00098448,0.0012095037,0.0013107787,0.00048446242,0.001432343],"category_scores_gemma":[0.020003183,0.00048154205,0.00081562554,0.009590891,0.0004341127,0.0010532486,0.0012388044,0.0005812171,0.00049627334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004472769,0.0003605093,0.8406635,0.0034212817,0.00026169172,0.0016673692,0.0029073071,0.0006328958,0.0014247553,0.0003701336,0.036137883,0.1117054],"study_design_scores_gemma":[0.0000856069,0.00040216814,0.97152,0.0010878337,0.00013942335,0.0006725476,0.0018088871,0.000993236,0.0012173016,0.000052795334,0.021954477,0.00006575889],"about_ca_topic_score_codex":0.046571437,"about_ca_topic_score_gemma":0.059929956,"teacher_disagreement_score":0.046571437,"about_ca_system_score_codex":0.0047314917,"about_ca_system_score_gemma":0.01027152,"threshold_uncertainty_score":0.0926007},"labels":[],"label_agreement":null},{"id":"W2171426021","doi":"10.1345/aph.1c522","title":"Adverse Event Reporting with Selective Serotonin-Reuptake Inhibitors","year":2003,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Sertraline; Fluvoxamine; Adverse effect; Paroxetine; Fluoxetine; Adverse Event Reporting System; Serotonin reuptake inhibitor; Medicine; Citalopram; Reuptake inhibitor; Psychiatry; Pharmacology; Internal medicine; Antidepressant; Serotonin; Anxiety","score_opus":0.1980676768599562,"score_gpt":0.4967580464527629,"score_spread":0.2986903695928067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171426021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544307,0.014083243,0.009584193,0.0008890033,0.00020233369,0.0011646221,0.005367103,0.00021576631,0.0140631115],"genre_scores_gemma":[0.9918719,0.0017052927,0.0030723764,0.0003082115,0.00017974184,0.0002883123,0.0017546655,0.00001810957,0.0008013917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9672468,0.0121808555,0.008115754,0.001934127,0.01006737,0.00045514925],"domain_scores_gemma":[0.8266225,0.059297144,0.0985957,0.0044672824,0.010136734,0.00088068086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014335993,0.00033754858,0.00051025086,0.001698922,0.00035844347,0.00079872843,0.0005191762,0.00038027274,0.0019883628],"category_scores_gemma":[0.049946032,0.0001205735,0.0008881747,0.0024037242,0.00038771224,0.0007417578,0.0007452392,0.00055041537,0.0003042215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006605115,0.00012299474,0.94984096,0.00067380175,0.00045689027,0.00042903147,0.00028452332,0.00030179546,0.0008200796,0.00019984705,0.0011245756,0.045084942],"study_design_scores_gemma":[0.000036566995,0.0010121668,0.9860698,0.0003122092,0.00022327273,0.0035515386,0.00020507892,0.00074060354,0.002130923,0.00028485153,0.0054102694,0.000022764652],"about_ca_topic_score_codex":0.0011897717,"about_ca_topic_score_gemma":0.0012089722,"teacher_disagreement_score":0.014335993,"about_ca_system_score_codex":0.00052755635,"about_ca_system_score_gemma":0.0006295999,"threshold_uncertainty_score":0.07581687},"labels":[],"label_agreement":null},{"id":"W2173591266","doi":"10.1002/pds.3908","title":"Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System","year":2015,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Food and Drug Administration; Hamilton Health Sciences Foundation; U.S. Department of Health and Human Services","keywords":"Medicine; Food and drug administration; Cohort; Environmental health; Population; Vaccination; Emergency medicine; Medical emergency; Pediatrics; Internal medicine; Virology","score_opus":0.24923482320181728,"score_gpt":0.48510603864804197,"score_spread":0.2358712154462247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173591266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87721455,0.0008035655,0.096305355,0.0016569494,0.00030994733,0.0015408555,0.016252238,0.00080117496,0.005115322],"genre_scores_gemma":[0.9129817,0.0003148962,0.07381885,0.00047083988,0.00016903855,0.0008594759,0.010809393,0.000059298407,0.00051653216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9835782,0.010370877,0.0015576221,0.0019130205,0.0021664733,0.00041383653],"domain_scores_gemma":[0.9494328,0.012277645,0.016419405,0.008816386,0.01089169,0.0021620903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03040975,0.0005723376,0.00057682226,0.0014877071,0.00046231726,0.0010243932,0.001489767,0.00041826366,0.0015230478],"category_scores_gemma":[0.039633594,0.00043214037,0.00084515766,0.0013671056,0.00047644682,0.0016432578,0.0021006793,0.00056979735,0.0004929883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008026287,0.0002584916,0.9384402,0.00035051847,0.0004067078,0.00006756739,0.0005077472,0.004215665,0.0028838266,0.0012127111,0.004338808,0.046515204],"study_design_scores_gemma":[0.00062432134,0.0056862915,0.86666584,0.0008196748,0.0007767256,0.0004386955,0.0013935015,0.08345097,0.011584143,0.0035555835,0.024851128,0.00015306831],"about_ca_topic_score_codex":0.010219279,"about_ca_topic_score_gemma":0.013963141,"teacher_disagreement_score":0.03040975,"about_ca_system_score_codex":0.0011514095,"about_ca_system_score_gemma":0.003478196,"threshold_uncertainty_score":0.16082406},"labels":[],"label_agreement":null},{"id":"W2181417408","doi":"","title":"Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Drug reaction; Adverse effect; Adverse drug reaction; Emergency medicine; Pharmacology; Intensive care medicine","score_opus":0.0643590773031085,"score_gpt":0.33539218113724006,"score_spread":0.2710331038341316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181417408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993917,0.0002279522,0.00002267215,0.00005039442,0.0000023912046,0.000006624939,0.00014959554,0.0000015259578,0.0001471081],"genre_scores_gemma":[0.9993699,0.00016922937,0.00014417093,0.0000365629,0.000004167008,0.000009825759,0.00018178704,5.1648766e-7,0.00008389173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938154,0.00013515311,0.00009515088,0.00009945608,0.00018012349,0.00010851214],"domain_scores_gemma":[0.9989348,0.00010833181,0.0006851093,0.000020965463,0.00010879432,0.00014201271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048329544,0.00016930708,0.00021911779,0.0006406097,0.00037714772,0.00042188508,0.00027747222,0.0002864832,0.0009554506],"category_scores_gemma":[0.0011684725,0.00024056234,0.00020558045,0.00079989876,0.00021393344,0.00033599368,0.00041248125,0.00025453177,0.00007391493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025121062,0.000020221409,0.99783915,0.000028975199,0.000021149981,0.00011891914,0.00021766369,0.000012466951,0.0002491023,0.00001307732,0.00007177013,0.0013824665],"study_design_scores_gemma":[0.000002045168,0.00008995732,0.99841654,0.000012639744,0.000006753661,0.00047133252,0.00075096276,0.00004081915,0.00005259629,0.0000050709227,0.00014820426,0.0000029868868],"about_ca_topic_score_codex":0.009156431,"about_ca_topic_score_gemma":0.013632982,"teacher_disagreement_score":0.009156431,"about_ca_system_score_codex":0.0004665402,"about_ca_system_score_gemma":0.00062381534,"threshold_uncertainty_score":0.018206298},"labels":[],"label_agreement":null},{"id":"W2182051824","doi":"10.2196/publichealth.4605","title":"Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study","year":2015,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Popularity; Medicine; Medical emergency; Drug reaction; Internet privacy; Adverse effect; Patient safety; Electronic health record; Drug; Public health; Family medicine; Health care; Pharmacology; Psychology; Computer science; Nursing","score_opus":0.22200515433348977,"score_gpt":0.4807427434490249,"score_spread":0.2587375891155351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182051824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993087,0.00007381692,0.00095742854,0.00019990989,0.000016977536,0.0076742894,0.00011356811,0.000016808439,0.001016334],"genre_scores_gemma":[0.9799517,0.0002738246,0.009097566,0.000341256,0.000057600355,0.009660192,0.00017631408,0.000006385754,0.0004351877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98591924,0.010358835,0.0011652494,0.000516475,0.0011981585,0.0008421492],"domain_scores_gemma":[0.96648407,0.018061507,0.006067062,0.001805882,0.004475726,0.0031057578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022852363,0.0006387079,0.00040573272,0.0012303969,0.0010550091,0.00082443026,0.0010365641,0.001077846,0.0036951152],"category_scores_gemma":[0.027587073,0.0006042755,0.0008176118,0.00069687894,0.00085314567,0.0021235137,0.0013943213,0.0010658548,0.0007879707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02036853,0.18689391,0.5521119,0.0024874383,0.0001889931,0.0023822202,0.020613661,0.00075055595,0.008439399,0.0005509922,0.0020423094,0.20317008],"study_design_scores_gemma":[0.008546271,0.42153037,0.54252946,0.0004201101,0.00023281328,0.0018461625,0.014269742,0.0027178014,0.002958691,0.0002674274,0.004520328,0.00016083125],"about_ca_topic_score_codex":0.0019062281,"about_ca_topic_score_gemma":0.0025280036,"teacher_disagreement_score":0.022852363,"about_ca_system_score_codex":0.0009007333,"about_ca_system_score_gemma":0.004094061,"threshold_uncertainty_score":0.120856285},"labels":[],"label_agreement":null},{"id":"W2182436270","doi":"10.1007/s40264-015-0360-2","title":"Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase®","year":2015,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Circulatory and Respiratory Health; World Health Organization","keywords":"Medicine; Montelukast; Anxiety; Psychiatry; Depression (economics); Population; Pharmacovigilance; Pediatrics; Internal medicine; Drug; Asthma","score_opus":0.04465659511420584,"score_gpt":0.39752481724631095,"score_spread":0.3528682221321051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182436270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997538,0.0011722042,0.00011706313,0.00006979241,0.0000074450486,0.000014740592,0.000753027,0.000005223859,0.0003224575],"genre_scores_gemma":[0.9987067,0.000505532,0.00013484023,0.000046764613,0.000011401839,0.000009190881,0.00050471956,0.00000542004,0.00007540221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978542,0.0004961659,0.00030435977,0.000442374,0.0006340442,0.00026879282],"domain_scores_gemma":[0.9965834,0.0008761502,0.0019171953,0.00016271761,0.00022381931,0.00023665634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010471237,0.0003426131,0.000764747,0.0017145207,0.00030884793,0.0007047266,0.00034962202,0.00039506247,0.0011619023],"category_scores_gemma":[0.004097718,0.00027010782,0.0018170538,0.0018401606,0.000353286,0.0004405823,0.0011147908,0.0007262027,0.00013546407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071950664,0.000024663981,0.9932613,0.000079668556,0.0008612082,0.0003912707,0.00009690334,0.00003865703,0.00041707745,0.0000546347,0.0001754959,0.0038797858],"study_design_scores_gemma":[0.00004390207,0.0002429668,0.99576074,0.000044076085,0.0008015921,0.001895059,0.00028016773,0.00017839142,0.00026370626,0.000024861485,0.00045326722,0.000011385371],"about_ca_topic_score_codex":0.007212792,"about_ca_topic_score_gemma":0.0072788266,"teacher_disagreement_score":0.007212792,"about_ca_system_score_codex":0.00085540983,"about_ca_system_score_gemma":0.00073077524,"threshold_uncertainty_score":0.014341593},"labels":[],"label_agreement":null},{"id":"W2192171349","doi":"10.1371/journal.pone.0144337","title":"Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada","year":2015,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of General Medical Sciences","keywords":"Pharmacovigilance; Adverse Event Reporting System; Rivastigmine; Adverse effect; Medicine; Database; Cholinesterase; Odds ratio; Dementia; Pharmacology; Pharmacoepidemiology; Internal medicine; Disease; Donepezil","score_opus":0.12821406201849403,"score_gpt":0.3728073676692244,"score_spread":0.24459330565073037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192171349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8251962,0.0087605165,0.00083833735,0.00072952,0.000020865875,0.0002898345,0.1576826,0.00011333782,0.006368848],"genre_scores_gemma":[0.9516172,0.005090063,0.0009454288,0.00034678352,0.000021318725,0.00012525398,0.041116484,0.00001738453,0.00072011014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99429387,0.00059918704,0.0014364446,0.0006902339,0.00267327,0.00030696375],"domain_scores_gemma":[0.97919077,0.0033629453,0.01021692,0.00051669223,0.0060440837,0.00066859904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002260857,0.0002648106,0.00047918851,0.005920665,0.000640661,0.0012453467,0.0007375941,0.00023351515,0.0011875293],"category_scores_gemma":[0.018511513,0.0002196386,0.0007209923,0.011905381,0.0002550582,0.00046188777,0.0006689353,0.00027644268,0.00016721881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001262666,0.000017130506,0.9877473,0.00025925375,0.0003090234,0.000080856254,0.00019837075,0.00019145694,0.00009748114,0.00008831171,0.003366586,0.0075179003],"study_design_scores_gemma":[0.000014374694,0.000024386876,0.995756,0.00009213329,0.00014483975,0.000283159,0.00028312847,0.00035043265,0.00013493534,0.00002849038,0.0028740917,0.000014143036],"about_ca_topic_score_codex":0.846841,"about_ca_topic_score_gemma":0.836958,"teacher_disagreement_score":0.15315902,"about_ca_system_score_codex":0.0074815825,"about_ca_system_score_gemma":0.013314958,"threshold_uncertainty_score":0.30812198},"labels":[],"label_agreement":null},{"id":"W2195497078","doi":"10.1684/jpc.2015.0313","title":"Identification des causes de défaillance à l’origine de retraits tardifs du marché et récentes réformes du système de pharmacovigilance au Canada","year":2015,"lang":"fr","type":"article","venue":"Journal de Pharmacie Clinique","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science; Humanities; Pharmacovigilance; Philosophy; Medicine; Drug","score_opus":0.10665495110156464,"score_gpt":0.43510681586808353,"score_spread":0.3284518647665189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2195497078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8981281,0.020164343,0.0021215193,0.051778615,0.00029750235,0.00015508465,0.005475607,0.0001562171,0.021723041],"genre_scores_gemma":[0.98717207,0.0061648665,0.00071463897,0.0015886372,0.00011818721,0.000023376386,0.00094894937,0.000039701557,0.003229586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626666,0.00038579336,0.0003129537,0.00045574116,0.0015398996,0.0010390125],"domain_scores_gemma":[0.9828759,0.0020938409,0.0062698643,0.00055714935,0.0057329647,0.0024702859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027944525,0.00025765144,0.00043120075,0.0021362691,0.0019052332,0.0023642292,0.0010780118,0.0008075763,0.0055767274],"category_scores_gemma":[0.016265202,0.0003613597,0.0006571687,0.0039140075,0.0013717382,0.0008707635,0.0011500124,0.0030289493,0.00027359437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022796029,0.00005678738,0.93027943,0.00018807343,0.00013652329,0.00091563957,0.0026255166,0.00037676634,0.00040936464,0.0027769909,0.00909918,0.052907754],"study_design_scores_gemma":[0.000012061434,0.000042534666,0.98229086,0.00027433352,0.00006031418,0.00078184827,0.0025335143,0.00067186885,0.00039243168,0.0004535627,0.012456399,0.000030236013],"about_ca_topic_score_codex":0.8716032,"about_ca_topic_score_gemma":0.899106,"teacher_disagreement_score":0.9771882,"about_ca_system_score_codex":0.022811787,"about_ca_system_score_gemma":0.037668932,"threshold_uncertainty_score":0.2583059},"labels":[],"label_agreement":null},{"id":"W2231684654","doi":"10.1177/1060028015602274","title":"Adverse Drug Reactions Reported With Cholinesterase Inhibitors","year":2015,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Top Institute Pharma; Novo Nordisk; College ter Beoordeling van Geneesmiddelen; GlaxoSmithKline; World Health Organization; Universiteit Utrecht","keywords":"Medicine; Pharmacovigilance; Rivastigmine; Donepezil; Galantamine; Adverse drug reaction; Disease; Adverse effect; Dementia; Pharmacology; Drug; Internal medicine","score_opus":0.3178635584416977,"score_gpt":0.5096920044994403,"score_spread":0.19182844605774257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231684654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88871455,0.07026064,0.0013366354,0.0007693254,0.00016108845,0.00060655706,0.026115961,0.00014554294,0.011889648],"genre_scores_gemma":[0.977857,0.013047308,0.001215173,0.000558415,0.00013117079,0.00017611042,0.0063839843,0.000015760437,0.00061503035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99363047,0.0013806792,0.0025663553,0.00069395325,0.0015216867,0.00020686215],"domain_scores_gemma":[0.97633356,0.0042082663,0.017320428,0.00057319703,0.0012700091,0.00029453292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029922398,0.0003446854,0.0006759482,0.0019718234,0.00018987994,0.00071702903,0.00033739835,0.0003060452,0.0021440294],"category_scores_gemma":[0.011906783,0.000115075716,0.0012254601,0.0030864095,0.0002799106,0.00037620065,0.00052951684,0.00041441547,0.00032194165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062069105,0.000034682,0.9610189,0.0025988456,0.0011951743,0.0012093998,0.0003333817,0.00027773913,0.0005212568,0.00008678156,0.0018830616,0.030220164],"study_design_scores_gemma":[0.00005712467,0.00030288947,0.98036534,0.0012253489,0.0007122843,0.005811408,0.00034180467,0.00019602041,0.00081493263,0.0001220417,0.01003011,0.000020584677],"about_ca_topic_score_codex":0.0029211142,"about_ca_topic_score_gemma":0.0027629752,"teacher_disagreement_score":0.0029922398,"about_ca_system_score_codex":0.0006864429,"about_ca_system_score_gemma":0.00058025564,"threshold_uncertainty_score":0.015824676},"labels":[],"label_agreement":null},{"id":"W2255285771","doi":"10.1002/pds.3979","title":"Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014","year":2016,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Food and drug administration; Adverse Event Reporting System; Drug; Adverse effect; Pharmacoepidemiology; Completeness (order theory); Drug administration; Administration (probate law); Adverse drug event; Pharmacology; Internal medicine; Medical prescription","score_opus":0.05127452043649648,"score_gpt":0.3988565176269323,"score_spread":0.3475819971904358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255285771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8966126,0.009121723,0.006780202,0.002622183,0.00024761364,0.0010141779,0.06976967,0.0007042395,0.013127611],"genre_scores_gemma":[0.9505787,0.0025176513,0.0046636024,0.0006615351,0.00015313792,0.00035414874,0.039747216,0.00007892538,0.0012451647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95728064,0.012141243,0.013775895,0.0028013345,0.012958281,0.0010425749],"domain_scores_gemma":[0.76901656,0.061612114,0.09506488,0.012827856,0.059153445,0.0023252433],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.035721477,0.00044949492,0.00059468934,0.00916462,0.0004913541,0.0019486313,0.0014092918,0.000508289,0.0015056444],"category_scores_gemma":[0.13636611,0.00044111375,0.00093055144,0.00650382,0.00062620343,0.0017011021,0.0021915848,0.0006073727,0.0006257664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040152587,0.000055884346,0.9498927,0.0005797201,0.00033240335,0.00009941752,0.0008076936,0.00050086644,0.00027968432,0.0002547723,0.0068170405,0.03997833],"study_design_scores_gemma":[0.00003285938,0.0002484579,0.980698,0.0004027285,0.00016957418,0.00039822067,0.000841294,0.00095344876,0.0014426546,0.00016366698,0.0146114845,0.000037710455],"about_ca_topic_score_codex":0.012901968,"about_ca_topic_score_gemma":0.006052156,"teacher_disagreement_score":0.9642785,"about_ca_system_score_codex":0.0021846136,"about_ca_system_score_gemma":0.0038518712,"threshold_uncertainty_score":0.18891549},"labels":[],"label_agreement":null},{"id":"W2260989074","doi":"","title":"Veterinary Pharmacovigilance: Adverse Reactions to Veterinary Medicinal Products","year":2011,"lang":"en","type":"article","venue":"Europe PMC (PubMed Central)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; European union; Veterinary Drugs; Government (linguistics); Medicine; Veterinary medicine; Business; Pharmacology; Adverse effect","score_opus":0.1797442158882626,"score_gpt":0.3892993087736338,"score_spread":0.2095550928853712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260989074","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061663482,0.3330504,0.019622847,0.040584445,0.049823254,0.00084826024,0.004141942,0.0025420303,0.54322046],"genre_scores_gemma":[0.024953654,0.22735807,0.018983064,0.045121517,0.026543396,0.0004906726,0.00513831,0.0012584059,0.65015286],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99767846,0.00044897513,0.00020420429,0.00024075447,0.0013153581,0.000112267444],"domain_scores_gemma":[0.99620456,0.0020726437,0.00054131245,0.00018554198,0.00084414834,0.00015186435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011255232,0.0013569735,0.0013985903,0.002037303,0.00086554675,0.00447788,0.001108613,0.0026734474,0.04622888],"category_scores_gemma":[0.0049223257,0.0006488356,0.001361658,0.002297126,0.00093699,0.003284341,0.0014892955,0.0039050537,0.026513906],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053973035,0.00009668931,0.00047253317,0.0020713985,0.00003076655,0.00033818636,0.0005369654,0.0006595855,0.0013012402,0.01149024,0.7801496,0.20279889],"study_design_scores_gemma":[0.0000069548983,0.00007161105,0.0010435139,0.00095949083,0.000010504346,0.00075502123,0.00012081641,0.0001611229,0.00022195066,0.0033343707,0.9932991,0.0000155006],"about_ca_topic_score_codex":0.0019210302,"about_ca_topic_score_gemma":0.0025612593,"teacher_disagreement_score":0.04622888,"about_ca_system_score_codex":0.0012180296,"about_ca_system_score_gemma":0.0018831708,"threshold_uncertainty_score":0.15465105},"labels":[],"label_agreement":null},{"id":"W2262941380","doi":"10.1186/s12916-016-0579-5","title":"Drug safety: withdrawn medications are only part of the picture","year":2016,"lang":"en","type":"letter","venue":"BMC Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital","funders":"","keywords":"Medicine; Patient safety; Agency (philosophy); Drug approval; Drug; Risk analysis (engineering); Pharmacology; Health care; Law","score_opus":0.0862098308551564,"score_gpt":0.4069625153012961,"score_spread":0.3207526844461397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262941380","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005835408,0.004998861,0.00023720549,0.98563856,0.006503809,0.000006311909,0.00003337981,0.00003097446,0.0019673724],"genre_scores_gemma":[0.0062304023,0.005371872,0.00043650003,0.9631371,0.021678943,0.000010729991,0.000033792458,0.00002426556,0.003076435],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914955,0.0023781562,0.0012837922,0.001085034,0.0032576995,0.00049973116],"domain_scores_gemma":[0.9818657,0.009300847,0.002393534,0.0006845965,0.0038408556,0.0019145778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058254194,0.0008291127,0.0012106685,0.0009604961,0.0038653018,0.003664835,0.0015324062,0.02813955,0.007149305],"category_scores_gemma":[0.03395898,0.00043651933,0.0012328763,0.00094617234,0.0047260625,0.011024342,0.0022636768,0.03233205,0.0071146786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010294623,0.000055610955,0.0022531461,0.0004032146,0.000038806047,0.01126652,0.0010437471,0.00008836761,0.00074239715,0.0069435914,0.9145661,0.062495645],"study_design_scores_gemma":[0.000061641644,0.00013333414,0.0020583891,0.0012258595,0.00004727757,0.03406612,0.0017991477,0.0002215723,0.00042494823,0.015933093,0.9439294,0.0000992531],"about_ca_topic_score_codex":0.00398286,"about_ca_topic_score_gemma":0.004897686,"teacher_disagreement_score":0.02813955,"about_ca_system_score_codex":0.004614257,"about_ca_system_score_gemma":0.0034576105,"threshold_uncertainty_score":0.033478975},"labels":[],"label_agreement":null},{"id":"W2263354170","doi":"","title":"Comments to regional problems of analgesic risk perception.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Analgesic; Visual analogue scale; Medicine; Perception; Quarter (Canadian coin); Adverse drug reaction; Drug; Risk perception; Adverse effect; Drug reaction; Anesthesia; Family medicine; Psychology; Pharmacology; Geography","score_opus":0.27595013409316305,"score_gpt":0.3973573173645603,"score_spread":0.12140718327139727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263354170","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89953345,0.010213478,0.0016761997,0.05876633,0.0016541518,0.00017608328,0.0009110003,0.00010734498,0.02696191],"genre_scores_gemma":[0.9840506,0.0024365343,0.00041336275,0.008305262,0.0006219087,0.000051195737,0.00013915595,0.000014846797,0.003967174],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977812,0.0014069431,0.000150465,0.00011998726,0.00032792386,0.00021343297],"domain_scores_gemma":[0.9849842,0.0073445966,0.004581589,0.0003017885,0.0019675386,0.00082021474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029900686,0.00022280095,0.00015197461,0.00035888783,0.00063775806,0.00053927326,0.00027583397,0.0010462297,0.009675871],"category_scores_gemma":[0.018320499,0.00010183005,0.00031182403,0.0004406489,0.0006482997,0.00062116724,0.0008564493,0.000917078,0.0008507513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014648731,0.00039705826,0.5152982,0.004481994,0.00019892931,0.010960198,0.13067496,0.00068416557,0.007836539,0.0021587487,0.09977101,0.22607334],"study_design_scores_gemma":[0.0001850987,0.0017547881,0.5535007,0.0021149027,0.00017455754,0.015974138,0.16565062,0.0006554413,0.002099088,0.000861425,0.25688684,0.00014238767],"about_ca_topic_score_codex":0.0021958568,"about_ca_topic_score_gemma":0.0024888322,"teacher_disagreement_score":0.009675871,"about_ca_system_score_codex":0.00065779436,"about_ca_system_score_gemma":0.0005988688,"threshold_uncertainty_score":0.032368958},"labels":[],"label_agreement":null},{"id":"W2279956772","doi":"10.1503/cmaj.150901","title":"Macrolide antibiotics and the risk of ventricular arrhythmia in older adults","year":2016,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Institute for Clinical Evaluative Sciences; Western University","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Pfizer","keywords":"Antibiotics; Medicine; Macrolide Antibiotics; Cardiac arrhythmia; Intensive care medicine; Internal medicine; Cardiology; Computer science; Atrial fibrillation; Microbiology; Biology; Erythromycin","score_opus":0.012503925636734262,"score_gpt":0.32226199396704175,"score_spread":0.3097580683303075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279956772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995229,0.0035733,0.00010033856,0.00016702285,0.000013503207,0.0000088089555,0.00027701803,0.0000033555161,0.0006275671],"genre_scores_gemma":[0.99904555,0.0006533487,0.0000665839,0.00004103735,0.000019328243,0.000003290525,0.00010920619,6.8779246e-7,0.000061006966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956554,0.00011545088,0.00005929236,0.000080630685,0.00012176844,0.00005719208],"domain_scores_gemma":[0.9977556,0.00027025677,0.0014921303,0.000100100726,0.0001556699,0.00022627987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000648767,0.00014828346,0.00019160459,0.00036614775,0.00018158146,0.0003779165,0.00019971808,0.00035500838,0.0007961505],"category_scores_gemma":[0.0031405347,0.000115692186,0.0005688128,0.0004093358,0.00017001062,0.0001784577,0.00030256843,0.00038519767,0.00008117181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010764777,0.000011391767,0.9980767,0.000020618874,0.00008867903,0.000025937421,0.000017864922,0.000025609706,0.00007410873,0.000014923657,0.00005770207,0.0014788948],"study_design_scores_gemma":[0.000010590256,0.00007994643,0.9992506,0.000019536563,0.000068575115,0.00015695099,0.00002621516,0.00014095855,0.000028828788,0.000030716514,0.00018532116,0.0000016642367],"about_ca_topic_score_codex":0.0076659615,"about_ca_topic_score_gemma":0.009397258,"teacher_disagreement_score":0.0076659615,"about_ca_system_score_codex":0.0003502285,"about_ca_system_score_gemma":0.0003374318,"threshold_uncertainty_score":0.015242696},"labels":[],"label_agreement":null},{"id":"W2291886830","doi":"10.1186/s40064-016-1838-9","title":"Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study—study protocol","year":2016,"lang":"en","type":"article","venue":"SpringerPlus","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"University of Ottawa","keywords":"Pharmacovigilance; Medicine; Drug reaction; Adverse drug reaction; Vigilance (psychology); Seriousness; Family medicine; Medical emergency; Adverse effect; Drug; Pharmacology; Psychology","score_opus":0.07610000520316419,"score_gpt":0.44525697866229375,"score_spread":0.36915697345912957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291886830","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077937176,0.00051996135,0.0017666103,0.00013524419,0.00007727987,0.98729044,0.001739935,0.00003513966,0.0006415766],"genre_scores_gemma":[0.010073396,0.00024778355,0.0050397785,0.0002575458,0.00002484419,0.9836309,0.00045590647,0.000005515266,0.00026443493],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9638187,0.01702239,0.007378889,0.0035999888,0.0061342902,0.0020456538],"domain_scores_gemma":[0.9625551,0.009308136,0.007414592,0.004056082,0.0147623215,0.0019037217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057807315,0.003257801,0.0060028415,0.0037575837,0.0053142696,0.003926235,0.0038230014,0.004415627,0.019073088],"category_scores_gemma":[0.050560478,0.0031794219,0.0053569963,0.0054187677,0.0031587502,0.0028737467,0.0024019983,0.0027896848,0.0033620305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30376503,0.05961693,0.11898028,0.14805023,0.013450107,0.0037352757,0.02349025,0.009391693,0.0060168933,0.016501177,0.073541194,0.22346097],"study_design_scores_gemma":[0.33152613,0.080133274,0.2998481,0.039953846,0.0088624535,0.0011562357,0.013607653,0.014784538,0.0045504444,0.007546431,0.19641997,0.0016109364],"about_ca_topic_score_codex":0.09737273,"about_ca_topic_score_gemma":0.17271507,"teacher_disagreement_score":0.9026273,"about_ca_system_score_codex":0.021728918,"about_ca_system_score_gemma":0.068406895,"threshold_uncertainty_score":0.30571795},"labels":[],"label_agreement":null},{"id":"W2302755114","doi":"","title":"Perception de la pharmacovigilance par les futurs pharmaciens hospitaliers belges, français, québécois et suisses","year":2014,"lang":"fr","type":"article","venue":"ORBi (University of Liège)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacovigilance; Perception; Humanities; Psychology; Psychiatry; Drug; Art","score_opus":0.03192790049339992,"score_gpt":0.3513369735820085,"score_spread":0.31940907308860855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302755114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499184,0.0008923033,0.000102426915,0.0011309921,0.00001807027,0.00003975492,0.00070258597,0.0000064808564,0.0021155472],"genre_scores_gemma":[0.9977939,0.0004080663,0.00013157068,0.0003017539,0.00001119502,0.000027367276,0.00028001302,0.0000025905665,0.0010436524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979588,0.0006745707,0.00016138545,0.00016854441,0.00055503746,0.00048154296],"domain_scores_gemma":[0.99165183,0.0017788459,0.0032000805,0.00014450232,0.0017450306,0.0014796429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032215728,0.00017695829,0.0002627514,0.00097252073,0.0010681638,0.0014423605,0.00033592674,0.0004381828,0.0034279698],"category_scores_gemma":[0.008151833,0.00021625272,0.00044854343,0.0014945114,0.00061455247,0.00069422345,0.0006572868,0.00052532664,0.000216637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002077709,0.00007016472,0.98029363,0.000098771816,0.00007641365,0.00010771634,0.006360734,0.00010086891,0.00026637863,0.0001629547,0.0023455499,0.009909195],"study_design_scores_gemma":[0.00000816107,0.00009355924,0.9931172,0.000051034964,0.000014818349,0.00003839755,0.0047192923,0.000086750915,0.000030575764,0.000007190521,0.0018247509,0.000008226114],"about_ca_topic_score_codex":0.726611,"about_ca_topic_score_gemma":0.72387314,"teacher_disagreement_score":0.726611,"about_ca_system_score_codex":0.006139872,"about_ca_system_score_gemma":0.0064646103,"threshold_uncertainty_score":0.54999804},"labels":[],"label_agreement":null},{"id":"W2304094619","doi":"10.1111/bcp.12944","title":"Adverse drug event reporting systems: a systematic review","year":2016,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Simon Fraser University; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"MedDRA; Comparability; Terminology; Pharmacovigilance; Data quality; Computer science; Data mining; Grey literature; Data science; Incident report; Adverse Event Reporting System; Medicine; Information retrieval; Risk analysis (engineering); MEDLINE; Drug; Business; Computer security; Pharmacology; Mathematics","score_opus":0.3077336007264174,"score_gpt":0.5964871728549426,"score_spread":0.28875357212852515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304094619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014285485,0.9922943,0.0010781055,0.0013938136,0.00028358254,0.0014315721,0.0014673222,0.000037703197,0.0005849884],"genre_scores_gemma":[0.029606512,0.9547403,0.007221449,0.0015157441,0.0003055069,0.004332974,0.0020554147,0.00003078371,0.00019125227],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.88103145,0.056709662,0.041264687,0.0041115256,0.015923083,0.00095962844],"domain_scores_gemma":[0.6285489,0.2634338,0.06905561,0.0063854535,0.0313233,0.0012529176],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07920685,0.0019525561,0.0079816375,0.027368149,0.0013845065,0.004328716,0.0033617348,0.002567387,0.005592274],"category_scores_gemma":[0.267902,0.0015370877,0.008909037,0.028051088,0.0019830076,0.0066842088,0.003294717,0.002154323,0.0008026256],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017497076,0.000024484783,0.0017394373,0.90972376,0.004094465,0.00006540219,0.00036923477,0.00020093103,0.000080150174,0.00053382997,0.0044757267,0.078517675],"study_design_scores_gemma":[0.00023566998,0.00019324919,0.0050948695,0.95621157,0.01544268,0.00021840667,0.00036377012,0.00018678533,0.0001488298,0.00064459135,0.021204643,0.000054968234],"about_ca_topic_score_codex":0.0069241705,"about_ca_topic_score_gemma":0.0134845115,"teacher_disagreement_score":0.9207932,"about_ca_system_score_codex":0.008038532,"about_ca_system_score_gemma":0.023198422,"threshold_uncertainty_score":0.41889083},"labels":[],"label_agreement":null},{"id":"W2306613735","doi":"","title":"カナダにおける医薬品安全対策と医療データベース（1）―保健省の取り組みと州のデータベース","year":2010,"lang":"ja","type":"article","venue":"医学のあゆみ","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.09322393058777492,"score_gpt":0.4566806979627404,"score_spread":0.36345676737496546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306613735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51783687,0.01128039,0.045896422,0.011934623,0.0009357169,0.00050788996,0.0006676787,0.00024478624,0.41069567],"genre_scores_gemma":[0.95072514,0.0023549076,0.012527932,0.0012204407,0.000399048,0.00009602023,0.00015221168,0.000019353538,0.032504927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990502,0.00029913062,0.000063819614,0.00021148074,0.00029373236,0.00008165992],"domain_scores_gemma":[0.9977946,0.000756004,0.0004629163,0.000085549604,0.0006949137,0.00020600286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015209812,0.00028611772,0.0002697105,0.0006899001,0.00079923816,0.0022915287,0.00048691122,0.00070674665,0.008199904],"category_scores_gemma":[0.0034101135,0.00020549793,0.00037522803,0.0003455751,0.0012000683,0.001436211,0.0005276345,0.00081504864,0.0012607931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012164059,0.00076377357,0.12294768,0.001032431,0.00038351034,0.0010365924,0.0050485455,0.0026267928,0.060307093,0.1508331,0.011841049,0.641963],"study_design_scores_gemma":[0.00029393926,0.004387077,0.33080128,0.0008093987,0.001372203,0.0061227777,0.0091858525,0.008247391,0.121342555,0.20362933,0.31349626,0.0003120144],"about_ca_topic_score_codex":0.002670267,"about_ca_topic_score_gemma":0.0022263327,"teacher_disagreement_score":0.9988226,"about_ca_system_score_codex":0.001177358,"about_ca_system_score_gemma":0.0013407858,"threshold_uncertainty_score":0.027431428},"labels":[],"label_agreement":null},{"id":"W2307987278","doi":"10.1186/s40545-016-0053-y","title":"Governance and pharmacovigilance in Brazil: a scoping review","year":2016,"lang":"en","type":"review","venue":"Journal of Pharmaceutical Policy and Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College; University of Toronto","funders":"York University","keywords":"Pharmacovigilance; Mandate; Corporate governance; Public administration; Stakeholder; Equity (law); Regulatory authority; Business; Political science; Medicine; Public relations; Pharmacology; Finance; Law; Drug","score_opus":0.26858377892039464,"score_gpt":0.6202632099419906,"score_spread":0.35167943102159593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307987278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005663826,0.9970884,0.00020785899,0.0010571138,0.00007736163,0.00005772421,0.000080432925,0.0000040042523,0.0008607155],"genre_scores_gemma":[0.0105310995,0.98815733,0.0005227421,0.0004302687,0.00007486289,0.00011745797,0.000092752845,0.000003275969,0.000070301285],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9869652,0.00517311,0.0042604487,0.0008551707,0.0023545718,0.00039160746],"domain_scores_gemma":[0.91538167,0.06441171,0.011399574,0.0011269865,0.007054923,0.00062508695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015708538,0.0011253152,0.0027021193,0.01783968,0.001255888,0.005061674,0.0020062556,0.002940849,0.0028726934],"category_scores_gemma":[0.08531373,0.0010333114,0.003681598,0.022537135,0.0020033305,0.0038314534,0.0022804986,0.0017087919,0.0002670244],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011506236,0.000057336652,0.0059986785,0.6088997,0.0024258206,0.000576488,0.0033472844,0.00094631605,0.00027525687,0.013152229,0.0102412,0.3539646],"study_design_scores_gemma":[0.000033362983,0.0000669099,0.005886977,0.8880234,0.004236277,0.0006679804,0.0015634814,0.00026161983,0.00018492714,0.0023918126,0.09664448,0.00003888665],"about_ca_topic_score_codex":0.03583349,"about_ca_topic_score_gemma":0.047782302,"teacher_disagreement_score":0.03583349,"about_ca_system_score_codex":0.00785334,"about_ca_system_score_gemma":0.038662657,"threshold_uncertainty_score":0.08307564},"labels":[],"label_agreement":null},{"id":"W2310997862","doi":"10.7439/ijbr.v7i3.3040","title":"Vaccine adverse events reporting system globally","year":2016,"lang":"en","type":"article","venue":"International Journal of Biomedical Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Pharmacovigilance; Adverse Event Reporting System; Vaccination; Polio vaccine; Diphtheria; Immunization; Pharmacist; Pediatrics; Harm; Family medicine; Medical emergency; Intensive care medicine; Poliomyelitis; Immunology; Pharmacy; Internal medicine","score_opus":0.27309838283736354,"score_gpt":0.5865539016787366,"score_spread":0.313455518841373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2310997862","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011520115,0.0119789345,0.031939995,0.022123951,0.0033594624,0.0065761684,0.6462717,0.029734291,0.23649544],"genre_scores_gemma":[0.086291745,0.018219287,0.040316835,0.017713299,0.0026769214,0.007128467,0.7612845,0.0029053895,0.063463606],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.97122926,0.007857887,0.009673245,0.0021482483,0.007991026,0.0011004193],"domain_scores_gemma":[0.8514866,0.026199937,0.046846893,0.013184296,0.05905059,0.0032316856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01978466,0.0013365918,0.0014018967,0.012283539,0.0007061461,0.0037987102,0.002516391,0.0024201067,0.040914387],"category_scores_gemma":[0.062088806,0.00057496125,0.0011725326,0.0128425835,0.0005462913,0.0038072239,0.0022917574,0.00230534,0.046164177],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048998394,0.00013690707,0.020619871,0.0034284287,0.00018961895,0.00033292398,0.00040009143,0.00085311406,0.002420949,0.007990256,0.7645374,0.19860047],"study_design_scores_gemma":[0.00009343012,0.00015340367,0.021119563,0.001277025,0.000096295844,0.00049097795,0.00016978297,0.0010535074,0.0018601312,0.0019879667,0.97161794,0.00007998775],"about_ca_topic_score_codex":0.0064632203,"about_ca_topic_score_gemma":0.0017757196,"teacher_disagreement_score":0.040914387,"about_ca_system_score_codex":0.0021617191,"about_ca_system_score_gemma":0.008391774,"threshold_uncertainty_score":0.13687223},"labels":[],"label_agreement":null},{"id":"W2321936058","doi":"10.5649/jjphcs.35.542","title":"Effect of Instructions on the Use of HMG-CoA Reductase Inhibitors (Statins) on Patient Compliance:-Information on Rhabdomyolysis Provided by Pharmacists Working at Pharmacy Outlets-","year":2009,"lang":"en","type":"article","venue":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Rhabdomyolysis; Medicine; Pharmacy; Adverse effect; Pharmacist; Drug; Compliance (psychology); Family medicine; Medical emergency; Pharmacology; Intensive care medicine; Internal medicine; Psychology","score_opus":0.17413681858037627,"score_gpt":0.4739984842644608,"score_spread":0.2998616656840845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321936058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987087,0.00015316824,0.00003730122,0.00027643263,0.000013755239,0.00004478247,0.000052881707,0.00000760346,0.0007053628],"genre_scores_gemma":[0.99865925,0.0001513666,0.00038339582,0.00022921509,0.000030447332,0.000056655444,0.00009070929,0.0000033637375,0.00039560915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938699,0.0040752,0.00067365804,0.00022311477,0.0007966942,0.00036143884],"domain_scores_gemma":[0.9296579,0.049663864,0.014477553,0.0013169812,0.0019945374,0.0028891375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059937946,0.00028516835,0.00042822742,0.0003219745,0.00047525097,0.00050146814,0.00032609052,0.0010184476,0.0045359936],"category_scores_gemma":[0.050390225,0.00027351323,0.0009898046,0.00044595962,0.00024604698,0.00070091116,0.00055123784,0.0010181144,0.0004854889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03607212,0.049420565,0.73829997,0.0009596686,0.0010845005,0.00040912133,0.0026743081,0.00087819836,0.0025323983,0.00010250679,0.0013614034,0.16620524],"study_design_scores_gemma":[0.0017029169,0.043222003,0.9486852,0.00015561364,0.00057911844,0.00020807683,0.0007526649,0.0017157012,0.001478316,0.00006798853,0.0013981814,0.000034231933],"about_ca_topic_score_codex":0.0024965426,"about_ca_topic_score_gemma":0.0032068458,"teacher_disagreement_score":0.0059937946,"about_ca_system_score_codex":0.00050669216,"about_ca_system_score_gemma":0.001076395,"threshold_uncertainty_score":0.031698644},"labels":[],"label_agreement":null},{"id":"W2323447718","doi":"10.3389/fphar.2016.00090","title":"Patient Participation and the Use of Ehealth Tools for Pharmacoviligance","year":2016,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacovigilance; The Internet; Upload; Mobile phone; eHealth; Internet privacy; Data collection; Phone; Information and Communications Technology; Medicine; World Wide Web; Computer science; Health care; Drug; Telecommunications; Pharmacology","score_opus":0.2909917475334471,"score_gpt":0.5107007981387006,"score_spread":0.21970905060525353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323447718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006754507,0.9924074,0.00074256764,0.002035236,0.0002656673,0.000034104956,0.00007398663,0.00002435201,0.0037413468],"genre_scores_gemma":[0.010220217,0.9843462,0.0015625422,0.001689134,0.00079560897,0.000102183745,0.00014627363,0.00001009468,0.0011276691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99364203,0.003237275,0.0006715634,0.0004572915,0.0018394293,0.0001523595],"domain_scores_gemma":[0.9779196,0.01848884,0.0019138637,0.0004174973,0.0010048737,0.00025537438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008202394,0.00064861984,0.0013209833,0.002185154,0.0002570498,0.0020096553,0.0010573807,0.0018645896,0.0064279255],"category_scores_gemma":[0.0160268,0.0002051156,0.0010898171,0.00209707,0.0008552081,0.0020161958,0.0015014047,0.0017781139,0.0013813857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070662216,0.000060354716,0.0006453146,0.010367781,0.000098671415,0.00007572077,0.00019403269,0.0000729283,0.00017661016,0.0022663313,0.0059345555,0.9800371],"study_design_scores_gemma":[0.00014870432,0.00042485763,0.00858739,0.04459618,0.0006778366,0.003058874,0.00046215777,0.00027243394,0.001433591,0.006066604,0.9341817,0.00008968595],"about_ca_topic_score_codex":0.0006308573,"about_ca_topic_score_gemma":0.00066008157,"teacher_disagreement_score":0.008202394,"about_ca_system_score_codex":0.000584804,"about_ca_system_score_gemma":0.0016552213,"threshold_uncertainty_score":0.04337889},"labels":[],"label_agreement":null},{"id":"W2332365614","doi":"10.2146/ajhp120665","title":"Safety profile of antiviral medications: A pharmacovigilance study using the Italian spontaneous-reporting database","year":2013,"lang":"en","type":"article","venue":"American Journal of Health-System Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Pharmacovigilance; Database; Medicine; Pharmacology; Drug; Computer science","score_opus":0.12508181981453187,"score_gpt":0.4800280596124958,"score_spread":0.3549462397979639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332365614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951846,0.00090829557,0.0005902191,0.00010035724,0.0000096784925,0.00016148355,0.0024514406,0.00002403615,0.00056977564],"genre_scores_gemma":[0.99323785,0.00038007574,0.0007484431,0.00009474286,0.000041500407,0.00012045761,0.0052786614,0.000013128548,0.0000850792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98582315,0.007322396,0.0020313964,0.0020460426,0.0022905904,0.00048634165],"domain_scores_gemma":[0.9640066,0.008195595,0.020731857,0.0036451395,0.0026984054,0.0007224328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012032737,0.0006586165,0.0009102117,0.0033250153,0.00032349906,0.0015436279,0.0008747861,0.00068099226,0.001121318],"category_scores_gemma":[0.027517825,0.0004323326,0.0019521837,0.0049658394,0.00046960748,0.0009346041,0.0012846262,0.0004551191,0.00038466373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004707593,0.00007342469,0.99561584,0.00009765756,0.0003700754,0.00012608287,0.000120786426,0.00015811318,0.0001550634,0.000019926027,0.0002390217,0.0025532388],"study_design_scores_gemma":[0.00005604851,0.0002753537,0.9974706,0.00002586934,0.00022678485,0.00047460475,0.00007518911,0.0008513253,0.00011262524,0.00001184125,0.00041016817,0.000009646121],"about_ca_topic_score_codex":0.008319967,"about_ca_topic_score_gemma":0.004272815,"teacher_disagreement_score":0.012032737,"about_ca_system_score_codex":0.0014834214,"about_ca_system_score_gemma":0.0015183063,"threshold_uncertainty_score":0.063635945},"labels":[],"label_agreement":null},{"id":"W2333871802","doi":"","title":"Pilot study about hospital pharmacy residents’ perception of pharmacovigilance in Belgium, France, Canada and Switzerland","year":2015,"lang":"en","type":"article","venue":"Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacovigilance; Medicine; Pharmacy; Family medicine; Adverse drug reaction; Pharmacist; Drug reaction; Health care; Curriculum; Patient safety; Nursing; Pharmacology; Adverse effect; Drug; Psychology","score_opus":0.02723424391519509,"score_gpt":0.2845137579643984,"score_spread":0.2572795140492033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333871802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898297,0.000043311247,0.000020688321,0.00011180843,0.0000045928186,0.00003215964,0.00006881963,0.0000014673708,0.00073405844],"genre_scores_gemma":[0.9989467,0.00005819967,0.00007567199,0.00011970736,0.0000056045733,0.000035017463,0.00007744035,0.0000018254532,0.0006798034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836487,0.0005406257,0.00010458352,0.00011795807,0.00038228586,0.0004896874],"domain_scores_gemma":[0.9925761,0.0015880382,0.0011408022,0.00008766706,0.0026877734,0.0019197478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019859427,0.00023390511,0.00031285256,0.000997245,0.0021891668,0.0015587437,0.00039422783,0.0005580689,0.0029292307],"category_scores_gemma":[0.006208546,0.00024844983,0.00039787765,0.0011304294,0.0008075717,0.0005182318,0.00073125144,0.00083623856,0.00020947444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052304624,0.0010778836,0.9460092,0.0000722103,0.000055085893,0.0006725982,0.041235667,0.00010996064,0.000589819,0.00015352196,0.0015615947,0.0079393275],"study_design_scores_gemma":[0.00003662457,0.00063235225,0.9202344,0.000052952866,0.00002173198,0.0001699123,0.076945595,0.00020508708,0.00014125384,0.00001700508,0.0015183858,0.000024718545],"about_ca_topic_score_codex":0.71852237,"about_ca_topic_score_gemma":0.80974376,"teacher_disagreement_score":0.71852237,"about_ca_system_score_codex":0.008644799,"about_ca_system_score_gemma":0.008886726,"threshold_uncertainty_score":0.5662706},"labels":[],"label_agreement":null},{"id":"W2334334975","doi":"10.1136/bmj.e6379","title":"A major rethink is needed on reporting adverse drug reactions","year":2012,"lang":"en","type":"letter","venue":"BMJ","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Drug reaction; Drug; Adverse drug reaction; Intensive care medicine; Medicine; Risk analysis (engineering); Medical emergency; Pharmacology","score_opus":0.1908295855374275,"score_gpt":0.47313196940405755,"score_spread":0.2823023838666301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334334975","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007398564,0.00095895637,0.00046464446,0.98714787,0.01064922,0.00002269173,0.000034069264,0.00007980637,0.00056875247],"genre_scores_gemma":[0.00091454876,0.00138488,0.0023779825,0.96903515,0.025279092,0.00006877033,0.00006378943,0.00004885857,0.0008268254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.78022313,0.07244537,0.06228741,0.009820364,0.07017422,0.0050494415],"domain_scores_gemma":[0.37016127,0.4197242,0.038456284,0.031294826,0.11905982,0.021303536],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15071246,0.0020721762,0.005467659,0.0059343423,0.0063544624,0.014665321,0.0137562165,0.10858034,0.011058438],"category_scores_gemma":[0.4203144,0.0028061913,0.0074269036,0.004820533,0.021374453,0.03696051,0.008847869,0.14692856,0.018079158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009049437,0.00009517062,0.0009752946,0.0005759385,0.000069217625,0.0007654467,0.0006687356,0.00011696109,0.000538877,0.008636956,0.9499463,0.03752071],"study_design_scores_gemma":[0.00020209598,0.00023354372,0.003313898,0.004479838,0.0001097924,0.0027274333,0.0014499801,0.0008413963,0.00042029854,0.02504634,0.9607514,0.0004239466],"about_ca_topic_score_codex":0.014593847,"about_ca_topic_score_gemma":0.019247431,"teacher_disagreement_score":0.8492875,"about_ca_system_score_codex":0.012981556,"about_ca_system_score_gemma":0.01887649,"threshold_uncertainty_score":0.7970532},"labels":[],"label_agreement":null},{"id":"W2344407614","doi":"10.1016/s1470-2045(16)00152-2","title":"Under-reporting of harm in clinical trials","year":2016,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Observational study; Harm; Clinical trial; Tolerability; Pharmacovigilance; Intensive care medicine; Clinical Practice; Adverse effect; Family medicine; Pharmacology; Internal medicine","score_opus":0.8462647241493233,"score_gpt":0.7183082145743631,"score_spread":0.1279565095749602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344407614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009868374,0.98857224,0.0035455122,0.003685222,0.0007672046,0.00012712875,0.00041103957,0.000050429047,0.0018543286],"genre_scores_gemma":[0.06464254,0.90603435,0.011864804,0.012416766,0.0029722978,0.00043891216,0.0007221582,0.00005675995,0.0008514127],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.8094066,0.10828016,0.038533524,0.009212241,0.0332978,0.0012696941],"domain_scores_gemma":[0.37696105,0.5245117,0.076052345,0.010262705,0.01100694,0.0012053498],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1400078,0.0012703683,0.0070471726,0.005202515,0.0004133961,0.0051074666,0.0041254745,0.005778745,0.0053016134],"category_scores_gemma":[0.33441362,0.0012733035,0.006227079,0.005604328,0.0034984332,0.0051997844,0.003420426,0.0045379666,0.000581717],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011626893,0.00007233509,0.0061649345,0.15887582,0.011059545,0.00039230342,0.0005628994,0.0010947859,0.0004993375,0.008394855,0.015709518,0.796011],"study_design_scores_gemma":[0.002484423,0.0016934332,0.03643125,0.41820005,0.04856718,0.0071466994,0.0010780161,0.0033594917,0.0034781403,0.06820541,0.40894452,0.00041134685],"about_ca_topic_score_codex":0.0010573878,"about_ca_topic_score_gemma":0.0015399833,"teacher_disagreement_score":0.8599922,"about_ca_system_score_codex":0.002390679,"about_ca_system_score_gemma":0.0054025245,"threshold_uncertainty_score":0.74044085},"labels":[],"label_agreement":null},{"id":"W2347147152","doi":"10.1007/s40801-016-0071-8","title":"Accuracy of Adverse Drug Reaction Documentation upon Implementation of an Ambulatory Electronic Health Record System","year":2016,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Documentation; Medicine; Ambulatory; Drug reaction; Electronic health record; Pharmacy; Health records; Health care; Medical emergency; Adverse drug reaction; Patient safety; Ambulatory care; Drug; Family medicine; Pharmacology; Internal medicine; Computer science","score_opus":0.0429544082367456,"score_gpt":0.4518422858514289,"score_spread":0.40888787761468326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2347147152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907392,0.0017578906,0.0032440808,0.0005644452,0.000058957867,0.00015932719,0.0013040325,0.000088645116,0.002083373],"genre_scores_gemma":[0.995342,0.00046223885,0.0031176256,0.000099815166,0.0000255448,0.00004634096,0.0007299198,0.000014092319,0.00016239144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94964194,0.015578603,0.0168621,0.0025244486,0.014202299,0.0011907201],"domain_scores_gemma":[0.6578056,0.115701646,0.15437332,0.017289497,0.053226944,0.0016029654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03419897,0.0002190785,0.0005414846,0.002941281,0.00049373956,0.0018361404,0.001005573,0.0004677418,0.00072981627],"category_scores_gemma":[0.16521941,0.00029909034,0.00073191203,0.004193776,0.0005503081,0.0016163622,0.0015657701,0.0009519999,0.00023845735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018586109,0.000025366686,0.9775083,0.00020807279,0.00006241946,0.00010786246,0.0009834336,0.00027768724,0.00024184746,0.000055094377,0.0003116541,0.020032477],"study_design_scores_gemma":[0.000009347851,0.00022280814,0.9944918,0.0002994468,0.00007148219,0.00047464273,0.0008283223,0.0011489098,0.0009584692,0.000038857146,0.0014401649,0.000015650377],"about_ca_topic_score_codex":0.0058277724,"about_ca_topic_score_gemma":0.005060128,"teacher_disagreement_score":0.03419897,"about_ca_system_score_codex":0.0019203421,"about_ca_system_score_gemma":0.002254569,"threshold_uncertainty_score":0.18086362},"labels":[],"label_agreement":null},{"id":"W2395395078","doi":"10.18192/riss-ijhs.v3i1.1448","title":"Under-reporting of Adverse Drug Reactions: The Need for an Automated Reporting System","year":2013,"lang":"en","type":"article","venue":"Revue interdisciplinaire des sciences de la santé - Interdisciplinary Journal of Health Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Health care; Pharmacovigilance; Drug reaction; Health informatics; Ignorance; Health professionals; Medicine; Informatics; Drug; Adverse drug reaction; Business; Public health; Nursing; Political science; Pharmacology","score_opus":0.21513959078338513,"score_gpt":0.5625348572860858,"score_spread":0.34739526650270064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395395078","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066180184,0.030685054,0.534626,0.23128635,0.0058448473,0.0081811575,0.015142418,0.057224717,0.050829265],"genre_scores_gemma":[0.28513142,0.015201301,0.6432085,0.023421392,0.0055127135,0.0027751117,0.01638718,0.0009738302,0.0073885564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9321201,0.025444701,0.012273419,0.0075444244,0.021168735,0.0014486102],"domain_scores_gemma":[0.5307078,0.16762067,0.05579461,0.046847355,0.19174094,0.0072886795],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07357627,0.001038219,0.002762983,0.009417063,0.0024162256,0.010228269,0.0067577288,0.0029636305,0.0049142563],"category_scores_gemma":[0.17799963,0.000978743,0.0013090508,0.009104452,0.0014530122,0.010470203,0.0033529946,0.0038006902,0.0040636235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043515716,0.0004770673,0.09074623,0.0020338087,0.00033289424,0.00031429157,0.0012376875,0.003661109,0.0036447302,0.007873766,0.115665585,0.77357775],"study_design_scores_gemma":[0.000984313,0.0012704267,0.19675153,0.008438165,0.0016259667,0.0035236175,0.0058506206,0.14656098,0.01874118,0.03337376,0.5815165,0.0013628369],"about_ca_topic_score_codex":0.07746728,"about_ca_topic_score_gemma":0.05420137,"teacher_disagreement_score":0.9264237,"about_ca_system_score_codex":0.008303699,"about_ca_system_score_gemma":0.027393635,"threshold_uncertainty_score":0.3891132},"labels":[],"label_agreement":null},{"id":"W2396595164","doi":"","title":"Post-market drug evaluation research training capacity in Canada: an environmental scan of Canadian educational institutions.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Pharmacovigilance; Pharmacoeconomics; Medicine; Biostatistics; Medical education; Pharmacogenomics; Health economics; Public relations; Public health; Political science; Pharmacology; Drug; Nursing","score_opus":0.4219857160954123,"score_gpt":0.4359383684957461,"score_spread":0.013952652400333776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396595164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.889035,0.019008601,0.002020154,0.02959401,0.00018520278,0.0011488827,0.025494847,0.00045815666,0.033055093],"genre_scores_gemma":[0.9760109,0.0076618334,0.004064984,0.002491455,0.000044351837,0.00023012095,0.004367239,0.000051776988,0.0050773914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98623264,0.0016738873,0.000883777,0.0009740387,0.0067810826,0.00345451],"domain_scores_gemma":[0.8916528,0.015193625,0.01589323,0.002270779,0.045213338,0.029776258],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010373477,0.00038497098,0.0003857,0.007006459,0.005121275,0.0026382767,0.0028275845,0.0007244391,0.004122514],"category_scores_gemma":[0.032588888,0.00065932394,0.0005566985,0.012891685,0.0021372358,0.001154588,0.003639758,0.00083671836,0.00033958818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004043195,0.00030949162,0.7408808,0.0023897886,0.00012319176,0.00041288222,0.0062122867,0.00082391547,0.0010871842,0.0028233116,0.024802798,0.21973012],"study_design_scores_gemma":[0.000020196005,0.000103105325,0.9668316,0.00047181454,0.00004476076,0.00010236561,0.00538093,0.00041556757,0.00041707713,0.00011933448,0.026060436,0.000032910564],"about_ca_topic_score_codex":0.9656173,"about_ca_topic_score_gemma":0.98682064,"teacher_disagreement_score":0.9896265,"about_ca_system_score_codex":0.0936188,"about_ca_system_score_gemma":0.28879553,"threshold_uncertainty_score":0.6792551},"labels":[],"label_agreement":null},{"id":"W2398094643","doi":"","title":"Knowledge representation in Health Research: the modeling of Adverse Events Following Immunization.","year":2012,"lang":"en","type":"article","venue":"ICBO","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; MedDRA; Adverse effect; Standardization; Terminology; Computer science; Medicine; Set (abstract data type); Event (particle physics); Public health; Pharmacology","score_opus":0.5457483984127662,"score_gpt":0.5925566924100223,"score_spread":0.046808293997256056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398094643","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03423886,0.019381205,0.8995962,0.017885935,0.0005806888,0.0010670184,0.012907556,0.0014611601,0.012881284],"genre_scores_gemma":[0.56872076,0.013672789,0.39744142,0.0024732964,0.0008405712,0.0017612735,0.010537451,0.000108177606,0.004444319],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9938852,0.0039065736,0.00045013684,0.0007996184,0.00072652596,0.00023197103],"domain_scores_gemma":[0.96101,0.033940647,0.002217778,0.0011444077,0.0011170593,0.00057005434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011018174,0.0010568651,0.0015136827,0.005297348,0.00065181596,0.005038444,0.0030861367,0.003598891,0.003859226],"category_scores_gemma":[0.044413824,0.0005908281,0.0023412693,0.005055847,0.0010475612,0.0029983202,0.0022212605,0.0021830073,0.00085154246],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036944743,0.00034933173,0.01801271,0.0019373202,0.0007774979,0.00087996665,0.0007166031,0.7089682,0.00061996875,0.07527151,0.015541033,0.1765563],"study_design_scores_gemma":[0.000034974313,0.000094096045,0.0017461003,0.00031093022,0.00017617755,0.0002303996,0.0001254093,0.8608085,0.00022162305,0.12647882,0.009742104,0.00003084783],"about_ca_topic_score_codex":0.02275062,"about_ca_topic_score_gemma":0.017678348,"teacher_disagreement_score":0.02275062,"about_ca_system_score_codex":0.0038251448,"about_ca_system_score_gemma":0.0035053086,"threshold_uncertainty_score":0.058270335},"labels":[],"label_agreement":null},{"id":"W2402844755","doi":"","title":"Health and Drug Alerts : CMAJ, Health Canada changing way adverse drug information delivered","year":2002,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Adverse effect; Alternative medicine; Food and drug administration; Table (database); Medical emergency; Pharmacology; Data mining; Computer science","score_opus":0.027575062223767183,"score_gpt":0.32933477500266317,"score_spread":0.301759712778896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402844755","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017017587,0.01690493,0.0014992139,0.7156284,0.06197387,0.0003462092,0.005188386,0.0034400956,0.19331716],"genre_scores_gemma":[0.01782624,0.03076386,0.008625838,0.37529325,0.025797471,0.0002233803,0.0059314994,0.0015534158,0.533985],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99165666,0.00064792583,0.00063776755,0.00048749565,0.005842839,0.0007272595],"domain_scores_gemma":[0.9451786,0.0047430843,0.0019759128,0.0011610364,0.02650876,0.020432567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005147793,0.00093017425,0.0009991599,0.004019093,0.0061910474,0.0114279175,0.0028263894,0.012638979,0.14248073],"category_scores_gemma":[0.034342114,0.000957766,0.00078610406,0.0056996723,0.0025780604,0.0037328447,0.0017555594,0.007532116,0.040703826],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014921039,0.000012507424,0.00025944118,0.000052596042,0.0000028490583,0.000053606505,0.00001723628,0.000016350525,0.00004951101,0.00041632613,0.9843907,0.014713974],"study_design_scores_gemma":[0.000045139175,0.000018405808,0.0034087691,0.00016572796,0.000012125524,0.000102075166,0.000083594496,0.00009455484,0.000105651176,0.00039203707,0.9955403,0.00003155664],"about_ca_topic_score_codex":0.6615652,"about_ca_topic_score_gemma":0.83818763,"teacher_disagreement_score":0.9667225,"about_ca_system_score_codex":0.03327749,"about_ca_system_score_gemma":0.08793885,"threshold_uncertainty_score":0.6808559},"labels":[],"label_agreement":null},{"id":"W2407348336","doi":"10.1016/j.jclinepi.2016.03.033","title":"Pharmacosurveillance without borders: electronic health records in different countries can be used to address important methodological issues in estimating the risk of adverse events","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Epidemiology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Confidence interval; Comorbidity; Medical prescription; Pharmacoepidemiology; Proportional hazards model; Health records; Type 2 diabetes; Diabetes mellitus; Electronic health record; Adverse effect; Obesity; Emergency medicine; Environmental health; Internal medicine; Health care; Pharmacology","score_opus":0.4881862941247638,"score_gpt":0.6341412808256246,"score_spread":0.14595498670086082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407348336","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66253877,0.009963546,0.25271565,0.010943878,0.0012646057,0.0037510556,0.02202161,0.00048454822,0.03631633],"genre_scores_gemma":[0.91826564,0.0011162977,0.06990523,0.0018029046,0.0002021432,0.0017681869,0.0063280636,0.00009864355,0.0005127934],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.698507,0.2466455,0.033840027,0.008794749,0.010105332,0.0021074854],"domain_scores_gemma":[0.51342607,0.2949476,0.09134304,0.07442916,0.024067285,0.0017868517],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12872255,0.0011053403,0.0020326134,0.008666797,0.001213678,0.0068815253,0.0028647098,0.0024967361,0.002136515],"category_scores_gemma":[0.41314006,0.0011004421,0.0025866923,0.017440695,0.0019710446,0.010368744,0.0075907465,0.0017770944,0.0004013626],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010653122,0.00029139238,0.8467858,0.002361097,0.009824291,0.000379338,0.004375278,0.0052863825,0.00070406357,0.018406766,0.005625672,0.10489467],"study_design_scores_gemma":[0.00044211894,0.00091706234,0.8775526,0.004520341,0.005957525,0.001583929,0.008423844,0.03325432,0.0034407848,0.031623572,0.03191453,0.0003693767],"about_ca_topic_score_codex":0.015935319,"about_ca_topic_score_gemma":0.0124383485,"teacher_disagreement_score":0.87127745,"about_ca_system_score_codex":0.0015945049,"about_ca_system_score_gemma":0.0032783162,"threshold_uncertainty_score":0.680758},"labels":[],"label_agreement":null},{"id":"W2411351210","doi":"10.1007/s40120-016-0045-5","title":"Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada","year":2016,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MedDRA; Drug reaction; Mefloquine; Family medicine; Drug; Adverse drug reaction; Patient safety; Psychiatry; Pharmacovigilance; Malaria; Pathology; Health care; Chloroquine","score_opus":0.060984874766783125,"score_gpt":0.3718949081555471,"score_spread":0.310910033388764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411351210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8009948,0.18518698,0.0010314684,0.0011010232,0.00008736465,0.0014957952,0.0068366956,0.000046629728,0.0032191856],"genre_scores_gemma":[0.9558115,0.038341053,0.0022188316,0.00058997684,0.000031285454,0.0005547462,0.0022475151,0.00001595354,0.00018902247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9587205,0.013789521,0.015127806,0.0024366262,0.009412572,0.0005129965],"domain_scores_gemma":[0.8383292,0.07669931,0.06224957,0.0030558333,0.018449083,0.0012169944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02663318,0.0002808411,0.001618703,0.007245014,0.0004617414,0.001087288,0.00062262616,0.0006990503,0.00050907035],"category_scores_gemma":[0.087360725,0.00034303253,0.0020861935,0.010101682,0.0009025206,0.00078041543,0.0010004624,0.00045730892,0.00005679222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029687965,0.00013156496,0.76396227,0.06581573,0.010504205,0.00039183313,0.010243061,0.00045613278,0.0011179689,0.00027502884,0.002816177,0.14131716],"study_design_scores_gemma":[0.0004887418,0.0008959019,0.94365174,0.028890206,0.010567939,0.00075224024,0.0036483991,0.00068629655,0.0006879588,0.000089899535,0.009532234,0.00010839405],"about_ca_topic_score_codex":0.071267635,"about_ca_topic_score_gemma":0.16099189,"teacher_disagreement_score":0.071267635,"about_ca_system_score_codex":0.0039039818,"about_ca_system_score_gemma":0.0106903585,"threshold_uncertainty_score":0.14170563},"labels":[],"label_agreement":null},{"id":"W2413974287","doi":"10.1007/s40264-016-0434-9","title":"Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale","year":2016,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Ontario HIV Treatment Network","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; Australian Government; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; National Eye Institute; National Cancer Institute; Canadian Institutes of Health Research; National Institute on Minority Health and Health Disparities; U.S. President’s Emergency Plan for AIDS Relief; Centers for Disease Control and Prevention; Ministerie van Buitenlandse Zaken; National Center for Advancing Translational Sciences; Health Resources and Services Administration; Government of Alberta; Agency for Healthcare Research and Quality; National Institute of Mental Health; Mbarara University of Science and Technology; Vanderbilt University; United States Agency for International Development; National Institutes of Health; National Institute on Drug Abuse; Aids Fonds","keywords":"Pharmacovigilance; Medicine; Staffing; Documentation; Outreach; Medical emergency; Family medicine; Adverse effect; Environmental health; Nursing; Pharmacology; Economic growth","score_opus":0.2686755808106513,"score_gpt":0.491746583398983,"score_spread":0.22307100258833168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413974287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77011836,0.0032206613,0.15213917,0.004294203,0.00016921341,0.029922124,0.016449915,0.0010993945,0.022587033],"genre_scores_gemma":[0.83995277,0.001088346,0.1388533,0.00057694886,0.00007436842,0.013688528,0.0053241025,0.000057127367,0.0003844747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.747909,0.16951968,0.052129906,0.0060474067,0.021723647,0.0026703982],"domain_scores_gemma":[0.45926604,0.25125873,0.19830838,0.035020884,0.051043745,0.0051022326],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20728838,0.0007077621,0.0007385398,0.0076836217,0.0010071784,0.003540358,0.0029151042,0.0007752111,0.0015981498],"category_scores_gemma":[0.300068,0.00058588356,0.0017672309,0.0068254126,0.0014203436,0.004121306,0.006393259,0.00089963106,0.0003826164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078060734,0.00028745696,0.84201634,0.003784696,0.00077522645,0.00025959776,0.008744993,0.0016428268,0.00080063083,0.0019790402,0.005168958,0.13375968],"study_design_scores_gemma":[0.00035915506,0.0040414254,0.90800494,0.004436807,0.0012111383,0.0017438313,0.019505147,0.012453115,0.004630049,0.003821146,0.039519843,0.0002734591],"about_ca_topic_score_codex":0.00274964,"about_ca_topic_score_gemma":0.0032224949,"teacher_disagreement_score":0.20728838,"about_ca_system_score_codex":0.0023031149,"about_ca_system_score_gemma":0.008893171,"threshold_uncertainty_score":0.97755456},"labels":[],"label_agreement":null},{"id":"W2418141439","doi":"10.1111/bcp.13032","title":"Performance of trigger tools in identifying adverse drug events in emergency department patients: a validation study","year":2016,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Emergency department; Medicine; Emergency medicine; Prospective cohort study; Point of care; Confidence interval; Medical record; Adverse effect; Retrospective cohort study; Medical emergency; Cohort study; Adverse drug event; Internal medicine","score_opus":0.18305975917173242,"score_gpt":0.5093568506495926,"score_spread":0.3262970914778601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418141439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759644,0.00016444759,0.00089596387,0.000025492725,0.000017366283,0.0005422611,0.00028342195,0.000015965543,0.0004587164],"genre_scores_gemma":[0.99632865,0.00011033989,0.0020375035,0.000052624935,0.000021459056,0.0004052705,0.000935603,0.000007818717,0.00010076634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98235345,0.0095285345,0.0025147176,0.0016631177,0.00322624,0.00071389007],"domain_scores_gemma":[0.92332345,0.043438185,0.013760409,0.0063353083,0.011592168,0.0015503368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030928219,0.0009822213,0.0007633952,0.0015903186,0.0004960823,0.0011222942,0.0009893846,0.0010958205,0.00068902195],"category_scores_gemma":[0.078210086,0.00055806653,0.0014708198,0.0010611118,0.0009807869,0.0013871818,0.0012551975,0.0007155075,0.0004845058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018273941,0.000847142,0.9886204,0.00008599543,0.00019074934,0.000051313647,0.000581642,0.0002558948,0.00037023667,0.000032271357,0.00015248498,0.006984548],"study_design_scores_gemma":[0.00060114404,0.009528035,0.9836885,0.000092937735,0.0002544871,0.00056006043,0.00043178187,0.0027051389,0.0013223409,0.000058956346,0.0007194989,0.000037143604],"about_ca_topic_score_codex":0.0015025717,"about_ca_topic_score_gemma":0.0012668987,"teacher_disagreement_score":0.030928219,"about_ca_system_score_codex":0.0009101575,"about_ca_system_score_gemma":0.0012838673,"threshold_uncertainty_score":0.16356605},"labels":[],"label_agreement":null},{"id":"W2425374265","doi":"10.1016/j.pharma.2015.08.001","title":"Étude pilote permettant de calculer le ratio d’effets indésirables médicamenteux par 10 000 doses définies journalières et 10 000 jours de traitement d’anti-infectieux en 2012–2013","year":2015,"lang":"fr","type":"article","venue":"Annales Pharmaceutiques Françaises","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Gynecology; Medicine; Physics","score_opus":0.11837569671229893,"score_gpt":0.4320393126133057,"score_spread":0.3136636159010068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2425374265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97352815,0.004732655,0.01107444,0.00043541874,0.00018978945,0.00255964,0.0034696688,0.00029597475,0.0037142904],"genre_scores_gemma":[0.97716683,0.0013274235,0.014720336,0.00033661697,0.000088579036,0.0021248255,0.0013091438,0.00006051186,0.0028658444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99500775,0.0025273473,0.00042085513,0.0007858995,0.0010813778,0.00017668268],"domain_scores_gemma":[0.9810817,0.011376557,0.0024426293,0.001249845,0.0034062408,0.00044299744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009400123,0.00086111686,0.0013737306,0.0007310476,0.00036574565,0.0012802655,0.0005617919,0.00093180774,0.0044745207],"category_scores_gemma":[0.021355744,0.0007072627,0.0017685109,0.00066736346,0.0007059345,0.0011314481,0.00041486786,0.0008848858,0.0009182334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16803879,0.009805145,0.4930997,0.0037843692,0.007899336,0.0007931425,0.002978541,0.0027675475,0.056105074,0.0011125972,0.004588768,0.24902692],"study_design_scores_gemma":[0.015887061,0.12456135,0.7871628,0.0006338024,0.0065272013,0.0030212938,0.0010100262,0.006039756,0.02777591,0.00073852227,0.026468001,0.00017423242],"about_ca_topic_score_codex":0.00552219,"about_ca_topic_score_gemma":0.004395282,"teacher_disagreement_score":0.009400123,"about_ca_system_score_codex":0.0011365457,"about_ca_system_score_gemma":0.001465297,"threshold_uncertainty_score":0.049713254},"labels":[],"label_agreement":null},{"id":"W2432199245","doi":"10.2196/resprot.5621","title":"Using Social Media Data to Identify Potential Candidates for Drug Repurposing: A Feasibility Study","year":2016,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. National Library of Medicine; National Institute of General Medical Sciences","keywords":"Repurposing; Drug repositioning; Social media; Drug; Drug development; Medicine; Data science; Computer science; Pharmacology; World Wide Web; Engineering","score_opus":0.8354165269847041,"score_gpt":0.7292692315110744,"score_spread":0.10614729547362978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432199245","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879545,0.00019702832,0.0039599305,0.00039556198,0.00002803446,0.0039962465,0.0021112096,0.00009015281,0.0012673305],"genre_scores_gemma":[0.95755064,0.0002967257,0.033080734,0.0002916822,0.00009207065,0.004004319,0.0040023453,0.00002015398,0.0006612696],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880184,0.007919931,0.0009381255,0.0008458684,0.0017695922,0.000508202],"domain_scores_gemma":[0.9141706,0.065175325,0.004659447,0.0032987704,0.01035482,0.0023410362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014261763,0.00072609825,0.00058145093,0.0048363954,0.00082850695,0.001479742,0.0008779174,0.0013911201,0.001958656],"category_scores_gemma":[0.036322173,0.0004073985,0.000960751,0.0018583632,0.0006340134,0.0027219367,0.0014392061,0.00069413544,0.0009803183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036202252,0.0130783,0.815468,0.0026165494,0.0005101771,0.0021075546,0.0044677733,0.0015897282,0.009411892,0.00046247314,0.0029534318,0.14371386],"study_design_scores_gemma":[0.0023295463,0.025541076,0.83325994,0.0007607616,0.0014110398,0.0036780017,0.020919176,0.0798683,0.0134125305,0.0010199352,0.01746635,0.0003332238],"about_ca_topic_score_codex":0.0045259004,"about_ca_topic_score_gemma":0.006048812,"teacher_disagreement_score":0.014261763,"about_ca_system_score_codex":0.0005908208,"about_ca_system_score_gemma":0.0015934358,"threshold_uncertainty_score":0.07542431},"labels":[],"label_agreement":null},{"id":"W2467680869","doi":"10.3163/1536-5050.104.3.007","title":"Effectiveness of adverse effects search filters: drugs versus medical devices","year":2016,"lang":"en","type":"article","venue":"Journal of the Medical Library Association JMLA","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"MEDLINE; Medicine; Adverse effect; Medical record; Search engine indexing; Emergency medicine; Medical emergency; Computer science; Information retrieval; Surgery; Pharmacology","score_opus":0.03733547095465894,"score_gpt":0.40225441773601256,"score_spread":0.3649189467813536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467680869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8549962,0.11422001,0.008850631,0.0029119516,0.0005924139,0.003178376,0.005720089,0.00059131655,0.008939046],"genre_scores_gemma":[0.95642495,0.012974187,0.024718685,0.0011791323,0.00043103338,0.00083028333,0.0027227188,0.00010782722,0.000611085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8129007,0.09183474,0.056726467,0.011088201,0.025584696,0.0018652233],"domain_scores_gemma":[0.20073362,0.72823346,0.046589803,0.0073766788,0.015742505,0.0013238781],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14114706,0.001474529,0.004064596,0.014964711,0.0011003049,0.005428825,0.0017160297,0.0036703215,0.0021262032],"category_scores_gemma":[0.547337,0.0009912428,0.004736221,0.0078768525,0.0015402436,0.007581767,0.0023458123,0.00078323385,0.0005440719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05402611,0.0014831899,0.5663061,0.036756717,0.014129111,0.00057106523,0.0034096679,0.0028062256,0.005346597,0.0006937071,0.004016404,0.31045517],"study_design_scores_gemma":[0.006147057,0.03615576,0.7938279,0.024922978,0.045990802,0.005904121,0.003250861,0.030552523,0.028262887,0.0024817057,0.02144225,0.0010611537],"about_ca_topic_score_codex":0.0042906012,"about_ca_topic_score_gemma":0.0056737266,"teacher_disagreement_score":0.8588529,"about_ca_system_score_codex":0.0026304678,"about_ca_system_score_gemma":0.0040795426,"threshold_uncertainty_score":0.7464659},"labels":[],"label_agreement":null},{"id":"W2507679269","doi":"10.1002/pds.4090","title":"Can social media data lead to earlier detection of drug‐related adverse events?","year":2016,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Adverse Event Reporting System; Social media; Sibutramine; Atorvastatin; Adverse effect; Internal medicine; World Wide Web; Weight loss; Computer science; Obesity","score_opus":0.12515230787390588,"score_gpt":0.434621748955007,"score_spread":0.3094694410811011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507679269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645153,0.0057519926,0.0026483247,0.0046636635,0.0007622939,0.00018286392,0.013573828,0.00019245953,0.0077091516],"genre_scores_gemma":[0.99164784,0.0010675644,0.001903713,0.00072417076,0.0006246878,0.00008302865,0.002509224,0.00002539854,0.0014143726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612844,0.0016774122,0.00062712847,0.0007284491,0.0005713272,0.00026723035],"domain_scores_gemma":[0.963183,0.014612132,0.017938174,0.0012669683,0.002274813,0.00072498556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004665282,0.00052599004,0.0003699788,0.0030108588,0.00027752935,0.0019831245,0.00044289476,0.0009321754,0.0058029387],"category_scores_gemma":[0.027186556,0.00027671427,0.0010981702,0.002400342,0.0003147613,0.002006817,0.00083661743,0.0007950709,0.0012967767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037894657,0.000086928274,0.9707082,0.00023996561,0.00035765237,0.00009702804,0.00016400995,0.00015294818,0.00038010752,0.000120271565,0.0017768791,0.025537113],"study_design_scores_gemma":[0.000042138985,0.000246536,0.98736995,0.0002221815,0.00038462703,0.00041772338,0.0004073316,0.0030102786,0.001263946,0.00038606464,0.006220028,0.000029212184],"about_ca_topic_score_codex":0.003626312,"about_ca_topic_score_gemma":0.00607381,"teacher_disagreement_score":0.0058029387,"about_ca_system_score_codex":0.00041430723,"about_ca_system_score_gemma":0.00036806244,"threshold_uncertainty_score":0.024672687},"labels":[],"label_agreement":null},{"id":"W2511023995","doi":"10.2196/resprot.5967","title":"Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design","year":2016,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University; Vancouver General Hospital; University of British Columbia; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; Simon Fraser University","funders":"","keywords":"Adverse drug event; Medicine; Adverse effect; Drug; Unintended consequences; Protocol (science); Medical emergency; Intensive care medicine; Culprit; Health care; Alternative medicine; Pharmacology; Psychiatry","score_opus":0.6464221052643018,"score_gpt":0.7052035877603337,"score_spread":0.05878148249603188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511023995","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006237433,0.00006270597,0.003296048,0.00008464132,0.00007571195,0.99499303,0.00045090963,0.000029100893,0.0003840435],"genre_scores_gemma":[0.0003277771,0.0000377563,0.004418602,0.000045245208,0.0000055509095,0.9949929,0.0000406361,0.0000028766942,0.00012866441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9565368,0.025641734,0.006988341,0.003620397,0.0045425785,0.0026701372],"domain_scores_gemma":[0.93235856,0.02430972,0.0065152333,0.009422582,0.024028778,0.003365075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09326243,0.003902611,0.005199266,0.004172976,0.0069238353,0.004145765,0.004215554,0.0067730285,0.065263726],"category_scores_gemma":[0.097919784,0.00363053,0.005571098,0.004173398,0.0037731365,0.0039056004,0.0036028156,0.007859041,0.01303531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11903483,0.04785992,0.007968037,0.13889752,0.0021471046,0.0029089665,0.028893823,0.009168876,0.0100506535,0.042600006,0.11959255,0.47087774],"study_design_scores_gemma":[0.22427592,0.06324359,0.020150848,0.042027675,0.0024316353,0.00046519793,0.011987565,0.009280059,0.011551033,0.03140829,0.58207595,0.0011022466],"about_ca_topic_score_codex":0.008165187,"about_ca_topic_score_gemma":0.014313607,"teacher_disagreement_score":0.09326243,"about_ca_system_score_codex":0.009053793,"about_ca_system_score_gemma":0.047052532,"threshold_uncertainty_score":0.49322474},"labels":[],"label_agreement":null},{"id":"W2515166661","doi":"10.1136/bmjqs-2016-005629","title":"Responding to the challenge of look-alike, sound-alike drug names","year":2016,"lang":"en","type":"letter","venue":"BMJ Quality & Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto","funders":"","keywords":"Medicine; Sound (geography); Drug; Internet privacy; Pharmacology; Computer science; Acoustics","score_opus":0.19464929237481485,"score_gpt":0.5034605609060532,"score_spread":0.3088112685312383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515166661","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006527539,0.014742456,0.0101657435,0.9456707,0.017892186,0.00004867746,0.000037217807,0.00009217612,0.0048232344],"genre_scores_gemma":[0.12463646,0.02591782,0.016466672,0.7723384,0.056089144,0.0001021957,0.000047527814,0.0002484449,0.004153349],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9533001,0.025837297,0.004404031,0.0025140313,0.012424853,0.0015197493],"domain_scores_gemma":[0.7242503,0.20405658,0.02332099,0.009839001,0.03364564,0.0048874323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049929403,0.00051000627,0.001058269,0.0015220265,0.003804964,0.01127239,0.003675375,0.020988565,0.0033787892],"category_scores_gemma":[0.22047743,0.00061345584,0.0010969077,0.0010613591,0.015963301,0.016590875,0.0053998325,0.02368581,0.0018336863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047285567,0.00030649258,0.013072035,0.0037724194,0.00019678191,0.0083137825,0.056276564,0.0007826249,0.0031339705,0.11903711,0.49947402,0.2951614],"study_design_scores_gemma":[0.00005871317,0.00039346068,0.0040489845,0.0033311578,0.00009950502,0.009878601,0.021744806,0.0009353041,0.0033721833,0.079018526,0.8768954,0.00022331058],"about_ca_topic_score_codex":0.0025807372,"about_ca_topic_score_gemma":0.0055054324,"teacher_disagreement_score":0.049929403,"about_ca_system_score_codex":0.0032209177,"about_ca_system_score_gemma":0.0072130924,"threshold_uncertainty_score":0.264055},"labels":[],"label_agreement":null},{"id":"W2522694534","doi":"10.1111/bcp.13081","title":"Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study","year":2016,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Observational study; Drug reaction; Pharmacoepidemiology; Pharmacogenomics; Polypharmacy; Internal medicine; Adverse drug reaction; Logistic regression; Pharmacovigilance; Drug; Population; Emergency medicine; Pediatrics; Prospective cohort study; Adverse effect; Pharmacology; Medical prescription","score_opus":0.17298565730825496,"score_gpt":0.5048113542633578,"score_spread":0.3318256969551028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522694534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879324,0.00017185872,0.00007946875,0.000030813717,0.000004860555,0.000024275276,0.00069144566,0.0000032060682,0.00020075562],"genre_scores_gemma":[0.9989737,0.000121166646,0.000077745695,0.000035202032,0.000009784579,0.00002118415,0.0007166854,0.0000016315796,0.000042857766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981281,0.00047862166,0.00048699012,0.00042046045,0.00030499458,0.00018082985],"domain_scores_gemma":[0.9929756,0.0009903114,0.0042688893,0.00042622443,0.0004131227,0.00092596665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014579596,0.00043030083,0.00074163376,0.0010299638,0.00047330264,0.0009567003,0.0005062811,0.00067989115,0.0018123974],"category_scores_gemma":[0.004463843,0.0005335563,0.00096003176,0.0018171836,0.00048718022,0.0009506788,0.0008418037,0.00089087297,0.0003560338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006162615,0.000019930261,0.9995085,0.000011200747,0.000040215604,0.000045166013,0.000035285128,0.00001312194,0.000038818525,0.0000031946797,0.000029439458,0.00019340785],"study_design_scores_gemma":[0.000008745635,0.00014817067,0.99926764,0.000008190292,0.000019236993,0.00023834953,0.00014108187,0.000090652095,0.000016147473,0.000008737824,0.000048639275,0.0000044997037],"about_ca_topic_score_codex":0.0038978949,"about_ca_topic_score_gemma":0.0028698524,"teacher_disagreement_score":0.0038978949,"about_ca_system_score_codex":0.00040891633,"about_ca_system_score_gemma":0.0004566466,"threshold_uncertainty_score":0.0077504516},"labels":[],"label_agreement":null},{"id":"W2528414212","doi":"10.1002/cpt.526","title":"Development and Validation of Algorithms for the Detection of Statin Myopathy Signals From Electronic Medical Records","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Myopathy; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Algorithm; Medical record; Computer science; Medicine; Internal medicine","score_opus":0.21957639952806643,"score_gpt":0.5056059265231236,"score_spread":0.28602952699505724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528414212","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4181976,0.0012669761,0.5665769,0.00069092726,0.00014862281,0.001809697,0.0028872553,0.0067230645,0.0016990928],"genre_scores_gemma":[0.43205693,0.00025103707,0.5619277,0.00025442094,0.000053875174,0.0006006531,0.004314558,0.00010075003,0.00044008912],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9887639,0.0048981393,0.0020527546,0.0020429792,0.0018821335,0.00036009087],"domain_scores_gemma":[0.9562553,0.031579647,0.0030267453,0.0019601649,0.0068137236,0.00036441543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01764839,0.0013077466,0.0011329083,0.006775271,0.00066672044,0.0023677903,0.0019276501,0.0016297929,0.0008161099],"category_scores_gemma":[0.053846333,0.0004778543,0.0010471372,0.002046505,0.00046785196,0.001794124,0.0011140853,0.001206746,0.00060830056],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001283475,0.0016381599,0.29869863,0.0005573675,0.0011742634,0.00044222618,0.00044507705,0.11198948,0.022346018,0.001781283,0.004245801,0.5553983],"study_design_scores_gemma":[0.00021986435,0.00048652294,0.046037752,0.00011997743,0.00021483039,0.00059670163,0.0001920579,0.9209374,0.02684879,0.001644092,0.002646306,0.00005573209],"about_ca_topic_score_codex":0.0044411,"about_ca_topic_score_gemma":0.0029630612,"teacher_disagreement_score":0.01764839,"about_ca_system_score_codex":0.0011539205,"about_ca_system_score_gemma":0.0021560243,"threshold_uncertainty_score":0.093334675},"labels":[],"label_agreement":null},{"id":"W2558003693","doi":"10.1093/ofid/ofw172.686","title":"Detailed Piperacillin-Tazobactam Use Audit in a North American Tertiary Care Hospital—Not Necessarily Wrong, Not Quite Right: Directions for Stewardship","year":2016,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Piperacillin/tazobactam; Medicine; Stewardship (theology); Antimicrobial stewardship; Audit; Piperacillin; Tertiary care; Intensive care medicine; Antibiotic Stewardship; Tazobactam; Emergency medicine; Family medicine; Antibiotics; Microbiology; Accounting","score_opus":0.03969693559027408,"score_gpt":0.3803702078289917,"score_spread":0.34067327223871763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558003693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951363,0.00050285214,0.00026157207,0.001334249,0.000021613947,0.00020767057,0.0008502812,0.00005808199,0.0016275243],"genre_scores_gemma":[0.9964652,0.00047161942,0.0014119799,0.0006734184,0.000029287552,0.000058907553,0.0005449672,0.000007839068,0.0003367389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645966,0.00065884285,0.0010215135,0.00034885205,0.0010457471,0.00046522435],"domain_scores_gemma":[0.97852147,0.0024918488,0.008019376,0.00068306195,0.0066025094,0.0036816814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002804636,0.00025209755,0.00031414913,0.002104388,0.0014622081,0.0011667724,0.0007955222,0.00043371067,0.0007516938],"category_scores_gemma":[0.0072480845,0.00058725325,0.00023971406,0.0034367316,0.0007375853,0.0006865888,0.0013982466,0.0007851966,0.00015041645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009355702,0.00013166745,0.98432654,0.00009735185,0.000025211528,0.0007635108,0.0014600209,0.00014951924,0.0006812565,0.000045631332,0.0024286988,0.009796953],"study_design_scores_gemma":[0.000005660106,0.00012244693,0.9958294,0.00007394821,0.000014211035,0.00033503215,0.001798761,0.0004468399,0.0003072593,0.000016012644,0.0010391579,0.00001119384],"about_ca_topic_score_codex":0.15878189,"about_ca_topic_score_gemma":0.3510343,"teacher_disagreement_score":0.15878189,"about_ca_system_score_codex":0.006939344,"about_ca_system_score_gemma":0.012445029,"threshold_uncertainty_score":0.31571537},"labels":[],"label_agreement":null},{"id":"W2558732480","doi":"10.1300/j381v10n03_08","title":"Canadian Adverse Drug Reaction Monitoring Program (CADRMP)—Adverse Reaction (AR) Database &lt;http://www.hc-sc.gc.ca/dhp-mps/medeff/databasdon/index_e.html&gt;","year":2006,"lang":"en","type":"article","venue":"Journal of Consumer Health on the Internet","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Database; Adverse drug reaction; Adverse effect; Medicine; Drug reaction; Drug; Pharmacology; Computer science","score_opus":0.07455171673926346,"score_gpt":0.41173431967740814,"score_spread":0.33718260293814467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558732480","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00516901,0.00736324,0.0060718353,0.008704859,0.00037032922,0.0028097522,0.7400147,0.005307044,0.22418916],"genre_scores_gemma":[0.08715496,0.016580995,0.037798554,0.008596018,0.0005183399,0.0032679683,0.7024721,0.0011923661,0.14241876],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99524325,0.00050378806,0.00055638567,0.0002290143,0.0032159379,0.00025154607],"domain_scores_gemma":[0.9656524,0.0036843373,0.0042968886,0.0014394001,0.022991188,0.0019358463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035970614,0.00092123216,0.0015798287,0.006368653,0.001623453,0.0018846815,0.0024054754,0.0011342565,0.07306099],"category_scores_gemma":[0.01822853,0.00044734168,0.0008191348,0.008372571,0.0005147704,0.00082728255,0.0008602573,0.0015892257,0.018396273],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019527237,0.000084315674,0.0063014827,0.0008605482,0.00006618001,0.000092738934,0.000069858965,0.00026585066,0.0003410261,0.0014484304,0.90131515,0.088959195],"study_design_scores_gemma":[0.00019460898,0.0000756001,0.039721243,0.00053310307,0.00014414992,0.00021050176,0.000045148092,0.0007653117,0.0013006185,0.0008775078,0.9560588,0.00007343846],"about_ca_topic_score_codex":0.68435204,"about_ca_topic_score_gemma":0.75777864,"teacher_disagreement_score":0.9892911,"about_ca_system_score_codex":0.010708902,"about_ca_system_score_gemma":0.029209463,"threshold_uncertainty_score":0.6350137},"labels":[],"label_agreement":null},{"id":"W2560571493","doi":"10.1111/bcp.13159","title":"Factors affecting patient reporting of adverse drug reactions: a systematic review","year":2016,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada; International Development Research Centre; Institute of Population and Public Health; Ottawa Public Health; Ottawa Hospital; Public Health Ontario; University of Ottawa","funders":"World Health Organization","keywords":"PsycINFO; CINAHL; Medicine; MEDLINE; Systematic review; Family medicine; Confusion; Drug reaction; Patient safety; Alternative medicine; Health care; Drug; Psychological intervention; Nursing; Psychiatry; Psychology; Pathology","score_opus":0.35125105731468015,"score_gpt":0.5775183091693521,"score_spread":0.22626725185467195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560571493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026143412,0.99597114,0.00012673071,0.00026999143,0.0000646881,0.0004260239,0.00024868958,0.000006451045,0.00027198967],"genre_scores_gemma":[0.031746395,0.9658454,0.0008637427,0.000507919,0.00006865924,0.000691123,0.00019173077,0.000004203847,0.000080716934],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9811794,0.007560957,0.0068078474,0.00076573016,0.0034002883,0.0002857166],"domain_scores_gemma":[0.9152616,0.061820354,0.016702473,0.0007051354,0.005004371,0.00050608366],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014059318,0.0011879015,0.0055522835,0.007970538,0.0006229782,0.0026353823,0.0014570598,0.0017706705,0.003004123],"category_scores_gemma":[0.076947525,0.0010049553,0.0068761506,0.009638404,0.00092432037,0.0025297562,0.001429056,0.0012386799,0.00022651945],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019680483,0.000027891892,0.0029052838,0.9478982,0.0067183194,0.00011765658,0.0004604562,0.000058336067,0.00006453675,0.000105825966,0.0010852484,0.040361404],"study_design_scores_gemma":[0.00025591443,0.00032972477,0.012506023,0.92599773,0.046521083,0.00082581764,0.0009819166,0.00008770496,0.00014507523,0.00017015175,0.012126925,0.00005190018],"about_ca_topic_score_codex":0.0061454414,"about_ca_topic_score_gemma":0.017856238,"teacher_disagreement_score":0.9859407,"about_ca_system_score_codex":0.002962392,"about_ca_system_score_gemma":0.010075765,"threshold_uncertainty_score":0.074353695},"labels":[],"label_agreement":null},{"id":"W2563277061","doi":"","title":"Анализ систем мониторинга побочных реакций в разных странах мира","year":2015,"lang":"ru","type":"article","venue":"Vestnik","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Drug reaction; Medicine; Adverse effect; Drug; Business; Environmental health; Intensive care medicine; Political science; Pharmacology","score_opus":0.2929562731033103,"score_gpt":0.48836590537680463,"score_spread":0.19540963227349434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563277061","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11818257,0.046156153,0.2046584,0.011523203,0.0039753853,0.00055607525,0.0012581529,0.0012042292,0.6124858],"genre_scores_gemma":[0.7071617,0.022987215,0.15854156,0.0006984421,0.00090503384,0.0005509521,0.000364979,0.00048782935,0.10830218],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998458,0.00028743644,0.00009165947,0.00022315659,0.00079745514,0.00014230548],"domain_scores_gemma":[0.9985636,0.00041417414,0.00022777006,0.00021467594,0.00044072972,0.00013917488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011981546,0.00041755076,0.00038053823,0.0021845181,0.001905061,0.0036612637,0.00053356466,0.0010468538,0.024269106],"category_scores_gemma":[0.0032462506,0.0005504999,0.00043645708,0.0020333854,0.001515481,0.0016623337,0.0012884138,0.0018717884,0.008190942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029677624,0.00015491991,0.003885002,0.0007855194,0.000063599866,0.0025194762,0.0034052264,0.0019130011,0.040493805,0.40234998,0.01618232,0.52795035],"study_design_scores_gemma":[0.000055382876,0.00020262733,0.006077835,0.00035304844,0.0001034486,0.0035806943,0.0018338923,0.0018739589,0.025432663,0.08639703,0.87394226,0.000147153],"about_ca_topic_score_codex":0.0047963983,"about_ca_topic_score_gemma":0.0067996536,"teacher_disagreement_score":0.024269106,"about_ca_system_score_codex":0.0011529428,"about_ca_system_score_gemma":0.0027853781,"threshold_uncertainty_score":0.08118826},"labels":[],"label_agreement":null},{"id":"W2564627979","doi":"10.1182/blood.v112.11.4662.4662","title":"Novel Dissemination Efforts for Hematology-Related Serious Adverse Drug Reactions (sADRs): Findings from the Research on Adverse Drug Events and Reports Project (RADAR)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Expanded access; Medical education; Family medicine; Adverse effect; Internal medicine; Oncology","score_opus":0.10340757094669442,"score_gpt":0.44112807564473805,"score_spread":0.3377205046980436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564627979","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1588974,0.049556732,0.018686729,0.6953873,0.003160117,0.006638368,0.0074042287,0.0014460317,0.058823064],"genre_scores_gemma":[0.7418792,0.052773643,0.052422907,0.12267893,0.00627936,0.0056063323,0.008447502,0.0004261716,0.009485919],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8988298,0.06563431,0.008544355,0.004419836,0.01917373,0.00339789],"domain_scores_gemma":[0.48879558,0.32104763,0.075250976,0.019354155,0.07758138,0.01797028],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14095242,0.00075720093,0.000658609,0.0040299566,0.001774116,0.0072374595,0.0021329701,0.0031015775,0.011346882],"category_scores_gemma":[0.31827652,0.00051016355,0.0024569342,0.004149854,0.0017713484,0.008092494,0.0060678865,0.005336428,0.0015994185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010305295,0.0023578417,0.123873256,0.006432173,0.0012133437,0.00058726786,0.0074545555,0.00087499275,0.00060930656,0.012714072,0.17492966,0.66792303],"study_design_scores_gemma":[0.0037207224,0.0046920325,0.47350243,0.022648487,0.0031602036,0.0014321931,0.023031838,0.0045016753,0.0034698416,0.013621381,0.4458044,0.00041480095],"about_ca_topic_score_codex":0.007441146,"about_ca_topic_score_gemma":0.004769707,"teacher_disagreement_score":0.8590476,"about_ca_system_score_codex":0.0044685625,"about_ca_system_score_gemma":0.02743926,"threshold_uncertainty_score":0.74543655},"labels":[],"label_agreement":null},{"id":"W2564790786","doi":"10.2196/cancer.6701","title":"Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project","year":2016,"lang":"en","type":"article","venue":"JMIR Cancer","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Food and Drug Administration","keywords":"Investigational Drugs; Clinical trial; Medicine; Drug; Investigational device exemption; Pharmacology; Internal medicine","score_opus":0.6039039582388719,"score_gpt":0.6421311764728272,"score_spread":0.03822721823395536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564790786","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004230417,0.0075142165,0.06670871,0.8526637,0.0041582,0.018829154,0.0016566803,0.0053653335,0.038873557],"genre_scores_gemma":[0.02248305,0.020394573,0.74286616,0.15694246,0.0025789596,0.03419982,0.0042147962,0.0013124349,0.015007787],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.72833425,0.1813316,0.031439215,0.0047596255,0.045520525,0.008614772],"domain_scores_gemma":[0.498169,0.21661054,0.045510303,0.029672898,0.14544176,0.064595565],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.31663102,0.0029710596,0.0026721316,0.0069102817,0.005338362,0.02239476,0.013079941,0.02335498,0.013523953],"category_scores_gemma":[0.3245043,0.0028897307,0.00499234,0.0075805946,0.0073476313,0.020768238,0.017265724,0.028246824,0.013276798],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000466808,0.0028151348,0.009025078,0.00608043,0.00015638108,0.0008916574,0.003910752,0.0018271836,0.0012374248,0.020738458,0.64422125,0.30862948],"study_design_scores_gemma":[0.0019863283,0.0018030875,0.01546862,0.026522696,0.00043936516,0.0012469275,0.008403336,0.004882934,0.0020331582,0.02359,0.9131693,0.00045424147],"about_ca_topic_score_codex":0.010238725,"about_ca_topic_score_gemma":0.015864676,"teacher_disagreement_score":0.683369,"about_ca_system_score_codex":0.007512586,"about_ca_system_score_gemma":0.13293464,"threshold_uncertainty_score":0.8427156},"labels":[],"label_agreement":null},{"id":"W2564956899","doi":"10.1345/aph.1k191","title":"Pharmacovigilance, 2nd Edition: Edited by Ronald D Mann MD FRCP FRCGP FFPM FISPE Hon Member ISoP and Elizabeth B Andrews MPH PhD. Published by John Wiley &amp; Sons, Ltd., West Sussex, England, 2007. ISBN 978-0-470-01803-3. Clothbound, xviii + 686 pp. (25.5 x 19.5 cm), $315.00. www.wiley.com","year":2007,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Pharmacovigilance; Classics; Library science; History; Pharmacology; Drug; Computer science","score_opus":0.0778501511093074,"score_gpt":0.4065043217525835,"score_spread":0.32865417064327607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564956899","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011275931,0.84968054,0.00918891,0.024526332,0.047011983,0.000161081,0.004197994,0.0015669666,0.06253868],"genre_scores_gemma":[0.00780989,0.67257094,0.02011783,0.010020932,0.024609968,0.00024969812,0.004612588,0.00087301276,0.2591352],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992238,0.0001499363,0.000094482595,0.00008444589,0.00041370027,0.00003367567],"domain_scores_gemma":[0.99715155,0.00079878076,0.00042840999,0.00010815473,0.0012079169,0.0003051449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021422328,0.00204017,0.002309739,0.003759926,0.00036993105,0.0017993957,0.0013451761,0.00124265,0.063333094],"category_scores_gemma":[0.005660507,0.0009521985,0.00068056764,0.0031256732,0.00051719113,0.0020212827,0.0013069347,0.0028067718,0.063572444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035117904,0.000017170783,0.00015779378,0.00053135067,0.000018907507,0.000091699556,0.00005891758,0.00018691515,0.00028401744,0.00046709896,0.8673931,0.1307579],"study_design_scores_gemma":[0.000016582731,0.000036624577,0.0007940826,0.00091056863,0.00002275705,0.0011860542,0.00005719922,0.0002316542,0.00010648926,0.0011159903,0.99550337,0.000018699528],"about_ca_topic_score_codex":0.005004791,"about_ca_topic_score_gemma":0.011465905,"teacher_disagreement_score":0.063333094,"about_ca_system_score_codex":0.00080536114,"about_ca_system_score_gemma":0.002469399,"threshold_uncertainty_score":0.21187031},"labels":[],"label_agreement":null},{"id":"W2567239969","doi":"10.1007/s40290-016-0172-4","title":"The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore","year":2016,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Timeline; Food and drug administration; Regulatory affairs; Agency (philosophy); Medicine; Certificate; Business; Medical education; Political science; Public administration; Environmental health; Computer science; Sociology","score_opus":0.15703231075620758,"score_gpt":0.4712236755776073,"score_spread":0.31419136482139975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567239969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.671095,0.02629941,0.003296691,0.034249756,0.0006024882,0.0028091737,0.003907763,0.0005979202,0.2571417],"genre_scores_gemma":[0.93975335,0.010439916,0.0056438907,0.006710508,0.00013753813,0.00040487666,0.0025060168,0.00016272342,0.034241185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9712742,0.0069667934,0.0020074288,0.0013310382,0.01629326,0.0021272488],"domain_scores_gemma":[0.9298582,0.009508683,0.0088574225,0.0017546271,0.0427507,0.0072704772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027431706,0.00029658672,0.00027990554,0.0034145068,0.002445966,0.0051490283,0.0012818128,0.00088858267,0.005542532],"category_scores_gemma":[0.04180086,0.0003203108,0.00050118385,0.005893929,0.0014508242,0.001588114,0.0018540485,0.0009029429,0.0013643367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016077613,0.00047115755,0.4263487,0.0017727041,0.0001909232,0.0013567725,0.015698783,0.0010017602,0.002666732,0.016257325,0.06590999,0.46671748],"study_design_scores_gemma":[0.00017116462,0.0007615577,0.69337124,0.00075931713,0.00009586459,0.0011202241,0.011679662,0.0016510942,0.0023667212,0.00041104842,0.28748277,0.00012932351],"about_ca_topic_score_codex":0.6437771,"about_ca_topic_score_gemma":0.6721751,"teacher_disagreement_score":0.35622293,"about_ca_system_score_codex":0.026837774,"about_ca_system_score_gemma":0.09718445,"threshold_uncertainty_score":0.71664155},"labels":[],"label_agreement":null},{"id":"W2574028069","doi":"10.1136/bmjopen-2016-013474","title":"Utility of social media and crowd-sourced data for pharmacovigilance: a scoping review protocol","year":2017,"lang":"en","type":"review","venue":"BMJ Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pharmacovigilance; Social media; Grey literature; MEDLINE; Protocol (science); Systematic review; Agency (philosophy); Alternative medicine; Family medicine; Adverse effect; World Wide Web; Pharmacology; Computer science; Pathology","score_opus":0.797630337611478,"score_gpt":0.7147683673648757,"score_spread":0.08286197024660225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574028069","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027360278,0.0007572404,0.0011872478,0.00032119156,0.000091687674,0.9946523,0.0021655252,0.000065003456,0.0004862699],"genre_scores_gemma":[0.00023160313,0.00063938467,0.0027926322,0.00012039626,0.000014750927,0.99561524,0.00039729444,0.0000065380605,0.00018223279],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.93757904,0.025264394,0.022972688,0.004244672,0.007310888,0.0026283278],"domain_scores_gemma":[0.8949061,0.03509909,0.017664433,0.009219324,0.038004167,0.0051068896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14919595,0.006043863,0.013123389,0.02549309,0.0059881588,0.009704163,0.007522167,0.011425048,0.07217588],"category_scores_gemma":[0.12774608,0.0069861556,0.013632443,0.019524049,0.0063630277,0.01140208,0.008780628,0.007296437,0.020204794],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008735141,0.0010742048,0.0019774374,0.7911704,0.0015414564,0.001653481,0.008273333,0.0021951387,0.0027275195,0.010782129,0.06556359,0.10430609],"study_design_scores_gemma":[0.020996971,0.0029315664,0.00872766,0.6010729,0.004692819,0.0010539588,0.007532839,0.0025468043,0.0042429985,0.016045168,0.32933813,0.00081823306],"about_ca_topic_score_codex":0.006918369,"about_ca_topic_score_gemma":0.0130385365,"teacher_disagreement_score":0.14919595,"about_ca_system_score_codex":0.016747458,"about_ca_system_score_gemma":0.10048388,"threshold_uncertainty_score":0.78903306},"labels":[],"label_agreement":null},{"id":"W2574974965","doi":"10.1136/bmjopen-2015-010568","title":"Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients","year":2017,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; African Population and Health Research Center; International Development Research Centre; Wellcome Trust","keywords":"Medicine; Incidence (geometry); Prospective cohort study; Logistic regression; Risk factor; Referral; Tertiary referral hospital; Internal medicine; Cohort study; Cohort; Emergency medicine; Pediatrics; Retrospective cohort study; Family medicine","score_opus":0.07748687835537225,"score_gpt":0.44013940408766455,"score_spread":0.3626525257322923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574974965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999655,0.00008393848,0.000020262112,0.000010015638,0.0000017354364,0.000008447447,0.000103719896,5.6560697e-7,0.00011629124],"genre_scores_gemma":[0.9995307,0.00012984246,0.0000515522,0.000010689206,0.0000045993966,0.000012116663,0.00018511059,7.113016e-7,0.00007476748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958235,0.00010987291,0.000057778376,0.00008085512,0.000080420774,0.00008866378],"domain_scores_gemma":[0.9990299,0.00012519365,0.00050340523,0.000078426405,0.000086049826,0.0001770477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048780034,0.00031857638,0.00042148994,0.00077501684,0.0005644536,0.0006225701,0.00027197952,0.0003197561,0.0011151885],"category_scores_gemma":[0.00211579,0.00045372537,0.00030035822,0.00075947476,0.0002423086,0.00053573254,0.0007141682,0.00041542167,0.00022569786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004224348,0.000020240692,0.9993537,0.0000043184527,0.000009207657,0.00007110408,0.00006352931,0.000009797621,0.000043121825,0.000003388723,0.000023817314,0.00035554433],"study_design_scores_gemma":[0.0000051372986,0.00010620866,0.99888736,0.000009064797,0.000008811244,0.00047049424,0.00029412005,0.00009481005,0.000022593642,0.000007613847,0.0000907584,0.0000030534943],"about_ca_topic_score_codex":0.0038947004,"about_ca_topic_score_gemma":0.0033756,"teacher_disagreement_score":0.0038947004,"about_ca_system_score_codex":0.00022091283,"about_ca_system_score_gemma":0.00029069802,"threshold_uncertainty_score":0.0077440143},"labels":[],"label_agreement":null},{"id":"W2583291693","doi":"10.2196/publichealth.6174","title":"Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis","year":2017,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Drug and Alcohol Research Centre; Medical Research Council; Australian Government; GlaxoSmithKline","keywords":"Context (archaeology); Active listening; Social media; Medicine; Psychology; Internet privacy; Computer science; World Wide Web","score_opus":0.6160078940471051,"score_gpt":0.5527913765552113,"score_spread":0.06321651749189383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583291693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778575,0.0001799869,0.005818935,0.0002637265,0.000047671045,0.0032201384,0.007920644,0.00021941526,0.004471982],"genre_scores_gemma":[0.9298264,0.0003674533,0.04820304,0.00022936797,0.00019507091,0.0071447776,0.011214172,0.00010650754,0.0027132903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634725,0.0014057788,0.0006397968,0.00049122126,0.00087603193,0.00023983255],"domain_scores_gemma":[0.96753013,0.020786095,0.00434201,0.0012662326,0.0055047236,0.0005707768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065746433,0.00058518205,0.0004858889,0.01685436,0.00086203305,0.0013837899,0.00051592744,0.0005508079,0.002204816],"category_scores_gemma":[0.019330138,0.000202962,0.0005840684,0.006719904,0.0009417058,0.0016168222,0.0019191998,0.00053043343,0.00080154417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017517644,0.0010721423,0.39928335,0.0061319526,0.0002478516,0.0014149485,0.12316381,0.0008584769,0.06241539,0.0016749827,0.009009455,0.3929759],"study_design_scores_gemma":[0.000077419594,0.0011667984,0.9079168,0.00067614694,0.0002629535,0.00075108773,0.046905983,0.009994749,0.012837196,0.0012193463,0.018007541,0.0001840425],"about_ca_topic_score_codex":0.002076552,"about_ca_topic_score_gemma":0.0038737585,"teacher_disagreement_score":0.01685436,"about_ca_system_score_codex":0.0010354606,"about_ca_system_score_gemma":0.0010153339,"threshold_uncertainty_score":0.03477049},"labels":[],"label_agreement":null},{"id":"W2587751694","doi":"10.1177/1715163517690744","title":"Risk of falls associated with antiepileptic drug use in ambulatory elderly populations","year":2017,"lang":"en","type":"review","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Ambulatory; Falls in older adults; Cochrane Library; Odds ratio; Cohort study; Observational study; Retrospective cohort study; Poison control; MEDLINE; Pediatrics; Emergency medicine; Injury prevention; Internal medicine; Meta-analysis","score_opus":0.2950823208623205,"score_gpt":0.4404799389397761,"score_spread":0.1453976180774556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587751694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060719484,0.99275017,0.000071148796,0.00023367492,0.00006548323,0.00005346793,0.00037496447,0.0000031103762,0.00037596867],"genre_scores_gemma":[0.07236065,0.9256408,0.00072492997,0.00043373747,0.00014379557,0.00021412589,0.0003907157,0.0000025644133,0.00008860754],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936619,0.00157877,0.002859672,0.00046384113,0.00134135,0.00009444107],"domain_scores_gemma":[0.97207433,0.018221822,0.007846074,0.00013653487,0.0015664501,0.0001547897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00474679,0.0005321027,0.0032152322,0.008299841,0.00025337876,0.0014902033,0.00083824014,0.0013986096,0.0018834728],"category_scores_gemma":[0.027796784,0.00046611414,0.0033173459,0.008000061,0.00033661164,0.0009732373,0.0006350611,0.0005852478,0.00014158351],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007868652,0.00005245603,0.041895647,0.7779147,0.020549465,0.00059796305,0.0005754197,0.00021774748,0.00033872697,0.00042928965,0.0026191121,0.15402265],"study_design_scores_gemma":[0.0006839257,0.0011430163,0.19766156,0.6832632,0.07954179,0.0053317654,0.0012126366,0.00037316477,0.0005831562,0.0010859844,0.028992277,0.00012757805],"about_ca_topic_score_codex":0.0038801723,"about_ca_topic_score_gemma":0.006771996,"teacher_disagreement_score":0.008299841,"about_ca_system_score_codex":0.0010683668,"about_ca_system_score_gemma":0.0019737997,"threshold_uncertainty_score":0.025103748},"labels":[],"label_agreement":null},{"id":"W2589058495","doi":"10.22374/1710-6222.24.1.1","title":"Use of continuous exposure variables when examining dose-dependent pharmacological effects – Application to the association between exposure to higher statin doses and the incidence of diabetes","year":2017,"lang":"en","type":"article","venue":"Journal of Population Therapeutics and Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Université Laval; Centre Hospitalier de l’Université de Montréal; Programs for Assessment of Technology in Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Diabetes mellitus; Statin; Internal medicine; Cumulative incidence; Incidence (geometry); Akaike information criterion; Logistic regression; Type 2 diabetes; Cohort; Endocrinology; Statistics; Mathematics","score_opus":0.15268484714036376,"score_gpt":0.4611353063512005,"score_spread":0.3084504592108367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589058495","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48384437,0.009849363,0.48058408,0.0065269293,0.0016463825,0.0024196415,0.006834819,0.0005491902,0.007745271],"genre_scores_gemma":[0.87525094,0.00078934175,0.11895654,0.0010822152,0.0003296663,0.0017524189,0.0009723265,0.00009344412,0.0007730034],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.77535355,0.20576426,0.0054751975,0.0047507137,0.0077006975,0.00095556636],"domain_scores_gemma":[0.5869864,0.368314,0.019617766,0.017919619,0.005529672,0.0016324663],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12963615,0.0012632627,0.0018589876,0.0046808515,0.0011417211,0.0024083962,0.0034683926,0.0023717394,0.004381758],"category_scores_gemma":[0.22656547,0.00059659686,0.005622633,0.0068761925,0.002705583,0.0017120325,0.0021710508,0.0037811873,0.00029486883],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002346165,0.00041632936,0.9081806,0.001218632,0.011590039,0.0008990326,0.00082442455,0.014229106,0.0007888148,0.007658835,0.002821841,0.04902615],"study_design_scores_gemma":[0.000472936,0.005261554,0.7797766,0.0012362213,0.0045332564,0.0010657549,0.0017583865,0.1651807,0.0019042878,0.025096133,0.013426306,0.00028792],"about_ca_topic_score_codex":0.009905805,"about_ca_topic_score_gemma":0.009703187,"teacher_disagreement_score":0.87036383,"about_ca_system_score_codex":0.001251278,"about_ca_system_score_gemma":0.0029773787,"threshold_uncertainty_score":0.6855897},"labels":[],"label_agreement":null},{"id":"W2589235489","doi":"10.2196/publichealth.6872","title":"Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance","year":2017,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; The Internet; Narrative; Social media; Internet privacy; Exploratory research; Medicine; World Wide Web; Computer science; Sociology; Pharmacology; Drug; Social science","score_opus":0.16009630618559675,"score_gpt":0.47391189922480514,"score_spread":0.31381559303920836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589235489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821055,0.00010374075,0.00030318313,0.00017001535,0.0000063760526,0.00008593498,0.000615402,0.0000092312275,0.0004955684],"genre_scores_gemma":[0.99504614,0.0002973286,0.0024810615,0.00019513012,0.00002382523,0.00028180695,0.0011239039,0.000023769584,0.0005270126],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9966175,0.0022208048,0.0002465692,0.0002955925,0.00037447197,0.00024516255],"domain_scores_gemma":[0.97569764,0.01795476,0.0037978773,0.0006430527,0.0009481649,0.00095859956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00407643,0.00038633423,0.00043316322,0.0042968453,0.0013687211,0.0022963262,0.0006419974,0.00077081524,0.0013259351],"category_scores_gemma":[0.019060396,0.0002813967,0.00031413833,0.002983165,0.0013015659,0.0023726083,0.0028549358,0.000701655,0.00027790878],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039019345,0.00046030036,0.32455054,0.0007518487,0.000068451016,0.0032289848,0.63154054,0.00014406159,0.0042351163,0.0005837837,0.0024948115,0.031551346],"study_design_scores_gemma":[0.00004061441,0.00030864606,0.25764152,0.00030137153,0.00007102611,0.0024872983,0.7201505,0.001704447,0.0016361637,0.00057024596,0.015005905,0.000082304396],"about_ca_topic_score_codex":0.0019025691,"about_ca_topic_score_gemma":0.0039783604,"teacher_disagreement_score":0.0042968453,"about_ca_system_score_codex":0.001114992,"about_ca_system_score_gemma":0.00088671694,"threshold_uncertainty_score":0.021558523},"labels":[],"label_agreement":null},{"id":"W2597828908","doi":"10.1186/s12992-017-0232-x","title":"Matching safety to access: global actors and pharmacogovernance in Kenya- a case study","year":2017,"lang":"en","type":"article","venue":"Globalization and Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College; York University; University of Toronto","funders":"University of Toronto","keywords":"Public relations; Pharmacovigilance; Government (linguistics); Public administration; Legislation; Public health; Civil society; Stakeholder; Global health; Stakeholder engagement; Corporate governance; Political science; Business; Medicine; Nursing; Law; Politics","score_opus":0.19863566943272842,"score_gpt":0.5594800842513481,"score_spread":0.3608444148186197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597828908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707372,0.0011311049,0.0004058718,0.0043645296,0.000024542389,0.00020214192,0.00006903976,0.0000025750428,0.023063093],"genre_scores_gemma":[0.9955124,0.0013402508,0.00045625644,0.0005240068,0.000008412553,0.00007824692,0.00002718028,0.0000028426953,0.002050353],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99570113,0.0027550336,0.00011038845,0.000170323,0.0002931058,0.0009700219],"domain_scores_gemma":[0.9945589,0.0035519656,0.0008450822,0.00009563573,0.00023900444,0.0007094087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005206102,0.00042898147,0.00031385274,0.0015331388,0.015551719,0.0039552758,0.00094053603,0.0026986315,0.0054808394],"category_scores_gemma":[0.005523871,0.00034482474,0.00028097554,0.0025229992,0.006905758,0.003799914,0.0051752995,0.0022682145,0.00020095108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016002658,0.00052533334,0.08209636,0.0006341699,0.00002930236,0.029353535,0.8287516,0.00036072696,0.00094289315,0.033307843,0.0030961714,0.020742081],"study_design_scores_gemma":[0.000024551011,0.0001284096,0.025088452,0.00053290644,0.000024745736,0.0020150612,0.9423868,0.00029104113,0.0003272051,0.0013735032,0.027784135,0.000023225726],"about_ca_topic_score_codex":0.048162088,"about_ca_topic_score_gemma":0.11458307,"teacher_disagreement_score":0.048162088,"about_ca_system_score_codex":0.010052996,"about_ca_system_score_gemma":0.007334875,"threshold_uncertainty_score":0.095763564},"labels":[],"label_agreement":null},{"id":"W2600910988","doi":"10.2165/00002018-200831100-00128","title":"Case Series in Drug Safety Surveillance: Are they Useful as a Risk Management Tool?","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Drug; Series (stratigraphy); Intensive care medicine; Pharmacology","score_opus":0.05273912787287435,"score_gpt":0.36304461591476417,"score_spread":0.31030548804188984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600910988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7131932,0.044633042,0.03230467,0.05002614,0.010168575,0.0013532097,0.0012872372,0.0017757614,0.14525832],"genre_scores_gemma":[0.95856494,0.008683125,0.01252271,0.005625715,0.0114624845,0.0002908048,0.00043602634,0.00013082723,0.0022833957],"study_design_codex":"case_report","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99454826,0.0021452983,0.0011446152,0.000537563,0.0009746814,0.00064965343],"domain_scores_gemma":[0.9513332,0.028877089,0.00866244,0.0029605886,0.0034268084,0.0047398],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040070494,0.0027314564,0.0013686422,0.007842995,0.0021933517,0.0036314395,0.002518399,0.011459626,0.006349298],"category_scores_gemma":[0.07381386,0.0013846087,0.0014424428,0.0029931078,0.0025068256,0.010390598,0.0023182959,0.0055238632,0.0036093537],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020610797,0.0002797463,0.1348193,0.00034521433,0.000049210466,0.8246621,0.0010295365,0.00063116965,0.0007153286,0.0021238434,0.009844778,0.025293613],"study_design_scores_gemma":[0.00003232423,0.00009763289,0.006798314,0.00034528473,0.00005126549,0.9840475,0.00098274,0.0014492588,0.0006377103,0.0014072141,0.0041044788,0.00004637161],"about_ca_topic_score_codex":0.0010127462,"about_ca_topic_score_gemma":0.0010601185,"teacher_disagreement_score":0.99599296,"about_ca_system_score_codex":0.0011465357,"about_ca_system_score_gemma":0.0012592534,"threshold_uncertainty_score":0.021240532},"labels":[],"label_agreement":null},{"id":"W2604178951","doi":"","title":"Spontaneous adverse drug reactions reporting by patients in Canada: A multi-method study","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Care & Health Systems","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Medicine; Drug reaction; Adverse drug reaction; Adverse effect; Intensive care medicine; Pharmacology","score_opus":0.12260641143048583,"score_gpt":0.4904382722179166,"score_spread":0.36783186078743074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604178951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286383,0.00084778026,0.00055891153,0.00022146293,0.000023314811,0.0010364096,0.0032116042,0.00002075835,0.001215905],"genre_scores_gemma":[0.9930333,0.00084569847,0.0017101223,0.00064599264,0.000027206277,0.0005590973,0.0022265413,0.000021777043,0.00093019207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9890554,0.002815183,0.0016634229,0.0012455474,0.0036932416,0.0015272626],"domain_scores_gemma":[0.9796078,0.0036120624,0.0054903706,0.0007981208,0.008748326,0.0017432885],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0045942366,0.0010075355,0.0015700243,0.0029699663,0.0043529565,0.0031202429,0.0025047816,0.0015008801,0.002502387],"category_scores_gemma":[0.016779227,0.0011221872,0.0018816116,0.0082922885,0.0017133851,0.0012769179,0.0025273124,0.0014187645,0.00039220435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039821095,0.00025558993,0.9923299,0.00013303262,0.00031843007,0.00014302212,0.002013068,0.00011969666,0.00013559996,0.000098927485,0.00067092536,0.003383636],"study_design_scores_gemma":[0.00012732079,0.0002842712,0.9945787,0.000068926216,0.00020478762,0.00021537297,0.0029432215,0.0006351219,0.000090562586,0.000034156896,0.0007606541,0.00005682518],"about_ca_topic_score_codex":0.9644895,"about_ca_topic_score_gemma":0.9689389,"teacher_disagreement_score":0.9954058,"about_ca_system_score_codex":0.03551925,"about_ca_system_score_gemma":0.039624184,"threshold_uncertainty_score":0.2577114},"labels":[],"label_agreement":null},{"id":"W2605264062","doi":"10.18203/2319-2003.ijbcp20171499","title":"A comparative study of adverse drug reactions reported by healthcare professionals and patients in a tertiary care teaching hospital","year":2017,"lang":"en","type":"article","venue":"International Journal of Basic & Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Drug reaction; Adverse drug reaction; Health care; Health professionals; Family medicine; Adverse effect; Pharmacovigilance; Population; Pharmacotherapy; Emergency medicine; Pediatrics; Drug; Internal medicine; Environmental health; Psychiatry","score_opus":0.11184369835689884,"score_gpt":0.5549266549723115,"score_spread":0.4430829566154127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605264062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996325,0.00008491928,0.00001539078,0.000026193962,0.0000030839121,0.00001739388,0.00005269993,5.602986e-7,0.0001673638],"genre_scores_gemma":[0.99966574,0.00009625432,0.000033297358,0.000038646023,0.000009890452,0.000017736485,0.00007084209,5.1147344e-7,0.000067113084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979729,0.0005935355,0.0003292426,0.00028739817,0.00042685654,0.0003900799],"domain_scores_gemma":[0.9948008,0.0010886511,0.0024491367,0.00014450277,0.0006522783,0.0008647063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012143853,0.00019769199,0.0005059825,0.001453296,0.0009673472,0.0009065243,0.0003990858,0.00062168995,0.0018502305],"category_scores_gemma":[0.005115219,0.00035407077,0.00050427084,0.0014653662,0.0007327006,0.00067580875,0.0010140009,0.0006838516,0.0002547248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013218092,0.00016292278,0.9945926,0.000054643948,0.00002843748,0.0003566769,0.0032458634,0.000010217098,0.00014734772,0.00001621319,0.00006730885,0.0011855828],"study_design_scores_gemma":[0.00001639815,0.00094796525,0.9847424,0.000025065812,0.000021118723,0.0008401094,0.0130155245,0.000047762103,0.000070581285,0.000011739687,0.00025056957,0.000010765814],"about_ca_topic_score_codex":0.006164427,"about_ca_topic_score_gemma":0.008905595,"teacher_disagreement_score":0.006164427,"about_ca_system_score_codex":0.0015188443,"about_ca_system_score_gemma":0.0013221287,"threshold_uncertainty_score":0.012257099},"labels":[],"label_agreement":null},{"id":"W2610937402","doi":"10.2196/publichealth.6396","title":"TwiMed: Twitter and PubMed Comparable Corpus of Drugs, Diseases, Symptoms, and Their Relations","year":2017,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Annotation; Pharmacovigilance; Computer science; Set (abstract data type); Information retrieval; Natural language processing; Resource (disambiguation); Artificial intelligence; Data science; Medicine; Drug","score_opus":0.110992696657757,"score_gpt":0.4170413079632729,"score_spread":0.30604861130551586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610937402","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.072256,0.0032023415,0.017752524,0.004664448,0.0013812443,0.0017609881,0.8814226,0.0036507614,0.013909192],"genre_scores_gemma":[0.06900657,0.001053997,0.04838778,0.0008811171,0.00029322528,0.0044019106,0.87010187,0.00059527037,0.0052782716],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997633,0.00077971956,0.0005779356,0.0004857979,0.0004247825,0.00009868134],"domain_scores_gemma":[0.9818491,0.012330945,0.0012901736,0.0012835857,0.0027213448,0.00052487943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002091566,0.0011025608,0.00066168606,0.0059158397,0.002217107,0.0017755285,0.0013417047,0.0018004811,0.01237976],"category_scores_gemma":[0.015285949,0.0004421076,0.0007154264,0.005654769,0.0011442815,0.0028426922,0.002378099,0.0017013006,0.00495704],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017801162,0.00049951783,0.008341951,0.023988264,0.00022755344,0.005787323,0.009862179,0.0038834915,0.028442927,0.015370698,0.7957617,0.106054254],"study_design_scores_gemma":[0.00041768295,0.00018837689,0.029585818,0.0014358681,0.00015805435,0.002004226,0.0047747567,0.009359277,0.009556884,0.0037045865,0.938639,0.00017551742],"about_ca_topic_score_codex":0.010085353,"about_ca_topic_score_gemma":0.017154384,"teacher_disagreement_score":0.01237976,"about_ca_system_score_codex":0.001720051,"about_ca_system_score_gemma":0.0025753165,"threshold_uncertainty_score":0.04141444},"labels":[],"label_agreement":null},{"id":"W2617709648","doi":"10.1093/ndt/gfx145.sp259","title":"SP259EFFECTS OF EMPAGLIFLOZIN ON RENAL OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME® TRIAL","year":2017,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Empagliflozin; EMPA; Medicine; Outcome (game theory); Internal medicine; Intensive care medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.10345637739416705,"score_gpt":0.44713646244138633,"score_spread":0.34368008504721925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617709648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667387,0.022399591,0.0006031672,0.0014492583,0.0004509254,0.00061615213,0.0034515832,0.00014794222,0.00414272],"genre_scores_gemma":[0.9869739,0.0043030335,0.00062879926,0.0013387756,0.00053642434,0.0009145638,0.0039859093,0.000017344433,0.0013013302],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992367,0.00035430267,0.000064999986,0.00013863582,0.0001080356,0.000097349555],"domain_scores_gemma":[0.99916494,0.00019872848,0.00028800117,0.00007822261,0.00006963264,0.00020039259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002348443,0.00095147477,0.002014508,0.00026831063,0.0002302763,0.0010831801,0.0005254844,0.0010786636,0.0025698876],"category_scores_gemma":[0.0019946091,0.00022964855,0.002490387,0.00033807126,0.00047039686,0.00068349845,0.00043648249,0.0019866168,0.00037123056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93231905,0.0018991427,0.0074917786,0.001636504,0.005986248,0.0000540717,0.000043986485,0.0007264089,0.0013860313,0.00027461865,0.0038599935,0.044322096],"study_design_scores_gemma":[0.85140616,0.06928536,0.061169676,0.0004400781,0.010110633,0.00016246742,0.00008156623,0.0014424811,0.00084488053,0.001094259,0.0038950199,0.000067391724],"about_ca_topic_score_codex":0.0006197796,"about_ca_topic_score_gemma":0.0009501817,"teacher_disagreement_score":0.0025698876,"about_ca_system_score_codex":0.00042393003,"about_ca_system_score_gemma":0.00042177408,"threshold_uncertainty_score":0.012419879},"labels":[],"label_agreement":null},{"id":"W2619319027","doi":"10.2196/mhealth.6261","title":"Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability","year":2017,"lang":"en","type":"article","venue":"JMIR mhealth and uhealth","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Usability; Medicine; Adverse effect; Pharmacovigilance; Adverse drug reaction; System usability scale; Mobile apps; Drug reaction; Scale (ratio); Drug; Medical emergency; Pharmacology; World Wide Web; Heuristic evaluation; Computer science","score_opus":0.2507058802433056,"score_gpt":0.5494571709237669,"score_spread":0.2987512906804613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619319027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4416758,0.02292742,0.35172048,0.0071429396,0.0031029454,0.10019381,0.005963166,0.015687078,0.051586322],"genre_scores_gemma":[0.37991267,0.008526823,0.5473909,0.0017288936,0.0005406625,0.047408193,0.0018728727,0.0004630072,0.012155989],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.994793,0.0027869751,0.0007650883,0.00032679932,0.001097367,0.00023069837],"domain_scores_gemma":[0.9831025,0.00946791,0.0015966778,0.0009740759,0.0041530463,0.00070584443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008195011,0.0010079051,0.00061258173,0.0019929402,0.00073842856,0.0016352347,0.00089168304,0.0009657333,0.0058315066],"category_scores_gemma":[0.027930476,0.0004824403,0.0013696123,0.0006102918,0.00037158537,0.0017430725,0.0014261656,0.000902841,0.0024577393],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002412965,0.0017018488,0.016296588,0.005403716,0.00022380699,0.0009869767,0.002936532,0.00072587084,0.0118858805,0.0018938035,0.024877869,0.9306542],"study_design_scores_gemma":[0.0072400244,0.042849515,0.21362664,0.017227737,0.0042739515,0.011976981,0.0072428975,0.04608812,0.06832805,0.017010147,0.5627439,0.0013920659],"about_ca_topic_score_codex":0.0005132065,"about_ca_topic_score_gemma":0.0010173464,"teacher_disagreement_score":0.008195011,"about_ca_system_score_codex":0.00045466685,"about_ca_system_score_gemma":0.0019003295,"threshold_uncertainty_score":0.043339908},"labels":[],"label_agreement":null},{"id":"W2621160508","doi":"10.4103/0366-6999.207468","title":"Active Monitoring of Adverse Drug Reactions with Neural Network Technology","year":2017,"lang":"en","type":"article","venue":"Chinese Medical Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug reaction; Drug; Medicine; Intensive care medicine; Adverse effect; Artificial neural network; Adverse drug reaction; Computer science; Pharmacology; Artificial intelligence","score_opus":0.05517251529413519,"score_gpt":0.4409156993388912,"score_spread":0.385743184044756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621160508","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15762925,0.014056616,0.8018636,0.0018825966,0.00085154857,0.00035445899,0.0015796105,0.00480379,0.016978519],"genre_scores_gemma":[0.9308999,0.0028999029,0.059409827,0.00044505313,0.00029051982,0.00014192279,0.00086972537,0.000036739875,0.0050065015],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994943,0.00007450383,0.00004576873,0.00016236857,0.00017146545,0.000051581996],"domain_scores_gemma":[0.9995859,0.00011890371,0.00009701271,0.000026321653,0.00015219377,0.000019635912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004989635,0.00082729047,0.0005934663,0.001127553,0.00020959451,0.00079920347,0.0007152373,0.0007483242,0.0015355875],"category_scores_gemma":[0.0013325982,0.00018176492,0.00045503865,0.0007382885,0.00024114933,0.0007366289,0.0004662097,0.0008242826,0.00046677823],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043437284,0.00040509825,0.012900155,0.00034668762,0.00019852683,0.00028639464,0.000050297513,0.13479319,0.012293459,0.0016635405,0.007965471,0.82866275],"study_design_scores_gemma":[0.0000121806015,0.00013407771,0.0039543556,0.00003594234,0.00005095256,0.00011216455,0.00001742368,0.9887328,0.0036361925,0.00188403,0.0014119488,0.000017979304],"about_ca_topic_score_codex":0.004354457,"about_ca_topic_score_gemma":0.002677729,"teacher_disagreement_score":0.004354457,"about_ca_system_score_codex":0.00049204065,"about_ca_system_score_gemma":0.00036262829,"threshold_uncertainty_score":0.00865823},"labels":[],"label_agreement":null},{"id":"W2715985536","doi":"10.2196/publichealth.6577","title":"Filtering Entities to Optimize Identification of Adverse Drug Reaction From Social Media: How Can the Number of Words Between Entities in the Messages Help?","year":2017,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Popularity; False positive paradox; Term (time); Social media; Recall; Drug; Computer science; Medicine; Information retrieval; Psychiatry; Psychology; Machine learning; Cognitive psychology; World Wide Web; Social psychology","score_opus":0.1290499107859054,"score_gpt":0.437439936973234,"score_spread":0.30839002618732864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2715985536","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78287953,0.0070335353,0.18841249,0.0036799842,0.0004922492,0.0009492655,0.005466739,0.0035672123,0.007519084],"genre_scores_gemma":[0.84659964,0.0010656668,0.14452006,0.00039502146,0.00031969318,0.00020598115,0.004332333,0.00012962418,0.002431904],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99590945,0.0015730336,0.0004581781,0.0009620816,0.00084665365,0.0002507025],"domain_scores_gemma":[0.9800238,0.014842252,0.0019175356,0.0008850901,0.0019877453,0.00034358553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067359833,0.0015747583,0.0014515484,0.008250163,0.000934829,0.0026191068,0.000846631,0.0015791436,0.0013689037],"category_scores_gemma":[0.024445185,0.00038285065,0.0010488604,0.002345097,0.00057234935,0.0029468029,0.0010053661,0.0011644956,0.0016557304],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001342415,0.000740158,0.32811236,0.0015959926,0.0007904569,0.0006793893,0.0017640075,0.007020884,0.031396993,0.0020679862,0.01329072,0.6111986],"study_design_scores_gemma":[0.00020570292,0.0010563842,0.46019506,0.00064173015,0.0011421185,0.0027328038,0.0030147072,0.43901232,0.05424905,0.009146599,0.028310366,0.00029308192],"about_ca_topic_score_codex":0.0069800145,"about_ca_topic_score_gemma":0.009859618,"teacher_disagreement_score":0.008250163,"about_ca_system_score_codex":0.00092180906,"about_ca_system_score_gemma":0.0010634506,"threshold_uncertainty_score":0.03562367},"labels":[],"label_agreement":null},{"id":"W2724666143","doi":"10.1007/s40264-017-0555-9","title":"Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research; Pfizer Canada","keywords":"Pharmacovigilance; Medicine; Parametric statistics; Hazard; Postmarketing surveillance; Data mining; Parametric model; Computer science; Adverse effect; Statistics; Pharmacology","score_opus":0.12619630181361044,"score_gpt":0.43792640679558714,"score_spread":0.31173010498197673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724666143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74982584,0.00093475013,0.24128483,0.0023010985,0.00018892929,0.00019710149,0.0012441401,0.001751679,0.0022715633],"genre_scores_gemma":[0.9778511,0.0000956134,0.020874485,0.00016429764,0.00005137015,0.00004162605,0.0003855904,0.00003446908,0.0005015157],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99612314,0.0023325644,0.00027024283,0.00078370643,0.00026603256,0.0002242799],"domain_scores_gemma":[0.94818085,0.04460711,0.0033766292,0.0017511217,0.0013729043,0.0007114279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009399913,0.0014818043,0.0019349903,0.0011212272,0.0005511816,0.0022141743,0.0016087987,0.0020341228,0.0018139473],"category_scores_gemma":[0.03864748,0.0010766422,0.0015210499,0.00075685757,0.00043989118,0.0021187458,0.0010650129,0.0018983561,0.00025188996],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089418836,0.00027406335,0.021705432,0.00006693499,0.00028418697,0.000109369554,0.00006438831,0.9579095,0.00055012247,0.00073688384,0.0005591583,0.016845826],"study_design_scores_gemma":[0.000042459145,0.00010641389,0.0010403638,0.00000586641,0.000054191532,0.000031410258,0.000009296622,0.9979107,0.00022861685,0.00046893946,0.00009163526,0.000010058277],"about_ca_topic_score_codex":0.029426651,"about_ca_topic_score_gemma":0.017209591,"teacher_disagreement_score":0.029426651,"about_ca_system_score_codex":0.0015923247,"about_ca_system_score_gemma":0.003154807,"threshold_uncertainty_score":0.05851078},"labels":[],"label_agreement":null},{"id":"W2729070252","doi":"","title":"What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims","year":2016,"lang":"en","type":"article","venue":"The Sydney eScholarship Repository (The University of Sydney)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Medical prescription; Medicine; Risk analysis (engineering); Pharmacology","score_opus":0.12013693665214595,"score_gpt":0.41791299772707097,"score_spread":0.29777606107492505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729070252","genre_codex":"review","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005647591,0.70576453,0.111764446,0.1437425,0.008486573,0.010686881,0.004573002,0.000352719,0.008981778],"genre_scores_gemma":[0.13580827,0.3560274,0.41830325,0.04419689,0.008276943,0.032518115,0.0022420015,0.0007284613,0.0018986745],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.28565338,0.48232716,0.1166938,0.014261601,0.09925027,0.0018138327],"domain_scores_gemma":[0.056004144,0.82106024,0.026032152,0.02182578,0.07422438,0.0008532635],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.59508234,0.0043317364,0.0112882815,0.050790954,0.0047946344,0.024570137,0.0107466085,0.0072067846,0.0036686657],"category_scores_gemma":[0.8469334,0.005292204,0.011515154,0.030724343,0.019687923,0.023531131,0.0106737735,0.013226021,0.0009228808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081701326,0.00012346513,0.014408398,0.2967474,0.012038507,0.00056222564,0.02314142,0.0024685585,0.0005677165,0.08627908,0.050394937,0.51245135],"study_design_scores_gemma":[0.00029567556,0.00065461965,0.01130694,0.56517524,0.008551761,0.0009587606,0.010027738,0.0044469307,0.001769222,0.13241713,0.26361063,0.0007852923],"about_ca_topic_score_codex":0.019637614,"about_ca_topic_score_gemma":0.020754213,"teacher_disagreement_score":0.40491766,"about_ca_system_score_codex":0.03192781,"about_ca_system_score_gemma":0.06748497,"threshold_uncertainty_score":0.4993356},"labels":[],"label_agreement":null},{"id":"W2734614665","doi":"10.1016/j.jsps.2017.07.006","title":"Comparison of the safety information on drug labels in three developed countries: The USA, UK and Canada","year":2017,"lang":"en","type":"article","venue":"Saudi Pharmaceutical Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Value (mathematics); Medicine; Business; Drug; Marketing; Computer science; Pharmacology","score_opus":0.12798735313503742,"score_gpt":0.4626367589393489,"score_spread":0.33464940580431146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734614665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96987444,0.0031966304,0.00047162105,0.0007499244,0.000028350934,0.00010345152,0.003468672,0.000017888966,0.022089098],"genre_scores_gemma":[0.9961945,0.0013193925,0.00038180873,0.00015342099,0.000004097583,0.000016627291,0.0010338308,0.0000071242507,0.000889082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960335,0.000661201,0.0004004551,0.00026372191,0.00218434,0.0004566507],"domain_scores_gemma":[0.9843652,0.0041305986,0.0028180163,0.00034912318,0.0076146764,0.0007223639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021927163,0.00016630134,0.00025036262,0.003961728,0.00080121733,0.0015669456,0.00035845579,0.00023731896,0.0016167145],"category_scores_gemma":[0.012133582,0.00013307911,0.00035212058,0.006965491,0.0008181686,0.00043522712,0.00065683405,0.00037829045,0.00010166269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072264054,0.00006701007,0.91754895,0.0007655101,0.00034414578,0.0007137313,0.0077478457,0.00062163314,0.0011635026,0.0021920302,0.003172658,0.06494034],"study_design_scores_gemma":[0.000012445453,0.000047836955,0.9885513,0.00015109153,0.000097680124,0.00018833221,0.0039023415,0.00024398162,0.0005955697,0.00006611278,0.0061176904,0.000025783052],"about_ca_topic_score_codex":0.85476124,"about_ca_topic_score_gemma":0.88010395,"teacher_disagreement_score":0.14523876,"about_ca_system_score_codex":0.009223425,"about_ca_system_score_gemma":0.013026674,"threshold_uncertainty_score":0.29218817},"labels":[],"label_agreement":null},{"id":"W2739588986","doi":"10.1136/bmjqs-2017-006481","title":"Factors influencing the reporting of adverse medical device events: qualitative interviews with physicians about higher risk implantable devices","year":2017,"lang":"en","type":"article","venue":"BMJ Quality & Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Women and Children’s Health Research Institute; Concordia Hospital; University of Alberta; Université de Montréal; University of Calgary; University of Toronto; Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Medical device; Qualitative research; Patient safety; Adverse effect; Medical emergency; Medical education; Risk management; Family medicine; Nursing; Health care; Internal medicine; Biomedical engineering","score_opus":0.32161039343456654,"score_gpt":0.5710185778483863,"score_spread":0.24940818441381973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739588986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988675,0.0012226407,0.0027481518,0.0041131093,0.000067950365,0.00021519542,0.00014309291,0.000015216255,0.00279966],"genre_scores_gemma":[0.9949981,0.0009396884,0.0012343304,0.0015113817,0.000027281227,0.0002015085,0.00004392312,0.000011748871,0.0010320856],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9849723,0.011873602,0.00042183118,0.00055133685,0.0007635681,0.0014173355],"domain_scores_gemma":[0.9237137,0.06471651,0.004504573,0.00057373574,0.0029643648,0.003527008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018184843,0.00053521525,0.00065057125,0.0012259119,0.006135556,0.0027747855,0.0013553766,0.0022839296,0.0025737137],"category_scores_gemma":[0.041041136,0.0008134112,0.00034869983,0.0011772274,0.007362058,0.0032972249,0.003518249,0.0032086829,0.00026207187],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029774326,0.00002262143,0.0027400586,0.00012627406,0.0000028786924,0.00037546805,0.9942683,0.000026234587,0.00047609903,0.0002572924,0.00023288785,0.0014420701],"study_design_scores_gemma":[0.000006197387,0.000050142688,0.0017385345,0.00018270727,0.0000040531013,0.0001670701,0.9940221,0.000066343615,0.00020249213,0.00019010351,0.0033599902,0.000010237593],"about_ca_topic_score_codex":0.0097123,"about_ca_topic_score_gemma":0.012312297,"teacher_disagreement_score":0.018184843,"about_ca_system_score_codex":0.0051551997,"about_ca_system_score_gemma":0.0047606076,"threshold_uncertainty_score":0.0961718},"labels":[],"label_agreement":null},{"id":"W2748474322","doi":"10.12927/hcq.2017.25229","title":"Medication Incidents Involving Antiepileptic Drugs in Canadian Hospitals: A Multi-Incident Analysis","year":2017,"lang":"en","type":"article","venue":"Healthcare Quarterly","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Baycrest Hospital","funders":"","keywords":"Best practice; Incident report; Medical emergency; Medicine; Business; Family medicine; Computer security; Political science; Computer science","score_opus":0.08461061677234741,"score_gpt":0.46361041543569653,"score_spread":0.3789997986633491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748474322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97227705,0.0014824186,0.00067043956,0.00044543867,0.000023061577,0.0003768676,0.02225042,0.000038225895,0.0024362307],"genre_scores_gemma":[0.9849081,0.001560679,0.0017177376,0.00026898127,0.000020337637,0.00015131914,0.010859315,0.000014412992,0.0004991525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99140024,0.00063145545,0.0014164705,0.00079864985,0.0041762055,0.0015770427],"domain_scores_gemma":[0.976769,0.0027606683,0.006480812,0.00076317636,0.011323479,0.0019030045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037177168,0.00080230826,0.0009210667,0.009844328,0.00388491,0.0022919604,0.0021376966,0.0008000882,0.0016723744],"category_scores_gemma":[0.016261732,0.0005965312,0.0016690141,0.017816076,0.0007127607,0.0008158,0.0022640398,0.0010884902,0.00017789892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013449907,0.00005310425,0.991912,0.00022844397,0.0002456652,0.0001443285,0.00072988553,0.0002376307,0.00008710189,0.000095378855,0.0011245152,0.005007282],"study_design_scores_gemma":[0.000010820093,0.000045160403,0.99587077,0.00007968871,0.00013890181,0.000114443996,0.0016853964,0.000693937,0.00010834192,0.000020263657,0.0012043118,0.000027982896],"about_ca_topic_score_codex":0.9866502,"about_ca_topic_score_gemma":0.98507994,"teacher_disagreement_score":0.042420022,"about_ca_system_score_codex":0.042420022,"about_ca_system_score_gemma":0.05575552,"threshold_uncertainty_score":0.30778027},"labels":[],"label_agreement":null},{"id":"W2752363805","doi":"10.4212/cjhp.v70i4.1677","title":"Pharmacy Student Facilitation of Reporting of Adverse Drug Reactions in a Hospital","year":2017,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Waterloo; Ottawa Hospital","funders":"","keywords":"Pharmacy; Medicine; Drug reaction; Facilitation; Family medicine; Health care; Drug; Pharmacology; Psychology","score_opus":0.10723689611693536,"score_gpt":0.4560792235873409,"score_spread":0.3488423274704055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752363805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639195,0.00009918344,0.00024911042,0.0007156613,0.000028066914,0.00028553052,0.000035127032,0.000055734316,0.0021397467],"genre_scores_gemma":[0.9978998,0.00011088698,0.00091768464,0.0002863102,0.000025193896,0.00011874221,0.0000440697,0.000004350154,0.0005928884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.989717,0.0062825363,0.000385513,0.0005928223,0.0013923125,0.001629688],"domain_scores_gemma":[0.9642731,0.0069798063,0.0075034653,0.0019953798,0.0053990213,0.013849242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057091517,0.0003064709,0.00030387886,0.00047905647,0.0014893656,0.0011964821,0.0014344293,0.00061768765,0.0047239484],"category_scores_gemma":[0.020163296,0.00041002923,0.00034432427,0.00039706775,0.0006916328,0.00050970085,0.0031054723,0.0010736729,0.0006025979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002571153,0.01676524,0.7182016,0.00060672354,0.00013851526,0.00074339553,0.011012212,0.0005657055,0.0060270512,0.00017499569,0.0064757615,0.23671764],"study_design_scores_gemma":[0.00034256457,0.015900725,0.9576146,0.00022528386,0.00007328657,0.00036731313,0.013252013,0.00083505776,0.0038415715,0.00007712559,0.0073891273,0.00008137102],"about_ca_topic_score_codex":0.021963276,"about_ca_topic_score_gemma":0.03488077,"teacher_disagreement_score":0.021963276,"about_ca_system_score_codex":0.0033965625,"about_ca_system_score_gemma":0.014055801,"threshold_uncertainty_score":0.043670833},"labels":[],"label_agreement":null},{"id":"W2753387015","doi":"10.1002/pds.4288","title":"Validity of the days supply field in pharmacy administrative claims data for the identification of blister packaging of medications","year":2017,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Manitoba Health; Health Sciences Centre","funders":"","keywords":"Medicine; Pharmacy; Pharmacoepidemiology; Medical prescription; Drug packaging; Emergency medicine; Family medicine; Pharmacology","score_opus":0.3528401326168454,"score_gpt":0.5444400340588046,"score_spread":0.1915999014419592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753387015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800025,0.001735703,0.0062553817,0.0006029311,0.00018227284,0.00051570026,0.005294312,0.00007644737,0.005334661],"genre_scores_gemma":[0.99305636,0.0002137134,0.0035328974,0.00018649767,0.00007913589,0.00013824532,0.002639368,0.000015927293,0.00013787326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.91829306,0.041887715,0.011928256,0.0052149096,0.02102828,0.0016477673],"domain_scores_gemma":[0.7501103,0.11932315,0.09559296,0.015502857,0.017251527,0.002219161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051496554,0.00067654176,0.0009491945,0.0056245606,0.0007832582,0.0032361583,0.0019286703,0.0013490616,0.0010893433],"category_scores_gemma":[0.20299454,0.0005655414,0.0023349626,0.005528693,0.0014952765,0.0028229149,0.002330354,0.0013644886,0.0006810559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023146163,0.000066495406,0.9941949,0.000079466045,0.00016820653,0.00002428413,0.00014855518,0.0002273268,0.000104916,0.00009357122,0.00030437158,0.0043565594],"study_design_scores_gemma":[0.000037854632,0.00034597662,0.989151,0.00034828868,0.0001264856,0.00030619281,0.00045981168,0.0065652076,0.0006021247,0.00037532352,0.0016569543,0.000024805651],"about_ca_topic_score_codex":0.008038106,"about_ca_topic_score_gemma":0.0077543813,"teacher_disagreement_score":0.051496554,"about_ca_system_score_codex":0.0014363546,"about_ca_system_score_gemma":0.0021738,"threshold_uncertainty_score":0.27234304},"labels":[],"label_agreement":null},{"id":"W2753715438","doi":"10.4212/cjhp.v70i4.1687","title":"Implications of Changes to the Mefloquine Product Monograph","year":2017,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mefloquine; Medicine; Malaria; Immunology","score_opus":0.1357753015473339,"score_gpt":0.44549049687873904,"score_spread":0.3097151953314051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753715438","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019417359,0.004227095,0.0007594876,0.87495786,0.034517918,0.00020046286,0.0055486034,0.0003929565,0.05997826],"genre_scores_gemma":[0.17520587,0.0038671615,0.003875494,0.7172785,0.016697798,0.00019304485,0.004235972,0.00019356266,0.07845255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99231875,0.0015846827,0.0011314087,0.0005694201,0.0034513373,0.0009444848],"domain_scores_gemma":[0.955772,0.012860635,0.0059052664,0.0012448531,0.019072017,0.0051452965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056446726,0.0002550259,0.00041158768,0.0016453367,0.0013590559,0.002889853,0.0017679562,0.010628441,0.026797248],"category_scores_gemma":[0.052894242,0.000259244,0.001899605,0.0011334724,0.0005538622,0.0012489681,0.0007664841,0.005446787,0.004459973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070193806,0.00042855451,0.029159859,0.0004032137,0.00014954948,0.00181851,0.00032326384,0.00045211267,0.0007965911,0.0046448247,0.85580313,0.10531839],"study_design_scores_gemma":[0.00024647624,0.0002928212,0.06322705,0.00091976137,0.00024992446,0.0012079687,0.0007147418,0.000694895,0.0011346479,0.0014412765,0.9298011,0.00006947621],"about_ca_topic_score_codex":0.0760958,"about_ca_topic_score_gemma":0.12247616,"teacher_disagreement_score":0.0760958,"about_ca_system_score_codex":0.00520025,"about_ca_system_score_gemma":0.011762834,"threshold_uncertainty_score":0.15130574},"labels":[],"label_agreement":null},{"id":"W2758259715","doi":"10.2196/resprot.6463","title":"The Adverse Drug Reactions from Patient Reports in Social Media Project: Five Major Challenges to Overcome to Operationalize Analysis and Efficiently Support Pharmacovigilance Process","year":2017,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Operationalization; Social media; Process (computing); Drug reaction; Adverse drug reaction; Process management; Knowledge management; Management science; Drug; Computer science; Medicine; Business; Pharmacology; Engineering; World Wide Web","score_opus":0.3358941425931998,"score_gpt":0.6155112352223252,"score_spread":0.27961709262912543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758259715","genre_codex":"methods","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06414902,0.0023172724,0.861412,0.02102468,0.0005362001,0.007574116,0.014322109,0.020016849,0.0086477585],"genre_scores_gemma":[0.08286554,0.0010191916,0.88520044,0.0015199509,0.00028376913,0.00357203,0.021526653,0.0011919187,0.002820547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92116666,0.03793883,0.009191158,0.0071486733,0.022774382,0.0017802705],"domain_scores_gemma":[0.85490376,0.061338764,0.013035164,0.027535046,0.036883984,0.006303417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08242152,0.00179937,0.0014966981,0.007089524,0.002226232,0.009613506,0.0033663516,0.0026406466,0.0019528349],"category_scores_gemma":[0.09694824,0.0007668122,0.0025084764,0.0044161873,0.002304374,0.006758529,0.011674795,0.003533147,0.002363288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011217658,0.0012126531,0.06082697,0.005666373,0.0009757635,0.0014868283,0.008777518,0.006746867,0.033357006,0.032078918,0.053991497,0.7937579],"study_design_scores_gemma":[0.0006920741,0.0024656234,0.10030847,0.0039282665,0.0011503113,0.004126438,0.01039415,0.14985941,0.11468424,0.08561794,0.5260153,0.0007577888],"about_ca_topic_score_codex":0.0048385393,"about_ca_topic_score_gemma":0.0035708519,"teacher_disagreement_score":0.08242152,"about_ca_system_score_codex":0.0020840752,"about_ca_system_score_gemma":0.012360746,"threshold_uncertainty_score":0.43589187},"labels":[],"label_agreement":null},{"id":"W2759784818","doi":"10.1016/j.jcjo.2017.08.001","title":"Major FDA medical device recalls in ophthalmology from 2003 to 2015","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Context (archaeology); Food and drug administration; Recall; Medical emergency; Family medicine; Psychology","score_opus":0.15147869703361116,"score_gpt":0.4766649802140409,"score_spread":0.32518628318042975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759784818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7311707,0.064567305,0.0012027526,0.0041800537,0.0009036888,0.0002959321,0.16647808,0.00041132898,0.030790163],"genre_scores_gemma":[0.9385414,0.010397289,0.00074843626,0.0034556831,0.00032756434,0.0000838917,0.039473545,0.00005033605,0.0069218646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948543,0.0003483239,0.0015198973,0.0007965427,0.0019946955,0.0004862546],"domain_scores_gemma":[0.9763506,0.0025501535,0.0148516465,0.000499752,0.0050611612,0.0006867731],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020752333,0.0003459809,0.0006184245,0.0046419823,0.0005489779,0.0024606194,0.0007342533,0.0010873703,0.0021250087],"category_scores_gemma":[0.014527051,0.00038707722,0.0011192205,0.004105462,0.00038733616,0.00097083073,0.0011227492,0.0012264252,0.0005540087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062545156,0.00007269497,0.94500256,0.00068363105,0.00050756027,0.00053479447,0.00048505672,0.00020853207,0.0003644737,0.00030119365,0.023732014,0.02748194],"study_design_scores_gemma":[0.000014642481,0.00006553855,0.9730348,0.0005713666,0.0002620797,0.0013519385,0.00051105843,0.00027588182,0.0005206841,0.00004020817,0.023322996,0.000028887653],"about_ca_topic_score_codex":0.22487506,"about_ca_topic_score_gemma":0.22161452,"teacher_disagreement_score":0.99891263,"about_ca_system_score_codex":0.004876489,"about_ca_system_score_gemma":0.0038052225,"threshold_uncertainty_score":0.4471323},"labels":[],"label_agreement":null},{"id":"W2761677898","doi":"10.1002/cpdd.394","title":"Categorization of Abuse Potential–Related Adverse Events","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Categorization; Adverse effect; Medical emergency; Pharmacology; Artificial intelligence","score_opus":0.13228444398396244,"score_gpt":0.5026786822963262,"score_spread":0.37039423831236373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761677898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79958344,0.018166758,0.08096488,0.0026666264,0.0007482588,0.02063377,0.018670699,0.0012368927,0.057328638],"genre_scores_gemma":[0.8164594,0.0057741627,0.15275653,0.0012297326,0.000265005,0.0034515818,0.015232043,0.00014968512,0.0046818894],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.991823,0.0019684378,0.0028094677,0.0003619548,0.0026768504,0.00036032384],"domain_scores_gemma":[0.9842455,0.0040091276,0.0040454683,0.0010332913,0.0062106634,0.00045601168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006369513,0.00067256304,0.0010050945,0.007816344,0.00081140106,0.0011754155,0.001017358,0.0006177786,0.003038819],"category_scores_gemma":[0.014435649,0.00015640682,0.001282631,0.003034035,0.00047947225,0.0009703388,0.0012914774,0.0008085469,0.00072204496],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002881922,0.00074300164,0.536884,0.005865731,0.000589082,0.0047172653,0.0027783134,0.0035631238,0.025272219,0.0058389627,0.015342989,0.3955233],"study_design_scores_gemma":[0.0002558334,0.0027799031,0.8526664,0.002110005,0.00063488894,0.0133690685,0.0032780406,0.014566303,0.015141988,0.0118305655,0.08309729,0.0002697214],"about_ca_topic_score_codex":0.0025391479,"about_ca_topic_score_gemma":0.003153119,"teacher_disagreement_score":0.007816344,"about_ca_system_score_codex":0.0009140443,"about_ca_system_score_gemma":0.0021536753,"threshold_uncertainty_score":0.033685625},"labels":[],"label_agreement":null},{"id":"W2762654722","doi":"10.1016/j.clinthera.2017.08.018","title":"Differences in Adverse Event Reporting Rates of Therapeutic Failure Between Two Once-daily Extended-release Methylphenidate Medications in Canada: Analysis of Spontaneous Adverse Event Reporting Databases","year":2017,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"START Clinic; Université de Montréal; Ontario Centre of Excellence for Child and Youth Mental Health","funders":"Janssen Canada; Health Canada","keywords":"Methylphenidate; Medicine; Adverse effect; Pharmacovigilance; Immediate release; Population; Adverse Event Reporting System; Bioequivalence; Pharmacology; Attention deficit hyperactivity disorder; Psychiatry; Pharmacokinetics; Environmental health","score_opus":0.3360918816147973,"score_gpt":0.5414426882056637,"score_spread":0.20535080659086635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762654722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9277696,0.0046532387,0.00091664627,0.0007593849,0.000041051895,0.0002357681,0.063135356,0.0000774005,0.0024115692],"genre_scores_gemma":[0.96835124,0.0017733187,0.00115058,0.00033971563,0.000016785232,0.00009154263,0.027661825,0.000033841847,0.0005812154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874445,0.0016491516,0.0031200647,0.0017911624,0.0048960936,0.0010989647],"domain_scores_gemma":[0.9330892,0.015720198,0.022314746,0.0018500304,0.024795946,0.0022298559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007062116,0.00047444573,0.0010361085,0.0053004315,0.0010610244,0.0022972408,0.0026341432,0.0007810244,0.0015432171],"category_scores_gemma":[0.04502651,0.0005666337,0.0018124484,0.013664494,0.00068559364,0.00095277984,0.0013227258,0.0009074022,0.00014559577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004176254,0.000033778782,0.98907906,0.00020035506,0.0010046287,0.000064622844,0.00035797147,0.0005720144,0.000117697324,0.00023896353,0.0021126394,0.0058005713],"study_design_scores_gemma":[0.00004485652,0.00002933892,0.99684685,0.00006666992,0.0002257491,0.00009092306,0.00033230407,0.0012000168,0.00012051773,0.000031456442,0.000985381,0.00002602638],"about_ca_topic_score_codex":0.97560215,"about_ca_topic_score_gemma":0.9655476,"teacher_disagreement_score":0.02439785,"about_ca_system_score_codex":0.022203662,"about_ca_system_score_gemma":0.033166043,"threshold_uncertainty_score":0.16109961},"labels":[],"label_agreement":null},{"id":"W2772269827","doi":"10.1007/s40264-017-0619-x","title":"The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Public Health Ontario","funders":"","keywords":"Medicine; Checklist; Quality (philosophy); Statement (logic)","score_opus":0.4569020067255501,"score_gpt":0.5970565743537308,"score_spread":0.14015456762818074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772269827","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.092981614,0.024184404,0.45653555,0.038957644,0.0045611616,0.308663,0.0432854,0.006534644,0.024296595],"genre_scores_gemma":[0.080840066,0.0071310042,0.6653404,0.0044767587,0.0005977117,0.22952028,0.0102311475,0.00034939588,0.0015132825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.50180393,0.26436615,0.19599636,0.0040191216,0.031484734,0.002329692],"domain_scores_gemma":[0.25005227,0.4336001,0.121260315,0.025631288,0.16436979,0.005086208],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.39791846,0.0034755294,0.004395814,0.017455386,0.0027719527,0.004531623,0.005781011,0.0036628158,0.005062959],"category_scores_gemma":[0.49253246,0.0024422829,0.008615853,0.008257087,0.0035009524,0.0066385213,0.008534137,0.0046732486,0.0019829103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034521879,0.0013707591,0.07673243,0.11393256,0.0044850744,0.00062788755,0.018719615,0.006372102,0.0053026285,0.012986174,0.18936068,0.56665796],"study_design_scores_gemma":[0.006232925,0.0071584918,0.19368131,0.148456,0.0052952664,0.0021396484,0.021078577,0.021001177,0.017913928,0.03394402,0.5405792,0.0025194993],"about_ca_topic_score_codex":0.0030129664,"about_ca_topic_score_gemma":0.0051061343,"teacher_disagreement_score":0.60208154,"about_ca_system_score_codex":0.0074655283,"about_ca_system_score_gemma":0.035093628,"threshold_uncertainty_score":0.7424737},"labels":[],"label_agreement":null},{"id":"W2772514355","doi":"10.2196/medinform.9170","title":"Adverse Drug Event Discovery Using Biomedical Literature: A Big Data Neural Network Adventure","year":2017,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Center for Advancing Translational Sciences; Institute for Clinical and Translational Research, University of Wisconsin, Madison; Marshfield Clinic Research Institute","keywords":"Big data; Computer science; Social media; SPARK (programming language); Data science; Scalability; Knowledge extraction; Analytics; World Wide Web; Social media analytics; Artificial intelligence; Machine learning; Data mining; Database","score_opus":0.13489986250865116,"score_gpt":0.46254582550016193,"score_spread":0.3276459629915108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772514355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66438544,0.04703921,0.1892852,0.045197465,0.0026803536,0.0010216127,0.02452841,0.006079237,0.01978317],"genre_scores_gemma":[0.7453778,0.010837504,0.21955991,0.0026461098,0.00158589,0.00030576834,0.014961237,0.000080809805,0.0046450244],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99899346,0.00027195676,0.0001262523,0.00026528747,0.00027954922,0.00006353398],"domain_scores_gemma":[0.9964095,0.0018880308,0.00040192707,0.00040929756,0.0006530279,0.00023820558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020942949,0.000977688,0.0007043265,0.006499468,0.0008876138,0.002275047,0.0012711708,0.0013569439,0.0011724728],"category_scores_gemma":[0.0064035025,0.00038567826,0.00103958,0.0039948598,0.00046581385,0.0021274781,0.0011810564,0.0012986152,0.00050836214],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010965909,0.0016222582,0.093009405,0.0014745705,0.0011137926,0.0024863535,0.0006426146,0.042252395,0.0073128967,0.004151529,0.04516658,0.79967105],"study_design_scores_gemma":[0.000080938444,0.00034177382,0.027988752,0.00031698414,0.00037925123,0.0007995937,0.000651623,0.918868,0.0069085755,0.017694935,0.025895037,0.00007446059],"about_ca_topic_score_codex":0.009095694,"about_ca_topic_score_gemma":0.014575681,"teacher_disagreement_score":0.009095694,"about_ca_system_score_codex":0.0010829949,"about_ca_system_score_gemma":0.0013676697,"threshold_uncertainty_score":0.01808554},"labels":[],"label_agreement":null},{"id":"W2777004267","doi":"","title":"Bulleuze fixed drug eruption op basis van 'APC'.","year":2013,"lang":"nl","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Drug eruption; Geology; Medicine; Drug; Pharmacology","score_opus":0.06599333619195862,"score_gpt":0.3721555747173846,"score_spread":0.30616223852542596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777004267","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27708432,0.23507816,0.036434278,0.029889941,0.0037575003,0.0009544838,0.009842492,0.004537055,0.4024219],"genre_scores_gemma":[0.89404994,0.028770285,0.010564533,0.005237407,0.00074328994,0.000100725694,0.0024043687,0.00036154425,0.057767868],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99929774,0.00011578839,0.00006083468,0.00008947536,0.00034877512,0.00008729488],"domain_scores_gemma":[0.9994555,0.00022639924,0.00012593782,0.000058289927,0.00009070131,0.000043190263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006383428,0.00026351656,0.00056951965,0.0006864242,0.00039191943,0.0016372288,0.00042754586,0.0012967674,0.01767407],"category_scores_gemma":[0.002730463,0.00015652932,0.00055787823,0.00060531317,0.000328803,0.0009022209,0.0004422699,0.0017824306,0.0032620155],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015824378,0.00029703535,0.01586496,0.0014207233,0.00032671585,0.02968773,0.00030382542,0.0007266593,0.016765455,0.00980637,0.078581706,0.84463644],"study_design_scores_gemma":[0.0007564139,0.0010760853,0.04018521,0.0017275298,0.0005864282,0.25504535,0.00044588544,0.004394361,0.03735436,0.009364231,0.64894396,0.00012020023],"about_ca_topic_score_codex":0.0051341793,"about_ca_topic_score_gemma":0.0039637326,"teacher_disagreement_score":0.01767407,"about_ca_system_score_codex":0.0005532298,"about_ca_system_score_gemma":0.0006094591,"threshold_uncertainty_score":0.059125602},"labels":[],"label_agreement":null},{"id":"W2781518627","doi":"10.2196/publichealth.7823","title":"Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis","year":2018,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation","keywords":"Social media; Zolpidem; Food and drug administration; Medicine; Internet privacy; Public health; Advertising; World Wide Web; Computer science; Business; Pharmacology","score_opus":0.0930005130886447,"score_gpt":0.4966942208481064,"score_spread":0.4036937077594617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781518627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685832,0.0021326882,0.007635458,0.0006657669,0.00024709583,0.0036275375,0.01398485,0.00016634018,0.0029569895],"genre_scores_gemma":[0.9661501,0.00061460887,0.010084373,0.0006870032,0.0002410486,0.013558287,0.006206628,0.00013063433,0.0023272827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9752092,0.015490956,0.0018784429,0.0033027222,0.0026177824,0.001500868],"domain_scores_gemma":[0.92092246,0.061620217,0.008988756,0.003974539,0.0033884493,0.0011055758],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028415589,0.0012280213,0.0017619284,0.0039619785,0.0013230684,0.002953587,0.0023485739,0.0017283247,0.0095828045],"category_scores_gemma":[0.06224737,0.00075017277,0.0071738684,0.0037849452,0.001104009,0.002588186,0.0026626394,0.0028667932,0.0015967891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01131086,0.0053996686,0.8684347,0.0057404456,0.027467055,0.00065321074,0.007451141,0.0036499335,0.0013520251,0.0030630135,0.01170702,0.053770985],"study_design_scores_gemma":[0.0009837936,0.0073964433,0.9239368,0.0011544863,0.0128064435,0.00037277743,0.00937169,0.030620966,0.00160101,0.0025386533,0.008932549,0.00028449154],"about_ca_topic_score_codex":0.010074967,"about_ca_topic_score_gemma":0.006962075,"teacher_disagreement_score":0.97158444,"about_ca_system_score_codex":0.0014241575,"about_ca_system_score_gemma":0.0017128119,"threshold_uncertainty_score":0.1502778},"labels":[],"label_agreement":null},{"id":"W2788998495","doi":"10.2196/publichealth.9282","title":"Why Clinicians Don’t Report Adverse Drug Events: Qualitative Study","year":2018,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Simon Fraser University; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Health Canada; Michael Smith Health Research BC","keywords":"Adverse effect; Medicine; Drug; Postmarketing surveillance; Intensive care medicine; Pharmacovigilance; Unintended consequences; Medical emergency; Pharmacology","score_opus":0.1636646958909291,"score_gpt":0.528023373214813,"score_spread":0.36435867732388383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788998495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694686,0.0017622227,0.00713242,0.0147088,0.00025073322,0.0006696321,0.00032219972,0.000052360232,0.0056330063],"genre_scores_gemma":[0.9903984,0.0011485156,0.0022390934,0.0041351295,0.00004263754,0.00068125705,0.000096769916,0.000057119363,0.0012010637],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9468395,0.03971999,0.0021680212,0.0028223991,0.004174939,0.004275137],"domain_scores_gemma":[0.8442753,0.11908991,0.009838698,0.0026496577,0.015852908,0.008293521],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.045156587,0.0007419081,0.0012738549,0.0023819346,0.013138226,0.0065754997,0.0031761036,0.0033601488,0.0028615433],"category_scores_gemma":[0.10569525,0.0013368591,0.0005957116,0.002775358,0.01398383,0.00899949,0.008686187,0.004889494,0.0004820854],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000208751,0.000034620534,0.0030913677,0.00022467412,0.000004832999,0.00045579654,0.99249744,0.000024207206,0.00022934326,0.00060159265,0.0006845687,0.0021307238],"study_design_scores_gemma":[0.000006251088,0.000024226614,0.0005245688,0.00023557805,0.0000025632671,0.0001331656,0.9942988,0.00007180923,0.00010130144,0.0002627251,0.004327274,0.000011589499],"about_ca_topic_score_codex":0.018314693,"about_ca_topic_score_gemma":0.020217545,"teacher_disagreement_score":0.9548434,"about_ca_system_score_codex":0.013391224,"about_ca_system_score_gemma":0.016965257,"threshold_uncertainty_score":0.2388137},"labels":[],"label_agreement":null},{"id":"W2790986871","doi":"10.1016/j.jsps.2018.03.002","title":"Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience","year":2018,"lang":"en","type":"article","venue":"Saudi Pharmaceutical Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Pharmacovigilance; Perception; Health care; Intervention (counseling); Medicine; Affect (linguistics); Medical education; Nursing; Psychology; Family medicine; Adverse effect; Pharmacology; Political science","score_opus":0.05588357342340644,"score_gpt":0.5041578006213056,"score_spread":0.4482742271978991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790986871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912757,0.000084368534,0.000052122195,0.00016160947,0.000013867164,0.00016501141,0.000017578805,0.000010985218,0.0003669518],"genre_scores_gemma":[0.9980075,0.00020560632,0.00057383644,0.00019260976,0.000030850788,0.00020967475,0.000035679514,0.000002894822,0.0007414892],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903214,0.00028209953,0.000048903363,0.00008530875,0.000079698475,0.00047179474],"domain_scores_gemma":[0.996356,0.0005479774,0.00033393304,0.00008946833,0.00029113272,0.0023816065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015697328,0.0005321527,0.000574373,0.00037662406,0.0013065285,0.00060810783,0.00070119044,0.00078927306,0.00487474],"category_scores_gemma":[0.0032414617,0.00032332828,0.0005802861,0.00029477946,0.00044036712,0.00043963583,0.0015018943,0.0011510366,0.0003627403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013410123,0.31436333,0.28511485,0.0021551296,0.00023244489,0.0056344657,0.03425647,0.0013995311,0.01467719,0.00023795533,0.0050155334,0.3235028],"study_design_scores_gemma":[0.0048114504,0.11334162,0.8305328,0.0005816786,0.00030966397,0.00087413867,0.035411727,0.0013289568,0.007329149,0.0001621019,0.0051699067,0.00014683482],"about_ca_topic_score_codex":0.00450052,"about_ca_topic_score_gemma":0.0072941096,"teacher_disagreement_score":0.00487474,"about_ca_system_score_codex":0.0017613473,"about_ca_system_score_gemma":0.0042276895,"threshold_uncertainty_score":0.016307592},"labels":[],"label_agreement":null},{"id":"W2794322693","doi":"10.18203/2394-6040.ijcmph20180744","title":"Predicting adverse drug reaction outcomes with machine learning","year":2018,"lang":"en","type":"article","venue":"International Journal of Community Medicine and Public Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Machine learning; Medical prescription; Drug reaction; Computer science; Artificial intelligence; Adverse effect; Drug; Predictive modelling; Resource (disambiguation); Medicine; Data mining; Pharmacology","score_opus":0.20912728828008623,"score_gpt":0.49981080616001394,"score_spread":0.29068351787992774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794322693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5100431,0.010664316,0.44649726,0.0077092494,0.00059787143,0.000768511,0.0052310596,0.0047666533,0.013721954],"genre_scores_gemma":[0.9290981,0.0014339312,0.06420968,0.0003951678,0.00030680955,0.00021099225,0.002841068,0.00004606932,0.0014582825],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99795365,0.0010638342,0.0001508875,0.00031698385,0.00039604394,0.000118639946],"domain_scores_gemma":[0.9839497,0.012708045,0.001184542,0.00067776075,0.0012592819,0.00022067533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003673387,0.0014120572,0.0008333784,0.0023508687,0.0002899753,0.0011749823,0.00091493095,0.0010677822,0.0020852457],"category_scores_gemma":[0.017516417,0.00030528053,0.0013303427,0.0014240382,0.00035943635,0.0011342127,0.0006638609,0.0019683759,0.0010411816],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034128188,0.001175542,0.14204194,0.00034379427,0.0007457947,0.00015660192,0.00007528805,0.5325136,0.00047097527,0.0010341771,0.0072603677,0.31384075],"study_design_scores_gemma":[0.000024860256,0.00022331618,0.009504316,0.000077567376,0.000067493966,0.00007400712,0.000024109637,0.9826706,0.0008070298,0.005561866,0.0009440143,0.000020775486],"about_ca_topic_score_codex":0.006216206,"about_ca_topic_score_gemma":0.0039076786,"teacher_disagreement_score":0.006216206,"about_ca_system_score_codex":0.0009822446,"about_ca_system_score_gemma":0.00095686805,"threshold_uncertainty_score":0.019427001},"labels":[],"label_agreement":null},{"id":"W2800317565","doi":"10.2196/publichealth.8214","title":"Causality Patterns for Detecting Adverse Drug Reactions From Social Media: Text Mining Approach","year":2018,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Innovative Medicines Initiative; Medical Research Council; National Institute for Health and Care Research","keywords":"Causality (physics); Set (abstract data type); Adverse drug reaction; Computer science; Social media; Drug; Data mining; Drug reaction; Reliability (semiconductor); Pharmacovigilance; Artificial intelligence; Machine learning; Medicine; Pharmacology","score_opus":0.17362055703099913,"score_gpt":0.44691772779631955,"score_spread":0.27329717076532045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800317565","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38732266,0.0079421885,0.53719306,0.004137269,0.0005937143,0.0044763903,0.043748956,0.006200739,0.008385008],"genre_scores_gemma":[0.62833387,0.0022727342,0.34358004,0.0005750314,0.00046950195,0.0013793188,0.02124976,0.000088473986,0.002051281],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977336,0.00039787614,0.0005274291,0.00061385887,0.0006007386,0.00012647873],"domain_scores_gemma":[0.9935535,0.003727588,0.0014797146,0.0002550548,0.00079381955,0.00019042497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717943,0.0015436007,0.0010847332,0.016924756,0.00075773615,0.001455808,0.0011625272,0.0014731194,0.001218144],"category_scores_gemma":[0.007082908,0.00038108643,0.0018432821,0.00682807,0.00048343898,0.00227148,0.0010177095,0.0011228459,0.00095554756],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081899884,0.0017715157,0.1836322,0.0027331011,0.0009110515,0.004278212,0.0007813168,0.022458274,0.02317102,0.0043031047,0.014869969,0.7402713],"study_design_scores_gemma":[0.00021878636,0.0006389251,0.102939814,0.00051153556,0.00075648125,0.0048829946,0.0016386083,0.8234317,0.014667953,0.030868232,0.019268652,0.00017638066],"about_ca_topic_score_codex":0.0036646693,"about_ca_topic_score_gemma":0.0062994463,"teacher_disagreement_score":0.016924756,"about_ca_system_score_codex":0.0007490373,"about_ca_system_score_gemma":0.0012624465,"threshold_uncertainty_score":0.009085417},"labels":[],"label_agreement":null},{"id":"W2802963693","doi":"10.2147/clep.s153000","title":"Derivation and validation of a multivariable model to predict when primary care physicians prescribe antidepressants for indications other than depression","year":2018,"lang":"en","type":"article","venue":"Clinical Epidemiology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Concordance; Medicine; Medical prescription; Depression (economics); Workload; Antidepressant; Statistic; Medical record; Emergency medicine; Psychiatry; Family medicine; Internal medicine; Statistics; Anxiety","score_opus":0.3380306777013947,"score_gpt":0.5400212628127203,"score_spread":0.20199058511132562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802963693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8993832,0.00029008387,0.095643714,0.00077380385,0.00010181649,0.0005208092,0.0018516583,0.0005070086,0.0009279365],"genre_scores_gemma":[0.9652367,0.00009098118,0.031828,0.00008374803,0.0000338783,0.00026753763,0.0019300571,0.000024247942,0.00050491723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972361,0.001778619,0.00014747075,0.0004204089,0.00022617736,0.00019120752],"domain_scores_gemma":[0.9876486,0.0089979,0.00058096385,0.00035070302,0.0021115365,0.00031044576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012022804,0.0012138595,0.0010824415,0.0017667145,0.0008733673,0.0011546644,0.0013198063,0.0007834335,0.0015690842],"category_scores_gemma":[0.0177048,0.0005560838,0.0017241505,0.0009841983,0.00036630817,0.00046665096,0.0010445144,0.0016294206,0.00044435938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010048447,0.0009575607,0.7597452,0.00010932892,0.001154346,0.00027471987,0.0004005133,0.1787425,0.0010433098,0.000886659,0.0039035664,0.051777385],"study_design_scores_gemma":[0.00008584713,0.0002849075,0.051089704,0.000040254512,0.00018417164,0.00007022801,0.00009032483,0.94680935,0.00027165486,0.0006417787,0.00041275294,0.000019042667],"about_ca_topic_score_codex":0.0440183,"about_ca_topic_score_gemma":0.024367701,"teacher_disagreement_score":0.0440183,"about_ca_system_score_codex":0.0013596041,"about_ca_system_score_gemma":0.0035659587,"threshold_uncertainty_score":0.087524176},"labels":[],"label_agreement":null},{"id":"W2803172705","doi":"10.1111/ijpp.12458","title":"What can we learn from the public’s understanding of drug information and safety? A population survey","year":2018,"lang":"en","type":"article","venue":"International Journal of Pharmacy Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Ministerio de Economía y Competitividad","keywords":"Medicine; Medical prescription; Quarter (Canadian coin); Family medicine; Population; Perception; Alternative medicine; Environmental health; Nursing","score_opus":0.1852147677097528,"score_gpt":0.47168555618977903,"score_spread":0.2864707884800263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803172705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897377,0.0014716657,0.00016151145,0.0051620086,0.000035353674,0.000040333405,0.0005639045,0.0000071391223,0.0028203228],"genre_scores_gemma":[0.9958853,0.001833416,0.00013191949,0.001513798,0.00006655494,0.00004936566,0.00027899913,0.0000019751894,0.00023861465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964715,0.0020343598,0.00023473008,0.00024115469,0.0005748544,0.00044346508],"domain_scores_gemma":[0.9911816,0.0037882328,0.002744899,0.00024930612,0.0011785633,0.00085744803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044569084,0.00021146718,0.00042961576,0.0016681111,0.00037790873,0.0017651905,0.00035647227,0.0011562158,0.0021496539],"category_scores_gemma":[0.015632551,0.00028498025,0.0004995903,0.0013237201,0.00077984075,0.003754021,0.001236865,0.0012106356,0.00059588393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016177462,0.00051620515,0.9091826,0.0008567676,0.000101538404,0.00043068163,0.033615712,0.000078059245,0.00048659157,0.00025832778,0.0030800968,0.051231507],"study_design_scores_gemma":[0.000019057521,0.0007648937,0.94572425,0.00040393687,0.000039686758,0.00046955995,0.046546865,0.00018697519,0.00010975059,0.00022416894,0.00548512,0.000025753907],"about_ca_topic_score_codex":0.005156484,"about_ca_topic_score_gemma":0.003262896,"teacher_disagreement_score":0.005156484,"about_ca_system_score_codex":0.000720149,"about_ca_system_score_gemma":0.00092400465,"threshold_uncertainty_score":0.023570657},"labels":[],"label_agreement":null},{"id":"W2803820034","doi":"10.2196/10248","title":"Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset","year":2018,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Vancouver Coastal Health Research Institute; Simon Fraser University; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Health Canada; Michael Smith Health Research BC","keywords":"Medicine; Adverse effect; Adverse drug event; Computer science; Intensive care medicine; Medical emergency; Emergency medicine; Pharmacology","score_opus":0.1651963355801252,"score_gpt":0.5752440876773514,"score_spread":0.41004775209722616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803820034","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12223119,0.024472764,0.5558795,0.0063347165,0.0015149132,0.10948053,0.17116635,0.0038408935,0.005079194],"genre_scores_gemma":[0.27284425,0.0014320966,0.43543836,0.0021316048,0.00017520238,0.25251952,0.03439356,0.0003533314,0.00071197527],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.53699785,0.34434175,0.06070908,0.027410427,0.02741767,0.0031232138],"domain_scores_gemma":[0.29541498,0.6221614,0.039557103,0.027667692,0.014318814,0.0008799824],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2723267,0.0026309784,0.0053929863,0.0089036,0.0016982106,0.004164484,0.0055952314,0.0041951486,0.011971562],"category_scores_gemma":[0.5753262,0.0015832997,0.022489622,0.009242081,0.0022906372,0.0040286896,0.0062800325,0.0041984585,0.0014608894],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014618503,0.0021245985,0.28791502,0.21254238,0.105891086,0.0019304154,0.010931084,0.03611449,0.0025900255,0.042987563,0.06917057,0.21318416],"study_design_scores_gemma":[0.013583261,0.012542776,0.2874635,0.06291431,0.09448274,0.0025653234,0.008607819,0.20385902,0.008636333,0.08476085,0.2182385,0.0023455573],"about_ca_topic_score_codex":0.0060793143,"about_ca_topic_score_gemma":0.006091176,"teacher_disagreement_score":0.7276733,"about_ca_system_score_codex":0.0047913296,"about_ca_system_score_gemma":0.0078469375,"threshold_uncertainty_score":0.8973507},"labels":[],"label_agreement":null},{"id":"W2805077342","doi":"10.4212/cjhp.v52i1.1766","title":"An update on cisapride adverse drug reactions","year":2018,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cisapride; Drug; Drug reaction; Medicine; Adverse effect; Pharmacology; Adverse drug reaction; Intensive care medicine","score_opus":0.06692762866309562,"score_gpt":0.41772420071006133,"score_spread":0.3507965720469657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805077342","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020922099,0.9279325,0.0019313599,0.029359924,0.015914349,0.00009819031,0.0010241847,0.00031686368,0.021330403],"genre_scores_gemma":[0.008725244,0.9177976,0.0043538935,0.02617975,0.029771881,0.00008960777,0.0023048124,0.000067150824,0.010710035],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973999,0.00042855777,0.0008996017,0.00017000047,0.00097522605,0.00012669798],"domain_scores_gemma":[0.98981714,0.0036830194,0.0019285214,0.00028904006,0.0037438776,0.0005384324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002093405,0.0010715914,0.0020583586,0.0040921816,0.0003836378,0.0019673822,0.0012085036,0.0023755198,0.005313173],"category_scores_gemma":[0.008899423,0.00048066594,0.0015250782,0.0025915795,0.0003834559,0.0022573767,0.00093886675,0.0031508459,0.0029694072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001774467,0.00009368145,0.0015754923,0.0042248922,0.00020811231,0.0013212947,0.000056521203,0.00020373662,0.0007089942,0.00054973486,0.23128399,0.75959605],"study_design_scores_gemma":[0.0001098303,0.00021113065,0.004953363,0.006370324,0.0005725101,0.0069616,0.000054969987,0.00017946232,0.00043790217,0.00056551915,0.9795416,0.00004167098],"about_ca_topic_score_codex":0.0035010474,"about_ca_topic_score_gemma":0.0100813415,"teacher_disagreement_score":0.005313173,"about_ca_system_score_codex":0.0009696789,"about_ca_system_score_gemma":0.0021411076,"threshold_uncertainty_score":0.017774403},"labels":[],"label_agreement":null},{"id":"W2805155289","doi":"","title":"Extracting Positive Mentions of Adverse Drug Reactions from Product Labels using a Machine Learning Centric Approach.","year":2017,"lang":"en","type":"article","venue":"Theory and applications of categories","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science; Product (mathematics); Artificial intelligence; Machine learning; Drug reaction; Natural language processing; Drug; Pharmacology; Mathematics; Medicine","score_opus":0.05997973488236706,"score_gpt":0.3983670202963445,"score_spread":0.33838728541397745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805155289","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31166792,0.02235116,0.52171135,0.0061073154,0.0021119365,0.0018752628,0.08598756,0.012662874,0.03552459],"genre_scores_gemma":[0.64051837,0.0024732703,0.2813053,0.0012548486,0.0006561659,0.00066798355,0.06617242,0.0002584518,0.006693147],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964006,0.0007520275,0.0005116223,0.00079540414,0.0012996993,0.00024063373],"domain_scores_gemma":[0.98535895,0.007934126,0.0017927099,0.0011622822,0.003399624,0.00035229052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023757662,0.0009800886,0.0009483501,0.013541032,0.0011139665,0.0017809168,0.001621407,0.0020863623,0.0024931438],"category_scores_gemma":[0.0146349445,0.00037000052,0.0012216356,0.0071197296,0.00050382735,0.0018737233,0.0018180712,0.001154445,0.0021027275],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001120938,0.00086938334,0.1055429,0.0035844748,0.00070885103,0.0037328487,0.0011168837,0.0075246287,0.032105885,0.013146755,0.08542941,0.74511707],"study_design_scores_gemma":[0.0003077991,0.00096209097,0.20497982,0.0018721333,0.0022303306,0.010704229,0.0030900042,0.32360217,0.067206524,0.107952125,0.2766342,0.00045850867],"about_ca_topic_score_codex":0.0068668174,"about_ca_topic_score_gemma":0.015089606,"teacher_disagreement_score":0.013541032,"about_ca_system_score_codex":0.0010507772,"about_ca_system_score_gemma":0.0026832419,"threshold_uncertainty_score":0.013653696},"labels":[],"label_agreement":null},{"id":"W2805245456","doi":"","title":"MC-UC3M Participation at TAC 2017 Adverse Drug Reaction Extraction from Drug Labels.","year":2017,"lang":"en","type":"article","venue":"Theory and applications of categories","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug; Extraction (chemistry); Adverse drug reaction; Drug reaction; Pharmacology; Chromatography; Medicine; Chemistry","score_opus":0.06393887548150282,"score_gpt":0.4336010436140604,"score_spread":0.3696621681325576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805245456","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051951975,0.0055925413,0.15576532,0.041755587,0.0055348687,0.0047611394,0.3990126,0.0512977,0.28432828],"genre_scores_gemma":[0.26650906,0.001198817,0.18680014,0.009141698,0.002031682,0.002855382,0.41334608,0.0109494515,0.10716764],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98095506,0.0075795883,0.0008692167,0.0016990122,0.0077980203,0.0010990235],"domain_scores_gemma":[0.9598172,0.012213916,0.0023403007,0.0072668553,0.014528342,0.003833405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025998991,0.0009949328,0.0011419164,0.0034586408,0.0014282635,0.0045828936,0.0023301134,0.0024489637,0.07352613],"category_scores_gemma":[0.07223913,0.00041387006,0.0010869633,0.0023163522,0.00064927083,0.0021425518,0.0048055775,0.0017602829,0.03597525],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021639857,0.00028493573,0.01240201,0.00051802734,0.00014659046,0.00031746356,0.0005046639,0.0024413345,0.0062778564,0.011534528,0.8183412,0.14506733],"study_design_scores_gemma":[0.00031867996,0.00022694372,0.00983173,0.00028719445,0.00008289449,0.00033108314,0.0002546548,0.014035451,0.01102895,0.011367816,0.95217746,0.000057232148],"about_ca_topic_score_codex":0.01743229,"about_ca_topic_score_gemma":0.0136039015,"teacher_disagreement_score":0.07352613,"about_ca_system_score_codex":0.00315019,"about_ca_system_score_gemma":0.008471498,"threshold_uncertainty_score":0.24596941},"labels":[],"label_agreement":null},{"id":"W2805720231","doi":"10.1007/s00228-018-2496-3","title":"Tamoxifen and the risk of Parkinsonism: a case/non-case study","year":2018,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tamoxifen; Medicine; Parkinsonism; Oncology; Internal medicine; Pharmacology; Breast cancer; Disease; Cancer","score_opus":0.20605437582554453,"score_gpt":0.5328072979525367,"score_spread":0.32675292212699214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805720231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656063,0.0014536767,0.00015843053,0.00018671792,0.00001000133,0.000032280353,0.000109575034,0.0000056237964,0.001483067],"genre_scores_gemma":[0.9988024,0.0006768777,0.00010858825,0.000062705425,0.000038527498,0.000007773499,0.000059543905,0.0000026864034,0.00024089149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994407,0.00013118405,0.00009085372,0.00014175008,0.000085193846,0.00011020993],"domain_scores_gemma":[0.9984413,0.0006447081,0.00045960143,0.00012722106,0.00010872677,0.00021858743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041180098,0.00051720615,0.00071925606,0.0013693131,0.0014029031,0.0009587127,0.0005161107,0.0017715455,0.0046224943],"category_scores_gemma":[0.0027395384,0.000632831,0.0010592333,0.0011258943,0.00074426475,0.00084820075,0.00064045493,0.00074320193,0.00054516597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094162585,0.000870487,0.8263207,0.00015201434,0.0003519515,0.16365136,0.0009790845,0.000102430364,0.0009582781,0.00026538307,0.00041417134,0.00499256],"study_design_scores_gemma":[0.00012823401,0.0017696031,0.3978315,0.00013402126,0.00055634405,0.59388727,0.0023994478,0.0008162573,0.00041665547,0.00045885323,0.0015168267,0.00008506059],"about_ca_topic_score_codex":0.0035564073,"about_ca_topic_score_gemma":0.0032298737,"teacher_disagreement_score":0.0046224943,"about_ca_system_score_codex":0.00051087793,"about_ca_system_score_gemma":0.00043737213,"threshold_uncertainty_score":0.015463769},"labels":[],"label_agreement":null},{"id":"W2806534782","doi":"","title":"UTH_CCB System for Adverse Drug Reaction Extraction from Drug Labels at TAC-ADR 2017.","year":2017,"lang":"en","type":"article","venue":"Theory and applications of categories","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug; Adverse drug reaction; Extraction (chemistry); Computer science; Pharmacology; Chemistry; Medicine; Chromatography","score_opus":0.055184767890967074,"score_gpt":0.411657228408309,"score_spread":0.35647246051734194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806534782","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009183854,0.0030000748,0.12613057,0.0017724173,0.0006428276,0.001181754,0.5234215,0.2990197,0.03564727],"genre_scores_gemma":[0.08082321,0.0022731745,0.198286,0.0028982242,0.00058919983,0.0024395827,0.66606647,0.02201147,0.02461266],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971239,0.0006918691,0.0005892393,0.000506672,0.00085679913,0.00023159246],"domain_scores_gemma":[0.98686546,0.004583248,0.0017954902,0.0033104178,0.0030226184,0.00042274778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046546566,0.0013878789,0.0014033935,0.008767308,0.0007596289,0.0032810252,0.0020826943,0.0019926594,0.10710016],"category_scores_gemma":[0.022260895,0.0007634942,0.0015242833,0.004609968,0.00049368147,0.002554873,0.0029699774,0.0011738999,0.07171296],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022013623,0.0001881653,0.01478403,0.0035725469,0.00048420686,0.0006708342,0.0004247006,0.003208246,0.0077618826,0.01499249,0.7476753,0.20403625],"study_design_scores_gemma":[0.00047274528,0.000206561,0.018791199,0.0009434612,0.00023285931,0.001133339,0.0001504398,0.022399236,0.026869318,0.018718071,0.90985507,0.00022771105],"about_ca_topic_score_codex":0.007361992,"about_ca_topic_score_gemma":0.0044960594,"teacher_disagreement_score":0.10710016,"about_ca_system_score_codex":0.0014675313,"about_ca_system_score_gemma":0.004240506,"threshold_uncertainty_score":0.35828573},"labels":[],"label_agreement":null},{"id":"W2807093725","doi":"10.1186/s12913-018-3251-2","title":"Comparing the application of two theoretical frameworks to describe determinants of adverse medical device event reporting: secondary analysis of qualitative interview data","year":2018,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Women's College Hospital","funders":"","keywords":"Psychological intervention; Nursing research; Health informatics; CLARITY; Medicine; Qualitative research; Health administration; Incentive; Intervention (counseling); Public health; Audit; Applied psychology; Medical education; Psychology; Nursing; Accounting","score_opus":0.5083180201228603,"score_gpt":0.6716423895987035,"score_spread":0.16332436947584317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807093725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91712415,0.0006110432,0.059203703,0.002322047,0.000079442325,0.0071257097,0.0021397301,0.00007588664,0.011318205],"genre_scores_gemma":[0.94692266,0.0004560194,0.035003927,0.00062360783,0.00001726195,0.014491631,0.0010819223,0.000061748724,0.0013411256],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.94251144,0.045088388,0.0028868816,0.002140467,0.004637445,0.0027353123],"domain_scores_gemma":[0.8135038,0.15115468,0.0099183135,0.0045708576,0.019651404,0.001200922],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08005473,0.0007402008,0.000763009,0.0067755724,0.002702853,0.0036106792,0.0019207946,0.0010253941,0.002581458],"category_scores_gemma":[0.15379375,0.0006488387,0.0009320848,0.0066155028,0.0054275715,0.005266807,0.005949165,0.0020313032,0.00036770542],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013794054,0.000097156175,0.022485746,0.0014161413,0.00003317646,0.000147197,0.9389342,0.00035834784,0.001006286,0.0066134064,0.000893504,0.027876943],"study_design_scores_gemma":[0.000053865897,0.0001510267,0.027232721,0.0017866555,0.00004046808,0.00012596558,0.9523902,0.0026081405,0.0014571776,0.0059494837,0.00815215,0.000052126627],"about_ca_topic_score_codex":0.015054567,"about_ca_topic_score_gemma":0.0133779375,"teacher_disagreement_score":0.91994524,"about_ca_system_score_codex":0.01319499,"about_ca_system_score_gemma":0.011928277,"threshold_uncertainty_score":0.42337495},"labels":[],"label_agreement":null},{"id":"W2807245675","doi":"","title":"Overview of the TAC 2017 Adverse Reaction Extraction from Drug Labels Track.","year":2017,"lang":"en","type":"article","venue":"Theory and applications of categories","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Track (disk drive); Extraction (chemistry); Adverse drug reaction; Computer science; Drug; Drug reaction; Chemistry; Chromatography; Pharmacology; Medicine","score_opus":0.09181320740700182,"score_gpt":0.44244806078188215,"score_spread":0.3506348533748803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807245675","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012408476,0.015904479,0.36615318,0.0038658206,0.0011931903,0.0018613868,0.46435067,0.095792085,0.038470693],"genre_scores_gemma":[0.03062289,0.0050674737,0.24756065,0.0013550061,0.00037863516,0.0009116756,0.7008898,0.002612322,0.010601585],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946936,0.00074204017,0.0008472801,0.000954318,0.0024518298,0.0003110506],"domain_scores_gemma":[0.9858949,0.0042411378,0.0012663769,0.0028636612,0.005208668,0.00052525295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054829577,0.0014942217,0.0013990578,0.018037235,0.0012071397,0.0046763993,0.0024608043,0.0017906459,0.013463974],"category_scores_gemma":[0.020880677,0.00069937354,0.002443753,0.009173627,0.0005033293,0.0037456057,0.0030467224,0.001680905,0.016107816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049873523,0.00021544789,0.017025119,0.0034281348,0.00054689846,0.0005845521,0.00033113785,0.0047274637,0.008375096,0.014144935,0.50861883,0.4415036],"study_design_scores_gemma":[0.00012636189,0.00020613412,0.018143337,0.0013970264,0.0005073668,0.0014102074,0.00024868528,0.04485491,0.014878254,0.021364547,0.89666677,0.00019629147],"about_ca_topic_score_codex":0.028853664,"about_ca_topic_score_gemma":0.033607543,"teacher_disagreement_score":0.028853664,"about_ca_system_score_codex":0.0018556515,"about_ca_system_score_gemma":0.0070503904,"threshold_uncertainty_score":0.057371438},"labels":[],"label_agreement":null},{"id":"W2807677634","doi":"","title":"Combining rule-based and neural network systems for extracting adverse reactions from drug labels.","year":2017,"lang":"en","type":"article","venue":"Theory and applications of categories","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Artificial neural network; Computer science; Adverse drug reaction; Drug reaction; Artificial intelligence; Drug; Machine learning; Data mining; Pharmacology; Medicine","score_opus":0.06277136325383446,"score_gpt":0.39822745936414716,"score_spread":0.3354560961103127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807677634","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15462466,0.0071079987,0.8035216,0.0016561002,0.0008140695,0.0014554299,0.0054699806,0.0112191755,0.014130963],"genre_scores_gemma":[0.4892643,0.0016807101,0.49792293,0.00048771204,0.00018566419,0.00054516626,0.0062328954,0.00014212828,0.0035386274],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99840873,0.0004500008,0.00023843507,0.00039471127,0.00039381805,0.000114360184],"domain_scores_gemma":[0.99389726,0.0037645733,0.00033113634,0.0003143261,0.0015598938,0.00013274317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025687537,0.0012344656,0.0010283868,0.0048225718,0.00051663636,0.0019771042,0.0014767107,0.0013318717,0.0015891531],"category_scores_gemma":[0.010518039,0.0003374181,0.0010926359,0.0025046696,0.00034034482,0.0016759656,0.0010286768,0.0011689656,0.0014993243],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048834935,0.00052759214,0.01817455,0.0005551352,0.0004847149,0.00048817127,0.0002128153,0.03835982,0.0065122815,0.0021972717,0.010127007,0.9218724],"study_design_scores_gemma":[0.00008639027,0.00025654436,0.011655065,0.00025942983,0.0005441117,0.00034567658,0.00030355918,0.95028955,0.009216517,0.017897366,0.00904034,0.00010539097],"about_ca_topic_score_codex":0.023983752,"about_ca_topic_score_gemma":0.029906102,"teacher_disagreement_score":0.023983752,"about_ca_system_score_codex":0.0009789566,"about_ca_system_score_gemma":0.001678849,"threshold_uncertainty_score":0.047688305},"labels":[],"label_agreement":null},{"id":"W2808265942","doi":"10.1159/000489703","title":"National Trends in Emergency Room Visits of Dialysis Patients for Adverse Drug Reactions","year":2018,"lang":"en","type":"article","venue":"American Journal of Nephrology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Dialysis; Emergency department; Odds ratio; Emergency medicine; Propensity score matching; Intensive care medicine; Internal medicine","score_opus":0.0521884591147852,"score_gpt":0.42758080106412927,"score_spread":0.37539234194934407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808265942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768038,0.0021317373,0.00045248424,0.0007301552,0.00003451195,0.000027916769,0.016760642,0.000057193993,0.0030016992],"genre_scores_gemma":[0.98900443,0.0009784533,0.0005976262,0.0003632645,0.000036539528,0.00005152388,0.008477053,0.0000071251025,0.00048401262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933666,0.00010612751,0.00013034997,0.0001754238,0.00015890898,0.00009248567],"domain_scores_gemma":[0.997008,0.00033855988,0.0017664349,0.00007577259,0.00058263174,0.00022869473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005749207,0.00010539148,0.00024095351,0.00086258067,0.00017020704,0.00032295735,0.00036721933,0.00028325073,0.0019237148],"category_scores_gemma":[0.0025105714,0.00011654067,0.00047525595,0.0010813345,0.00009415209,0.0003145921,0.00037144014,0.0005373335,0.00021661716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003392521,0.000022169503,0.9951132,0.00007068686,0.00007403915,0.000038480594,0.00004020133,0.00008824279,0.00011887657,0.000050651393,0.0017331865,0.002616452],"study_design_scores_gemma":[0.0000024224983,0.000017679004,0.99876356,0.00001917419,0.000015506037,0.00020113637,0.00008865599,0.00016449779,0.00003965198,0.000013340958,0.0006720095,0.000002326914],"about_ca_topic_score_codex":0.012618056,"about_ca_topic_score_gemma":0.017641455,"teacher_disagreement_score":0.012618056,"about_ca_system_score_codex":0.00057742017,"about_ca_system_score_gemma":0.00042590956,"threshold_uncertainty_score":0.025089264},"labels":[],"label_agreement":null},{"id":"W2808345718","doi":"10.1186/s12911-018-0621-y","title":"Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review","year":2018,"lang":"en","type":"review","venue":"BMC Medical Informatics and Decision Making","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Public Health Ontario; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Health Canada; Canada Research Chairs","keywords":"Social media; Health informatics; Pharmacovigilance; Data extraction; Computer science; Reliability (semiconductor); Data science; MEDLINE; Medicine; World Wide Web; Public health; Adverse effect; Nursing","score_opus":0.5075659774165958,"score_gpt":0.6059076082814882,"score_spread":0.09834163086489234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808345718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092470186,0.9928428,0.0012485858,0.0021403984,0.00038930273,0.00085473736,0.00046020222,0.0000190893,0.0011201621],"genre_scores_gemma":[0.013269535,0.97697234,0.0047091227,0.0014692576,0.00039118205,0.0025275466,0.00048531182,0.000019018056,0.00015673508],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9365918,0.027090965,0.022607341,0.0027907914,0.01024738,0.00067175983],"domain_scores_gemma":[0.54662776,0.39702135,0.025876515,0.0054429667,0.024103284,0.00092796603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06346302,0.0018861836,0.0063465396,0.05599152,0.0018393324,0.008971779,0.003532672,0.0056838994,0.0037173545],"category_scores_gemma":[0.27399287,0.0018040481,0.0077349306,0.037100893,0.0037073356,0.009413061,0.0048388885,0.0030651472,0.0007317512],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013674078,0.000050572675,0.001862629,0.77767736,0.002764633,0.00017722476,0.0013932219,0.00036215378,0.00019955657,0.002803214,0.003932886,0.20863983],"study_design_scores_gemma":[0.000024337487,0.000056870493,0.0010171615,0.970464,0.0033366012,0.00015180746,0.00051289843,0.00018263653,0.0001405928,0.0011940666,0.022889534,0.00002953268],"about_ca_topic_score_codex":0.0074677938,"about_ca_topic_score_gemma":0.011636059,"teacher_disagreement_score":0.06346302,"about_ca_system_score_codex":0.0074147647,"about_ca_system_score_gemma":0.026341025,"threshold_uncertainty_score":0.3356285},"labels":[],"label_agreement":null},{"id":"W2809263774","doi":"10.1093/bioinformatics/bty475","title":"HUME: large-scale detection of causal genetic factors of adverse drug reactions","year":2018,"lang":"en","type":"article","venue":"Bioinformatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; Simon Fraser University","funders":"Institute of Cancer Research; Canada Foundation for Innovation; Genome Canada","keywords":"Confounding; Drug reaction; Drug; Data mining; Adverse drug reaction; Computer science; Adverse effect; Medicine; Bioinformatics; Intensive care medicine; Internal medicine; Pharmacology; Biology","score_opus":0.05633522496170181,"score_gpt":0.38342296736908704,"score_spread":0.32708774240738525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809263774","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1422997,0.0015902757,0.8287697,0.0026515073,0.00014833681,0.00134408,0.01296107,0.008572947,0.0016623723],"genre_scores_gemma":[0.43687496,0.00037631,0.5481468,0.00050753815,0.00016889903,0.00085483294,0.011437036,0.00019044656,0.0014431684],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972652,0.001538626,0.00016067427,0.00062486104,0.000327925,0.00008268839],"domain_scores_gemma":[0.9662929,0.02966309,0.0014091491,0.0014051213,0.0007438974,0.00048580486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008814045,0.0010246636,0.0012082424,0.0031830932,0.0006688668,0.0012123632,0.001727929,0.0014705816,0.0058196066],"category_scores_gemma":[0.034925807,0.0005991408,0.0015312772,0.0011879614,0.00058699585,0.001094994,0.0018096933,0.0011630822,0.0006679116],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022945018,0.0009451678,0.31919795,0.0020028502,0.0034583155,0.0037125212,0.0006085846,0.22641706,0.0071036094,0.013306783,0.031821888,0.3891309],"study_design_scores_gemma":[0.0005288216,0.00031674467,0.027259672,0.0001166426,0.000454037,0.0012237005,0.00011601512,0.93003947,0.0030036427,0.031379506,0.00550571,0.00005595074],"about_ca_topic_score_codex":0.0022627756,"about_ca_topic_score_gemma":0.005302159,"teacher_disagreement_score":0.008814045,"about_ca_system_score_codex":0.00048428023,"about_ca_system_score_gemma":0.0014894032,"threshold_uncertainty_score":0.046613693},"labels":[],"label_agreement":null},{"id":"W2883963541","doi":"10.2196/medinform.9878","title":"Validating a Framework for Coding Patient-Reported Health Information to the Medical Dictionary for Regulatory Activities Terminology: An Evaluative Study","year":2018,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Terminology; Coding (social sciences); Computer science; Medical terminology; Health informatics; Medical classification; Natural language processing; Knowledge management; Data science; Information retrieval; Medicine; Linguistics; Public health; Nursing","score_opus":0.1535582157098413,"score_gpt":0.5209795949836761,"score_spread":0.3674213792738348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883963541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87244785,0.0011582787,0.05914634,0.0015434426,0.00035104828,0.05560841,0.0019355185,0.00018619584,0.007622844],"genre_scores_gemma":[0.7731852,0.0007648184,0.16323888,0.0008370403,0.00009591713,0.05856262,0.002319356,0.00013519237,0.00086095143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.73768497,0.21331908,0.021271173,0.0054993406,0.01964438,0.0025810914],"domain_scores_gemma":[0.5050316,0.30711916,0.03171733,0.026280928,0.12629883,0.0035522003],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2611531,0.0010417248,0.0013064519,0.00696157,0.0028632921,0.004407342,0.002328581,0.0015345337,0.002420969],"category_scores_gemma":[0.3500373,0.0007080302,0.002384761,0.004637895,0.005367352,0.004355987,0.0073451065,0.0024123716,0.0006990437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006961192,0.01112295,0.34000105,0.006388104,0.0006395702,0.00077268016,0.22488387,0.0035444514,0.006407968,0.0091031585,0.008228755,0.38194624],"study_design_scores_gemma":[0.005188174,0.041369956,0.39257902,0.011883731,0.0020451415,0.0021951774,0.3795929,0.04420015,0.027310042,0.01175547,0.0807196,0.001160692],"about_ca_topic_score_codex":0.0038783078,"about_ca_topic_score_gemma":0.0059139305,"teacher_disagreement_score":0.7388469,"about_ca_system_score_codex":0.010266276,"about_ca_system_score_gemma":0.012848116,"threshold_uncertainty_score":0.9111298},"labels":[],"label_agreement":null},{"id":"W2884768548","doi":"10.5539/gjhs.v10n8p107","title":"Reporting on Adverse Drug Reactions: Knowledge, Attitudes and Practice Among Physicians Working at Healthcare Institutions in Al-Buraimi Governorate-Oman","year":2018,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Family medicine; Drug reaction; Under-reporting; Adverse drug reaction; Health care; Affect (linguistics); Cross-sectional study; Significant difference; Questionnaire; Adverse effect; Drug; Internal medicine; Psychiatry; Psychology","score_opus":0.20527253944879637,"score_gpt":0.5353807749340069,"score_spread":0.33010823548521057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884768548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993086,0.0002078854,0.00001583198,0.00016698899,0.0000027692965,0.000005845846,0.000041745225,0.0000011814582,0.00024922634],"genre_scores_gemma":[0.99927264,0.0003493221,0.000072398405,0.00008925162,0.00000966129,0.000006564401,0.000048447306,3.445445e-7,0.00015138969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940646,0.00015988159,0.00007648083,0.000059391234,0.00019494299,0.000102889215],"domain_scores_gemma":[0.9977385,0.00043698837,0.0013370193,0.00004506303,0.00019525546,0.0002471136],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.000925425,0.0001207431,0.0001831574,0.00055095495,0.00049264304,0.00040436466,0.00019849927,0.00041182945,0.0015584402],"category_scores_gemma":[0.0025899778,0.00017303869,0.00016227171,0.00080633257,0.00030439557,0.0005067581,0.00034187976,0.00024757703,0.0001929396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021289696,0.00009353737,0.9925063,0.000052086118,0.000012443918,0.0001792267,0.0020166514,0.0000184991,0.0003150402,0.000010808887,0.00018194808,0.0045920685],"study_design_scores_gemma":[0.00000219794,0.00012946679,0.9971673,0.00002281031,0.000004666971,0.00025361666,0.0020635857,0.000043383487,0.000036830603,0.0000042858733,0.00026961387,0.0000022269194],"about_ca_topic_score_codex":0.008382721,"about_ca_topic_score_gemma":0.010652979,"teacher_disagreement_score":0.9990746,"about_ca_system_score_codex":0.00039940496,"about_ca_system_score_gemma":0.0005976694,"threshold_uncertainty_score":0.016667843},"labels":[],"label_agreement":null},{"id":"W2887322021","doi":"10.1007/s40264-018-0713-8","title":"The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database","year":2018,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada); Université de Montréal","funders":"","keywords":"Medicine; Vigilance (psychology); Seriousness; MedDRA; Pharmacovigilance; Database; Drug reaction; Social media; Descriptive statistics; Adverse drug reaction; Adverse effect; Family medicine; Drug; Pharmacology; Psychology","score_opus":0.05427527113949559,"score_gpt":0.4369644921105809,"score_spread":0.3826892209710853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887322021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90291536,0.0029592027,0.0004640587,0.0020369845,0.000029945615,0.00029690415,0.08645079,0.00005742021,0.004789471],"genre_scores_gemma":[0.9651742,0.0015515175,0.0005963042,0.0005114069,0.000026757833,0.000086576896,0.03121284,0.000022245136,0.0008181699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9892502,0.0017744921,0.00147762,0.0009062666,0.005780409,0.0008109819],"domain_scores_gemma":[0.9345995,0.017167484,0.02318408,0.0021163106,0.019800447,0.003132215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004694171,0.00036177092,0.0006029535,0.0059930137,0.001166943,0.0019839061,0.0019518343,0.0007425291,0.0013778375],"category_scores_gemma":[0.039046664,0.00037227658,0.00095998426,0.014609126,0.0005730696,0.00070039165,0.0013731597,0.0009393534,0.00018502415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015390644,0.000032718825,0.9907114,0.00010932591,0.00022835859,0.00011914799,0.00033939353,0.00030200765,0.0000591346,0.00018228259,0.0037750278,0.003987393],"study_design_scores_gemma":[0.000011845099,0.000021943046,0.9959638,0.000054764285,0.00009152349,0.000088773966,0.00040474033,0.0012755021,0.00005958161,0.00002531151,0.0019872643,0.000014957509],"about_ca_topic_score_codex":0.96155936,"about_ca_topic_score_gemma":0.95767057,"teacher_disagreement_score":0.038440645,"about_ca_system_score_codex":0.019936707,"about_ca_system_score_gemma":0.035321698,"threshold_uncertainty_score":0.14465165},"labels":[],"label_agreement":null},{"id":"W2888190576","doi":"10.2196/11021","title":"Extraction and Standardization of Patient Complaints from Electronic Medication Histories for Pharmacovigilance: Natural Language Processing Analysis in Japanese","year":2018,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Standardization; Natural language processing; Computer science; Information extraction; Medicine; Adverse effect; Pharmacology","score_opus":0.02668859490989499,"score_gpt":0.43925949113698126,"score_spread":0.41257089622708626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888190576","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7878723,0.0017937729,0.20086716,0.0008235568,0.00012447385,0.0006695591,0.0042495625,0.0019147019,0.0016849636],"genre_scores_gemma":[0.6089907,0.000829901,0.38007417,0.0003530759,0.0001494051,0.0005038539,0.007362834,0.00019961408,0.0015364338],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974491,0.00076664035,0.0006473114,0.0006539409,0.00039375183,0.0000892905],"domain_scores_gemma":[0.991067,0.004570674,0.0015787282,0.0005737162,0.0020406377,0.0001692408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029553291,0.00083464844,0.0005251169,0.0030637458,0.00054420804,0.0011434392,0.0005547781,0.00066565024,0.0006964998],"category_scores_gemma":[0.0087427925,0.00030483032,0.0010557913,0.001879859,0.0004699232,0.0010124559,0.0008991358,0.00042021295,0.0005562331],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010810843,0.000502477,0.11922825,0.0037597253,0.000350289,0.0046819057,0.009943405,0.0064595174,0.24388978,0.0011087642,0.008589345,0.6004055],"study_design_scores_gemma":[0.00024314887,0.0010914317,0.5779062,0.00044864774,0.0012955308,0.005874403,0.009928695,0.19707587,0.16669077,0.004071634,0.034922693,0.0004510192],"about_ca_topic_score_codex":0.00537934,"about_ca_topic_score_gemma":0.0063122194,"teacher_disagreement_score":0.00537934,"about_ca_system_score_codex":0.0006342037,"about_ca_system_score_gemma":0.0014739113,"threshold_uncertainty_score":0.01562947},"labels":[],"label_agreement":null},{"id":"W2890243962","doi":"10.4212/cjhp.v71i4.2824","title":"Impact of a Policy Change on Pharmacists’ Reporting of Adverse Drug Reactions","year":2018,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Canadian Armed Forces; Jewish General Hospital","funders":"Université de Montréal","keywords":"Workload; Medicine; Psychological intervention; Drug reaction; Adverse effect; Drug; Family medicine; Pharmacology; Nursing","score_opus":0.18359547972782309,"score_gpt":0.4903131585900064,"score_spread":0.3067176788621833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890243962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7243618,0.0023832484,0.0017957983,0.23333663,0.0029876688,0.0016285329,0.0022963583,0.00063854345,0.030571507],"genre_scores_gemma":[0.95262086,0.0010520527,0.004064947,0.035608057,0.0006603889,0.00046690973,0.0008237659,0.000040039435,0.004663072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9501212,0.016368618,0.0056745526,0.0025292009,0.01734455,0.0079618115],"domain_scores_gemma":[0.8184076,0.07352751,0.031200558,0.010991671,0.047510333,0.018362332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042858075,0.00047347188,0.00051356887,0.0017901312,0.0027079373,0.0045856615,0.0027272005,0.0059724124,0.0038111361],"category_scores_gemma":[0.18584974,0.0006745556,0.0017775901,0.0015958651,0.0018510451,0.002465676,0.0026357034,0.0049947905,0.00052321306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037099628,0.0071169427,0.5191031,0.0022181666,0.0008617798,0.002554687,0.011332172,0.010945469,0.005094359,0.005627544,0.07621519,0.35522068],"study_design_scores_gemma":[0.00040599142,0.0017140044,0.9405721,0.00085707736,0.00032959058,0.00022245751,0.0048910817,0.003719149,0.0027944806,0.00053683866,0.043713365,0.00024384481],"about_ca_topic_score_codex":0.5719792,"about_ca_topic_score_gemma":0.4899376,"teacher_disagreement_score":0.42802078,"about_ca_system_score_codex":0.035590883,"about_ca_system_score_gemma":0.105483845,"threshold_uncertainty_score":0.8610829},"labels":[],"label_agreement":null},{"id":"W2891205900","doi":"10.1136/bmjopen-2018-023090","title":"Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation","year":2018,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Database; Pharmacovigilance; Medicine; Pharmacoepidemiology; Descriptive statistics; Health care; Medical prescription; Computer science; Drug","score_opus":0.2834810434222595,"score_gpt":0.5331905837304134,"score_spread":0.2497095403081539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891205900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370487,0.015175555,0.0019495935,0.00078582525,0.00003503986,0.000618927,0.039970975,0.00006346546,0.0043517957],"genre_scores_gemma":[0.97964203,0.0028546015,0.0028005205,0.00020891632,0.000030039098,0.00067127,0.013554728,0.000023774894,0.00021415105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9757683,0.006860347,0.010484911,0.0021433495,0.0039645163,0.0007784931],"domain_scores_gemma":[0.86517483,0.075387105,0.047346015,0.003709056,0.0070021832,0.0013808644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013809235,0.00023975749,0.00097317644,0.016672652,0.0004878815,0.0025880742,0.0007778703,0.0006843712,0.002698095],"category_scores_gemma":[0.07987018,0.00023040433,0.0012802638,0.029605212,0.0006123625,0.00302354,0.002434529,0.0005609222,0.0003893269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044001584,0.000073759686,0.9750293,0.0012232625,0.00034669533,0.00016417558,0.00076211826,0.00019051277,0.00011851734,0.0007093065,0.0014747055,0.019467592],"study_design_scores_gemma":[0.00004842127,0.00014759523,0.9809682,0.0016181018,0.00029235063,0.0015420832,0.004034548,0.00075551483,0.00031698938,0.0006334841,0.0096099125,0.00003276231],"about_ca_topic_score_codex":0.0016450696,"about_ca_topic_score_gemma":0.0010025029,"teacher_disagreement_score":0.016672652,"about_ca_system_score_codex":0.001070388,"about_ca_system_score_gemma":0.0013558653,"threshold_uncertainty_score":0.07303107},"labels":[],"label_agreement":null},{"id":"W2892289807","doi":"10.14745/ccdr.v44i12a04","title":"Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017","year":2018,"lang":"en","type":"article","venue":"Canada Communicable Disease Report","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Adverse effect; Rash; Vaccination; Immunization; Pediatrics; Pharmacovigilance; Population; Environmental health; Internal medicine; Immunology; Antibody","score_opus":0.06271169867412098,"score_gpt":0.39322887094109926,"score_spread":0.3305171722669783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892289807","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1639782,0.056990005,0.004203048,0.017391827,0.0015624791,0.0028318823,0.6227552,0.0021182226,0.12816907],"genre_scores_gemma":[0.5741878,0.06944995,0.008922689,0.008122311,0.00062721147,0.0010901719,0.30268908,0.00034665022,0.03456421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99077636,0.00034939038,0.0008209461,0.00044994152,0.006650799,0.00095254445],"domain_scores_gemma":[0.9432338,0.0018243927,0.00556709,0.0006207598,0.045942683,0.0028113131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036202471,0.00077036914,0.00045567195,0.0075966436,0.0024010935,0.0020144533,0.0016772577,0.0005312989,0.0050165183],"category_scores_gemma":[0.01923155,0.00038869627,0.0006786198,0.010472915,0.00066127506,0.0006155062,0.0012212017,0.0008356355,0.0010879993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003657419,0.00008854445,0.45711645,0.00395015,0.00027902581,0.0005541179,0.0015048244,0.00088221085,0.0009737903,0.0013811652,0.39996785,0.13293615],"study_design_scores_gemma":[0.000052650717,0.00009802783,0.6365109,0.0021150955,0.00017014024,0.00035014705,0.0015708576,0.0010341502,0.0014226579,0.00020310463,0.3563956,0.00007666049],"about_ca_topic_score_codex":0.9918182,"about_ca_topic_score_gemma":0.99065924,"teacher_disagreement_score":0.050993267,"about_ca_system_score_codex":0.050993267,"about_ca_system_score_gemma":0.20331134,"threshold_uncertainty_score":0.36998373},"labels":[],"label_agreement":null},{"id":"W2892305493","doi":"10.4212/cjhp.v71i4.2821","title":"Adverse Drug Reaction Reporting: Opportunities to Increase Pharmacists’ Role","year":2018,"lang":"en","type":"editorial","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Drug; Adverse drug reaction; Drug reaction; Medicine; Adverse effect; Family medicine; Pharmacology; Business; Medical emergency","score_opus":0.10987755533378159,"score_gpt":0.422245343077128,"score_spread":0.31236778774334645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892305493","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043081098,0.009184357,0.00013166093,0.116181955,0.8725468,0.000026766224,0.000040208917,0.00008569922,0.0017595191],"genre_scores_gemma":[0.0004223325,0.005649278,0.00019078863,0.045873776,0.94446343,0.0000222217,0.000028536168,0.000026577332,0.0033230733],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9708909,0.0055569024,0.005514197,0.0021173363,0.014576255,0.0013444485],"domain_scores_gemma":[0.81055593,0.06397094,0.012469487,0.0042641577,0.08807779,0.020661714],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024990758,0.0038976115,0.004130077,0.006544915,0.00402732,0.014590488,0.006371761,0.045336306,0.015144079],"category_scores_gemma":[0.108805045,0.0017873709,0.005071469,0.0033442338,0.0038999375,0.008211336,0.0034504053,0.033175733,0.009663365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020541695,0.00001890234,0.00006401346,0.00031041342,0.000026554624,0.00010745745,0.000016910984,0.000013173567,0.000022442462,0.00018957918,0.99203134,0.0071787047],"study_design_scores_gemma":[0.00014736994,0.0000484869,0.00072292314,0.0016725676,0.00012418946,0.00044092748,0.00009400875,0.00019398553,0.000075425494,0.00087413745,0.995574,0.000031924526],"about_ca_topic_score_codex":0.0047027,"about_ca_topic_score_gemma":0.016428623,"teacher_disagreement_score":0.97500926,"about_ca_system_score_codex":0.0071427207,"about_ca_system_score_gemma":0.011323054,"threshold_uncertainty_score":0.13216531},"labels":[],"label_agreement":null},{"id":"W2896600084","doi":"10.1371/journal.pone.0205426","title":"Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews","year":2018,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Systematic review; Medicine; Incidence (geometry); MEDLINE; Cochrane Library; Meta-analysis; Emergency medicine; Internal medicine","score_opus":0.3174236154425038,"score_gpt":0.4644576341870336,"score_spread":0.14703401874452982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896600084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015850936,0.99676776,0.00018722536,0.00017227889,0.000093734496,0.0004783973,0.0004841381,0.0000096433505,0.00022170425],"genre_scores_gemma":[0.02892009,0.96763813,0.0012771176,0.00044655905,0.00009539725,0.0011817993,0.0003352793,0.000007599362,0.000098114535],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9742477,0.009278033,0.009974534,0.0014823559,0.0045725293,0.00044483042],"domain_scores_gemma":[0.9280569,0.049596366,0.01585493,0.00097458943,0.005144824,0.0003722916],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015959721,0.0018829574,0.009436847,0.0127707245,0.0006503589,0.0028195733,0.0018259031,0.0015267426,0.0021953816],"category_scores_gemma":[0.07980355,0.0015097139,0.010440647,0.013486699,0.0010339726,0.0024642176,0.0017488769,0.0014937866,0.00020459642],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013329515,0.000009406984,0.0016914294,0.9630851,0.016476732,0.00009392941,0.00021480405,0.000094125964,0.00008420195,0.00012625416,0.0008289775,0.017161692],"study_design_scores_gemma":[0.00021457417,0.00020304821,0.007904384,0.8511243,0.12827216,0.00054271636,0.0003812099,0.000121135716,0.00021510606,0.00027781972,0.0106962565,0.00004727597],"about_ca_topic_score_codex":0.008292727,"about_ca_topic_score_gemma":0.026072143,"teacher_disagreement_score":0.98404026,"about_ca_system_score_codex":0.004977539,"about_ca_system_score_gemma":0.012934436,"threshold_uncertainty_score":0.08440411},"labels":[],"label_agreement":null},{"id":"W2896937317","doi":"10.1111/jgs.15543","title":"What Is Known About Preventing, Detecting, and Reversing Prescribing Cascades: A Scoping Review","year":2018,"lang":"en","type":"review","venue":"Journal of the American Geriatrics Society","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Queen's University; University of Toronto; McMaster University; Women's College Hospital","funders":"Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences; Gordon and Betty Moore Foundation","keywords":"CINAHL; Medicine; MEDLINE; Reversing; Deprescribing; Cochrane Library; Categorization; Intensive care medicine; Alternative medicine; Family medicine; Polypharmacy; Nursing; Psychological intervention; Artificial intelligence; Pathology","score_opus":0.14059272067077977,"score_gpt":0.48895174391094387,"score_spread":0.3483590232401641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896937317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007015901,0.9936754,0.00056165596,0.0026855625,0.0004113613,0.00057561306,0.00027738704,0.000022423685,0.0010889547],"genre_scores_gemma":[0.005599324,0.98940676,0.0016554737,0.0016146129,0.0002524674,0.0011239139,0.00019226133,0.00001232111,0.00014280756],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9604453,0.01584505,0.01558103,0.0016351205,0.0055833138,0.0009102139],"domain_scores_gemma":[0.74661106,0.20952201,0.022865726,0.003070235,0.016429106,0.0015018272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037516218,0.0019593458,0.007250198,0.036179177,0.001823591,0.007582869,0.0030309514,0.0046066153,0.007413322],"category_scores_gemma":[0.20327654,0.0023789282,0.0067199427,0.026160272,0.0022068436,0.010331673,0.0042109545,0.00256235,0.0010586996],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082700506,0.00003381383,0.00067569135,0.8560864,0.001834252,0.0001338168,0.0012803843,0.00012681777,0.00015490901,0.0010612259,0.004420683,0.13410933],"study_design_scores_gemma":[0.000026006293,0.000034285906,0.0005327079,0.97623706,0.0038568468,0.00011797347,0.0004839897,0.000044363886,0.000072109,0.0004140368,0.018162936,0.000017730812],"about_ca_topic_score_codex":0.010539663,"about_ca_topic_score_gemma":0.028443916,"teacher_disagreement_score":0.037516218,"about_ca_system_score_codex":0.006511796,"about_ca_system_score_gemma":0.041148514,"threshold_uncertainty_score":0.19840711},"labels":[],"label_agreement":null},{"id":"W2897647360","doi":"10.1002/cpt.1255","title":"Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Artificial Intelligence in Medicine (Canada)","funders":"Pfizer","keywords":"Pharmacovigilance; Adverse effect; Event (particle physics); Complex event processing; Adverse Event Reporting System; Artificial intelligence; Computer science; Medicine; Pharmacology","score_opus":0.4092247310207464,"score_gpt":0.5705374598262889,"score_spread":0.16131272880554248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897647360","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2773281,0.0008935601,0.69393486,0.0036342107,0.00011916168,0.0026274053,0.00038611318,0.0034519765,0.017624585],"genre_scores_gemma":[0.42261297,0.00024043092,0.5754886,0.00033434195,0.00004579041,0.00030948684,0.00025489047,0.00007340533,0.00064013764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97731656,0.012798183,0.0019472128,0.0016511627,0.0058921995,0.00039462306],"domain_scores_gemma":[0.92630637,0.052821446,0.0056379596,0.006167106,0.008390008,0.00067714805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0238436,0.00087123696,0.0006003541,0.0048570717,0.0006467236,0.0041499883,0.0016522368,0.0010659564,0.0012983921],"category_scores_gemma":[0.055691715,0.00041861428,0.00078045746,0.0028019086,0.0015785513,0.00284629,0.0023944415,0.0014469691,0.00048001914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012055753,0.0012711778,0.052375156,0.0010582521,0.00052242115,0.0007635986,0.002786552,0.036582638,0.03401413,0.016578915,0.0032147537,0.84962684],"study_design_scores_gemma":[0.00054173934,0.0031437213,0.085578434,0.000840673,0.0005365775,0.002502964,0.0022852493,0.71690726,0.08624762,0.07235815,0.028474351,0.0005832103],"about_ca_topic_score_codex":0.0022356203,"about_ca_topic_score_gemma":0.0020800924,"teacher_disagreement_score":0.0238436,"about_ca_system_score_codex":0.0019485859,"about_ca_system_score_gemma":0.0022018494,"threshold_uncertainty_score":0.12609851},"labels":[],"label_agreement":null},{"id":"W2899011686","doi":"10.2196/10788","title":"Detection of Bleeding Events in Electronic Health Record Notes Using Convolutional Neural Network Models Enhanced With Recurrent Neural Network Autoencoders: Deep Learning Approach","year":2018,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Pharmacovigilance; Medicine; Health records; Electronic health record; Convolutional neural network; Deep learning; Major bleeding; Artificial neural network; Intensive care medicine; Artificial intelligence; Adverse effect; Medical emergency; Computer science; Internal medicine; Health care","score_opus":0.08366403244212085,"score_gpt":0.40861089249951993,"score_spread":0.3249468600573991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899011686","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45743647,0.002022632,0.5270098,0.0011833773,0.00018213254,0.00023139406,0.0030383605,0.005629954,0.0032658866],"genre_scores_gemma":[0.8748649,0.00064493134,0.11589727,0.00028278818,0.0000791204,0.0001147406,0.004149839,0.000058221114,0.0039080875],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997391,0.000057006662,0.000027122318,0.00008551538,0.000051770887,0.000039458453],"domain_scores_gemma":[0.99912626,0.00044178075,0.00012079215,0.000058773694,0.0002248782,0.000027568278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078263925,0.0008333403,0.0003254349,0.0009007633,0.00019682343,0.00047150344,0.00063475466,0.0006155631,0.000901643],"category_scores_gemma":[0.0021874532,0.0003165066,0.00058037456,0.00045506703,0.00017377845,0.00067971135,0.0004202692,0.00092573673,0.00045663505],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007113754,0.00079258,0.028499378,0.0003615276,0.00035856917,0.0009411924,0.00029383018,0.28126025,0.03616778,0.0017583779,0.012800551,0.6360546],"study_design_scores_gemma":[0.000006922269,0.000040370673,0.0020094288,0.000010479992,0.000027512639,0.000035779227,0.000015405194,0.9935464,0.0034099407,0.0005238066,0.0003666558,0.0000073282667],"about_ca_topic_score_codex":0.015456294,"about_ca_topic_score_gemma":0.02013391,"teacher_disagreement_score":0.015456294,"about_ca_system_score_codex":0.0008154658,"about_ca_system_score_gemma":0.0007825483,"threshold_uncertainty_score":0.030732632},"labels":[],"label_agreement":null},{"id":"W2899568719","doi":"10.4212/cjhp.v71i5.2842","title":"Characterization of Serious Adverse Drug Reactions in Hospital to Determine Potential Implications of Mandatory Reporting","year":2018,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Saint-Boniface; Ottawa Hospital; University of Ottawa; St. Boniface Hospital","funders":"","keywords":"Medicine; Observational study; Drug reaction; Confidence interval; Pediatrics; Emergency medicine; Medical record; Causality (physics); Adverse drug reaction; Family medicine; Drug; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.048685818463641374,"score_gpt":0.3810559403481763,"score_spread":0.3323701218845349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899568719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94577616,0.0021766503,0.011157327,0.003414757,0.00025358354,0.0036515426,0.00964991,0.00028754902,0.023632577],"genre_scores_gemma":[0.9884996,0.00041564545,0.0064456505,0.00062036916,0.000056079876,0.0006557575,0.0023259586,0.000021954995,0.0009590189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9681429,0.013650528,0.009493434,0.0015300155,0.00593839,0.0012446698],"domain_scores_gemma":[0.873537,0.02881297,0.061423056,0.0074186753,0.024937872,0.0038704837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020133255,0.000266423,0.0004995498,0.0030289406,0.0004954129,0.0013825769,0.0010937008,0.00050150615,0.003299846],"category_scores_gemma":[0.06855142,0.00021052567,0.0008227991,0.0020385978,0.0004997684,0.0012454552,0.0014011327,0.0008252151,0.00063777395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006377603,0.00015667827,0.95887756,0.00045280275,0.00009908564,0.00035430404,0.000728208,0.00061352964,0.00078532053,0.0005320197,0.00290817,0.033854518],"study_design_scores_gemma":[0.000036058384,0.0010903934,0.98520315,0.0003528746,0.000053074975,0.00085980725,0.0020640444,0.0025292842,0.0021049136,0.0003896609,0.005273132,0.0000435576],"about_ca_topic_score_codex":0.005109025,"about_ca_topic_score_gemma":0.0046570967,"teacher_disagreement_score":0.020133255,"about_ca_system_score_codex":0.0016465848,"about_ca_system_score_gemma":0.0035068663,"threshold_uncertainty_score":0.10647613},"labels":[],"label_agreement":null},{"id":"W2900069888","doi":"10.2196/12159","title":"Extraction of Information Related to Adverse Drug Events from Electronic Health Record Notes: Design of an End-to-End Model Based on Deep Learning","year":2018,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Conditional random field; Deep learning; Artificial intelligence; Named-entity recognition; Computer science; Machine learning; Pharmacovigilance; Information extraction; Relationship extraction; Task (project management); Multi-task learning; Natural language processing; Medicine; Adverse effect; Engineering","score_opus":0.05238572201969314,"score_gpt":0.4292452800969486,"score_spread":0.37685955807725546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900069888","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054604538,0.00066563045,0.93519,0.0013251499,0.00012251992,0.00033270335,0.0012178096,0.0045517744,0.0019897986],"genre_scores_gemma":[0.6414566,0.0008930759,0.34271675,0.0011584699,0.00011468836,0.0010102879,0.004903112,0.00014501922,0.007602005],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995658,0.00005621157,0.000041329793,0.00019632456,0.00006439306,0.00007598147],"domain_scores_gemma":[0.9991843,0.00032945402,0.00008257625,0.000054265565,0.00029103924,0.000058382135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012177752,0.0011990909,0.0008339043,0.00088396005,0.0003930874,0.00097099034,0.002189019,0.0018263176,0.0019032283],"category_scores_gemma":[0.0022879057,0.00074355584,0.0009862083,0.00065529183,0.0005108051,0.0017298524,0.0012783605,0.0022745423,0.001103395],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003850909,0.0005954051,0.0070060086,0.00019711674,0.00017839852,0.00028137528,0.00010138749,0.7101559,0.008135154,0.0036681264,0.006143273,0.26315278],"study_design_scores_gemma":[0.000004711785,0.000025395895,0.00015313392,0.0000069486537,0.000011488012,0.000011442351,0.000003840772,0.9977482,0.0010473051,0.0007655724,0.00021792694,0.000004120704],"about_ca_topic_score_codex":0.012954982,"about_ca_topic_score_gemma":0.012769793,"teacher_disagreement_score":0.012954982,"about_ca_system_score_codex":0.0015242477,"about_ca_system_score_gemma":0.0021020554,"threshold_uncertainty_score":0.02575916},"labels":[],"label_agreement":null},{"id":"W2902193528","doi":"10.1186/s12874-018-0617-4","title":"Methods for evaluating adverse drug event preventability in emergency department patients","year":2018,"lang":"en","type":"article","venue":"BMC Medical Research Methodology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; Vancouver Coastal Health; Vancouver General Hospital","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Emergency department; Medicine; Adverse drug event; Adverse effect; Medical emergency; Drug; MEDLINE; Emergency medicine; Pharmacology; Psychiatry","score_opus":0.7224820786822599,"score_gpt":0.7322219610896736,"score_spread":0.009739882407413747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902193528","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30560112,0.014453428,0.5183769,0.0057095727,0.0011908018,0.113723375,0.008631151,0.0011579373,0.031155704],"genre_scores_gemma":[0.29943666,0.0030584505,0.5708424,0.000859441,0.00021038171,0.12255591,0.0017988012,0.000110085624,0.0011278887],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.68148726,0.20715125,0.05793069,0.007697306,0.04417163,0.0015619098],"domain_scores_gemma":[0.4510829,0.34587076,0.10956182,0.019216698,0.072192885,0.0020749848],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22297724,0.0018485448,0.0018824993,0.016473297,0.0019843206,0.0034146444,0.003258947,0.0012470442,0.0037199163],"category_scores_gemma":[0.36626303,0.0011126656,0.0049024806,0.008626058,0.0025015848,0.0041194493,0.0055973916,0.0018309368,0.00067040353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018862856,0.0011271634,0.28926846,0.02771833,0.0023062518,0.00029091406,0.053051412,0.0023663642,0.0017986725,0.008484842,0.009607619,0.6020937],"study_design_scores_gemma":[0.002824246,0.011164814,0.6343047,0.049116053,0.0042419536,0.0035097376,0.09331009,0.031605206,0.017152017,0.040262017,0.11078722,0.0017220256],"about_ca_topic_score_codex":0.0028703914,"about_ca_topic_score_gemma":0.00549625,"teacher_disagreement_score":0.22297724,"about_ca_system_score_codex":0.0054533826,"about_ca_system_score_gemma":0.009390243,"threshold_uncertainty_score":0.9582074},"labels":[],"label_agreement":null},{"id":"W2904134443","doi":"10.4103/picr.picr_89_17","title":"Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices","year":2018,"lang":"en","type":"review","venue":"Perspectives in Clinical Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Harmonization; Legislation; SAFER; Globe; Business; Identification (biology); Medicine; Environmental health; Environmental planning; Political science; Geography; Drug; Pharmacology; Law","score_opus":0.8040160537013871,"score_gpt":0.711854432697247,"score_spread":0.09216162100414005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904134443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039673876,0.9845035,0.00032355703,0.004241304,0.0001689993,0.000040890456,0.00016572264,0.000012959644,0.006575701],"genre_scores_gemma":[0.0610654,0.9342541,0.0010447643,0.0024811921,0.00014567011,0.000048093472,0.0003069433,0.0000105207555,0.0006432454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889417,0.003019555,0.0012753706,0.00054310507,0.0056304685,0.00058986567],"domain_scores_gemma":[0.976862,0.010351666,0.003271012,0.0004763381,0.008488734,0.00055026694],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014761019,0.00035263758,0.0011292907,0.0034743918,0.00060833705,0.0030040746,0.0014631205,0.0010494086,0.0014444917],"category_scores_gemma":[0.025030302,0.00017996844,0.0009979007,0.0068925065,0.0011456121,0.0011413296,0.0010277099,0.0012538951,0.00015388428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036207587,0.00005985252,0.009564129,0.04558005,0.0008965854,0.00035970024,0.0015795839,0.0008675814,0.0006959584,0.027077952,0.017766677,0.8951898],"study_design_scores_gemma":[0.00010154792,0.00044530455,0.093567334,0.063147716,0.0027937228,0.0017560446,0.0032545712,0.0004779421,0.0023834081,0.0033749724,0.82858807,0.000109452485],"about_ca_topic_score_codex":0.15290844,"about_ca_topic_score_gemma":0.17294209,"teacher_disagreement_score":0.9903771,"about_ca_system_score_codex":0.009622885,"about_ca_system_score_gemma":0.037667688,"threshold_uncertainty_score":0.30403686},"labels":[],"label_agreement":null},{"id":"W2906409000","doi":"10.2196/11448","title":"The Adverse Drug Reactions From Patient Reports in Social Media Project: Protocol for an Evaluation Against a Gold Standard","year":2018,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Région Normandie","keywords":"Terminology; Pharmacovigilance; Protocol (science); Social media; Lexicon; Computer science; MedDRA; Adverse drug reaction; Gold standard (test); Guideline; Sample (material); Data science; Artificial intelligence; Medicine; Drug; World Wide Web; Alternative medicine; Pathology; Pharmacology","score_opus":0.562351022002949,"score_gpt":0.6681715625162281,"score_spread":0.10582054051327916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906409000","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049021826,0.00016254993,0.010434703,0.00019277984,0.00014739462,0.98098856,0.0018783709,0.00020455987,0.0010887862],"genre_scores_gemma":[0.0016129029,0.000052018557,0.007613221,0.0000628676,0.000017659562,0.9899154,0.0005400681,0.000017334849,0.00016846717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8659906,0.085661486,0.024879197,0.007151985,0.013658155,0.0026586321],"domain_scores_gemma":[0.8054851,0.06501232,0.01701725,0.029864134,0.078583404,0.0040376987],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17093503,0.0040515834,0.0038329803,0.005643931,0.0047388803,0.0032305308,0.004215712,0.0059306556,0.028262798],"category_scores_gemma":[0.15250817,0.0026243762,0.0039678803,0.004116004,0.0049419464,0.0029608826,0.0057991087,0.0040468858,0.010886003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14177456,0.039455347,0.021779718,0.11744477,0.0027276033,0.004408443,0.021607924,0.013614764,0.032943796,0.017907577,0.14192489,0.44441062],"study_design_scores_gemma":[0.110765345,0.08077194,0.07903408,0.038778972,0.0025862565,0.0020738728,0.010116314,0.015725046,0.034735553,0.014134825,0.6096978,0.0015799355],"about_ca_topic_score_codex":0.0018687664,"about_ca_topic_score_gemma":0.0029477556,"teacher_disagreement_score":0.82906497,"about_ca_system_score_codex":0.006512437,"about_ca_system_score_gemma":0.017829206,"threshold_uncertainty_score":0.90400165},"labels":[],"label_agreement":null},{"id":"W2908980962","doi":"10.1002/pds.4722","title":"How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias","year":2019,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; McGill University; Jewish General Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Pharmacoepidemiology; Transparency (behavior); Audit; Pharmacovigilance; Observational study; Medicine; Protocol (science); Comparative effectiveness research; Data science; Computer science; Data mining; Risk analysis (engineering); Accounting; Computer security; Pharmacology; Drug; Alternative medicine; Business","score_opus":0.1658637283289198,"score_gpt":0.45687870154477134,"score_spread":0.29101497321585157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908980962","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058647958,0.0012865823,0.934501,0.03817171,0.00088848337,0.0013739804,0.0007355,0.0021908924,0.014987089],"genre_scores_gemma":[0.15070614,0.0013001928,0.83103305,0.0067807077,0.0012101465,0.0023310464,0.00080820126,0.0009208759,0.0049096495],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8154536,0.14436924,0.010010305,0.0114939585,0.016265484,0.002407449],"domain_scores_gemma":[0.57708436,0.27227056,0.025711356,0.08844276,0.031080222,0.005410782],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19518583,0.0010774204,0.0014995771,0.0039252723,0.0022144471,0.0114462655,0.0036598844,0.0038235772,0.010513817],"category_scores_gemma":[0.35594666,0.0018330589,0.0020468156,0.0038865288,0.005062863,0.022181131,0.008960374,0.0056023225,0.0033143389],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001016594,0.00034084983,0.020261157,0.0009864204,0.0011416506,0.0006058946,0.003481474,0.05424555,0.0019477787,0.4386601,0.050869115,0.42644346],"study_design_scores_gemma":[0.0005339106,0.00016517742,0.0025326116,0.00070255087,0.00025065232,0.0004723987,0.00060413365,0.060630914,0.0021994407,0.80912995,0.12258572,0.00019250829],"about_ca_topic_score_codex":0.0045315023,"about_ca_topic_score_gemma":0.0038784996,"teacher_disagreement_score":0.80481416,"about_ca_system_score_codex":0.0042120744,"about_ca_system_score_gemma":0.014588741,"threshold_uncertainty_score":0.99247915},"labels":[],"label_agreement":null},{"id":"W2927462243","doi":"10.2196/11264","title":"Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection","year":2019,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. National Library of Medicine","keywords":"Pharmacovigilance; Medicine; Population; Robustness (evolution); Public health; Clinical trial; Adverse effect; Internal medicine; Nursing; Environmental health","score_opus":0.05015372774896675,"score_gpt":0.415397698240466,"score_spread":0.36524397049149926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927462243","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14539084,0.0015832095,0.7539419,0.0030935835,0.00033895345,0.0022798618,0.024402022,0.065522656,0.0034469648],"genre_scores_gemma":[0.4222824,0.0005054124,0.5556262,0.0008737833,0.00028601603,0.0010035202,0.017113818,0.00044107562,0.0018677537],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99762446,0.0006147692,0.000293014,0.0009082593,0.00043783296,0.000121627745],"domain_scores_gemma":[0.9910766,0.006154476,0.0010643755,0.00049131864,0.0009906394,0.00022260123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031445215,0.0019110033,0.0008328703,0.0050813965,0.00071241346,0.0015952088,0.0010501107,0.0015578638,0.0029450157],"category_scores_gemma":[0.010947263,0.00046796058,0.0017395348,0.0014443961,0.00046812766,0.001988146,0.0014401452,0.0015704355,0.002871897],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018126331,0.0012511624,0.051317073,0.0020492086,0.0006619618,0.0034045393,0.001559146,0.021681577,0.10562228,0.002353663,0.03417454,0.7741123],"study_design_scores_gemma":[0.00015208933,0.0007111993,0.029068619,0.00014804244,0.0003296993,0.0015092035,0.00051714014,0.8955225,0.04504118,0.011320312,0.0155097,0.0001702816],"about_ca_topic_score_codex":0.0038736612,"about_ca_topic_score_gemma":0.004087627,"teacher_disagreement_score":0.0050813965,"about_ca_system_score_codex":0.0008301934,"about_ca_system_score_gemma":0.0012602973,"threshold_uncertainty_score":0.016629994},"labels":[],"label_agreement":null},{"id":"W2931878050","doi":"10.1007/978-3-030-11775-7_2","title":"Principles of Patient Assessment","year":2019,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacist; Clinical pharmacy; Pharmacy; Patient assessment; Pharmaceutical care; Patient care; Pharmacy practice; Adverse effect; Drug reaction; Drug; Patient safety; Intensive care medicine; Family medicine; Health care; Nursing; Internal medicine; Psychiatry","score_opus":0.15426261428182364,"score_gpt":0.44815331950821147,"score_spread":0.2938907052263878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2931878050","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081958534,0.016688146,0.2164236,0.05761412,0.0045215897,0.0006953369,0.00042246454,0.0008958411,0.7019194],"genre_scores_gemma":[0.06077492,0.030828627,0.3145855,0.04193754,0.003503157,0.0026224914,0.000843878,0.00060769386,0.54429615],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934144,0.0028579242,0.00035028456,0.00042478502,0.0026161312,0.00033650274],"domain_scores_gemma":[0.9967121,0.0014968633,0.0001100733,0.0002548258,0.0011244535,0.0003017523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069409516,0.0009202014,0.0006752657,0.0018541886,0.0018974916,0.006519889,0.002658617,0.0038192023,0.033255033],"category_scores_gemma":[0.014464864,0.0005540845,0.0006977927,0.000994384,0.0046429452,0.0039480594,0.00473449,0.0051112915,0.022609066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020194315,0.000067310146,0.00052430766,0.00028209097,0.000009508854,0.00029975193,0.0019803497,0.0005372512,0.0001972754,0.4312281,0.29124194,0.2736118],"study_design_scores_gemma":[0.0000074402274,0.000022779062,0.00033278772,0.00072945334,0.00000588685,0.001256911,0.0006579559,0.00051350205,0.000118217875,0.17458388,0.8217527,0.000018379054],"about_ca_topic_score_codex":0.003194148,"about_ca_topic_score_gemma":0.0051350314,"teacher_disagreement_score":0.033255033,"about_ca_system_score_codex":0.0025004393,"about_ca_system_score_gemma":0.007878704,"threshold_uncertainty_score":0.11124921},"labels":[],"label_agreement":null},{"id":"W2938438954","doi":"10.1093/schbul/sbz021.212","title":"O5.4. PROBLEM GAMBLING ASSOCIATED WITH ARIPIPRAZOLE: A NESTED CASE-CONTROL STUDY IN A FIRST-EPISODE PSYCHOSIS COHORT USING A SYSTEMATIC PHARMACOVIGILANCE APPROACH","year":2019,"lang":"en","type":"article","venue":"Schizophrenia Bulletin","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centres Intégré Universitaires de Santé et de Services Sociaux; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Institut Universitaire en Santé Mentale de Québec","funders":"","keywords":"Aripiprazole; Pharmacovigilance; Psychosis; Psychiatry; Nested case-control study; Psychology; Medicine; Cohort; Schizophrenia (object-oriented programming); Internal medicine; Drug","score_opus":0.06139738725737557,"score_gpt":0.3694391989088434,"score_spread":0.3080418116514678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938438954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766386,0.0077383886,0.0062011937,0.000507874,0.0001807138,0.0024794012,0.0040598493,0.00007205828,0.002121946],"genre_scores_gemma":[0.9932649,0.0005248655,0.0032911596,0.00034599841,0.000060911112,0.0009830293,0.0011432243,0.000011666916,0.00037419575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99153227,0.003912256,0.0013418428,0.0018788904,0.0009456624,0.0003890238],"domain_scores_gemma":[0.99455076,0.0013890867,0.0023577926,0.00073089224,0.0006634354,0.00030797828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005718802,0.00061491923,0.00090519636,0.0015831181,0.0011637072,0.0010642076,0.0011493788,0.0013243518,0.002170996],"category_scores_gemma":[0.011070908,0.0007146724,0.004081536,0.0014503077,0.0006301134,0.0005358559,0.0007479114,0.00056681386,0.00032443556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015730346,0.00023144392,0.9828295,0.0016272875,0.0051199403,0.00082026614,0.00077401265,0.0001328446,0.0014735672,0.0003358032,0.000977163,0.0041051838],"study_design_scores_gemma":[0.0011090222,0.0022624137,0.9750461,0.0012420459,0.009593289,0.002925707,0.0006669167,0.002216768,0.000568043,0.00061619363,0.0036919366,0.00006153562],"about_ca_topic_score_codex":0.011708571,"about_ca_topic_score_gemma":0.017772697,"teacher_disagreement_score":0.011708571,"about_ca_system_score_codex":0.00069026614,"about_ca_system_score_gemma":0.0017138206,"threshold_uncertainty_score":0.030244231},"labels":[],"label_agreement":null},{"id":"W2943360211","doi":"10.5542/ljpcp.v3i0.v1i0.571902","title":"ADVERSE DRUG REACTIONS: AN OVERVIEW OF THE OLD AND CONTINUOUS CHALLENGE TO DRUG THERAPY AND DEVELOPMENT","year":2012,"lang":"en","type":"article","venue":"The Libyan Journal of Pharmacy and Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Drug; Intensive care medicine; Drug reaction; Drug development; Pharmacology; Clinical pharmacology; Adverse effect; Adverse drug reaction; Pharmacotherapy; Internal medicine","score_opus":0.3263628690272051,"score_gpt":0.5224323503272872,"score_spread":0.19606948130008206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943360211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067701685,0.9868122,0.00210199,0.0049217823,0.0009836076,0.00004328092,0.00006920111,0.00007214577,0.0043187826],"genre_scores_gemma":[0.003030407,0.9885633,0.0027579423,0.0016067616,0.002039956,0.0000310125,0.000116981035,0.000009870177,0.0018438027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961903,0.0010266615,0.00069978216,0.00023752125,0.0017222902,0.0001233128],"domain_scores_gemma":[0.9953041,0.0023059787,0.00069223513,0.000113133785,0.0012713685,0.00031326467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034413715,0.001722263,0.002342661,0.0059080883,0.00071571517,0.003067799,0.0012492952,0.0027800126,0.0037027958],"category_scores_gemma":[0.0034667333,0.0003857768,0.00089116837,0.004857724,0.0011160318,0.004035026,0.0014010993,0.0027654779,0.0024133758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098751734,0.0001641942,0.0019276601,0.008549251,0.00009691913,0.0008198616,0.00030985326,0.00046872595,0.000925035,0.0046822,0.04858406,0.93337345],"study_design_scores_gemma":[0.000021181128,0.0004480867,0.0074442513,0.007417673,0.00013287866,0.013515866,0.0006598808,0.0004935887,0.00045853519,0.008679928,0.960651,0.000077176985],"about_ca_topic_score_codex":0.0015937141,"about_ca_topic_score_gemma":0.0027184593,"teacher_disagreement_score":0.0059080883,"about_ca_system_score_codex":0.0015672015,"about_ca_system_score_gemma":0.0028116582,"threshold_uncertainty_score":0.01819998},"labels":[],"label_agreement":null},{"id":"W2950115631","doi":"10.1111/hir.12260","title":"The development of search filters for adverse effects of medical devices in <scp>medline</scp> and <scp>embase</scp>","year":2019,"lang":"en","type":"article","venue":"Health Information & Libraries Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"Research Trainees Coordinating Centre; National Institute for Health and Care Research","keywords":"MEDLINE; Adverse effect; Medicine; Intensive care medicine; Internal medicine","score_opus":0.06439272458283396,"score_gpt":0.4121289376292361,"score_spread":0.3477362130464021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950115631","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2579365,0.070248544,0.41287428,0.0057588145,0.0012845646,0.18370819,0.049017806,0.004835812,0.014335501],"genre_scores_gemma":[0.2347552,0.008271497,0.62963367,0.0015766042,0.00029382404,0.10763095,0.016539097,0.00036921963,0.0009299591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7277069,0.111657664,0.12872612,0.008299533,0.021703977,0.0019057484],"domain_scores_gemma":[0.25496113,0.6348871,0.050881352,0.020183805,0.037978142,0.001108477],"candidate_categories":["metaresearch","scholarly_communication"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.32390887,0.0030754532,0.006811902,0.04337647,0.0019292744,0.005451368,0.004019583,0.0036559417,0.0035852117],"category_scores_gemma":[0.65397865,0.0021447765,0.009363544,0.019689912,0.0016500431,0.0055219564,0.0047995285,0.0017563376,0.0010223624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008335379,0.00081207464,0.12046782,0.22499923,0.02190269,0.0011951078,0.009249475,0.012349693,0.0132206315,0.009079444,0.019985244,0.5584032],"study_design_scores_gemma":[0.013127603,0.009933543,0.35491648,0.21040662,0.098260164,0.0038671177,0.004715602,0.0755475,0.04772724,0.026574448,0.1529205,0.0020032173],"about_ca_topic_score_codex":0.0064155585,"about_ca_topic_score_gemma":0.012099024,"teacher_disagreement_score":0.9945486,"about_ca_system_score_codex":0.006060279,"about_ca_system_score_gemma":0.015739245,"threshold_uncertainty_score":0.8337407},"labels":[],"label_agreement":null},{"id":"W2950479796","doi":"10.1136/bmjpo-2019-000469","title":"Safety of azithromycin in paediatrics: a systematic review protocol","year":2019,"lang":"en","type":"review","venue":"BMJ Paediatrics Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"World Health Organization","keywords":"Azithromycin; Medicine; CINAHL; MEDLINE; Randomized controlled trial; Protocol (science); Adverse effect; Critical appraisal; Systematic review; Pediatrics; Intensive care medicine; Family medicine; Alternative medicine; Psychological intervention; Internal medicine; Pathology; Psychiatry; Antibiotics","score_opus":0.24938886108014946,"score_gpt":0.5634152639403869,"score_spread":0.3140264028602374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950479796","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066172617,0.0036105912,0.00088228896,0.00029889538,0.00015011009,0.9903363,0.0035160792,0.00006265599,0.0004813387],"genre_scores_gemma":[0.0008956154,0.0021952812,0.001936664,0.00021819657,0.000026420868,0.99378115,0.00059777516,0.0000077617,0.00034113167],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.97695756,0.008556777,0.007505444,0.0023225497,0.0033837205,0.0012740273],"domain_scores_gemma":[0.97368884,0.008614298,0.0064039263,0.0020669121,0.0076468904,0.0015791275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.054126546,0.005615516,0.01808447,0.011826728,0.0033763398,0.006766421,0.0045571476,0.0064948723,0.069425896],"category_scores_gemma":[0.051720466,0.00499393,0.012787039,0.010715417,0.004592357,0.007954459,0.0040306915,0.0056926557,0.0072682425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058387658,0.00031820106,0.0009126704,0.94583684,0.0027124868,0.0004103597,0.0014200254,0.0007017037,0.0009611205,0.0024951736,0.014080855,0.024311949],"study_design_scores_gemma":[0.04238569,0.0032753216,0.010446526,0.7721508,0.020336963,0.000886482,0.0029458727,0.0016736044,0.001975702,0.005858176,0.13755524,0.00050960726],"about_ca_topic_score_codex":0.0059031723,"about_ca_topic_score_gemma":0.014952921,"teacher_disagreement_score":0.069425896,"about_ca_system_score_codex":0.013989689,"about_ca_system_score_gemma":0.057465818,"threshold_uncertainty_score":0.28625196},"labels":[],"label_agreement":null},{"id":"W2950866768","doi":"10.1503/cmaj.190347","title":"La déclaration RECORD-PE (Reporting of Studies Conducted Using Observational Routinely Collected Health Data Statement for Pharmacoepdemiology) : directives pour la communication des études realisées à partir de données de santé observationelles collectées en routine en pharmacoépidémiologie","year":2019,"lang":"fr","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Public Health","funders":"Medical Research Council; National Institute for Health and Care Research; Wellcome Trust","keywords":"Statement (logic); Observational study; Computer science; Medicine; Political science","score_opus":0.42579865990317617,"score_gpt":0.5224204944057482,"score_spread":0.09662183450257206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950866768","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015653877,0.022366067,0.300869,0.1045368,0.05953549,0.19921836,0.20292406,0.002773054,0.09212336],"genre_scores_gemma":[0.059558805,0.017364105,0.5080574,0.043856904,0.009544695,0.27391282,0.060358137,0.000990157,0.026356976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.6436996,0.18313058,0.13419826,0.010092992,0.024614384,0.0042642453],"domain_scores_gemma":[0.3856768,0.40487233,0.07258344,0.06952707,0.06031314,0.007027343],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.30970365,0.0023403997,0.005136226,0.004925985,0.0028742452,0.009850312,0.0065139825,0.015873613,0.014149521],"category_scores_gemma":[0.3927585,0.0033080666,0.004032901,0.009124159,0.006930567,0.004327194,0.004270454,0.016658945,0.0068194414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007238073,0.0007645756,0.011231044,0.104750335,0.0022437947,0.0017385114,0.011978901,0.0016135729,0.0053755124,0.11739724,0.56884617,0.16682228],"study_design_scores_gemma":[0.0024228417,0.00076377933,0.012395446,0.046562232,0.0008514046,0.0010964421,0.0019130517,0.0023878315,0.0023759375,0.019870207,0.9091287,0.0002320691],"about_ca_topic_score_codex":0.005897165,"about_ca_topic_score_gemma":0.004788593,"teacher_disagreement_score":0.69029635,"about_ca_system_score_codex":0.0070939288,"about_ca_system_score_gemma":0.036094584,"threshold_uncertainty_score":0.8512583},"labels":[],"label_agreement":null},{"id":"W2951953919","doi":"10.1002/pds.4840","title":"Determination of good pharmacovigilance reporting practices in Quebec hospital pharmacies using a modified Delphi method","year":2019,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacovigilance; Delphi method; Pharmacy; Medicine; Delphi; Hospital pharmacy; Adverse drug reaction; Pharmaceutical care; Health care; Family medicine; Medical education; Adverse effect; Pharmacology; Drug; Computer science","score_opus":0.19538582324278622,"score_gpt":0.5216925064972767,"score_spread":0.3263066832544905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951953919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9328916,0.00043730016,0.030462412,0.0021435723,0.0000383838,0.024202337,0.0004999922,0.000120140736,0.00920438],"genre_scores_gemma":[0.90614486,0.00031629967,0.07113112,0.0006230197,0.000013569278,0.019965902,0.00030172494,0.00001770409,0.0014858121],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.93528,0.046662346,0.0051763416,0.002571012,0.0065271864,0.0037830425],"domain_scores_gemma":[0.9248921,0.04125959,0.0069049727,0.0021053252,0.023009872,0.0018280868],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.078996286,0.00086267974,0.00058781327,0.0053533516,0.0040686904,0.0024189374,0.0017981892,0.0010682472,0.0025576502],"category_scores_gemma":[0.071514286,0.0006602137,0.0009883854,0.0031895374,0.0025020717,0.00174091,0.0040839347,0.000997444,0.00030073014],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013491224,0.0010565666,0.21570338,0.003371563,0.00024078808,0.0017612511,0.4860036,0.0042273756,0.012451275,0.0048949188,0.0074437186,0.26149645],"study_design_scores_gemma":[0.0005601671,0.0031948057,0.45393452,0.0040472494,0.00021740957,0.001214462,0.44725972,0.032281388,0.010419847,0.004585872,0.04167699,0.0006075878],"about_ca_topic_score_codex":0.08647238,"about_ca_topic_score_gemma":0.115691595,"teacher_disagreement_score":0.98265904,"about_ca_system_score_codex":0.017340967,"about_ca_system_score_gemma":0.029245459,"threshold_uncertainty_score":0.4177773},"labels":[],"label_agreement":null},{"id":"W2953312545","doi":"10.1016/j.jval.2019.01.014","title":"Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Governo Brasil; International Network of Agencies for Health Technology Assessment; Novartis Pharmaceuticals Corporation","keywords":"Real world evidence; Latin Americans; Health care; Political science; Data science; Computer science; Medicine; Economics; Economic growth","score_opus":0.5635607403954428,"score_gpt":0.616140320756119,"score_spread":0.052579580360676226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953312545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032230152,0.9982229,0.00006775486,0.0008918163,0.00003861093,0.00000809909,0.00005507969,0.0000015078131,0.0003918973],"genre_scores_gemma":[0.0052655186,0.99344105,0.00054391153,0.0005585481,0.00007060389,0.000017362761,0.00006348605,0.000002511123,0.000036944733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936858,0.0024352893,0.0018367931,0.00046666941,0.0013478465,0.00022768174],"domain_scores_gemma":[0.9156551,0.07368795,0.0050527016,0.0007604247,0.0043439367,0.00050006725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020207984,0.0010014767,0.0034730893,0.009030204,0.00047800032,0.0051650084,0.0018136019,0.0024619915,0.0043055858],"category_scores_gemma":[0.052494332,0.000566906,0.002384128,0.014487484,0.0015007443,0.0029120345,0.0018384719,0.0028583058,0.0003295901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046110348,0.00010852407,0.003789113,0.25170484,0.003484448,0.00048989675,0.0008455003,0.0008242274,0.00022945687,0.0071955766,0.011054692,0.7198127],"study_design_scores_gemma":[0.00024493353,0.00024434025,0.014703594,0.6582397,0.010180427,0.0016402727,0.0019613518,0.00047774936,0.00039631338,0.008865526,0.30293489,0.00011090377],"about_ca_topic_score_codex":0.009960258,"about_ca_topic_score_gemma":0.022047728,"teacher_disagreement_score":0.020207984,"about_ca_system_score_codex":0.0053326506,"about_ca_system_score_gemma":0.010807468,"threshold_uncertainty_score":0.10687131},"labels":[],"label_agreement":null},{"id":"W2957790583","doi":"10.1002/pds.4808","title":"The comparative effectiveness of fourth‐line drugs in resistant hypertension: An application in electronic health record data","year":2019,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Diabetes UK; National Institute for Health and Care Research; British Heart Foundation; Wellcome Trust; National Institute on Handicapped Research; Medical Research Council; Wellcome; GlaxoSmithKline","keywords":"Medicine; Pharmacoepidemiology; Electronic health record; Health records; Health data; Family medicine; Pharmacology; Health care; Medical prescription","score_opus":0.13519253366268297,"score_gpt":0.47429010925195786,"score_spread":0.3390975755892749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957790583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7979908,0.10296323,0.06337064,0.00999336,0.001027303,0.0023947118,0.0116376225,0.00022948063,0.010392789],"genre_scores_gemma":[0.96820885,0.0038480782,0.024509057,0.0009975763,0.0004928668,0.0005760252,0.0011760455,0.000028068396,0.00016344762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.49568394,0.4540488,0.01605982,0.0071171024,0.02638316,0.0007071809],"domain_scores_gemma":[0.13946599,0.78546536,0.052149534,0.016244553,0.005886359,0.00078832894],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.28670323,0.00070203457,0.0027429224,0.005539069,0.0005805696,0.0039848923,0.0023674548,0.0022230612,0.0021007343],"category_scores_gemma":[0.5845444,0.000625181,0.005115651,0.010118914,0.0021099127,0.0042038765,0.0030329477,0.001852599,0.00016183473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012137999,0.00034878397,0.77526045,0.0061271903,0.03178749,0.00019732086,0.0011035891,0.0057912236,0.00029012922,0.0057801385,0.0014878759,0.15968782],"study_design_scores_gemma":[0.005232341,0.011612618,0.870937,0.0074195475,0.025117967,0.0017300096,0.0011877822,0.04775154,0.0023954578,0.012970958,0.013299948,0.0003448576],"about_ca_topic_score_codex":0.0025492532,"about_ca_topic_score_gemma":0.0016065493,"teacher_disagreement_score":0.28670323,"about_ca_system_score_codex":0.0020769967,"about_ca_system_score_gemma":0.0016110116,"threshold_uncertainty_score":0.8796219},"labels":[],"label_agreement":null},{"id":"W2959058664","doi":"","title":"[Drugs are responsible for a quarter of acute renal failure].","year":2016,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Pharmacology; Internal medicine; Toxicology; Biology","score_opus":0.08839209484390578,"score_gpt":0.39148347073742407,"score_spread":0.3030913758935183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959058664","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06381516,0.5697511,0.004616035,0.12395435,0.010574361,0.00031665544,0.039020862,0.001368525,0.186583],"genre_scores_gemma":[0.46371207,0.35475677,0.00553528,0.09524223,0.010294216,0.0002653641,0.023767715,0.00029202885,0.04613422],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99891603,0.00021967087,0.0002076209,0.00012169152,0.00041323007,0.00012168792],"domain_scores_gemma":[0.99686027,0.00047988162,0.0013771936,0.00011073872,0.000852143,0.00031979967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000903938,0.00027880367,0.00052704895,0.0016046851,0.00046363063,0.0007520958,0.00044097853,0.000896985,0.01816899],"category_scores_gemma":[0.006427813,0.00012466192,0.0008465891,0.003612366,0.0002494113,0.00078574155,0.0006469825,0.0013239395,0.005346346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003311802,0.000055773573,0.074172325,0.0028968249,0.00046933978,0.0018389121,0.00015111966,0.00012567197,0.0012472545,0.0031348276,0.49251616,0.4230607],"study_design_scores_gemma":[0.00014337104,0.00017815844,0.2492382,0.0041255667,0.00078132265,0.020438919,0.00046042068,0.00028598544,0.00095431827,0.0030613265,0.7202745,0.000057855526],"about_ca_topic_score_codex":0.0101720095,"about_ca_topic_score_gemma":0.011221475,"teacher_disagreement_score":0.01816899,"about_ca_system_score_codex":0.00054117944,"about_ca_system_score_gemma":0.002315667,"threshold_uncertainty_score":0.0607813},"labels":[],"label_agreement":null},{"id":"W2959633080","doi":"10.1007/s13181-019-00719-w","title":"Adverse Drug Events and Reactions Managed by Medical Toxicologists: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010–2016","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Toxicology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Emergency department; Emergency medicine; Retrospective cohort study; Intensive care unit; Drug reaction; Pediatrics; Internal medicine; Drug; Pharmacology; Psychiatry","score_opus":0.05365552942766577,"score_gpt":0.407930336274204,"score_spread":0.3542748068465382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959633080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516951,0.0047860667,0.0004191235,0.0005826959,0.00005966896,0.0001283001,0.03964704,0.000065598004,0.0026163603],"genre_scores_gemma":[0.9656664,0.0023412174,0.00043221135,0.00042171087,0.00006779114,0.00011148221,0.030169655,0.000038767233,0.0007507327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99339336,0.0009909769,0.0021355597,0.0010767813,0.0018296973,0.0005735144],"domain_scores_gemma":[0.97231996,0.0027361105,0.0196112,0.0009463237,0.0028618022,0.001524551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041448954,0.0003881732,0.00065152184,0.0040737074,0.0004946421,0.0015120339,0.000827809,0.00071613176,0.0010555821],"category_scores_gemma":[0.0138736265,0.00045323904,0.0016120924,0.007440674,0.00040701518,0.0015284496,0.0019266485,0.0011805642,0.00032725622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019476213,0.000027712116,0.9958698,0.00006877666,0.00017519124,0.00007521349,0.000083636194,0.00008843453,0.00005293979,0.00003967405,0.0013898774,0.001933915],"study_design_scores_gemma":[0.000020672931,0.00003925855,0.99770015,0.00007052817,0.000109248154,0.0002989182,0.000274059,0.00018679438,0.00007409053,0.000019989082,0.0011975163,0.000008844101],"about_ca_topic_score_codex":0.038188055,"about_ca_topic_score_gemma":0.050982334,"teacher_disagreement_score":0.038188055,"about_ca_system_score_codex":0.002013379,"about_ca_system_score_gemma":0.0040127337,"threshold_uncertainty_score":0.07593155},"labels":[],"label_agreement":null},{"id":"W2965604457","doi":"10.1371/journal.pone.0219521","title":"Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions","year":2019,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Cancer Institute; University of North Carolina at Chapel Hill; University of Texas MD Anderson Cancer Center; Università di Pisa; National Institutes of Health; Queen's University; University of Melbourne; University of Utah; Louisiana State University; Case Western Reserve University; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; Baylor University; McGill University; University of Chicago; Medical University of South Carolina; University of South Carolina; University of Illinois at Urbana-Champaign; Tulane University; Singapore General Hospital; University of Pennsylvania; University of Miami; Nara Medical University; Yale University; Université Pierre et Marie Curie; American Cancer Society","keywords":"Medicine; Drug reaction; MEDLINE; Publishing; Drug; Oncology; Intensive care medicine; Pharmacology; Chemistry","score_opus":0.14618991473585083,"score_gpt":0.41144265679026343,"score_spread":0.2652527420544126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965604457","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039208446,0.0070441104,0.018481568,0.82214326,0.056909088,0.0025993076,0.013795435,0.0016905816,0.038128216],"genre_scores_gemma":[0.28123686,0.004595533,0.048818048,0.6056529,0.014428287,0.018574283,0.0027994676,0.0011019233,0.02279269],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.8766465,0.06823944,0.023797255,0.00643396,0.01887279,0.0060100495],"domain_scores_gemma":[0.3053899,0.6014242,0.031488203,0.018587667,0.03991168,0.003198303],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.072756924,0.0016267877,0.0015494004,0.0057682097,0.008044188,0.0071164807,0.009463316,0.013005577,0.054271147],"category_scores_gemma":[0.502712,0.0013807504,0.0022149917,0.0054429937,0.010433259,0.015294077,0.009176007,0.009192591,0.0076069674],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040611904,0.000082479804,0.018573673,0.011117421,0.00019642916,0.0021541952,0.06569192,0.00032028143,0.0005172998,0.016056873,0.8332626,0.05162063],"study_design_scores_gemma":[0.00024067001,0.00015294575,0.017443463,0.024827367,0.00027439283,0.008438079,0.104129314,0.0020719261,0.0012383724,0.02657218,0.8141519,0.00045932614],"about_ca_topic_score_codex":0.023715843,"about_ca_topic_score_gemma":0.052892733,"teacher_disagreement_score":0.98699445,"about_ca_system_score_codex":0.007820017,"about_ca_system_score_gemma":0.01737813,"threshold_uncertainty_score":0.38478},"labels":[],"label_agreement":null},{"id":"W2970132222","doi":"10.1111/bcp.14104","title":"Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta‐analysis","year":2019,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"","keywords":"Confidence interval; Medicine; Relative risk; Meta-analysis; Interrupted Time Series Analysis; Family medicine; Internal medicine; Statistics","score_opus":0.342949846412742,"score_gpt":0.5975179890362511,"score_spread":0.2545681426235091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970132222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006728893,0.9909642,0.0007042212,0.00022673787,0.00016977057,0.00035792153,0.0005947843,0.000027714972,0.00022575594],"genre_scores_gemma":[0.27053392,0.72113115,0.0032226134,0.0009951395,0.00035249998,0.0021930777,0.0011384321,0.00005103383,0.0003820592],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9686262,0.01592397,0.00906817,0.0024676207,0.0033728103,0.000541154],"domain_scores_gemma":[0.9186488,0.0610175,0.013966347,0.0019379687,0.0040229466,0.00040650708],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.029161265,0.0025032237,0.01709961,0.0070845042,0.00054901274,0.0036892775,0.0017778117,0.0020874457,0.002391499],"category_scores_gemma":[0.09204119,0.0015439544,0.039646294,0.008473053,0.00087587535,0.0023013263,0.00173925,0.0021421053,0.00024641745],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024093986,0.000034930144,0.005515902,0.33998924,0.6365104,0.000101686695,0.000097752905,0.0006649087,0.00014830091,0.000111106485,0.00055222836,0.01386424],"study_design_scores_gemma":[0.0006926773,0.00039388353,0.007109783,0.032178894,0.95718145,0.00012167249,0.000062187035,0.00030898777,0.00018406793,0.00017687921,0.0015570325,0.000032428758],"about_ca_topic_score_codex":0.007792583,"about_ca_topic_score_gemma":0.013546091,"teacher_disagreement_score":0.9829004,"about_ca_system_score_codex":0.0037311546,"about_ca_system_score_gemma":0.0049145687,"threshold_uncertainty_score":0.1542213},"labels":[],"label_agreement":null},{"id":"W2971965618","doi":"10.23977/acss.2019.31005","title":"Application of Modern Computer Technology in Adverse Drug Reactions","year":2019,"lang":"en","type":"article","venue":"Advances in Computer Signals and Systems","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Adverse drug reaction; Field (mathematics); Drug reaction; Data mining; Medical record; Computer science; Data science; Drug; Medicine; Pharmacology; Internal medicine","score_opus":0.03437384594873865,"score_gpt":0.38255489733497644,"score_spread":0.3481810513862378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971965618","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03304704,0.7527613,0.121197276,0.015215231,0.0032665462,0.00042943365,0.0009871122,0.00089760404,0.07219844],"genre_scores_gemma":[0.29074493,0.575869,0.10741728,0.0057777036,0.004946678,0.0003632422,0.0010569798,0.00007669685,0.013747523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828476,0.0005225312,0.00022570722,0.00022404945,0.0006728503,0.000069986876],"domain_scores_gemma":[0.9971644,0.0015356349,0.00033405007,0.00020221029,0.00069122354,0.00007239423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017435389,0.0005765271,0.0005669481,0.0045482614,0.00031828496,0.0017143837,0.00071766,0.0009479278,0.003861461],"category_scores_gemma":[0.004468919,0.00019172594,0.0007869164,0.0033882936,0.00063918956,0.0016882401,0.000801569,0.0011524826,0.0011639617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013644609,0.00014062574,0.01867561,0.004272656,0.00019409646,0.0010115082,0.00041741357,0.0028203551,0.005537824,0.029740382,0.01755474,0.9194983],"study_design_scores_gemma":[0.00012197251,0.0009180156,0.05860307,0.0043640663,0.0006232818,0.012316982,0.0010308636,0.02178321,0.017974269,0.102490805,0.779538,0.0002354308],"about_ca_topic_score_codex":0.0016477894,"about_ca_topic_score_gemma":0.0012146992,"teacher_disagreement_score":0.0045482614,"about_ca_system_score_codex":0.0009107873,"about_ca_system_score_gemma":0.001235189,"threshold_uncertainty_score":0.012917876},"labels":[],"label_agreement":null},{"id":"W2975162082","doi":"10.1007/s40264-019-00861-y","title":"Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Context (archaeology); Credibility; Adverse effect; Odds; Odds ratio; MedDRA; Database; Geography; Pharmacology; Logistic regression; Pathology","score_opus":0.10533322493989772,"score_gpt":0.44578388009204156,"score_spread":0.34045065515214384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975162082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95672303,0.00071179663,0.006516585,0.0003358101,0.000030283265,0.0005848235,0.03398202,0.000311892,0.0008036911],"genre_scores_gemma":[0.9251846,0.00021316521,0.016684344,0.00013868466,0.000025495983,0.0009919511,0.056449067,0.00007717506,0.00023563174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98364073,0.007258235,0.0033722252,0.0029661153,0.0023143913,0.00044832964],"domain_scores_gemma":[0.92813486,0.038841326,0.016937485,0.008253848,0.0068745245,0.0009579782],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023691664,0.00043990795,0.0007466467,0.0034833597,0.00040204483,0.0014630549,0.0008131488,0.0004259451,0.0014378902],"category_scores_gemma":[0.080786854,0.00033698222,0.00175794,0.0035489276,0.0005103433,0.0010586991,0.0019073281,0.00079192605,0.0004140141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025212232,0.00012477198,0.9584153,0.0007181485,0.001159197,0.0002366291,0.0010663895,0.0036132715,0.0010629793,0.00037910137,0.004465296,0.026237596],"study_design_scores_gemma":[0.00031155045,0.0005817099,0.95029676,0.00029273375,0.0014051996,0.00093435595,0.001360171,0.03212469,0.002868025,0.00084985927,0.008861548,0.00011344323],"about_ca_topic_score_codex":0.008653254,"about_ca_topic_score_gemma":0.0071638026,"teacher_disagreement_score":0.97630835,"about_ca_system_score_codex":0.0010625933,"about_ca_system_score_gemma":0.0019701715,"threshold_uncertainty_score":0.12529504},"labels":[],"label_agreement":null},{"id":"W2979436120","doi":"10.1016/j.arcped.2019.09.004","title":"Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding","year":2019,"lang":"en","type":"article","venue":"Archives de Pédiatrie","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacovigilance; Identification (biology); Coding (social sciences); Medicine; Intervention (counseling); Drug reaction; Drug; Medical emergency; Medical record; Pharmacology; Psychiatry; Internal medicine","score_opus":0.038840450305914716,"score_gpt":0.4135762122270715,"score_spread":0.3747357619211568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979436120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76154333,0.0016119302,0.16950664,0.019596696,0.0014128438,0.018165274,0.0033194027,0.0036881426,0.021155672],"genre_scores_gemma":[0.75896585,0.0008421492,0.22827046,0.0027374981,0.00034589594,0.004055595,0.0019001523,0.00024540682,0.0026369633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.89431554,0.05005446,0.035079833,0.0055338144,0.0132631995,0.001753201],"domain_scores_gemma":[0.6279113,0.1767099,0.110229395,0.029770851,0.05116038,0.0042181644],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08075437,0.00070886436,0.0008403631,0.007140578,0.0020749082,0.0026881578,0.003043924,0.0014258254,0.0022549778],"category_scores_gemma":[0.21791495,0.0009012668,0.0007658358,0.0039322684,0.0008756855,0.0038986374,0.004085822,0.0028409678,0.0007217829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012819807,0.0016623781,0.6448483,0.001166441,0.00017502463,0.0013298021,0.01826242,0.0018184071,0.0062981993,0.0022596032,0.014089179,0.30680835],"study_design_scores_gemma":[0.0004090742,0.0016597125,0.8602946,0.0032400747,0.00039017422,0.0037178118,0.03072598,0.03591875,0.026814256,0.00328323,0.033138882,0.00040745566],"about_ca_topic_score_codex":0.01339227,"about_ca_topic_score_gemma":0.015842052,"teacher_disagreement_score":0.9192456,"about_ca_system_score_codex":0.0038354483,"about_ca_system_score_gemma":0.01410515,"threshold_uncertainty_score":0.42707503},"labels":[],"label_agreement":null},{"id":"W2980362927","doi":"10.1002/mds.27876","title":"Parkinsonism Associated with Gabapentinoid Drugs: A Pharmacoepidemiologic Study","year":2019,"lang":"en","type":"article","venue":"Movement Disorders","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Pregabalin; Duloxetine; Gabapentin; Parkinsonism; Medicine; Odds ratio; Psychiatry; Internal medicine; Anesthesia; Disease","score_opus":0.06237457195919372,"score_gpt":0.4064980297687937,"score_spread":0.34412345780959996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980362927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968438,0.0020752854,0.00012753397,0.00006349941,0.00000496732,0.00004876475,0.00032171138,0.0000027109036,0.0005117967],"genre_scores_gemma":[0.9989629,0.00060743064,0.000081928134,0.000051430725,0.000018324974,0.000013704314,0.00020538691,9.896056e-7,0.00005788901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984133,0.00058658514,0.00030112715,0.00026184693,0.00029962094,0.00013748267],"domain_scores_gemma":[0.994457,0.0018363349,0.0026872787,0.00029980604,0.00040365732,0.00031597144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015194186,0.00024785407,0.000420947,0.0020816312,0.00053655275,0.00082130096,0.00023458943,0.0004558012,0.0026452257],"category_scores_gemma":[0.005236002,0.00030285356,0.0009011316,0.0023977605,0.00042133988,0.0005022797,0.00063391397,0.0004911946,0.000297046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026690232,0.00007029207,0.9968478,0.000070059374,0.0002185166,0.00046446934,0.00006253051,0.000017825476,0.000120002325,0.000019283772,0.0000546576,0.0017875673],"study_design_scores_gemma":[0.00004853118,0.0004053544,0.995239,0.000047094454,0.0003586646,0.0030051447,0.00023394839,0.00015181022,0.000077936296,0.000040327606,0.00038425773,0.00000792543],"about_ca_topic_score_codex":0.0030134863,"about_ca_topic_score_gemma":0.0032379155,"teacher_disagreement_score":0.0030134863,"about_ca_system_score_codex":0.00063579844,"about_ca_system_score_gemma":0.0006033772,"threshold_uncertainty_score":0.008849144},"labels":[],"label_agreement":null},{"id":"W2981242837","doi":"10.1111/jgs.16190","title":"Screening for Adverse Drug Reactions in Dementia Patients on Cholinesterase Inhibitor Therapy","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Geriatrics Society","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivastigmine; Dementia; Donepezil; Medicine; Galantamine; Pharmacovigilance; Adverse effect; Intensive care medicine; Population; Psychiatry; Disease; Pediatrics; Internal medicine","score_opus":0.0793936417525911,"score_gpt":0.40302402941716053,"score_spread":0.3236303876645694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981242837","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9407294,0.02728078,0.0012311542,0.003297416,0.00023657778,0.00082320505,0.0029204434,0.000118209,0.023362929],"genre_scores_gemma":[0.98832613,0.0056934827,0.0016064827,0.0019947207,0.00023894885,0.00013067793,0.0011207111,0.000009516514,0.0008793028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997171,0.00088951143,0.00070871314,0.00020498624,0.000786642,0.00023910575],"domain_scores_gemma":[0.9943944,0.0010981761,0.0025546572,0.00012959677,0.001296082,0.00052703876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021745937,0.00035019146,0.0008894073,0.0018182894,0.00075567485,0.00095977116,0.00046050578,0.0007225282,0.0025507668],"category_scores_gemma":[0.009380166,0.0002411967,0.0008338538,0.0016134537,0.0002431348,0.00075873215,0.0005640956,0.0012440373,0.00058679224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032762944,0.00020090034,0.96801066,0.00028727247,0.00008628774,0.0015609739,0.00033029812,0.00006349124,0.00020263829,0.00006124906,0.0028859973,0.02598253],"study_design_scores_gemma":[0.00007064072,0.0007379115,0.9838869,0.0006423765,0.00016409117,0.008578643,0.00067732687,0.00050603884,0.00033736238,0.00021959878,0.004145481,0.000033637756],"about_ca_topic_score_codex":0.009192295,"about_ca_topic_score_gemma":0.009833722,"teacher_disagreement_score":0.009192295,"about_ca_system_score_codex":0.00091114757,"about_ca_system_score_gemma":0.0011894505,"threshold_uncertainty_score":0.018277586},"labels":[],"label_agreement":null},{"id":"W2981369305","doi":"10.1016/j.eclinm.2019.10.001","title":"Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century","year":2019,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Hartstichting; ZonMw","keywords":"Medicine; Demography; Drug reaction; Adverse effect; Pharmacoepidemiology; Adverse drug reaction; Family medicine; Drug; Pediatrics; Internal medicine; Psychiatry; Medical prescription; Pharmacology","score_opus":0.08332716608921137,"score_gpt":0.4249432748494502,"score_spread":0.34161610876023885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981369305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86866826,0.08568861,0.0021667343,0.00090994884,0.00020567422,0.0004985775,0.035646167,0.00007779104,0.0061382256],"genre_scores_gemma":[0.9740414,0.013212189,0.00087679346,0.00046673208,0.00017714917,0.00024375368,0.010735518,0.000030856976,0.00021563563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97238153,0.008882608,0.0077816327,0.004839704,0.005397013,0.00071761466],"domain_scores_gemma":[0.8756224,0.032782674,0.07258209,0.0071326015,0.010432798,0.0014475109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016525285,0.0005843989,0.0012644611,0.009742823,0.00046407455,0.0021334956,0.0008750082,0.00072432274,0.0018622173],"category_scores_gemma":[0.05935289,0.00048545742,0.0019548342,0.011155407,0.0010963383,0.0019061547,0.0025294528,0.0006855998,0.00043318636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017735214,0.0000132515115,0.98658085,0.0010292409,0.001267938,0.00009429185,0.0008240616,0.000053838972,0.00004927644,0.000050065224,0.00081036775,0.00904945],"study_design_scores_gemma":[0.000011907495,0.000086913824,0.99352103,0.00092175906,0.0007783301,0.00063645147,0.0011187956,0.000083483275,0.00007526478,0.000082837076,0.0026640065,0.000019254],"about_ca_topic_score_codex":0.005741875,"about_ca_topic_score_gemma":0.006217169,"teacher_disagreement_score":0.016525285,"about_ca_system_score_codex":0.00084885897,"about_ca_system_score_gemma":0.000901692,"threshold_uncertainty_score":0.08739507},"labels":[],"label_agreement":null},{"id":"W2981901589","doi":"10.1111/bcp.14139","title":"Preventable adverse drug events: Descriptive epidemiology","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Adverse effect; Pharmacovigilance; Observational study; Emergency medicine; Emergency department; Epidemiology; Drug; Logistic regression; Intensive care medicine; Retrospective cohort study; Internal medicine; Pharmacology; Psychiatry","score_opus":0.2196845947986859,"score_gpt":0.53379924834461,"score_spread":0.3141146535459241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981901589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492771,0.019509055,0.009667602,0.0007090275,0.000060808437,0.0007122552,0.016235732,0.00012738067,0.003701021],"genre_scores_gemma":[0.98534006,0.0045093563,0.0033591564,0.0001396897,0.000086982975,0.00033007096,0.006000455,0.00001452556,0.00021967493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946802,0.001705193,0.0015434045,0.00097436225,0.0008742777,0.00022258273],"domain_scores_gemma":[0.97132295,0.0074473834,0.01765207,0.0010500585,0.002016146,0.0005113864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043817502,0.000295877,0.0005773671,0.006203029,0.00032989,0.0011546292,0.00057890423,0.0005460539,0.0016302569],"category_scores_gemma":[0.015259028,0.00036082286,0.00075786543,0.006897574,0.0005111115,0.0011023396,0.00091251585,0.0004519088,0.00027881723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033837718,0.000023174516,0.9957533,0.00017041348,0.00007932017,0.00005663186,0.000057064437,0.000093946706,0.0000397387,0.00012860233,0.00018252592,0.0033814108],"study_design_scores_gemma":[0.000014050351,0.00014185089,0.99396616,0.00019887122,0.00008081402,0.0020762065,0.00056306046,0.0007078499,0.00009196049,0.0003479003,0.0017944181,0.000016834842],"about_ca_topic_score_codex":0.0040828623,"about_ca_topic_score_gemma":0.003306842,"teacher_disagreement_score":0.006203029,"about_ca_system_score_codex":0.00072082394,"about_ca_system_score_gemma":0.0011251116,"threshold_uncertainty_score":0.023173153},"labels":[],"label_agreement":null},{"id":"W2988331059","doi":"10.7554/elife.25818.018","title":"Author response: Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets","year":2017,"lang":"en","type":"peer-review","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Pharmacovigilance; Adverse effect; Medicine; Clinical trial; Thalidomide; Pharmacology; Computer science; Internal medicine","score_opus":0.28920038153635635,"score_gpt":0.5516558905495709,"score_spread":0.2624555090132145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988331059","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001024324,0.0026932717,0.015187569,0.79561096,0.113167115,0.00047935668,0.017811565,0.005088596,0.048937205],"genre_scores_gemma":[0.016391171,0.0056149615,0.034002498,0.72828025,0.040378492,0.0011280264,0.01244046,0.004472471,0.1572917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9814631,0.005959576,0.0023285311,0.0019529045,0.0071108704,0.001185041],"domain_scores_gemma":[0.89198965,0.04376379,0.009310442,0.012457786,0.03738646,0.005091849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023185961,0.0013380871,0.0016507737,0.002047019,0.0021485218,0.006127132,0.003176724,0.011735041,0.21888678],"category_scores_gemma":[0.16258392,0.0011597709,0.0023062758,0.0018234937,0.0028104137,0.0045164316,0.0050029135,0.0114683,0.12391105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009380241,0.000009536845,0.00030014623,0.00013022729,0.000014954934,0.00010443269,0.000055733035,0.00006212911,0.00014791626,0.0014760927,0.98252743,0.0150775425],"study_design_scores_gemma":[0.00009313342,0.000030821702,0.00046176818,0.0003429556,0.00002133044,0.00021767883,0.00017740388,0.00017916858,0.0007033258,0.0047362708,0.9929957,0.000040385137],"about_ca_topic_score_codex":0.0043799407,"about_ca_topic_score_gemma":0.008906083,"teacher_disagreement_score":0.21888678,"about_ca_system_score_codex":0.0036755637,"about_ca_system_score_gemma":0.0088776415,"threshold_uncertainty_score":0.73224926},"labels":[],"label_agreement":null},{"id":"W2992414637","doi":"","title":"EVALUATION OF SIGNAL DETECTION FOR PLATINUM COMPOUNDS IN CANADIAN SPONTANEOUS ADVERSE EVENT REPORTS","year":2015,"lang":"en","type":"article","venue":"International Journal of Pharmacy and Pharmaceutical Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Confidence interval; Statistics; Odds ratio; Detection limit; Medicine; Mathematics; Internal medicine","score_opus":0.23728382646305016,"score_gpt":0.5181508879851084,"score_spread":0.2808670615220583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992414637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92489624,0.010261096,0.01749078,0.0011195197,0.00020923493,0.003314016,0.03001593,0.00045598016,0.012237263],"genre_scores_gemma":[0.9769116,0.0021262718,0.011546855,0.00017202867,0.000054855296,0.0007918807,0.0076422854,0.000020946132,0.0007332467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.958991,0.008516618,0.0095579075,0.0023875404,0.019788168,0.0007587034],"domain_scores_gemma":[0.89542323,0.026315125,0.03826154,0.0026734676,0.036137883,0.0011888177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024423897,0.0005182296,0.00067836954,0.005916838,0.00056223146,0.0014393101,0.0012766327,0.000439814,0.0015585315],"category_scores_gemma":[0.09051228,0.00020326993,0.0014634165,0.0042128908,0.00051652035,0.00068333856,0.001155099,0.00050627027,0.00022596311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013462923,0.00008822665,0.9098076,0.0024978498,0.0005573153,0.00030766547,0.0007860391,0.00095635914,0.0012025137,0.00037134782,0.0027825243,0.07929642],"study_design_scores_gemma":[0.00010583704,0.0007826595,0.9783372,0.00051305944,0.0007007724,0.0008517471,0.00077440264,0.006332826,0.003964108,0.0002314197,0.0073307054,0.000075187745],"about_ca_topic_score_codex":0.091222495,"about_ca_topic_score_gemma":0.09158016,"teacher_disagreement_score":0.9087775,"about_ca_system_score_codex":0.004209967,"about_ca_system_score_gemma":0.007198438,"threshold_uncertainty_score":0.18138301},"labels":[],"label_agreement":null},{"id":"W2994726901","doi":"10.1016/j.cjca.2019.11.035","title":"Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Roche; Novartis; Merck Sharp and Dohme; Bristol-Myers Squibb","keywords":"Medicine; Pharmacovigilance; Adverse effect; Acute coronary syndrome; Event (particle physics); Intensive care medicine; Internal medicine; Myocardial infarction","score_opus":0.03395011915084729,"score_gpt":0.3392945134256134,"score_spread":0.3053443942747661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994726901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.880286,0.014301824,0.02676456,0.039500013,0.0009797683,0.003359224,0.0016753261,0.0003424554,0.032790754],"genre_scores_gemma":[0.9749315,0.0032378114,0.009217678,0.008882363,0.0012616122,0.00023913613,0.00058668177,0.000050369283,0.0015927645],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99673754,0.00098366,0.00042156785,0.00047323556,0.0009852241,0.0003987434],"domain_scores_gemma":[0.9909038,0.0049404907,0.0017026773,0.0004726852,0.0008142533,0.001166106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002813754,0.0009133488,0.00091799017,0.0009000083,0.0013221861,0.0034244854,0.0011343759,0.004617795,0.0035482799],"category_scores_gemma":[0.012913044,0.0004973443,0.0018739206,0.00032285514,0.0011805154,0.0013517373,0.0014059392,0.0034944739,0.0008832066],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037035258,0.0028300832,0.15376318,0.0013320097,0.00050280854,0.73238546,0.0023797443,0.0013364797,0.013444388,0.009629388,0.014262383,0.06443062],"study_design_scores_gemma":[0.0012408233,0.006729613,0.038113065,0.001018407,0.0008822231,0.88913035,0.0016872702,0.0060397577,0.010567795,0.0055973725,0.038844623,0.00014865483],"about_ca_topic_score_codex":0.0009817829,"about_ca_topic_score_gemma":0.0012138428,"teacher_disagreement_score":0.004617795,"about_ca_system_score_codex":0.0018694184,"about_ca_system_score_gemma":0.002349765,"threshold_uncertainty_score":0.014880717},"labels":[],"label_agreement":null},{"id":"W2995092269","doi":"10.2196/14379","title":"Expedited Safety Reporting to Sponsors Through the Implementation of an Alert System for Clinical Trial Management at an Academic Medical Center: Retrospective Design Study","year":2019,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Korea Health Industry Development Institute","keywords":"Medicine; Timeline; Clinical trial; Adverse effect; Patient safety; Emergency department; Medical emergency; Emergency medicine; Health care; Internal medicine; Nursing","score_opus":0.24788131467223273,"score_gpt":0.5794674934008301,"score_spread":0.3315861787285974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995092269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739376,0.0028902804,0.010226297,0.00021453829,0.000103379985,0.008555815,0.0022509592,0.000103580816,0.0017176481],"genre_scores_gemma":[0.9804874,0.00065572385,0.008608168,0.0004090174,0.00013431523,0.008149269,0.0011701877,0.00003649491,0.000349504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.89806366,0.053387243,0.026306393,0.008033751,0.011576116,0.0026328566],"domain_scores_gemma":[0.7232415,0.07427062,0.14032343,0.02859061,0.028166862,0.0054069646],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.062744275,0.000868842,0.0012937991,0.0050403783,0.0012189244,0.0022048624,0.001350646,0.0011814884,0.0029595683],"category_scores_gemma":[0.1276207,0.0012247569,0.0025059066,0.005380085,0.0013911036,0.0020895696,0.0021072458,0.0015058654,0.0008251321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010456545,0.0014129576,0.953346,0.00108093,0.0010908083,0.000114891205,0.0015123807,0.00041388322,0.0004414074,0.00030922535,0.0013202961,0.028500605],"study_design_scores_gemma":[0.003227936,0.03169553,0.94435084,0.0009679196,0.0025154673,0.00062787,0.00216503,0.002968257,0.0021799833,0.00035810604,0.008765274,0.00017785068],"about_ca_topic_score_codex":0.0022598323,"about_ca_topic_score_gemma":0.0020794363,"teacher_disagreement_score":0.93725574,"about_ca_system_score_codex":0.0024844182,"about_ca_system_score_gemma":0.00694867,"threshold_uncertainty_score":0.3318274},"labels":[],"label_agreement":null},{"id":"W2998223723","doi":"10.2533/chimia.2019.1012","title":"Pharmacoepidemiology and Big Data Analytics: Challenges and Opportunities when Moving towards Precision Medicine","year":2019,"lang":"en","type":"article","venue":"CHIMIA International Journal for Chemistry","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Eidgenössische Technische Hochschule Zürich; Universiteit Maastricht","keywords":"Pharmacoepidemiology; Observational study; Data science; Analytics; Variety (cybernetics); Health records; Drug reaction; Health care; Big data; Precision medicine; Computer science; Patient safety; Health professionals; Medicine; Data mining; Drug; Artificial intelligence; Pharmacology; Internal medicine","score_opus":0.4964147528714341,"score_gpt":0.4975781032053113,"score_spread":0.001163350333877211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998223723","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00830565,0.28048652,0.0688239,0.6276907,0.004591753,0.00021417078,0.001741198,0.00069646054,0.007449682],"genre_scores_gemma":[0.1745862,0.43516716,0.28864852,0.065390274,0.029131915,0.00079139887,0.0027664872,0.0004411802,0.0030767932],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98307425,0.008706606,0.0010820042,0.0015367405,0.0049382853,0.00066206144],"domain_scores_gemma":[0.82220626,0.15230605,0.0034058325,0.0047887014,0.011565561,0.005727582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045081932,0.0014487575,0.0036513328,0.004942582,0.0017949799,0.015936388,0.0040299622,0.0072725313,0.003723208],"category_scores_gemma":[0.065885685,0.0010755751,0.0017753342,0.0075747706,0.0069144783,0.025639366,0.007709716,0.013452496,0.0019066427],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054243737,0.0003411531,0.020768996,0.0083520925,0.00075355737,0.00061200303,0.0016241237,0.013509509,0.0014680055,0.16945675,0.15355049,0.629021],"study_design_scores_gemma":[0.000112811744,0.00026312997,0.008329601,0.0050964733,0.0001803662,0.0008370503,0.0056881784,0.03982657,0.0007223687,0.67853194,0.2601289,0.00028271432],"about_ca_topic_score_codex":0.003614706,"about_ca_topic_score_gemma":0.004016963,"teacher_disagreement_score":0.045081932,"about_ca_system_score_codex":0.002718991,"about_ca_system_score_gemma":0.0069956286,"threshold_uncertainty_score":0.23841888},"labels":[],"label_agreement":null},{"id":"W2998304825","doi":"10.15586/jptcp.v26i2.607","title":"Preparing for Vanessa’s Law: Collaboration between the Medical Records and Pharmacy Departments at a Canadian Hospital Center","year":2019,"lang":"en","type":"article","venue":"Journal of Population Therapeutics and Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacy; Medical record; Coding (social sciences); Medicine; Clinical pharmacy; Context (archaeology); Medical classification; Diagnosis code; Information center; Medical diagnosis; Medical emergency; Family medicine; Nursing; Internal medicine; Psychology","score_opus":0.10448298796033545,"score_gpt":0.5025750682912555,"score_spread":0.3980920803309201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998304825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8781591,0.0062288884,0.0072954562,0.07834122,0.0005908443,0.0018224643,0.0012273646,0.00029323064,0.026041508],"genre_scores_gemma":[0.96924603,0.0023518153,0.014317164,0.00887587,0.00017649503,0.00029600965,0.00057170185,0.0000805909,0.0040843515],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.94888616,0.019059004,0.0041722464,0.0045817923,0.015148139,0.008152631],"domain_scores_gemma":[0.895271,0.024158671,0.022162108,0.004468449,0.030142821,0.02379691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03085473,0.00043188132,0.00048891036,0.004952949,0.0140002435,0.0061173225,0.0036260912,0.0011481232,0.002417012],"category_scores_gemma":[0.07060245,0.0009585731,0.0005035004,0.006448539,0.0044069947,0.002723226,0.007028791,0.0029774946,0.00028229688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024136926,0.00052861107,0.6434977,0.00054022117,0.00014686267,0.005540027,0.10798104,0.00067037065,0.0014017296,0.0034064127,0.04279415,0.19325149],"study_design_scores_gemma":[0.000071248185,0.00049907813,0.6092154,0.001975136,0.00012675769,0.0030689116,0.2383785,0.0026883043,0.0015434799,0.0013741198,0.14066117,0.0003979119],"about_ca_topic_score_codex":0.9269651,"about_ca_topic_score_gemma":0.9598682,"teacher_disagreement_score":0.112564035,"about_ca_system_score_codex":0.112564035,"about_ca_system_score_gemma":0.27854535,"threshold_uncertainty_score":0.81671304},"labels":[],"label_agreement":null},{"id":"W3006136946","doi":"","title":"Quality of electronic records documenting adverse drug reactions within a hospital setting: identification of discrepancies and information completeness.","year":2019,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Documentation; Drug allergy; Medical record; Electronic data; Medical emergency; Allergy; Drug reaction; Patient safety; Electronic medical record; Pediatrics; Drug; Health care; Database; Internal medicine; Pharmacology","score_opus":0.041905411107002334,"score_gpt":0.36137164523298476,"score_spread":0.3194662341259824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006136946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97449046,0.0103024505,0.007859521,0.0013892142,0.00012104293,0.00031146148,0.002769043,0.00014553884,0.0026112397],"genre_scores_gemma":[0.99177307,0.0011703545,0.004877708,0.00026593235,0.00007995885,0.000091205686,0.0015027836,0.000017278795,0.00022183463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8957878,0.043560717,0.029341577,0.0048597623,0.02538759,0.0010626167],"domain_scores_gemma":[0.53626835,0.22775552,0.17017685,0.02261311,0.041414358,0.0017718191],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06174779,0.00033366727,0.00093308627,0.005836999,0.0006662157,0.0032283468,0.0011733756,0.0009319112,0.0006307572],"category_scores_gemma":[0.22401717,0.000457969,0.0007428341,0.0070687467,0.0010194631,0.002619315,0.0025078335,0.00073964096,0.0002610315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043244942,0.00007213418,0.94442815,0.0009556653,0.00030529074,0.00014417901,0.0023939214,0.0004378609,0.0006912232,0.00012009511,0.0006350045,0.049384132],"study_design_scores_gemma":[0.000029011979,0.00064340886,0.98733497,0.0009793603,0.00021734348,0.0012439793,0.0022411665,0.0014374249,0.0017892806,0.00030254538,0.003727735,0.00005377607],"about_ca_topic_score_codex":0.0028893296,"about_ca_topic_score_gemma":0.0020955738,"teacher_disagreement_score":0.9382522,"about_ca_system_score_codex":0.001695604,"about_ca_system_score_gemma":0.0017687734,"threshold_uncertainty_score":0.3265574},"labels":[],"label_agreement":null},{"id":"W3006709925","doi":"10.5489/cuaj.6498","title":"Dangerous fluoroquinolones: The urologist’s dilemma","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Dilemma; Medicine; Philosophy; Epistemology","score_opus":0.11452466258839597,"score_gpt":0.3636481374290896,"score_spread":0.2491234748406936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006709925","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009844468,0.024437308,0.0009495885,0.96474993,0.0048122574,0.0000073423303,0.00004407916,0.000051697425,0.0039633033],"genre_scores_gemma":[0.049805153,0.051912613,0.005591041,0.81731844,0.07275765,0.000033242308,0.00009746187,0.00015608488,0.0023283819],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98204744,0.006450218,0.0027339854,0.002016844,0.005693533,0.0010578634],"domain_scores_gemma":[0.8627567,0.075886786,0.009344762,0.0034800554,0.028725818,0.019805891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02234505,0.0008312402,0.0025480834,0.0043982333,0.0055620833,0.007839371,0.004231714,0.036118157,0.010401656],"category_scores_gemma":[0.096817166,0.0012577226,0.0018001521,0.0019053221,0.009532155,0.014171899,0.0054546837,0.039858386,0.004421404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017124663,0.00015770458,0.009640091,0.0008747686,0.00022286727,0.020080803,0.0019412236,0.0004984735,0.00043641453,0.019740462,0.78885216,0.15738378],"study_design_scores_gemma":[0.00023382132,0.00033479516,0.006524501,0.0074317656,0.00022806205,0.083280385,0.009072487,0.001337339,0.00049616717,0.0988065,0.7918525,0.00040171525],"about_ca_topic_score_codex":0.011309018,"about_ca_topic_score_gemma":0.021726554,"teacher_disagreement_score":0.036118157,"about_ca_system_score_codex":0.0067282617,"about_ca_system_score_gemma":0.017614512,"threshold_uncertainty_score":0.11817336},"labels":[],"label_agreement":null},{"id":"W3008985683","doi":"10.1111/bcp.14255","title":"Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab","year":2020,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research","keywords":"Denosumab; Citalopram; Drug; Medicine; Pharmacology; Business; Internal medicine; Antidepressant; Osteoporosis","score_opus":0.17003330387653368,"score_gpt":0.48195990258326343,"score_spread":0.3119265987067298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008985683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97899866,0.0034151217,0.00034048906,0.0070121805,0.00008251985,0.00010793269,0.00014162691,0.00001467065,0.009886874],"genre_scores_gemma":[0.9921336,0.004019438,0.0004923253,0.0016303675,0.00021432147,0.00004727693,0.00007931975,0.00002173931,0.0013616645],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9890232,0.006574217,0.00084284984,0.00045678543,0.0021450385,0.00095783],"domain_scores_gemma":[0.92035896,0.0543619,0.018895462,0.0014564401,0.003039737,0.0018874758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076029906,0.0005005465,0.00045398192,0.0048444993,0.005575786,0.0043506464,0.0010640367,0.0031168421,0.0044692243],"category_scores_gemma":[0.05154404,0.0007953228,0.0006588538,0.0048444257,0.0035953529,0.004008888,0.0030498088,0.0032096226,0.0004453523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059265,0.00075814896,0.24801347,0.0019422165,0.00021681821,0.13899405,0.5301895,0.00018684234,0.0015270665,0.0052980506,0.010843533,0.06143766],"study_design_scores_gemma":[0.000091612186,0.0004992203,0.17206515,0.00347925,0.0003886408,0.15883186,0.6037598,0.0012946912,0.0017564313,0.0010916111,0.05654912,0.0001925222],"about_ca_topic_score_codex":0.030189142,"about_ca_topic_score_gemma":0.03269654,"teacher_disagreement_score":0.030189142,"about_ca_system_score_codex":0.0046886583,"about_ca_system_score_gemma":0.0028936851,"threshold_uncertainty_score":0.060026884},"labels":[],"label_agreement":null},{"id":"W3009217446","doi":"10.1111/jgs.16382","title":"Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies","year":2020,"lang":"en","type":"review","venue":"Journal of the American Geriatrics Society","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Institut Universitaire de Gériatrie de Montréal; University of Toronto; University Health Network; McGill University","funders":"Fonds de Recherche du Québec - Santé; McGill University Health Centre","keywords":"Deprescribing; Medicine; Adjudication; Polypharmacy; MEDLINE; Intensive care medicine","score_opus":0.14743083311786584,"score_gpt":0.5410370656728456,"score_spread":0.39360623255497973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009217446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060235185,0.9948907,0.0014807209,0.0004100033,0.00026330078,0.001562375,0.00028297797,0.000017520111,0.0004900419],"genre_scores_gemma":[0.012907648,0.96916384,0.010469783,0.00077100896,0.00023379407,0.0057857637,0.00042030372,0.000027405531,0.00022039568],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7924741,0.099287264,0.08135828,0.0048426497,0.02114528,0.0008924374],"domain_scores_gemma":[0.5271985,0.3850431,0.05921536,0.0050091655,0.022682002,0.0008519866],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11520854,0.002500663,0.009096618,0.027857956,0.0014087886,0.005444217,0.0038733813,0.0030516956,0.0049074497],"category_scores_gemma":[0.32292312,0.0018652215,0.010258295,0.025851421,0.0025050296,0.0052830703,0.0038694846,0.002201289,0.0008013169],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002686569,0.000023275465,0.000828888,0.85270905,0.0029137705,0.00006870199,0.00059335405,0.00007670395,0.00012397402,0.00048299803,0.0017182748,0.14019236],"study_design_scores_gemma":[0.00032841167,0.00024344226,0.0031113115,0.9425795,0.015551598,0.00031848298,0.00051120354,0.00015983189,0.00039045734,0.00072343333,0.03599802,0.0000844077],"about_ca_topic_score_codex":0.0036934565,"about_ca_topic_score_gemma":0.007835648,"teacher_disagreement_score":0.8847915,"about_ca_system_score_codex":0.005596338,"about_ca_system_score_gemma":0.013941446,"threshold_uncertainty_score":0.6092882},"labels":[],"label_agreement":null},{"id":"W3010852553","doi":"10.1007/s40290-020-00329-w","title":"US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Adverse Event Reporting System; Food and drug administration; Adverse effect; Medicine; Drug; Food safety; Environmental health; Emergency medicine; Pharmacology","score_opus":0.20345642122992655,"score_gpt":0.47564872300221445,"score_spread":0.2721923017722879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010852553","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03246432,0.018549984,0.10385513,0.061365325,0.00898831,0.018011283,0.32424325,0.02187622,0.4106461],"genre_scores_gemma":[0.21730511,0.027366491,0.17528042,0.07696211,0.0066626263,0.017528784,0.36713398,0.0024824021,0.10927809],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9713032,0.00961176,0.0068735476,0.0014919378,0.009710562,0.0010089331],"domain_scores_gemma":[0.80708456,0.047516145,0.04509468,0.01468462,0.08114378,0.00447627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022594623,0.001139287,0.0016632576,0.008200706,0.0012847082,0.003712856,0.0022403118,0.0038434674,0.026332978],"category_scores_gemma":[0.106616996,0.0007464368,0.0020620713,0.0072637373,0.00077947974,0.001885653,0.0014689035,0.00398992,0.012695119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089553476,0.0008544763,0.035557173,0.0020029158,0.0005180546,0.00030779943,0.00022680916,0.0014488355,0.003797287,0.009034003,0.67552733,0.26982984],"study_design_scores_gemma":[0.00080974586,0.00077962264,0.08687391,0.002185274,0.0006552602,0.0011328146,0.00021343883,0.0047933166,0.0081931595,0.0076665315,0.88648564,0.00021125095],"about_ca_topic_score_codex":0.0153945135,"about_ca_topic_score_gemma":0.008883152,"teacher_disagreement_score":0.026332978,"about_ca_system_score_codex":0.0028671683,"about_ca_system_score_gemma":0.015197874,"threshold_uncertainty_score":0.11949319},"labels":[],"label_agreement":null},{"id":"W3013273263","doi":"10.3390/data5020033","title":"Multiple Regression Analysis and Frequent Itemset Mining of Electronic Medical Records: A Visual Analytics Approach Using VISA_M3R3","year":2020,"lang":"en","type":"article","venue":"Data","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Visual analytics; Medical record; Visualization; Analytics; Health records; Data science; Acute kidney injury; Computer science; Electronic medical record; Medicine; Medical emergency; Data mining; Health care; Internal medicine","score_opus":0.291107209982754,"score_gpt":0.4973330205812096,"score_spread":0.20622581059845557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013273263","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.079643205,0.0018706407,0.74625736,0.0030966639,0.00026800248,0.0006735025,0.042985544,0.119443186,0.0057619703],"genre_scores_gemma":[0.18184812,0.00071237277,0.7978849,0.00037604512,0.00008900555,0.0004306437,0.015636807,0.0013422485,0.0016799392],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99820316,0.0005483479,0.00029561904,0.00040314568,0.0004713745,0.00007839664],"domain_scores_gemma":[0.989036,0.0075985156,0.0012159486,0.00085503806,0.001005135,0.00028940974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038018005,0.001335067,0.000997578,0.008345149,0.00054516,0.0030401538,0.0015372407,0.0008286653,0.0061105047],"category_scores_gemma":[0.014467712,0.0005847884,0.0019918014,0.0041239155,0.00032376937,0.0017063576,0.0019688273,0.0011684747,0.0017968084],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026795124,0.0006252305,0.047714636,0.0029175703,0.0014109485,0.0023473427,0.003116264,0.05053808,0.026155831,0.018188747,0.074265905,0.77004004],"study_design_scores_gemma":[0.00028062618,0.00038812353,0.017946905,0.00051744084,0.00032791912,0.0015429878,0.0012417567,0.85699856,0.01846242,0.040409736,0.06166999,0.00021348565],"about_ca_topic_score_codex":0.0056887544,"about_ca_topic_score_gemma":0.0080798,"teacher_disagreement_score":0.008345149,"about_ca_system_score_codex":0.00072322844,"about_ca_system_score_gemma":0.0013336481,"threshold_uncertainty_score":0.020441711},"labels":[],"label_agreement":null},{"id":"W3014455110","doi":"10.12927/hcq.2020.26140","title":"Adverse Drug Reactions in Canada in 2009–2018: Insights from the Canada Vigilance Database","year":2020,"lang":"en","type":"article","venue":"Healthcare Quarterly","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Vigilance (psychology); Drug reaction; Database; National database; Adverse drug reaction; Adverse effect; Medicine; Drug; Psychology; Computer science; Pharmacology","score_opus":0.0747633694219078,"score_gpt":0.3690539890223339,"score_spread":0.2942906196004261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014455110","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3058999,0.024149958,0.0011008844,0.018586876,0.00020943688,0.00039383283,0.61913925,0.0002764588,0.030243432],"genre_scores_gemma":[0.79726636,0.025952656,0.0028077853,0.005948051,0.00018548878,0.00019907577,0.1627188,0.00008660633,0.0048351157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965739,0.00023646887,0.0005729556,0.00034578628,0.0017304169,0.00054038566],"domain_scores_gemma":[0.98050904,0.0016332085,0.003801853,0.0004371236,0.012078249,0.0015404775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017030142,0.00033145145,0.00043384774,0.0048406525,0.0017169128,0.0021800273,0.0011223456,0.00044456046,0.0026910077],"category_scores_gemma":[0.014538011,0.0002733227,0.00068154477,0.015849667,0.00044105697,0.0006655104,0.0012869819,0.0010960209,0.00037364886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025044187,0.000044496024,0.7969947,0.0010024824,0.00027771032,0.0004267817,0.0015686346,0.0006809509,0.000138404,0.001512559,0.14769763,0.04940527],"study_design_scores_gemma":[0.000020872243,0.000022012793,0.9324935,0.0010270945,0.00016025182,0.00033000603,0.0018734079,0.001039834,0.00016707073,0.00026990645,0.06253753,0.000058471363],"about_ca_topic_score_codex":0.9938532,"about_ca_topic_score_gemma":0.99618274,"teacher_disagreement_score":0.033761587,"about_ca_system_score_codex":0.033761587,"about_ca_system_score_gemma":0.065256946,"threshold_uncertainty_score":0.24495864},"labels":[],"label_agreement":null},{"id":"W3017227766","doi":"10.2196/17353","title":"Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study","year":2020,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; National Institutes of Health","keywords":"Observational study; Data science; Informatics; Data mining; Computer science; Health informatics; Health data; Medicine; Health care; Public health; Engineering; Internal medicine; Pathology","score_opus":0.3511945429628822,"score_gpt":0.4961855859945183,"score_spread":0.14499104303163607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017227766","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01853149,0.00041315475,0.9765162,0.00084854086,0.000030415364,0.0006943388,0.0012854516,0.0011228397,0.0005576007],"genre_scores_gemma":[0.20283408,0.00049265305,0.79040384,0.0003453942,0.00008082021,0.00092483155,0.0042483057,0.000050730814,0.00061929633],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99112105,0.0028917352,0.0012451463,0.0023132954,0.0020004692,0.00042828],"domain_scores_gemma":[0.9855828,0.007825074,0.0017346387,0.0014708033,0.0028381557,0.0005485175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010762274,0.0010622486,0.0014474004,0.0071485126,0.00089948584,0.0032924835,0.001870116,0.0012967836,0.0008297343],"category_scores_gemma":[0.018152928,0.0004831377,0.0039223763,0.004256448,0.00118109,0.00297077,0.0026980052,0.0016658795,0.00036102018],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009000241,0.0020220003,0.13131979,0.0023683286,0.0020537598,0.0017602552,0.0015598164,0.26552603,0.010807593,0.12870729,0.011651882,0.44132322],"study_design_scores_gemma":[0.000040729166,0.00016456048,0.0067394036,0.000100664525,0.00016044333,0.00024691698,0.00020470373,0.9720976,0.0016888445,0.014621078,0.0038995491,0.000035458066],"about_ca_topic_score_codex":0.023452828,"about_ca_topic_score_gemma":0.021645008,"teacher_disagreement_score":0.023452828,"about_ca_system_score_codex":0.0028408978,"about_ca_system_score_gemma":0.006657973,"threshold_uncertainty_score":0.05691701},"labels":[],"label_agreement":null},{"id":"W3018455288","doi":"10.1016/j.clinthera.2020.03.006","title":"Use of Real-world Data for New Drug Applications and Line Extensions","year":2020,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi","keywords":"Medicine; Orphan drug; Timeline; Drug; Agency (philosophy); Regulatory science; Food and drug administration; Drug approval; Tolerability; Regulatory agency; MEDLINE; Pharmacology; Family medicine; Data science; Adverse effect; Bioinformatics; Computer science; Pathology","score_opus":0.7882468021714223,"score_gpt":0.643252198100617,"score_spread":0.14499460407080533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018455288","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7261467,0.021142714,0.031050982,0.015051384,0.0007991361,0.0028845728,0.12503365,0.0010765768,0.07681427],"genre_scores_gemma":[0.8972707,0.005120059,0.022799646,0.0030910536,0.00036194883,0.0013652877,0.067285076,0.0002970302,0.0024091005],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9072986,0.027424745,0.023779247,0.008390935,0.030972369,0.002134134],"domain_scores_gemma":[0.5923579,0.23408346,0.11218336,0.028783636,0.030742977,0.0018486473],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.042580724,0.00070225337,0.0006749228,0.014342349,0.0011834286,0.006502809,0.0017387957,0.0017490974,0.0035184915],"category_scores_gemma":[0.18761064,0.00055878103,0.0011430025,0.021140333,0.001553222,0.0062584537,0.003343668,0.0018670859,0.0015091713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011534005,0.00040746294,0.7026824,0.0068660956,0.00065941265,0.0036175018,0.013186122,0.004058665,0.0031934362,0.016748985,0.045787986,0.20163858],"study_design_scores_gemma":[0.00009777375,0.00044064474,0.40804178,0.0072383783,0.0005229343,0.0058409665,0.01792935,0.006631287,0.011429796,0.008655598,0.53275,0.00042137696],"about_ca_topic_score_codex":0.0051130718,"about_ca_topic_score_gemma":0.004477045,"teacher_disagreement_score":0.9574193,"about_ca_system_score_codex":0.0040383516,"about_ca_system_score_gemma":0.004407449,"threshold_uncertainty_score":0.22519106},"labels":[],"label_agreement":null},{"id":"W3020842424","doi":"10.14745/ccdr.v40is3a02","title":"(CAEFISS) Annual report for vaccines administered in 2012","year":2014,"lang":"en","type":"article","venue":"Canada Communicable Disease Report","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Pharmacovigilance; Vaccination; Rash; Adverse effect; Immunization; Population; Public health; Pediatrics; Environmental health; Family medicine; Immunology; Pharmacology; Internal medicine","score_opus":0.08608546724876052,"score_gpt":0.42802004933957194,"score_spread":0.3419345820908114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020842424","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015425914,0.011125745,0.000746106,0.0034043544,0.00079070695,0.0006027745,0.88563144,0.0008197506,0.08145322],"genre_scores_gemma":[0.11654035,0.023004264,0.0054394864,0.0032900723,0.00048540763,0.00055931095,0.77021676,0.00020049415,0.08026381],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9974203,0.00008382635,0.0001956347,0.00014246428,0.0018604465,0.00029737505],"domain_scores_gemma":[0.99246323,0.00012609457,0.00063728384,0.00006848834,0.0063395845,0.00036529114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010920042,0.00062150473,0.00037173557,0.00439664,0.00081664545,0.0009917057,0.00095908786,0.00038019737,0.011131614],"category_scores_gemma":[0.004740376,0.00018141809,0.0004479467,0.00537014,0.00015070042,0.0003550664,0.0004197667,0.00060791743,0.0031244194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002595156,0.00004897536,0.07449991,0.0010698854,0.00011231535,0.00013069341,0.00009464885,0.00040164674,0.0004549045,0.0007851677,0.8586466,0.06349573],"study_design_scores_gemma":[0.000058158796,0.00007657051,0.31686655,0.00067490735,0.000108797314,0.00032234652,0.00018067866,0.00040315956,0.00082329696,0.00011551972,0.68033844,0.000031527405],"about_ca_topic_score_codex":0.9513984,"about_ca_topic_score_gemma":0.9543725,"teacher_disagreement_score":0.048601627,"about_ca_system_score_codex":0.01773644,"about_ca_system_score_gemma":0.03268102,"threshold_uncertainty_score":0.1286875},"labels":[],"label_agreement":null},{"id":"W3021147388","doi":"10.4212/cjhp.v73i2.2983","title":"Have Current Systems of Pharmacovigilance Had Their Day?","year":2020,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Current (fluid); Medicine; Pharmacology; Engineering; Adverse effect","score_opus":0.14711344188591544,"score_gpt":0.41253442678172114,"score_spread":0.2654209848958057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021147388","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039448556,0.022729626,0.0023933332,0.9451931,0.010013039,0.000026773212,0.00032323608,0.0002373248,0.015138707],"genre_scores_gemma":[0.23289524,0.038043633,0.0147117525,0.6750693,0.020440519,0.000107008476,0.0009986748,0.00038087813,0.017353049],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97311336,0.008444683,0.002108416,0.002593092,0.009570672,0.0041698017],"domain_scores_gemma":[0.8644581,0.026778102,0.010389494,0.00961843,0.06538397,0.02337185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051615022,0.00078322156,0.0011869583,0.0023278012,0.0042319694,0.023460297,0.0046552382,0.010538713,0.029904297],"category_scores_gemma":[0.09990262,0.0005310215,0.0013465849,0.003511832,0.012144487,0.027540488,0.0057804273,0.017497946,0.006498036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031814945,0.00039606108,0.03394778,0.0013801627,0.00028157677,0.0003450142,0.0030540733,0.00039711685,0.0005662451,0.23645592,0.49372935,0.22912842],"study_design_scores_gemma":[0.000107861735,0.00022487222,0.03341672,0.0047884868,0.00017683479,0.0007848931,0.00911767,0.0009050975,0.0006888608,0.07733157,0.8721876,0.00026952822],"about_ca_topic_score_codex":0.10100298,"about_ca_topic_score_gemma":0.14149028,"teacher_disagreement_score":0.10100298,"about_ca_system_score_codex":0.02228042,"about_ca_system_score_gemma":0.036065802,"threshold_uncertainty_score":0.27296954},"labels":[],"label_agreement":null},{"id":"W3030204569","doi":"10.3899/jrheum.200023","title":"Antineoplastic Drug-induced Aortitis: An Unraveled Adverse Effect Using the World Health Organization Pharmacovigilance Database","year":2020,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Aortitis; Giant cell arteritis; Adverse effect; Arteritis; MedDRA; Polymyalgia rheumatica; Tocilizumab; Database; Internal medicine; Disease; Vasculitis; Intensive care medicine; Aorta","score_opus":0.09081399547953616,"score_gpt":0.43017461227340525,"score_spread":0.3393606167938691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030204569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65759486,0.05806837,0.028701633,0.010269026,0.0008426867,0.0012521663,0.23873222,0.0013325022,0.0032065026],"genre_scores_gemma":[0.81463504,0.0141953435,0.05129757,0.0026893313,0.0013882658,0.00076886575,0.11437171,0.00014787866,0.0005059348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922616,0.0020313752,0.0031160736,0.00095906196,0.0014602619,0.00017173753],"domain_scores_gemma":[0.9516682,0.029017588,0.013126971,0.0024085022,0.003016029,0.0007628127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006954147,0.00044713018,0.0011966713,0.007420365,0.00033817685,0.0023091973,0.00093909254,0.0010976875,0.001476019],"category_scores_gemma":[0.029362813,0.00024013703,0.0013150307,0.0077979057,0.00021852879,0.0011332792,0.0012315554,0.00086107623,0.0003316297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013954695,0.00025882438,0.81412905,0.007949204,0.0028494804,0.0037206702,0.00043390112,0.0023121287,0.0017900999,0.0011464389,0.027940404,0.13607432],"study_design_scores_gemma":[0.0005605039,0.0009500959,0.79156893,0.004597831,0.00876133,0.010742101,0.00096946344,0.04773502,0.005361639,0.0038752616,0.12458946,0.00028835863],"about_ca_topic_score_codex":0.0020960555,"about_ca_topic_score_gemma":0.0021826646,"teacher_disagreement_score":0.007420365,"about_ca_system_score_codex":0.00045048518,"about_ca_system_score_gemma":0.0012261898,"threshold_uncertainty_score":0.036777496},"labels":[],"label_agreement":null},{"id":"W3031412772","doi":"10.1186/s40545-020-00219-1","title":"Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety","year":2020,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Policy and Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Misinformation; Medicine; Public health; Health care; Pharmacovigilance; Drug reaction; Pharmacy; Patient safety; Medical emergency; Pandemic; Adverse drug reaction; Coronavirus disease 2019 (COVID-19); Family medicine; Adverse effect; Nursing; Drug; Psychiatry; Pharmacology; Political science; Internal medicine","score_opus":0.23217981482385788,"score_gpt":0.5698670491434951,"score_spread":0.3376872343196372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031412772","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0577076,0.0021369143,0.004031839,0.9148632,0.0023572813,0.00022733738,0.00011339881,0.00023779513,0.018324705],"genre_scores_gemma":[0.61450934,0.003704541,0.010096551,0.36490726,0.002979251,0.00026600386,0.00022920057,0.0002340287,0.003073827],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.80875397,0.107212454,0.020203393,0.00548178,0.05084932,0.007499117],"domain_scores_gemma":[0.46405602,0.20186488,0.122513294,0.024104623,0.12745434,0.060006805],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16739129,0.00047289566,0.0008095348,0.0024418856,0.009577412,0.016621578,0.0027559444,0.005684834,0.004708987],"category_scores_gemma":[0.28043094,0.0006884459,0.00065119035,0.0015193766,0.014719808,0.011308096,0.013947793,0.015894685,0.0013188494],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029705185,0.00089031423,0.26398042,0.002098165,0.000243625,0.0029602135,0.11829627,0.0004509903,0.0047949674,0.059973165,0.29400948,0.2520053],"study_design_scores_gemma":[0.00014768036,0.0013400398,0.17508641,0.0070453095,0.00019272837,0.00716998,0.23176317,0.0033545706,0.004818651,0.041120093,0.5271445,0.00081692805],"about_ca_topic_score_codex":0.013539917,"about_ca_topic_score_gemma":0.006833816,"teacher_disagreement_score":0.8326087,"about_ca_system_score_codex":0.012066142,"about_ca_system_score_gemma":0.038239975,"threshold_uncertainty_score":0.88526034},"labels":[],"label_agreement":null},{"id":"W3031933442","doi":"10.2196/17653","title":"Medical Knowledge Graph to Enhance Fraud, Waste, and Abuse Detection on Claim Data: Model Development and Performance Evaluation","year":2020,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities","keywords":"Computer science; Data science; Medical waste; Computer security; Data mining; Medical emergency; Risk analysis (engineering); Knowledge management; Business; Medicine; Engineering","score_opus":0.1515249600550641,"score_gpt":0.4736024870147421,"score_spread":0.322077526959678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031933442","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55157936,0.0126406215,0.39308795,0.006898612,0.00069893623,0.0017841196,0.010424618,0.014038208,0.008847553],"genre_scores_gemma":[0.7892337,0.0021483167,0.19257659,0.00075239304,0.00021139604,0.0005715641,0.011966983,0.00013015138,0.0024089508],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99867356,0.0004898431,0.000118187796,0.00031596198,0.00027258802,0.00012978063],"domain_scores_gemma":[0.9917258,0.0061049694,0.00030687454,0.00046144275,0.0011919023,0.00020889101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005056356,0.0016699409,0.0013874202,0.0054966956,0.0007861328,0.0014911899,0.0022122841,0.0020202894,0.002209771],"category_scores_gemma":[0.011560324,0.00039431296,0.0020715236,0.0025910719,0.00058360683,0.0020706633,0.0012845345,0.0021836096,0.0007348428],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009466991,0.0013410611,0.02855171,0.0004241275,0.00053027674,0.00031578413,0.00014104706,0.6337066,0.001080755,0.0027412567,0.011057668,0.31916296],"study_design_scores_gemma":[0.000015836873,0.00003643063,0.00075082807,0.000014095793,0.00003282747,0.000018859073,0.0000120026325,0.99792767,0.00017228669,0.0007490579,0.00026544358,0.000004758412],"about_ca_topic_score_codex":0.066457376,"about_ca_topic_score_gemma":0.041786432,"teacher_disagreement_score":0.066457376,"about_ca_system_score_codex":0.003057568,"about_ca_system_score_gemma":0.0027885376,"threshold_uncertainty_score":0.13214111},"labels":[],"label_agreement":null},{"id":"W3036628295","doi":"","title":"COVID-19 pharmacologic therapy guidance for BC","year":2020,"lang":"en","type":"article","venue":"British Columbia medical journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Virology; Viral therapy; Pandemic; Betacoronavirus; Internal medicine; Infectious disease (medical specialty); Disease; Outbreak","score_opus":0.18013258702931334,"score_gpt":0.46272946326014675,"score_spread":0.2825968762308334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036628295","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028025024,0.029077144,0.021241643,0.208641,0.010713369,0.0020659165,0.022005877,0.005799198,0.6976534],"genre_scores_gemma":[0.03838935,0.042619724,0.10872801,0.22081183,0.009678637,0.005412421,0.049051866,0.0028666474,0.5224416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992093,0.0022710778,0.0016136885,0.0002955702,0.003078777,0.0006480014],"domain_scores_gemma":[0.9812806,0.005029671,0.0020492356,0.00052701705,0.008869265,0.0022441938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005812989,0.0010869033,0.001619386,0.0034443457,0.0014521298,0.0034874172,0.002932335,0.007805405,0.056555245],"category_scores_gemma":[0.028547775,0.0006903266,0.0025769682,0.0014274714,0.0006918843,0.0013275197,0.002759014,0.0077855294,0.040193073],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098107055,0.000112017726,0.00079117395,0.00030876335,0.000017788905,0.00019799467,0.00004197197,0.0004799742,0.00023331563,0.00413263,0.8995044,0.09408195],"study_design_scores_gemma":[0.00012272755,0.000077925906,0.0018682404,0.0017663002,0.000036985883,0.00045941988,0.00003555239,0.0005775513,0.0002777923,0.0031128325,0.99164,0.000024624966],"about_ca_topic_score_codex":0.033931967,"about_ca_topic_score_gemma":0.06070769,"teacher_disagreement_score":0.966068,"about_ca_system_score_codex":0.0047353376,"about_ca_system_score_gemma":0.019753138,"threshold_uncertainty_score":0.18919611},"labels":[],"label_agreement":null},{"id":"W3037281766","doi":"10.2196/19266","title":"Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis","year":2020,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Center of Mathematical Sciences and Applications, Harvard University; Purdue University","keywords":"Adverse Event Reporting System; Social media; Pharmacovigilance; Medicine; Pharmacy; MEDLINE; Internet privacy; Computer science; Food and drug administration; Information retrieval; Adverse effect; Family medicine; Medical emergency; World Wide Web; Pharmacology; Political science","score_opus":0.1820914446900666,"score_gpt":0.44544220281211594,"score_spread":0.26335075812204933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037281766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602638,0.008086531,0.009853784,0.0014278694,0.0005564487,0.0016292558,0.01233894,0.00016158793,0.005681688],"genre_scores_gemma":[0.9724743,0.0017248944,0.010250575,0.00030520558,0.0004255653,0.0011290637,0.013104972,0.00008260162,0.0005028267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9277019,0.045455866,0.0066449177,0.0055458713,0.013292219,0.0013591987],"domain_scores_gemma":[0.7038662,0.21355101,0.026225725,0.013517803,0.040951774,0.0018875445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07559928,0.0009888366,0.0009645325,0.010073592,0.0006891668,0.0032453635,0.0015640097,0.0010905218,0.0027720807],"category_scores_gemma":[0.21243939,0.00049412425,0.0041228035,0.008357786,0.00078406354,0.0048246663,0.003346552,0.001496746,0.0008177832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038524317,0.00074862107,0.8702131,0.0038172482,0.011945413,0.00020984306,0.003244455,0.0019088133,0.0006155343,0.0014839153,0.0057536275,0.096207045],"study_design_scores_gemma":[0.00036592045,0.0027186328,0.95453984,0.001311478,0.0086074965,0.0004705359,0.0048541212,0.01436548,0.0010831458,0.0009963287,0.010517701,0.00016923613],"about_ca_topic_score_codex":0.011455852,"about_ca_topic_score_gemma":0.013069554,"teacher_disagreement_score":0.07559928,"about_ca_system_score_codex":0.0016396497,"about_ca_system_score_gemma":0.0019686345,"threshold_uncertainty_score":0.39981198},"labels":[],"label_agreement":null},{"id":"W3037918575","doi":"10.1007/s40264-020-00963-y","title":"Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Auckland","keywords":"Medicine; Pharmacovigilance; Pharmacy; Intensive care; Health care; Family medicine; Medical emergency; Adverse effect; Pharmacology; Intensive care medicine","score_opus":0.18115496397628034,"score_gpt":0.48468168332548767,"score_spread":0.30352671934920733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037918575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206726,0.00073923555,0.05762638,0.0016836567,0.00015319149,0.0062860018,0.0022114122,0.0028288192,0.0077986447],"genre_scores_gemma":[0.8337768,0.00038038017,0.1581589,0.00077006937,0.000096056734,0.0018679362,0.0019617574,0.00021163208,0.0027765385],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9868547,0.0077541946,0.0012555016,0.00088581024,0.0030699908,0.00017988356],"domain_scores_gemma":[0.9405744,0.04157768,0.004249819,0.0034179694,0.009143158,0.0010369744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020556927,0.0005891577,0.0007466026,0.0011617932,0.00041018167,0.0018997471,0.0011923618,0.0011805248,0.0038478738],"category_scores_gemma":[0.054111622,0.00043790636,0.0006517277,0.00084372895,0.0004404698,0.0015763352,0.0010340072,0.0007915534,0.0008930639],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024850532,0.010284989,0.17174694,0.0026804204,0.0016693062,0.0005686687,0.003834378,0.0043418896,0.029095126,0.0008726104,0.007476775,0.74257827],"study_design_scores_gemma":[0.009430869,0.04484552,0.6816783,0.0010823149,0.0039303624,0.002946409,0.0033754916,0.15543804,0.05082846,0.0014646158,0.044341806,0.00063777587],"about_ca_topic_score_codex":0.012379947,"about_ca_topic_score_gemma":0.012475911,"teacher_disagreement_score":0.020556927,"about_ca_system_score_codex":0.0010219062,"about_ca_system_score_gemma":0.0022948496,"threshold_uncertainty_score":0.10871673},"labels":[],"label_agreement":null},{"id":"W3042380614","doi":"10.1007/s40290-020-00345-w","title":"Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Université du Québec à Trois-Rivières","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Postmarketing surveillance; Adverse drug reaction; Data quality; Pharmacoepidemiology; Descriptive statistics; Drug; Pharmacology; Database; Adverse effect; Business; Marketing; Computer science; Statistics","score_opus":0.7319876051940398,"score_gpt":0.5953530109512966,"score_spread":0.13663459424274327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042380614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9168526,0.0012441796,0.0049787927,0.0012073178,0.00008686779,0.013027144,0.050025396,0.0001595088,0.01241814],"genre_scores_gemma":[0.9441758,0.0008431147,0.016512768,0.0016320342,0.00008854985,0.0052958173,0.02905522,0.00007354173,0.0023231083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96466774,0.009344156,0.0034832084,0.0026126266,0.017273795,0.002618571],"domain_scores_gemma":[0.9030915,0.022327479,0.011249094,0.006127276,0.053827487,0.0033772523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02586521,0.0014158302,0.0013002544,0.0063462965,0.0035841968,0.00335978,0.0029479295,0.0016620243,0.0034835534],"category_scores_gemma":[0.08209559,0.0007874502,0.002200712,0.012587592,0.0013365619,0.0017639063,0.0023216764,0.001382933,0.00095208926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026261224,0.0017441646,0.95022017,0.0009279409,0.00088900316,0.00035787918,0.002278506,0.0011754404,0.0008029054,0.001014685,0.007832881,0.030130276],"study_design_scores_gemma":[0.000905734,0.0012824999,0.9796718,0.00022589669,0.0007492065,0.0002694034,0.0016010524,0.003068893,0.00075352227,0.00019330978,0.011153359,0.00012530333],"about_ca_topic_score_codex":0.94697535,"about_ca_topic_score_gemma":0.94486046,"teacher_disagreement_score":0.96566844,"about_ca_system_score_codex":0.034331568,"about_ca_system_score_gemma":0.0916106,"threshold_uncertainty_score":0.24909413},"labels":[],"label_agreement":null},{"id":"W3042430577","doi":"10.1007/s00228-020-02958-1","title":"Patients’ experiences on adverse drug reactions reporting: a qualitative study","year":2020,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Confusion; Medicine; Usability; Drug reaction; Social media; Family medicine; Qualitative research; Adverse drug reaction; Content analysis; Pharmacovigilance; Drug; Psychology; Psychiatry","score_opus":0.440949099645519,"score_gpt":0.5933673748761954,"score_spread":0.15241827523067641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042430577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907986,0.0006998098,0.0008093508,0.0043568197,0.00010089709,0.00021083419,0.0002630852,0.000019655401,0.0027410486],"genre_scores_gemma":[0.9949805,0.00058470934,0.00058926945,0.0024850455,0.000033289136,0.000319231,0.00010736737,0.000021712389,0.00087887427],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9574476,0.033232532,0.0020414805,0.0013268885,0.0022020554,0.0037494896],"domain_scores_gemma":[0.87862325,0.09085893,0.011119205,0.001987746,0.007757224,0.009653606],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029829537,0.000690736,0.0014051234,0.0022563364,0.009572636,0.0066948547,0.0024507968,0.0036912903,0.0045369323],"category_scores_gemma":[0.07075822,0.001296775,0.0011107351,0.0022033951,0.007107565,0.0059037153,0.0087477,0.0072387443,0.0006634763],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006134741,0.00012547399,0.01021567,0.00017483819,0.000018683584,0.0004123723,0.98596025,0.000024127543,0.00025709378,0.0002527001,0.0004260755,0.0020713452],"study_design_scores_gemma":[0.0000120197565,0.000098217395,0.003567804,0.00015405916,0.000009384181,0.00025554007,0.9932439,0.000039552837,0.000094298404,0.0000931886,0.0024026302,0.00002951598],"about_ca_topic_score_codex":0.008261763,"about_ca_topic_score_gemma":0.014770808,"teacher_disagreement_score":0.97017044,"about_ca_system_score_codex":0.0072009093,"about_ca_system_score_gemma":0.007560668,"threshold_uncertainty_score":0.15775555},"labels":[],"label_agreement":null},{"id":"W3044187750","doi":"10.1002/pds.5072","title":"A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016","year":2020,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; York University","funders":"National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; Pharmacoepidemiology; Descriptive statistics; Environmental health; Family medicine; Pharmacology; Medical prescription","score_opus":0.10593768877981105,"score_gpt":0.4243459213497039,"score_spread":0.3184082325698928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044187750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94731545,0.0048693186,0.00023238763,0.00045363064,0.00003198264,0.0002464574,0.041484006,0.00004898613,0.005317798],"genre_scores_gemma":[0.97796017,0.003081402,0.00049545337,0.00045525382,0.000038834285,0.00024769432,0.015931405,0.000023493567,0.0017663693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931021,0.00050916715,0.0016275783,0.0008728739,0.0031331847,0.0007551336],"domain_scores_gemma":[0.9591393,0.005979469,0.022680538,0.00082168006,0.009737338,0.001641742],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0029851953,0.00025729745,0.0006075899,0.006813863,0.00088131597,0.0014080436,0.00079575455,0.0005538862,0.0020490228],"category_scores_gemma":[0.017199287,0.00037062823,0.0007455098,0.011225252,0.00063228933,0.0010900254,0.0011678276,0.00072800706,0.00037354804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001443791,0.00003324769,0.9871007,0.00038513396,0.000097917604,0.0001282882,0.0011772563,0.00006689612,0.00008997943,0.000090543435,0.0031601666,0.007525352],"study_design_scores_gemma":[0.00000443834,0.000037246853,0.99303365,0.00018378165,0.000042651343,0.00018686547,0.0012901425,0.00012539419,0.00010935177,0.000010773823,0.0049626846,0.00001305499],"about_ca_topic_score_codex":0.43624648,"about_ca_topic_score_gemma":0.41469803,"teacher_disagreement_score":0.9970148,"about_ca_system_score_codex":0.006855517,"about_ca_system_score_gemma":0.011672842,"threshold_uncertainty_score":0.8674145},"labels":[],"label_agreement":null},{"id":"W3047041840","doi":"10.15586/jptcp.v27i3.705","title":"Detection of serious adverse drug reactions using diagnostic codes in the International Statistical Classification of Diseases and Related Health Problems","year":2020,"lang":"en","type":"article","venue":"Journal of Population Therapeutics and Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Diagnosis code; Drug; Medicine; Intensive care medicine; Computer science; Risk analysis (engineering); Environmental health; Pharmacology","score_opus":0.18840062059799698,"score_gpt":0.5015138883131763,"score_spread":0.31311326771517933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047041840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960574,0.0019376266,0.0068692733,0.0007971464,0.00017705302,0.0019400174,0.014979738,0.00018953074,0.012535648],"genre_scores_gemma":[0.97946966,0.0011282428,0.010525028,0.00019662805,0.00005169801,0.0003436878,0.007425044,0.000012941684,0.00084716437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98838633,0.0027698767,0.0021032959,0.0008805115,0.0050380416,0.00082193944],"domain_scores_gemma":[0.9655249,0.00764548,0.016294885,0.0015983441,0.007757447,0.0011789042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065902555,0.0004917078,0.00050594343,0.0066108694,0.0005895169,0.0009943519,0.00086438213,0.00029193563,0.00086512044],"category_scores_gemma":[0.030718219,0.00025353438,0.00061182963,0.0060938383,0.0005970752,0.00050171796,0.0012555383,0.0006532114,0.00024196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013228004,0.000054426855,0.9721338,0.00023962211,0.00006830435,0.00008291755,0.00051362073,0.00016737511,0.00047900356,0.00014587762,0.0014084226,0.024574414],"study_design_scores_gemma":[0.000010377643,0.00008899859,0.9969216,0.000069920854,0.00002598483,0.00014295295,0.00038652628,0.0005500923,0.00032718483,0.00006556121,0.0013957695,0.000015029775],"about_ca_topic_score_codex":0.3071749,"about_ca_topic_score_gemma":0.50496453,"teacher_disagreement_score":0.3071749,"about_ca_system_score_codex":0.0029702445,"about_ca_system_score_gemma":0.00881652,"threshold_uncertainty_score":0.61077386},"labels":[],"label_agreement":null},{"id":"W3049587632","doi":"10.1007/s40267-020-00768-0","title":"Correction to: Adverse drug reaction reporting in Canada: consumer versus physician reports","year":2020,"lang":"en","type":"article","venue":"Drugs & Therapy Perspectives","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Statistics Canada","funders":"","keywords":"Pharmacy; Adverse drug reaction; Medicine; Alternative medicine; Family medicine; Drug reaction; Drug; Pharmacology; Pathology","score_opus":0.09823142144238274,"score_gpt":0.4051484780851085,"score_spread":0.3069170566427258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049587632","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002568335,0.001499352,0.0002831083,0.122924305,0.86820763,0.00004104107,0.0034877758,0.00034640974,0.0029535512],"genre_scores_gemma":[0.023455922,0.012053497,0.0036639727,0.32272342,0.44657853,0.00033310507,0.0057099764,0.0015524063,0.18392922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98726326,0.0010909133,0.002203506,0.0014414262,0.006191004,0.0018098754],"domain_scores_gemma":[0.8550358,0.01910111,0.0066670724,0.0048911707,0.10624048,0.00806442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006280952,0.0021856055,0.0031885915,0.0068916413,0.004715441,0.007708964,0.005295318,0.013989498,0.050932083],"category_scores_gemma":[0.100900464,0.0017519679,0.0019818565,0.007343101,0.0038266403,0.0018660537,0.0022013644,0.014863592,0.020256257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014522768,0.0000029852245,0.00010459615,0.000061752115,0.000009861144,0.00006801659,0.000013856863,0.000018612674,0.000009780466,0.00015530923,0.99782664,0.0017141469],"study_design_scores_gemma":[0.0001103728,0.000014843751,0.0030739948,0.0006984103,0.000067320936,0.00036177682,0.00023694574,0.00037688322,0.00017074114,0.00057505275,0.99425054,0.00006309818],"about_ca_topic_score_codex":0.5097597,"about_ca_topic_score_gemma":0.49760813,"teacher_disagreement_score":0.49024028,"about_ca_system_score_codex":0.01983245,"about_ca_system_score_gemma":0.04426466,"threshold_uncertainty_score":0.9862548},"labels":[],"label_agreement":null},{"id":"W3062014249","doi":"10.1007/978-1-0716-0912-5_8","title":"Value and Methods of Pharmacovigilance in the Monitoring of Drug Safety in Parkinson’s Disease","year":2020,"lang":"en","type":"book-chapter","venue":"Neuromethods","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pharmacovigilance; Medicine; Drug; Disease; Value (mathematics); Parkinson's disease; Pharmacology; Computer science; Internal medicine","score_opus":0.1522526958112832,"score_gpt":0.48902013468596245,"score_spread":0.33676743887467925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3062014249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00463983,0.36958405,0.3361123,0.026887272,0.005056415,0.00021984518,0.00059885974,0.00045407654,0.25644743],"genre_scores_gemma":[0.06759458,0.2334888,0.5665455,0.008217164,0.004146467,0.00040833515,0.000447084,0.0004248841,0.11872714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99386877,0.002924774,0.00023339136,0.00030818765,0.0025948244,0.000070065034],"domain_scores_gemma":[0.98226386,0.015638445,0.00036484507,0.00048782598,0.0011572465,0.00008770368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0084895445,0.0010319729,0.000691443,0.0029267292,0.00032682036,0.0045301216,0.0015920459,0.0017055116,0.0033111149],"category_scores_gemma":[0.014827253,0.0005664091,0.00081734144,0.0020463248,0.0028459392,0.0037596012,0.0015041842,0.0028305196,0.001504781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006256806,0.00005528931,0.002401065,0.0013245862,0.00014721154,0.00022031143,0.0009258308,0.0025000423,0.0015131981,0.24339253,0.04766844,0.6997889],"study_design_scores_gemma":[0.000021998498,0.00015541175,0.00761667,0.004063372,0.00012945732,0.0022905075,0.00066479814,0.014499524,0.0026410553,0.40354463,0.56424165,0.00013091762],"about_ca_topic_score_codex":0.0026586181,"about_ca_topic_score_gemma":0.0046800007,"teacher_disagreement_score":0.0084895445,"about_ca_system_score_codex":0.0013915839,"about_ca_system_score_gemma":0.0013627172,"threshold_uncertainty_score":0.044897556},"labels":[],"label_agreement":null},{"id":"W3086162593","doi":"10.3390/pharmacy8030174","title":"Potential for Detection of Safety Signals for Over-the-Counter Medicines Using National ADR Spontaneous Reporting Data: The Example of OTC NSAID-Associated Gastrointestinal Bleeding","year":2020,"lang":"en","type":"article","venue":"Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Over-the-counter; Postmarketing surveillance; Adverse effect; Odds ratio; Adverse drug reaction; Gastrointestinal bleeding; Drug; Pharmacology; Internal medicine; Medical prescription","score_opus":0.31331852171373425,"score_gpt":0.47928294445876723,"score_spread":0.16596442274503298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086162593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87740046,0.0055292235,0.058385152,0.011460494,0.00040503117,0.0009923591,0.02954598,0.00058676687,0.015694607],"genre_scores_gemma":[0.95531255,0.0010623443,0.027729675,0.0016956619,0.00017091003,0.00032034208,0.013015954,0.00006410508,0.00062845246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.86468863,0.081342734,0.016730532,0.009605502,0.025612924,0.0020196766],"domain_scores_gemma":[0.49889025,0.29978514,0.11437994,0.046385393,0.039059315,0.0014999998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.098665975,0.0007637918,0.00083429815,0.004830137,0.00080261234,0.003617027,0.0017741321,0.0016297254,0.00096952106],"category_scores_gemma":[0.29083505,0.00060417305,0.0016240452,0.008595383,0.0012166249,0.0029020042,0.0025794993,0.0018330241,0.00041980174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054026337,0.000088851106,0.95189804,0.0007111601,0.0007412444,0.00047595685,0.0013753761,0.0025194774,0.0011041402,0.0025656708,0.0044541266,0.03352557],"study_design_scores_gemma":[0.0002467861,0.0007329023,0.8660993,0.0018147691,0.0014175066,0.0032917587,0.0028629776,0.053410206,0.011098567,0.008466942,0.05028429,0.00027394787],"about_ca_topic_score_codex":0.027061965,"about_ca_topic_score_gemma":0.018163309,"teacher_disagreement_score":0.098665975,"about_ca_system_score_codex":0.0020524217,"about_ca_system_score_gemma":0.0032842737,"threshold_uncertainty_score":0.5218018},"labels":[],"label_agreement":null},{"id":"W3095032810","doi":"10.2196/22661","title":"Identification of Adverse Drug Event–Related Japanese Articles: Natural Language Processing Analysis","year":2020,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Recall; Context (archaeology); Sentence; Precision and recall; Computer science; Identification (biology); F1 score; Natural language processing; Unified Medical Language System; Medicine; Artificial intelligence; Information retrieval; Psychology","score_opus":0.03530902873429379,"score_gpt":0.41876947934502956,"score_spread":0.38346045061073575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095032810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.700637,0.0057186605,0.24911575,0.0030692916,0.0004925613,0.002621579,0.023646422,0.007722003,0.0069766715],"genre_scores_gemma":[0.5202633,0.001998208,0.43741938,0.0009039324,0.00048393078,0.0010892639,0.034381986,0.00026732488,0.0031926704],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979943,0.00044935118,0.00047233325,0.0005437907,0.00044502935,0.000095214],"domain_scores_gemma":[0.98863983,0.0059165074,0.0016330027,0.0003463201,0.0032446154,0.00021967883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019250701,0.0011497106,0.00069850823,0.00540334,0.00072118366,0.0014122273,0.00081083836,0.000897947,0.0017185778],"category_scores_gemma":[0.008407645,0.00028291607,0.0011160249,0.0028140296,0.00046814285,0.0013069379,0.00063717423,0.0007043838,0.0012092331],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010160725,0.0009645492,0.058111127,0.008446665,0.00046741538,0.0077398634,0.003911688,0.008663716,0.27501792,0.0016155776,0.03593051,0.5981149],"study_design_scores_gemma":[0.0002744801,0.0011940481,0.31741348,0.0007906176,0.0018944717,0.0096512,0.0065011326,0.38718,0.19623725,0.0070258183,0.07139768,0.00043982302],"about_ca_topic_score_codex":0.006812921,"about_ca_topic_score_gemma":0.008807465,"teacher_disagreement_score":0.006812921,"about_ca_system_score_codex":0.00093552034,"about_ca_system_score_gemma":0.0016351622,"threshold_uncertainty_score":0.013546526},"labels":[],"label_agreement":null},{"id":"W3097297978","doi":"10.2196/21452","title":"Patient Perspectives on Health Data Privacy and Implications for Adverse Drug Event Documentation and Communication: Qualitative Study","year":2020,"lang":"en","type":"article","venue":"Journal of Medical Internet Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Simon Fraser University; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Documentation; Qualitative research; Internet privacy; Event (particle physics); Adverse drug event; Medicine; Drug; Psychology; Computer science; Psychiatry; Sociology","score_opus":0.44219351723899236,"score_gpt":0.6594830612355445,"score_spread":0.2172895439965521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097297978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496974,0.0014586472,0.0031875162,0.0057516964,0.0001001994,0.00032658532,0.00023681407,0.000020010604,0.0039487635],"genre_scores_gemma":[0.9938508,0.0012534446,0.0011387379,0.0020109592,0.000033525077,0.0004050091,0.00006359697,0.000019123812,0.0012247992],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9706297,0.0241986,0.00087367493,0.00087111734,0.0013597794,0.002067103],"domain_scores_gemma":[0.9302349,0.058134716,0.0035553002,0.00097120285,0.0037333814,0.0033704657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03134578,0.00055125856,0.0008874163,0.0015553879,0.008370735,0.0038754868,0.0014591384,0.0022453973,0.0041100485],"category_scores_gemma":[0.045737945,0.00078558957,0.0007088572,0.0017315783,0.0074252053,0.0056609227,0.006628784,0.00358076,0.00038660664],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048580943,0.000049817125,0.0029511617,0.00022789753,0.0000065696513,0.0004908579,0.99132174,0.000021872353,0.00032103198,0.0007060993,0.00038495267,0.0034695587],"study_design_scores_gemma":[0.000008363234,0.00007895526,0.0008241281,0.00024670776,0.0000066352477,0.00028376776,0.9933128,0.00006198653,0.00019287938,0.00021733112,0.0047524995,0.000013930584],"about_ca_topic_score_codex":0.0051614493,"about_ca_topic_score_gemma":0.0052316897,"teacher_disagreement_score":0.03134578,"about_ca_system_score_codex":0.005287781,"about_ca_system_score_gemma":0.0066231973,"threshold_uncertainty_score":0.16577435},"labels":[],"label_agreement":null},{"id":"W3097645936","doi":"10.1002/pds.5167","title":"The utility of <scp>real‐world</scp> evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studies","year":2020,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Health Canada","funders":"","keywords":"Medicine; Stakeholder; Stakeholder engagement; Risk analysis (engineering); Data collection; Product (mathematics); Brace; Reimbursement; Risk assessment; Health care; Operations management; Engineering; Computer science; Public relations; Computer security","score_opus":0.4756097215586652,"score_gpt":0.5926517581892958,"score_spread":0.11704203663063062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097645936","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09846195,0.6045188,0.07395442,0.0772472,0.0022258954,0.013248617,0.0025326163,0.00016244638,0.12764816],"genre_scores_gemma":[0.689044,0.16280088,0.121031605,0.014759144,0.0009015158,0.0086345095,0.0007653222,0.000105330895,0.0019576568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7069659,0.2338934,0.032391924,0.0033722324,0.021904131,0.0014723742],"domain_scores_gemma":[0.22253944,0.72682524,0.019721232,0.014687638,0.015259338,0.00096710405],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22231075,0.0009777141,0.0017826385,0.012250491,0.0021319522,0.010160239,0.0033798618,0.008207515,0.0063688518],"category_scores_gemma":[0.40879574,0.00094857294,0.0032060714,0.011689098,0.0074302475,0.008794421,0.005733053,0.004129161,0.0006938666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019241268,0.00077778427,0.025339553,0.24983804,0.0055571473,0.024049075,0.027185302,0.0050973278,0.0020966704,0.18307313,0.026649943,0.4484118],"study_design_scores_gemma":[0.0010444009,0.0023026962,0.011564521,0.5392743,0.0063747885,0.019846335,0.018240714,0.004476267,0.0048557115,0.05980867,0.33193526,0.0002762731],"about_ca_topic_score_codex":0.0028433627,"about_ca_topic_score_gemma":0.006637094,"teacher_disagreement_score":0.7776892,"about_ca_system_score_codex":0.009340121,"about_ca_system_score_gemma":0.011142348,"threshold_uncertainty_score":0.9590293},"labels":[],"label_agreement":null},{"id":"W3102018481","doi":"10.1002/prp2.680","title":"Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Harm; Drug; Business; Medicine; Pharmacology; Risk analysis (engineering); Medical emergency; Actuarial science; Environmental health; Political science; Law","score_opus":0.27701040248965586,"score_gpt":0.5256327882399979,"score_spread":0.24862238575034207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102018481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344605,0.0012865276,0.0003526545,0.00040323674,0.000018870915,0.0002729657,0.0006365145,0.00002138216,0.0035618148],"genre_scores_gemma":[0.9968424,0.0009356409,0.00062449806,0.00034439776,0.00001772413,0.00019845703,0.000676681,0.000017339478,0.00034288404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9663876,0.011880197,0.007439926,0.0022789047,0.010402815,0.0016105574],"domain_scores_gemma":[0.8463864,0.058957282,0.064560935,0.0049959226,0.020623222,0.0044762576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027720587,0.00023999899,0.0007228247,0.0046030656,0.0010307844,0.002390349,0.0009515147,0.00088654744,0.0019005076],"category_scores_gemma":[0.09662948,0.000503873,0.0013824372,0.005894974,0.0017348726,0.003102691,0.0033998212,0.0012788202,0.00029040215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015167934,0.0005007801,0.9294315,0.0009904484,0.0005128839,0.00012962018,0.012000953,0.00019862899,0.00048041934,0.0005296634,0.0010638351,0.052644413],"study_design_scores_gemma":[0.00009054637,0.00063132145,0.98358625,0.00033355688,0.00022704512,0.0001822811,0.009940274,0.00035617233,0.00030967162,0.00007785713,0.0042224224,0.000042557956],"about_ca_topic_score_codex":0.02143689,"about_ca_topic_score_gemma":0.023516014,"teacher_disagreement_score":0.027720587,"about_ca_system_score_codex":0.004678926,"about_ca_system_score_gemma":0.0055095092,"threshold_uncertainty_score":0.14660221},"labels":[],"label_agreement":null},{"id":"W3104008342","doi":"10.1093/bioinformatics/btaa973","title":"MetaADEDB 2.0: a comprehensive database on adverse drug events","year":2020,"lang":"en","type":"article","venue":"Bioinformatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Adverse Event Reporting System; Computer science; Database; Drug; Online database; Drug reaction; Adverse effect; Information retrieval; World Wide Web; Data mining; Medicine; Pharmacology","score_opus":0.1810652966885001,"score_gpt":0.4259213948965154,"score_spread":0.24485609820801532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104008342","genre_codex":"dataset","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026796511,0.002959221,0.0073366235,0.00094683276,0.00012253861,0.00045517282,0.97026676,0.010894507,0.004338686],"genre_scores_gemma":[0.018317029,0.0029562141,0.02457144,0.0008571651,0.00025170055,0.0018367573,0.94669175,0.002707258,0.0018106945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99393624,0.0015536672,0.0024348474,0.00075329933,0.0010937682,0.00022822745],"domain_scores_gemma":[0.96920246,0.014652211,0.007497018,0.0030405244,0.003444743,0.0021630004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069982037,0.0016397054,0.0033928438,0.021069335,0.00061447575,0.0039960626,0.003347285,0.0016617364,0.06862343],"category_scores_gemma":[0.040347874,0.0013328933,0.0025552195,0.017524403,0.00042666355,0.0032962253,0.003796466,0.001905772,0.024096057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030090332,0.00018141262,0.023271555,0.022147793,0.00226421,0.0006274288,0.00047441392,0.0023242803,0.002488575,0.0064232354,0.79819554,0.13859247],"study_design_scores_gemma":[0.0012668555,0.00019886282,0.033402983,0.0031585228,0.0015934833,0.0011314757,0.00020824611,0.0033385365,0.0022577057,0.009670735,0.9434421,0.00033047175],"about_ca_topic_score_codex":0.0046766438,"about_ca_topic_score_gemma":0.004847838,"teacher_disagreement_score":0.06862343,"about_ca_system_score_codex":0.001178845,"about_ca_system_score_gemma":0.0055281715,"threshold_uncertainty_score":0.22956824},"labels":[],"label_agreement":null},{"id":"W3112986797","doi":"10.1007/s40264-020-01008-0","title":"Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations","year":2020,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Pharmacovigilance; Legislation; Medicine; Scope (computer science); Benchmarking; European union; Obligation; Business; Marketing authorization; Risk analysis (engineering); Pharmacology; Marketing; International trade; Political science","score_opus":0.13453499215065462,"score_gpt":0.47553821532083984,"score_spread":0.3410032231701852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112986797","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011324857,0.11882791,0.07229249,0.75856346,0.010041696,0.0029843287,0.0019064525,0.0018406353,0.03241056],"genre_scores_gemma":[0.025528114,0.20111859,0.4351967,0.28874278,0.008011922,0.01049079,0.013078592,0.00095473917,0.016877761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9149339,0.044358805,0.012388513,0.0037468933,0.019222971,0.0053488044],"domain_scores_gemma":[0.8409117,0.06442265,0.011152513,0.0073227836,0.06267325,0.013517076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1734497,0.0031888646,0.004083766,0.009538739,0.0026388038,0.014144692,0.01586989,0.029329704,0.016170956],"category_scores_gemma":[0.1722909,0.0018489426,0.009892668,0.006845651,0.004887796,0.012939881,0.0134297535,0.020329585,0.013370519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025036125,0.000677577,0.0011490397,0.0117962025,0.00043787417,0.00063247985,0.0010526037,0.004728996,0.00074757787,0.07855177,0.410015,0.48996046],"study_design_scores_gemma":[0.00032006486,0.00026097696,0.0014206843,0.07081811,0.0005447922,0.0006287961,0.0006745811,0.0026370836,0.00080813165,0.0862838,0.83550197,0.0001010088],"about_ca_topic_score_codex":0.013835787,"about_ca_topic_score_gemma":0.007888345,"teacher_disagreement_score":0.1734497,"about_ca_system_score_codex":0.013683351,"about_ca_system_score_gemma":0.08325591,"threshold_uncertainty_score":0.91730064},"labels":[],"label_agreement":null},{"id":"W3113526150","doi":"10.1016/j.eclinm.2020.100693","title":"Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)","year":2020,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Food and Drug Administration; University of North Carolina at Chapel Hill; University of Texas MD Anderson Cancer Center; University of California; Università di Pisa; National Institutes of Health; University of Pennsylvania; University of Texas at San Antonio; Saint Louis University; Case Western Reserve University; Tulane University; Johns Hopkins University; Indiana University; Baylor University; University of Utah; Medical University of South Carolina; American Cancer Society; Stanford University; University of New Mexico; Health Sciences Center, University of Oregon; University of Miami; University of Melbourne; Université Pierre et Marie Curie; Yale University; Københavns Universitet; McGill University; U.S. Food and Drug Administration; University of Chicago","keywords":"Medicine; Drug reaction; Adverse effect; Sonar; Adverse drug reaction; Intensive care medicine; Drug; Medical emergency; Psychiatry; Pharmacology; Oceanography","score_opus":0.12062239025428702,"score_gpt":0.45458149271199155,"score_spread":0.33395910245770455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113526150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98138714,0.0013099656,0.00082572096,0.009145941,0.000058175316,0.00032663613,0.001912333,0.000015596896,0.005018578],"genre_scores_gemma":[0.99122286,0.0019416909,0.0010592323,0.003112837,0.00003848091,0.00059570087,0.0008069008,0.00003040081,0.0011918335],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9798028,0.013213807,0.001521914,0.00084766996,0.0030307458,0.0015830648],"domain_scores_gemma":[0.9033419,0.063854344,0.017102757,0.001461034,0.011708213,0.002531667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02633368,0.00026723224,0.0004085729,0.0034574876,0.0034308233,0.0031926997,0.0010234661,0.0010711566,0.0022580654],"category_scores_gemma":[0.068667516,0.0004544987,0.00051343575,0.0035772773,0.0028966954,0.0041097635,0.005431112,0.002069885,0.0002878705],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012725231,0.000048855956,0.10275013,0.0009649819,0.000038143702,0.00080078124,0.8716639,0.00008520858,0.00046428345,0.0011222776,0.005129457,0.016804596],"study_design_scores_gemma":[0.00000839655,0.00006325901,0.05406654,0.00070777955,0.000018374922,0.00031367777,0.9323142,0.00016203638,0.00020350213,0.00022847806,0.011880634,0.00003309862],"about_ca_topic_score_codex":0.026446076,"about_ca_topic_score_gemma":0.03563003,"teacher_disagreement_score":0.026446076,"about_ca_system_score_codex":0.010115628,"about_ca_system_score_gemma":0.008376725,"threshold_uncertainty_score":0.13926744},"labels":[],"label_agreement":null},{"id":"W3118216497","doi":"10.5539/gjhs.v13n2p1","title":"Challenges of Pharmacovigilance in Brazil","year":2020,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Universidade Federal de Mato Grosso do Sul; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Pharmacovigilance; Medicine; Drug reaction; Adverse effect; Patient safety; Health care; Risk analysis (engineering); Adverse drug reaction; Medical emergency; Business; Drug; Intensive care medicine; Pharmacology","score_opus":0.2272909292940381,"score_gpt":0.52899434946616,"score_spread":0.3017034201721219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118216497","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18262482,0.079160795,0.063573666,0.59733915,0.0015617034,0.0009728535,0.0035787076,0.0015276304,0.06966074],"genre_scores_gemma":[0.9355427,0.017805597,0.016997118,0.025520625,0.00043382906,0.00023060206,0.00073990395,0.00019808154,0.0025316793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97414804,0.010551992,0.0037563571,0.0023767264,0.007918917,0.0012479014],"domain_scores_gemma":[0.93374705,0.029169187,0.01142332,0.0039451835,0.017734889,0.0039803865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0260385,0.0004099022,0.0007356205,0.0030934056,0.0015656971,0.006085333,0.0022768357,0.0018550731,0.0027838054],"category_scores_gemma":[0.06529201,0.0005301264,0.0010314343,0.003361257,0.002340128,0.0024697245,0.003859915,0.0022167356,0.00039353376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039257566,0.00026048455,0.23938917,0.005687149,0.0007499047,0.007830651,0.020492893,0.005280726,0.0044561955,0.14695889,0.071802825,0.49669856],"study_design_scores_gemma":[0.00029570318,0.00041375012,0.24311504,0.0147734545,0.00064760767,0.013346666,0.020868266,0.021282397,0.0037352715,0.123416424,0.55771005,0.00039545313],"about_ca_topic_score_codex":0.14268064,"about_ca_topic_score_gemma":0.08016283,"teacher_disagreement_score":0.14268064,"about_ca_system_score_codex":0.015487099,"about_ca_system_score_gemma":0.03728169,"threshold_uncertainty_score":0.2837003},"labels":[],"label_agreement":null},{"id":"W3120114948","doi":"10.1016/j.semarthrit.2020.09.023","title":"Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group","year":2021,"lang":"en","type":"review","venue":"Seminars in Arthritis and Rheumatism","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Calgary; University of Ottawa","funders":"National Institute for Health and Care Research; Parker Institute for Cancer Immunotherapy; Leeds Biomedical Research Centre; Oak Foundation","keywords":"Medicine; Cochrane Library; Internal medicine; Randomized controlled trial; Rheumatology; Alternative medicine; Physical therapy; Drug trial; Drug; Family medicine; Cochrane collaboration; Systematic review; Clinical trial; MEDLINE; Pharmacology; Pathology","score_opus":0.12857127131552984,"score_gpt":0.46772349966689314,"score_spread":0.33915222835136327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120114948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011957536,0.99701524,0.00023133459,0.00031973651,0.0001211995,0.00034055646,0.0006022721,0.000020346351,0.00015363982],"genre_scores_gemma":[0.031902805,0.9636341,0.0015834853,0.0010925694,0.00017362308,0.0009455945,0.00044854314,0.000024407691,0.00019489789],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96981746,0.013151388,0.011620684,0.0018675622,0.0030936622,0.0004492347],"domain_scores_gemma":[0.911178,0.067294925,0.016916685,0.0011313462,0.0027883623,0.00069056964],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02065703,0.0020645072,0.017004978,0.010884053,0.00060045056,0.0040999134,0.0018951171,0.0028220052,0.0066118245],"category_scores_gemma":[0.09140071,0.0018295123,0.0137215005,0.0092135,0.0014950735,0.0031754104,0.0028042893,0.0027918958,0.00038504694],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013259302,0.000013973322,0.0008200999,0.9165867,0.05589768,0.00005795643,0.00012027466,0.000099787576,0.00015639659,0.00015640823,0.0015201322,0.023244645],"study_design_scores_gemma":[0.0049360143,0.00047335916,0.008436274,0.5175177,0.45358965,0.0004041279,0.00028300958,0.00017390717,0.00034059648,0.0008335246,0.012915005,0.00009683219],"about_ca_topic_score_codex":0.0061855814,"about_ca_topic_score_gemma":0.017862495,"teacher_disagreement_score":0.98299503,"about_ca_system_score_codex":0.0040281713,"about_ca_system_score_gemma":0.006943881,"threshold_uncertainty_score":0.109246135},"labels":[],"label_agreement":null},{"id":"W3125649098","doi":"10.1136/bmjoq-2020-001161","title":"Preventable adverse drug events causing hospitalisation: identifying root causes and developing a surveillance and learning system at an urban community hospital, a cross-sectional observational study","year":2021,"lang":"en","type":"article","venue":"BMJ Open Quality","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Island University; University of British Columbia; Richmond Hospital","funders":"Vancouver Coastal Health Research Institute","keywords":"Observational study; Cross-sectional study; Medicine; Adverse effect; Root cause analysis; Drug; Environmental health; Medical emergency; Pharmacology; Internal medicine","score_opus":0.48010608678865985,"score_gpt":0.5680339561260433,"score_spread":0.0879278693373835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125649098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994943,0.000047054175,0.000080059865,0.000045661043,0.0000017077775,0.000079603145,0.00012189279,0.000001921115,0.00012780177],"genre_scores_gemma":[0.99911946,0.000098874945,0.000337051,0.00008648924,0.0000059551307,0.00008108812,0.00019310741,0.000001497273,0.00007644924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833447,0.00070452417,0.0001954431,0.00018262632,0.00025081943,0.00033207744],"domain_scores_gemma":[0.99544203,0.0009981482,0.0015611358,0.00019424582,0.0007090115,0.0010953082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002422379,0.00033194444,0.0003475184,0.0011964325,0.0012778608,0.00090864854,0.00046015036,0.00060921954,0.001283611],"category_scores_gemma":[0.0055535343,0.0007818181,0.0004269146,0.0011434179,0.00052674237,0.0013435462,0.001151953,0.0009911796,0.00023475007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047244743,0.00035654806,0.99697924,0.00002972505,0.000013411859,0.000118960415,0.0012024033,0.00002182379,0.00012728617,0.000008882308,0.00008890194,0.0010056065],"study_design_scores_gemma":[0.000023634937,0.00094546657,0.99123424,0.000029874425,0.000017653467,0.00022275238,0.007009463,0.00023023442,0.00008507276,0.000012543865,0.00017764806,0.000011463516],"about_ca_topic_score_codex":0.02397622,"about_ca_topic_score_gemma":0.03383302,"teacher_disagreement_score":0.02397622,"about_ca_system_score_codex":0.0015429122,"about_ca_system_score_gemma":0.0024070665,"threshold_uncertainty_score":0.047673285},"labels":[],"label_agreement":null},{"id":"W3126908388","doi":"10.1186/s13063-021-05061-7","title":"Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Trials","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Adverse effect; Randomized controlled trial; Culprit; Protocol (science); Documentation; Clinical trial; Emergency medicine; Pharmacy; Alternative medicine; Intensive care medicine; Medical emergency; Family medicine; Internal medicine","score_opus":0.40289007533992033,"score_gpt":0.6075947384089619,"score_spread":0.20470466306904161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126908388","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022607052,0.00058599544,0.0014365327,0.0002670021,0.00070161367,0.9922637,0.0012578935,0.00014783132,0.0010787253],"genre_scores_gemma":[0.0022456045,0.0001606715,0.0017065016,0.00017756021,0.000055342454,0.9951237,0.00011821442,0.000008291538,0.0004041279],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98244864,0.00973675,0.0021651539,0.0016602821,0.0021434808,0.001845687],"domain_scores_gemma":[0.98535186,0.005074386,0.0031976388,0.0017835472,0.003055821,0.0015368622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027937787,0.00637258,0.0119016515,0.00223578,0.002606664,0.0051353876,0.0027254182,0.006716904,0.068951644],"category_scores_gemma":[0.03676869,0.0028785712,0.0059238486,0.0030852184,0.003312037,0.0040671895,0.001550999,0.0072042304,0.009481118],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9086144,0.0100067835,0.00081614556,0.027392298,0.0039162454,0.00022219065,0.0003108195,0.0013810309,0.0016331957,0.0037369926,0.019148564,0.022821344],"study_design_scores_gemma":[0.962273,0.013104251,0.001233239,0.0023260382,0.0011422283,0.000030570714,0.000078332334,0.0010489831,0.00042848042,0.002167378,0.01610568,0.00006187061],"about_ca_topic_score_codex":0.002089315,"about_ca_topic_score_gemma":0.00441447,"teacher_disagreement_score":0.068951644,"about_ca_system_score_codex":0.004040915,"about_ca_system_score_gemma":0.01236201,"threshold_uncertainty_score":0.23066622},"labels":[],"label_agreement":null},{"id":"W3130296845","doi":"10.1002/pds.5214","title":"Suitability of databases in the <scp>Asia‐Pacific</scp> for collaborative monitoring of vaccine safety","year":2021,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"National Health and Medical Research Council; Medical Research Council; International Society for Pharmacoepidemiology; Australian Government","keywords":"Medicine; Database; Vaccine safety; Pharmacoepidemiology; Vaccination; Data sharing; Environmental health; Alternative medicine; Computer science; Pharmacology; Immunology","score_opus":0.14072262780298347,"score_gpt":0.45916000684751107,"score_spread":0.3184373790445276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130296845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4090276,0.1260253,0.1002406,0.057685718,0.000991501,0.008137079,0.14941011,0.0018844213,0.14659771],"genre_scores_gemma":[0.7971593,0.03225844,0.11055931,0.0042687277,0.00038264113,0.0038999256,0.04975236,0.00023629567,0.0014829393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.91436785,0.045983206,0.02030371,0.006596054,0.011099455,0.0016497064],"domain_scores_gemma":[0.5596604,0.2588126,0.07593738,0.03650317,0.06328021,0.005806269],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10821872,0.00042286268,0.00093586853,0.015214211,0.0011102172,0.010391045,0.0032303913,0.0011999077,0.005325947],"category_scores_gemma":[0.23393203,0.0006269451,0.0010805895,0.030096244,0.0010134233,0.009303387,0.0046905163,0.0010334876,0.0013641067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056266686,0.00012711184,0.48637608,0.0211151,0.0013241468,0.0004307185,0.006648035,0.0017069048,0.002464333,0.010643753,0.02690845,0.44169274],"study_design_scores_gemma":[0.00028048106,0.00045145705,0.53609663,0.05466688,0.001638025,0.002259145,0.023768675,0.0048804767,0.006572826,0.010874105,0.35821533,0.00029598852],"about_ca_topic_score_codex":0.01082984,"about_ca_topic_score_gemma":0.0076340884,"teacher_disagreement_score":0.8917813,"about_ca_system_score_codex":0.0027965752,"about_ca_system_score_gemma":0.016406687,"threshold_uncertainty_score":0.57232213},"labels":[],"label_agreement":null},{"id":"W3135769848","doi":"10.1002/pds.5217","title":"Global <scp>COVID</scp>‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system","year":2021,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Foundation for Anesthesia Education and Research","keywords":"Adverse Event Reporting System; Pandemic; Medicine; Outbreak; Adverse effect; Food and drug administration; Coronavirus disease 2019 (COVID-19); Chloroquine; Confidence interval; Environmental health; Internal medicine; Virology; Disease; Infectious disease (medical specialty); Malaria; Immunology","score_opus":0.1684249638764256,"score_gpt":0.47385343812535985,"score_spread":0.30542847424893427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135769848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98701894,0.00035506402,0.00039190231,0.00025695367,0.000015862805,0.00009237232,0.010324339,0.000040827752,0.0015035799],"genre_scores_gemma":[0.9906589,0.0001678607,0.00030667128,0.00010274945,0.000017019114,0.000056597066,0.008485263,0.00001153578,0.00019347604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969524,0.00092945975,0.0006325171,0.00041462737,0.0007458739,0.00032512276],"domain_scores_gemma":[0.9754101,0.0031713997,0.016946422,0.0009168159,0.0028176163,0.00073754124],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0041196737,0.00028198675,0.00026122143,0.0025821247,0.0002521944,0.00073781906,0.00046003528,0.00032771143,0.0010813423],"category_scores_gemma":[0.012684682,0.0001445034,0.000711508,0.0040191305,0.00032213633,0.00087609567,0.0006489522,0.00044232534,0.00030499804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051184663,0.000010268837,0.99764925,0.000014325,0.00004141184,0.00001840256,0.00008552066,0.00009209374,0.00007600883,0.000018817831,0.00042207883,0.0015206529],"study_design_scores_gemma":[0.0000017151708,0.000029886893,0.99880993,0.00001172489,0.000008816058,0.00006038948,0.0002522403,0.00034123394,0.000075548705,0.0000069842463,0.00039716004,0.0000043633163],"about_ca_topic_score_codex":0.041728105,"about_ca_topic_score_gemma":0.031050466,"teacher_disagreement_score":0.9958803,"about_ca_system_score_codex":0.0013592079,"about_ca_system_score_gemma":0.0013146275,"threshold_uncertainty_score":0.08297044},"labels":[],"label_agreement":null},{"id":"W3143119123","doi":"10.1111/cts.13025","title":"Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Tabula Rasa HealthCare","keywords":"Medicine; Pharmacovigilance; Drug; Hydroxychloroquine; Adverse effect; Pharmacology; Internal medicine; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.0784886944355763,"score_gpt":0.4849883158320545,"score_spread":0.4064996213964782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143119123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971787,0.000071848524,0.0021606123,0.000046512752,0.0000043723717,0.00008428664,0.00015134586,0.000013826038,0.00028851812],"genre_scores_gemma":[0.99699163,0.000046791014,0.0024729029,0.000030535077,0.0000065086074,0.000085802305,0.00019935064,0.0000015480143,0.00016484862],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99659747,0.0027328492,0.000117717595,0.00026077067,0.00019395823,0.000097117525],"domain_scores_gemma":[0.97090584,0.023764545,0.00271778,0.0015300945,0.00054983393,0.00053177297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075865663,0.00066949404,0.0007223017,0.00051332905,0.00021484839,0.00074881787,0.0008496034,0.0008270513,0.0012575112],"category_scores_gemma":[0.013700383,0.00036072207,0.0016722941,0.00035794597,0.00047223977,0.0005828978,0.00073597074,0.0007315981,0.00011555911],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025970347,0.0063598235,0.34299994,0.00030301503,0.0034422085,0.00055805437,0.0005366526,0.58134085,0.0035911044,0.002929004,0.00075187004,0.031217126],"study_design_scores_gemma":[0.0012123802,0.015863298,0.04608403,0.000022335667,0.0006879296,0.00039027035,0.00015727557,0.93165123,0.0019690164,0.0012128839,0.0006964444,0.000052916774],"about_ca_topic_score_codex":0.002223078,"about_ca_topic_score_gemma":0.0022097141,"teacher_disagreement_score":0.0075865663,"about_ca_system_score_codex":0.0010961812,"about_ca_system_score_gemma":0.00075594895,"threshold_uncertainty_score":0.04012209},"labels":[],"label_agreement":null},{"id":"W3152312459","doi":"10.1002/edm2.237","title":"A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes","year":2021,"lang":"en","type":"article","venue":"Endocrinology Diabetes & Metabolism","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; University of Toronto","funders":"National Institute on Aging; Brigham and Women's Hospital","keywords":"Canagliflozin; Medicine; Adverse effect; Propensity score matching; Type 2 diabetes; Pairwise comparison; Internal medicine; Diabetes mellitus; Emergency medicine; Computer science; Endocrinology; Artificial intelligence","score_opus":0.04968597067545214,"score_gpt":0.3749862262306809,"score_spread":0.32530025555522873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152312459","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5130433,0.0015102068,0.429411,0.003817039,0.0003488542,0.0023927563,0.032404874,0.013098269,0.0039737397],"genre_scores_gemma":[0.6795189,0.00036627217,0.3035487,0.00076622784,0.00014674244,0.0011369742,0.013666577,0.00011495079,0.0007346015],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969789,0.0008496751,0.0007880432,0.000784481,0.0004896222,0.00010922947],"domain_scores_gemma":[0.9859235,0.009977107,0.0016057862,0.0009093759,0.001235779,0.00034841232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004888007,0.00085062283,0.0010759655,0.0043222597,0.0005105284,0.0011934453,0.0010807213,0.00092423457,0.0020053345],"category_scores_gemma":[0.02008954,0.00037562422,0.0019204918,0.0026643241,0.00024128915,0.000689331,0.0012217648,0.00089799584,0.00059510407],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025543661,0.0014080836,0.5306006,0.00081600243,0.0017942633,0.0013927531,0.0004405132,0.034958083,0.0051060137,0.0019992227,0.013450217,0.40547985],"study_design_scores_gemma":[0.00060995645,0.0010774722,0.067154564,0.00015338392,0.0005156678,0.0015663865,0.00040619113,0.9066412,0.0058746473,0.0071734926,0.00875322,0.000073845185],"about_ca_topic_score_codex":0.0029484464,"about_ca_topic_score_gemma":0.0041383994,"teacher_disagreement_score":0.004888007,"about_ca_system_score_codex":0.00046193178,"about_ca_system_score_gemma":0.0015577007,"threshold_uncertainty_score":0.025850594},"labels":[],"label_agreement":null},{"id":"W3154179323","doi":"10.2196/28616","title":"Distributed Ledger Infrastructure to Verify Adverse Event Reporting (DeLIVER): Proposal for a Proof-of-Concept Study","year":2021,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Event (particle physics); Interoperability; Computer science; Ledger; Interface (matter); Unique identifier; Identifier; Computer security; World Wide Web; Business","score_opus":0.37160303511311443,"score_gpt":0.6290031261266158,"score_spread":0.25740009101350136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154179323","genre_codex":"methods","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08248969,0.0047072084,0.76599467,0.0124480305,0.0035407764,0.089590594,0.0025488616,0.0072825365,0.03139775],"genre_scores_gemma":[0.17532106,0.0046240455,0.7231408,0.005391188,0.00059591327,0.058259398,0.002691801,0.00063536956,0.029340371],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97838026,0.008185301,0.0009461886,0.0016032774,0.009017924,0.0018670592],"domain_scores_gemma":[0.9803641,0.004623445,0.0018838628,0.0021176154,0.008408552,0.0026023376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040207624,0.0019687526,0.0013737973,0.0012931827,0.0013792581,0.00507875,0.0057913195,0.005169533,0.016896013],"category_scores_gemma":[0.026213106,0.0010491583,0.0024667599,0.0006188715,0.002229655,0.0059233685,0.005563384,0.0038863039,0.006088867],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009473612,0.017434146,0.009654216,0.01663903,0.0011163654,0.004689031,0.0043169563,0.011208619,0.24063776,0.0700777,0.09383938,0.5209131],"study_design_scores_gemma":[0.006333342,0.07347201,0.006816485,0.0036639539,0.0009922386,0.0034179308,0.0027085443,0.028275618,0.24401413,0.012550432,0.6171951,0.00056015205],"about_ca_topic_score_codex":0.0014739493,"about_ca_topic_score_gemma":0.0008020835,"teacher_disagreement_score":0.040207624,"about_ca_system_score_codex":0.0021517465,"about_ca_system_score_gemma":0.011015275,"threshold_uncertainty_score":0.21264076},"labels":[],"label_agreement":null},{"id":"W3154219648","doi":"10.15173/m.v1i28.2620","title":"The implications of antimalarial overprescription","year":2021,"lang":"en","type":"article","venue":"The Meducator","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"MEDLINE; Medicine; Data science; Computer science; Biology","score_opus":0.12619162882282442,"score_gpt":0.46977795051453547,"score_spread":0.34358632169171105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154219648","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052684836,0.10940257,0.0012749343,0.7686093,0.0031345948,0.00002981203,0.00061012234,0.000036552286,0.064217255],"genre_scores_gemma":[0.8503849,0.05873413,0.0017131297,0.077706836,0.007840203,0.000020988542,0.00015780788,0.000025465868,0.0034165443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98827666,0.006342029,0.001026235,0.0005777012,0.0033292107,0.000448093],"domain_scores_gemma":[0.9291849,0.039706588,0.018420774,0.0013142865,0.009213236,0.0021602286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0086572515,0.00030296127,0.0004960087,0.0014010672,0.0011892483,0.003216044,0.00081705645,0.0030236808,0.0063497676],"category_scores_gemma":[0.09136468,0.00020291633,0.000843438,0.00132693,0.0018550494,0.0024117907,0.0013238639,0.0049075545,0.00049634266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012944484,0.00034666067,0.14497209,0.0018317096,0.00057144003,0.00826761,0.0015236221,0.0013710422,0.0011941427,0.0638515,0.103710905,0.67106485],"study_design_scores_gemma":[0.00036410702,0.0010343116,0.27256483,0.013482154,0.0017350856,0.0279888,0.010323309,0.0065324674,0.0033117342,0.14115281,0.52116704,0.00034333274],"about_ca_topic_score_codex":0.00833601,"about_ca_topic_score_gemma":0.010792837,"teacher_disagreement_score":0.0086572515,"about_ca_system_score_codex":0.00300773,"about_ca_system_score_gemma":0.0047564525,"threshold_uncertainty_score":0.045784473},"labels":[],"label_agreement":null},{"id":"W3155177414","doi":"10.3390/jcm10081660","title":"Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adverse Event Reporting System; Mace; Pharmacovigilance; Odds ratio; Food and drug administration; Adverse effect; Myocardial infarction; Internal medicine; Emergency medicine; Medical emergency; Percutaneous coronary intervention","score_opus":0.13295451322977705,"score_gpt":0.4897166761109131,"score_spread":0.35676216288113605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155177414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925012,0.0021053709,0.0010177555,0.0002451156,0.000010635767,0.00012774629,0.003333445,0.00003054092,0.00062821625],"genre_scores_gemma":[0.99603695,0.00029363867,0.0006821355,0.00010142589,0.000019484525,0.00006144591,0.0027474312,0.0000068341565,0.000050711566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98726326,0.00506002,0.0029788706,0.001684602,0.0026633602,0.00034992353],"domain_scores_gemma":[0.9683652,0.0066415137,0.020650476,0.0014970208,0.002331515,0.00051421433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014090529,0.00034374752,0.0007098067,0.0036794178,0.00027639206,0.0010038179,0.00055344,0.0004257204,0.00070152397],"category_scores_gemma":[0.021068312,0.00026513272,0.0017903792,0.0044243857,0.00025613437,0.0008789314,0.0010478317,0.00043758668,0.00013789741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042932486,0.000028403201,0.99353105,0.000095449475,0.0008074607,0.00007075212,0.000080792895,0.000093841336,0.00039367186,0.000027252123,0.00019696822,0.0042451574],"study_design_scores_gemma":[0.000027920723,0.0001042704,0.9979221,0.000025482137,0.00045084505,0.00024362285,0.000061334365,0.0006946331,0.00015624549,0.000018499739,0.00028817673,0.000006914786],"about_ca_topic_score_codex":0.00399079,"about_ca_topic_score_gemma":0.0033644487,"teacher_disagreement_score":0.014090529,"about_ca_system_score_codex":0.0008597579,"about_ca_system_score_gemma":0.000766532,"threshold_uncertainty_score":0.07451868},"labels":[],"label_agreement":null},{"id":"W3155276984","doi":"10.18433/jpps31417","title":"High-quality reports and their characteristics in the Japanese Adverse Drug Event Report database (JADER)","year":2021,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Documentation; Medicine; Grading (engineering); Adverse effect; Drug; Pharmacovigilance; Adverse drug reaction; Database; Adverse drug event; Postmarketing surveillance; Drug reaction; Pharmacology; Computer science","score_opus":0.16197213803579338,"score_gpt":0.497913645523162,"score_spread":0.3359415074873686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155276984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7899337,0.014607831,0.016230237,0.0013057474,0.00022202922,0.0009864691,0.17189294,0.0007414878,0.0040796497],"genre_scores_gemma":[0.739787,0.0030624752,0.019309038,0.00037402473,0.00015011209,0.0009951821,0.23532906,0.00010572791,0.0008873603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9785413,0.0038523325,0.009403272,0.0026478085,0.0048831617,0.0006722077],"domain_scores_gemma":[0.8992091,0.029425701,0.04136813,0.0088098785,0.01932898,0.0018582596],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017649753,0.0005475839,0.0010195052,0.011418119,0.0005605868,0.0023506852,0.0009314163,0.0006372826,0.0012888567],"category_scores_gemma":[0.059860997,0.0002735839,0.0013798316,0.010399168,0.0004980184,0.0014348316,0.0019313644,0.0005407958,0.00047888124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003954648,0.00006671159,0.93888783,0.0026472218,0.00060067524,0.0003218473,0.00069631747,0.00063110475,0.001397629,0.0003211568,0.008321436,0.045712687],"study_design_scores_gemma":[0.00005403048,0.00014210625,0.9710354,0.0004775172,0.00066910434,0.00070453336,0.00090567255,0.002171129,0.001514618,0.00028491524,0.021980304,0.000060600545],"about_ca_topic_score_codex":0.008838361,"about_ca_topic_score_gemma":0.009017092,"teacher_disagreement_score":0.98235023,"about_ca_system_score_codex":0.0010456125,"about_ca_system_score_gemma":0.0024040763,"threshold_uncertainty_score":0.09334195},"labels":[],"label_agreement":null},{"id":"W3155338345","doi":"10.1186/s12913-021-06346-y","title":"Detection of adverse drug events in e-prescribing and administrative health data: a validation study","year":2021,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gold standard (test); Adverse effect; Diagnosis code; Emergency medicine; Antidepressant; Drug; Prospective cohort study; Health care; Internal medicine; Psychiatry; Population","score_opus":0.3951830884829906,"score_gpt":0.5966214590806832,"score_spread":0.2014383705976926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155338345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995423,0.00015684754,0.0019927118,0.00008193827,0.000021186945,0.00076506997,0.00087429915,0.000019148532,0.00066564826],"genre_scores_gemma":[0.9925121,0.00010351106,0.0035492901,0.00019082733,0.000044730343,0.0005087326,0.0029148702,0.000015583691,0.00016046884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95611805,0.029759632,0.00318709,0.0033374769,0.0063313623,0.0012664226],"domain_scores_gemma":[0.8467043,0.072916634,0.029464036,0.028525256,0.019436365,0.0029533466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049299978,0.0011399791,0.00080032763,0.0019933025,0.0009641061,0.0016819944,0.0023120178,0.0018216115,0.0009223726],"category_scores_gemma":[0.09842567,0.00084794994,0.002144309,0.0019684378,0.002025902,0.0016091863,0.0022465386,0.0015786256,0.0006781924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008492743,0.00091561035,0.99288636,0.00006209651,0.0002660027,0.00007889984,0.00038931982,0.00025058087,0.00029964387,0.000050777282,0.00016400097,0.0037874216],"study_design_scores_gemma":[0.00040872794,0.0018345817,0.99244976,0.00008494523,0.00024133033,0.00047813266,0.00028617636,0.0027375873,0.0005430572,0.00010777819,0.00079962495,0.000028213768],"about_ca_topic_score_codex":0.006141735,"about_ca_topic_score_gemma":0.005334527,"teacher_disagreement_score":0.049299978,"about_ca_system_score_codex":0.0010854665,"about_ca_system_score_gemma":0.0024332672,"threshold_uncertainty_score":0.26072627},"labels":[],"label_agreement":null},{"id":"W3155505183","doi":"10.2196/28763","title":"Detecting Adverse Drug Events Through the Chronological Relationship Between the Medication Period and the Presence of Adverse Reactions From Electronic Medical Record Systems: Observational Study","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Ticlopidine; Aspirin; Adverse effect; Medical record; Adverse drug reaction; Postmarketing surveillance; Drug; Pharmacovigilance; Emergency medicine; Observational study; Internal medicine; Pharmacology","score_opus":0.1546224626638324,"score_gpt":0.4413911666600811,"score_spread":0.2867687039962487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155505183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778134,0.00031168843,0.0008866045,0.000024413464,0.000009667447,0.00014649812,0.0005899417,0.000007748627,0.00024211573],"genre_scores_gemma":[0.99720865,0.00023976831,0.0011666873,0.00004900726,0.00003321561,0.00012858976,0.001097811,0.0000043673526,0.000071916016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994531,0.0020745324,0.0011389061,0.00087679655,0.0010855196,0.00029330605],"domain_scores_gemma":[0.97185713,0.008164367,0.013360282,0.0025338142,0.0030448372,0.0010394568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005372308,0.00049561315,0.00060766394,0.0027339424,0.00063580024,0.0008555675,0.0006304711,0.0006570876,0.0010681103],"category_scores_gemma":[0.018610885,0.00057607645,0.0013417074,0.0024093003,0.0005188591,0.0013763084,0.0009138545,0.00097456184,0.00029191197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018071229,0.00017722158,0.9980254,0.000027957107,0.000100491605,0.00005128264,0.000087808716,0.00004655891,0.00007701954,0.000009400213,0.000068015535,0.0011481242],"study_design_scores_gemma":[0.00008148048,0.0010335995,0.9957004,0.000030438523,0.00020948633,0.0005218511,0.00030282678,0.0014583055,0.00022277341,0.000033457414,0.0003862703,0.00001912523],"about_ca_topic_score_codex":0.0053105983,"about_ca_topic_score_gemma":0.005529999,"teacher_disagreement_score":0.005372308,"about_ca_system_score_codex":0.0006105365,"about_ca_system_score_gemma":0.0012424641,"threshold_uncertainty_score":0.028411806},"labels":[],"label_agreement":null},{"id":"W3159478449","doi":"","title":"A REVIEW ON ROLE OF PHARMACIST ON ECONOMIC BURDEN OF ADVERSE DRUG REACTIONS","year":2005,"lang":"en","type":"review","venue":"World Journal of Pharmaceutical and life sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug reaction; Pharmacist; Adverse drug reaction; Incidence (geometry); Drug; Pharmacovigilance; Pharmacy; Intervention (counseling); Health care; Intensive care medicine; Emergency medicine; Medical emergency; Family medicine; Pharmacology; Nursing","score_opus":0.20384516458119062,"score_gpt":0.511194763266717,"score_spread":0.30734959868552636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159478449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013249477,0.9987011,0.000040191473,0.00026815926,0.00014252811,0.000003934565,0.000021646281,0.0000025982883,0.0006873174],"genre_scores_gemma":[0.000716008,0.99878985,0.00008288008,0.00011681946,0.0001016971,0.0000041267926,0.000018812305,5.780562e-7,0.00016924231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945384,0.00014779238,0.0001014883,0.000058272824,0.00021028804,0.00002829442],"domain_scores_gemma":[0.9985008,0.0008233386,0.00028395388,0.000017855515,0.00032090017,0.00005307773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009206499,0.0007882077,0.0020819323,0.0034934066,0.00022591832,0.0011530207,0.00096465,0.0011029557,0.00612035],"category_scores_gemma":[0.002384515,0.00026621987,0.00094538805,0.0053811823,0.00024161651,0.0012892424,0.0004078353,0.0007763943,0.0011460744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014324531,0.000056199926,0.00045625234,0.049360868,0.00027404306,0.00038175518,0.000049892144,0.0003359692,0.00026763257,0.001284025,0.034689505,0.91270065],"study_design_scores_gemma":[0.00011002114,0.00035299957,0.008385979,0.05045006,0.001225298,0.0040708175,0.00024213435,0.00031472696,0.00042668573,0.0020284704,0.93234044,0.000052357536],"about_ca_topic_score_codex":0.0022250928,"about_ca_topic_score_gemma":0.003799858,"teacher_disagreement_score":0.00612035,"about_ca_system_score_codex":0.00087117305,"about_ca_system_score_gemma":0.001837095,"threshold_uncertainty_score":0.020474613},"labels":[],"label_agreement":null},{"id":"W3162984560","doi":"10.3899/jrheum.201373","title":"Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals","year":2021,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"ZonMw; Biogen; Sanofi; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Discontinuation; Internal medicine; Etanercept; Adalimumab; Adverse effect; Drug reaction; Gastroenterology; Drug; Rheumatoid arthritis; Pharmacology","score_opus":0.10546824254931095,"score_gpt":0.44107126440477307,"score_spread":0.3356030218554621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162984560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887976,0.0018622414,0.0005038024,0.00021868915,0.000010982572,0.000080307356,0.0069343983,0.000010758745,0.0015812899],"genre_scores_gemma":[0.9936352,0.00068044657,0.0004505548,0.00012021264,0.00002507537,0.000083906576,0.0048774076,0.0000035480048,0.00012363981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98767686,0.0056776735,0.0028775146,0.0014666195,0.0019866994,0.0003145431],"domain_scores_gemma":[0.9654887,0.007864599,0.022815371,0.0012087364,0.0020374586,0.0005852474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046196277,0.0002063845,0.0004799613,0.0016488385,0.00016901465,0.0009553672,0.0002901946,0.00051676214,0.0015234752],"category_scores_gemma":[0.019790394,0.00017250757,0.0006192456,0.0028390142,0.00027851117,0.0009478999,0.00066156505,0.00028592243,0.00040318878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026249408,0.0000471762,0.9930058,0.00017265636,0.00015812095,0.0000759813,0.00021010364,0.00012054426,0.00010569018,0.000019829453,0.00028130796,0.0055403896],"study_design_scores_gemma":[0.000046162942,0.00018684176,0.99679273,0.000070310576,0.00006333437,0.0007192268,0.00043608688,0.00037339178,0.00011177352,0.000030340616,0.0011546599,0.000015150377],"about_ca_topic_score_codex":0.0024351962,"about_ca_topic_score_gemma":0.0021653767,"teacher_disagreement_score":0.0046196277,"about_ca_system_score_codex":0.00044227942,"about_ca_system_score_gemma":0.00042023315,"threshold_uncertainty_score":0.024431229},"labels":[],"label_agreement":null},{"id":"W3164549179","doi":"10.1080/09546634.2021.1937480","title":"Data mining for detecting signals of adverse drug reaction of doxycycline using the Korea adverse event reporting system database","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Pharmacovigilance; Malaise; Adverse drug reaction; Doxycycline; Dermatology; Adverse Event Reporting System; Hyperpigmentation; Internal medicine; Paronychia; Database; Surgery; Drug; Antibiotics; Pharmacology","score_opus":0.3452900453759856,"score_gpt":0.4972952069914539,"score_spread":0.1520051616154683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164549179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6395812,0.004796623,0.04779315,0.0015687098,0.00023410628,0.0035822033,0.29483613,0.003652788,0.0039551333],"genre_scores_gemma":[0.6081443,0.001992261,0.11148109,0.00041324447,0.000108328044,0.0029211987,0.2739524,0.00006621664,0.0009209079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954991,0.0006107698,0.0018215827,0.0009975736,0.00088602834,0.00018497401],"domain_scores_gemma":[0.98941165,0.0036342258,0.0034474442,0.00085070706,0.002214801,0.00044111675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004093361,0.00091330963,0.0011915301,0.008505575,0.00046628856,0.0012896004,0.0011778752,0.00081440114,0.0011665517],"category_scores_gemma":[0.010667181,0.00027642975,0.001436577,0.0055809123,0.0002161781,0.0009742685,0.0009098519,0.0007688415,0.00050159363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019533762,0.0010868775,0.6873643,0.006519412,0.0017098314,0.004852987,0.0006154762,0.014583495,0.011206845,0.00183061,0.033155102,0.23512171],"study_design_scores_gemma":[0.00075574836,0.0020180708,0.6636211,0.0012703359,0.0021678712,0.005092742,0.001933656,0.21990839,0.026594607,0.0035889507,0.07270825,0.00034024898],"about_ca_topic_score_codex":0.0055519673,"about_ca_topic_score_gemma":0.00551612,"teacher_disagreement_score":0.008505575,"about_ca_system_score_codex":0.0008208847,"about_ca_system_score_gemma":0.0025710235,"threshold_uncertainty_score":0.02164805},"labels":[],"label_agreement":null},{"id":"W3169738411","doi":"10.2196/30137","title":"The Use of Social Media in Detecting Drug Safety–Related New Black Box Warnings, Labeling Changes, or Withdrawals: Scoping Review","year":2021,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Chungnam National University","keywords":"Social media; Checklist; Social media analytics; Health care; Internet privacy; Psychology; Applied psychology; Medicine; Data science; Computer science; Political science; World Wide Web","score_opus":0.20970858092086167,"score_gpt":0.4557462666501132,"score_spread":0.24603768572925153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169738411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012640437,0.9935215,0.00073863607,0.00078133837,0.00040620397,0.0019378407,0.00042412928,0.00001761586,0.0009086315],"genre_scores_gemma":[0.016279157,0.97583765,0.0027950187,0.0009061299,0.0002477623,0.0033032028,0.00039529765,0.000017229382,0.0002185944],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.94421935,0.022880623,0.020559413,0.0025908938,0.008973132,0.0007766354],"domain_scores_gemma":[0.7512621,0.19473207,0.029815374,0.003657661,0.01979293,0.0007398289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049917758,0.0024459101,0.0074327476,0.028699001,0.001857722,0.006000253,0.003103219,0.0043643457,0.004413211],"category_scores_gemma":[0.21922432,0.0017507768,0.012278282,0.018714169,0.0023186665,0.0064788642,0.0036235733,0.0024729948,0.0006327481],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018087961,0.000035697867,0.0010365049,0.9132792,0.005287922,0.00010185294,0.0005979046,0.00014470065,0.00013589933,0.0005084589,0.0018023947,0.076888554],"study_design_scores_gemma":[0.00005127202,0.00009781653,0.0011031022,0.968123,0.018206764,0.00012493815,0.0003412228,0.000101967846,0.00019080048,0.00033131655,0.011301893,0.00002581662],"about_ca_topic_score_codex":0.009802154,"about_ca_topic_score_gemma":0.019545594,"teacher_disagreement_score":0.049917758,"about_ca_system_score_codex":0.0073896204,"about_ca_system_score_gemma":0.024317266,"threshold_uncertainty_score":0.2639935},"labels":[],"label_agreement":null},{"id":"W3170524640","doi":"10.1177/17151635211020306","title":"Explosive drug information in the time of COVID-19","year":2021,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Explosive material; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Drug; Medicine; Virology; History; Pharmacology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.08962081486514584,"score_gpt":0.37809641616618833,"score_spread":0.2884756013010425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170524640","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0459867,0.021898067,0.004652986,0.40258226,0.04714437,0.0006775522,0.023600785,0.0023711247,0.4510862],"genre_scores_gemma":[0.39894095,0.011246224,0.0057086926,0.30125564,0.018225573,0.00025147488,0.013725959,0.0010322896,0.24961312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917514,0.00084354414,0.00081887195,0.0005477192,0.004707241,0.0013312815],"domain_scores_gemma":[0.97077066,0.0065097422,0.0032617555,0.0013598253,0.011799847,0.0062981956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050941673,0.00033152444,0.0006327351,0.0035972956,0.0027856405,0.0062744017,0.0011933459,0.005301827,0.029231666],"category_scores_gemma":[0.04069353,0.00044890656,0.000704961,0.0021021832,0.0010395888,0.0021405914,0.002639606,0.0068972376,0.0077343234],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006751011,0.00014111146,0.034228746,0.00037535353,0.00007504587,0.0059094136,0.0007357179,0.0002476848,0.0009984925,0.02053831,0.824419,0.11165589],"study_design_scores_gemma":[0.000044267257,0.000095976044,0.024697702,0.0005440349,0.000041826188,0.0015704356,0.00042529064,0.00031814122,0.0009863514,0.0019862675,0.9692384,0.000051219842],"about_ca_topic_score_codex":0.15064293,"about_ca_topic_score_gemma":0.22047956,"teacher_disagreement_score":0.84935707,"about_ca_system_score_codex":0.011107616,"about_ca_system_score_gemma":0.016339906,"threshold_uncertainty_score":0.29953218},"labels":[],"label_agreement":null},{"id":"W3170989721","doi":"10.1002/jgh3.12585","title":"Systemic quinolones and risk of acute liver failure I: Analysis of data from the <scp>US FDA</scp> adverse event reporting system","year":2021,"lang":"en","type":"article","venue":"JGH Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; Children's Hospital of Eastern Ontario; McGill University; Nutrition International; McGill University Health Centre; Ottawa Public Health; Institute of Population and Public Health; University of Ottawa","funders":"","keywords":"Moxifloxacin; Pharmacovigilance; Levofloxacin; Quinolone; Adverse Event Reporting System; Ciprofloxacin; Medicine; Antibiotics; Ofloxacin; Adverse effect; Gatifloxacin; Internal medicine; Pharmacology; Microbiology","score_opus":0.15765379636744395,"score_gpt":0.446258836865798,"score_spread":0.288605040498354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170989721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861822,0.0030203843,0.001240614,0.00023999777,0.000015593847,0.00012479926,0.008445855,0.000026816882,0.0007036287],"genre_scores_gemma":[0.9950841,0.00028563777,0.0006685103,0.000063784624,0.000019724252,0.000053902982,0.003745684,0.000007643311,0.00007100139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98811483,0.005334199,0.0027991107,0.0013574986,0.0019236833,0.00047066284],"domain_scores_gemma":[0.9497316,0.020145535,0.024280448,0.0025102696,0.0025486848,0.0007833812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009862803,0.00034216492,0.00060189044,0.004552076,0.00019617722,0.0009082872,0.00043851184,0.00051459495,0.002217858],"category_scores_gemma":[0.02512229,0.00016299839,0.00271282,0.004296786,0.0003160947,0.0006670493,0.0007872472,0.0005305386,0.000256797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077349076,0.000030575582,0.9928387,0.0001958993,0.0016819565,0.000087656634,0.00005155009,0.00022769882,0.00028275783,0.000035076482,0.00033110622,0.0034635447],"study_design_scores_gemma":[0.000037839636,0.00033723994,0.9961825,0.00007020411,0.0006968086,0.00035492599,0.00013553105,0.0013350901,0.00024377076,0.000048014495,0.0005437804,0.000014320577],"about_ca_topic_score_codex":0.003555922,"about_ca_topic_score_gemma":0.0025639944,"teacher_disagreement_score":0.009862803,"about_ca_system_score_codex":0.00070456846,"about_ca_system_score_gemma":0.0008000942,"threshold_uncertainty_score":0.052160084},"labels":[],"label_agreement":null},{"id":"W3172264585","doi":"10.1016/j.phclin.2021.06.001","title":"COVID-19 treatments and associated adverse reactions: The need for effective strategies to strengthen pharmacovigilance system in Lower- and middle-income countries","year":2021,"lang":"en","type":"article","venue":"Le Pharmacien Clinicien","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Business; Revenue; Workload; Quarter (Canadian coin); Accounting; Product (mathematics); Pandemic; Data collection; Marketing; Coronavirus disease 2019 (COVID-19); Medicine; Adverse effect; Economics","score_opus":0.14116643916112082,"score_gpt":0.4697803144095855,"score_spread":0.3286138752484647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172264585","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.084274024,0.22058988,0.01405476,0.6313952,0.00515603,0.00057655736,0.007096181,0.00090136594,0.035955977],"genre_scores_gemma":[0.66157824,0.10999074,0.04818952,0.1587093,0.006797686,0.000700569,0.009673723,0.00025808823,0.004102095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99210197,0.0041380175,0.0011325853,0.0004955121,0.0013270174,0.0008050396],"domain_scores_gemma":[0.95997894,0.011172968,0.012418844,0.001173501,0.00817776,0.0070779673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013393921,0.00057325483,0.001565206,0.001870815,0.0008596403,0.0055577573,0.0014841527,0.001961864,0.0080542695],"category_scores_gemma":[0.03165076,0.00028921105,0.0012541196,0.002620946,0.0010358251,0.0034710022,0.0026617937,0.005032851,0.000934248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009719688,0.00058949715,0.25015214,0.004880491,0.00093301747,0.0012692076,0.0009890115,0.0017700234,0.0009385112,0.01917474,0.1922946,0.52603686],"study_design_scores_gemma":[0.00055639347,0.0007938852,0.49020314,0.01971165,0.0011637532,0.003135306,0.005254111,0.0039932895,0.0009055561,0.021945281,0.45205194,0.0002857188],"about_ca_topic_score_codex":0.018944662,"about_ca_topic_score_gemma":0.014543114,"teacher_disagreement_score":0.018944662,"about_ca_system_score_codex":0.0027924706,"about_ca_system_score_gemma":0.014563604,"threshold_uncertainty_score":0.0708347},"labels":[],"label_agreement":null},{"id":"W3173725356","doi":"10.2196/29238","title":"Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance: Natural Language Processing Analysis of Patient-Generated Texts About Systemic Lupus Erythematosus","year":2021,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Epidemiology; Disease; Health care; Quality of life (healthcare); Systemic lupus erythematosus; Database; Family medicine; Pediatrics; Internal medicine; Adverse effect; Nursing","score_opus":0.07143323700768511,"score_gpt":0.4229865856696252,"score_spread":0.3515533486619401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173725356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548292,0.0010070849,0.026122302,0.0018057964,0.00009954183,0.00047621358,0.013243045,0.00058274734,0.0018341093],"genre_scores_gemma":[0.8824244,0.0005039997,0.09724942,0.000393415,0.00014970398,0.00050368765,0.017965982,0.00007320725,0.00073629705],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964265,0.0019783252,0.00048360924,0.0004893409,0.00051047246,0.000111763795],"domain_scores_gemma":[0.9569388,0.037570793,0.0028372929,0.0007977079,0.0015622041,0.00029323314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039256904,0.00053759525,0.00031467248,0.0041693714,0.0004392446,0.0016930278,0.00042984827,0.0008985059,0.000670554],"category_scores_gemma":[0.020598255,0.00018775607,0.00053204544,0.0025136373,0.0004929926,0.0014594245,0.00079828594,0.0006820279,0.0003122173],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024263668,0.0023564987,0.35084823,0.0057426267,0.00068268034,0.012127769,0.055818148,0.020328447,0.06392057,0.0044576097,0.01852973,0.46276134],"study_design_scores_gemma":[0.00029236247,0.0010315473,0.44346064,0.0012321599,0.0007540231,0.005184871,0.043495793,0.38491747,0.037851904,0.014297981,0.067039095,0.00044212257],"about_ca_topic_score_codex":0.0026199853,"about_ca_topic_score_gemma":0.004434376,"teacher_disagreement_score":0.0041693714,"about_ca_system_score_codex":0.0007500255,"about_ca_system_score_gemma":0.0008802883,"threshold_uncertainty_score":0.020761311},"labels":[],"label_agreement":null},{"id":"W3174972277","doi":"10.2174/1574886316666210609115148","title":"ADR in Journals: Are They Translated into Regulatory Frameworks?","year":2021,"lang":"en","type":"article","venue":"Current Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Casual; Drug reaction; Adverse drug reaction; Pharmacovigilance; Regulatory authority; Package insert; Family medicine; Drug; Pharmacology","score_opus":0.10822666213416897,"score_gpt":0.4663708271501905,"score_spread":0.35814416501602153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174972277","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12176897,0.6036836,0.0116841085,0.11514536,0.022119628,0.002409512,0.036000855,0.00114935,0.086038575],"genre_scores_gemma":[0.49582246,0.39565945,0.0246664,0.03264142,0.02079433,0.0021923599,0.01867799,0.0011593308,0.008386264],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.87185884,0.032706663,0.049021926,0.0055623916,0.039445303,0.0014049169],"domain_scores_gemma":[0.43434504,0.29258066,0.18771857,0.015296516,0.066769995,0.0032892511],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04530696,0.00066582224,0.0013689597,0.023941223,0.0010436152,0.0077718166,0.00174911,0.001486333,0.018623488],"category_scores_gemma":[0.30413964,0.0006334677,0.0012439253,0.039767683,0.003980336,0.008574745,0.0026535883,0.0013900317,0.0053696567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007537043,0.0001637196,0.074990205,0.11437573,0.00055003684,0.0026105528,0.012338078,0.00019986894,0.00204276,0.016408535,0.13538592,0.6401809],"study_design_scores_gemma":[0.00014199453,0.00032598668,0.13996741,0.06712464,0.0008963061,0.007741079,0.014724513,0.0002598797,0.0017601242,0.0074725063,0.75937116,0.00021428737],"about_ca_topic_score_codex":0.0019155034,"about_ca_topic_score_gemma":0.0016362446,"teacher_disagreement_score":0.954693,"about_ca_system_score_codex":0.0027215418,"about_ca_system_score_gemma":0.00686753,"threshold_uncertainty_score":0.239609},"labels":[],"label_agreement":null},{"id":"W3180978662","doi":"10.4212/cjhp.v73i2.3186","title":"Have Current Systems of Pharmacovigilance Had Their Day? The “Pro” Side","year":2021,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Pharmacovigilance; Side effect (computer science); Medicine; Current (fluid); Pharmacology; Computer science; Adverse effect; Engineering","score_opus":0.11786647671945265,"score_gpt":0.4151490583255636,"score_spread":0.29728258160611093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180978662","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007588982,0.01847328,0.0011852557,0.966579,0.009314001,0.00000938342,0.00009021112,0.000068810805,0.0035210806],"genre_scores_gemma":[0.055350535,0.033964783,0.0064560384,0.85296476,0.04557939,0.000083686646,0.00019158387,0.00023474889,0.0051744194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9628334,0.015611479,0.0030988932,0.00296879,0.012798908,0.0026886086],"domain_scores_gemma":[0.7970275,0.09483145,0.010663168,0.011108198,0.06260061,0.023769073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.100767635,0.0015597006,0.0023649323,0.0022351216,0.0056925584,0.020131651,0.004588888,0.01637715,0.02539042],"category_scores_gemma":[0.14106436,0.0009579737,0.0017722548,0.0024233288,0.025066866,0.03812376,0.0066408333,0.03407271,0.0061412985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000612359,0.00035065928,0.006373602,0.0018145053,0.0004197693,0.00026824858,0.0016670689,0.00071470154,0.0007352791,0.20484672,0.5842815,0.1979156],"study_design_scores_gemma":[0.00030750854,0.000525433,0.010139551,0.0042600236,0.0002851281,0.0004509826,0.0070339614,0.0011477394,0.00055990653,0.19147128,0.78345585,0.00036272084],"about_ca_topic_score_codex":0.017335605,"about_ca_topic_score_gemma":0.025036164,"teacher_disagreement_score":0.100767635,"about_ca_system_score_codex":0.00982017,"about_ca_system_score_gemma":0.019342933,"threshold_uncertainty_score":0.53291655},"labels":[],"label_agreement":null},{"id":"W3187063758","doi":"10.2196/24651","title":"Candidemia Risk Prediction (CanDETEC) Model for Patients With Malignancy: Model Development and Validation in a Single-Center Retrospective Study","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Korea Health Industry Development Institute","keywords":"Medicine; Random forest; Retrospective cohort study; Receiver operating characteristic; Logistic regression; Machine learning; Artificial intelligence; Cancer; Internal medicine; Algorithm; Computer science","score_opus":0.0641049387357311,"score_gpt":0.38042674950844796,"score_spread":0.31632181077271687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187063758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97379273,0.00072278007,0.023443945,0.00024357063,0.000037478905,0.0002589465,0.0010264042,0.0001661798,0.00030787278],"genre_scores_gemma":[0.9843918,0.00020322352,0.013669369,0.00004669089,0.000016656026,0.00018137446,0.0013558472,0.000012856107,0.00012218922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974504,0.0014833984,0.00019825659,0.0005108029,0.0002144941,0.00014263867],"domain_scores_gemma":[0.9824551,0.013329631,0.0011217307,0.0010241995,0.0017069186,0.0003624733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017375778,0.0012061984,0.0016687798,0.0018238175,0.00045014688,0.0014082533,0.0014132169,0.0008797835,0.0010191594],"category_scores_gemma":[0.019507337,0.0005437741,0.002428354,0.00085267634,0.00037325313,0.0006026258,0.00088160444,0.0014907633,0.00023024008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003903206,0.0009750294,0.7012886,0.00022001428,0.0022285169,0.0004370766,0.0002025477,0.25364718,0.0007301094,0.0006249073,0.0015062902,0.034236513],"study_design_scores_gemma":[0.00011942505,0.00065181765,0.030382782,0.000039517192,0.00040282478,0.00019464793,0.000070731774,0.96717805,0.0003932411,0.00030802874,0.00023506512,0.000023857874],"about_ca_topic_score_codex":0.010175549,"about_ca_topic_score_gemma":0.004536805,"teacher_disagreement_score":0.017375778,"about_ca_system_score_codex":0.0010014924,"about_ca_system_score_gemma":0.0016677459,"threshold_uncertainty_score":0.09189302},"labels":[],"label_agreement":null},{"id":"W3197931111","doi":"10.1016/j.curtheres.2021.100644","title":"Potentially Inappropriate Drug Duplication in a Cohort of Older Adults with Dementia","year":2021,"lang":"en","type":"article","venue":"Current Therapeutic Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Department of Health and Wellness; Department of Health, Western Cape Government; Consortium canadien en neurodégénérescence associée au vieillissement","keywords":"Medicine; Cohort; Dementia; Logistic regression; Internal medicine; Hazard ratio; Retrospective cohort study; Confidence interval; Disease","score_opus":0.14800080911331628,"score_gpt":0.48805487278385956,"score_spread":0.34005406367054325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197931111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992341,0.00015236728,0.000025094934,0.000040947045,0.0000039181555,0.0000113658025,0.00029612987,0.0000012768223,0.00023475316],"genre_scores_gemma":[0.99936193,0.000120664954,0.000051846007,0.00004489894,0.000007802102,0.000007740648,0.0003176274,7.585028e-7,0.0000868562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992267,0.000112628826,0.00010655107,0.00017685929,0.00021804225,0.00015923797],"domain_scores_gemma":[0.99690264,0.00027604116,0.0019680767,0.00016363634,0.00032992085,0.00035959115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000686897,0.00028839134,0.00037521837,0.0014205722,0.0009789864,0.0007777691,0.00043238988,0.00040397648,0.0011350748],"category_scores_gemma":[0.0032179202,0.00037160236,0.00048826396,0.0015993052,0.00034777803,0.00047457643,0.00083685276,0.0005936258,0.00016470179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020824415,0.00000773101,0.99943393,0.000003832394,0.000009771438,0.000102180165,0.00007091041,0.0000061149035,0.00003495838,0.000004035411,0.000040584313,0.0002650496],"study_design_scores_gemma":[0.0000018412558,0.000024785728,0.99911755,0.000009329202,0.0000079638085,0.00048051417,0.00019858511,0.00006698807,0.000017311166,0.000006137186,0.00006711986,0.0000017612114],"about_ca_topic_score_codex":0.097596325,"about_ca_topic_score_gemma":0.13657735,"teacher_disagreement_score":0.097596325,"about_ca_system_score_codex":0.0009855367,"about_ca_system_score_gemma":0.0011338536,"threshold_uncertainty_score":0.19405651},"labels":[],"label_agreement":null},{"id":"W3199673018","doi":"10.2196/32730","title":"Adverse Drug Event Prediction Using Noisy Literature-Derived Knowledge Graphs: Algorithm Development and Validation","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Machine learning; Artificial intelligence; Computer science; Inference; Natural language processing; Representation (politics); Pharmacovigilance; Named-entity recognition; Benchmark (surveying); Graph; Theoretical computer science; Task (project management); Medicine; Adverse effect","score_opus":0.057696897619780765,"score_gpt":0.41431844613195923,"score_spread":0.3566215485121785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199673018","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1494045,0.006364369,0.82087946,0.0024648348,0.00034562187,0.0013526843,0.0057326457,0.00984826,0.003607721],"genre_scores_gemma":[0.43474713,0.0016002343,0.54863024,0.0006214929,0.0001883206,0.0012056198,0.011388361,0.00021916404,0.0013994905],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99698955,0.001206436,0.00028279636,0.00083854416,0.00052049436,0.00016235586],"domain_scores_gemma":[0.9676416,0.026470482,0.0012526695,0.001822202,0.0024887554,0.0003242635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006898103,0.0017533896,0.0016413267,0.00389572,0.00082839484,0.0020967936,0.0035760116,0.003121845,0.002819025],"category_scores_gemma":[0.037064813,0.0006440707,0.0017426244,0.0026415186,0.0010533755,0.0023272398,0.0022014847,0.0029807747,0.0013435917],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053122867,0.0006555608,0.008732663,0.00048335927,0.00034251387,0.00024760375,0.00013001978,0.70097095,0.00083348237,0.0031994628,0.007362144,0.27651104],"study_design_scores_gemma":[0.000052697425,0.000044855886,0.00041171908,0.00003300344,0.000025395497,0.000045945497,0.000020769068,0.99454814,0.00032431266,0.003977094,0.0005094769,0.0000065711],"about_ca_topic_score_codex":0.010457119,"about_ca_topic_score_gemma":0.008073107,"teacher_disagreement_score":0.010457119,"about_ca_system_score_codex":0.002195811,"about_ca_system_score_gemma":0.0033499666,"threshold_uncertainty_score":0.036481082},"labels":[],"label_agreement":null},{"id":"W3201283871","doi":"10.1002/jac5.1524","title":"Current and recommended practices for evaluating adverse drug events using electronic health records: A systematic review","year":2021,"lang":"en","type":"review","venue":"JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CINAHL; MEDLINE; Health records; Confounding; Electronic health record; Pharmacoepidemiology; Covariate; Family medicine; Medical prescription; Health care; Psychological intervention; Internal medicine; Computer science; Pharmacology","score_opus":0.510080389029251,"score_gpt":0.6680824526535131,"score_spread":0.15800206362426206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201283871","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001714562,0.98824406,0.0020161944,0.0018856747,0.00040273866,0.0039777304,0.0010514676,0.00004035289,0.00066708436],"genre_scores_gemma":[0.03846984,0.9303945,0.018175744,0.001840187,0.00022268164,0.009711176,0.0009762214,0.00002803441,0.00018156225],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7830626,0.0789174,0.10067296,0.0073598963,0.028644271,0.0013428392],"domain_scores_gemma":[0.62674963,0.24418405,0.07008957,0.008257805,0.048936035,0.0017829131],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13211131,0.0026442006,0.010863718,0.0428176,0.0016445075,0.0071932976,0.005420083,0.0031656646,0.0029080303],"category_scores_gemma":[0.3526389,0.0027469061,0.012546143,0.03087511,0.003205133,0.009101919,0.0038618497,0.0021096838,0.00048529758],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010777482,0.000021320891,0.002641434,0.9301756,0.007773574,0.000074256364,0.00067528716,0.00015690253,0.00011663343,0.0004950493,0.0018212583,0.05594103],"study_design_scores_gemma":[0.000118939744,0.000073656534,0.0022241487,0.9708646,0.017594073,0.0001417187,0.00043265254,0.0001397502,0.00014447224,0.00037564398,0.007849922,0.000040440977],"about_ca_topic_score_codex":0.012345736,"about_ca_topic_score_gemma":0.028096715,"teacher_disagreement_score":0.8678887,"about_ca_system_score_codex":0.011748448,"about_ca_system_score_gemma":0.035094637,"threshold_uncertainty_score":0.69867975},"labels":[],"label_agreement":null},{"id":"W3201829940","doi":"10.2196/20652","title":"Tracking the Presence of Software as a Medical Device in US Food and Drug Administration Databases: Retrospective Data Analysis","year":2021,"lang":"en","type":"article","venue":"JMIR Biomedical Engineering","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Food and drug administration; Tracking (education); Database; Drug; Software; Drug administration; Computer science; Medicine; Pharmacology; Psychology","score_opus":0.08613789977954613,"score_gpt":0.44025505917988716,"score_spread":0.35411715940034105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201829940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86615777,0.009221339,0.003148344,0.0009241389,0.00006173795,0.0009708779,0.11505834,0.0001225396,0.0043349057],"genre_scores_gemma":[0.9316239,0.0032920232,0.0038569514,0.0005926665,0.00006908373,0.001284613,0.058807127,0.000046506106,0.00042714857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97540945,0.0044962997,0.009517492,0.0035645063,0.005909976,0.0011023786],"domain_scores_gemma":[0.89349747,0.03189897,0.055229265,0.007381775,0.010358253,0.0016342571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011967276,0.00047705672,0.0011026164,0.011593302,0.000800405,0.0019603623,0.0012238444,0.0009002297,0.0026038713],"category_scores_gemma":[0.048763055,0.0006766962,0.0015679611,0.016222266,0.0007060203,0.002297282,0.0019040628,0.0015997727,0.00081921514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039081482,0.00008248618,0.98681074,0.00075237756,0.00048491106,0.00008922814,0.0002482503,0.00022324901,0.00012419518,0.0002490423,0.003203879,0.0073408335],"study_design_scores_gemma":[0.000064486674,0.00027160966,0.9856048,0.0008929716,0.0006493787,0.0007480882,0.0011516749,0.0017661804,0.00065575045,0.00034113746,0.0077994075,0.000054416763],"about_ca_topic_score_codex":0.014738158,"about_ca_topic_score_gemma":0.014217452,"teacher_disagreement_score":0.014738158,"about_ca_system_score_codex":0.0017594384,"about_ca_system_score_gemma":0.0033878458,"threshold_uncertainty_score":0.06328976},"labels":[],"label_agreement":null},{"id":"W3202078810","doi":"10.2196/26407","title":"Chinese-Named Entity Recognition From Adverse Drug Event Records: Radical Embedding-Combined Dynamic Embedding–Based BERT in a Bidirectional Long Short-term Conditional Random Field (Bi-LSTM-CRF) Model","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"China Pharmaceutical University; National Natural Science Foundation of China","keywords":"Conditional random field; Pharmacovigilance; Named-entity recognition; Computer science; Artificial intelligence; Natural language processing; Drug reaction; Recall; Adverse drug reaction; Medicine; Machine learning; Adverse effect; Drug; Pharmacology; Engineering; Psychology; Cognitive psychology","score_opus":0.03818304628788474,"score_gpt":0.42150453957782535,"score_spread":0.3833214932899406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202078810","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26779288,0.002481614,0.7130421,0.0015557433,0.00044570692,0.00026924914,0.0024636243,0.0065691825,0.00537987],"genre_scores_gemma":[0.8952323,0.0007331762,0.093374364,0.00032761658,0.00010638162,0.00018044666,0.0037334382,0.000102472804,0.0062097176],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99952173,0.0001032025,0.000041167634,0.0002173133,0.000056507717,0.000060050468],"domain_scores_gemma":[0.9991394,0.00045368017,0.000092912844,0.00009650605,0.00017828203,0.000039108872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011084519,0.0009534886,0.0006552216,0.0007351958,0.00034366283,0.00050001335,0.0012905211,0.0008562078,0.0013418659],"category_scores_gemma":[0.0022809664,0.00035424737,0.00093364646,0.0007534964,0.0003744219,0.0018574938,0.000766169,0.0012539242,0.000634383],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065472553,0.00040020028,0.008049357,0.00035171674,0.00023687938,0.0006463665,0.00035871277,0.4745489,0.011177578,0.0065988605,0.010431987,0.48654473],"study_design_scores_gemma":[0.0000110772025,0.000046627963,0.0007988916,0.00000823714,0.000033136588,0.00005078577,0.000016877337,0.9953544,0.0016198875,0.001368295,0.00067617564,0.000015634967],"about_ca_topic_score_codex":0.016650058,"about_ca_topic_score_gemma":0.016404409,"teacher_disagreement_score":0.016650058,"about_ca_system_score_codex":0.0008624048,"about_ca_system_score_gemma":0.0013165033,"threshold_uncertainty_score":0.033106267},"labels":[],"label_agreement":null},{"id":"W3211149929","doi":"10.46610/jctr.2021.v03i02.003","title":"Pharmacovigilance Awareness and Interpretation towards Patient Safety by Community Pharmacists: A Review across various Geographies","year":2021,"lang":"en","type":"review","venue":"Journal of Clinical Trials and Regulations","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Pharmacist; Documentation; Medicine; Drug reaction; Health care; Health professionals; Patient safety; Family medicine; Community pharmacist; Business; Nursing; Medical emergency; Pharmacy; Drug; Political science; Pharmacology","score_opus":0.5320693082347794,"score_gpt":0.6602911112209199,"score_spread":0.1282218029861405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211149929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021119764,0.9991221,0.000058663412,0.00023798094,0.000041914056,0.000012619302,0.000035668778,0.0000026146165,0.00027729257],"genre_scores_gemma":[0.0017087162,0.9978667,0.00015306786,0.00013487323,0.000036530684,0.000010206202,0.00003341478,9.3242204e-7,0.00005555277],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982652,0.00041357367,0.0005306088,0.00019204333,0.0005321458,0.000066435015],"domain_scores_gemma":[0.98745626,0.008582948,0.0017573711,0.00016055164,0.0018856428,0.00015723622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035242403,0.0007211049,0.0019949765,0.0067101754,0.00035526804,0.0015767058,0.0011903311,0.001155094,0.0032837666],"category_scores_gemma":[0.010134257,0.00036353516,0.0021458177,0.007094154,0.0005359557,0.0017512703,0.0008317814,0.00096501,0.00042054756],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001296732,0.00007062692,0.0012967628,0.17673078,0.0009758923,0.00016796905,0.00025463753,0.0002232004,0.00028679334,0.0009033312,0.008970609,0.80998975],"study_design_scores_gemma":[0.00011577021,0.00051992986,0.02064697,0.3737941,0.010097215,0.004033543,0.000862899,0.00035633286,0.00087167247,0.0016787776,0.5869222,0.00010041853],"about_ca_topic_score_codex":0.0046149967,"about_ca_topic_score_gemma":0.010089101,"teacher_disagreement_score":0.0067101754,"about_ca_system_score_codex":0.0012151037,"about_ca_system_score_gemma":0.0051188185,"threshold_uncertainty_score":0.018638194},"labels":[],"label_agreement":null},{"id":"W3211918290","doi":"10.1186/s12913-021-07260-z","title":"Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database","year":2021,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Adverse effect; Randomized controlled trial; Adverse drug reaction; Pharmacovigilance; Clinical trial; Emergency medicine; Database; Intensive care medicine; Internal medicine; Pharmacology; Drug","score_opus":0.1749748005091063,"score_gpt":0.5212074696072412,"score_spread":0.3462326690981349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211918290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8402897,0.005453693,0.10758055,0.0058647012,0.00010986357,0.0034012925,0.019212943,0.0005760838,0.017511101],"genre_scores_gemma":[0.8996601,0.0007571245,0.09306475,0.00041769142,0.00004842626,0.00052960636,0.005068813,0.000050385268,0.00040301567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.963963,0.02520859,0.002327793,0.0013855293,0.0065641394,0.0005509048],"domain_scores_gemma":[0.7821667,0.18143374,0.011548015,0.0069297543,0.017027598,0.00089421734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033847764,0.0008111641,0.0007750471,0.0066153174,0.00096791424,0.0027653344,0.0018452202,0.0008623949,0.0013760346],"category_scores_gemma":[0.11228623,0.0003564624,0.0020215588,0.010353084,0.00094481616,0.0012125197,0.0016552797,0.0012083425,0.0000921834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063591595,0.0016072103,0.48152697,0.0032991625,0.0038332099,0.0020617465,0.001683963,0.20401342,0.0020280578,0.046137054,0.016745651,0.23070444],"study_design_scores_gemma":[0.002475446,0.0010375957,0.29409325,0.0006666158,0.0017121847,0.0010231467,0.0014514212,0.6455781,0.0036319997,0.018530335,0.029446231,0.00035373826],"about_ca_topic_score_codex":0.39061236,"about_ca_topic_score_gemma":0.3850063,"teacher_disagreement_score":0.60938764,"about_ca_system_score_codex":0.009213957,"about_ca_system_score_gemma":0.012572712,"threshold_uncertainty_score":0.7766775},"labels":[],"label_agreement":null},{"id":"W3212397734","doi":"10.2196/27188","title":"The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods Study","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Internet Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver General Hospital; Simon Fraser University; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Medical diagnosis; Medicine; Psychology; Computer science","score_opus":0.21964044503598706,"score_gpt":0.6269022897868434,"score_spread":0.4072618447508563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212397734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90242356,0.02429653,0.049977627,0.00090481783,0.00031508395,0.016805883,0.0019499904,0.000108644475,0.0032178692],"genre_scores_gemma":[0.9056239,0.0027836405,0.073549114,0.0013838757,0.00018028058,0.014829534,0.0012590109,0.000063738764,0.00032685217],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.6774184,0.23940651,0.040733553,0.011762081,0.028893523,0.0017859668],"domain_scores_gemma":[0.47169086,0.38666442,0.069398016,0.026638562,0.04337592,0.0022321504],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22712511,0.0014910622,0.0017028489,0.010001004,0.0020017799,0.0043890974,0.002774379,0.0015862015,0.0014016671],"category_scores_gemma":[0.31322575,0.0013634,0.0058326703,0.006501518,0.0022184597,0.0036232152,0.0036279268,0.0010726991,0.00023492114],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051794066,0.0022622999,0.8399587,0.0106654,0.022616679,0.00031231664,0.02232761,0.0007775169,0.0010100908,0.0021296276,0.0011486097,0.091611765],"study_design_scores_gemma":[0.005042113,0.026889937,0.7904953,0.018585816,0.040935893,0.0028230913,0.04995301,0.025153972,0.009148216,0.00798223,0.021714874,0.0012754891],"about_ca_topic_score_codex":0.009157651,"about_ca_topic_score_gemma":0.014031002,"teacher_disagreement_score":0.7728749,"about_ca_system_score_codex":0.005905182,"about_ca_system_score_gemma":0.0046430603,"threshold_uncertainty_score":0.95309234},"labels":[],"label_agreement":null},{"id":"W3213545386","doi":"10.1051/e3sconf/202131901042","title":"Risk Management Assessments of Anti-tuberculosis Adverse Drug Reaction: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"E3S Web of Conferences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Medical prescription; Intensive care medicine; Tuberculosis; MEDLINE; Systematic review; Pharmacology; Internal medicine; Pathology","score_opus":0.1354421029015658,"score_gpt":0.4835740092919583,"score_spread":0.3481319063903925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213545386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008027697,0.9980652,0.00018121621,0.00016961862,0.000060623224,0.00038009492,0.00013494407,0.000008452081,0.00019705587],"genre_scores_gemma":[0.01707968,0.9803781,0.0012680108,0.00031172007,0.000092619404,0.0006125659,0.00013948976,0.000004303911,0.000113636925],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9904101,0.0038907789,0.0032412393,0.00051037193,0.0017672238,0.00018027633],"domain_scores_gemma":[0.9673396,0.02274049,0.006821978,0.0003895869,0.0024687336,0.00023969934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009128807,0.0015546482,0.006852755,0.0099097295,0.0006019822,0.0021812888,0.0015497732,0.0015603356,0.0037735896],"category_scores_gemma":[0.039051887,0.000860443,0.0075600673,0.0071868813,0.0006209621,0.0018875846,0.0012417329,0.0010136922,0.00022654775],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021205001,0.000022215945,0.00080156693,0.9222044,0.008904151,0.00009240723,0.00012364675,0.00012437362,0.00010375583,0.00013113779,0.000998447,0.06628185],"study_design_scores_gemma":[0.0004410494,0.00034360823,0.0050668395,0.8859138,0.0878309,0.00061472366,0.0002635257,0.000229564,0.00023211566,0.00038393293,0.01862773,0.00005219404],"about_ca_topic_score_codex":0.0039817006,"about_ca_topic_score_gemma":0.011477293,"teacher_disagreement_score":0.0099097295,"about_ca_system_score_codex":0.0028834464,"about_ca_system_score_gemma":0.007809032,"threshold_uncertainty_score":0.04827833},"labels":[],"label_agreement":null},{"id":"W3216233619","doi":"10.2196/28632","title":"Text Mining of Adverse Events in Clinical Trials: Deep Learning Approach","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; Cancer Research UK; Health and Care Research Wales","keywords":"Unified Medical Language System; Pharmacovigilance; Natural language processing; Computer science; Adverse effect; Coding (social sciences); MedDRA; Information retrieval; Artificial intelligence; Medicine; Data mining; Data science","score_opus":0.23613502148488288,"score_gpt":0.5376509902351951,"score_spread":0.3015159687503123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216233619","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22369291,0.015889527,0.71692806,0.007975554,0.0006738972,0.0019890047,0.020491108,0.0065801395,0.0057798396],"genre_scores_gemma":[0.66961217,0.0028923666,0.29592943,0.0019064579,0.00048586816,0.001119823,0.025193598,0.00012692505,0.0027333905],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969169,0.0012712798,0.0006220897,0.0005603372,0.00047116372,0.00015817794],"domain_scores_gemma":[0.9880481,0.008980498,0.0009982423,0.00053433795,0.0011459693,0.0002929391],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004928547,0.0010564856,0.001342493,0.0047862804,0.0004497538,0.0014358137,0.0017639432,0.0014913384,0.0011768333],"category_scores_gemma":[0.015128916,0.00037417156,0.0014708681,0.003215613,0.00044173,0.0011346645,0.0011445109,0.0020038805,0.00075790804],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009458921,0.0012716601,0.036313098,0.0020385922,0.000862339,0.0011214252,0.0003066221,0.13485236,0.0053890045,0.0028571698,0.027962802,0.786079],"study_design_scores_gemma":[0.00011039144,0.0002191407,0.0043790624,0.00026002884,0.00023615913,0.00026447102,0.00010476261,0.9716552,0.0033826828,0.013975596,0.005387032,0.000025503045],"about_ca_topic_score_codex":0.004058834,"about_ca_topic_score_gemma":0.0070060943,"teacher_disagreement_score":0.9950715,"about_ca_system_score_codex":0.0011489935,"about_ca_system_score_gemma":0.002364191,"threshold_uncertainty_score":0.026064932},"labels":[],"label_agreement":null},{"id":"W3216917910","doi":"10.2196/33311","title":"Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study","year":2021,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Research Foundation of Korea; Kyungpook National University; National Research Foundation","keywords":"Pharmacovigilance; Tramadol; Adverse Event Reporting System; Medicine; Adverse effect; Observational study; Odds ratio; Emergency medicine; Medical emergency; Pharmacology; Internal medicine; Analgesic","score_opus":0.5858597792254632,"score_gpt":0.5870660933459554,"score_spread":0.0012063141204922134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216917910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329525,0.0023425932,0.0005298773,0.0000986213,0.000030526,0.00031791232,0.0027022378,0.000015858972,0.0006671177],"genre_scores_gemma":[0.99570316,0.00045042636,0.00047394997,0.00013005985,0.00006300714,0.0003123284,0.0027577677,0.000009863873,0.00009929066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9706297,0.013354643,0.005499271,0.004711206,0.0047544455,0.0010507846],"domain_scores_gemma":[0.86170715,0.055449206,0.0644728,0.0067833886,0.009250888,0.0023366308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014740541,0.0005340182,0.001349126,0.0043177577,0.00057961175,0.0017843175,0.0009909525,0.0011007398,0.002494247],"category_scores_gemma":[0.068769954,0.0006238715,0.0024402032,0.0045673884,0.0007756626,0.0025017632,0.001764453,0.0010603423,0.00047612473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027425115,0.00035686107,0.98995507,0.0004144482,0.002053357,0.00008973297,0.00037639381,0.000069428395,0.0000957888,0.000052931897,0.0004442523,0.0033492506],"study_design_scores_gemma":[0.0005448651,0.0019251994,0.9921124,0.00015718985,0.0015961461,0.0006296385,0.0008681212,0.0008007998,0.0001823935,0.00007805274,0.0010582032,0.000047123547],"about_ca_topic_score_codex":0.0034130109,"about_ca_topic_score_gemma":0.0031195811,"teacher_disagreement_score":0.014740541,"about_ca_system_score_codex":0.0015710666,"about_ca_system_score_gemma":0.00144032,"threshold_uncertainty_score":0.07795638},"labels":[],"label_agreement":null},{"id":"W3217124584","doi":"10.1016/s2589-7500(21)00229-6","title":"Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review","year":2021,"lang":"en","type":"review","venue":"The Lancet Digital Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Hôpitaux Universitaires de Genève","keywords":"Harm; Key (lock); Computer science; Artificial intelligence; Data science; Medicine; Machine learning; Computer security; Psychology","score_opus":0.5085600766227186,"score_gpt":0.5797631553033683,"score_spread":0.07120307868064968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217124584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019103801,0.99577063,0.0005451917,0.0015614969,0.00039114768,0.0002960771,0.00013241729,0.000016598675,0.0010954484],"genre_scores_gemma":[0.0017288122,0.99537295,0.0013796483,0.00074428285,0.00012642205,0.0003276463,0.00011607548,0.0000055211453,0.00019874211],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99260736,0.0023301814,0.0027701636,0.0003833519,0.0017197123,0.00018933628],"domain_scores_gemma":[0.9558515,0.03429288,0.0042142356,0.00054489216,0.004761866,0.0003347341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012647622,0.001880993,0.003915908,0.01720701,0.0008240749,0.0037529184,0.0021604153,0.0032817335,0.0062774327],"category_scores_gemma":[0.048005693,0.0009195974,0.004771546,0.011917491,0.0012685432,0.0039276485,0.002073126,0.0020212962,0.0012784664],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009893388,0.00003639227,0.00033320585,0.64670545,0.0012265278,0.000199512,0.00042635156,0.00039399046,0.00037211063,0.0034953959,0.010530865,0.3361812],"study_design_scores_gemma":[0.000041912557,0.0000654584,0.00048577078,0.89278245,0.0037497943,0.00024836263,0.00019803955,0.00014425941,0.00021881836,0.0020283076,0.100011654,0.000025267358],"about_ca_topic_score_codex":0.0064763823,"about_ca_topic_score_gemma":0.012770461,"teacher_disagreement_score":0.01720701,"about_ca_system_score_codex":0.0044412455,"about_ca_system_score_gemma":0.013863871,"threshold_uncertainty_score":0.066887856},"labels":[],"label_agreement":null},{"id":"W32227235","doi":"10.2165/00002018-200831050-00003","title":"Improving Global Monitoring of Vaccine Safety","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Ottawa","funders":"","keywords":"Medicine; Intensive care medicine; Vaccine safety; Immunology; Immunization","score_opus":0.07106683433441272,"score_gpt":0.4053396881695194,"score_spread":0.33427285383510663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32227235","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5030327,0.069972,0.17662314,0.11085572,0.0026057544,0.0018004302,0.018739277,0.00644513,0.10992587],"genre_scores_gemma":[0.9106574,0.012361243,0.0538343,0.011084738,0.0015708274,0.00050247094,0.00651498,0.0002323693,0.0032417034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98418206,0.008993402,0.0017109565,0.0016063862,0.0028994726,0.00060775375],"domain_scores_gemma":[0.9144153,0.025714643,0.020316385,0.008211804,0.02806635,0.003275646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037677992,0.0010095676,0.0012330983,0.0048330002,0.00036444518,0.0021702358,0.0013669553,0.0012595088,0.002863039],"category_scores_gemma":[0.048817128,0.0003821436,0.0007881096,0.0032309487,0.000553267,0.0038074956,0.0021045853,0.0020745636,0.0008775532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003658654,0.00030538603,0.40006983,0.0009059298,0.0005385037,0.00007769602,0.0005520787,0.0031193264,0.004538929,0.0018911023,0.024694584,0.5629407],"study_design_scores_gemma":[0.00022275634,0.0020926073,0.8426255,0.0014537304,0.0011650069,0.00083511375,0.0011937403,0.008828234,0.010000323,0.005075036,0.1264211,0.00008682223],"about_ca_topic_score_codex":0.005018406,"about_ca_topic_score_gemma":0.005213931,"teacher_disagreement_score":0.037677992,"about_ca_system_score_codex":0.0016919031,"about_ca_system_score_gemma":0.0042740847,"threshold_uncertainty_score":0.19926262},"labels":[],"label_agreement":null},{"id":"W3690670","doi":"10.1016/j.ohc.2005.07.008","title":"10.1016/j.ohc.2005.07.008","year":2000,"lang":"en","type":"review","venue":"Time to knit","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nasolacrimal duct; Drug; Pharmacotherapy; Intensive care medicine; Disease; Pharmacology; Internal medicine; Surgery","score_opus":0.11830318941222855,"score_gpt":0.4160125337324466,"score_spread":0.29770934432021806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3690670","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027527183,0.14042613,0.0021094666,0.0033577105,0.002042806,0.00012359927,0.0020191327,0.000976251,0.8461922],"genre_scores_gemma":[0.008652412,0.065637015,0.002669553,0.0027027328,0.0007417346,0.00010257586,0.0014876478,0.00013939504,0.91786695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998739,0.00001129477,0.000010433758,0.000028177192,0.000039957755,0.000036172365],"domain_scores_gemma":[0.9997657,0.000057846868,0.000029382933,0.000011642113,0.00006186361,0.00007349893],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029242283,0.0010593499,0.0006595429,0.0012882138,0.00049797783,0.0014351426,0.0010717758,0.0030572019,0.81941295],"category_scores_gemma":[0.0005407149,0.00024028773,0.00041066567,0.0010681644,0.00041749646,0.0017598373,0.0006922263,0.0011185154,0.7271822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011479843,0.00016459067,0.00067699695,0.0011348772,0.000026862746,0.00031925974,0.000040739047,0.00013980598,0.0004732402,0.0015815425,0.12922679,0.86610055],"study_design_scores_gemma":[0.000035396577,0.00007302034,0.0011460996,0.0010053013,0.000028516884,0.0019359929,0.00007448298,0.000056772933,0.00018048302,0.0008164916,0.99463886,0.000008585739],"about_ca_topic_score_codex":0.00243079,"about_ca_topic_score_gemma":0.002532991,"teacher_disagreement_score":0.18058705,"about_ca_system_score_codex":0.0005314618,"about_ca_system_score_gemma":0.0007751668,"threshold_uncertainty_score":0.25758547},"labels":[],"label_agreement":null},{"id":"W4200177929","doi":"10.1111/bcp.15178","title":"Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors","year":2021,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Pharmacovigilance; Canagliflozin; Medicine; Pharmacology; Drug; Diabetes mellitus; Endocrinology; Type 2 diabetes","score_opus":0.3449341323481257,"score_gpt":0.5532142112426917,"score_spread":0.20828007889456596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200177929","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3668231,0.05417191,0.5387753,0.0073264414,0.0015628787,0.006459205,0.013481638,0.0015204189,0.009879113],"genre_scores_gemma":[0.9019188,0.0024216406,0.086285174,0.0025457903,0.00046415726,0.0022288994,0.0035256608,0.00016183848,0.00044802722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.564921,0.36534294,0.033189647,0.015467397,0.01991755,0.0011614347],"domain_scores_gemma":[0.48716962,0.39654478,0.060530655,0.036830574,0.017597336,0.0013269942],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2508307,0.0014381661,0.003068919,0.005276762,0.0007654717,0.0036701388,0.0020568948,0.0018362699,0.0029630319],"category_scores_gemma":[0.39508116,0.00078669307,0.0118769705,0.005001371,0.0010615466,0.0026205622,0.0039475868,0.0027870636,0.0003341661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032834835,0.0008074223,0.53880394,0.015980111,0.12397996,0.0012311961,0.0017321606,0.012546081,0.00603253,0.015489728,0.010684321,0.23987767],"study_design_scores_gemma":[0.010808702,0.023546277,0.5569109,0.010126011,0.12714502,0.007107024,0.0014574707,0.1004438,0.025124222,0.061826188,0.07442878,0.0010755779],"about_ca_topic_score_codex":0.0016632187,"about_ca_topic_score_gemma":0.0012889655,"teacher_disagreement_score":0.2508307,"about_ca_system_score_codex":0.0011478667,"about_ca_system_score_gemma":0.0018070104,"threshold_uncertainty_score":0.9238591},"labels":[],"label_agreement":null},{"id":"W4200270337","doi":"10.5703/1288284317444","title":"Improving Pharmacovigilliance Quality Management System in the Pharmacy and Poisions Board of Kenya","year":2021,"lang":"en","type":"report","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"Purdue University; Bill and Melinda Gates Foundation","keywords":"Pharmacovigilance; Pharmacy; Quality (philosophy); Medicine; Agency (philosophy); Under-reporting; Adverse drug reaction; Quality management system; Data collection; Drug reaction; Business; Management system; Adverse effect; Quality management; Pharmacology; Family medicine; Operations management; Drug; Engineering; Political science","score_opus":0.22201942205369365,"score_gpt":0.5069975030545351,"score_spread":0.28497808100084143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200270337","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8768559,0.017020939,0.014475988,0.034368437,0.000485447,0.0038150114,0.0035114575,0.000664291,0.048802562],"genre_scores_gemma":[0.96017444,0.007164129,0.020649262,0.0022294265,0.00012674916,0.0004831733,0.0015906522,0.000038067203,0.0075441203],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99151564,0.002955081,0.0012676428,0.00069721753,0.002818701,0.0007457487],"domain_scores_gemma":[0.97333544,0.004298349,0.0092949495,0.00092447404,0.010386011,0.0017606741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0103687495,0.00021998945,0.00024457814,0.003835986,0.0021991346,0.004236881,0.0011238786,0.0006873535,0.0034726458],"category_scores_gemma":[0.022882963,0.00037858862,0.00030766358,0.003913178,0.0005240586,0.0025254474,0.0014542436,0.0006573469,0.00053814537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005518933,0.00062481407,0.5692449,0.0030225276,0.00018588452,0.00291178,0.007297258,0.002112992,0.010525307,0.0072042993,0.026590005,0.36972842],"study_design_scores_gemma":[0.000224398,0.0014445323,0.7259442,0.0027369228,0.00032556345,0.002451286,0.017722342,0.006297946,0.008364076,0.001300786,0.23292153,0.00026629504],"about_ca_topic_score_codex":0.05442768,"about_ca_topic_score_gemma":0.05317482,"teacher_disagreement_score":0.05442768,"about_ca_system_score_codex":0.0068221837,"about_ca_system_score_gemma":0.021375746,"threshold_uncertainty_score":0.10822177},"labels":[],"label_agreement":null},{"id":"W4205416179","doi":"10.2196/27017","title":"Finding Potential Adverse Events in the Unstructured Text of Electronic Health Care Records: Development of the Shakespeare Method","year":2021,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Massachusetts Institute of Technology; U.S. Department of Health and Human Services","keywords":"Standardization; Documentation; Adverse effect; Medicine; Health care; Harm; Computer science; Psychology; Political science; Internal medicine","score_opus":0.06645867244282337,"score_gpt":0.45790879701977744,"score_spread":0.39145012457695405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205416179","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043534082,0.0006489977,0.98836946,0.0011339001,0.00030416957,0.0010849705,0.00081101974,0.0008552604,0.0024388707],"genre_scores_gemma":[0.029818105,0.00051667367,0.96397704,0.00045633834,0.000382878,0.0018233196,0.0008589669,0.00019901867,0.001967685],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.92223924,0.041217834,0.00943169,0.011488341,0.014878301,0.0007445731],"domain_scores_gemma":[0.7221176,0.22196446,0.010896155,0.017649679,0.025465146,0.0019069703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058073632,0.0022594894,0.0022156157,0.021654824,0.0032857212,0.009401174,0.0046033715,0.003800244,0.0061881496],"category_scores_gemma":[0.23084372,0.0018542098,0.003209496,0.0093549,0.0075499313,0.012026871,0.009732859,0.004943844,0.0041096094],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047111997,0.00032009635,0.03606694,0.0025528325,0.00066852523,0.0012885449,0.011154968,0.0060462463,0.0059875543,0.10015335,0.021418309,0.8138715],"study_design_scores_gemma":[0.00042821115,0.00062409736,0.025360683,0.0027426966,0.0005280944,0.0055214423,0.00822843,0.34056556,0.011208711,0.42824045,0.17575668,0.00079488143],"about_ca_topic_score_codex":0.0038133054,"about_ca_topic_score_gemma":0.003633284,"teacher_disagreement_score":0.058073632,"about_ca_system_score_codex":0.0020549127,"about_ca_system_score_gemma":0.007278241,"threshold_uncertainty_score":0.30712634},"labels":[],"label_agreement":null},{"id":"W4205534020","doi":"10.1186/s40545-020-00231-5","title":"Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety","year":2020,"lang":"en","type":"erratum","venue":"Journal of Pharmaceutical Policy and Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Adverse drug reaction; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Drug reaction; Public health; Medicine; Pharmacy; Drug; Adverse effect; Pandemic; Pharmacology; Medical emergency; Virology; Family medicine; Internal medicine; Nursing","score_opus":0.17112526429994288,"score_gpt":0.558197657030968,"score_spread":0.3870723927310251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205534020","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010470808,0.00049746153,0.00037962865,0.122386195,0.87124044,0.000023469562,0.0010878344,0.00028367763,0.00399661],"genre_scores_gemma":[0.0097938245,0.0056635225,0.0051318984,0.28612053,0.4515611,0.0002672831,0.0028304465,0.0014207142,0.23721065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935719,0.0010004962,0.0013429084,0.0007940311,0.0027010436,0.0005895844],"domain_scores_gemma":[0.95391226,0.013850461,0.00235851,0.002126227,0.025278615,0.002473934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059256707,0.0020181926,0.0013940963,0.0030887974,0.003859585,0.0054393653,0.0026670913,0.0104424395,0.046782188],"category_scores_gemma":[0.07736421,0.0011472015,0.0015454958,0.0022874833,0.0026333178,0.0025414834,0.0022625637,0.018060979,0.03757058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009838931,0.0000028539662,0.000043033906,0.00003422622,0.000003139072,0.00008501461,0.000017846798,0.000014062055,0.000012101654,0.00039717674,0.9970451,0.0023356045],"study_design_scores_gemma":[0.000029204408,0.000011593093,0.00049516466,0.00033973926,0.000014152151,0.00026771918,0.000086095184,0.00012879114,0.00011806666,0.0010004442,0.99748343,0.000025570818],"about_ca_topic_score_codex":0.030467393,"about_ca_topic_score_gemma":0.036832165,"teacher_disagreement_score":0.046782188,"about_ca_system_score_codex":0.00458633,"about_ca_system_score_gemma":0.0096365595,"threshold_uncertainty_score":0.15650201},"labels":[],"label_agreement":null},{"id":"W4205894312","doi":"10.1136/bmjqs-2021-013910","title":"Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis","year":2022,"lang":"en","type":"review","venue":"BMJ Quality & Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; McMaster University; York University; University of British Columbia","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Medical Research Council; Australian Government","keywords":"Medicine; Drug; Interrupted Time Series Analysis; Interrupted time series; Medical emergency; Pharmacology; Nursing; Psychological intervention; Statistics","score_opus":0.31666358864698146,"score_gpt":0.5429821267447899,"score_spread":0.22631853809780839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205894312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08388484,0.8944637,0.014203194,0.0009998424,0.00075541186,0.00080401864,0.0033807766,0.00019897545,0.0013092564],"genre_scores_gemma":[0.80954343,0.17013937,0.011323188,0.0013461843,0.00052283966,0.0022752844,0.0036850574,0.00016767233,0.0009968665],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97722214,0.015764788,0.0031328157,0.0019981943,0.0014073183,0.00047458647],"domain_scores_gemma":[0.9514886,0.036798365,0.0069767474,0.0028982665,0.0015471019,0.0002909026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03480423,0.002124224,0.009706386,0.0028305626,0.000408283,0.0028238897,0.0018339858,0.0020546047,0.0028850976],"category_scores_gemma":[0.064692184,0.0011211551,0.046835728,0.004960623,0.00057357125,0.0012217939,0.0011430456,0.002486285,0.00023690052],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012634547,0.000091310314,0.01662929,0.029602038,0.9243303,0.00010435159,0.000063218955,0.0029955467,0.00021489474,0.0002300064,0.00061434007,0.012490203],"study_design_scores_gemma":[0.0023517732,0.0008377193,0.017620219,0.0035544191,0.9704893,0.00011367287,0.00003336992,0.0026692704,0.00023230034,0.00038264622,0.0016814555,0.000033814893],"about_ca_topic_score_codex":0.0063687917,"about_ca_topic_score_gemma":0.004247044,"teacher_disagreement_score":0.03480423,"about_ca_system_score_codex":0.0017652779,"about_ca_system_score_gemma":0.0015668268,"threshold_uncertainty_score":0.18406451},"labels":[],"label_agreement":null},{"id":"W4206588379","doi":"10.1128/microbe.3.398.2","title":"Canada Approves New Cephalosporin, FDA Imposes Fluoroquinolone Warnings","year":2008,"lang":"en","type":"article","venue":"Microbe Magazine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cephalosporin; Drug approval; Computer science; Medicine; Biology; Pharmacology; Microbiology; Drug; Antibiotics","score_opus":0.0834130345723334,"score_gpt":0.35632357569680173,"score_spread":0.27291054112446833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206588379","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03788711,0.004776752,0.0012577189,0.22495636,0.009759189,0.00022987525,0.0067927865,0.0017721461,0.7125681],"genre_scores_gemma":[0.12272249,0.0049158186,0.002771236,0.1674497,0.0021821125,0.00003519617,0.003048893,0.00040550783,0.6964691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748707,0.000093958544,0.00006947687,0.00011258307,0.001846276,0.0003905991],"domain_scores_gemma":[0.99177915,0.0014038583,0.00032736306,0.00014419803,0.005227554,0.0011179454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001025865,0.0003576828,0.0003436556,0.0018556771,0.0043704603,0.0029340743,0.00078704057,0.0042789318,0.036344703],"category_scores_gemma":[0.0077574747,0.00041244747,0.0008003688,0.0010350198,0.0009714909,0.00061962754,0.0005152438,0.003242448,0.0061611007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013512984,0.000063436004,0.008869516,0.00007038138,0.000025389832,0.0007103815,0.00013059405,0.0000861185,0.0015570886,0.003510021,0.9496229,0.035218887],"study_design_scores_gemma":[0.000060835886,0.000071365146,0.020007014,0.00009056363,0.00007003757,0.00053853006,0.00028482673,0.00022882933,0.0017764472,0.0005610516,0.97627443,0.000035983794],"about_ca_topic_score_codex":0.8363971,"about_ca_topic_score_gemma":0.9389656,"teacher_disagreement_score":0.16360289,"about_ca_system_score_codex":0.012873912,"about_ca_system_score_gemma":0.046174288,"threshold_uncertainty_score":0.32913274},"labels":[],"label_agreement":null},{"id":"W4207070465","doi":"10.2196/31063","title":"Development of a Pipeline for Adverse Drug Reaction Identification in Clinical Notes: Word Embedding Models and String Matching","year":2022,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Punctuation; Computer science; Identification (biology); Natural language processing; Word (group theory); Matching (statistics); Artificial intelligence; Set (abstract data type); Medicine; Pathology; Mathematics","score_opus":0.14801492972473201,"score_gpt":0.4922374196700689,"score_spread":0.3442224899453369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207070465","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020512305,0.00069254887,0.9387293,0.00046123093,0.00018373043,0.00080061384,0.004078079,0.03348141,0.001060773],"genre_scores_gemma":[0.07424672,0.0005163718,0.91134626,0.00020369323,0.00006993893,0.0006706845,0.009658023,0.000581082,0.002707128],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99858874,0.00037587128,0.00019645615,0.00046224537,0.00029266244,0.00008407932],"domain_scores_gemma":[0.995676,0.0023904298,0.0003283116,0.0005253013,0.000939658,0.00014031587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028114403,0.0020932576,0.0011420453,0.003687026,0.00048354888,0.0018360637,0.0018290753,0.0019809788,0.0070012426],"category_scores_gemma":[0.008884345,0.00070353487,0.002014782,0.0025153572,0.0003483272,0.0032023024,0.0015569614,0.001959149,0.008820197],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041434207,0.00029964748,0.003247256,0.0005827244,0.00021119497,0.00028778968,0.00019273511,0.01325406,0.016013863,0.00157031,0.014753132,0.9491729],"study_design_scores_gemma":[0.00010896177,0.00035754358,0.0037372515,0.00013600531,0.00015360549,0.00044480976,0.00029594314,0.940925,0.03319072,0.008398313,0.012174556,0.00007727475],"about_ca_topic_score_codex":0.0066829994,"about_ca_topic_score_gemma":0.0063853883,"teacher_disagreement_score":0.0070012426,"about_ca_system_score_codex":0.0010279856,"about_ca_system_score_gemma":0.0019898252,"threshold_uncertainty_score":0.023421526},"labels":[],"label_agreement":null},{"id":"W4210874944","doi":"10.2196/32543","title":"Artificial Intelligence–Enabled Social Media Analysis for Pharmacovigilance of COVID-19 Vaccinations in the United Kingdom: Observational Study","year":2022,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"UK Research and Innovation; Government of the United Kingdom; Engineering and Physical Sciences Research Council; Scottish Government","keywords":"Pharmacovigilance; Observational study; Social media; Coronavirus disease 2019 (COVID-19); Vaccination; 2019-20 coronavirus outbreak; Environmental health; Medicine; Data science; Family medicine; Virology; Internet privacy; Computer science; Outbreak; World Wide Web; Pharmacology; Adverse effect","score_opus":0.5443496671783672,"score_gpt":0.5426264483448469,"score_spread":0.0017232188335203347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210874944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922845,0.0011376526,0.0002908339,0.00024604282,0.00001393631,0.00012629775,0.0050205947,0.000013376089,0.00086681894],"genre_scores_gemma":[0.99601495,0.0006772248,0.00042255002,0.00020540298,0.000028911416,0.0001409462,0.0022257417,0.000008133962,0.00027624602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996779,0.0010906286,0.00085588585,0.00051170046,0.00043926793,0.00032349702],"domain_scores_gemma":[0.98371834,0.0043604425,0.0079730125,0.00088324473,0.0020660283,0.0009990331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018527391,0.00042840277,0.00069614773,0.0018822254,0.00048737004,0.0014256564,0.00066374196,0.00082758855,0.002282258],"category_scores_gemma":[0.012761632,0.00048154392,0.00073378684,0.0030995465,0.00047835652,0.0011081436,0.0017701884,0.00080790924,0.00063124736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002178769,0.000094466785,0.9926082,0.00036179097,0.00012135955,0.0003842614,0.0009141726,0.00011007001,0.00017520647,0.000045565375,0.0012303643,0.0037366298],"study_design_scores_gemma":[0.00002439642,0.00020163224,0.9932969,0.00025438727,0.00011817917,0.00051248993,0.002451877,0.0011887191,0.00014352005,0.00003470537,0.0017480588,0.000025102981],"about_ca_topic_score_codex":0.059578698,"about_ca_topic_score_gemma":0.057516836,"teacher_disagreement_score":0.059578698,"about_ca_system_score_codex":0.0018150891,"about_ca_system_score_gemma":0.0013921864,"threshold_uncertainty_score":0.118463814},"labels":[],"label_agreement":null},{"id":"W4211169320","doi":"10.17269/s41997-022-00609-9","title":"Is vaccine hesitancy justified? Benchmarking post-market vaccine risks with five commonly used medicinal products in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Public Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre; McMaster University","funders":"","keywords":"Medicine; Adverse effect; Vaccination; Benchmarking; Immunization; Intensive care medicine; Environmental health; Pharmacology; Business; Immunology; Marketing; Immune system","score_opus":0.16693472301548454,"score_gpt":0.4015879245475664,"score_spread":0.23465320153208188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211169320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9140869,0.01969341,0.0015820527,0.022678273,0.0001521002,0.00029938496,0.013261906,0.00013059343,0.028115397],"genre_scores_gemma":[0.9929636,0.0024538178,0.0008124006,0.0013749391,0.000028256576,0.000017312013,0.0014267724,0.00001858942,0.00090423325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9879368,0.001943447,0.0009619036,0.0008843257,0.0065723807,0.0017011599],"domain_scores_gemma":[0.9501975,0.009406286,0.012016043,0.00092561945,0.022929007,0.004525439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00684056,0.00026102128,0.00050638634,0.00246541,0.0015304522,0.0031511588,0.0013226381,0.0010274745,0.0022759151],"category_scores_gemma":[0.03373447,0.00030404635,0.0011240119,0.0045296615,0.0014624692,0.0009668478,0.0010666974,0.0019196741,0.00018373446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093428895,0.00012270125,0.93382365,0.0005377864,0.0004908773,0.00038271188,0.0013092809,0.00217777,0.00039380052,0.0020187397,0.009853247,0.04795516],"study_design_scores_gemma":[0.00005503844,0.00035371893,0.9685941,0.00056939037,0.0004701081,0.00036497082,0.0025382522,0.0040054074,0.00090232654,0.0004006506,0.021668889,0.00007710426],"about_ca_topic_score_codex":0.9725009,"about_ca_topic_score_gemma":0.97940516,"teacher_disagreement_score":0.05872917,"about_ca_system_score_codex":0.05872917,"about_ca_system_score_gemma":0.09017447,"threshold_uncertainty_score":0.42611194},"labels":[],"label_agreement":null},{"id":"W4213156898","doi":"10.1080/00085030.2019.1647672","title":"Correction","year":2019,"lang":"en","type":"article","venue":"Canadian Society of Forensic Science Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Section (typography); Philosophy; Epistemology; Computer science; Library science","score_opus":0.061785886169434714,"score_gpt":0.39369799825187984,"score_spread":0.33191211208244514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213156898","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023965906,0.0017733368,0.0014474816,0.057728596,0.8648281,0.00009547991,0.006774573,0.0011381264,0.06597458],"genre_scores_gemma":[0.007652825,0.003665498,0.0035672807,0.04028687,0.08954006,0.00024875824,0.009769117,0.0021215621,0.84314793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944376,0.0007360076,0.00066524366,0.00080715376,0.0027971154,0.0005568623],"domain_scores_gemma":[0.9649838,0.0061437036,0.001330986,0.0037725929,0.022361938,0.0014071133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034796013,0.0012428067,0.00097579847,0.005176692,0.0027168596,0.0062136115,0.002258351,0.004125287,0.33872655],"category_scores_gemma":[0.065108664,0.00060082576,0.00127826,0.0027937628,0.0014534565,0.0027590415,0.0025681122,0.0059374264,0.2068975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010916554,0.0000022250101,0.000039984447,0.000062097846,0.00000314481,0.000040034967,0.000023621757,0.000013313672,0.000020540423,0.0018893467,0.9891775,0.00871741],"study_design_scores_gemma":[0.0000061515384,0.0000028826375,0.00017587432,0.00012009198,0.0000048481006,0.00007031783,0.00003185755,0.000022613041,0.000057453348,0.00080563535,0.9986959,0.0000063332413],"about_ca_topic_score_codex":0.014629274,"about_ca_topic_score_gemma":0.016244791,"teacher_disagreement_score":0.33872655,"about_ca_system_score_codex":0.0037797114,"about_ca_system_score_gemma":0.0076132007,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4221038512","doi":"10.1186/s12913-022-07720-0","title":"A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China","year":2022,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Social Science Fund of China","keywords":"Medicine; Public health; Cross-sectional study; China; Descriptive statistics; Family medicine; Adverse drug reaction; Health administration; Logistic regression; Health informatics; Nursing research; Drug reaction; Test (biology); Environmental health; Demography; Drug; Nursing; Psychiatry; Internal medicine; Geography","score_opus":0.33468931820843023,"score_gpt":0.5973846040049965,"score_spread":0.26269528579656626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221038512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997017,0.000024656223,0.00001661008,0.000017993245,0.0000013830446,0.000016109165,0.000053774802,7.160635e-7,0.0001669241],"genre_scores_gemma":[0.9995627,0.000045947367,0.00004423754,0.00004156858,0.0000039190363,0.000026071339,0.000121180165,5.610401e-7,0.00015386824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992793,0.00013019293,0.00011008961,0.00012692099,0.0001929737,0.00016054662],"domain_scores_gemma":[0.9982122,0.00026097507,0.00069435046,0.00010899081,0.00032800666,0.00039558703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015955232,0.00035006378,0.00036409686,0.0010713193,0.0008098123,0.0005447673,0.00028238035,0.00044754,0.0016358816],"category_scores_gemma":[0.001716622,0.00034468147,0.00043808526,0.0013143709,0.0005598443,0.00058012735,0.0005845326,0.0004229806,0.00018602078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039654344,0.00013238288,0.99740297,0.000020815522,0.000020263447,0.000066640416,0.0012189898,0.000014464171,0.00016179967,0.0000151146405,0.000046160643,0.00086073176],"study_design_scores_gemma":[0.0000052478563,0.00017351688,0.9978168,0.0000051494912,0.000010734467,0.00006912174,0.001734391,0.00006308353,0.000034221008,0.000007091153,0.00007747937,0.00000321061],"about_ca_topic_score_codex":0.019369556,"about_ca_topic_score_gemma":0.017172176,"teacher_disagreement_score":0.019369556,"about_ca_system_score_codex":0.0009061132,"about_ca_system_score_gemma":0.0010262306,"threshold_uncertainty_score":0.0385136},"labels":[],"label_agreement":null},{"id":"W4226090661","doi":"10.32388/txe86u.2","title":"The Implementation of Drug Checking Services for People Who Use Drugs: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Research, Innovation and Science; St. Michael's Hospital Foundation","keywords":"PsycINFO; Grey literature; MEDLINE; Systematic review; Scopus; Medicine; Family medicine; Political science","score_opus":0.15872310220815558,"score_gpt":0.5139177537500285,"score_spread":0.3551946515418729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226090661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004539892,0.9910313,0.00030046285,0.0005767932,0.00014172301,0.0022446527,0.0006675717,0.00002473057,0.00047279964],"genre_scores_gemma":[0.044180594,0.94971335,0.0015773566,0.0006822276,0.00008835044,0.003201503,0.00038409428,0.000010688083,0.00016193358],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9813737,0.008572604,0.005398481,0.0010010382,0.0031486347,0.00050552876],"domain_scores_gemma":[0.94114476,0.042117212,0.009489337,0.00093938125,0.005537344,0.0007720215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022667283,0.0014166463,0.008432655,0.0078638615,0.00086917775,0.0031075869,0.0021658742,0.0017825527,0.004845343],"category_scores_gemma":[0.08480077,0.0013200244,0.0074588815,0.010156615,0.0011002027,0.003603031,0.002083156,0.001621888,0.0003316705],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027338063,0.000023714047,0.0009958735,0.96238214,0.007242457,0.00004468527,0.00041956716,0.00005590082,0.00007010838,0.000151286,0.0010785606,0.027262347],"study_design_scores_gemma":[0.00039534929,0.0002781757,0.004090295,0.9407931,0.045048796,0.00012661768,0.00069717574,0.00009391874,0.00012225377,0.00017684944,0.008135861,0.000041747116],"about_ca_topic_score_codex":0.013936373,"about_ca_topic_score_gemma":0.03930759,"teacher_disagreement_score":0.022667283,"about_ca_system_score_codex":0.006959652,"about_ca_system_score_gemma":0.029172296,"threshold_uncertainty_score":0.11987752},"labels":[],"label_agreement":null},{"id":"W4226315319","doi":"10.1016/j.vaccine.2022.04.065","title":"Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance","year":2022,"lang":"en","type":"article","venue":"Vaccine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Ottawa; Public Health Ontario; University of Toronto","funders":"Department of Family and Community Medicine, University of Toronto; Canadian Institutes of Health Research; Canadian Immunization Research Network; University of Toronto; Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Acute disseminated encephalomyelitis; Myocarditis; Transverse myelitis; Guillain-Barre syndrome; Pericarditis; Population; Pediatrics; Incidence (geometry); Internal medicine; Immunology; Disease; Multiple sclerosis","score_opus":0.08421759937698739,"score_gpt":0.42149910440043403,"score_spread":0.33728150502344667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226315319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51083,0.021255594,0.0035289726,0.011879055,0.0005502836,0.0011243538,0.4028345,0.00048586537,0.04751138],"genre_scores_gemma":[0.9141253,0.010609388,0.0035726891,0.0033758152,0.00024648354,0.00046462743,0.059637845,0.00006695655,0.007900874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968362,0.00014524697,0.00040660493,0.00039699036,0.0015656214,0.0006493334],"domain_scores_gemma":[0.9865094,0.0005305157,0.003906692,0.00017544514,0.007335485,0.001542503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001753852,0.00053234625,0.0004368153,0.0026950906,0.001385996,0.0014202631,0.0013082008,0.0005154811,0.004002971],"category_scores_gemma":[0.008649336,0.00032502128,0.0010273923,0.0039050295,0.0005105116,0.0005508578,0.0008738963,0.00097257685,0.0003401755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018989328,0.000039983825,0.9485973,0.00083200005,0.00027209934,0.00008633517,0.00035894325,0.00082390907,0.00020360592,0.00059482025,0.033888206,0.01411293],"study_design_scores_gemma":[0.000027680378,0.0000575408,0.9819802,0.00046912426,0.00011147259,0.00009730558,0.00049476704,0.0005768264,0.00015002395,0.00008943391,0.015924335,0.000021345151],"about_ca_topic_score_codex":0.9916905,"about_ca_topic_score_gemma":0.9947635,"teacher_disagreement_score":0.045096975,"about_ca_system_score_codex":0.045096975,"about_ca_system_score_gemma":0.09429807,"threshold_uncertainty_score":0.32720304},"labels":[],"label_agreement":null},{"id":"W4226502826","doi":"10.2196/33099","title":"Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study","year":2022,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. National Library of Medicine","keywords":"Vaccination; Medicine; Observational study; Influenza vaccine; Cohort study; Population; Covariate; Demography; Environmental health; Immunology; Internal medicine; Statistics","score_opus":0.29898850649382874,"score_gpt":0.4917818210366668,"score_spread":0.19279331454283805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226502826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559325,0.0053720144,0.03312322,0.00045713928,0.00029014147,0.0008120761,0.002865025,0.000072105686,0.0010757619],"genre_scores_gemma":[0.98965424,0.00036206222,0.007331585,0.00024727354,0.000112222624,0.0005503856,0.0015450513,0.000020107076,0.0001770654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8808644,0.08611885,0.011509351,0.010846528,0.008008184,0.0026528218],"domain_scores_gemma":[0.7330718,0.13478966,0.07104118,0.05266495,0.0062583406,0.0021740475],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12999463,0.0009083477,0.0014866472,0.002131293,0.0010334708,0.0022584058,0.0026667186,0.002281435,0.0017282292],"category_scores_gemma":[0.2294128,0.00075638783,0.0051903087,0.0036575536,0.0014370325,0.0014206066,0.0026757086,0.0019306357,0.00024826275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028911098,0.00013360211,0.98180586,0.00019281298,0.0044177254,0.00008275607,0.000373352,0.0008055948,0.00023421753,0.0006843768,0.00055207487,0.007826548],"study_design_scores_gemma":[0.00051788165,0.0019060225,0.9704946,0.0003074868,0.0051344275,0.00049868214,0.00051996787,0.014161743,0.0011684002,0.00255424,0.0026352096,0.00010134318],"about_ca_topic_score_codex":0.0057664,"about_ca_topic_score_gemma":0.0039326567,"teacher_disagreement_score":0.87000537,"about_ca_system_score_codex":0.0011923414,"about_ca_system_score_gemma":0.002106561,"threshold_uncertainty_score":0.6874856},"labels":[],"label_agreement":null},{"id":"W4237950786","doi":"10.1007/s13181-018-0696-y","title":"Adverse Drug Events and Reactions Managed by Medical Toxicologists: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010–2016","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Toxicology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"World Health Organization; Dorothy Rider Pool Health Care Trust","keywords":"Medicine; Emergency department; Emergency medicine; Drug reaction; Retrospective cohort study; Intensive care unit; Pediatrics; Drug; Internal medicine; Pharmacology; Psychiatry","score_opus":0.05365552942766577,"score_gpt":0.407930336274204,"score_spread":0.3542748068465382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237950786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516951,0.0047860667,0.0004191235,0.0005826959,0.00005966896,0.0001283001,0.03964704,0.000065598004,0.0026163603],"genre_scores_gemma":[0.9656664,0.0023412174,0.00043221135,0.00042171087,0.00006779114,0.00011148221,0.030169655,0.000038767233,0.0007507327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99339336,0.0009909769,0.0021355597,0.0010767813,0.0018296973,0.0005735144],"domain_scores_gemma":[0.97231996,0.0027361105,0.0196112,0.0009463237,0.0028618022,0.001524551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041448954,0.0003881732,0.00065152184,0.0040737074,0.0004946421,0.0015120339,0.000827809,0.00071613176,0.0010555821],"category_scores_gemma":[0.0138736265,0.00045323904,0.0016120924,0.007440674,0.00040701518,0.0015284496,0.0019266485,0.0011805642,0.00032725622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019476213,0.000027712116,0.9958698,0.00006877666,0.00017519124,0.00007521349,0.000083636194,0.00008843453,0.00005293979,0.00003967405,0.0013898774,0.001933915],"study_design_scores_gemma":[0.000020672931,0.00003925855,0.99770015,0.00007052817,0.000109248154,0.0002989182,0.000274059,0.00018679438,0.00007409053,0.000019989082,0.0011975163,0.000008844101],"about_ca_topic_score_codex":0.038188055,"about_ca_topic_score_gemma":0.050982334,"teacher_disagreement_score":0.038188055,"about_ca_system_score_codex":0.002013379,"about_ca_system_score_gemma":0.0040127337,"threshold_uncertainty_score":0.07593155},"labels":[],"label_agreement":null},{"id":"W4239514468","doi":"10.22215/etd/2011-08614","title":"An overview of statistical methods for active pharmacovigilance with applications to diabetes patients","year":2011,"lang":"en","type":"dissertation","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Canadian Heritage; Library and Archives Canada","funders":"","keywords":"Pharmacovigilance; Computer science; Library science; Medicine; Pharmacology; Drug","score_opus":0.1935479745647612,"score_gpt":0.567223457518097,"score_spread":0.3736754829533358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239514468","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000545145,0.02328793,0.9681487,0.0021714969,0.00059354043,0.00045348326,0.001167575,0.0021082747,0.0015237093],"genre_scores_gemma":[0.007048378,0.024196604,0.96093404,0.00087568356,0.0012650291,0.0022759417,0.0014168869,0.0006294048,0.00135796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9558627,0.032051206,0.004035444,0.0022946117,0.005481192,0.00027476397],"domain_scores_gemma":[0.81132233,0.16755188,0.00449913,0.0068618,0.008774459,0.0009904237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050850723,0.0027334238,0.0028956847,0.0083984155,0.00090857275,0.0037574603,0.002744864,0.0021718815,0.008268896],"category_scores_gemma":[0.12494123,0.0015788046,0.005510907,0.009548899,0.0016902649,0.002408395,0.0023393533,0.0071491157,0.0057615545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000200517,0.00023463882,0.0044736783,0.005691798,0.0019152444,0.00026794345,0.000383548,0.011184405,0.0016152965,0.06752211,0.06353468,0.84297615],"study_design_scores_gemma":[0.00041641286,0.00097283284,0.012615184,0.006411026,0.0012652191,0.00251063,0.00034775244,0.16193078,0.00404163,0.43884537,0.37017485,0.00046838383],"about_ca_topic_score_codex":0.003503264,"about_ca_topic_score_gemma":0.004206758,"teacher_disagreement_score":0.050850723,"about_ca_system_score_codex":0.0016479024,"about_ca_system_score_gemma":0.005421338,"threshold_uncertainty_score":0.2689275},"labels":[],"label_agreement":null},{"id":"W4244224894","doi":"10.1503/cmaj.1041338","title":"Corrections","year":2004,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Computer science; World Wide Web; Information retrieval; Data science","score_opus":0.0479322943113069,"score_gpt":0.3991550188517705,"score_spread":0.3512227245404636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244224894","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005624064,0.0011011692,0.0032011748,0.14720191,0.78952354,0.00023556882,0.008887731,0.0038353975,0.045451075],"genre_scores_gemma":[0.017951928,0.002586376,0.011438353,0.093073696,0.091301054,0.00058439863,0.01268291,0.005664969,0.76471627],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98503184,0.0023766514,0.0020621254,0.0018126345,0.0075460207,0.0011708562],"domain_scores_gemma":[0.85458666,0.019333346,0.0052427435,0.010145863,0.10757583,0.0031156112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006612069,0.0018087365,0.0011866213,0.005173802,0.0040554064,0.0054801162,0.0038077487,0.0042923596,0.28102073],"category_scores_gemma":[0.13956422,0.0010683561,0.0018883961,0.0034130742,0.0022076503,0.0030522428,0.0026721496,0.00834073,0.17317995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014106833,0.0000033667784,0.00003395957,0.000045432444,0.0000025750523,0.000053729975,0.000044022243,0.000018752862,0.000032038657,0.0012378796,0.9929229,0.005591106],"study_design_scores_gemma":[0.000016501339,0.000009588773,0.00036083872,0.00016371824,0.000007970879,0.00014285685,0.00009342958,0.000055484,0.00014900917,0.0012446342,0.9977374,0.000018448625],"about_ca_topic_score_codex":0.021113308,"about_ca_topic_score_gemma":0.021737725,"teacher_disagreement_score":0.28102073,"about_ca_system_score_codex":0.0055735074,"about_ca_system_score_gemma":0.00740039,"threshold_uncertainty_score":0.940108},"labels":[],"label_agreement":null},{"id":"W4246112560","doi":"10.1016/j.cmi.2018.11.022","title":"Clustered observations","year":2018,"lang":"en","type":"editorial","venue":"Clinical Microbiology and Infection","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Medicine; Quarter (Canadian coin); Cluster (spacecraft); Pediatrics; Randomization; Cluster randomised controlled trial; Randomized controlled trial; Surgery; Internal medicine; History","score_opus":0.20185690614268667,"score_gpt":0.5103987061880851,"score_spread":0.30854180004539844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246112560","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036383557,0.011094163,0.0037967046,0.13662751,0.83925796,0.000061599414,0.00089016795,0.00047594466,0.0074320594],"genre_scores_gemma":[0.0043134233,0.011087421,0.0024146207,0.069962926,0.8921293,0.00010563605,0.0008227909,0.00022634467,0.018937549],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918493,0.0021789407,0.0013418049,0.001378957,0.0028050232,0.00044601978],"domain_scores_gemma":[0.9608293,0.016285395,0.0042947833,0.004601528,0.012345923,0.0016430828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067072622,0.0015660885,0.001673302,0.0028669569,0.0010071204,0.0036312307,0.0027647074,0.0066747773,0.022626543],"category_scores_gemma":[0.06281103,0.0008128847,0.0024780037,0.002017486,0.0016651406,0.0030646794,0.002414168,0.012596739,0.0121414205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048771723,0.000005480475,0.00013266585,0.00022779142,0.00005442093,0.00012193647,0.00002056685,0.00003317778,0.00005453939,0.0006865012,0.9800283,0.018585881],"study_design_scores_gemma":[0.000078469784,0.000029333121,0.0010669779,0.00095188076,0.0001398123,0.0007010303,0.00006067892,0.00023756827,0.0002294957,0.0035959526,0.99287593,0.00003281096],"about_ca_topic_score_codex":0.0017423856,"about_ca_topic_score_gemma":0.0048456006,"teacher_disagreement_score":0.022626543,"about_ca_system_score_codex":0.0019249328,"about_ca_system_score_gemma":0.0024995676,"threshold_uncertainty_score":0.07569337},"labels":[],"label_agreement":null},{"id":"W4246993210","doi":"10.2196/preprints.10248","title":"Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset (Preprint)","year":2018,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Vancouver Coastal Health Research Institute; Simon Fraser University; Vancouver Coastal Health","funders":"","keywords":"Documentation; Preprint; Patient safety; Clinical decision support system; Health care; Best practice; Medicine; Pharmacovigilance; Computer science; Event (particle physics); MEDLINE; Medical emergency; Adverse effect; Data science; Data mining; Decision support system; World Wide Web","score_opus":0.25230456761213493,"score_gpt":0.5839796586718853,"score_spread":0.33167509105975035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246993210","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07454871,0.015322993,0.25646347,0.009084796,0.0024870983,0.18519135,0.4456276,0.004167158,0.0071068034],"genre_scores_gemma":[0.148115,0.0012012977,0.2757452,0.0028677993,0.00021229994,0.51442444,0.055717066,0.00046967223,0.0012472386],"study_design_codex":"systematic_review","study_design_gemma":"qualitative","domain_scores_codex":[0.73650366,0.17658648,0.050862696,0.015057969,0.018625502,0.0023637633],"domain_scores_gemma":[0.43385303,0.4910244,0.0312478,0.026258675,0.016782863,0.0008332711],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16321012,0.0014590027,0.0042292434,0.006018268,0.0012849475,0.0033761424,0.0036578474,0.0029531352,0.036540765],"category_scores_gemma":[0.52578163,0.0012340654,0.015210182,0.0074616005,0.0013263002,0.003182942,0.004514177,0.0032903932,0.0035253544],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013257107,0.0015726883,0.1173257,0.30981103,0.060395006,0.0014256035,0.007133499,0.016506195,0.0016832168,0.03631912,0.2650711,0.1694998],"study_design_scores_gemma":[0.019309506,0.007684536,0.22815008,0.10693866,0.06421857,0.0014799926,0.0063367956,0.077992424,0.0063334787,0.058593556,0.42113614,0.0018262881],"about_ca_topic_score_codex":0.0050288886,"about_ca_topic_score_gemma":0.006960888,"teacher_disagreement_score":0.83678985,"about_ca_system_score_codex":0.0036260413,"about_ca_system_score_gemma":0.007956742,"threshold_uncertainty_score":0.863148},"labels":[],"label_agreement":null},{"id":"W4247749853","doi":"10.1503/cmaj.1041330","title":"Corrections","year":2004,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Computer science; Data science; World Wide Web","score_opus":0.0479322943113069,"score_gpt":0.3991550188517705,"score_spread":0.3512227245404636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247749853","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007316981,0.002282404,0.002767136,0.15337121,0.6604369,0.00029208616,0.014103478,0.0042900303,0.16172494],"genre_scores_gemma":[0.008646015,0.00228611,0.004263424,0.04795719,0.045907512,0.00026231847,0.009901391,0.002770728,0.8780053],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923665,0.0010247905,0.0008958509,0.00095835095,0.0040312237,0.0007233102],"domain_scores_gemma":[0.9395095,0.008190651,0.0019129459,0.0053239446,0.043240145,0.0018227677],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0042024394,0.0014486609,0.00092528126,0.004884696,0.003271031,0.005099148,0.0032170254,0.0042578303,0.41636693],"category_scores_gemma":[0.08090527,0.00089039386,0.0016790503,0.0031420651,0.0015970233,0.0036932111,0.0023564447,0.0064642,0.25255415],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013362635,0.000003495199,0.00004245179,0.0000339522,0.0000018319079,0.000045037348,0.000025265519,0.00001247226,0.000025421532,0.0012677416,0.99104637,0.0074826214],"study_design_scores_gemma":[0.000009117573,0.0000057266516,0.00023925751,0.000086479304,0.000004067478,0.00011517545,0.000051923245,0.00002701512,0.00006992763,0.00078572915,0.99859697,0.0000085796455],"about_ca_topic_score_codex":0.022269802,"about_ca_topic_score_gemma":0.024295626,"teacher_disagreement_score":0.58363307,"about_ca_system_score_codex":0.0043589147,"about_ca_system_score_gemma":0.0065607834,"threshold_uncertainty_score":0.83248174},"labels":[],"label_agreement":null},{"id":"W4248970304","doi":"10.5195/jmla.2016.15","title":"Effectiveness of adverse effects search filters: drugs versus medical devices","year":2016,"lang":"en","type":"article","venue":"Journal of the Medical Library Association JMLA","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"MEDLINE; Medicine; Adverse effect; Medical record; Search engine indexing; Emergency medicine; Medical emergency; Information retrieval; Surgery; Computer science; Pharmacology","score_opus":0.03733547095465894,"score_gpt":0.40225441773601256,"score_spread":0.3649189467813536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248970304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8530109,0.11655253,0.008684056,0.002937159,0.00061086996,0.0031497683,0.005542509,0.0005672961,0.008944844],"genre_scores_gemma":[0.95716757,0.013034364,0.02399583,0.0011837754,0.00043977407,0.0008133378,0.00266141,0.00010669433,0.0005971993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.80654854,0.09515677,0.058512516,0.011332297,0.026545469,0.0019044739],"domain_scores_gemma":[0.19769703,0.72962415,0.04807215,0.0075948746,0.015676243,0.0013354772],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1458872,0.001507506,0.004159851,0.014980977,0.0011142939,0.0055209044,0.0017454362,0.003741304,0.002143798],"category_scores_gemma":[0.55271804,0.0010209209,0.004901111,0.007937228,0.0015751903,0.007860744,0.0024004928,0.000805231,0.00054604013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055775803,0.0015291556,0.5655647,0.037617497,0.015005756,0.0005695762,0.0034673112,0.0028023724,0.0052970406,0.0007030042,0.0040559713,0.30761182],"study_design_scores_gemma":[0.0062491046,0.03645317,0.79273146,0.025420057,0.04700699,0.005862387,0.003257495,0.030264959,0.02770545,0.0024761164,0.021502797,0.0010701137],"about_ca_topic_score_codex":0.0042014117,"about_ca_topic_score_gemma":0.0055763884,"teacher_disagreement_score":0.8541128,"about_ca_system_score_codex":0.0026823299,"about_ca_system_score_gemma":0.0041148546,"threshold_uncertainty_score":0.77153444},"labels":[],"label_agreement":null},{"id":"W4252588608","doi":"10.2165/00128415-200811840-00003","title":"The Canadian Adverse Drug Reaction Monitoring Program has been renamed as Canada Vigilance.","year":2008,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vigilance (psychology); Drug reaction; Drug; Adverse drug reaction; Pharmacology; Medicine; Psychology; Neuroscience","score_opus":0.10612927307531016,"score_gpt":0.3986718314294761,"score_spread":0.2925425583541659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252588608","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052471094,0.05795036,0.01614827,0.40819898,0.03788363,0.0011397925,0.030504376,0.0061353026,0.3895683],"genre_scores_gemma":[0.43548256,0.032853633,0.040162887,0.20400661,0.005308988,0.00064870954,0.02782732,0.0013113393,0.252398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99013686,0.0008560738,0.0005033837,0.00055016484,0.0065560923,0.0013974322],"domain_scores_gemma":[0.9533889,0.0031936062,0.003648298,0.0011266866,0.030589001,0.008053557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006304281,0.0005288445,0.00057128194,0.0034488202,0.0029324898,0.0031692598,0.0021894814,0.0025971888,0.0060560605],"category_scores_gemma":[0.02293644,0.00027143708,0.00083528645,0.005658537,0.0014965665,0.0010761869,0.0012090069,0.0047891927,0.0012696686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015815323,0.00009761536,0.026576195,0.0003119348,0.000069874266,0.00023698677,0.00033610754,0.00032873437,0.0012880871,0.011092607,0.76504695,0.19445685],"study_design_scores_gemma":[0.00003368591,0.00007148541,0.07734841,0.00025065357,0.000054650463,0.00034495257,0.0002294636,0.00052492745,0.0007899059,0.00059718866,0.91968197,0.000072576935],"about_ca_topic_score_codex":0.92573726,"about_ca_topic_score_gemma":0.9439732,"teacher_disagreement_score":0.07426274,"about_ca_system_score_codex":0.029696139,"about_ca_system_score_gemma":0.074493386,"threshold_uncertainty_score":0.21546155},"labels":[],"label_agreement":null},{"id":"W4255513542","doi":"10.1093/pch/16.suppl_a.18ab","title":"Can Active Surveillance Improve Reporting of Serious and Life-Threatening Adverse Drug Reactions? — The CPSP Experience","year":2011,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Paediatric Society","funders":"","keywords":"Drug; Adverse effect; Medicine; Drug reaction; Intensive care medicine; Pharmacology","score_opus":0.08269957441539692,"score_gpt":0.39628419533044335,"score_spread":0.3135846209150464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255513542","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09418606,0.01257268,0.007491545,0.8419871,0.005042711,0.0006388682,0.0018327383,0.00046982238,0.035778478],"genre_scores_gemma":[0.78410035,0.019425461,0.01671968,0.16356295,0.0075344113,0.00048421053,0.0022036075,0.0002529005,0.0057164095],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97622925,0.013244902,0.0021000723,0.0013828744,0.0055215997,0.0015212592],"domain_scores_gemma":[0.7979493,0.102822214,0.022822032,0.013632795,0.037494212,0.02527941],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07472422,0.00055927096,0.000531798,0.0016291621,0.00085731683,0.004953548,0.0023322008,0.004725583,0.0048806],"category_scores_gemma":[0.14293316,0.00058503816,0.001084388,0.0015865942,0.0016146493,0.0066039027,0.004925398,0.00691289,0.00072326325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014757585,0.0008663085,0.21135688,0.0007633133,0.00034216294,0.0015901239,0.0025632943,0.0012315476,0.00092955964,0.005964941,0.18911144,0.5838047],"study_design_scores_gemma":[0.0016141786,0.0045133457,0.46032038,0.0036934821,0.00053121225,0.0060599796,0.007119876,0.005408572,0.003015851,0.0072996505,0.5000953,0.00032821842],"about_ca_topic_score_codex":0.019898979,"about_ca_topic_score_gemma":0.017022364,"teacher_disagreement_score":0.9252758,"about_ca_system_score_codex":0.0034667547,"about_ca_system_score_gemma":0.011717982,"threshold_uncertainty_score":0.39518416},"labels":[],"label_agreement":null},{"id":"W4280550674","doi":"10.2196/37821","title":"Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom","year":2022,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Welsh Ambulance Services NHS Trust; Swansea University; Public Health Wales; Royal College of General Practitioners; National Institute for Health and Care Research; Llywodraeth Cymru","keywords":"Pharmacovigilance; Observational study; Terminology; Medicine; Analytics; Family medicine; Data science; Computer science; Adverse effect; Pathology","score_opus":0.8552325583730792,"score_gpt":0.6711400886450754,"score_spread":0.18409246972800386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280550674","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41378498,0.0011893695,0.5271608,0.0063842167,0.00040027872,0.04018318,0.005854815,0.00026890475,0.004773477],"genre_scores_gemma":[0.6739004,0.00016585608,0.2725221,0.0010684191,0.00005907929,0.04989082,0.0019981712,0.000054264896,0.00034094122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.44062448,0.48922682,0.03059925,0.017224468,0.020398442,0.0019266044],"domain_scores_gemma":[0.25003764,0.62965614,0.03772114,0.05738214,0.022977114,0.002225883],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.4015467,0.0012945288,0.0021287673,0.003970689,0.0026113072,0.007226781,0.0056502344,0.0028575596,0.0034508102],"category_scores_gemma":[0.6728409,0.0015104379,0.007799706,0.007234534,0.0042748805,0.007915308,0.008924318,0.003994317,0.00041835516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007826845,0.0031590862,0.70980215,0.006413267,0.012585891,0.00093867513,0.027611293,0.03426879,0.0010889964,0.093267046,0.005873815,0.09716404],"study_design_scores_gemma":[0.009118557,0.016556058,0.3635449,0.00715647,0.008883682,0.0020609342,0.034196775,0.33055866,0.0043459884,0.18138552,0.041210532,0.0009819564],"about_ca_topic_score_codex":0.01598449,"about_ca_topic_score_gemma":0.008832361,"teacher_disagreement_score":0.4015467,"about_ca_system_score_codex":0.010150582,"about_ca_system_score_gemma":0.0130727235,"threshold_uncertainty_score":0.7379995},"labels":[],"label_agreement":null},{"id":"W4281655021","doi":"10.1111/hir.12441","title":"Updated generic search filters for finding studies of adverse drug effects in Ovid <scp>medline</scp> and Embase may retrieve up to 90% of relevant studies","year":2022,"lang":"en","type":"article","venue":"Health Information & Libraries Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"MEDLINE; Adverse effect; Medicine; Recall; Set (abstract data type); Information retrieval; Systematic review; Computer science; Internal medicine; Psychology","score_opus":0.1861800497179004,"score_gpt":0.4697499416266629,"score_spread":0.2835698919087625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281655021","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16165732,0.3006406,0.11994622,0.018477011,0.003897591,0.17278586,0.17326295,0.0060475417,0.04328484],"genre_scores_gemma":[0.271563,0.070495956,0.4162248,0.011500472,0.001618897,0.13890927,0.08281098,0.0010493573,0.0058272784],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.84124607,0.042383213,0.0929309,0.0043420307,0.017424425,0.0016733595],"domain_scores_gemma":[0.5007638,0.35532275,0.06672579,0.022511212,0.05280566,0.0018708514],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1803546,0.0027359258,0.0064946045,0.051715318,0.0018539706,0.0049204486,0.0038454214,0.003929339,0.013577545],"category_scores_gemma":[0.44504133,0.0014911984,0.008585823,0.024656223,0.0014403812,0.005711683,0.0038822703,0.0017940993,0.0033251669],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006338521,0.00040814048,0.059274368,0.42951086,0.012192273,0.0012019243,0.004268948,0.0023732204,0.0073812637,0.005963076,0.06642191,0.40466556],"study_design_scores_gemma":[0.0060675563,0.0038793306,0.19218308,0.38783696,0.06657307,0.0028108507,0.0019267562,0.0055449554,0.009521951,0.013396459,0.30931976,0.0009391769],"about_ca_topic_score_codex":0.0072441846,"about_ca_topic_score_gemma":0.018185757,"teacher_disagreement_score":0.8196454,"about_ca_system_score_codex":0.0054708906,"about_ca_system_score_gemma":0.013540101,"threshold_uncertainty_score":0.95381767},"labels":[],"label_agreement":null},{"id":"W4283021033","doi":"10.2196/34305","title":"Vaccine Adverse Event Mining of Twitter Conversations: 2-Phase Classification Study","year":2022,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Monash University","keywords":"Social media; Computer science; Vaccine safety; Event (particle physics); Resource (disambiguation); Adverse effect; Data science; Medicine; Immunization; World Wide Web; Immunology","score_opus":0.132246056489117,"score_gpt":0.4883925738319701,"score_spread":0.3561465173428531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283021033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614076,0.0011072314,0.0289986,0.0007184137,0.00023723686,0.001904658,0.0038013975,0.0003405824,0.001484332],"genre_scores_gemma":[0.9544052,0.00040949314,0.030657351,0.00027032202,0.00026508598,0.0011065102,0.011082633,0.000042109175,0.0017612508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958831,0.0018600033,0.00050107646,0.00082129164,0.0006036618,0.0003308873],"domain_scores_gemma":[0.9875942,0.008208873,0.0008197118,0.0010861623,0.0017587583,0.0005322731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00863128,0.0010765324,0.001424239,0.0023699112,0.0009061171,0.0014414912,0.0013152356,0.0017679443,0.0016269294],"category_scores_gemma":[0.012436394,0.00045030745,0.0027273174,0.001141359,0.0006247843,0.001994541,0.0014258288,0.0016778662,0.0011457293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071462733,0.014508741,0.6216624,0.0021313468,0.001154674,0.0017121003,0.0025918519,0.03535285,0.012767106,0.0021049937,0.012523013,0.28634468],"study_design_scores_gemma":[0.0006547925,0.0046046274,0.18031086,0.0001784485,0.0005979611,0.0013684386,0.004032288,0.78856736,0.01068391,0.0026144958,0.006229635,0.00015718826],"about_ca_topic_score_codex":0.0034623109,"about_ca_topic_score_gemma":0.0037394504,"teacher_disagreement_score":0.00863128,"about_ca_system_score_codex":0.0007597842,"about_ca_system_score_gemma":0.0010620655,"threshold_uncertainty_score":0.045647085},"labels":[],"label_agreement":null},{"id":"W4283077601","doi":"10.1007/s40264-022-01192-1","title":"Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.”","year":2022,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Drug; Myopathy; Pharmacology; Transporter; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Adverse drug reaction; Drug-drug interaction; Drug reaction; Statin; Adverse effect; Internal medicine; Biochemistry","score_opus":0.11189344049358511,"score_gpt":0.43026414368380944,"score_spread":0.3183707031902243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283077601","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024735456,0.0005861653,0.00006761323,0.9796681,0.018127639,0.000011445348,0.000118893506,0.000028686829,0.0011440634],"genre_scores_gemma":[0.00072979846,0.00019461979,0.00007987241,0.9891479,0.007817908,0.000017117454,0.000019871104,0.000013693976,0.0019792165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99249,0.0016558606,0.0012864472,0.0010457439,0.0024549942,0.0010668765],"domain_scores_gemma":[0.97995925,0.011020934,0.001285513,0.000466202,0.005077407,0.0021907652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009001132,0.0010195941,0.0019190921,0.0012990204,0.0051077697,0.004833952,0.0036694848,0.07408251,0.0079272315],"category_scores_gemma":[0.042830944,0.0013863425,0.0027104148,0.0014191524,0.0035990824,0.004367918,0.0021439274,0.05413541,0.009773649],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050689938,0.000020345213,0.0005929132,0.00003509325,0.000021004695,0.00070459116,0.00010844609,0.00003453488,0.00011355041,0.0008345308,0.99496764,0.0025166087],"study_design_scores_gemma":[0.00021870562,0.000099497905,0.0032647513,0.0005487575,0.00011240031,0.0017544194,0.0008165136,0.00042471776,0.00058719027,0.0062024416,0.9857611,0.00020963747],"about_ca_topic_score_codex":0.02147946,"about_ca_topic_score_gemma":0.034617897,"teacher_disagreement_score":0.07408251,"about_ca_system_score_codex":0.0051650326,"about_ca_system_score_gemma":0.010419803,"threshold_uncertainty_score":0.04760313},"labels":[],"label_agreement":null},{"id":"W4283796715","doi":"10.1136/bmjopen-2021-055551","title":"Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions","year":2022,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Medical Research Council; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; Vistagen Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Polypharmacy; Observational study; Prospective cohort study; Emergency medicine; Drug reaction; Pharmacoepidemiology; Pediatrics; Adverse drug reaction; Medical prescription; Drug; Internal medicine; Psychiatry; Pharmacology","score_opus":0.20325754199186322,"score_gpt":0.5469174082111258,"score_spread":0.3436598662192626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283796715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981573,0.00041363607,0.00009439319,0.000038751892,0.0000060637412,0.000030984163,0.0010706785,0.0000036364597,0.00018454729],"genre_scores_gemma":[0.99862516,0.00022001084,0.000101640486,0.000022705264,0.00001757186,0.000023917588,0.0009126191,0.0000024376425,0.00007390639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770075,0.0006924265,0.00047369875,0.00039457186,0.00044857105,0.00028988885],"domain_scores_gemma":[0.98903465,0.0010951946,0.007862559,0.0003723488,0.00059327984,0.0010420609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001477091,0.00044651495,0.0007697546,0.0019784726,0.00052071846,0.001007725,0.00052867085,0.00062406063,0.0014612052],"category_scores_gemma":[0.0063354084,0.0006404683,0.0012938498,0.0028466647,0.00034890132,0.0011757811,0.0013450006,0.00084294355,0.00033265247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010105583,0.000016904592,0.9993216,0.0000142053805,0.000053749845,0.00004820895,0.00003405007,0.00003422692,0.000028654418,0.000003244716,0.000040563806,0.00030348412],"study_design_scores_gemma":[0.000004873446,0.00012361207,0.999433,0.000008737478,0.000017620438,0.0001617227,0.00007702018,0.00010213574,0.000013881686,0.0000046494097,0.000048875092,0.0000040187047],"about_ca_topic_score_codex":0.008658754,"about_ca_topic_score_gemma":0.01077602,"teacher_disagreement_score":0.008658754,"about_ca_system_score_codex":0.00068276346,"about_ca_system_score_gemma":0.0005610147,"threshold_uncertainty_score":0.017216742},"labels":[],"label_agreement":null},{"id":"W4283808279","doi":"10.18433/jpps32867","title":"Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System（FAERS）","year":2022,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Adverse Event Reporting System; Medicine; QT interval; Prolongation; Adverse effect; Antifungal; Torsades de pointes; Fluconazole; Database; Internal medicine; Computer science; Dermatology","score_opus":0.18430557720168966,"score_gpt":0.47932321183100485,"score_spread":0.2950176346293152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283808279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915958,0.0048366464,0.0007044591,0.00019859744,0.000022738353,0.00015630024,0.001854854,0.000015974492,0.0006146259],"genre_scores_gemma":[0.99666035,0.0010121174,0.00043043855,0.00015601149,0.000050191844,0.0000634707,0.0015211289,0.000004876835,0.00010141081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943703,0.0014456194,0.0016357808,0.0010391568,0.0012773232,0.00023177682],"domain_scores_gemma":[0.9872687,0.0030174237,0.0073527414,0.00066660484,0.0013153685,0.00037913385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004268911,0.0003840566,0.0007148713,0.0020935934,0.000390911,0.0009960296,0.00037853108,0.00053669006,0.0014914207],"category_scores_gemma":[0.011131069,0.0003358795,0.0014086236,0.0026240991,0.00030842333,0.00077240536,0.00065062987,0.00055677915,0.0002190877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053702755,0.00008371214,0.99336916,0.0002269838,0.00045225685,0.00032896097,0.00015662891,0.000044690223,0.00026602877,0.000043518798,0.00026153124,0.004229422],"study_design_scores_gemma":[0.00007112147,0.00056007586,0.99430424,0.0001282546,0.0010801074,0.0015365703,0.0003002123,0.0005909696,0.0003418605,0.00005954005,0.0010096375,0.000017280061],"about_ca_topic_score_codex":0.002419607,"about_ca_topic_score_gemma":0.002190291,"teacher_disagreement_score":0.004268911,"about_ca_system_score_codex":0.0006705201,"about_ca_system_score_gemma":0.0009916669,"threshold_uncertainty_score":0.022576451},"labels":[],"label_agreement":null},{"id":"W4284681137","doi":"10.2196/40456","title":"Automatic Detection of Adverse Drug Events in Geriatric Care: Study Proposal","year":2022,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Universität Zürich; Centre Hospitalier Universitaire Vaudois; Université de Genève; Université de Lausanne; Hôpitaux Universitaires de Genève","keywords":"Drug; Medicine; Adverse effect; Computer science; Pharmacology","score_opus":0.24661069258402518,"score_gpt":0.5997845955250113,"score_spread":0.3531739029409861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284681137","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8993372,0.0018014276,0.03766815,0.0011390244,0.00016775729,0.029944675,0.023544272,0.0004946988,0.0059027676],"genre_scores_gemma":[0.90073925,0.0010965209,0.04993691,0.00047217144,0.0003223715,0.028114168,0.017980862,0.000031425556,0.0013063394],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944115,0.0029571191,0.0007213047,0.0010328597,0.0006541251,0.00022307014],"domain_scores_gemma":[0.9850032,0.008302273,0.0019581942,0.0012996728,0.0027958567,0.0006408623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008210159,0.0009350187,0.00049428816,0.0021435786,0.0007212682,0.0013378558,0.0011582953,0.0010223746,0.0038807052],"category_scores_gemma":[0.018206859,0.0003836939,0.0015978918,0.0015916069,0.00072915165,0.0010676556,0.0012952485,0.00036161247,0.0010381646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003741099,0.002486197,0.9034039,0.0016205619,0.00063629256,0.00048781777,0.0006814227,0.0026145428,0.0010311647,0.0013305218,0.003923522,0.0780431],"study_design_scores_gemma":[0.007374716,0.015908059,0.8686235,0.0010304184,0.0031922124,0.004246652,0.0032687145,0.06309867,0.0055315145,0.0040437793,0.0233944,0.00028744354],"about_ca_topic_score_codex":0.005772502,"about_ca_topic_score_gemma":0.003570141,"teacher_disagreement_score":0.008210159,"about_ca_system_score_codex":0.0008777969,"about_ca_system_score_gemma":0.0032187875,"threshold_uncertainty_score":0.043419957},"labels":[],"label_agreement":null},{"id":"W4285095129","doi":"10.4314/rjmhs.v5i2.11","title":"Pharmacovigilance: Awareness and Practice of Nurses and Midwives in Monitoring and Reporting Adverse Drug Reactions in a Selected University Teaching Hospital, Rwanda","year":2022,"lang":"en","type":"article","venue":"Rwanda Journal of Medicine and Health Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Adverse drug reaction; Drug; Medical emergency; Family medicine; Pharmacology","score_opus":0.15970655144690254,"score_gpt":0.5098542666582755,"score_spread":0.35014771521137295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285095129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992342,0.0002616826,0.00003654619,0.00016447315,0.0000050439244,0.000010634898,0.000019373012,0.0000017870834,0.00026636763],"genre_scores_gemma":[0.9993381,0.00036094192,0.00008340263,0.00006731996,0.0000066482794,0.0000119147135,0.000014371915,6.4626425e-7,0.000116600015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984742,0.0007090735,0.00019815992,0.00016196696,0.0001889179,0.00026766508],"domain_scores_gemma":[0.9958325,0.001095648,0.0021743646,0.00009698497,0.00035389158,0.00044669642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015229733,0.00017951017,0.00017924301,0.00059568713,0.0006642121,0.0006160306,0.00037252883,0.00044065248,0.0010205786],"category_scores_gemma":[0.006068352,0.0003567917,0.00016663593,0.0004908389,0.000539366,0.00063847663,0.0007322483,0.00038920052,0.00014872568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007775008,0.00013531912,0.97914106,0.00012699538,0.000016107895,0.0006210049,0.011138307,0.000040920106,0.0008892681,0.000026842226,0.00023168385,0.0075547933],"study_design_scores_gemma":[0.000007855021,0.00044001095,0.97467875,0.00013222675,0.000019763196,0.0010428104,0.022708785,0.00013910723,0.00023773272,0.000016192454,0.0005622968,0.000014434126],"about_ca_topic_score_codex":0.013969485,"about_ca_topic_score_gemma":0.017593293,"teacher_disagreement_score":0.013969485,"about_ca_system_score_codex":0.0012937888,"about_ca_system_score_gemma":0.0021572895,"threshold_uncertainty_score":0.02777636},"labels":[],"label_agreement":null},{"id":"W4287094865","doi":"10.1016/j.clinthera.2022.07.007","title":"Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey","year":2022,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Revenue; Workload; Business; Pandemic; Quarter (Canadian coin); Data collection; Coronavirus disease 2019 (COVID-19); Product (mathematics); Marketing; Accounting; Medicine; Economics; Management","score_opus":0.45276977082375525,"score_gpt":0.547388937798317,"score_spread":0.09461916697456174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287094865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977684,0.00009967468,0.00009924972,0.0007374762,0.000003547811,0.000032365897,0.00026317415,0.000003843628,0.0009922016],"genre_scores_gemma":[0.99907,0.00012920825,0.000111994705,0.00027643505,0.000008576974,0.000039126113,0.00020720939,0.0000018534439,0.0001556057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941362,0.0027300965,0.0005178004,0.0004083435,0.0014209906,0.0007865752],"domain_scores_gemma":[0.9677797,0.00999067,0.014862421,0.000737734,0.0035989601,0.0030305446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077679753,0.00019582195,0.00017057083,0.00124711,0.00065048353,0.001392071,0.00036224283,0.000644005,0.0015370738],"category_scores_gemma":[0.02205383,0.0002451228,0.00033280568,0.0012797224,0.0006565574,0.002024629,0.0017336212,0.00097032776,0.00026376816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004744684,0.00014440864,0.9883116,0.000030134262,0.000020144627,0.00009937799,0.0031698404,0.00010230969,0.00016143013,0.000059620055,0.00068900734,0.007164635],"study_design_scores_gemma":[0.000004353452,0.00028666342,0.98690677,0.00004074151,0.000008325433,0.00013573862,0.011023886,0.00035682353,0.0001081729,0.000027397044,0.0010904912,0.000010618231],"about_ca_topic_score_codex":0.012285391,"about_ca_topic_score_gemma":0.013621022,"teacher_disagreement_score":0.012285391,"about_ca_system_score_codex":0.0017329529,"about_ca_system_score_gemma":0.0017720804,"threshold_uncertainty_score":0.041081488},"labels":[],"label_agreement":null},{"id":"W4289534184","doi":"10.2196/38701","title":"A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study","year":2022,"lang":"en","type":"article","venue":"JMIR Human Factors","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Mobile apps; Context (archaeology); Usability; Adverse effect; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Smartphone app; Computer science; Medicine; Internet privacy; Psychology; World Wide Web; Virology; Internal medicine; Geography; Human–computer interaction","score_opus":0.34502066274617316,"score_gpt":0.502270548560436,"score_spread":0.1572498858142628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289534184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88290745,0.0019847055,0.08512327,0.0011598809,0.00035977655,0.015362636,0.0019198743,0.004381542,0.0068008723],"genre_scores_gemma":[0.76384956,0.0014977996,0.21405302,0.001056181,0.00015813025,0.0150995925,0.001273182,0.00023947877,0.0027730328],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99560034,0.0029716853,0.0003690094,0.00035869115,0.00046758726,0.00023270045],"domain_scores_gemma":[0.9879126,0.008737562,0.0006223162,0.0008335412,0.0013970109,0.0004970604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007901163,0.0007981992,0.00051263545,0.0010606362,0.00038543882,0.0015783228,0.0007516723,0.0008670341,0.0025802143],"category_scores_gemma":[0.020158384,0.0003511106,0.00091524224,0.00035925853,0.0003916768,0.0014530276,0.0019393724,0.0005482641,0.0007254791],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004131584,0.00457909,0.10003637,0.0076552634,0.00079712755,0.0021503007,0.017128289,0.0016407856,0.030154068,0.0015787227,0.014520475,0.815628],"study_design_scores_gemma":[0.0042701946,0.041979734,0.5550201,0.010325331,0.0048868344,0.016448889,0.023413414,0.058743466,0.050150763,0.009947568,0.2233305,0.0014831017],"about_ca_topic_score_codex":0.0003827193,"about_ca_topic_score_gemma":0.00079119555,"teacher_disagreement_score":0.007901163,"about_ca_system_score_codex":0.0002567894,"about_ca_system_score_gemma":0.000725144,"threshold_uncertainty_score":0.041785836},"labels":[],"label_agreement":null},{"id":"W4290776083","doi":"10.22541/au.166005544.42911441/v1","title":"Comparison of the Liverpool Causality Assessment Tool versus the Naranjo Scale for Predicting the Likelihood of an Adverse Drug Reaction","year":2022,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Causality (physics); Medicine; Clinical history; Adverse drug reaction; Scale (ratio); Drug reaction; Pediatrics; Internal medicine; Drug; Psychiatry; Cartography","score_opus":0.14859789997038478,"score_gpt":0.5071980114738803,"score_spread":0.3586001115034956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290776083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165756,0.0018320356,0.0027918587,0.00022571986,0.0000831756,0.00021281806,0.0004642734,0.000051455485,0.0026811312],"genre_scores_gemma":[0.99661106,0.00023318495,0.002497497,0.00005303035,0.00004379385,0.0000863396,0.00027434924,0.0000043866185,0.00019622645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98726976,0.007360561,0.0018105268,0.00069656235,0.0025275776,0.00033504955],"domain_scores_gemma":[0.9401743,0.043767586,0.010273248,0.0009871756,0.0034663482,0.0013313538],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014201042,0.00060924893,0.0009096152,0.0037893546,0.00025522875,0.0009337465,0.00061322114,0.0006916549,0.0025116568],"category_scores_gemma":[0.04841418,0.00024323935,0.0011384294,0.0009606334,0.00043539645,0.0016057319,0.0010628231,0.00051482953,0.00043407298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022571047,0.00011805384,0.9779228,0.00016648101,0.00047478793,0.00012694871,0.00008246659,0.00067683443,0.00024275642,0.00007383845,0.00043097342,0.017427055],"study_design_scores_gemma":[0.00044295672,0.004854533,0.9737925,0.00025267017,0.00042268477,0.0019724467,0.00036743772,0.015565878,0.00089479546,0.00034959818,0.0010073422,0.000077100776],"about_ca_topic_score_codex":0.00069297187,"about_ca_topic_score_gemma":0.000982848,"teacher_disagreement_score":0.98579895,"about_ca_system_score_codex":0.00040912806,"about_ca_system_score_gemma":0.00055535656,"threshold_uncertainty_score":0.07510322},"labels":[],"label_agreement":null},{"id":"W4290803566","doi":"10.1007/978-3-031-07275-8_12","title":"Development of a Natural Health Product Active Surveillance Method in Outpatient Centers in Canada","year":2022,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Product (mathematics); Natural (archaeology); Medicine; Geography; Archaeology","score_opus":0.09881647928998794,"score_gpt":0.42155741478980413,"score_spread":0.3227409354998162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290803566","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62330955,0.011447705,0.1298112,0.015653385,0.0009091797,0.009901496,0.009757771,0.0038893938,0.19532032],"genre_scores_gemma":[0.5955813,0.0056539592,0.33169034,0.0033684645,0.00008711443,0.0012446304,0.0032883089,0.00032479182,0.05876119],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760616,0.0005157471,0.000120947705,0.0002397939,0.0012743796,0.00024289555],"domain_scores_gemma":[0.99573344,0.0008837172,0.00017374379,0.00009304917,0.0028439653,0.00027208065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028778692,0.0003271296,0.0003084389,0.0012815307,0.0013753794,0.0016933607,0.001539243,0.00057527644,0.0031706358],"category_scores_gemma":[0.0052522626,0.00031573055,0.00034147844,0.0014685721,0.00041943972,0.00047065146,0.0005550909,0.00050640444,0.0006434958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032388637,0.00047099462,0.10609406,0.00038521652,0.000035097815,0.00060325675,0.0028833656,0.0022760907,0.0076461756,0.0037329914,0.03918972,0.8363591],"study_design_scores_gemma":[0.00030210806,0.0017675364,0.59189767,0.0011901626,0.0002490656,0.0018594943,0.011564161,0.05343188,0.03154621,0.0015728839,0.3043917,0.00022712052],"about_ca_topic_score_codex":0.94337165,"about_ca_topic_score_gemma":0.9699063,"teacher_disagreement_score":0.056628346,"about_ca_system_score_codex":0.015188892,"about_ca_system_score_gemma":0.04671865,"threshold_uncertainty_score":0.11392361},"labels":[],"label_agreement":null},{"id":"W4290960432","doi":"10.2196/37812","title":"Mining Severe Drug Hypersensitivity Reaction Cases in Pediatric Electronic Health Records: Methodology Development and Applications","year":2022,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science; Task (project management); Identification (biology); Set (abstract data type); Sentence; Inference; Artificial intelligence; Machine learning; Data mining; Information retrieval; Medicine","score_opus":0.12353839754543865,"score_gpt":0.4521835774824478,"score_spread":0.32864517993700915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290960432","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12774351,0.001698629,0.8603241,0.001118409,0.00008983699,0.0014110953,0.0026400546,0.0039073015,0.0010670335],"genre_scores_gemma":[0.22795017,0.00083352195,0.763586,0.00019477512,0.00006336691,0.0010567348,0.0053686816,0.00006323012,0.00088359707],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99728227,0.0009289819,0.00048606127,0.00072928565,0.00044921777,0.00012421132],"domain_scores_gemma":[0.99565816,0.0021576274,0.0003736316,0.0004478656,0.0012385268,0.0001241932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048006973,0.0008798531,0.0006274347,0.0028757844,0.0005363186,0.0012064105,0.0016603504,0.0010580971,0.0012836601],"category_scores_gemma":[0.01003486,0.00040944194,0.0010413596,0.002181206,0.00030251965,0.0013030197,0.0011665601,0.00078983663,0.0007217261],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027858326,0.0008064988,0.046006605,0.0006917303,0.0003778546,0.00078286644,0.00054134877,0.049562037,0.013651434,0.002868592,0.009038287,0.87539417],"study_design_scores_gemma":[0.00009347779,0.0002977812,0.009498858,0.00008509017,0.00012587104,0.00051872095,0.0006665922,0.96655697,0.011627305,0.0037663234,0.0067277956,0.000035221085],"about_ca_topic_score_codex":0.00591122,"about_ca_topic_score_gemma":0.0071589947,"teacher_disagreement_score":0.00591122,"about_ca_system_score_codex":0.00068011536,"about_ca_system_score_gemma":0.0022551785,"threshold_uncertainty_score":0.025388777},"labels":[],"label_agreement":null},{"id":"W4293066067","doi":"10.2196/37605","title":"Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study","year":2022,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Usability; Likert scale; mHealth; Adverse effect; Medicine; Patient safety; Digital health; System usability scale; Psychology; Applied psychology; Medical education; Health care; Nursing; Computer science; Web usability; Psychological intervention; Pharmacology","score_opus":0.14713728831510162,"score_gpt":0.5101662120247679,"score_spread":0.3630289237096662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293066067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.861731,0.000598831,0.091392085,0.00034037014,0.000073422205,0.042062446,0.00032355814,0.0006457787,0.0028325268],"genre_scores_gemma":[0.5853265,0.00097037567,0.3651538,0.0005280293,0.000050323393,0.04521026,0.0004581265,0.00017782554,0.0021247857],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98735577,0.008102843,0.0013750745,0.0008703595,0.0017548711,0.0005411187],"domain_scores_gemma":[0.9704863,0.018700853,0.0011876185,0.0013315765,0.0073181004,0.0009755164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023525381,0.00087803823,0.0010403488,0.0020434319,0.0008748331,0.0016678767,0.0013253279,0.0014471166,0.0016355414],"category_scores_gemma":[0.03017671,0.00081346347,0.0011760573,0.0008984229,0.00087180664,0.0018154839,0.0014954666,0.0007302378,0.0005203878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004252094,0.029307835,0.10106355,0.016725535,0.00070443284,0.004232623,0.061006613,0.0072337836,0.080723606,0.002268416,0.0041111214,0.68837047],"study_design_scores_gemma":[0.014265024,0.23400827,0.33327553,0.008466793,0.005365215,0.008208645,0.06648979,0.078170344,0.154149,0.0040057753,0.092271335,0.0013243197],"about_ca_topic_score_codex":0.001225557,"about_ca_topic_score_gemma":0.0014287131,"teacher_disagreement_score":0.023525381,"about_ca_system_score_codex":0.0010758891,"about_ca_system_score_gemma":0.0033514427,"threshold_uncertainty_score":0.124415636},"labels":[],"label_agreement":null},{"id":"W4293247753","doi":"10.2196/preprints.39700","title":"Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial (Preprint)","year":2022,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Toronto","funders":"","keywords":"Medicine; Mobile apps; Notification system; Vaccination; Adverse effect; Influenza vaccine; Web application; Smartphone app; Randomized controlled trial; Internet privacy; World Wide Web; Family medicine; Medical emergency; Computer science; Internal medicine; Immunology","score_opus":0.17174192206871775,"score_gpt":0.4305927400037728,"score_spread":0.25885081793505504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293247753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252346,0.01921259,0.0019743934,0.0027035754,0.0059003555,0.0358039,0.0026403128,0.00037386935,0.006156394],"genre_scores_gemma":[0.91998386,0.00786352,0.0053784344,0.0030310196,0.0024241533,0.05472965,0.0012138466,0.000050849125,0.005324673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961128,0.0022595634,0.0005605654,0.0005030543,0.0003055797,0.000258367],"domain_scores_gemma":[0.9958033,0.00205921,0.001059615,0.00021408986,0.00032218025,0.000541591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038651277,0.0016087482,0.0036134766,0.0006270246,0.0006854525,0.0019116794,0.0012338132,0.0035487115,0.014460826],"category_scores_gemma":[0.010100103,0.0009059108,0.005150758,0.00060026086,0.0012424096,0.002063041,0.0007790798,0.0035970055,0.0014450441],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9789692,0.0045632306,0.00035518807,0.0027554848,0.0025877636,0.000019757328,0.000050710998,0.00009590786,0.00031271606,0.00010350313,0.0007974891,0.009388965],"study_design_scores_gemma":[0.9536342,0.041703504,0.0011948715,0.00035461652,0.001993921,0.000011875542,0.000035548215,0.00028115066,0.0001799836,0.00011882254,0.00047525665,0.00001633839],"about_ca_topic_score_codex":0.0026823885,"about_ca_topic_score_gemma":0.0033600593,"teacher_disagreement_score":0.014460826,"about_ca_system_score_codex":0.0013723569,"about_ca_system_score_gemma":0.002542725,"threshold_uncertainty_score":0.04837632},"labels":[],"label_agreement":null},{"id":"W4293729944","doi":"10.3390/medicina58091171","title":"Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants","year":2022,"lang":"en","type":"article","venue":"Medicina","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Institute on Aging; National Institutes of Health","keywords":"Warfarin; Medicine; Concomitant; Confidence interval; Muscle relaxant; Anesthesia; Pharmacoepidemiology; Rate ratio; Atrial fibrillation; Emergency medicine; Internal medicine; Pharmacology; Medical prescription","score_opus":0.0735295202447823,"score_gpt":0.39425478632787386,"score_spread":0.32072526608309154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293729944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973181,0.0020575998,0.00010089921,0.000023432054,0.0000049338596,0.000016131624,0.00021804875,0.000002692568,0.00025820913],"genre_scores_gemma":[0.9990326,0.00049626315,0.00017305312,0.000025569312,0.000015525975,0.000013182431,0.00019695777,0.0000010515819,0.000045793942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974427,0.0009484541,0.0004810379,0.00056230655,0.00044687907,0.00011857424],"domain_scores_gemma":[0.9913784,0.002509223,0.005237121,0.0003289153,0.00030857243,0.00023775101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021295839,0.00026405073,0.0004718974,0.0013569483,0.00028510555,0.0008056854,0.00039654344,0.00056376134,0.0010289517],"category_scores_gemma":[0.007407122,0.0003282937,0.0011642821,0.0013797968,0.00031544382,0.0003973466,0.0003757313,0.00046252465,0.0000875247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038312687,0.000027183105,0.99811053,0.000020616508,0.00028105985,0.000045426554,0.000030274148,0.00002265518,0.00011367676,0.000009038187,0.000014954709,0.00094136293],"study_design_scores_gemma":[0.00005887366,0.000518363,0.9976476,0.000021465958,0.00043536606,0.00068068365,0.00007792043,0.00017784377,0.00019845621,0.000025841182,0.00015094642,0.0000068112286],"about_ca_topic_score_codex":0.0017046795,"about_ca_topic_score_gemma":0.0017175506,"teacher_disagreement_score":0.0021295839,"about_ca_system_score_codex":0.00037181127,"about_ca_system_score_gemma":0.00026772136,"threshold_uncertainty_score":0.011262476},"labels":[],"label_agreement":null},{"id":"W4295014627","doi":"10.2196/38140","title":"An Assessment of Mentions of Adverse Drug Events on Social Media With Natural Language Processing: Model Development and Analysis","year":2022,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science; Natural language processing; Drug development; Social media; Data science; Medicine; Drug; World Wide Web; Pharmacology","score_opus":0.057769677737070195,"score_gpt":0.4703392044594746,"score_spread":0.4125695267224044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295014627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5424237,0.0010354271,0.4416259,0.0033645788,0.00022044066,0.00088660995,0.0040643867,0.0024158836,0.00396301],"genre_scores_gemma":[0.90085834,0.00027433556,0.09329767,0.00023978594,0.00008966668,0.00066513673,0.0027560017,0.000045835535,0.0017732404],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988555,0.00042316364,0.00008991254,0.00039880074,0.0001496124,0.00008308393],"domain_scores_gemma":[0.99127823,0.007079219,0.0004510504,0.00026740116,0.0008050499,0.00011900896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040717754,0.0012795798,0.00064607424,0.0022591313,0.0004978395,0.0013451589,0.001636532,0.0013775601,0.001857037],"category_scores_gemma":[0.010790684,0.00053496583,0.0015670641,0.0010270781,0.00060071755,0.0019263772,0.001067048,0.0019318729,0.00065163826],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043911493,0.00090025226,0.046239786,0.0002958399,0.00045342965,0.00038981903,0.00051707414,0.8248989,0.0027558515,0.0037726515,0.0032704086,0.11606687],"study_design_scores_gemma":[0.0000036098586,0.000027992373,0.0011234113,0.000005749655,0.00001571962,0.000015070282,0.00001833741,0.9975914,0.00018416425,0.0008868394,0.00012262625,0.000005224058],"about_ca_topic_score_codex":0.02523986,"about_ca_topic_score_gemma":0.02245485,"teacher_disagreement_score":0.02523986,"about_ca_system_score_codex":0.0017987397,"about_ca_system_score_gemma":0.0012416986,"threshold_uncertainty_score":0.05018586},"labels":[],"label_agreement":null},{"id":"W4301317273","doi":"","title":"Report and abstracts of the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. 13-15 September 2000, Toronto, Canada.","year":2000,"lang":"en","type":"other","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lipodystrophy; Human immunodeficiency virus (HIV); Medicine; Drug; Drug reaction; Adverse effect; Pharmacology; Antiretroviral therapy; Family medicine","score_opus":0.03448897558332633,"score_gpt":0.33026011234508795,"score_spread":0.29577113676176164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301317273","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063545792,0.3427663,0.004200313,0.06655574,0.10858232,0.0022773766,0.13032311,0.0010931944,0.33784702],"genre_scores_gemma":[0.010420335,0.14806214,0.002471361,0.0048089675,0.013686239,0.0005333143,0.04982551,0.0003434355,0.7698489],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988329,0.0001410977,0.00013252614,0.000089177556,0.00064684154,0.00015757333],"domain_scores_gemma":[0.99451727,0.00055562175,0.00043424056,0.0001289459,0.0030307234,0.0013331209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020937508,0.0015394086,0.0011422972,0.0046939747,0.0009361597,0.0019640455,0.0013315121,0.0014933484,0.14021343],"category_scores_gemma":[0.0035080812,0.0004087967,0.0007610048,0.0029629006,0.00040372086,0.0008594909,0.0013805308,0.0011928173,0.03603134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013196454,0.00002947356,0.00068064634,0.0004360482,0.000016417824,0.00016821892,0.00003819094,0.00005336458,0.00018874099,0.00007185921,0.95149183,0.04669321],"study_design_scores_gemma":[0.00007063911,0.00006488227,0.012843279,0.0009207872,0.0000593913,0.00037302985,0.00014267002,0.000061938976,0.0004154687,0.00016514852,0.9848614,0.000021484477],"about_ca_topic_score_codex":0.1120016,"about_ca_topic_score_gemma":0.31265947,"teacher_disagreement_score":0.14021343,"about_ca_system_score_codex":0.0027491627,"about_ca_system_score_gemma":0.0075204577,"threshold_uncertainty_score":0.46906066},"labels":[],"label_agreement":null},{"id":"W4303633844","doi":"10.1080/14740338.2022.2134342","title":"How do safety warnings on medicines affect prescribing?","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; SAFER; Transparency (behavior); Patient safety; Intervention (counseling); Affect (linguistics); Access to medicines; Public relations; Public health; Family medicine; Health care; Nursing","score_opus":0.18995852560681586,"score_gpt":0.48312188938221584,"score_spread":0.2931633637754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303633844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029646518,0.99563247,0.00011129072,0.0024570879,0.00027233886,0.000011728456,0.00009763927,0.0000042638826,0.0011166654],"genre_scores_gemma":[0.0055571296,0.9923383,0.00018502436,0.0013466747,0.0002392243,0.000016580914,0.000057190104,0.0000026711434,0.0002571424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642605,0.0017901327,0.00053838023,0.00034101345,0.0008048878,0.00009964163],"domain_scores_gemma":[0.9817281,0.014902076,0.0019518507,0.00014332005,0.0011747117,0.0000998942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036927075,0.0005646128,0.0013828112,0.0014669473,0.00022961067,0.0015627154,0.0009565905,0.0021840462,0.007115177],"category_scores_gemma":[0.024949655,0.0002698921,0.0017555443,0.0017367053,0.00059041294,0.0016087659,0.0005268774,0.0016137509,0.0008634569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022565937,0.00003147364,0.00072803214,0.18377976,0.0009485591,0.0001045399,0.00043097982,0.00034587493,0.00031118785,0.004202152,0.02651065,0.7823812],"study_design_scores_gemma":[0.0001638264,0.0003254593,0.007368351,0.35926482,0.004034194,0.0010008211,0.0005715939,0.00030831707,0.0008027243,0.005132538,0.6209469,0.000080477956],"about_ca_topic_score_codex":0.006012546,"about_ca_topic_score_gemma":0.009509991,"teacher_disagreement_score":0.007115177,"about_ca_system_score_codex":0.0011934538,"about_ca_system_score_gemma":0.0034554491,"threshold_uncertainty_score":0.023802638},"labels":[],"label_agreement":null},{"id":"W4304587220","doi":"10.2196/40597","title":"Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework","year":2022,"lang":"en","type":"article","venue":"Interactive Journal of Medical Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Swinburne University of Technology","keywords":"Thematic analysis; Workflow; Psychological intervention; Incentive; Qualitative research; Adverse drug reaction; Qualitative property; Medicine; Task (project management); Knowledge management; Nursing; Drug; Pharmacology; Computer science","score_opus":0.19349574595728622,"score_gpt":0.5793192907137729,"score_spread":0.3858235447564866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304587220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485874,0.00027579564,0.001521894,0.00094199,0.000017065353,0.00033876178,0.00012278656,0.000009802958,0.0019132304],"genre_scores_gemma":[0.99610245,0.00041721715,0.0013867739,0.00039248104,0.000009096827,0.00041854105,0.000050230097,0.000010194417,0.001212938],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99366575,0.004125926,0.00022926947,0.00045086956,0.0005465963,0.0009815398],"domain_scores_gemma":[0.97985727,0.0151242735,0.0015543178,0.00036216475,0.0017041741,0.0013977451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008569148,0.00035958475,0.00055394135,0.0013425095,0.005405172,0.0021469255,0.0013587038,0.0011247161,0.0026672056],"category_scores_gemma":[0.018127818,0.00060753024,0.00042019272,0.00125347,0.0037486283,0.0024288162,0.0038814591,0.0017159553,0.00020696741],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035351306,0.000107228916,0.006563827,0.0003037505,0.0000064898068,0.0009267636,0.984371,0.000044363016,0.0007172178,0.00042088112,0.00033646045,0.006166627],"study_design_scores_gemma":[0.000006769118,0.00009012606,0.004292719,0.00018828147,0.000005637151,0.00021494443,0.99127156,0.000143046,0.00027543431,0.00014909467,0.0033497568,0.000012636129],"about_ca_topic_score_codex":0.01764706,"about_ca_topic_score_gemma":0.023243852,"teacher_disagreement_score":0.01764706,"about_ca_system_score_codex":0.0044099856,"about_ca_system_score_gemma":0.0077329287,"threshold_uncertainty_score":0.045318544},"labels":[],"label_agreement":null},{"id":"W4309166334","doi":"10.2196/37976","title":"Automatic Estimation of the Most Likely Drug Combination in Electronic Health Records Using the Smooth Algorithm: Development and Validation Study","year":2022,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Algorithm; Smoothing; Pharmacovigilance; Computer science; Data mining; Pharmacoepidemiology; Health records; Raw data; Machine learning; Medicine; Health care; Drug; Pharmacology","score_opus":0.05715280569491528,"score_gpt":0.4282553927645984,"score_spread":0.37110258706968313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309166334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5953572,0.0011036308,0.3959679,0.00030962302,0.000111720394,0.0008642405,0.00083136896,0.00455241,0.0009019391],"genre_scores_gemma":[0.50254834,0.00038418826,0.4942138,0.00010302773,0.00003941643,0.00027806108,0.0017287144,0.00010358773,0.00060087437],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99726033,0.0011765471,0.0002804647,0.000607134,0.00055834436,0.000117124],"domain_scores_gemma":[0.9893027,0.007661466,0.00052896136,0.00086903793,0.0014807073,0.00015728718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006466675,0.0008297691,0.000837222,0.0014450683,0.00025907697,0.0009629324,0.0011004354,0.0010457186,0.00089647627],"category_scores_gemma":[0.018879939,0.00037293657,0.0010653945,0.00090982846,0.00038731674,0.0008362847,0.0007428487,0.0007629654,0.000362456],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003352883,0.0013494303,0.051264156,0.000742535,0.00099386,0.0004827767,0.00028664825,0.36199927,0.014933496,0.002120283,0.003983345,0.55849135],"study_design_scores_gemma":[0.00013668413,0.0005276163,0.00505632,0.000019309893,0.00007704028,0.00014465442,0.00003471895,0.986771,0.0058974777,0.00039887303,0.00091640063,0.00002000003],"about_ca_topic_score_codex":0.004933182,"about_ca_topic_score_gemma":0.002862096,"teacher_disagreement_score":0.006466675,"about_ca_system_score_codex":0.00061163603,"about_ca_system_score_gemma":0.001600427,"threshold_uncertainty_score":0.034199417},"labels":[],"label_agreement":null},{"id":"W4310459135","doi":"10.1111/irv.13071","title":"Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22","year":2022,"lang":"en","type":"article","venue":"Influenza and Other Respiratory Viruses","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi Pasteur; Sanofi","keywords":"Reactogenicity; Vaccination; Medicine; Adverse effect; Pediatrics; Internal medicine; Virology; Immunization; Immunology; Antibody","score_opus":0.08695004881838764,"score_gpt":0.4141857928029323,"score_spread":0.32723574398454464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310459135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990361,0.0002698076,0.00015000165,0.000019424073,0.0000031707536,0.000027033624,0.00026614827,0.0000033422477,0.00022498982],"genre_scores_gemma":[0.9991535,0.00009162242,0.00020814691,0.000022963852,0.0000031673753,0.000016879729,0.00044137295,5.319261e-7,0.00006186496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986003,0.00056971086,0.00013098614,0.00022374632,0.0002874437,0.00018775895],"domain_scores_gemma":[0.99805367,0.00045737816,0.00089034636,0.00009144061,0.00032959285,0.00017767673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057374476,0.00034364252,0.00028828057,0.00074745435,0.0001462291,0.00047229155,0.0004460844,0.00045091778,0.00030955276],"category_scores_gemma":[0.0033743987,0.00019297363,0.00033311453,0.0004567152,0.00026463644,0.00051788345,0.000493713,0.00016880078,0.000056051977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010203427,0.00012012462,0.9800034,0.00012665529,0.00013708486,0.00014422147,0.00046239726,0.00086392363,0.0028144494,0.00005152025,0.0001849253,0.014070964],"study_design_scores_gemma":[0.000037744157,0.0010484564,0.9949367,0.000030545343,0.000066004184,0.00017379674,0.00024809863,0.0010476358,0.0019917963,0.000013536768,0.0003980437,0.000007558917],"about_ca_topic_score_codex":0.0100468565,"about_ca_topic_score_gemma":0.0068091727,"teacher_disagreement_score":0.0100468565,"about_ca_system_score_codex":0.0012269656,"about_ca_system_score_gemma":0.0009082599,"threshold_uncertainty_score":0.030342937},"labels":[],"label_agreement":null},{"id":"W4312065018","doi":"10.2196/41200","title":"Identifying Patterns of Clinical Interest in Clinicians’ Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review","year":2022,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley; Research for Patient Benefit Programme; Department of Health and Social Care; Wellcome Trust","keywords":"Outlier; Medical prescription; Ranking (information retrieval); Antipsychotic; Medicine; Set (abstract data type); Pharmacoepidemiology; Data mining; Computer science; Information retrieval; Psychiatry; Artificial intelligence; Schizophrenia (object-oriented programming); Pharmacology","score_opus":0.7306613394438053,"score_gpt":0.6003858122933607,"score_spread":0.13027552715044455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312065018","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13552353,0.002272851,0.830063,0.0091688195,0.00029187938,0.006348461,0.011702236,0.0019029769,0.0027263393],"genre_scores_gemma":[0.51406676,0.0003301585,0.4711682,0.0016387992,0.00027109272,0.0050017675,0.0068882615,0.00009407094,0.000540843],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.76446754,0.17890221,0.017713288,0.020156078,0.01701594,0.0017450396],"domain_scores_gemma":[0.29590458,0.62564564,0.03425567,0.029787453,0.01256061,0.0018460548],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22183259,0.0016851376,0.0034290678,0.016768664,0.0017071164,0.00693295,0.0054795556,0.0043279766,0.0031667463],"category_scores_gemma":[0.4618135,0.0015002507,0.007082485,0.012022565,0.0035351003,0.00425509,0.0038702493,0.0045140763,0.00083540543],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029124473,0.0016158851,0.502541,0.008671278,0.011873004,0.0024234268,0.007555164,0.0971005,0.0045895237,0.04493247,0.02099497,0.29479033],"study_design_scores_gemma":[0.0013022749,0.0017829369,0.12971681,0.0013983086,0.0021572313,0.0011133397,0.0042047002,0.6463587,0.0046414337,0.18691464,0.019929515,0.00048004327],"about_ca_topic_score_codex":0.005919153,"about_ca_topic_score_gemma":0.008010766,"teacher_disagreement_score":0.22183259,"about_ca_system_score_codex":0.0037667714,"about_ca_system_score_gemma":0.0071744057,"threshold_uncertainty_score":0.959619},"labels":[],"label_agreement":null},{"id":"W4312314366","doi":"10.35784/acs-2020-04","title":"UNSUPERVISED DYNAMIC TOPIC MODEL FOR EXTRACTING ADVERSE DRUG REACTION FROM HEALTH FORUMS","year":2020,"lang":"en","type":"article","venue":"Applied Computer Science","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Computer science; Side effect (computer science); Machine learning; Artificial intelligence; Drug; The Internet; Classifier (UML); Great Rift; Data science; World Wide Web; Medicine; Pharmacology","score_opus":0.132740532313952,"score_gpt":0.4273538343456269,"score_spread":0.2946133020316749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312314366","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39934298,0.020340733,0.53849304,0.0032924854,0.0013127427,0.00072711735,0.022670252,0.0050385576,0.008782072],"genre_scores_gemma":[0.89403003,0.0037825564,0.071927816,0.0004190751,0.0014465862,0.00054711464,0.020634718,0.00015726681,0.007054806],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988686,0.00032913702,0.00014272654,0.00034621017,0.00018324406,0.00013008346],"domain_scores_gemma":[0.9968766,0.0022028524,0.00031690366,0.00014270692,0.00035619902,0.00010472262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017309446,0.0011196235,0.00087127683,0.0046219807,0.00040755776,0.0008636597,0.0009382107,0.0014309952,0.0014481568],"category_scores_gemma":[0.004330708,0.0003285213,0.0012617206,0.0019270005,0.0003639237,0.001371368,0.0006768842,0.0010473033,0.0010728181],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019325999,0.0012845744,0.06743111,0.0019436566,0.0007630795,0.0025704736,0.0015791241,0.12717319,0.031750612,0.0074078725,0.045320127,0.71084356],"study_design_scores_gemma":[0.00005835918,0.0001370112,0.013303876,0.00006724016,0.0001717144,0.0004922584,0.00016478077,0.9678486,0.0028216944,0.0050230427,0.009873245,0.000038203998],"about_ca_topic_score_codex":0.0054322146,"about_ca_topic_score_gemma":0.0066000903,"teacher_disagreement_score":0.0054322146,"about_ca_system_score_codex":0.00059036905,"about_ca_system_score_gemma":0.0007806977,"threshold_uncertainty_score":0.010801196},"labels":[],"label_agreement":null},{"id":"W4312723781","doi":"10.2196/40080","title":"Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review","year":2022,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Swinburne University of Technology","keywords":"Medicine; CINAHL; Documentation; Pharmacovigilance; Adverse drug reaction; Family medicine; Scopus; Pharmacist; Alternative medicine; MEDLINE; Drug reaction; Health care; Medical emergency; Drug; Pharmacy; Pharmacology; Psychological intervention; Nursing","score_opus":0.23409459692177498,"score_gpt":0.5139008154864763,"score_spread":0.2798062185647013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312723781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011109606,0.9963111,0.00027129793,0.0006109358,0.00022379296,0.00053336896,0.0001653837,0.0000119909855,0.0007610484],"genre_scores_gemma":[0.008796395,0.98863006,0.0008934649,0.00045934867,0.00011756213,0.0007675092,0.0001700485,0.00000658409,0.00015909631],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9619661,0.012363183,0.017223265,0.0013663748,0.006531846,0.0005492026],"domain_scores_gemma":[0.82181245,0.11310978,0.038878743,0.002426596,0.022602698,0.0011696231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036287963,0.001397806,0.004987617,0.026004907,0.0012734649,0.005293635,0.0026225108,0.003253368,0.0027740228],"category_scores_gemma":[0.15514162,0.0014017179,0.00463437,0.022218047,0.0017255166,0.0049220948,0.0030373803,0.0018095054,0.00045847782],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000910569,0.000044658347,0.0013349161,0.8530812,0.0014097427,0.00018385949,0.0016219603,0.00018651261,0.0001923616,0.00044818365,0.003173452,0.13823205],"study_design_scores_gemma":[0.000032654778,0.00011144851,0.003980237,0.9640065,0.004513304,0.00030451815,0.0006138262,0.0000996504,0.00015376155,0.00021166424,0.025947092,0.000025332469],"about_ca_topic_score_codex":0.014539672,"about_ca_topic_score_gemma":0.024215344,"teacher_disagreement_score":0.036287963,"about_ca_system_score_codex":0.0058981995,"about_ca_system_score_gemma":0.027569447,"threshold_uncertainty_score":0.1919114},"labels":[],"label_agreement":null},{"id":"W4313641113","doi":"10.3390/pharmacy11010010","title":"Pharmacovigilance in High-Income Countries: Current Developments and a Review of Literature","year":2023,"lang":"en","type":"review","venue":"Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; European union; Agency (philosophy); Harmonization; Business; Medicine; Accounting; Pharmacology; Adverse effect; Economic policy","score_opus":0.212113019040574,"score_gpt":0.5466806056620547,"score_spread":0.3345675866214807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313641113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002436084,0.9982151,0.000075809425,0.001062989,0.00008894188,0.0000039531137,0.00002191746,0.000004446606,0.00028335763],"genre_scores_gemma":[0.0032119823,0.99565756,0.00022730762,0.00059784437,0.00023479214,0.0000071102727,0.00003581469,0.0000019105855,0.00002572577],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99667275,0.00090676226,0.0010273003,0.00046355015,0.0007808066,0.0001488689],"domain_scores_gemma":[0.9718366,0.021000719,0.00414347,0.00029947833,0.0021711835,0.0005485556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062354617,0.0008972441,0.0019811436,0.00996307,0.0006532133,0.00387193,0.0016664142,0.0021992256,0.003157734],"category_scores_gemma":[0.016658524,0.00051187107,0.001658414,0.018532014,0.0016914012,0.0039602458,0.0016122021,0.0018651267,0.0004172925],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015297112,0.00007979637,0.0050172107,0.08323439,0.0004071853,0.0006250871,0.0006742866,0.00035998426,0.00014263032,0.005053141,0.022248754,0.88200456],"study_design_scores_gemma":[0.00011309035,0.0004123999,0.039200734,0.3688954,0.0042075603,0.013081914,0.00440263,0.0010242036,0.00047916506,0.010036865,0.5579649,0.00018116737],"about_ca_topic_score_codex":0.005219549,"about_ca_topic_score_gemma":0.0055667986,"teacher_disagreement_score":0.00996307,"about_ca_system_score_codex":0.0027711552,"about_ca_system_score_gemma":0.005819107,"threshold_uncertainty_score":0.032976687},"labels":[],"label_agreement":null},{"id":"W4315785450","doi":"10.1016/j.clinthera.2022.12.005","title":"Drug–Drug Interactions: A Pharmacovigilance Road Less Traveled","year":2023,"lang":"en","type":"editorial","venue":"Clinical Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Medicine; Pharmacovigilance; Drug; Pharmacology; Drug-drug interaction","score_opus":0.3180098632796656,"score_gpt":0.5693123128962005,"score_spread":0.2513024496165349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315785450","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021610313,0.009444404,0.00011862979,0.06778636,0.92121,0.000019426452,0.000044491386,0.000051831248,0.0013033507],"genre_scores_gemma":[0.00022653819,0.004452455,0.000120063996,0.03697979,0.9548906,0.000015519656,0.00002828266,0.000025927753,0.00326078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9834436,0.003952246,0.0024825183,0.0014479627,0.0077504967,0.00092325493],"domain_scores_gemma":[0.92183477,0.02971054,0.007550282,0.0020847502,0.027942382,0.01087727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019686198,0.0044532353,0.0070040943,0.0071507874,0.004303358,0.014785304,0.00539931,0.039327513,0.020562116],"category_scores_gemma":[0.064450145,0.0025306745,0.005070697,0.003559367,0.003968372,0.00839539,0.003910055,0.036687072,0.013621765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028876897,0.000009858977,0.00001990036,0.00026588707,0.000032329826,0.00007380763,0.000009374463,0.000016567557,0.000023542958,0.00015858638,0.99506193,0.0042993147],"study_design_scores_gemma":[0.0002389547,0.000051593717,0.00040219107,0.0021524339,0.00022975952,0.0003988261,0.000066026194,0.00024239847,0.00007007176,0.001892681,0.9942116,0.000043465658],"about_ca_topic_score_codex":0.0038714167,"about_ca_topic_score_gemma":0.013400721,"teacher_disagreement_score":0.039327513,"about_ca_system_score_codex":0.0063431878,"about_ca_system_score_gemma":0.008485953,"threshold_uncertainty_score":0.10411179},"labels":[],"label_agreement":null},{"id":"W4317039038","doi":"10.21203/rs.3.rs-2057583/v1","title":"Clinical utility of overviews on adverse events of pharmacological interventions","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Adverse effect; Psychological intervention; Intensive care medicine; Medicine; Pharmacology; Psychiatry","score_opus":0.7382222756657683,"score_gpt":0.6822530476923189,"score_spread":0.05596922797344939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317039038","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58599275,0.27815232,0.0588068,0.011656819,0.0020911875,0.019949367,0.015883435,0.0006861361,0.026781177],"genre_scores_gemma":[0.93273175,0.014419623,0.04452768,0.0009196622,0.00049210666,0.0049170232,0.00168609,0.000033746295,0.0002722566],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.6955731,0.18034041,0.077401325,0.007216118,0.038018163,0.0014508236],"domain_scores_gemma":[0.26384628,0.6070561,0.079630546,0.008580281,0.03917765,0.0017091222],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25805232,0.001481424,0.00381823,0.021089265,0.0009365344,0.004008233,0.0012711855,0.0012139862,0.0028168515],"category_scores_gemma":[0.4815921,0.0007790761,0.00865415,0.012072379,0.0020895915,0.005376736,0.0061927694,0.0019167819,0.000253495],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011548241,0.0003609918,0.27803454,0.17031659,0.03268139,0.00047045064,0.011313312,0.004852724,0.002169608,0.004144131,0.007906031,0.47620195],"study_design_scores_gemma":[0.00415957,0.012726223,0.6819474,0.1298672,0.076480836,0.0023302843,0.011663279,0.016087415,0.006635257,0.027388161,0.029760813,0.0009534358],"about_ca_topic_score_codex":0.0008062645,"about_ca_topic_score_gemma":0.0019806724,"teacher_disagreement_score":0.25805232,"about_ca_system_score_codex":0.0028360484,"about_ca_system_score_gemma":0.003487086,"threshold_uncertainty_score":0.9149536},"labels":[],"label_agreement":null},{"id":"W4317910330","doi":"10.37489/2782-3784-myrwd-24","title":"DARWIN EU® is an electronic platform for the collection and analysis of health data in the European Union","year":2023,"lang":"en","type":"article","venue":"Real-World Data & Evidence","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"European union; Variety (cybernetics); Agency (philosophy); Health care; Interrogation; Quality (philosophy); Business; Knowledge management; Computer science; Political science; Law; International trade; Sociology","score_opus":0.46270953205431503,"score_gpt":0.5422200313050071,"score_spread":0.07951049925069203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317910330","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017031478,0.008738293,0.34240955,0.013138386,0.0033422122,0.0038400965,0.103461355,0.21151906,0.2965195],"genre_scores_gemma":[0.13914275,0.009372688,0.47488716,0.012738822,0.0018304966,0.006565174,0.22130771,0.041706946,0.09244828],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98336536,0.006738786,0.0024069278,0.0014593847,0.0054661524,0.00056347443],"domain_scores_gemma":[0.96410644,0.019486379,0.0031904352,0.0067566894,0.003618172,0.0028419162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020462552,0.0013195449,0.0017385033,0.0053732945,0.0010053489,0.006971275,0.0027181478,0.0022109952,0.043500386],"category_scores_gemma":[0.046242997,0.00070321205,0.0011586843,0.0057091867,0.0024253353,0.0056498838,0.009161689,0.0017730327,0.023867594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019404264,0.00022390611,0.004722155,0.0021738773,0.000322117,0.0010519966,0.002027293,0.0017589306,0.0064133815,0.073124796,0.528383,0.37785813],"study_design_scores_gemma":[0.0001932548,0.00013232432,0.005459162,0.00057187694,0.00004049319,0.00050602993,0.00021505739,0.002177392,0.002075152,0.0153605,0.9731746,0.00009423033],"about_ca_topic_score_codex":0.0036333774,"about_ca_topic_score_gemma":0.0010027727,"teacher_disagreement_score":0.043500386,"about_ca_system_score_codex":0.002091346,"about_ca_system_score_gemma":0.0071743648,"threshold_uncertainty_score":0.14552331},"labels":[],"label_agreement":null},{"id":"W4320075235","doi":"10.2196/39700","title":"Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial","year":2023,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Bruyère; University of Ottawa; BC Children's Hospital; Immunovaccine (Canada); Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Notification system; Mobile apps; Web application; Vaccination; Adverse effect; Influenza vaccine; Randomized controlled trial; Medical emergency; Internet privacy; Family medicine; World Wide Web; Immunology; Internal medicine; Computer science","score_opus":0.1960919842405757,"score_gpt":0.4440686191896431,"score_spread":0.24797663494906738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320075235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92957485,0.02082751,0.0021594572,0.0017836603,0.0038563858,0.035939053,0.0015737843,0.00031620386,0.0039691557],"genre_scores_gemma":[0.92784095,0.0073970817,0.0053317198,0.002172497,0.0016806227,0.05146657,0.0007271494,0.00003771932,0.0033456625],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942756,0.0032664384,0.00075395656,0.0008114324,0.0005010368,0.00039151026],"domain_scores_gemma":[0.99344903,0.003288339,0.001660731,0.00030963568,0.00046106832,0.0008312419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005235346,0.0018655165,0.0052316026,0.0010135339,0.00087145664,0.0022195787,0.0016564109,0.004580973,0.010592225],"category_scores_gemma":[0.012516835,0.0011487019,0.0052720336,0.00093249156,0.0018211389,0.0022791787,0.00091711426,0.0038161613,0.0010266878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9792061,0.006244596,0.00048507343,0.0027665643,0.0025375935,0.000025063617,0.00006114707,0.00009574681,0.00029023067,0.00008255347,0.0003731741,0.007832236],"study_design_scores_gemma":[0.9382037,0.057145953,0.0012179182,0.0003216988,0.0021273736,0.000015227565,0.00004199496,0.00031400673,0.00014575427,0.00010838874,0.00033983093,0.00001811342],"about_ca_topic_score_codex":0.0022766732,"about_ca_topic_score_gemma":0.002744792,"teacher_disagreement_score":0.010592225,"about_ca_system_score_codex":0.0014311404,"about_ca_system_score_gemma":0.0027857914,"threshold_uncertainty_score":0.035434484},"labels":[],"label_agreement":null},{"id":"W4320922586","doi":"10.3389/jpps.2023.11235","title":"Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System","year":2023,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse Event Reporting System; Adverse effect; Pharmacology; Internal medicine; Bioinformatics; Biology","score_opus":0.2647521590683805,"score_gpt":0.49543614351516335,"score_spread":0.23068398444678284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320922586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929322,0.002043455,0.0009302916,0.00025120232,0.000022212218,0.00019117101,0.0031063415,0.000024027717,0.00049902033],"genre_scores_gemma":[0.994142,0.0009798917,0.00084690354,0.0001329161,0.000043269152,0.000106720654,0.0036370768,0.0000073020665,0.00010391556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934642,0.0017961778,0.0016918106,0.0012228647,0.0014605405,0.00036436637],"domain_scores_gemma":[0.9814601,0.005647548,0.009173645,0.0010939713,0.0019383902,0.0006862763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005323207,0.00045661916,0.0009598251,0.0032807153,0.0005820326,0.00128494,0.0005988922,0.00085187634,0.0013818311],"category_scores_gemma":[0.014661788,0.00034231416,0.0013815535,0.0036977262,0.0005265958,0.0012690665,0.0012921311,0.0009074239,0.00024793277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036087172,0.00010788646,0.99087685,0.00031383146,0.00021806615,0.0008512165,0.00024211498,0.00017921663,0.00021081667,0.0000672349,0.00068919733,0.0058825584],"study_design_scores_gemma":[0.000057316855,0.00044524996,0.9882493,0.00016754937,0.00047781607,0.0035254555,0.0014448185,0.0029105057,0.00051247864,0.00014473152,0.0020183038,0.000046498255],"about_ca_topic_score_codex":0.00305633,"about_ca_topic_score_gemma":0.002327201,"teacher_disagreement_score":0.005323207,"about_ca_system_score_codex":0.0008198501,"about_ca_system_score_gemma":0.0010119355,"threshold_uncertainty_score":0.028152108},"labels":[],"label_agreement":null},{"id":"W4322487030","doi":"10.1111/bcp.15704","title":"Comparison of the Liverpool Causality Assessment Tool <i>vs</i>. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Causality (physics); Cohort; Retrospective cohort study; Drug reaction; Adverse drug reaction; Clinical history; Pharmacovigilance; Cohort study; Adverse effect; Pediatrics; Internal medicine; Drug; Pharmacology","score_opus":0.1219518409491297,"score_gpt":0.5341670616614511,"score_spread":0.4122152207123214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322487030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914277,0.00023533711,0.00015281289,0.000017217571,0.000009817043,0.000026551608,0.00017397327,0.0000029044072,0.00023855257],"genre_scores_gemma":[0.9993679,0.0000812429,0.00015141898,0.000015471343,0.000015314432,0.000021896363,0.0002759082,0.000003213069,0.00006752091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974953,0.0007438677,0.00036926562,0.0005974132,0.00058703637,0.0002071503],"domain_scores_gemma":[0.98978627,0.003390315,0.0044982038,0.0007300066,0.0010056247,0.0005895885],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003998899,0.0005280798,0.0005069391,0.001725455,0.00039576791,0.0008875094,0.0005716242,0.0007065537,0.001629336],"category_scores_gemma":[0.013278297,0.00038958696,0.0009929271,0.0007641791,0.00039607572,0.0010390418,0.0006469856,0.0006568678,0.0003645958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025419166,0.000019693398,0.9988611,0.0000075469875,0.00006450674,0.000042430904,0.000027487466,0.000021704862,0.00005728508,0.0000058627365,0.000025103851,0.00061306276],"study_design_scores_gemma":[0.000050476152,0.0009757526,0.9965462,0.00002194447,0.00012492407,0.0011648376,0.00017974387,0.00056831894,0.00014064291,0.000026030764,0.00018880793,0.000012412195],"about_ca_topic_score_codex":0.0019345953,"about_ca_topic_score_gemma":0.00139628,"teacher_disagreement_score":0.9960011,"about_ca_system_score_codex":0.0003680949,"about_ca_system_score_gemma":0.0003918529,"threshold_uncertainty_score":0.021148503},"labels":[],"label_agreement":null},{"id":"W4322719003","doi":"10.1177/14604582221136712","title":"Identifying adverse drug reactions from patient reviews on social media using natural language processing","year":2023,"lang":"en","type":"article","venue":"Health Informatics Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Pharmacovigilance; Drug reaction; Social media; Medicine; Adverse drug reaction; Drug; Globe; Health professionals; Public health; Medical emergency; Pharmacology; Health care; Computer science; Nursing; Political science; World Wide Web; Ophthalmology","score_opus":0.2917020809598433,"score_gpt":0.5211036278481078,"score_spread":0.22940154688826453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322719003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6144399,0.011660861,0.21757393,0.006222707,0.0010012721,0.0054942626,0.119278446,0.0090331705,0.015295491],"genre_scores_gemma":[0.6426223,0.0027801653,0.28804442,0.0012070576,0.00095508876,0.0016228954,0.05877863,0.00017450581,0.0038151015],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99447,0.0017526371,0.0010985654,0.00094947603,0.0015580934,0.00017114259],"domain_scores_gemma":[0.96965706,0.020048888,0.00564228,0.0010320763,0.0033080438,0.00031170613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034311672,0.0012963717,0.0008445418,0.009544471,0.0005846566,0.0019129589,0.0007704899,0.0009419018,0.0013339162],"category_scores_gemma":[0.015549311,0.00031142592,0.0011675929,0.0033050743,0.00035254934,0.0015757416,0.00097135856,0.0007730287,0.00096199353],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012129999,0.0012765189,0.13435468,0.007922448,0.0009650201,0.008061583,0.0035675503,0.0066218334,0.07501925,0.0021719332,0.043462988,0.7153631],"study_design_scores_gemma":[0.000258558,0.0015721676,0.40895063,0.0015848896,0.0012906201,0.01286336,0.0063879,0.32366613,0.08640966,0.013832994,0.14261967,0.00056340476],"about_ca_topic_score_codex":0.0036677506,"about_ca_topic_score_gemma":0.011544163,"teacher_disagreement_score":0.009544471,"about_ca_system_score_codex":0.0007132184,"about_ca_system_score_gemma":0.0012294322,"threshold_uncertainty_score":0.018145978},"labels":[],"label_agreement":null},{"id":"W4324054967","doi":"10.1186/s13223-023-00766-7","title":"Medical ID use by international patients with Aspirin-Exacerbated Respiratory Disease","year":2023,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Nasal polyps; Aspirin; Asthma; Disease; Nonsteroidal; Population; Health care; Family medicine; Internal medicine; Environmental health","score_opus":0.08059490581657786,"score_gpt":0.43614791020831234,"score_spread":0.3555530043917345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324054967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790466,0.00023936771,0.000031620188,0.00018295394,0.000007105276,0.000011050089,0.00022580942,0.0000022518448,0.0013951308],"genre_scores_gemma":[0.9992495,0.0002225167,0.00005445917,0.0001648535,0.000009411375,0.000008367425,0.000109817884,6.0544903e-7,0.00018041686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945873,0.00017893867,0.000095064795,0.000057074547,0.00014506548,0.00006507546],"domain_scores_gemma":[0.997445,0.0004677572,0.0015648663,0.000055268094,0.00018557294,0.00028145776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000575509,0.00012216037,0.00017705855,0.00054355257,0.00032361477,0.0006428307,0.00015621798,0.00030888326,0.0038514063],"category_scores_gemma":[0.0029658757,0.00009950194,0.00023468026,0.0006608958,0.00018321192,0.00046953993,0.0004205616,0.0004511276,0.00036918977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027082444,0.000056808207,0.99522746,0.000027788692,0.00001564768,0.00005920864,0.0007188213,0.000010956581,0.00009343689,0.00001428404,0.00023368902,0.0035147066],"study_design_scores_gemma":[0.0000061640026,0.00015790075,0.9958032,0.000037131387,0.000018322424,0.00049995846,0.0025636058,0.00009529406,0.00005878808,0.000011484933,0.0007436632,0.0000044320227],"about_ca_topic_score_codex":0.0030790123,"about_ca_topic_score_gemma":0.0030840193,"teacher_disagreement_score":0.0038514063,"about_ca_system_score_codex":0.00022165508,"about_ca_system_score_gemma":0.00022883045,"threshold_uncertainty_score":0.012884259},"labels":[],"label_agreement":null},{"id":"W4360597767","doi":"10.1007/978-1-4614-6625-3_31-1","title":"Pharmacoepidemiology","year":2022,"lang":"nl","type":"book-chapter","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Pharmacoepidemiology; Epidemiology; Medicine; Observational study; Scope (computer science); Harm; Drug reaction; Alternative medicine; Health care; Public health; Clinical study design; Intensive care medicine; Clinical trial; Pharmacology; Drug; Pathology; Psychology; Computer science; Political science","score_opus":0.21698249665860952,"score_gpt":0.4672356747408136,"score_spread":0.2502531780822041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360597767","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094066956,0.17812178,0.0098035075,0.025487669,0.011652417,0.00032024577,0.0016949209,0.0007241808,0.7712546],"genre_scores_gemma":[0.012005111,0.10889634,0.006181735,0.02099312,0.012413233,0.00027962023,0.0022800758,0.00028389657,0.8366669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991584,0.00023666036,0.00005785861,0.00009057625,0.00039952606,0.000057000612],"domain_scores_gemma":[0.99910295,0.00030058515,0.00005627129,0.0001207997,0.000307279,0.00011213616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012579251,0.0006685822,0.00072023825,0.0017848179,0.00031619266,0.0018476036,0.0006019151,0.0012489574,0.09182203],"category_scores_gemma":[0.0033750564,0.0002996692,0.00042496927,0.0011295403,0.00047716522,0.0008672609,0.0008735874,0.0019778672,0.07302515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045460994,0.00005587603,0.00021993977,0.00041362224,0.0000151523,0.00013558239,0.000038928858,0.000086880624,0.00054819824,0.010137661,0.4662082,0.52209455],"study_design_scores_gemma":[0.000015334437,0.000028741873,0.00047145528,0.00024189943,0.0000070639553,0.00063068134,0.000012102032,0.00006103601,0.00015462883,0.0046620914,0.9937111,0.00000394927],"about_ca_topic_score_codex":0.0010525344,"about_ca_topic_score_gemma":0.0014191739,"teacher_disagreement_score":0.09182203,"about_ca_system_score_codex":0.0007676149,"about_ca_system_score_gemma":0.0013016404,"threshold_uncertainty_score":0.30717528},"labels":[],"label_agreement":null},{"id":"W4365145847","doi":"10.3390/curroncol30040315","title":"Active Pharmacovigilance Study: A Follow-Up Model of Oral Anti-Cancer Drugs under Additional Monitoring","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"European Regional Development Fund","keywords":"Pharmacovigilance; Medicine; Discontinuation; Adverse effect; Drug; Drug reaction; Adverse drug reaction; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.470989666851178,"score_gpt":0.5764325990360892,"score_spread":0.10544293218491124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365145847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709783,0.0015393237,0.0068816952,0.00050935696,0.00005873463,0.005888474,0.010265446,0.0001305921,0.0037481163],"genre_scores_gemma":[0.980003,0.00035012644,0.0056758905,0.0004061007,0.00009131112,0.004440911,0.0075522517,0.00003433395,0.0014460977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9894649,0.0058165938,0.0012071425,0.001864058,0.0011207929,0.0005266057],"domain_scores_gemma":[0.9771022,0.005703872,0.009924144,0.0032590032,0.0027519823,0.0012588275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011495441,0.00074404705,0.00089772255,0.0016736988,0.0010055203,0.0013519517,0.0010134103,0.0010398692,0.003567755],"category_scores_gemma":[0.018771615,0.0006514734,0.0021727062,0.0028541787,0.00051305466,0.0014319555,0.0018950242,0.0013105533,0.00080135476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027249869,0.0038966704,0.9284132,0.0011535103,0.0021470108,0.0009493318,0.0013045771,0.0016332857,0.0012782692,0.0011175643,0.0034242892,0.027432464],"study_design_scores_gemma":[0.004667294,0.023204008,0.93952996,0.00029682394,0.003238495,0.0017009174,0.00073494384,0.00967209,0.0026652955,0.0011610931,0.013002709,0.00012638776],"about_ca_topic_score_codex":0.005515161,"about_ca_topic_score_gemma":0.00428797,"teacher_disagreement_score":0.011495441,"about_ca_system_score_codex":0.0018664605,"about_ca_system_score_gemma":0.0033539427,"threshold_uncertainty_score":0.060794413},"labels":[],"label_agreement":null},{"id":"W4365811063","doi":"10.1007/s40264-023-01293-5","title":"Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data”","year":2023,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Drug; Drug-drug interaction; Pharmacology; Myopathy; Transporter; Adverse effect; Drug interaction; Drug reaction; Internal medicine; Biochemistry","score_opus":0.12853240761187057,"score_gpt":0.4418769651472665,"score_spread":0.3133445575353959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365811063","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025830863,0.0005303865,0.00008797389,0.9784546,0.019300146,0.000014309898,0.00014539009,0.000024791538,0.0011840416],"genre_scores_gemma":[0.00064888276,0.00015995788,0.00008493039,0.98778874,0.009667726,0.000023781287,0.000020585758,0.0000116552155,0.0015937896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98746896,0.0027147029,0.0022806283,0.0018815805,0.0035844333,0.0020696605],"domain_scores_gemma":[0.9617347,0.022545407,0.0034005295,0.0009839842,0.0073307706,0.0040045357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011081735,0.0011781417,0.0029169037,0.001883523,0.0060603735,0.0073114247,0.0036674263,0.10294278,0.007554077],"category_scores_gemma":[0.060084242,0.001964208,0.0031506948,0.0023144356,0.0040190774,0.0045333398,0.0031924725,0.07038575,0.00878401],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073273455,0.000026900098,0.00085460785,0.000052890817,0.00004618783,0.0006861789,0.0001780101,0.000050067378,0.00011955708,0.0014123512,0.99377453,0.0027253137],"study_design_scores_gemma":[0.000313003,0.00012879583,0.0050434745,0.0009969095,0.00019545502,0.0011461797,0.0010913532,0.00061964995,0.00046877033,0.009269909,0.98043764,0.00028877484],"about_ca_topic_score_codex":0.023680037,"about_ca_topic_score_gemma":0.043362435,"teacher_disagreement_score":0.10294278,"about_ca_system_score_codex":0.006521717,"about_ca_system_score_gemma":0.012475792,"threshold_uncertainty_score":0.058606565},"labels":[],"label_agreement":null},{"id":"W4366351498","doi":"10.2196/44237","title":"Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England","year":2023,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; Research for Patient Benefit Programme; Department of Health and Social Care; Wellcome Trust","keywords":"Identification (biology); Ranking (information retrieval); Computer science; Service (business); Outlier; Project commissioning; Service delivery framework; Health care; Prioritization; Data collection; Data science; Process management; Medicine; Publishing; Information retrieval; Business; Political science","score_opus":0.3325982189546277,"score_gpt":0.5166053387484159,"score_spread":0.18400711979378814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366351498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776393,0.00008382039,0.011696402,0.00027564444,0.000024825558,0.00041972077,0.007270049,0.001713239,0.00087694195],"genre_scores_gemma":[0.91097146,0.00012732613,0.07745574,0.000089532085,0.000016858025,0.0005860025,0.010096023,0.0001222782,0.0005348821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958112,0.0018876216,0.000619113,0.00065522606,0.00087364815,0.00015319693],"domain_scores_gemma":[0.95850426,0.030444438,0.0031102155,0.0032201922,0.0038348795,0.0008859326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064491597,0.00061614305,0.0006310326,0.0029603732,0.00045038492,0.0017308161,0.00087083364,0.0006692178,0.00096796855],"category_scores_gemma":[0.030473856,0.0003647453,0.00073818513,0.0033707302,0.00047499323,0.0011530838,0.0016894073,0.0007938301,0.0003456705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015648442,0.0016951195,0.6926884,0.0018781166,0.0006337616,0.0019296699,0.02536298,0.034035563,0.00872912,0.0011706866,0.008441307,0.22187048],"study_design_scores_gemma":[0.00018109221,0.0015745866,0.7755504,0.00033375286,0.00015533055,0.00064076326,0.011419513,0.19036452,0.007099008,0.0013937198,0.011045085,0.00024222533],"about_ca_topic_score_codex":0.025181985,"about_ca_topic_score_gemma":0.03305216,"teacher_disagreement_score":0.025181985,"about_ca_system_score_codex":0.0011082006,"about_ca_system_score_gemma":0.0010546418,"threshold_uncertainty_score":0.050070822},"labels":[],"label_agreement":null},{"id":"W4366967258","doi":"10.1109/wi-iat55865.2022.00087","title":"Detecting Adverse Drug Reactions from User-Generated Twitter Data: A Case Study","year":2022,"lang":"en","type":"article","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Computer science; Pharmacovigilance; Support vector machine; Social media; Artificial intelligence; Machine learning; Drug reaction; Annotation; Sentiment analysis; Natural language processing; Data modeling; Information retrieval; World Wide Web; Database; Medicine; Drug","score_opus":0.2523266636311213,"score_gpt":0.47150304759585643,"score_spread":0.21917638396473516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366967258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768538,0.00093270664,0.01054493,0.0018827937,0.00015672008,0.00032685083,0.006187497,0.000616251,0.0024983338],"genre_scores_gemma":[0.9725624,0.00070666353,0.016875321,0.0004547099,0.00017657678,0.00015342735,0.0063566617,0.000046012843,0.002668373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989091,0.00032840724,0.00016410931,0.00020055233,0.0003040566,0.000093770905],"domain_scores_gemma":[0.996958,0.0017315445,0.00031339674,0.00028877766,0.0005489139,0.00015926723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010799046,0.0006170098,0.00043876775,0.0010536611,0.0005138443,0.0006217776,0.0006460817,0.0013801772,0.00075413607],"category_scores_gemma":[0.003547899,0.00016847692,0.0005773699,0.000881665,0.00034304353,0.0007739957,0.00056407973,0.0006472597,0.00059802237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026074836,0.0031245816,0.52073765,0.0021593804,0.0005267525,0.049761537,0.0031234557,0.03656108,0.040493935,0.0016886102,0.037828743,0.3013868],"study_design_scores_gemma":[0.00034102597,0.0026481813,0.31443846,0.00028075423,0.0004825137,0.024187615,0.0073976717,0.49701044,0.09801898,0.0031555407,0.051789943,0.00024887588],"about_ca_topic_score_codex":0.0064990115,"about_ca_topic_score_gemma":0.010274118,"teacher_disagreement_score":0.0064990115,"about_ca_system_score_codex":0.0005345308,"about_ca_system_score_gemma":0.0003851389,"threshold_uncertainty_score":0.012922406},"labels":[],"label_agreement":null},{"id":"W4367722416","doi":"10.3389/978-2-8325-2224-0","title":"Reducing the Harm of Medication - Recent Trends in Pharmacovigilance, Volume II","year":2023,"lang":"en","type":"book","venue":"Frontiers research topics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Canadian Institutes of Health Research; Ministerio de Economía y Competitividad; Deakin University; National Natural Science Foundation of China; Ministry of Food and Drug Safety","keywords":"Pharmacovigilance; Harm; Volume (thermodynamics); Do no harm; Medicine; Pharmacology; Psychology; Psychiatry; Adverse effect; Social psychology","score_opus":0.26441221156041267,"score_gpt":0.5188475478416705,"score_spread":0.25443533628125786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367722416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021188732,0.67666686,0.0019084641,0.28249946,0.01638851,0.000050469847,0.0003475184,0.00015283599,0.01986695],"genre_scores_gemma":[0.028198525,0.8635449,0.003906507,0.05321472,0.035936795,0.00008347124,0.0005997379,0.00013600191,0.0143794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948637,0.0018261669,0.0005493794,0.0005044707,0.0020304816,0.0002258423],"domain_scores_gemma":[0.97552955,0.01322845,0.0020058593,0.00077470654,0.0067776116,0.0016838757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008066565,0.0006069469,0.000987446,0.0029979344,0.00090402074,0.0072699697,0.0012401786,0.0037586456,0.0111852065],"category_scores_gemma":[0.022718955,0.00035271895,0.0012165189,0.0031114065,0.0022151752,0.0060494,0.0015594221,0.006509898,0.0031096824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018686311,0.0002379388,0.0033248346,0.0044458103,0.00018090886,0.00014829416,0.0003485741,0.00035914328,0.001190727,0.033139654,0.3544996,0.60193765],"study_design_scores_gemma":[0.00004942483,0.0002951566,0.008515407,0.0061071003,0.00014414653,0.00080493605,0.0003784006,0.0005974713,0.0007078204,0.02036266,0.9619756,0.00006191292],"about_ca_topic_score_codex":0.0047263457,"about_ca_topic_score_gemma":0.006465079,"teacher_disagreement_score":0.0111852065,"about_ca_system_score_codex":0.0044224747,"about_ca_system_score_gemma":0.007771728,"threshold_uncertainty_score":0.042660594},"labels":[],"label_agreement":null},{"id":"W4377019501","doi":"10.1016/j.jsps.2023.05.016","title":"Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting","year":2023,"lang":"en","type":"article","venue":"Saudi Pharmaceutical Journal","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Family medicine; Quarter (Canadian coin); Logistic regression; Cross-sectional study; Public health; Adverse drug reaction; Health care; Drug; Pediatrics; Psychiatry; Nursing; Internal medicine","score_opus":0.21679784708007038,"score_gpt":0.526190563444058,"score_spread":0.30939271636398763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377019501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674183,0.0006184175,0.000036871388,0.0005965768,0.000007813012,0.000011388287,0.00009607655,0.0000035618789,0.0018874641],"genre_scores_gemma":[0.9980433,0.0009476717,0.000108601474,0.00037124014,0.000024332861,0.000009884283,0.00008374538,0.0000010165104,0.0004101666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990583,0.00028898066,0.0001250175,0.00008557221,0.00031516262,0.00012699582],"domain_scores_gemma":[0.99629265,0.00050435116,0.0020822592,0.000075691365,0.00061625993,0.00042882076],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016370051,0.00015483452,0.00029002753,0.0007460354,0.00040905943,0.00082354114,0.0002333912,0.0004736319,0.002685592],"category_scores_gemma":[0.0039332937,0.0001870531,0.0002473286,0.0006938302,0.0004772575,0.0007393827,0.0004023335,0.00043140753,0.00039588148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053228418,0.00015181859,0.9833813,0.000086179774,0.000017933293,0.00016530782,0.0027855437,0.000038626757,0.00025913012,0.00003408471,0.0004392606,0.012587512],"study_design_scores_gemma":[0.000016419861,0.00045479526,0.9860801,0.00014477152,0.000024900426,0.0007681225,0.009997995,0.00022161887,0.00014000447,0.00005728138,0.0020827777,0.000011164306],"about_ca_topic_score_codex":0.0065812715,"about_ca_topic_score_gemma":0.0068928692,"teacher_disagreement_score":0.998363,"about_ca_system_score_codex":0.0004434283,"about_ca_system_score_gemma":0.0010679176,"threshold_uncertainty_score":0.013085961},"labels":[],"label_agreement":null},{"id":"W4377940739","doi":"10.1002/sim.9805","title":"The person‐time ratio distribution for the exact monitoring of adverse events: Historical vs surveillance Poisson data","year":2023,"lang":"en","type":"article","venue":"Statistics in Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health","funders":"National Institute of General Medical Sciences; Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Poisson distribution; Statistics; Estimator; Relative risk; Confidence interval; Interval (graph theory); Medicine; Mathematics; Econometrics; Computer science","score_opus":0.18267581425771495,"score_gpt":0.4783700553137205,"score_spread":0.29569424105600556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377940739","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18904689,0.0025966777,0.7989428,0.0011424959,0.00021931075,0.0005187307,0.0022376974,0.0007922812,0.0045031006],"genre_scores_gemma":[0.91631746,0.0013827147,0.07640986,0.0004288439,0.00018832492,0.0005429992,0.0021891487,0.00015762307,0.0023830035],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98431087,0.008288438,0.001031874,0.0024243062,0.00347569,0.00046888803],"domain_scores_gemma":[0.9335365,0.04499047,0.0094013885,0.008245284,0.0033778187,0.0004484698],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033672586,0.0004043853,0.001140602,0.00194347,0.0003358534,0.0015349056,0.0025610388,0.0014276352,0.0024240285],"category_scores_gemma":[0.12686689,0.0004161369,0.0014868652,0.0017888373,0.0016142221,0.002300629,0.0010713934,0.0017207962,0.000636274],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001210382,0.00021818854,0.47018498,0.0010429225,0.0012015596,0.0020403857,0.0025037075,0.07810409,0.0039407895,0.19665866,0.008059234,0.2348351],"study_design_scores_gemma":[0.00016668517,0.0014309791,0.27642286,0.0005230025,0.00075009017,0.009134962,0.0016418402,0.54806936,0.0055645066,0.1321312,0.02381426,0.00035012077],"about_ca_topic_score_codex":0.0051245843,"about_ca_topic_score_gemma":0.0021192753,"teacher_disagreement_score":0.9663274,"about_ca_system_score_codex":0.0011709583,"about_ca_system_score_gemma":0.00089435186,"threshold_uncertainty_score":0.17807978},"labels":[],"label_agreement":null},{"id":"W4378172514","doi":"10.1111/bcp.15802","title":"Considerations on the use of different comparators in pharmacovigilance: A methodological review","year":2023,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; University of Ottawa","funders":"Fonds de Recherche du Québec - Santé","keywords":"Pharmacovigilance; Comparator; Medicine; Proxy (statistics); Set (abstract data type); Computer science; Event (particle physics); Data mining; Drug; Pharmacology; Machine learning","score_opus":0.8930427184206804,"score_gpt":0.6813240477788266,"score_spread":0.2117186706418538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378172514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018250596,0.9913362,0.004311166,0.002895977,0.0005574737,0.00022581399,0.00010135227,0.000014671109,0.00037474406],"genre_scores_gemma":[0.008697766,0.9607872,0.023934146,0.0037267348,0.0007010158,0.0016155371,0.0002584514,0.00005214361,0.00022711017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.745945,0.1464985,0.06951655,0.007764941,0.02925323,0.0010218149],"domain_scores_gemma":[0.3908762,0.53741544,0.033622503,0.010055434,0.027273262,0.0007571836],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.28224134,0.002034942,0.009191935,0.013570919,0.0010427574,0.008322001,0.0068470486,0.0049192603,0.0030473932],"category_scores_gemma":[0.42777318,0.0019036969,0.012488758,0.015401489,0.003519346,0.008310911,0.0040768175,0.004910049,0.0008489273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006066812,0.000044648772,0.0016268535,0.37686846,0.008904651,0.00012042586,0.0008385581,0.0008628395,0.00037350814,0.016182734,0.008683287,0.5848873],"study_design_scores_gemma":[0.00037555821,0.00039188517,0.0028432733,0.76837206,0.022051444,0.00061404833,0.0007064361,0.00090917345,0.0009324348,0.019365584,0.183274,0.00016405758],"about_ca_topic_score_codex":0.004524248,"about_ca_topic_score_gemma":0.006138083,"teacher_disagreement_score":0.71775866,"about_ca_system_score_codex":0.00671881,"about_ca_system_score_gemma":0.015535536,"threshold_uncertainty_score":0.8851242},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4378417578","doi":"10.1016/j.jaad.2023.05.041","title":"A case-control pharmacovigilance study of TNF-alpha inhibitors and interleukin inhibitors on tuberculosis, Candida, lymphoma and suicidality using the FAERS database (2014-2020)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"McGill University","keywords":"Medicine; Pharmacovigilance; Adverse Event Reporting System; Tuberculosis; Tumor necrosis factor alpha; Pharmacology; Immunology; Database; Adverse effect; Pathology","score_opus":0.06389973989305911,"score_gpt":0.42089964981552613,"score_spread":0.356999909922467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378417578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939235,0.001051459,0.00032160085,0.000074948315,0.00003301088,0.0001387675,0.0038937484,0.000012099091,0.0005508174],"genre_scores_gemma":[0.99497616,0.00034490626,0.0004990414,0.00013931248,0.00002809388,0.000075018106,0.0035835316,0.000005666199,0.0003482671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974841,0.00054601784,0.00047405387,0.0008647661,0.00039388318,0.00023718487],"domain_scores_gemma":[0.9975006,0.0005787897,0.00091044937,0.00035462232,0.00040528466,0.00025018395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015027283,0.0005486405,0.0010783204,0.0022848763,0.0009944466,0.0015532159,0.0007895837,0.001286964,0.0023624676],"category_scores_gemma":[0.0050581647,0.0008700162,0.0020696318,0.00252383,0.000376908,0.00082248123,0.0008780299,0.0011368088,0.00040550827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024731532,0.00046160095,0.98911756,0.000148099,0.002201568,0.0013532828,0.0001657024,0.000097713426,0.0006339274,0.00010780846,0.00095111557,0.0022886219],"study_design_scores_gemma":[0.00052965747,0.0005646588,0.9941281,0.00005568012,0.0013585268,0.0017596971,0.00024432217,0.00047878822,0.00016366156,0.000055522527,0.0006293222,0.000032027416],"about_ca_topic_score_codex":0.035021327,"about_ca_topic_score_gemma":0.027269166,"teacher_disagreement_score":0.035021327,"about_ca_system_score_codex":0.0015713786,"about_ca_system_score_gemma":0.0010975975,"threshold_uncertainty_score":0.069634974},"labels":[],"label_agreement":null},{"id":"W4379280618","doi":"10.1200/jco.2023.41.16_suppl.e18858","title":"Characterizing of adverse events across 30,000 peer reviewed case report publications.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Adverse effect; Pharmacovigilance; MedDRA; Clinical trial; MEDLINE; Internal medicine; Oncology","score_opus":0.4588446939620104,"score_gpt":0.6311208187385584,"score_spread":0.17227612477654802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379280618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4002815,0.20417343,0.016911693,0.006746532,0.001435491,0.0045511066,0.33198372,0.0019637328,0.031952884],"genre_scores_gemma":[0.7799444,0.05921793,0.019991728,0.0024486266,0.0011261855,0.0036412477,0.1285343,0.0005606941,0.0045347186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9432217,0.009307895,0.026873982,0.0079151215,0.011677907,0.0010033643],"domain_scores_gemma":[0.7106207,0.14095084,0.1058388,0.015917253,0.024379736,0.0022925981],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.027611407,0.00089045276,0.0013900137,0.034572653,0.0009743222,0.004179633,0.0016781235,0.0010923528,0.012131845],"category_scores_gemma":[0.14780603,0.0005772914,0.00195219,0.025312008,0.0012124267,0.0029269697,0.0033180823,0.00083640794,0.004308921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086321804,0.00013314979,0.69111806,0.030185612,0.0026000363,0.008495652,0.0037076657,0.00070839544,0.0027583856,0.0026821548,0.071614735,0.18513285],"study_design_scores_gemma":[0.00018327835,0.00025509755,0.61848766,0.021301284,0.0029821494,0.03594472,0.0045094322,0.0017368763,0.0042661214,0.0030188477,0.30707926,0.00023527327],"about_ca_topic_score_codex":0.0018072529,"about_ca_topic_score_gemma":0.0026512395,"teacher_disagreement_score":0.99860996,"about_ca_system_score_codex":0.0014226123,"about_ca_system_score_gemma":0.0033671628,"threshold_uncertainty_score":0.14602482},"labels":[],"label_agreement":null},{"id":"W4380084157","doi":"10.4178/epih.e2023054","title":"Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events","year":2023,"lang":"en","type":"article","venue":"Epidemiology and Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Daiichi Sankyo Europe; National Research Foundation of Korea; Ministry of Food and Drug Safety; National Research Foundation; Pfizer","keywords":"Medicine; Adverse effect; Vaccination; Odds ratio; Internal medicine; Logistic regression; Coronavirus disease 2019 (COVID-19); Pediatrics; Disease; Immunology; Infectious disease (medical specialty)","score_opus":0.3570755738206277,"score_gpt":0.5778366822839613,"score_spread":0.22076110846333363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380084157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761121,0.0035436735,0.0029583804,0.00981106,0.00017279777,0.00022681564,0.0015893294,0.00004294215,0.005542871],"genre_scores_gemma":[0.9965107,0.00087828975,0.0010743183,0.0008228279,0.00009698264,0.000095089235,0.00036708638,0.0000068524146,0.00014792812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9728274,0.016165243,0.0043635634,0.0014651652,0.004104379,0.0010741154],"domain_scores_gemma":[0.8697249,0.054721516,0.05949816,0.0039487197,0.009519125,0.002587686],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029707659,0.00021396588,0.0003850295,0.0010328065,0.00042635822,0.0012039354,0.0007643484,0.0005599334,0.0012385926],"category_scores_gemma":[0.09969315,0.00024744676,0.0006216618,0.0011745078,0.0006142023,0.0016598445,0.0013042551,0.0009342715,0.0001915425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058011607,0.000050081482,0.9748157,0.00041620538,0.00013590547,0.00005973431,0.0016333349,0.00014697127,0.00014318505,0.00023509853,0.0011725788,0.021133287],"study_design_scores_gemma":[0.000008790688,0.00019239316,0.99142975,0.0006869538,0.000049261173,0.0003156865,0.0028435101,0.0007479254,0.0002246035,0.00018720992,0.0032968058,0.000017096248],"about_ca_topic_score_codex":0.01103969,"about_ca_topic_score_gemma":0.006835803,"teacher_disagreement_score":0.9702923,"about_ca_system_score_codex":0.00072738534,"about_ca_system_score_gemma":0.0024942032,"threshold_uncertainty_score":0.15711099},"labels":[],"label_agreement":null},{"id":"W4381547700","doi":"10.32725/jab.2023.010","title":"Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings","year":2023,"lang":"en","type":"review","venue":"Journal of Applied Biomedicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Université du Québec à Trois-Rivières; Université Laval","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Université du Québec à Trois-Rivières; Université Laval","keywords":"Pharmacovigilance; Context (archaeology); Causality (physics); MEDLINE; Adverse drug reaction; Medicine; Authorization; Computer science; Adverse effect; Drug; Pharmacology","score_opus":0.12097971034364266,"score_gpt":0.4986398814602072,"score_spread":0.3776601711165646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381547700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009009134,0.9934529,0.001042282,0.0012902927,0.000275098,0.0013893913,0.00091407716,0.000028078492,0.00070700113],"genre_scores_gemma":[0.019581258,0.9695068,0.0047100033,0.002157997,0.00034195048,0.0025564274,0.00083599373,0.000019134408,0.00029044825],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.97397965,0.0089634955,0.012309648,0.0010025484,0.0034692045,0.0002755933],"domain_scores_gemma":[0.79549617,0.1685163,0.024444623,0.0019202232,0.009062576,0.0005601149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02219331,0.0018456365,0.0064679068,0.018467251,0.0009266575,0.0038015747,0.0029733784,0.0027232105,0.007946455],"category_scores_gemma":[0.15400705,0.00088177377,0.0074780397,0.013163765,0.0012026237,0.006708428,0.0021692705,0.0016430833,0.00072698935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020628488,0.000019212184,0.00091616705,0.9257467,0.0020068462,0.0001845215,0.00034799273,0.00009978577,0.00007633407,0.0005792066,0.0031022704,0.066714674],"study_design_scores_gemma":[0.00018207668,0.00009506128,0.0014156635,0.96348023,0.010956727,0.00055973924,0.0003005406,0.00011461977,0.00014130239,0.00075734593,0.021955747,0.000040958366],"about_ca_topic_score_codex":0.0031416873,"about_ca_topic_score_gemma":0.0063229958,"teacher_disagreement_score":0.02219331,"about_ca_system_score_codex":0.0037949441,"about_ca_system_score_gemma":0.012621288,"threshold_uncertainty_score":0.117370844},"labels":[],"label_agreement":null},{"id":"W4382192792","doi":"10.2196/47068","title":"The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review","year":2023,"lang":"en","type":"review","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. National Library of Medicine","keywords":"Pharmacovigilance; Social media; Medicine; Adverse effect; Protocol (science); Intervention (counseling); Adverse drug reaction; Public health; Medical emergency; Internet privacy; Intensive care medicine; Drug; Alternative medicine; Pharmacology; Psychiatry; Nursing; Computer science","score_opus":0.8456474926792266,"score_gpt":0.762516312388987,"score_spread":0.08313118029023958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382192792","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024350653,0.0011313499,0.0009510519,0.0003685294,0.00022076239,0.99403846,0.0023876263,0.000057905756,0.0006007655],"genre_scores_gemma":[0.0002312127,0.0008681001,0.0026920433,0.0001383885,0.000024893578,0.99535596,0.0004094927,0.000006415957,0.00027359143],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.94018024,0.024416307,0.022565834,0.003253107,0.0069188806,0.0026655511],"domain_scores_gemma":[0.89186394,0.03725151,0.021599382,0.008282151,0.036765937,0.0042371247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.113953285,0.0050287074,0.012236282,0.020998297,0.0051950873,0.009163767,0.005623912,0.009571533,0.075675964],"category_scores_gemma":[0.13163237,0.0054901238,0.015114933,0.01781327,0.00531526,0.008505744,0.0075579635,0.006811208,0.01458225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006498526,0.0006096477,0.0011014917,0.84333146,0.0013848516,0.001151341,0.00433088,0.0015385955,0.002765695,0.0060400846,0.05528933,0.07595818],"study_design_scores_gemma":[0.012703702,0.0020362723,0.005014004,0.6030757,0.0035803616,0.0006469292,0.0032522026,0.0011639767,0.0024083026,0.008575075,0.35704198,0.0005014317],"about_ca_topic_score_codex":0.006009782,"about_ca_topic_score_gemma":0.0113073075,"teacher_disagreement_score":0.113953285,"about_ca_system_score_codex":0.01580772,"about_ca_system_score_gemma":0.079375856,"threshold_uncertainty_score":0.6026498},"labels":[],"label_agreement":null},{"id":"W4385585353","doi":"10.2196/48976","title":"A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacists in Australia: Usability Testing Study","year":2023,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Swinburne University of Technology","keywords":"Usability; Thematic analysis; Patient safety; Medicine; Computer science; Qualitative research; Health care","score_opus":0.38378113546118686,"score_gpt":0.5869969081476158,"score_spread":0.20321577268642899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385585353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730515,0.00007389857,0.00053512194,0.00008815247,0.0000049727096,0.001282156,0.000027866683,0.000013195238,0.00066941814],"genre_scores_gemma":[0.99038905,0.00028958905,0.0066290284,0.00025197465,0.000012282378,0.0017236405,0.00007849653,0.000014283193,0.00061167596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9859104,0.009275493,0.001169547,0.0007408868,0.002230848,0.0006727803],"domain_scores_gemma":[0.9687375,0.015822846,0.0028679084,0.001379855,0.009580902,0.0016110116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022554021,0.00047215898,0.0006712206,0.0016697429,0.001379718,0.0013887382,0.0007178245,0.00091987837,0.00087940757],"category_scores_gemma":[0.0423267,0.00066392636,0.0007263432,0.001016229,0.00094146887,0.0015680171,0.0022159826,0.00089690683,0.00025150552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018031169,0.020947315,0.38651353,0.0039089713,0.0003771234,0.0023700031,0.27146554,0.0008568567,0.013228465,0.00029531418,0.0017741399,0.29645965],"study_design_scores_gemma":[0.0006019667,0.02657142,0.8729925,0.00084442506,0.0002875691,0.0012264566,0.07898061,0.005239141,0.0029987744,0.00014934206,0.009935574,0.00017213641],"about_ca_topic_score_codex":0.009461184,"about_ca_topic_score_gemma":0.017978959,"teacher_disagreement_score":0.022554021,"about_ca_system_score_codex":0.0016145855,"about_ca_system_score_gemma":0.0039347103,"threshold_uncertainty_score":0.11927849},"labels":[],"label_agreement":null},{"id":"W4385658077","doi":"10.1080/14740338.2023.2244421","title":"Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; International Development Research Centre; Wellcome Trust; Health Research","keywords":"Medicine; Antithrombotic; Epidemiology; Drug; Drug reaction; Referral; Diabetes mellitus; Adverse effect; Pharmacoepidemiology; Intensive care medicine; Adverse drug reaction; Emergency medicine; Medical prescription; Pharmacology; Internal medicine; Family medicine","score_opus":0.19431172838170033,"score_gpt":0.4919582185759955,"score_spread":0.2976464901942951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385658077","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993505,0.00021389508,0.000020318992,0.000029856648,0.0000023550165,0.000012518025,0.00017026292,0.0000019212894,0.00019841273],"genre_scores_gemma":[0.99944144,0.00023116071,0.00006695938,0.000036160447,0.000005262726,0.000011413993,0.00015433393,6.570874e-7,0.0000527166],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999137,0.00019654263,0.00022788801,0.00012510394,0.00016300268,0.0001505313],"domain_scores_gemma":[0.99762565,0.00019419944,0.0015605488,0.00006888859,0.0001867051,0.0003640351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045807115,0.00024695747,0.0003536302,0.0013013063,0.0006908094,0.00071313884,0.00039367858,0.0003024346,0.0011828217],"category_scores_gemma":[0.0020744917,0.00037206706,0.00025805365,0.0013783566,0.0003929478,0.0003902858,0.00095467485,0.00040127232,0.00014602554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015241519,0.000011148999,0.9987902,0.000016740412,0.0000074356008,0.00016104817,0.00017940933,0.0000060918564,0.00007394899,0.0000047473386,0.000058844544,0.00067506114],"study_design_scores_gemma":[0.0000016816817,0.000057225243,0.99834216,0.000023232886,0.000004720727,0.0007404956,0.0006581612,0.000031595606,0.000024562933,0.000004555192,0.00010930709,0.0000024411852],"about_ca_topic_score_codex":0.009303615,"about_ca_topic_score_gemma":0.010427609,"teacher_disagreement_score":0.009303615,"about_ca_system_score_codex":0.0006156197,"about_ca_system_score_gemma":0.00067833916,"threshold_uncertainty_score":0.018498957},"labels":[],"label_agreement":null},{"id":"W4385992589","doi":"10.2196/43630","title":"Automating Detection of Drug-Related Harms on Social Media: Machine Learning Framework","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Internet Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; Canadian Centre on Substance Use and Addiction; Greo; Canadian Medical Protective Association; Carleton University; Saint Mary's University","funders":"Health Canada","keywords":"Social media; Enforcement; Warning system; Internet privacy; Law enforcement; Public health; Medicine; Public health surveillance; Business; Computer science; World Wide Web; Political science; Pathology","score_opus":0.22201196440057253,"score_gpt":0.5458263209758333,"score_spread":0.32381435657526075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385992589","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3417579,0.0024472652,0.6146403,0.005055502,0.000428427,0.001716867,0.010271928,0.009793335,0.013888445],"genre_scores_gemma":[0.79041624,0.00053166755,0.19732219,0.000428634,0.000326493,0.00043679637,0.0057895426,0.00007131531,0.004677175],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985013,0.0003490127,0.00012405659,0.00048420712,0.00031569874,0.0002258408],"domain_scores_gemma":[0.9961003,0.002180458,0.0004755936,0.00020145776,0.00086607115,0.0001760487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019634042,0.0012595137,0.0011012324,0.007267703,0.000995792,0.0016361332,0.001427725,0.0014568147,0.001362038],"category_scores_gemma":[0.005082725,0.00037062375,0.0011006566,0.002375601,0.0005603146,0.001767639,0.0013331344,0.0015909123,0.0012568508],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044651833,0.0020111375,0.124592334,0.00052195817,0.0004556583,0.000571782,0.00043700958,0.10053221,0.010326541,0.0034331796,0.019548357,0.73712337],"study_design_scores_gemma":[0.0000076359065,0.000055619912,0.008948649,0.00002165413,0.000031881307,0.000054851633,0.000120995515,0.98538244,0.0017702965,0.002054616,0.0015360175,0.00001531616],"about_ca_topic_score_codex":0.042125855,"about_ca_topic_score_gemma":0.041947186,"teacher_disagreement_score":0.042125855,"about_ca_system_score_codex":0.001662079,"about_ca_system_score_gemma":0.0018201008,"threshold_uncertainty_score":0.083761275},"labels":[],"label_agreement":null},{"id":"W4386828832","doi":"10.2196/preprints.52495","title":"Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study (Preprint)","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse Event Reporting System; Pharmacovigilance; Culprit; Adverse effect; Observational study; Emergency medicine; Internal medicine","score_opus":0.14425680609892505,"score_gpt":0.3969695866055706,"score_spread":0.25271278050664553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386828832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96434325,0.0024057222,0.00053842034,0.00053910393,0.000043730284,0.0004829753,0.02895512,0.000055733068,0.002636044],"genre_scores_gemma":[0.986169,0.0016917245,0.0005874887,0.0006378516,0.000027575863,0.00033571923,0.009367674,0.000028844079,0.0011541147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924839,0.0006972717,0.0016591969,0.0012980191,0.0024752605,0.0013863862],"domain_scores_gemma":[0.9667175,0.0029330272,0.011712121,0.0015860015,0.013787886,0.003263488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028878641,0.0007224504,0.0010011571,0.004733003,0.003106664,0.0028146973,0.002857477,0.0009571868,0.0027420695],"category_scores_gemma":[0.015032558,0.0011409394,0.00089362066,0.016710257,0.0014596281,0.00094254815,0.0022321427,0.0012037427,0.00055955595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000852425,0.000028522969,0.99505323,0.00015407626,0.00010202386,0.00007187619,0.0005616811,0.00006189335,0.000069078305,0.00004908917,0.0016614659,0.0021017725],"study_design_scores_gemma":[0.000014288055,0.000036897116,0.996382,0.00019022329,0.000066066226,0.00009132097,0.0019192643,0.00021842054,0.00006840408,0.000017553237,0.0009730051,0.000022559445],"about_ca_topic_score_codex":0.99215525,"about_ca_topic_score_gemma":0.99256635,"teacher_disagreement_score":0.041111797,"about_ca_system_score_codex":0.041111797,"about_ca_system_score_gemma":0.05442007,"threshold_uncertainty_score":0.29828835},"labels":[],"label_agreement":null},{"id":"W4387245287","doi":"10.1007/s40264-023-01348-7","title":"Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; University Health Network; University of British Columbia","funders":"Canadian Institutes of Health Research; Ministry of Health, British Columbia; Michael Smith Health Research BC","keywords":"Medicine; Adverse drug event; Drug; Medical emergency; Adverse effect; Family medicine; Intensive care medicine; Pharmacology","score_opus":0.09766998988305825,"score_gpt":0.4680446856590733,"score_spread":0.37037469577601506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387245287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612075,0.00041505322,0.0005852524,0.00020884152,0.000012137882,0.00024519674,0.0017510952,0.000016250075,0.00064533437],"genre_scores_gemma":[0.9971379,0.0002142331,0.0005709471,0.000078684294,0.000019460149,0.0002489878,0.0015538344,0.0000076075685,0.00016832582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9689196,0.012655526,0.0048990957,0.0025342852,0.008395361,0.0025962687],"domain_scores_gemma":[0.80396736,0.066051826,0.101125315,0.00558591,0.017793482,0.0054762415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02412643,0.0005462028,0.00062003126,0.0048184837,0.00081544643,0.002696992,0.0013389776,0.0007506369,0.0014468954],"category_scores_gemma":[0.086466655,0.00043445753,0.0015195531,0.007247892,0.00072432554,0.0019933784,0.003998656,0.0015949665,0.00027638205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015711309,0.0000829098,0.99550337,0.00005524311,0.00012059335,0.00002785807,0.0005029187,0.00006638871,0.00001924853,0.000029139821,0.0001659915,0.0032692244],"study_design_scores_gemma":[0.000022416047,0.0002293167,0.99654406,0.00006375521,0.00008465805,0.00007439174,0.0016880123,0.0007885958,0.00006210874,0.00004274326,0.00038704742,0.000012958907],"about_ca_topic_score_codex":0.029645935,"about_ca_topic_score_gemma":0.01985245,"teacher_disagreement_score":0.029645935,"about_ca_system_score_codex":0.0030710644,"about_ca_system_score_gemma":0.004640399,"threshold_uncertainty_score":0.12759423},"labels":[],"label_agreement":null},{"id":"W4387804977","doi":"10.1007/s40266-023-01072-y","title":"Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Drugs & Aging","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Drug Policy Research Network; Trillium Health Centre","funders":"","keywords":"Medicine; CINAHL; MEDLINE; Systematic review; Adverse effect; Scopus; Intensive care medicine; Family medicine; Psychiatry; Psychological intervention; Pharmacology","score_opus":0.3259244208590138,"score_gpt":0.520003612326483,"score_spread":0.19407919146746916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387804977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016755118,0.9910035,0.0009310978,0.0012525932,0.00037977286,0.0030850738,0.0009320013,0.000051128492,0.00068931346],"genre_scores_gemma":[0.01622172,0.9741907,0.0042656837,0.0013645892,0.00019736719,0.0029937963,0.0005248637,0.000015801357,0.00022549393],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9651402,0.013288515,0.012836732,0.0017511664,0.0064032655,0.0005800038],"domain_scores_gemma":[0.89741296,0.06839823,0.022611855,0.0017201478,0.0091970945,0.00065976614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030953517,0.0024336767,0.00828994,0.01462223,0.0010213932,0.0038464374,0.0028182757,0.0025435234,0.004982121],"category_scores_gemma":[0.13027169,0.0020941205,0.012562588,0.011143867,0.001249065,0.0058318963,0.0022614077,0.0021039245,0.0006957113],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021163737,0.000020576086,0.0008552142,0.93774813,0.007859965,0.0000734612,0.0003113747,0.00012812631,0.0001036812,0.0002159396,0.002008196,0.050463732],"study_design_scores_gemma":[0.00029055105,0.00012625169,0.0018409815,0.93786526,0.046605658,0.0001438494,0.00026217225,0.00012892485,0.00014450772,0.00032935146,0.012218117,0.00004443739],"about_ca_topic_score_codex":0.010236667,"about_ca_topic_score_gemma":0.032830793,"teacher_disagreement_score":0.030953517,"about_ca_system_score_codex":0.005524479,"about_ca_system_score_gemma":0.02765322,"threshold_uncertainty_score":0.16369975},"labels":[],"label_agreement":null},{"id":"W4388042304","doi":"10.1136/jitc-2023-sitc2023.1257","title":"1257 Augmenting post-market surveillance of serious drug-induced adverse events with artificial intelligence (AI)-aggregated case reports: proof-of-concept for PD-1/PD-L1 inhibitors for NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Medicine; Internal medicine","score_opus":0.06243865175087545,"score_gpt":0.37209425398336576,"score_spread":0.30965560223249033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4833061,0.06624377,0.10891384,0.01804941,0.0022644561,0.021694612,0.25053206,0.003625257,0.04537048],"genre_scores_gemma":[0.62834346,0.017079793,0.19678365,0.0044645583,0.0017050434,0.0084260395,0.13928305,0.00032749632,0.0035868876],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97712266,0.009267759,0.0073566493,0.0015480218,0.004295964,0.0004089466],"domain_scores_gemma":[0.81150997,0.10607633,0.044010587,0.014727373,0.021804437,0.0018713258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034643844,0.0005701524,0.00068419287,0.009393592,0.000524937,0.0035130754,0.0012536907,0.0010580703,0.0070779966],"category_scores_gemma":[0.15831241,0.00034631384,0.0019317772,0.0047091143,0.0006560004,0.0021649895,0.0024116635,0.0007868133,0.0018246277],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023107876,0.0006305385,0.3432617,0.026124232,0.0019001667,0.00304379,0.0021548925,0.003754363,0.0041378615,0.005613255,0.083434165,0.52363425],"study_design_scores_gemma":[0.0016231162,0.0022964175,0.36437538,0.0266342,0.0046698716,0.008130312,0.00341994,0.020274466,0.017155694,0.014726238,0.5363129,0.0003814649],"about_ca_topic_score_codex":0.0021766713,"about_ca_topic_score_gemma":0.0037913998,"teacher_disagreement_score":0.034643844,"about_ca_system_score_codex":0.001071982,"about_ca_system_score_gemma":0.0041329963,"threshold_uncertainty_score":0.18321633},"labels":[],"label_agreement":null},{"id":"W4388110358","doi":"10.1093/eurpub/ckab165.653","title":"Risk Management Assessments of Adverse Drug Reactions: A Systematic Review of the Literature","year":2021,"lang":"en","type":"review","venue":"European Journal of Public Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine; Adverse effect; Context (archaeology); Observational study; MEDLINE; Medical prescription; Discontinuation; Quality of life (healthcare); Tuberculosis; Pharmacotherapy; Pharmacology; Internal medicine","score_opus":0.20144150564224916,"score_gpt":0.5077197544914116,"score_spread":0.30627824884916244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388110358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068506115,0.99831414,0.00013706084,0.00019447399,0.00006506829,0.00033070164,0.000115672,0.0000056294866,0.00015227217],"genre_scores_gemma":[0.017781172,0.9798126,0.0009987912,0.00043042196,0.00011365795,0.0006838781,0.000108812565,0.0000039866222,0.0000666724],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97819155,0.009091603,0.007720683,0.0009850012,0.003691791,0.00031939874],"domain_scores_gemma":[0.91433233,0.06418427,0.015157667,0.0009046279,0.0049621435,0.0004589326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017377561,0.0017061399,0.0073599187,0.012334549,0.00065458805,0.0027164978,0.0018832522,0.0017851944,0.0036524883],"category_scores_gemma":[0.07967342,0.0009928354,0.008247124,0.0090921745,0.0010893279,0.0023104632,0.0015288448,0.0014025297,0.00023110597],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018386533,0.00002309433,0.00068201707,0.94776475,0.006473248,0.00008980583,0.00017960797,0.0000894395,0.00007281158,0.00011911735,0.0007277603,0.043594338],"study_design_scores_gemma":[0.0002922884,0.00025677975,0.0038110726,0.93392324,0.050377112,0.0005115434,0.00025575183,0.0001046469,0.00013501101,0.00027741483,0.0100157205,0.00003936921],"about_ca_topic_score_codex":0.0049124607,"about_ca_topic_score_gemma":0.012139682,"teacher_disagreement_score":0.017377561,"about_ca_system_score_codex":0.0042504277,"about_ca_system_score_gemma":0.010636828,"threshold_uncertainty_score":0.091902375},"labels":[],"label_agreement":null},{"id":"W4388132398","doi":"10.1080/14740338.2023.2274416","title":"Risk of serious skin and subcutaneous tissue disorders for nimesulide among the pediatric population: a jeopardy identified through the analysis of global individual case safety reports","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Nimesulide; Double jeopardy; Population; Subcutaneous tissue; Dermatology; Intensive care medicine; Surgery; Internal medicine; Environmental health","score_opus":0.04328827465123892,"score_gpt":0.42146180062452104,"score_spread":0.37817352597328213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388132398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942727,0.00479566,0.001326756,0.00026732066,0.000016632313,0.000106709704,0.0025512476,0.000030937117,0.0014774039],"genre_scores_gemma":[0.9961534,0.001500078,0.0009057169,0.00005219875,0.000024317726,0.000035861653,0.0012103129,0.00000716632,0.00011096086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937291,0.0019940953,0.0011932045,0.0010832447,0.0016644566,0.00033593492],"domain_scores_gemma":[0.9712583,0.005536736,0.019022718,0.0015545792,0.002112512,0.00051532727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055558444,0.00030004198,0.00037610365,0.0066901925,0.00024060662,0.0011490488,0.0003777515,0.0002804467,0.0015126445],"category_scores_gemma":[0.016907398,0.00019645762,0.0007612391,0.0050049885,0.0005128681,0.00095085864,0.0011516409,0.0003498171,0.00019757044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005909659,0.0000074550394,0.99064976,0.00007715311,0.000099657285,0.00015553004,0.00018717685,0.000040202907,0.00012884072,0.000071215945,0.00018111119,0.008342802],"study_design_scores_gemma":[0.000004156552,0.00010728818,0.9951545,0.00007528615,0.0001671367,0.0016835195,0.0007895585,0.00034695267,0.00032756498,0.00015234626,0.0011820331,0.00000961201],"about_ca_topic_score_codex":0.0023701335,"about_ca_topic_score_gemma":0.0018925745,"teacher_disagreement_score":0.0066901925,"about_ca_system_score_codex":0.0005745329,"about_ca_system_score_gemma":0.0007311964,"threshold_uncertainty_score":0.029382408},"labels":[],"label_agreement":null},{"id":"W4388722017","doi":"10.3389/fpubh.2023.1268730","title":"Patient safety discourse in a pandemic: a Twitter hashtag analysis study on #PatientSafety","year":2023,"lang":"en","type":"article","venue":"Frontiers in Public Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Social media; Analytics; Health care; Pandemic; Coronavirus disease 2019 (COVID-19); Patient safety; Social media analytics; Transformative learning; Health professionals; Computer science; Medical education; Medicine; Psychology; World Wide Web; Data science; Political science","score_opus":0.20717466548916239,"score_gpt":0.492742429208563,"score_spread":0.2855677637194006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388722017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960567,0.000076998425,0.00021485827,0.00083162746,0.00002345555,0.000046412988,0.0003680441,0.0000054892353,0.0023764495],"genre_scores_gemma":[0.9968284,0.00020394567,0.00040059473,0.0006550855,0.000047355454,0.0001486871,0.0004262023,0.000027081805,0.0012626344],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9985317,0.00078197947,0.000097980475,0.00015089789,0.00021032135,0.00022714477],"domain_scores_gemma":[0.99397814,0.0036816087,0.0011676096,0.00019332138,0.00060379354,0.0003754426],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0025105784,0.0002547583,0.00029512367,0.0013325734,0.002440267,0.0025200944,0.00033402245,0.0009462247,0.0031307703],"category_scores_gemma":[0.011521153,0.00022036019,0.0002651575,0.0018336935,0.001536501,0.0038756651,0.0026283981,0.0013323126,0.00085083686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028020545,0.00032099194,0.12841187,0.00036209237,0.000019606512,0.00083586824,0.8398521,0.00007307205,0.0025333932,0.0017095563,0.0050497195,0.02055143],"study_design_scores_gemma":[0.000015314521,0.00016480841,0.1545132,0.00021825261,0.000021906328,0.0002819162,0.8265905,0.0005852045,0.00080806983,0.00055987324,0.016197482,0.000043529013],"about_ca_topic_score_codex":0.006793332,"about_ca_topic_score_gemma":0.010428564,"teacher_disagreement_score":0.9986674,"about_ca_system_score_codex":0.0013431725,"about_ca_system_score_gemma":0.0010730246,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4389300096","doi":"10.22214/ijraset.2023.57254","title":"Regulatory Authority in Pharmacovigilance","year":2023,"lang":"en","type":"article","venue":"International Journal for Research in Applied Science and Engineering Technology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Agency (philosophy); Business; Harmonization; Gross national income; Medicine; Accounting; Gross domestic product; Economic growth; Pharmacology; Adverse effect; Economics","score_opus":0.2468668509247989,"score_gpt":0.5568623940347024,"score_spread":0.3099955431099035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389300096","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015784938,0.09096384,0.054184437,0.48406106,0.0064332867,0.00055377034,0.0009722132,0.001386029,0.34566042],"genre_scores_gemma":[0.6536065,0.04176627,0.0416314,0.21121684,0.010895387,0.0011753638,0.0017851588,0.00092388137,0.03699923],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.86575264,0.0755695,0.012973253,0.006921648,0.034821637,0.0039612814],"domain_scores_gemma":[0.6991373,0.19563079,0.023819484,0.013197819,0.06133514,0.0068795546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.106561825,0.000541432,0.0005894503,0.0030326925,0.0029939092,0.012774375,0.0029399851,0.0072005135,0.009175989],"category_scores_gemma":[0.16996734,0.00056889246,0.0009210386,0.0040606796,0.008214427,0.0067940685,0.005720225,0.010109199,0.0030686974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021910362,0.00013231886,0.016185515,0.0017448601,0.000121436286,0.0008885066,0.004587722,0.0013508261,0.0012039989,0.46614265,0.24163702,0.2657861],"study_design_scores_gemma":[0.000112762435,0.00011900585,0.009015328,0.0052048913,0.00009303687,0.0013990918,0.0010761971,0.0013423329,0.001782774,0.074156865,0.90562093,0.00007679814],"about_ca_topic_score_codex":0.0059678424,"about_ca_topic_score_gemma":0.002738033,"teacher_disagreement_score":0.106561825,"about_ca_system_score_codex":0.00627803,"about_ca_system_score_gemma":0.027070634,"threshold_uncertainty_score":0.56355953},"labels":[],"label_agreement":null},{"id":"W4389435428","doi":"10.2196/52495","title":"Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study","year":2023,"lang":"en","type":"article","venue":"JMIR Human Factors","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Pharmacovigilance; Medicine; Adverse effect; Adverse Event Reporting System; Observational study; Culprit; Drug; Retrospective cohort study; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.1392552100158599,"score_gpt":0.4078554156814674,"score_spread":0.2686002056656075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389435428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96874183,0.0029594768,0.0008484887,0.00054763374,0.0000472856,0.0005728949,0.022216808,0.000074794974,0.0039907205],"genre_scores_gemma":[0.988228,0.0015033436,0.0007428395,0.00053826947,0.000020958976,0.00027143097,0.007630642,0.00003375429,0.0010307145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990719,0.0007934315,0.0016197853,0.0016346714,0.0035383296,0.0016947682],"domain_scores_gemma":[0.96283364,0.0024154289,0.010523762,0.0015620097,0.018870512,0.0037946324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003111019,0.0008633886,0.001156944,0.0058934875,0.004000776,0.0031753064,0.0035912849,0.0009315698,0.002366698],"category_scores_gemma":[0.014156984,0.0011555495,0.00090895937,0.017539121,0.0017319022,0.00092531083,0.0026095381,0.0014412915,0.00048926164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074324154,0.000035563848,0.99498284,0.00013598581,0.000111956426,0.000103838036,0.0006153852,0.000083778745,0.00009862026,0.000062455205,0.0012732444,0.0024219356],"study_design_scores_gemma":[0.000013750459,0.000041309115,0.9953519,0.0001762649,0.000078761936,0.00013104481,0.0022580312,0.00036517048,0.00009278866,0.000024100289,0.0014389491,0.000027881233],"about_ca_topic_score_codex":0.99402446,"about_ca_topic_score_gemma":0.994626,"teacher_disagreement_score":0.055812433,"about_ca_system_score_codex":0.055812433,"about_ca_system_score_gemma":0.07024303,"threshold_uncertainty_score":0.40494943},"labels":[],"label_agreement":null},{"id":"W4389966161","doi":"10.1016/j.autrev.2023.103504","title":"Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study","year":2023,"lang":"en","type":"review","venue":"Autoimmunity Reviews","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sinai Health System; McGill University Health Centre; Lunenfeld-Tanenbaum Research Institute","funders":"Galápagos; Pfizer","keywords":"Medicine; Risk assessment; Family medicine; Pharmacovigilance; Likert scale; Internal medicine; Adverse effect; Psychology","score_opus":0.20911493138207912,"score_gpt":0.49735286366326514,"score_spread":0.288237932281186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389966161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001680969,0.97751904,0.0012919072,0.011290461,0.0010509628,0.00013912887,0.00046823212,0.000051598992,0.006507663],"genre_scores_gemma":[0.02465959,0.9528365,0.006949288,0.012586535,0.000693101,0.00019775581,0.00089865096,0.000028006738,0.0011505233],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9923074,0.003073072,0.0016916434,0.0004238981,0.0021969795,0.00030691252],"domain_scores_gemma":[0.9842939,0.0077242106,0.0036725549,0.00027396044,0.0036448021,0.00039064983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015327405,0.0005693932,0.0019820405,0.0017237772,0.00026647229,0.0023814938,0.0015227413,0.0023376,0.0027752207],"category_scores_gemma":[0.01729888,0.0002796372,0.0021161735,0.001976154,0.0005550158,0.0010848566,0.00075473177,0.0027763904,0.0005983519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007320958,0.00018827649,0.0021761335,0.02656559,0.0007749903,0.00021011154,0.00018249932,0.00063588726,0.00089100085,0.006778067,0.058175616,0.9026898],"study_design_scores_gemma":[0.0011120028,0.0006062049,0.015902825,0.0930935,0.0030002377,0.0009711838,0.00031703882,0.0008233064,0.001151255,0.0027435408,0.8801925,0.00008635977],"about_ca_topic_score_codex":0.0046793856,"about_ca_topic_score_gemma":0.008056449,"teacher_disagreement_score":0.015327405,"about_ca_system_score_codex":0.0018019001,"about_ca_system_score_gemma":0.009858654,"threshold_uncertainty_score":0.08106005},"labels":[],"label_agreement":null},{"id":"W4390281716","doi":"10.2196/49755","title":"Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review","year":2023,"lang":"en","type":"review","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Research Foundation of Korea; National Research Foundation","keywords":"Poison control; Medicine; Systematic review; MEDLINE; Risk analysis (engineering); Environmental health; Biology","score_opus":0.241532429205927,"score_gpt":0.5201094300740151,"score_spread":0.2785770008680881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390281716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019928934,0.9954391,0.0001995848,0.00032510294,0.000114801485,0.00026154588,0.0011255381,0.000010816083,0.0005306446],"genre_scores_gemma":[0.021370858,0.9760109,0.0007451334,0.0005651505,0.00012550669,0.0003252826,0.0007192367,0.000007414791,0.00013047717],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9905386,0.0025984303,0.004444867,0.0005272,0.001736763,0.00015421117],"domain_scores_gemma":[0.92757523,0.050663047,0.01601244,0.0007721003,0.0045933104,0.0003839196],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0072107813,0.001141831,0.0047841934,0.017120484,0.0005472489,0.0017918258,0.0016960948,0.0018005557,0.0064762407],"category_scores_gemma":[0.053840946,0.0008306448,0.0050818687,0.011946213,0.0009147387,0.0024543456,0.001293453,0.00083036115,0.00043798168],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018507567,0.00001668172,0.0019879804,0.946808,0.004918605,0.00017802864,0.00016872365,0.000054972952,0.00008831811,0.00014973998,0.0016127153,0.04383116],"study_design_scores_gemma":[0.00015911488,0.00013988376,0.006460164,0.9281374,0.043281633,0.000864322,0.00023085774,0.00007336773,0.00016630247,0.00026451092,0.02018554,0.000036889538],"about_ca_topic_score_codex":0.004889116,"about_ca_topic_score_gemma":0.012178118,"teacher_disagreement_score":0.9927892,"about_ca_system_score_codex":0.0021063325,"about_ca_system_score_gemma":0.0063133384,"threshold_uncertainty_score":0.038134694},"labels":[],"label_agreement":null},{"id":"W4390810997","doi":"10.1007/s40278-024-52358-9","title":"Adverse reactions to health products reported in Canada in 2022","year":2024,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.10670732571986656,"score_gpt":0.4375454589613459,"score_spread":0.3308381332414793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390810997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8217367,0.01859158,0.0006437781,0.005987949,0.00062028784,0.0003198762,0.07412772,0.00036801482,0.07760397],"genre_scores_gemma":[0.942002,0.0077507943,0.0007019593,0.003916225,0.000111982365,0.000046384797,0.016734038,0.00006747699,0.028669167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835545,0.00006382165,0.00013367203,0.00011090016,0.0010101905,0.0003259823],"domain_scores_gemma":[0.9968906,0.00012748453,0.0006944966,0.000023797866,0.0016306491,0.00063296483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005436777,0.0003469576,0.00030250844,0.0023693002,0.0011761641,0.0018914993,0.0005690687,0.000685203,0.005431673],"category_scores_gemma":[0.0029069742,0.00029223974,0.0006450812,0.0037645714,0.00030730446,0.00028842656,0.0005468232,0.0012929388,0.0006714403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083531253,0.00023675463,0.8823393,0.0005264883,0.00037378212,0.003198008,0.0010240151,0.00070566026,0.0015291525,0.00066696043,0.058732923,0.049831536],"study_design_scores_gemma":[0.000029861869,0.0000612557,0.97147185,0.000117028736,0.00006522289,0.0008536095,0.0008166943,0.0003203807,0.00041503427,0.00003701634,0.02578082,0.000031205414],"about_ca_topic_score_codex":0.98745394,"about_ca_topic_score_gemma":0.9873935,"teacher_disagreement_score":0.023734624,"about_ca_system_score_codex":0.023734624,"about_ca_system_score_gemma":0.026619097,"threshold_uncertainty_score":0.17220753},"labels":[],"label_agreement":null},{"id":"W4390903051","doi":"10.1016/j.clinthera.2023.12.008","title":"The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance","year":2024,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Novo Nordisk; CSL Behring; Alexion Pharmaceuticals; Celgene; Gilead Sciences; University of Portsmouth; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pharmacovigilance; Medicine; Timeline; Best practice; Knowledge management; Risk analysis (engineering); Pharmacology; Computer science; Adverse effect; Political science","score_opus":0.3403489431486682,"score_gpt":0.6136861542037463,"score_spread":0.2733372110550781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390903051","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026454753,0.16588354,0.19599928,0.5169015,0.055506404,0.0064667356,0.004045113,0.0027646427,0.049787425],"genre_scores_gemma":[0.040007774,0.22339076,0.49015403,0.1261051,0.05686898,0.01891654,0.01851884,0.003120211,0.022917774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.63352597,0.21673547,0.055399947,0.0154097825,0.07245731,0.006471458],"domain_scores_gemma":[0.291013,0.40393555,0.059135374,0.059047952,0.1603017,0.026566472],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.41454735,0.005016571,0.006388272,0.021519128,0.0038661005,0.031908397,0.01461074,0.018133154,0.015356702],"category_scores_gemma":[0.41371447,0.0023240193,0.009361089,0.0156709,0.013887379,0.02436978,0.02559365,0.025895653,0.00942733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046717862,0.00031648818,0.0055256616,0.010239875,0.0010958244,0.0003763444,0.004204197,0.002349292,0.0009889804,0.07245159,0.3734812,0.52850336],"study_design_scores_gemma":[0.00035583644,0.00025831745,0.0045569763,0.03317023,0.000754418,0.0006748701,0.0013674737,0.0026761596,0.0014839555,0.08866321,0.86581653,0.0002220982],"about_ca_topic_score_codex":0.0082100425,"about_ca_topic_score_gemma":0.002909279,"teacher_disagreement_score":0.41454735,"about_ca_system_score_codex":0.015401303,"about_ca_system_score_gemma":0.08078393,"threshold_uncertainty_score":0.72196734},"labels":[],"label_agreement":null},{"id":"W4390976974","doi":"10.1016/j.hlc.2023.12.005","title":"Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention","year":2024,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"Helse Vest Regionalt Helseføretak; Helse Vest","keywords":"Medicine; Percutaneous coronary intervention; Drug; Drug reaction; Adverse effect; Intervention (counseling); Adverse drug reaction; Internal medicine; Emergency medicine; Intensive care medicine; Medical emergency; Pharmacology; Psychiatry; Myocardial infarction","score_opus":0.02157239521975599,"score_gpt":0.35381096578017984,"score_spread":0.33223857056042383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390976974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994765,0.00014495823,0.000030085428,0.000045304034,0.0000051261372,0.0000048403404,0.000111298745,0.0000018710465,0.00017997643],"genre_scores_gemma":[0.99950457,0.00008042679,0.00006330821,0.00003111179,0.000008558289,0.0000037773564,0.0001769181,9.4690296e-7,0.00013039426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920326,0.00025981126,0.000117893534,0.00013894515,0.00016260451,0.00011746528],"domain_scores_gemma":[0.99281025,0.001411336,0.0045002126,0.00028022422,0.00040321934,0.0005948118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011650976,0.00023197244,0.00039927187,0.0005917394,0.00042814232,0.0010347206,0.0002598778,0.0007530331,0.0020219744],"category_scores_gemma":[0.007216775,0.00028775417,0.00068977027,0.0008802547,0.00028287966,0.00051034184,0.00040783623,0.0012763281,0.00021600997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012872991,0.00007506952,0.99883455,0.0000108467275,0.00003585749,0.000028881577,0.000090509595,0.000016722277,0.00006293552,0.000003999626,0.000042249285,0.00066966726],"study_design_scores_gemma":[0.000005196418,0.00009872404,0.9996402,0.0000046360224,0.000014264506,0.00005331332,0.00007395372,0.00004817973,0.000017322222,0.000006016556,0.000035859597,0.0000021455862],"about_ca_topic_score_codex":0.0053859088,"about_ca_topic_score_gemma":0.0052557667,"teacher_disagreement_score":0.0053859088,"about_ca_system_score_codex":0.0003637069,"about_ca_system_score_gemma":0.00046979642,"threshold_uncertainty_score":0.010709107},"labels":[],"label_agreement":null},{"id":"W4391248701","doi":"10.37766/inplasy2024.1.0108","title":"Case-level causality assessment methodologies, their application, utility, and limitations in determining possible adverse drug reaction: A Scoping review protocol","year":2024,"lang":"en","type":"review","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Portsmouth; McGill University","keywords":"Protocol (science); Causality (physics); Adverse drug reaction; Computer science; Drug reaction; Risk analysis (engineering); Drug; Management science; Medicine; Pharmacology; Engineering; Alternative medicine","score_opus":0.7061909484921309,"score_gpt":0.6263923545062497,"score_spread":0.07979859398588118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391248701","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021175877,0.015959578,0.015200007,0.0011379204,0.00048231176,0.95423603,0.008421416,0.00025797705,0.0021872013],"genre_scores_gemma":[0.00312357,0.009901361,0.044059694,0.00044087347,0.000052068735,0.93977034,0.001462358,0.000030667896,0.0011591035],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9227593,0.026743265,0.03753815,0.004214683,0.0074023167,0.001342307],"domain_scores_gemma":[0.86037815,0.06937271,0.020714117,0.011650783,0.036301993,0.0015822322],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15884043,0.0031379487,0.008519922,0.016927002,0.0042302897,0.0060216235,0.0049614026,0.006757073,0.038707096],"category_scores_gemma":[0.17544594,0.0038545819,0.014969962,0.0123365875,0.0032790238,0.0063336347,0.006497442,0.0043285335,0.004996331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027348674,0.0003506201,0.0024780561,0.78385764,0.0031149145,0.00057908095,0.0042280215,0.0013085402,0.0018468358,0.009411849,0.01814667,0.17194276],"study_design_scores_gemma":[0.0073276325,0.0011999101,0.008783814,0.73410386,0.023573164,0.00076405605,0.0032692258,0.0018642059,0.004028023,0.013640552,0.20091864,0.00052690896],"about_ca_topic_score_codex":0.006420676,"about_ca_topic_score_gemma":0.020727534,"teacher_disagreement_score":0.8411596,"about_ca_system_score_codex":0.0083698165,"about_ca_system_score_gemma":0.071932174,"threshold_uncertainty_score":0.84003854},"labels":[],"label_agreement":null},{"id":"W4391294433","doi":"10.1177/20420986231224227","title":"Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Medicine; Pharmacovigilance; Odds ratio; Database; Internal medicine; Interquartile range; Adverse effect","score_opus":0.0573512260930896,"score_gpt":0.4510608166314385,"score_spread":0.39370959053834886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391294433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892944,0.0038949386,0.000262114,0.0006792615,0.00002491666,0.000067295645,0.0050534066,0.000023652772,0.000700009],"genre_scores_gemma":[0.99575305,0.0005768149,0.00016975941,0.00025718656,0.00002816498,0.000035976456,0.0030921753,0.000005790253,0.000081049766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9887262,0.0033738858,0.0031235751,0.0019480472,0.002132685,0.00069563737],"domain_scores_gemma":[0.9478301,0.008542336,0.036751095,0.0018559796,0.003957697,0.0010627913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008413475,0.00030338095,0.0005618339,0.00395086,0.00044536887,0.0017287921,0.00080289075,0.00089006685,0.0013082618],"category_scores_gemma":[0.027058242,0.0003748201,0.001104837,0.006323005,0.000413471,0.0016987418,0.0013591608,0.0009062401,0.0002928768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001800487,0.000029388582,0.9972114,0.00005708051,0.00011765515,0.00011778965,0.00012329636,0.00004460587,0.000053702475,0.00003205128,0.0003957288,0.0016372451],"study_design_scores_gemma":[0.000020047348,0.000107212894,0.9969754,0.0000683518,0.000158417,0.00069249386,0.00046683103,0.00054484914,0.00007468801,0.000023275876,0.000856745,0.000011598576],"about_ca_topic_score_codex":0.015799472,"about_ca_topic_score_gemma":0.009520314,"teacher_disagreement_score":0.015799472,"about_ca_system_score_codex":0.0020619044,"about_ca_system_score_gemma":0.0015400853,"threshold_uncertainty_score":0.044495285},"labels":[],"label_agreement":null},{"id":"W4391546075","doi":"10.1177/20420986241228119","title":"Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harmonization; Pharmacovigilance; Medicine; Guideline; Drug reaction; Latin Americans; Authorization; Business; Regulatory authority; Environmental health; Accounting; Political science; Pharmacology; Adverse effect; Public administration; Drug; Computer security; Computer science","score_opus":0.18672207394740206,"score_gpt":0.5018522761571692,"score_spread":0.3151302022097672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391546075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013884111,0.7588277,0.074218355,0.067966074,0.0054637566,0.0043237885,0.0020211746,0.0009733495,0.07232176],"genre_scores_gemma":[0.13712351,0.69271594,0.11023464,0.030301148,0.004631571,0.005969164,0.0063621337,0.00059958507,0.01206231],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.89083636,0.03362687,0.02643795,0.0073408145,0.039114427,0.0026436397],"domain_scores_gemma":[0.84834546,0.067039706,0.018323893,0.008981761,0.055206534,0.0021027077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.109025285,0.00094243855,0.0017457322,0.008811371,0.002000422,0.008068892,0.007053011,0.004277646,0.0025905098],"category_scores_gemma":[0.11582103,0.0010533725,0.0019830114,0.008242477,0.0049946317,0.0055526444,0.0042715594,0.004806777,0.0013786876],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014901049,0.0002197979,0.0056796535,0.017075231,0.00017920129,0.0007024685,0.0034371098,0.0015462865,0.0021449174,0.066943325,0.05140433,0.8505186],"study_design_scores_gemma":[0.000057741418,0.0002122215,0.010442571,0.026408244,0.00025860936,0.0016110669,0.0013827338,0.0010013935,0.0023138612,0.010464594,0.9457098,0.00013721047],"about_ca_topic_score_codex":0.00805991,"about_ca_topic_score_gemma":0.0042575435,"teacher_disagreement_score":0.109025285,"about_ca_system_score_codex":0.0067672892,"about_ca_system_score_gemma":0.024359148,"threshold_uncertainty_score":0.5765877},"labels":[],"label_agreement":null},{"id":"W4391994317","doi":"10.4212/cjhp.3489","title":"Disponibilité de l’information médicale requise pour la déclaration d’une réaction indésirable médicamenteuse à Santé Canada : une étude exploratoire","year":2024,"lang":"fr","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Humanities; Political science; Philosophy","score_opus":0.03669814238357288,"score_gpt":0.3565232255531064,"score_spread":0.3198250831695335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391994317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74458313,0.11101702,0.014891958,0.039928406,0.0008183483,0.010538827,0.018978136,0.00025798948,0.05898615],"genre_scores_gemma":[0.94139975,0.02687105,0.015823431,0.006878142,0.00025698773,0.0024778023,0.0021732023,0.000053927484,0.00406578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94152135,0.024496429,0.005934177,0.0025282067,0.022862367,0.0026575017],"domain_scores_gemma":[0.8112415,0.0875949,0.043321706,0.0054884665,0.048298366,0.0040550735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044855013,0.0004896788,0.0010631563,0.0026277492,0.0024390751,0.0051112045,0.0018639038,0.0014191382,0.0062794434],"category_scores_gemma":[0.14772032,0.0007290106,0.0010323254,0.004529784,0.0027739294,0.0021182357,0.0022301842,0.002305905,0.00055060635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032323117,0.000884991,0.58719873,0.02831413,0.0015197214,0.00068033877,0.021063095,0.0009125235,0.0015671245,0.0072120666,0.025096303,0.32231873],"study_design_scores_gemma":[0.00059374346,0.0025157863,0.84306806,0.028818937,0.0023790428,0.0012991758,0.015351394,0.0022014177,0.004333666,0.0016080983,0.097521104,0.0003095804],"about_ca_topic_score_codex":0.6986434,"about_ca_topic_score_gemma":0.7048403,"teacher_disagreement_score":0.96310294,"about_ca_system_score_codex":0.03689705,"about_ca_system_score_gemma":0.12392825,"threshold_uncertainty_score":0.6062627},"labels":[],"label_agreement":null},{"id":"W4392130981","doi":"10.2196/49643","title":"Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses of VigiBase and QUEST","year":2024,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Identification (biology); Event (particle physics); Quality (philosophy); Computer science; Adverse effect; Medicine; Internal medicine","score_opus":0.10377161770668207,"score_gpt":0.49065606575359055,"score_spread":0.38688444804690847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392130981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869183,0.0003383176,0.00317688,0.00038949848,0.000038824735,0.000056918598,0.008506955,0.000085841886,0.0004884704],"genre_scores_gemma":[0.9873931,0.00007847776,0.0017104662,0.000038601385,0.00003117554,0.00005770044,0.010435703,0.000010485527,0.0002443984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978528,0.0006745247,0.00039973797,0.0005314557,0.00031914416,0.0002223812],"domain_scores_gemma":[0.9835186,0.007861892,0.005583626,0.0011389804,0.0012532745,0.0006437007],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006899227,0.00053102884,0.00056827953,0.0030306343,0.00032782892,0.001262909,0.00071377936,0.00061236025,0.0013976896],"category_scores_gemma":[0.017951282,0.00017465871,0.0014675179,0.0021502594,0.00041916055,0.0009211035,0.0010062462,0.0012043013,0.00051394204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002537956,0.0001501654,0.9822203,0.00006761808,0.00025916458,0.0001826498,0.00021094197,0.0051894593,0.0003934801,0.00019693932,0.0012166421,0.009658826],"study_design_scores_gemma":[0.000015304207,0.00024275955,0.93998355,0.00005357907,0.00012289415,0.000242701,0.00049067265,0.056235276,0.00059023604,0.00042119378,0.0015720456,0.000029728335],"about_ca_topic_score_codex":0.012003832,"about_ca_topic_score_gemma":0.00871138,"teacher_disagreement_score":0.99310076,"about_ca_system_score_codex":0.0007713369,"about_ca_system_score_gemma":0.00095958734,"threshold_uncertainty_score":0.036487043},"labels":[],"label_agreement":null},{"id":"W4392281651","doi":"10.14745/ccdr.v50i12a06","title":"National safety monitoring of vaccines from the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS), 2018–2019","year":2024,"lang":"en","type":"article","venue":"Canada Communicable Disease Report","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Immunization; Safety monitoring; Vaccine safety; Medicine; Virology; Immunology; Biology; Bioinformatics; Antibody","score_opus":0.05751149138911271,"score_gpt":0.37698148943628845,"score_spread":0.31946999804717574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392281651","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20443842,0.014925217,0.0056078453,0.007398079,0.0006727675,0.0034897425,0.6752813,0.0014642262,0.08672242],"genre_scores_gemma":[0.64217407,0.01385567,0.014694428,0.0031759054,0.00030898605,0.0018105801,0.3106029,0.00013751231,0.0132399835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930807,0.00042124593,0.0006530105,0.0004161842,0.0048852633,0.00054362975],"domain_scores_gemma":[0.9553475,0.0011632575,0.005199109,0.0005380934,0.03552216,0.0022298566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048943176,0.0005892403,0.00049587403,0.005851314,0.0016372442,0.0012398987,0.0014780303,0.00030720077,0.0026784702],"category_scores_gemma":[0.016475877,0.00028930564,0.0006280572,0.0071982336,0.00032010474,0.00052168674,0.0008995484,0.0008170253,0.0006341506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040324326,0.00010669497,0.7060998,0.0023829683,0.0003686369,0.00013271402,0.00079579256,0.001507278,0.0008518102,0.00093320565,0.1789063,0.107511476],"study_design_scores_gemma":[0.000033479344,0.00008702319,0.9275011,0.00058126246,0.00008452904,0.00006555918,0.0002874948,0.0009162324,0.00057950517,0.00007739213,0.069753274,0.000033199995],"about_ca_topic_score_codex":0.98136055,"about_ca_topic_score_gemma":0.98621297,"teacher_disagreement_score":0.034470916,"about_ca_system_score_codex":0.034470916,"about_ca_system_score_gemma":0.10737283,"threshold_uncertainty_score":0.25010514},"labels":[],"label_agreement":null},{"id":"W4392583468","doi":"10.1136/dtb.2023.000053","title":"Do regulatory safety warnings on medicines miss the mark?","year":2024,"lang":"en","type":"editorial","venue":"Drug and Therapeutics Bulletin","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Business; Medicine; Medical emergency","score_opus":0.03861476007896699,"score_gpt":0.3906476450834636,"score_spread":0.35203288500449664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392583468","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003263744,0.004596046,0.000112091155,0.065545335,0.9277915,0.00001871201,0.000058521648,0.00006991758,0.0017753064],"genre_scores_gemma":[0.00046171682,0.0041769603,0.00020884891,0.060414564,0.9259868,0.000031488198,0.000044311182,0.000045990208,0.008629392],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98846626,0.002654837,0.001707251,0.00081451226,0.0058122887,0.0005447452],"domain_scores_gemma":[0.938163,0.030222552,0.0042606913,0.0013670439,0.020518675,0.0054680896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018163988,0.0036982237,0.0049340697,0.005254428,0.0036546441,0.011241248,0.005958368,0.03646644,0.015858691],"category_scores_gemma":[0.06675619,0.0023571688,0.0035303512,0.0023240966,0.0034989668,0.006390152,0.0018228368,0.033239026,0.014808465],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033622815,0.000014051474,0.00002117012,0.00017845475,0.00002602296,0.000049129194,0.000008732709,0.000015077561,0.00002793979,0.00022156294,0.99541926,0.0039849794],"study_design_scores_gemma":[0.00023674301,0.000060957223,0.00036272823,0.0009265408,0.0001796906,0.0001627901,0.00007059376,0.00027925594,0.00012341712,0.002102222,0.9954587,0.000036367226],"about_ca_topic_score_codex":0.0035736437,"about_ca_topic_score_gemma":0.009212603,"teacher_disagreement_score":0.03646644,"about_ca_system_score_codex":0.0036447814,"about_ca_system_score_gemma":0.006107253,"threshold_uncertainty_score":0.09606153},"labels":[],"label_agreement":null},{"id":"W4392859025","doi":"10.3389/fphar.2024.1369384","title":"Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database","year":2024,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Adverse effect; Adverse Event Reporting System; Database; Drug reaction; Emergency medicine; Drug; Pharmacology; Computer science","score_opus":0.05261314076251862,"score_gpt":0.45221472126113715,"score_spread":0.39960158049861855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392859025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8364489,0.012882974,0.010647425,0.00066629914,0.000064087995,0.0008517667,0.13177,0.0005577955,0.0061107078],"genre_scores_gemma":[0.8999766,0.0033141312,0.008187684,0.00032210836,0.000079468475,0.00039149306,0.08691736,0.00003764706,0.00077355676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956014,0.0011894176,0.0012095482,0.00061712373,0.0012704767,0.00011194507],"domain_scores_gemma":[0.98577625,0.0035911002,0.008126191,0.00083582423,0.0014626957,0.00020788074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004447058,0.00044149547,0.00073882274,0.0027892697,0.00016360723,0.00094984315,0.00041595387,0.0004933009,0.00196604],"category_scores_gemma":[0.009852335,0.00011577661,0.0011988893,0.0024097865,0.0001547191,0.00057461637,0.00039916535,0.00043814018,0.0006415604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006657854,0.0003584657,0.84607565,0.004091781,0.0033819855,0.0008561754,0.00018884249,0.0070324983,0.0053499658,0.00051354646,0.00825999,0.11723324],"study_design_scores_gemma":[0.0005046613,0.0020301547,0.93933856,0.0005174789,0.0023719908,0.0035421553,0.00028798656,0.013082767,0.009282027,0.0005208831,0.028421657,0.000099658086],"about_ca_topic_score_codex":0.0021355066,"about_ca_topic_score_gemma":0.0023353547,"teacher_disagreement_score":0.004447058,"about_ca_system_score_codex":0.0006002073,"about_ca_system_score_gemma":0.0009623019,"threshold_uncertainty_score":0.023518562},"labels":[],"label_agreement":null},{"id":"W4393147050","doi":"10.1007/s00210-024-03053-3","title":"Pharmacological articles in the German magazine DIE ZEIT (THE TIME)—content, adequacy, and comprehensibility","year":2024,"lang":"en","type":"article","venue":"Naunyn-Schmiedeberg s Archives of Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"DAK-Gesundheit; Bundesinstitut für Arzneimittel und Medizinprodukte","keywords":"German; Medical prescription; Population; Psychology; Criticism; Quarter (Canadian coin); Medicine; History; Pharmacology; Political science","score_opus":0.12118354572024731,"score_gpt":0.4335634332071601,"score_spread":0.3123798874869128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393147050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8963551,0.021974431,0.007394224,0.0094526755,0.0021636502,0.00070904364,0.00418259,0.0002382285,0.05753006],"genre_scores_gemma":[0.9759621,0.0068281433,0.005629913,0.0016921072,0.0017810544,0.0004782556,0.002807759,0.00017614689,0.004644415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97911316,0.008164832,0.0033957334,0.0009035784,0.007935488,0.00048718863],"domain_scores_gemma":[0.68352157,0.2463983,0.029473,0.0064586885,0.03213474,0.0020136817],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.022160543,0.0005425618,0.0006916509,0.01447556,0.0008648579,0.0072216885,0.0005269083,0.0006071236,0.004125316],"category_scores_gemma":[0.14821707,0.00040393218,0.0007701108,0.008138781,0.0020993685,0.0060186186,0.0023348571,0.00075103255,0.001073626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001689623,0.0003678874,0.27816185,0.011334184,0.0011757385,0.0019362109,0.108779185,0.001144896,0.0077700377,0.01498559,0.042550378,0.5301044],"study_design_scores_gemma":[0.00009575651,0.00060173695,0.6784873,0.007219115,0.0006980201,0.0024751315,0.063389115,0.0016738028,0.0027777557,0.009757175,0.23262867,0.00019652215],"about_ca_topic_score_codex":0.0010007399,"about_ca_topic_score_gemma":0.0009586812,"teacher_disagreement_score":0.9927783,"about_ca_system_score_codex":0.0014614739,"about_ca_system_score_gemma":0.0012116936,"threshold_uncertainty_score":0.11719757},"labels":[],"label_agreement":null},{"id":"W4393256977","doi":"10.1001/jamanetworkopen.2024.3339","title":"Same Old Challenges in Subgroup Analysis—Should We Do More About Methods Implementation?","year":2024,"lang":"en","type":"letter","venue":"JAMA Network Open","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Philosophy","score_opus":0.3234392910239665,"score_gpt":0.5678975247934196,"score_spread":0.24445823376945308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393256977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035325915,0.014658602,0.016854595,0.94445246,0.0218861,0.00030126216,0.0003182272,0.00019861289,0.0009768865],"genre_scores_gemma":[0.01843813,0.017927345,0.133045,0.74566805,0.078295685,0.0038701957,0.00049648347,0.00060874794,0.0016504026],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.38822243,0.51663476,0.041207112,0.012874271,0.03832485,0.0027366683],"domain_scores_gemma":[0.096642464,0.7809731,0.01538479,0.041004203,0.059440296,0.0065552276],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.65719706,0.00299259,0.0082843285,0.006637638,0.0038807732,0.014188143,0.011971336,0.0184901,0.011169348],"category_scores_gemma":[0.8344232,0.0023926222,0.010362958,0.006622714,0.01943057,0.029464446,0.008610503,0.048211757,0.0054443516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001528127,0.0002298281,0.006129302,0.0071093244,0.0047589443,0.00023595827,0.0028038702,0.0012069324,0.00024562833,0.06638637,0.5620055,0.34736025],"study_design_scores_gemma":[0.0036914446,0.0006369606,0.0047575957,0.028740551,0.0027689217,0.00061696436,0.002129254,0.0068811364,0.00059181656,0.55213827,0.39634767,0.00069942494],"about_ca_topic_score_codex":0.015890054,"about_ca_topic_score_gemma":0.019612307,"teacher_disagreement_score":0.34280294,"about_ca_system_score_codex":0.012508668,"about_ca_system_score_gemma":0.03242879,"threshold_uncertainty_score":0.42273712},"labels":[],"label_agreement":null},{"id":"W4393902689","doi":"10.1080/17425255.2024.2339397","title":"Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Drug; Coronavirus disease 2019 (COVID-19); Medicine; Adverse effect; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Intensive care medicine; Virology; Pharmacology; Disease; Infectious disease (medical specialty); Outbreak; Internal medicine","score_opus":0.15530939311221637,"score_gpt":0.5037821129737068,"score_spread":0.3484727198614904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393902689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001058265,0.9980829,0.00005975315,0.0001762787,0.000049523638,0.00015581009,0.00028695218,0.0000037281416,0.00012677397],"genre_scores_gemma":[0.022889026,0.9752239,0.00043731366,0.00063497,0.00009681643,0.00037173607,0.00026055166,0.0000036100782,0.000081989034],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920236,0.0024416528,0.0033880218,0.0005613226,0.0014006038,0.0001848521],"domain_scores_gemma":[0.96159583,0.02663216,0.0085222125,0.00047717837,0.0024728342,0.0002997243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007850558,0.0010755064,0.006405963,0.010136764,0.0004962355,0.0020680784,0.0012353978,0.0017179839,0.0027207045],"category_scores_gemma":[0.03150322,0.0007603267,0.007086319,0.009757404,0.0007611071,0.0020985263,0.0011382668,0.0010192663,0.00017251134],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018732804,0.00001291021,0.0016922444,0.96425104,0.0077799754,0.00010631572,0.00012300372,0.0000626651,0.00009540646,0.00010434701,0.0009148963,0.024669813],"study_design_scores_gemma":[0.000254184,0.00031289295,0.010846585,0.9006972,0.070847236,0.0008806592,0.00032680063,0.00010789322,0.00018633425,0.0002748361,0.015219411,0.000045903227],"about_ca_topic_score_codex":0.005730681,"about_ca_topic_score_gemma":0.014966664,"teacher_disagreement_score":0.010136764,"about_ca_system_score_codex":0.0026187967,"about_ca_system_score_gemma":0.007425606,"threshold_uncertainty_score":0.04151821},"labels":[],"label_agreement":null},{"id":"W4394759105","doi":"10.1111/bcp.16067","title":"Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events","year":2024,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Documentation; Confidence interval; Diagnosis code; Prospective cohort study; Logistic regression; Odds ratio; Cohort study; Retrospective cohort study; Emergency medicine; Medical emergency; Internal medicine; Computer science; Environmental health","score_opus":0.40802075031775503,"score_gpt":0.5825975541490244,"score_spread":0.17457680383126933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394759105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8914422,0.0041685984,0.012114653,0.0032138082,0.00043612023,0.001762987,0.0718785,0.00026439395,0.01471873],"genre_scores_gemma":[0.96921635,0.0009222286,0.009466781,0.0004278907,0.00006247145,0.00036690576,0.018869095,0.000033565942,0.0006347373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96292394,0.008027828,0.0064785434,0.0034697768,0.0169032,0.0021967604],"domain_scores_gemma":[0.7903109,0.035208985,0.06563892,0.016340893,0.08833719,0.004163053],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029562097,0.00069415563,0.0008806482,0.00935875,0.0020866473,0.0028808578,0.0034645165,0.0006519849,0.001382282],"category_scores_gemma":[0.17016572,0.000623736,0.0012243686,0.012128,0.0011072409,0.0009979806,0.002579043,0.0012053783,0.0003552723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000591879,0.000025978345,0.9887903,0.00020882799,0.00018641794,0.000036612983,0.00036206192,0.00031231996,0.00009714608,0.0002508427,0.0022391551,0.007431158],"study_design_scores_gemma":[0.000017098293,0.000028610126,0.99225414,0.00038158512,0.00009577231,0.000065894754,0.00038810578,0.0026610638,0.00041637532,0.00012214958,0.00353625,0.000032963544],"about_ca_topic_score_codex":0.8723246,"about_ca_topic_score_gemma":0.8775581,"teacher_disagreement_score":0.9704379,"about_ca_system_score_codex":0.014803631,"about_ca_system_score_gemma":0.0340735,"threshold_uncertainty_score":0.2568546},"labels":[],"label_agreement":null},{"id":"W4394781087","doi":"10.1093/rheumatology/keae223","title":"‘I couldn’t carry on taking a drug like that’: a qualitative study of patient perspectives on side effects from rheumatology drugs","year":2024,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Calgary; McGill University; University of Ottawa; Research Canada; McGill University Health Centre","funders":"Parker Institute for Cancer Immunotherapy; Odense Universitetshospital; Oak Foundation","keywords":"Rheumatology; Carry (investment); Drug; Side effect (computer science); Medicine; Internal medicine; Qualitative research; Pharmacology; Computer science; Business; Sociology","score_opus":0.06527854004778764,"score_gpt":0.44256499843949837,"score_spread":0.3772864583917107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394781087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769602,0.0020529074,0.003354098,0.009386382,0.00024561217,0.00047088394,0.0003322589,0.000032992106,0.007164716],"genre_scores_gemma":[0.9908091,0.0014020223,0.0014045363,0.0029134022,0.00006836519,0.0005357003,0.00011241692,0.000043300966,0.0027111385],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9700925,0.024821382,0.00066659675,0.00089301355,0.0012127744,0.0023137631],"domain_scores_gemma":[0.94662356,0.04355747,0.0023952338,0.00071023,0.0029152702,0.003798134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028410928,0.0010262384,0.0014241115,0.0018678539,0.011695049,0.0051669586,0.0024624832,0.003296885,0.0050614127],"category_scores_gemma":[0.03908695,0.0010954619,0.00092647487,0.001537994,0.012706923,0.0072968313,0.0068435282,0.006280991,0.0006662545],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003105688,0.000029800274,0.00075791887,0.00011594747,0.0000034562347,0.00036143407,0.9964567,0.000014980961,0.00026599327,0.000364066,0.00032918097,0.0012694512],"study_design_scores_gemma":[0.0000066115945,0.000047176847,0.00050316047,0.00015706147,0.0000036273009,0.0001605146,0.9952864,0.0000453112,0.00008926062,0.00018234746,0.0035073373,0.000011147745],"about_ca_topic_score_codex":0.009752015,"about_ca_topic_score_gemma":0.013246903,"teacher_disagreement_score":0.028410928,"about_ca_system_score_codex":0.0067635565,"about_ca_system_score_gemma":0.0066855703,"threshold_uncertainty_score":0.15025312},"labels":[],"label_agreement":null},{"id":"W4396644034","doi":"10.1007/s40264-024-01433-5","title":"Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of Ottawa","funders":"Charité – Universitätsmedizin Berlin; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Canagliflozin; Pharmacovigilance; Food and drug administration; Adverse Event Reporting System; Confidence interval; Odds ratio; Adverse effect; Pharmacology; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.1663956603836436,"score_gpt":0.4818408762950039,"score_spread":0.3154452159113603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396644034","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06928549,0.01469501,0.865369,0.002518212,0.0012822534,0.040775348,0.0027134463,0.0005342613,0.002827054],"genre_scores_gemma":[0.5248557,0.00086365006,0.4252893,0.00214005,0.00032169733,0.04467427,0.0010314224,0.00010750794,0.00071643974],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.25078773,0.6669356,0.038939368,0.019238254,0.022454167,0.0016448606],"domain_scores_gemma":[0.26262787,0.5980247,0.07085891,0.049150757,0.018256757,0.0010808739],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.47181404,0.0025006463,0.005097813,0.003568757,0.0016897676,0.003565542,0.0047154813,0.0043040076,0.00822369],"category_scores_gemma":[0.6015263,0.0017901805,0.024180995,0.0034259735,0.0046155467,0.0046108915,0.0052601956,0.0033371544,0.0006167176],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056828342,0.002366067,0.19596124,0.062240794,0.26055896,0.00089421443,0.008805584,0.028140323,0.0032914057,0.117549516,0.010830736,0.25253287],"study_design_scores_gemma":[0.044131335,0.03297623,0.1257655,0.023598215,0.20570135,0.0024652844,0.0023441561,0.24992189,0.011776952,0.24604072,0.05364027,0.0016381337],"about_ca_topic_score_codex":0.0026609267,"about_ca_topic_score_gemma":0.0011783359,"teacher_disagreement_score":0.52818596,"about_ca_system_score_codex":0.004332401,"about_ca_system_score_gemma":0.0057762554,"threshold_uncertainty_score":0.6513474},"labels":[],"label_agreement":null},{"id":"W4396696102","doi":"10.1007/s40264-024-01423-7","title":"The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":273,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Health Canada","funders":"","keywords":"Pharmacovigilance; Medicine; Context (archaeology); Transparency (behavior); Risk analysis (engineering); Drug; Pharmacology; Computer science; Computer security","score_opus":0.10175047514503634,"score_gpt":0.44984887507257826,"score_spread":0.34809839992754193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396696102","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011612496,0.0042453622,0.6897272,0.24652983,0.011959541,0.014853615,0.0041497382,0.0028063385,0.01411594],"genre_scores_gemma":[0.042259093,0.003837269,0.88126546,0.044676192,0.0039846664,0.015412694,0.0016479385,0.0004952437,0.0064215115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.68245524,0.16868961,0.10552587,0.0053873546,0.034184255,0.0037576633],"domain_scores_gemma":[0.38376775,0.38391292,0.07007633,0.03220544,0.12759297,0.0024446172],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22196938,0.0017045602,0.0013363272,0.006276231,0.0025756508,0.0057277204,0.0032571398,0.010903757,0.004765239],"category_scores_gemma":[0.4263327,0.0019047754,0.0035071864,0.0039343177,0.0066619227,0.006267885,0.008174248,0.012185715,0.0036948414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006319318,0.0003115512,0.012366775,0.013897838,0.00032937515,0.0016419115,0.026917346,0.0037633155,0.006446663,0.20816499,0.42458382,0.30094448],"study_design_scores_gemma":[0.0002842237,0.0005663055,0.008005102,0.022257864,0.00039704182,0.0024146207,0.00594017,0.008862535,0.011791334,0.099945515,0.8389948,0.0005405348],"about_ca_topic_score_codex":0.0034424493,"about_ca_topic_score_gemma":0.0036168601,"teacher_disagreement_score":0.77803063,"about_ca_system_score_codex":0.0046947524,"about_ca_system_score_gemma":0.016981775,"threshold_uncertainty_score":0.95945024},"labels":[],"label_agreement":null},{"id":"W4396696202","doi":"10.1007/s40264-024-01421-9","title":"The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Pharmacovigilance; Checklist; Medicine; Delphi method; Delphi; Guideline; Family medicine; Medical education; Adverse effect; Pharmacology; Psychology; Pathology; Computer science","score_opus":0.12570790955569228,"score_gpt":0.45566756990142127,"score_spread":0.329959660345729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396696202","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025242079,0.0136588365,0.5943993,0.15100667,0.010931949,0.16868693,0.007493154,0.004176485,0.024404781],"genre_scores_gemma":[0.040081006,0.005281365,0.84068245,0.01780856,0.0014882901,0.08860199,0.0035307186,0.00036711738,0.002158465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.27478543,0.38590193,0.25570253,0.01039042,0.0692384,0.0039813044],"domain_scores_gemma":[0.17305776,0.38733643,0.11445927,0.048953913,0.26792273,0.008269908],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.54007584,0.002896931,0.0030177354,0.016793204,0.004339348,0.009562389,0.009027674,0.009462869,0.0025682112],"category_scores_gemma":[0.6416456,0.0032348945,0.0074497727,0.0074059432,0.008608452,0.01025766,0.018080486,0.010669208,0.0033962347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006237132,0.00065525365,0.029877242,0.060941182,0.0014155362,0.0009750037,0.028936418,0.0035020874,0.0049429,0.04334473,0.27036685,0.5544192],"study_design_scores_gemma":[0.0013080289,0.0023301276,0.03633376,0.15174446,0.002104644,0.0035348223,0.02040289,0.014354159,0.014536808,0.046927884,0.70494777,0.0014745676],"about_ca_topic_score_codex":0.004293737,"about_ca_topic_score_gemma":0.005416347,"teacher_disagreement_score":0.45992416,"about_ca_system_score_codex":0.0105179595,"about_ca_system_score_gemma":0.07104538,"threshold_uncertainty_score":0.5671684},"labels":[],"label_agreement":null},{"id":"W4396859712","doi":"10.2196/58273","title":"Authors’ Response to Peer Reviews of “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”","year":2024,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Medicine; Food and drug administration; Thyroid; Internal medicine; Drug; Endocrinology; Oncology; Pharmacology","score_opus":0.05769170772249277,"score_gpt":0.4087170299065804,"score_spread":0.3510253221840876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396859712","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012793314,0.0026534223,0.0006421205,0.6526479,0.33229756,0.00026091884,0.0034435673,0.00033194674,0.0064431503],"genre_scores_gemma":[0.016430454,0.0036560544,0.0018482766,0.75432426,0.18090019,0.00075949327,0.0029505265,0.00046189295,0.038668834],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9681809,0.006522176,0.008933188,0.0022990038,0.0117041,0.002360597],"domain_scores_gemma":[0.7601489,0.04580226,0.021422805,0.005788076,0.15977885,0.0070591117],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018365147,0.00094926497,0.0022055567,0.0030637328,0.0030958948,0.005250863,0.0021023864,0.014521386,0.03727765],"category_scores_gemma":[0.20888539,0.001001128,0.0029922698,0.0019819734,0.0016201425,0.0018345881,0.002667595,0.008906155,0.02584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009182585,0.000013363404,0.00092629314,0.00031312968,0.000050438204,0.00024196072,0.00007458685,0.0000254196,0.000084068044,0.00019262168,0.99443984,0.0035464757],"study_design_scores_gemma":[0.00018961665,0.00004725521,0.0041412846,0.0013894504,0.000105666564,0.0005001406,0.0005003987,0.00025682035,0.0004569569,0.00048408718,0.99184614,0.00008223695],"about_ca_topic_score_codex":0.0067498568,"about_ca_topic_score_gemma":0.009193359,"teacher_disagreement_score":0.98163486,"about_ca_system_score_codex":0.0036618083,"about_ca_system_score_gemma":0.008073688,"threshold_uncertainty_score":0.12470615},"labels":[],"label_agreement":null},{"id":"W4396859718","doi":"10.2196/59120","title":"Peer Review for “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”","year":2024,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Medicine; Food and drug administration; Thyroid; Drug; Hyperplasia; Adverse drug reaction; Internal medicine; Endocrinology; Pharmacology","score_opus":0.05913804553202054,"score_gpt":0.4095084238094665,"score_spread":0.350370378277446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396859718","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06405382,0.019500358,0.019114645,0.31702584,0.32150644,0.016295258,0.048325185,0.0042707743,0.18990767],"genre_scores_gemma":[0.33083946,0.017239861,0.04155255,0.09973492,0.10294594,0.007831319,0.07544602,0.0033825687,0.32102728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98299485,0.003914601,0.0038152682,0.0013175856,0.006882983,0.0010748003],"domain_scores_gemma":[0.7974234,0.016299333,0.010009387,0.008252477,0.16224757,0.005767867],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014124931,0.00049712864,0.0010961405,0.003038976,0.0021251552,0.003198972,0.0021049068,0.0033259746,0.07102847],"category_scores_gemma":[0.12240711,0.00040251767,0.0018082967,0.0016818703,0.0010761828,0.001723024,0.0018098612,0.0014597073,0.028414806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023580648,0.000058105437,0.0074665025,0.001599622,0.00012610621,0.0008394754,0.0002111366,0.000050949377,0.00080308685,0.0008340885,0.9426779,0.04509718],"study_design_scores_gemma":[0.00047377453,0.00016057563,0.030165505,0.0028979268,0.00018418762,0.0015317961,0.00058178144,0.0008073731,0.001724169,0.001259749,0.96013594,0.000077292825],"about_ca_topic_score_codex":0.004205727,"about_ca_topic_score_gemma":0.0064066374,"teacher_disagreement_score":0.98587507,"about_ca_system_score_codex":0.0016043688,"about_ca_system_score_gemma":0.0075752796,"threshold_uncertainty_score":0.23761392},"labels":[],"label_agreement":null},{"id":"W4396973057","doi":"10.1016/b978-0-323-95488-4.00003-6","title":"Idiosyncratic Adverse Drug Reactions","year":2024,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Drug reaction; Drug; Pharmacology; Medicine","score_opus":0.06646884981848428,"score_gpt":0.3875642777007197,"score_spread":0.32109542788223544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396973057","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007419433,0.09472462,0.010004601,0.0037531336,0.002539478,0.00023647533,0.0008310618,0.0011229236,0.8793683],"genre_scores_gemma":[0.03307036,0.03222427,0.0039920015,0.0053892336,0.0015873945,0.00012240707,0.00090611615,0.00015649326,0.92255175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995172,0.000119497105,0.000046272387,0.000054949716,0.00021107434,0.00005110752],"domain_scores_gemma":[0.9994591,0.00017962196,0.00010323757,0.00007848045,0.00012340551,0.000056248038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004541042,0.00073563243,0.00045869075,0.0010021061,0.00033975203,0.0011132869,0.00041646493,0.0011610062,0.10004855],"category_scores_gemma":[0.0013973236,0.00018032368,0.00063738105,0.0006461728,0.0002539832,0.00044246097,0.00094080355,0.0010957615,0.059340723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067530804,0.00008259061,0.00084050576,0.0006102253,0.00003499248,0.003215091,0.00010012448,0.00012723434,0.0064284746,0.0046616727,0.15641958,0.827412],"study_design_scores_gemma":[0.000022952969,0.00015297682,0.001676259,0.0005509661,0.000027341652,0.014565391,0.000042897376,0.0001099748,0.0017605082,0.002036083,0.9790444,0.00001026393],"about_ca_topic_score_codex":0.0004651266,"about_ca_topic_score_gemma":0.0012083764,"teacher_disagreement_score":0.10004855,"about_ca_system_score_codex":0.0002482199,"about_ca_system_score_gemma":0.0003685826,"threshold_uncertainty_score":0.3346957},"labels":[],"label_agreement":null},{"id":"W4396988997","doi":"10.1016/j.pmedr.2024.102765","title":"A comparison of two user-friendly methods to identify and support correction of misspelled medications","year":2024,"lang":"en","type":"article","venue":"Preventive Medicine Reports","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Occupational Safety and Health; Centers for Disease Control and Prevention; Northwell Health; Stony Brook University; School of Medicine, New York University; York University","keywords":"User Friendly; Computer science; Information retrieval; Medicine; Data mining; Programming language","score_opus":0.13242387251891521,"score_gpt":0.5980590842196215,"score_spread":0.4656352117007063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396988997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.908234,0.0056288936,0.06934234,0.0008678275,0.0003221357,0.0012797301,0.001955842,0.0083417455,0.0040276297],"genre_scores_gemma":[0.807107,0.0011522279,0.18580294,0.00078989926,0.00028393717,0.0010320499,0.0016030073,0.00040239986,0.0018266109],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9683201,0.021085152,0.0030114371,0.002232386,0.004825381,0.0005255757],"domain_scores_gemma":[0.73734874,0.22581008,0.013244142,0.008932054,0.011918551,0.0027464204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022008725,0.0017497696,0.0014680093,0.0045453263,0.0004797758,0.0018524632,0.0019775878,0.0022174348,0.002313052],"category_scores_gemma":[0.1091082,0.00076875504,0.0011112706,0.0016825179,0.00064478617,0.001889956,0.002552437,0.00083144184,0.0010341086],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038838368,0.0019004734,0.104036406,0.0025056005,0.0022377274,0.00035022476,0.0021650959,0.004470794,0.009042703,0.00046859303,0.004181578,0.82980233],"study_design_scores_gemma":[0.0113522215,0.063154556,0.50110453,0.001868012,0.006400123,0.009203301,0.0045057465,0.28495488,0.08637864,0.0035934628,0.025550533,0.0019340054],"about_ca_topic_score_codex":0.0021938675,"about_ca_topic_score_gemma":0.0034914133,"teacher_disagreement_score":0.022008725,"about_ca_system_score_codex":0.0007661559,"about_ca_system_score_gemma":0.0014533879,"threshold_uncertainty_score":0.1163947},"labels":[],"label_agreement":null},{"id":"W4399025576","doi":"10.2196/49811","title":"Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study","year":2024,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Interoperability; Computer science; Algorithm; Medicine; Data mining; World Wide Web","score_opus":0.2454823131502186,"score_gpt":0.4783544490241053,"score_spread":0.2328721358738867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399025576","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5157365,0.00040973746,0.4683918,0.000576651,0.00014899949,0.0030370846,0.0026605914,0.005738173,0.003300464],"genre_scores_gemma":[0.5980208,0.00013948983,0.3947738,0.00026401464,0.00002203407,0.0013933381,0.004808711,0.00013346705,0.00044440423],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99336725,0.0028659585,0.0009652448,0.0010936452,0.0013968651,0.0003110666],"domain_scores_gemma":[0.9639407,0.023421727,0.0020105224,0.0036419332,0.0065385965,0.00044651053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015513506,0.001124849,0.0007728898,0.0019399049,0.0004332648,0.0017108106,0.0021677548,0.0014486181,0.0015139941],"category_scores_gemma":[0.06447482,0.00036253838,0.0011649467,0.0012852191,0.00047601335,0.0018245773,0.0013233904,0.0015201053,0.0004598237],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018689135,0.004073008,0.19244134,0.000490087,0.0006427899,0.00044797498,0.00035523612,0.33909926,0.007375789,0.005502456,0.0065541402,0.44114906],"study_design_scores_gemma":[0.00032733657,0.0005111289,0.010940791,0.00006717776,0.000069697235,0.0001858662,0.000087463115,0.9803883,0.004171054,0.0015593013,0.001671693,0.000020257594],"about_ca_topic_score_codex":0.007337438,"about_ca_topic_score_gemma":0.0041288435,"teacher_disagreement_score":0.015513506,"about_ca_system_score_codex":0.0014151684,"about_ca_system_score_gemma":0.003994342,"threshold_uncertainty_score":0.082044244},"labels":[],"label_agreement":null},{"id":"W4399191423","doi":"10.2196/59167","title":"The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review","year":2024,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. National Library of Medicine; National Institutes of Health","keywords":"Pharmacovigilance; Social media; Value (mathematics); Data science; Internet privacy; Medicine; Computer science; Adverse effect; World Wide Web; Pharmacology","score_opus":0.1209939208437684,"score_gpt":0.48781111219921464,"score_spread":0.3668171913554462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399191423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006912062,0.9938152,0.0010283366,0.0013516237,0.00048284282,0.0011775783,0.00042662062,0.000024230863,0.0010024186],"genre_scores_gemma":[0.008905587,0.98349947,0.0033755938,0.00086621306,0.0003368331,0.0024377187,0.00037003917,0.000015974589,0.00019262446],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9618491,0.014123513,0.014664627,0.0015608382,0.007323749,0.00047814718],"domain_scores_gemma":[0.6901716,0.25719127,0.026649654,0.0034872838,0.021650529,0.0008496235],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043213498,0.0020319982,0.0072905263,0.047926936,0.0015610958,0.0073017897,0.0032585862,0.0043431944,0.004165481],"category_scores_gemma":[0.22167976,0.0015377743,0.007525125,0.033397075,0.0023077158,0.0066659222,0.0036337555,0.0023325912,0.00076638296],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094549476,0.000028528782,0.00093293714,0.8506343,0.0032545894,0.00014160879,0.0005430913,0.000281768,0.00014877728,0.0011918447,0.0034453047,0.13930278],"study_design_scores_gemma":[0.000020853826,0.000049339193,0.00073331554,0.9741615,0.0071120607,0.00011023208,0.00024886688,0.00015878491,0.000110794776,0.0006419083,0.016631585,0.00002079191],"about_ca_topic_score_codex":0.008723853,"about_ca_topic_score_gemma":0.013925657,"teacher_disagreement_score":0.9567865,"about_ca_system_score_codex":0.006692014,"about_ca_system_score_gemma":0.026831916,"threshold_uncertainty_score":0.22853756},"labels":[],"label_agreement":null},{"id":"W4399423395","doi":"10.1016/s1569-1993(24)00563-0","title":"P262 Lack of association between antibiotic regimen spectrum and pulmonary exacerbation treatment responses","year":2024,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cystic fibrosis; Exacerbation; Regimen; Antibiotics; Internal medicine; Intensive care medicine; Microbiology","score_opus":0.10032523500774479,"score_gpt":0.42713027693157,"score_spread":0.3268050419238252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399423395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951889,0.0027140009,0.002371152,0.004029025,0.0004350467,0.00007871712,0.008727804,0.00013365278,0.029621573],"genre_scores_gemma":[0.9968587,0.000110691675,0.00020709986,0.000335608,0.00010242521,0.000012484646,0.00072186376,0.000016950822,0.0016341729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823016,0.00041066456,0.00022814458,0.00042896194,0.00046248277,0.00023965689],"domain_scores_gemma":[0.9882251,0.0061436812,0.0030227068,0.000707477,0.0010850107,0.00081606547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015357644,0.00027500498,0.00036035862,0.00040852244,0.00037012258,0.0008441444,0.00066182297,0.000677774,0.022263978],"category_scores_gemma":[0.012455007,0.00014021996,0.0013431164,0.0008126318,0.00029315727,0.00078007823,0.00040637545,0.0012239494,0.0020312867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001764343,0.00014032528,0.9748253,0.00016905264,0.0007035313,0.0011704089,0.000106821164,0.00024197664,0.0011344755,0.00025541845,0.0040076147,0.015480805],"study_design_scores_gemma":[0.000044341712,0.00047070492,0.9905404,0.000071976785,0.00028269878,0.0026915572,0.00017940659,0.00092956144,0.00038693403,0.00059968047,0.0037887385,0.000014056459],"about_ca_topic_score_codex":0.0025929345,"about_ca_topic_score_gemma":0.0025473528,"teacher_disagreement_score":0.022263978,"about_ca_system_score_codex":0.00028814565,"about_ca_system_score_gemma":0.0006237918,"threshold_uncertainty_score":0.074480414},"labels":[],"label_agreement":null},{"id":"W4400512354","doi":"10.2196/58176","title":"Crowdsourcing Adverse Events Associated With Monoclonal Antibodies Targeting Calcitonin Gene–Related Peptide Signaling for Migraine Prevention: Natural Language Processing Analysis of Social Media","year":2024,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Epilepsy Society; National Institute on Aging; National Institutes of Health; New Jersey Health Foundation","keywords":"Calcitonin gene-related peptide; Crowdsourcing; Preprint; Social media; Calcitonin; Monoclonal antibody; Migraine; Adverse Childhood Experiences; Neuropeptide; Antibody; Medicine; Immunology; Internal medicine; Computer science; World Wide Web; Receptor","score_opus":0.10173174258764184,"score_gpt":0.503558826296366,"score_spread":0.4018270837087241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400512354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983696,0.0005576929,0.0046898164,0.0008495064,0.00009923664,0.00034372983,0.0069699953,0.00017018279,0.002623868],"genre_scores_gemma":[0.9839559,0.00027621997,0.0069743507,0.00023831507,0.00018466491,0.0004420784,0.006893472,0.000022735336,0.0010122282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973726,0.0011884524,0.0003198255,0.00040380566,0.00057457964,0.00014070867],"domain_scores_gemma":[0.98469234,0.009563471,0.0033457188,0.0007038314,0.001363033,0.0003315764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024273528,0.0005459428,0.0003879679,0.0044617625,0.0005879096,0.0010357422,0.00037673124,0.0006395458,0.0008747618],"category_scores_gemma":[0.013398257,0.000109983695,0.000798988,0.0023284259,0.0004314643,0.0008605644,0.00118104,0.0005032128,0.000585418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019240528,0.0009803548,0.7049253,0.00207498,0.0007762087,0.0017475683,0.008733897,0.0055385884,0.022197895,0.001410656,0.015757728,0.23393275],"study_design_scores_gemma":[0.0000727119,0.00041987014,0.9105708,0.00018801345,0.00028040784,0.0007708131,0.0064012655,0.063123554,0.00435922,0.0024880136,0.011193585,0.0001318223],"about_ca_topic_score_codex":0.004940392,"about_ca_topic_score_gemma":0.0076614683,"teacher_disagreement_score":0.004940392,"about_ca_system_score_codex":0.00063992257,"about_ca_system_score_gemma":0.0005628365,"threshold_uncertainty_score":0.012837231},"labels":[],"label_agreement":null},{"id":"W4401051079","doi":"10.1007/s40267-024-01078-5","title":"Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso","year":2024,"lang":"en","type":"article","venue":"Drugs & Therapy Perspectives","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Likert scale; Pharmacovigilance; Patient safety; Wilcoxon signed-rank test; Pharmacy; Test (biology); Family medicine; Health care; Intervention (counseling); Adverse effect; Medical emergency; Nursing; Psychology; Mann–Whitney U test; Internal medicine","score_opus":0.12484005561364808,"score_gpt":0.4824319605931088,"score_spread":0.3575919049794607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401051079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941176,0.00029882157,0.00083610555,0.00061767525,0.0000166192,0.0027037738,0.0001752381,0.000025501675,0.0012086732],"genre_scores_gemma":[0.9892601,0.0008314026,0.005790453,0.0002899746,0.00002330279,0.0031482824,0.0001551832,0.0000067584233,0.00049449765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99043244,0.0072053834,0.00082554796,0.00027412016,0.0008184617,0.00044404354],"domain_scores_gemma":[0.9844893,0.007903433,0.003291907,0.0005106632,0.0029209382,0.0008836024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017804889,0.00042275002,0.00034375623,0.000852988,0.0009157555,0.0013911553,0.00056665204,0.0005539028,0.0012342329],"category_scores_gemma":[0.037301157,0.00031500863,0.0004444077,0.00059547427,0.0004819634,0.0011730783,0.0011309464,0.0004803364,0.00021530078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042710835,0.009999017,0.5576582,0.0030139699,0.00028626103,0.0018376219,0.04474555,0.0014912544,0.010031711,0.00044563788,0.0012854104,0.3649342],"study_design_scores_gemma":[0.0016738528,0.04736222,0.883845,0.002677701,0.00053508225,0.0014152147,0.036131978,0.004804295,0.0070937094,0.00035720028,0.013939823,0.00016403593],"about_ca_topic_score_codex":0.013632309,"about_ca_topic_score_gemma":0.019713243,"teacher_disagreement_score":0.017804889,"about_ca_system_score_codex":0.0020938404,"about_ca_system_score_gemma":0.0044625103,"threshold_uncertainty_score":0.094162405},"labels":[],"label_agreement":null},{"id":"W4401210037","doi":"10.1007/978-3-031-52838-5_1","title":"Introduction","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Political science","score_opus":0.1130018189301829,"score_gpt":0.4339063114400468,"score_spread":0.3209044925098639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401210037","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026691362,0.0018168896,0.004145664,0.0021530315,0.0035304795,0.0001270234,0.0014498257,0.0007954051,0.98571473],"genre_scores_gemma":[0.0006473682,0.00093945797,0.0012706598,0.00091017404,0.0003557411,0.00005192305,0.00096434576,0.00017915221,0.99468106],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994605,0.000057177396,0.000016752781,0.00010548032,0.000299675,0.000060326147],"domain_scores_gemma":[0.9993789,0.000094857256,0.000019755314,0.00008001688,0.00030595632,0.00012040481],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060121674,0.0008722001,0.00048516624,0.0014068218,0.0011710776,0.0036309734,0.0014353914,0.0016303274,0.60593563],"category_scores_gemma":[0.0019009644,0.00031373848,0.00049347256,0.0011744933,0.0004826468,0.002499651,0.0022972529,0.0017160256,0.53168654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017287708,0.00003162036,0.0000665253,0.000111740264,0.0000014924518,0.0000581816,0.000101134894,0.00011086699,0.00031091194,0.020804243,0.80139387,0.17699213],"study_design_scores_gemma":[0.0000015409009,0.0000049129058,0.000050045823,0.000058022786,6.6576825e-7,0.00003665295,0.000031864438,0.00002029799,0.000056765348,0.0025111628,0.99722606,0.0000019955235],"about_ca_topic_score_codex":0.002747847,"about_ca_topic_score_gemma":0.004984956,"teacher_disagreement_score":0.60593563,"about_ca_system_score_codex":0.0010644272,"about_ca_system_score_gemma":0.001770588,"threshold_uncertainty_score":0.562085},"labels":[],"label_agreement":null},{"id":"W4401336690","doi":"10.1007/978-3-031-51089-2_14","title":"Ethics in Pharmacovigilance","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario","funders":"","keywords":"Pharmacovigilance; Engineering ethics; Medicine; Pharmacology; Engineering; Drug","score_opus":0.25350010148877705,"score_gpt":0.5056269231723531,"score_spread":0.2521268216835761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401336690","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016343677,0.07136427,0.02974326,0.08919194,0.0038585358,0.00013315286,0.00007556746,0.00016157168,0.80383724],"genre_scores_gemma":[0.105332606,0.08802036,0.049291946,0.078033574,0.008355316,0.00056833855,0.00019994723,0.00040729335,0.66979057],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934743,0.0037035614,0.00020492515,0.00027309585,0.0021269163,0.0002171949],"domain_scores_gemma":[0.99361825,0.0049425927,0.00022813397,0.00025155742,0.0007649132,0.00019451907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005390038,0.00067168963,0.00038912205,0.000890903,0.0027754623,0.006168267,0.0008091619,0.0037011432,0.006418629],"category_scores_gemma":[0.008262813,0.00036843403,0.00041090162,0.0010089513,0.008373526,0.005287861,0.0028549114,0.006337555,0.00382505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054097595,0.000017026146,0.00008961378,0.00013876107,0.000004212836,0.0001231474,0.0023468859,0.00039564798,0.000090225454,0.8473838,0.108139366,0.04126595],"study_design_scores_gemma":[0.0000040575887,0.000008360378,0.00010424737,0.0005128953,0.0000031283205,0.00024431464,0.00039861025,0.0003080781,0.00009204387,0.34870845,0.6496064,0.000009396688],"about_ca_topic_score_codex":0.0022685942,"about_ca_topic_score_gemma":0.003127932,"teacher_disagreement_score":0.006418629,"about_ca_system_score_codex":0.0036674822,"about_ca_system_score_gemma":0.00679883,"threshold_uncertainty_score":0.028505564},"labels":[],"label_agreement":null},{"id":"W4401344133","doi":"10.1007/s40264-024-01452-2","title":"Correction to: Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes","year":2024,"lang":"en","type":"erratum","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Adverse drug event; Drug; Adverse drug reaction; Adverse effect; Event (particle physics); Family medicine; Pharmacology; Medical emergency; Medical education","score_opus":0.06417309933637827,"score_gpt":0.4498013955058561,"score_spread":0.38562829616947786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401344133","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017109909,0.00091761356,0.005287738,0.117192164,0.81757635,0.00033740446,0.04783305,0.0023925274,0.006752174],"genre_scores_gemma":[0.091706246,0.0074413028,0.054651268,0.21959306,0.19334273,0.0032112154,0.08256567,0.015645253,0.33184332],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96770155,0.0066711023,0.009700354,0.0031654404,0.011042568,0.0017190583],"domain_scores_gemma":[0.68705463,0.124861725,0.023410091,0.020969987,0.13858736,0.005116223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021691727,0.0026112613,0.0019141556,0.006733626,0.0032814124,0.0048166825,0.0038770516,0.0048777135,0.09088858],"category_scores_gemma":[0.34143844,0.0016873579,0.0022779189,0.00924561,0.0022580363,0.0027861798,0.0027460142,0.008557258,0.048541065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009453382,0.000020604033,0.00088278594,0.00039065888,0.00004517448,0.00018383765,0.000117415206,0.00010674872,0.000043680924,0.0007449136,0.9893607,0.00800889],"study_design_scores_gemma":[0.00031200214,0.000077927674,0.009126082,0.0029681192,0.00022840066,0.0009410021,0.000528635,0.0011393094,0.00093346235,0.003195222,0.9803617,0.00018813598],"about_ca_topic_score_codex":0.044833984,"about_ca_topic_score_gemma":0.0366305,"teacher_disagreement_score":0.09088858,"about_ca_system_score_codex":0.0070235454,"about_ca_system_score_gemma":0.013593437,"threshold_uncertainty_score":0.30405265},"labels":[],"label_agreement":null},{"id":"W4401373177","doi":"10.2196/45289","title":"Bidirectional Long Short-Term Memory–Based Detection of Adverse Drug Reaction Posts Using Korean Social Networking Services Data: Deep Learning Approaches","year":2024,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aceclofenac; Lexicon; Artificial intelligence; Computer science; Natural language processing; Deep learning; Word embedding; Adverse drug reaction; Drug; Medicine; Pharmacology","score_opus":0.14517736590797112,"score_gpt":0.4296036022075044,"score_spread":0.28442623629953323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401373177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8652863,0.0030633453,0.119082145,0.0013153733,0.00035536865,0.0002132642,0.0038100507,0.0026276652,0.004246456],"genre_scores_gemma":[0.9663341,0.0006530176,0.024482073,0.00027735202,0.00008867874,0.00009363368,0.004843607,0.00003867801,0.003188805],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996138,0.0000703532,0.000042166714,0.00011082403,0.000067447734,0.000095410454],"domain_scores_gemma":[0.99927086,0.00023071803,0.00011838871,0.00006873108,0.0002465111,0.000064802036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091858604,0.0012456434,0.00058631925,0.0014611698,0.00026382424,0.00051499734,0.00091454486,0.0008081033,0.0010146381],"category_scores_gemma":[0.0019051679,0.00023042191,0.0007386689,0.00087868643,0.00023633154,0.0010522436,0.00075781636,0.0010520222,0.0006776788],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011377598,0.0017197855,0.07676167,0.0003499986,0.0004634542,0.0006141893,0.0002568309,0.18777017,0.013425588,0.0011101408,0.015952988,0.70043737],"study_design_scores_gemma":[0.000011512636,0.00010902976,0.003565369,0.000016556962,0.00003917424,0.00003571266,0.000058233112,0.99265176,0.0025427784,0.0004772479,0.00047989434,0.000012794387],"about_ca_topic_score_codex":0.013744403,"about_ca_topic_score_gemma":0.015653646,"teacher_disagreement_score":0.013744403,"about_ca_system_score_codex":0.00058503903,"about_ca_system_score_gemma":0.00086050987,"threshold_uncertainty_score":0.027328849},"labels":[],"label_agreement":null},{"id":"W4401521828","doi":"10.1080/17512433.2024.2390927","title":"Drug related adverse event assessment in neonates in clinical trials and clinical care","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; KU Leuven","keywords":"Medicine; Polypharmacy; Adverse effect; Adverse drug event; Drug; Intensive care medicine; Clinical trial; Seriousness; Pharmacotherapy; Pharmacology; Internal medicine","score_opus":0.3954129327834758,"score_gpt":0.701691288093323,"score_spread":0.30627835530984726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401521828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014235689,0.99601364,0.0007871627,0.0014983029,0.00030376596,0.00011882741,0.00009206946,0.000022601744,0.0010213178],"genre_scores_gemma":[0.004691352,0.9885024,0.003272121,0.0018179839,0.000768365,0.00036556539,0.00017926385,0.00001218901,0.0003908886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9805484,0.011544682,0.0034704872,0.0008663947,0.0033603546,0.00020971154],"domain_scores_gemma":[0.9204634,0.05911823,0.012131069,0.0010432462,0.0063969237,0.0008471254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022541432,0.0010312889,0.003949693,0.0027215134,0.000271182,0.002532466,0.0017153984,0.0022185906,0.004791721],"category_scores_gemma":[0.049035553,0.0003825657,0.002346116,0.0028105231,0.00090279494,0.0018217405,0.0013154717,0.0030752996,0.0012140018],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003169443,0.000060143306,0.00070211256,0.10651701,0.0008476653,0.000121818724,0.00013317198,0.00040980958,0.00034711926,0.004068208,0.019583406,0.8668926],"study_design_scores_gemma":[0.0006084498,0.00087539764,0.007251919,0.3142208,0.0035787567,0.0024458882,0.0002729892,0.0009625022,0.0008595571,0.011911131,0.6568784,0.00013428064],"about_ca_topic_score_codex":0.0011700105,"about_ca_topic_score_gemma":0.0016899976,"teacher_disagreement_score":0.022541432,"about_ca_system_score_codex":0.0013828079,"about_ca_system_score_gemma":0.0054070614,"threshold_uncertainty_score":0.11921191},"labels":[],"label_agreement":null},{"id":"W4401715832","doi":"10.1080/14740338.2024.2393274","title":"Considerations for practical use of tree-based scan statistics for signal detection using electronic healthcare data: a case study with insulin glargine","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Insulin glargine; Health care; Detection theory; SIGNAL (programming language); Statistics; Tree (set theory); Health records; Data mining; Insulin; Computer science; Internal medicine; Detector; Mathematics; Telecommunications","score_opus":0.33295204115155824,"score_gpt":0.5283326762861714,"score_spread":0.19538063513461318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715832","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24653654,0.0052533164,0.6389736,0.08589464,0.0008130883,0.003143439,0.0014568608,0.0005624857,0.017365979],"genre_scores_gemma":[0.60774857,0.0019359598,0.38155323,0.004948392,0.00049465965,0.002225649,0.00027935187,0.00021439187,0.0005997747],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.77030927,0.19737235,0.0128983315,0.004146816,0.014082345,0.0011908512],"domain_scores_gemma":[0.24936868,0.7005961,0.019929184,0.013598824,0.01465348,0.0018536631],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20526056,0.0007840269,0.0014274293,0.0024574553,0.0011721032,0.0042438353,0.0030921544,0.0039847447,0.0056010922],"category_scores_gemma":[0.4442587,0.0005555509,0.0028949056,0.0033133468,0.0024127604,0.0050908816,0.0018935176,0.003547496,0.0006617211],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021397222,0.00074389426,0.54081184,0.0031442763,0.0012234013,0.032792706,0.011154865,0.014760528,0.0012752116,0.04543848,0.023844514,0.32267058],"study_design_scores_gemma":[0.0016287698,0.006874411,0.17313741,0.013457665,0.0022043013,0.12207636,0.023164144,0.25971282,0.00935985,0.27458745,0.11288113,0.0009157397],"about_ca_topic_score_codex":0.003811364,"about_ca_topic_score_gemma":0.005051124,"teacher_disagreement_score":0.20526056,"about_ca_system_score_codex":0.0019225734,"about_ca_system_score_gemma":0.005216668,"threshold_uncertainty_score":0.9800552},"labels":[],"label_agreement":null},{"id":"W4401990211","doi":"10.2196/63808","title":"Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Adverse effect; MEDLINE; Meta-analysis; Systematic review; Database; Traditional medicine; Pharmacology; Computer science; Internal medicine","score_opus":0.36529181290741464,"score_gpt":0.5415637811841908,"score_spread":0.17627196827677616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401990211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003941667,0.9912252,0.0017011622,0.00025279395,0.00011276914,0.0008160432,0.0016300582,0.0000432973,0.00027697047],"genre_scores_gemma":[0.14390309,0.83934134,0.008042574,0.00093439524,0.0002663714,0.0044332836,0.00276102,0.00004829741,0.00026972577],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9704662,0.012829286,0.010723738,0.0020913852,0.003442306,0.00044705853],"domain_scores_gemma":[0.9415146,0.04408789,0.009062058,0.0015016366,0.0035435567,0.0002902329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03128192,0.0033591844,0.019506563,0.01787724,0.00068384316,0.0041669407,0.00307526,0.0023314196,0.0037825815],"category_scores_gemma":[0.07466185,0.0017591513,0.048124034,0.017116409,0.00078513526,0.0027538575,0.0023796107,0.0018746905,0.0003103163],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000753884,0.000025228806,0.0050066765,0.49063498,0.48892352,0.00008433118,0.00008665008,0.00076854706,0.00010094102,0.00018004466,0.00052301586,0.012912136],"study_design_scores_gemma":[0.0003868488,0.0001273487,0.0032654242,0.049707536,0.94386333,0.00009793362,0.00005183033,0.00036945418,0.00011264267,0.00029204666,0.0016960178,0.000029554063],"about_ca_topic_score_codex":0.006746153,"about_ca_topic_score_gemma":0.0122414995,"teacher_disagreement_score":0.03128192,"about_ca_system_score_codex":0.0035351822,"about_ca_system_score_gemma":0.0064426456,"threshold_uncertainty_score":0.16543657},"labels":[],"label_agreement":null},{"id":"W4402289239","doi":"10.22541/au.172564025.59779955/v1","title":"Masking in Active Comparator Designs in Pharmacovigilance: A Retrospective Bias Analysis on the Spontaneous Reporting of Thiazolidinediones and Cardiovascular Events","year":2024,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pharmacovigilance; Masking (illustration); Comparator; Medicine; Computer science; Data mining; Pharmacology; Adverse effect; Engineering; Electrical engineering","score_opus":0.2747209092808273,"score_gpt":0.4643537230751263,"score_spread":0.18963281379429897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402289239","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35273382,0.009920903,0.62571436,0.0017106713,0.00042536153,0.0036060838,0.0028250823,0.0005030794,0.0025606533],"genre_scores_gemma":[0.90579426,0.00060705433,0.08956769,0.00063208904,0.000110676236,0.0013284042,0.001087464,0.000056075893,0.00081621466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6784539,0.2595636,0.025470842,0.017956004,0.016400766,0.0021548863],"domain_scores_gemma":[0.42765495,0.43003356,0.07689403,0.051348425,0.013134144,0.00093485403],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25725567,0.0013777826,0.0015665748,0.0018400258,0.0009266444,0.0021077923,0.0022888712,0.002289565,0.0030133834],"category_scores_gemma":[0.45016304,0.0011151275,0.012064693,0.0025616856,0.0020177201,0.0027029535,0.002774573,0.0019490819,0.00031384887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02348979,0.0006206212,0.6347784,0.006608,0.043112278,0.0011127682,0.0035031505,0.05902084,0.0039683767,0.051712044,0.004387198,0.1676865],"study_design_scores_gemma":[0.007086329,0.013439432,0.44706395,0.0043509407,0.07662104,0.0030252049,0.0012703064,0.31504065,0.022320263,0.07618918,0.03274769,0.0008450396],"about_ca_topic_score_codex":0.004324499,"about_ca_topic_score_gemma":0.002123336,"teacher_disagreement_score":0.7427443,"about_ca_system_score_codex":0.0015492212,"about_ca_system_score_gemma":0.003116516,"threshold_uncertainty_score":0.915936},"labels":[],"label_agreement":null},{"id":"W4402312095","doi":"10.5195/pom.2024.181","title":"Sins and Risks in Underreporting Suspected Adverse Drug Reactions","year":2024,"lang":"en","type":"article","venue":"Philosophy of Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Drug; Drug reaction; Adverse drug reaction; Medicine; Intensive care medicine; Risk analysis (engineering); Pharmacology","score_opus":0.22492283784225126,"score_gpt":0.48711750054329495,"score_spread":0.2621946627010437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402312095","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07700337,0.028912408,0.0908873,0.71420985,0.0021515016,0.00017834031,0.000105886065,0.0000787018,0.08647266],"genre_scores_gemma":[0.9301557,0.008476293,0.015094055,0.04230428,0.0023424875,0.00009682774,0.000034130448,0.000024484034,0.0014716334],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8698088,0.0998841,0.0058927517,0.0046478207,0.018153472,0.0016130619],"domain_scores_gemma":[0.6896963,0.24194027,0.036798656,0.011949753,0.017070528,0.0025444266],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11506608,0.0006584615,0.0008585169,0.0038335342,0.004132041,0.009719416,0.0017931295,0.009119615,0.0015900271],"category_scores_gemma":[0.20398557,0.00087467395,0.001106965,0.0015341486,0.062711135,0.01414041,0.009286846,0.012559441,0.00044266996],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015486739,0.000087179644,0.016028715,0.00044511788,0.00016217865,0.0010182477,0.023704091,0.0008308607,0.00035428762,0.9009849,0.0071603265,0.04906927],"study_design_scores_gemma":[0.000044656044,0.00008542998,0.003499075,0.0010306435,0.000067907255,0.0016602363,0.0040127635,0.0011958587,0.00043353948,0.9712362,0.01665734,0.00007627028],"about_ca_topic_score_codex":0.0018411645,"about_ca_topic_score_gemma":0.0015522726,"teacher_disagreement_score":0.88493395,"about_ca_system_score_codex":0.0057224412,"about_ca_system_score_gemma":0.0062682624,"threshold_uncertainty_score":0.6085349},"labels":[],"label_agreement":null},{"id":"W4402580291","doi":"10.1097/jcp.0000000000001919","title":"Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"MicroDose; Medicine; Acute illness; MEDLINE; Environmental health; Psychiatry; Political science; Internal medicine","score_opus":0.14292716224361682,"score_gpt":0.5793482602812636,"score_spread":0.43642109803764684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402580291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6773328,0.011888211,0.0023934753,0.054940484,0.0020658348,0.00062051095,0.13073891,0.0025874258,0.11743229],"genre_scores_gemma":[0.9220811,0.0062881447,0.0023270166,0.017173318,0.0015312891,0.00015784583,0.032688934,0.00012728806,0.017625056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993592,0.00007415932,0.0001608318,0.000077361874,0.00025505634,0.00007338249],"domain_scores_gemma":[0.99480975,0.000780411,0.0022459927,0.00011486783,0.0011769456,0.0008721155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003339629,0.00031955648,0.00027367,0.0015943486,0.00047847716,0.00086781976,0.0003840769,0.0009806583,0.015221394],"category_scores_gemma":[0.0039559635,0.0001811329,0.000388952,0.0014776854,0.0001403971,0.00064361194,0.0009647677,0.00097107264,0.0013716893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028177808,0.00018100304,0.74219996,0.00044231393,0.00017436931,0.00097543997,0.00024162121,0.00029695977,0.00068922783,0.0005501128,0.19404392,0.059923276],"study_design_scores_gemma":[0.000069635105,0.00010243676,0.9669557,0.00043393052,0.000118544835,0.0010760752,0.00073417445,0.0010524489,0.00027823803,0.00038055427,0.028776307,0.000022039581],"about_ca_topic_score_codex":0.032127216,"about_ca_topic_score_gemma":0.040605582,"teacher_disagreement_score":0.032127216,"about_ca_system_score_codex":0.000745815,"about_ca_system_score_gemma":0.0019233896,"threshold_uncertainty_score":0.063880384},"labels":[],"label_agreement":null},{"id":"W4402600759","doi":"10.1007/s40264-024-01477-7","title":"23rd ISoP Annual Meeting “Global Perspectives on Pharmacovigilance in the Digital Age and Advanced Therapeutics” 1–5 October 2024 Montreal, Canada","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacovigilance; Family medicine; Pediatrics; Pharmacology; Adverse effect","score_opus":0.03077976993105358,"score_gpt":0.3800600807335554,"score_spread":0.3492803108025018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402600759","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030212863,0.040799778,0.0038491103,0.42203742,0.23248497,0.0006946924,0.01388615,0.0009763203,0.28225031],"genre_scores_gemma":[0.013424842,0.01746853,0.0027174135,0.05531832,0.024892222,0.00019815394,0.0067943013,0.00045999466,0.87872624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684674,0.00038200573,0.000085531356,0.00025719102,0.0015860522,0.00084245205],"domain_scores_gemma":[0.99190617,0.00032067703,0.00026087573,0.00013723187,0.0043162084,0.0030589737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054390407,0.0016574591,0.00096264214,0.0015727773,0.0029019779,0.005943264,0.0019308783,0.0060154987,0.13413623],"category_scores_gemma":[0.004988883,0.00054119516,0.0012936612,0.00095166976,0.0014191876,0.0012964674,0.0028346854,0.0049978057,0.032696184],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058252637,0.000017541175,0.00039417547,0.000053844986,0.000009231631,0.00005182767,0.00001724347,0.0000644828,0.00014904,0.00046395816,0.9882477,0.010472724],"study_design_scores_gemma":[0.000022101745,0.00001747812,0.0036583182,0.00016640156,0.000010811575,0.000030168016,0.000066396264,0.00008442211,0.00009512422,0.00024233553,0.9955918,0.00001468331],"about_ca_topic_score_codex":0.53588176,"about_ca_topic_score_gemma":0.8243214,"teacher_disagreement_score":0.46411824,"about_ca_system_score_codex":0.013824731,"about_ca_system_score_gemma":0.037545037,"threshold_uncertainty_score":0.93370306},"labels":[],"label_agreement":null},{"id":"W4402648740","doi":"10.1111/bcp.16259","title":"Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist","year":2024,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Checklist; Guideline; Agency (philosophy); China; Pharmacovigilance; Medicine; Risk assessment; Family medicine; Geography; Adverse effect; Pharmacology; Psychology","score_opus":0.32823362732291556,"score_gpt":0.57173226079799,"score_spread":0.24349863347507444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402648740","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06274614,0.07155024,0.3121905,0.13125028,0.01169564,0.21030368,0.0794537,0.007423259,0.11338664],"genre_scores_gemma":[0.13027589,0.014918636,0.61788464,0.026432026,0.001072419,0.1750249,0.027891323,0.00077956374,0.0057206787],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.37578097,0.34525892,0.19366634,0.006472649,0.07558561,0.0032355809],"domain_scores_gemma":[0.2182234,0.44109014,0.10797442,0.032411892,0.1960737,0.0042265006],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.48416898,0.0017569687,0.0038955163,0.01053162,0.0019553795,0.009164321,0.007091451,0.006521594,0.006490993],"category_scores_gemma":[0.6295696,0.0018188156,0.011079823,0.008217769,0.0027849467,0.004761875,0.0064399727,0.0069620186,0.0020633002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069312355,0.0015035433,0.0208476,0.08355206,0.0066385963,0.00042086618,0.0053839544,0.005703692,0.002662969,0.047632765,0.31807843,0.50064427],"study_design_scores_gemma":[0.009949317,0.005158233,0.053054985,0.13228169,0.008869274,0.000820314,0.0035924823,0.006834382,0.008831604,0.022791993,0.7467603,0.0010554412],"about_ca_topic_score_codex":0.006004438,"about_ca_topic_score_gemma":0.007056922,"teacher_disagreement_score":0.515831,"about_ca_system_score_codex":0.009368693,"about_ca_system_score_gemma":0.041480586,"threshold_uncertainty_score":0.6361115},"labels":[],"label_agreement":null},{"id":"W4402676643","doi":"10.1016/j.jaad.2024.09.022","title":"Gastrointestinal adverse events associated with use of biologic therapies available for psoriasis: A systematic review of pharmacovigilance studies","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacovigilance; Psoriasis; Adverse effect; Dermatology; Intensive care medicine; MEDLINE; Pharmacology","score_opus":0.2809996016138696,"score_gpt":0.5092898253715773,"score_spread":0.2282902237577077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402676643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022734432,0.99710923,0.0000808284,0.00007203185,0.000029200773,0.000050994462,0.00029206526,0.0000048077472,0.00008747005],"genre_scores_gemma":[0.03277704,0.96572024,0.0005691294,0.0003876472,0.000054718,0.000078650824,0.00033449449,0.0000042159963,0.000073873],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99649733,0.0008006709,0.0015734325,0.00045799275,0.0005703175,0.000100308556],"domain_scores_gemma":[0.9857429,0.0089671705,0.0042942376,0.00018481935,0.00067141885,0.00013939168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003793324,0.0010136927,0.005535863,0.0052533415,0.00031903625,0.0013984918,0.0011109393,0.0012269486,0.0026510616],"category_scores_gemma":[0.01379824,0.00063484994,0.008967155,0.0059894663,0.00046452464,0.0010983156,0.0012544218,0.00090726995,0.00013016567],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094893307,0.00003965074,0.0069813468,0.8473012,0.07196451,0.00021872102,0.00015439882,0.00022447998,0.00044148596,0.00014531412,0.0015677351,0.070012175],"study_design_scores_gemma":[0.0013420768,0.0005909654,0.052280184,0.3568593,0.5616145,0.0016496206,0.00042793842,0.0002903422,0.0005027696,0.0005195231,0.023777785,0.00014495647],"about_ca_topic_score_codex":0.004392405,"about_ca_topic_score_gemma":0.015786465,"teacher_disagreement_score":0.005535863,"about_ca_system_score_codex":0.0010732358,"about_ca_system_score_gemma":0.0022252991,"threshold_uncertainty_score":0.020061255},"labels":[],"label_agreement":null},{"id":"W4402693150","doi":"10.1002/pds.70012","title":"Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study","year":2024,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Culprit; Adverse effect; Prospective cohort study; Emergency medicine; Cohort study; Emergency department; Cohort; Retrospective cohort study; Internal medicine; Intensive care medicine; Psychiatry","score_opus":0.044400479832799815,"score_gpt":0.428936258852645,"score_spread":0.3845357790198452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402693150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955031,0.0008310464,0.00016064357,0.00020813462,0.000019075942,0.00007188688,0.002382439,0.000008054692,0.00081568625],"genre_scores_gemma":[0.9972421,0.0005780349,0.0002319431,0.00011841999,0.000018177932,0.000023337165,0.0015926819,0.00000386307,0.00019154923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997872,0.00017498586,0.00019500728,0.00047486954,0.0007323867,0.0005507238],"domain_scores_gemma":[0.99342656,0.0005336143,0.0028440137,0.0005629899,0.0017531916,0.0008797393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002038361,0.0005174544,0.00066922867,0.0020730086,0.0020559565,0.0014586943,0.0016747684,0.0006329058,0.0018510418],"category_scores_gemma":[0.0077353586,0.0005119521,0.0011613462,0.0040563545,0.00061447633,0.0006878203,0.0010761213,0.0012342052,0.00018278616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065771994,0.000021527512,0.99813443,0.000019273282,0.0000895883,0.0000791332,0.000120221164,0.000028578757,0.000039097264,0.00002444937,0.00022597947,0.0011520815],"study_design_scores_gemma":[0.0000094002535,0.000028515893,0.9989619,0.000022568,0.000048506707,0.00016445108,0.00020939525,0.00018728175,0.000026630176,0.00001760943,0.00031328487,0.000010467147],"about_ca_topic_score_codex":0.88305235,"about_ca_topic_score_gemma":0.89779466,"teacher_disagreement_score":0.11694765,"about_ca_system_score_codex":0.008765857,"about_ca_system_score_gemma":0.01182135,"threshold_uncertainty_score":0.2352727},"labels":[],"label_agreement":null},{"id":"W4402899379","doi":"10.1007/s40264-024-01483-9","title":"Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Pharmacovigilance; Safeguarding; Engineering ethics; Pharmacology; Drug; Nursing","score_opus":0.08335957136492661,"score_gpt":0.45565188133373374,"score_spread":0.37229230996880713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402899379","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002714728,0.0074345786,0.006705651,0.9698629,0.0021448587,0.00003204074,0.000019986286,0.00004986529,0.011035398],"genre_scores_gemma":[0.2701685,0.023792984,0.0229164,0.65233785,0.024045462,0.00022398368,0.00007617144,0.00022507914,0.0062135924],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8900764,0.08068033,0.0050735865,0.0029613874,0.01768325,0.0035250883],"domain_scores_gemma":[0.6304953,0.24852583,0.01946016,0.015604118,0.034348037,0.05156653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09246118,0.0005193041,0.001420834,0.0013901852,0.0061075,0.016217366,0.003250104,0.017192002,0.0039352207],"category_scores_gemma":[0.21734093,0.00054309657,0.000795811,0.0012887961,0.018271368,0.010418003,0.009388416,0.04127199,0.0018279003],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022092665,0.00051371,0.012853644,0.00091938674,0.00024388716,0.0028113748,0.019110113,0.0010107782,0.0017190375,0.34897077,0.36352348,0.24810292],"study_design_scores_gemma":[0.00008932026,0.00021571742,0.004359894,0.0032284365,0.0000717562,0.0033122378,0.009950687,0.0016231916,0.0008879492,0.46998492,0.50612044,0.000155495],"about_ca_topic_score_codex":0.0040374487,"about_ca_topic_score_gemma":0.003933303,"teacher_disagreement_score":0.09246118,"about_ca_system_score_codex":0.005223509,"about_ca_system_score_gemma":0.041078802,"threshold_uncertainty_score":0.48898733},"labels":[],"label_agreement":null},{"id":"W4403561168","doi":"10.1016/j.jad.2024.10.062","title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®)","year":2024,"lang":"en","type":"article","venue":"Journal of Affective Disorders","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation","funders":"","keywords":"Pharmacovigilance; Pharmacology; Glucagon-like peptide-1; Database; Medicine; Diabetes mellitus; Drug; Endocrinology; Computer science; Type 2 diabetes","score_opus":0.06897160120424506,"score_gpt":0.46320418391174445,"score_spread":0.3942325827074994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403561168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909066,0.0012496705,0.0014053821,0.00011406328,0.000051721483,0.0012712053,0.004210312,0.000036697784,0.00075438595],"genre_scores_gemma":[0.99322236,0.00033353516,0.001473147,0.00010324174,0.000039858085,0.0009392879,0.0035460119,0.000020416584,0.00032220874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661773,0.0014626608,0.000638186,0.00070206687,0.00042708666,0.00015220288],"domain_scores_gemma":[0.9923028,0.0011990058,0.0026186549,0.002500168,0.0010755077,0.0003039395],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0071391542,0.00081076694,0.0006672493,0.0009161496,0.00049955194,0.000955644,0.00097614335,0.00065581105,0.001909875],"category_scores_gemma":[0.013314801,0.00047824372,0.002297842,0.001072626,0.0005127994,0.00053912314,0.00066799787,0.000926094,0.000676318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005295956,0.0009121286,0.96694326,0.0015001001,0.0054453146,0.0006442182,0.0011053889,0.00026668227,0.0020297088,0.00014817872,0.0020228112,0.013686256],"study_design_scores_gemma":[0.00177873,0.0034593288,0.98361915,0.00032763512,0.00428556,0.0012267753,0.00058601686,0.0007261835,0.0010056832,0.000184719,0.0027453161,0.00005490894],"about_ca_topic_score_codex":0.0047283308,"about_ca_topic_score_gemma":0.0038752493,"teacher_disagreement_score":0.99286085,"about_ca_system_score_codex":0.0005142284,"about_ca_system_score_gemma":0.0010532411,"threshold_uncertainty_score":0.037755966},"labels":[],"label_agreement":null},{"id":"W4403604786","doi":"10.1139/cjpp-2024-0128","title":"Cardiovascular adverse events associated with norepinephrine–dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacovigilance; Adverse effect; Atomoxetine; Palpitations; Adverse Event Reporting System; Modafinil; Bupropion; Methylphenidate; Internal medicine; Attention deficit hyperactivity disorder; Psychiatry","score_opus":0.048775488547432466,"score_gpt":0.35410282193679443,"score_spread":0.30532733338936197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922172,0.0030053835,0.000894835,0.00020623369,0.000019487556,0.000277728,0.0024046989,0.000025467807,0.00094884326],"genre_scores_gemma":[0.99617684,0.00052452064,0.00062621996,0.00023321054,0.000041731837,0.00014868022,0.0021237656,0.000010440652,0.00011453813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9848719,0.0052864705,0.0040485794,0.002078976,0.0031904993,0.0005234874],"domain_scores_gemma":[0.9459645,0.014832645,0.031822916,0.001655333,0.0048926985,0.00083193555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014691714,0.00043364658,0.00084243884,0.0024849419,0.00036789756,0.0012189031,0.0006079403,0.00073622575,0.0009078606],"category_scores_gemma":[0.027275309,0.00034291536,0.0023466607,0.003807526,0.00029132006,0.0010279714,0.0009991195,0.0008983505,0.00017802313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015589282,0.00014296063,0.98966765,0.00027028756,0.0023489634,0.0001419454,0.0001842194,0.00011275184,0.00044968692,0.0000801461,0.00035714076,0.004685392],"study_design_scores_gemma":[0.000194061,0.00076050655,0.99456984,0.00008061002,0.0020141467,0.0004512925,0.00015706923,0.00079563184,0.00029614818,0.0000394366,0.0006188237,0.000022423095],"about_ca_topic_score_codex":0.0050085494,"about_ca_topic_score_gemma":0.0045893765,"teacher_disagreement_score":0.014691714,"about_ca_system_score_codex":0.0012363242,"about_ca_system_score_gemma":0.0011013268,"threshold_uncertainty_score":0.07769811},"labels":[],"label_agreement":null},{"id":"W4403658439","doi":"10.1002/cpt.3457","title":"Collaborative Real‐World Evidence Among Regulators: Lessons and Perspectives","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Timeline; Public relations; Transparency (behavior); Preparedness; Working group; Outreach; Business; Global health; Repurposing; Observational study; Pandemic; Public health; Political science; Coronavirus disease 2019 (COVID-19); Medicine; Engineering; Nursing; Infectious disease (medical specialty); Geography","score_opus":0.5045551526292459,"score_gpt":0.6237966433062814,"score_spread":0.11924149067703549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403658439","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001856013,0.041616634,0.011505161,0.93021786,0.004120092,0.00017923542,0.00013409449,0.000077096716,0.010293818],"genre_scores_gemma":[0.2525361,0.08407547,0.07674308,0.5609504,0.018058894,0.0019408603,0.000458758,0.00036263934,0.0048738346],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.6195799,0.30702296,0.012763172,0.01664862,0.03142175,0.012563559],"domain_scores_gemma":[0.25916305,0.6262455,0.017246954,0.021839311,0.050018508,0.025486708],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.43407288,0.0018732846,0.0035534021,0.0075567015,0.009824729,0.05051281,0.011536499,0.03571226,0.009727006],"category_scores_gemma":[0.4466087,0.0019945863,0.0034072823,0.0066501345,0.028563384,0.055409826,0.032386065,0.03643242,0.001853969],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027342048,0.0006853227,0.0071769473,0.0063938005,0.0009211662,0.0025168792,0.020939318,0.0037023595,0.00036380294,0.52519447,0.20468847,0.22714405],"study_design_scores_gemma":[0.00029196372,0.0002866401,0.0015104888,0.012604188,0.00020225259,0.0008309332,0.02571674,0.0016872396,0.000436931,0.6332969,0.32292464,0.00021113397],"about_ca_topic_score_codex":0.007358097,"about_ca_topic_score_gemma":0.010791168,"teacher_disagreement_score":0.56592715,"about_ca_system_score_codex":0.020065026,"about_ca_system_score_gemma":0.09012982,"threshold_uncertainty_score":0.6978889},"labels":[],"label_agreement":null},{"id":"W4403748659","doi":"10.1080/20523211.2024.2417410","title":"Exploring the influencing factors of adverse drug reaction reporting among medical personnel: a COM-B model-based study","year":2024,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Policy and Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Pharmacovigilance; Psychological intervention; Pharmacy; Medicine; Adverse drug reaction; Drug reaction; Enthusiasm; Drug; Adverse effect; Pharmacology; Family medicine; Nursing; Psychology","score_opus":0.3506433808735234,"score_gpt":0.5312617533397372,"score_spread":0.18061837246621382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403748659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258775,0.00017383893,0.003250075,0.0007093598,0.000010354536,0.0005711772,0.000107693304,0.000010681034,0.0025790352],"genre_scores_gemma":[0.99419963,0.00019648482,0.0043302993,0.0001289694,0.0000059244053,0.00069532817,0.000114639624,0.0000040114023,0.00032471298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923781,0.0054966,0.00035925818,0.0004679088,0.00070118415,0.000596897],"domain_scores_gemma":[0.96505815,0.027167462,0.0037042766,0.00093709485,0.0020883812,0.0010446114],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0155748995,0.0007322158,0.00048255292,0.0024022805,0.0023899227,0.0034102486,0.00177924,0.0013582355,0.0036151044],"category_scores_gemma":[0.023249475,0.000600397,0.0015449271,0.0015936587,0.0017388046,0.0022506155,0.0031454735,0.0017048313,0.00034077177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022160565,0.0041727633,0.89001644,0.00082236505,0.0002266418,0.0004309869,0.06643223,0.0013500626,0.0003789456,0.004036493,0.0008385216,0.03107302],"study_design_scores_gemma":[0.00034053018,0.0031637244,0.6817616,0.0018410458,0.00053575495,0.0012004616,0.25841948,0.04003144,0.0007881647,0.0052053784,0.006598077,0.000114305825],"about_ca_topic_score_codex":0.017176015,"about_ca_topic_score_gemma":0.016582623,"teacher_disagreement_score":0.9986418,"about_ca_system_score_codex":0.005805229,"about_ca_system_score_gemma":0.009034549,"threshold_uncertainty_score":0.08236897},"labels":[],"label_agreement":null},{"id":"W4404296055","doi":"10.2196/60084","title":"Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project)","year":2024,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Wellcome Trust","keywords":"Preprint; Protocol (science); Digital health; Event (particle physics); Alternative medicine; Medicine; Medical education; Computer science; Health care; World Wide Web","score_opus":0.7818341891324926,"score_gpt":0.7425506274433157,"score_spread":0.039283561689176905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404296055","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011998806,0.000096272255,0.0050147763,0.00025205212,0.0001134412,0.99105364,0.0010032341,0.00008854193,0.0011781236],"genre_scores_gemma":[0.00046641316,0.000046402398,0.005958024,0.00009305778,0.000007455567,0.9931264,0.00008924495,0.00000475166,0.00020828465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.91562307,0.057808142,0.010398637,0.0045024958,0.0075120353,0.004155491],"domain_scores_gemma":[0.87247527,0.042206902,0.012564511,0.021744275,0.044432983,0.0065761167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13018508,0.0029062626,0.0034427599,0.0045860033,0.0068193087,0.0063780476,0.004201416,0.007821519,0.06800294],"category_scores_gemma":[0.13824038,0.0031106523,0.005308412,0.003670463,0.0047923825,0.00472287,0.0071652276,0.0068319873,0.016771685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04835553,0.029532542,0.007136637,0.13262047,0.0011635588,0.0015909447,0.03608307,0.0071892017,0.007406925,0.03306867,0.15880345,0.53704894],"study_design_scores_gemma":[0.09255396,0.03152269,0.016975155,0.0768531,0.0013456198,0.0005083639,0.02129749,0.005017094,0.013001474,0.026199963,0.71390104,0.000823949],"about_ca_topic_score_codex":0.003962293,"about_ca_topic_score_gemma":0.0075635705,"teacher_disagreement_score":0.13018508,"about_ca_system_score_codex":0.009194375,"about_ca_system_score_gemma":0.052652817,"threshold_uncertainty_score":0.6884928},"labels":[],"label_agreement":null},{"id":"W4404474075","doi":"10.1080/14740338.2024.2430306","title":"Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Medicine; Accidental; Population; Pharmacology; Glucagon-like peptide-1; Internal medicine; Endocrinology; Environmental health; Diabetes mellitus","score_opus":0.07159680861154213,"score_gpt":0.4388225693700137,"score_spread":0.3672257607584716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404474075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997959,0.0003326869,0.0002334075,0.00010684717,0.000012244161,0.000033463188,0.0005952652,0.00000698217,0.0007199234],"genre_scores_gemma":[0.99932814,0.0001490196,0.000087506574,0.000092969574,0.000014867827,0.000018767827,0.0002121137,0.0000027730953,0.000093816234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963644,0.001212796,0.00065651885,0.000805848,0.0006813545,0.0002792324],"domain_scores_gemma":[0.9904321,0.0015804666,0.005768063,0.0008555169,0.00085979956,0.00050420075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024075727,0.00035943085,0.00042297292,0.0014047286,0.0005843655,0.0011500057,0.0006900491,0.0009346495,0.0034953458],"category_scores_gemma":[0.009454903,0.0005570724,0.0011354111,0.0019829397,0.0006023978,0.0011629825,0.0009093232,0.00091897947,0.00050731876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060375638,0.000045841305,0.9987534,0.00002002943,0.00010535826,0.00006955466,0.000107905325,0.000013618484,0.000046441375,0.000012515904,0.00009624172,0.00066873484],"study_design_scores_gemma":[0.000012980224,0.00020860741,0.9981166,0.000022399023,0.00012132147,0.00065464625,0.00037987062,0.0001653904,0.00004986726,0.000026525073,0.00023298754,0.000008792345],"about_ca_topic_score_codex":0.0064453958,"about_ca_topic_score_gemma":0.004543469,"teacher_disagreement_score":0.0064453958,"about_ca_system_score_codex":0.0005224484,"about_ca_system_score_gemma":0.0006029259,"threshold_uncertainty_score":0.0128157735},"labels":[],"label_agreement":null},{"id":"W4404836841","doi":"10.1093/intqhc/mzae109","title":"Underreporting of adverse events to health authorities by healthcare professionals: a red flag-raising descriptive study","year":2024,"lang":"en","type":"article","venue":"International Journal for Quality in Health Care","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Trois-Rivières; Université de Montréal; Université Laval; Centre Hospitalier Universitaire Sainte-Justine; Innovation and Economic Development Trois Rivières; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Université du Québec à Trois-Rivières; Université Laval","keywords":"Context (archaeology); Adverse effect; Medicine; Flag (linear algebra); Incidence (geometry); Health professionals; Health care; Medical emergency; Descriptive research; Environmental health; Geography; Law; Political science; Statistics","score_opus":0.3118424992139299,"score_gpt":0.6308469359374587,"score_spread":0.31900443672352874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404836841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981042,0.00022830296,0.00020651828,0.000051649567,0.0000061896512,0.0001008949,0.0008967568,0.0000033632243,0.0004019951],"genre_scores_gemma":[0.9989298,0.00009662559,0.00013363319,0.000087127104,0.000012425046,0.00006539555,0.00057603297,0.0000022783706,0.0000968229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936593,0.0019772034,0.0012775889,0.0010054363,0.0013633118,0.00071714434],"domain_scores_gemma":[0.9727686,0.0065817228,0.014658727,0.0017134935,0.0031852638,0.0010921656],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005292114,0.00027620848,0.00047234853,0.0029224146,0.00073368085,0.0010473287,0.00092730107,0.0005674439,0.0017276568],"category_scores_gemma":[0.013334568,0.00042140053,0.0007897843,0.0032589997,0.00094444404,0.0010093272,0.0010846406,0.0005097171,0.00033595524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100011144,0.000035883695,0.9987954,0.000023038305,0.000022210977,0.00004434689,0.000255356,0.000008808769,0.000031558957,0.000012912538,0.00009214372,0.00057825545],"study_design_scores_gemma":[0.000014228388,0.00028743988,0.9974287,0.000030803563,0.00003935503,0.0003140271,0.0013475075,0.00013071037,0.000078168865,0.000016091402,0.00030351998,0.00000937342],"about_ca_topic_score_codex":0.02534516,"about_ca_topic_score_gemma":0.028362267,"teacher_disagreement_score":0.9947079,"about_ca_system_score_codex":0.0023428202,"about_ca_system_score_gemma":0.0021749402,"threshold_uncertainty_score":0.05039525},"labels":[],"label_agreement":null},{"id":"W4404922694","doi":"10.1139/cjpp-2024-0078","title":"Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Adverse Event Reporting System; Medicine; Jaccard index; MEDLINE; Adverse effect; Information retrieval; Computer science; Database; Internal medicine; Artificial intelligence; Cluster analysis","score_opus":0.06996894958974106,"score_gpt":0.41051598750061535,"score_spread":0.34054703791087426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404922694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7904114,0.023224585,0.043729857,0.0014500371,0.00052272226,0.0038132917,0.12900017,0.0016337641,0.006214082],"genre_scores_gemma":[0.6532176,0.0056360248,0.120418064,0.00066220603,0.00034894745,0.004019742,0.2131572,0.00031696243,0.0022232186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9472039,0.009345459,0.020423897,0.00482135,0.017042913,0.0011624612],"domain_scores_gemma":[0.6693197,0.21241085,0.049170908,0.021950943,0.045033876,0.0021136922],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0411437,0.0007989027,0.0022320228,0.047517013,0.0017191112,0.0033131265,0.0021825233,0.0015981139,0.0021944144],"category_scores_gemma":[0.18811452,0.00047523985,0.0018573542,0.042766105,0.0010060794,0.001825426,0.0027647272,0.00090101047,0.000981307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004486494,0.0009693027,0.55245703,0.030148927,0.0035037387,0.013444615,0.006317698,0.0062211957,0.015242323,0.008676092,0.029315505,0.32921714],"study_design_scores_gemma":[0.0009283912,0.0016102364,0.66510975,0.0059314705,0.008490651,0.016390815,0.006598117,0.045597516,0.05076767,0.013873687,0.184133,0.0005687251],"about_ca_topic_score_codex":0.0043202983,"about_ca_topic_score_gemma":0.0038140644,"teacher_disagreement_score":0.9984019,"about_ca_system_score_codex":0.0017975706,"about_ca_system_score_gemma":0.0062714447,"threshold_uncertainty_score":0.21759129},"labels":[],"label_agreement":null},{"id":"W4405035341","doi":"10.1182/blood-2024-206590","title":"Serious Adverse Drug Reactions (sADRs) Involving Hematology and Resulting in Black Box Warnings or FDA Non-Approval: Results from the First Quarter Century of RADAR/Sonar","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Hematology; Drug approval; Adverse effect; Drug; Internal medicine; Pharmacology; History","score_opus":0.03813034272224414,"score_gpt":0.34989285379049095,"score_spread":0.3117625110682468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035341","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2715341,0.68419033,0.0054411134,0.006143315,0.0006308498,0.0007192081,0.002515589,0.00018810664,0.02863738],"genre_scores_gemma":[0.7717126,0.21016048,0.005316309,0.007816261,0.00087781996,0.00022801087,0.0024696742,0.000060174323,0.0013585882],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9824033,0.008645651,0.0031717215,0.001161275,0.0042304443,0.00038759512],"domain_scores_gemma":[0.8515991,0.09013599,0.03839175,0.0039428603,0.0145590715,0.0013712284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017206075,0.0004566821,0.0006893017,0.0020920557,0.000338993,0.0016758123,0.00035154884,0.00095929933,0.0020950113],"category_scores_gemma":[0.038348906,0.00015957652,0.0015685465,0.002055432,0.00081358716,0.001112441,0.0007697638,0.0011329725,0.00050719694],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040856237,0.00034546878,0.19923823,0.016540008,0.0018219176,0.003273179,0.0014094916,0.0007508845,0.002846733,0.0020269377,0.015186935,0.7524746],"study_design_scores_gemma":[0.0010646563,0.010770362,0.46471208,0.027312418,0.009386382,0.07208395,0.004165461,0.001778021,0.033796832,0.005432495,0.36916736,0.00032990577],"about_ca_topic_score_codex":0.0005021871,"about_ca_topic_score_gemma":0.0009354295,"teacher_disagreement_score":0.017206075,"about_ca_system_score_codex":0.0010604747,"about_ca_system_score_gemma":0.0011501772,"threshold_uncertainty_score":0.09099549},"labels":[],"label_agreement":null},{"id":"W4405509487","doi":"10.1007/s40264-024-01507-4","title":"Advances in Drug Safety: Highlights from the 23rd Annual Meeting of the International Society of Pharmacovigilance","year":2024,"lang":"en","type":"editorial","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Health Canada; BC Children's Hospital; Magna International (Canada)","funders":"","keywords":"Medicine; Pharmacovigilance; Drug; Pharmacology","score_opus":0.0228139303988318,"score_gpt":0.3798366206024882,"score_spread":0.3570226902036564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405509487","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002240037,0.015427026,0.0001150834,0.032741275,0.950836,0.000016263904,0.00005408484,0.00004685226,0.000741079],"genre_scores_gemma":[0.00018519878,0.007830527,0.000105420186,0.018730834,0.9705885,0.000016613933,0.000038794235,0.000023681987,0.0024804906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98964345,0.0016181741,0.0013581634,0.0010299542,0.0057543586,0.00059592293],"domain_scores_gemma":[0.9588841,0.01441507,0.0035888809,0.0006834407,0.016585063,0.0058433786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013944678,0.0063435873,0.007182548,0.0060008503,0.0033065793,0.01280329,0.0055227582,0.024317425,0.010800105],"category_scores_gemma":[0.03195005,0.0018519263,0.0052949106,0.0032992614,0.0025264218,0.0061399597,0.0028086412,0.02660506,0.00949984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005350033,0.000016524074,0.000029026467,0.00031497612,0.00003947908,0.000071370145,0.0000073693313,0.000023549968,0.000043910615,0.00010700775,0.9945147,0.0047785915],"study_design_scores_gemma":[0.00029037395,0.00007772799,0.0007299116,0.0016671299,0.0002828821,0.0003939304,0.000056257584,0.00036954085,0.00014169225,0.0010921571,0.9948488,0.000049621205],"about_ca_topic_score_codex":0.0037120252,"about_ca_topic_score_gemma":0.011829937,"teacher_disagreement_score":0.024317425,"about_ca_system_score_codex":0.0048898584,"about_ca_system_score_gemma":0.006372948,"threshold_uncertainty_score":0.07374734},"labels":[],"label_agreement":null},{"id":"W4405638294","doi":"10.2196/53424","title":"Application of a Language Model Tool for COVID-19 Vaccine Adverse Event Monitoring Using Web and Social Media Content: Algorithm Development and Validation Study","year":2024,"lang":"en","type":"article","venue":"JMIR Infodemiology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Social media; Pharmacovigilance; Computer science; MedDRA; Context (archaeology); World Wide Web; Medicine; Adverse effect","score_opus":0.21913468940712208,"score_gpt":0.503030671452772,"score_spread":0.2838959820456499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405638294","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27689388,0.0012578595,0.6931397,0.0009085347,0.00022204612,0.0014608328,0.003433342,0.020261375,0.0024224704],"genre_scores_gemma":[0.47316962,0.00043486955,0.5165931,0.00028722623,0.000048644564,0.0015630041,0.006114584,0.0003229655,0.0014659083],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99732155,0.0012600009,0.0003012405,0.00061134866,0.0003729795,0.00013288077],"domain_scores_gemma":[0.9838913,0.013256918,0.00046794073,0.0005444342,0.0016932909,0.00014609814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061005335,0.0015736439,0.00083012023,0.0030046343,0.00063999457,0.0017467636,0.00145346,0.001841473,0.0027390486],"category_scores_gemma":[0.019953689,0.00045721047,0.0015918707,0.0013597906,0.00035910582,0.0018285904,0.0012026248,0.0019162347,0.0013995711],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010995239,0.0020768624,0.042056695,0.00070575275,0.0009604872,0.0007145427,0.0004280746,0.2691133,0.008274308,0.0033202998,0.012130954,0.6591192],"study_design_scores_gemma":[0.000054846718,0.000092116235,0.0013397537,0.00002199482,0.00004870391,0.00007916409,0.00006795381,0.9955005,0.0014425167,0.0006547565,0.00068781717,0.000009781611],"about_ca_topic_score_codex":0.012824649,"about_ca_topic_score_gemma":0.010319252,"teacher_disagreement_score":0.012824649,"about_ca_system_score_codex":0.0013578184,"about_ca_system_score_gemma":0.0021063345,"threshold_uncertainty_score":0.0322631},"labels":[],"label_agreement":null},{"id":"W4406041641","doi":"10.3389/fphar.2024.1529260","title":"Drug-induced Parkinson-like events: a real-world study from 2004 to the first quarter of 2024 based on FAERS","year":2025,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Southwest Medical University","keywords":"Quarter (Canadian coin); Medicine; Geography","score_opus":0.039555239479536417,"score_gpt":0.40121528205974843,"score_spread":0.361660042580212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406041641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97586685,0.0034858256,0.00027164057,0.00031076188,0.000027727978,0.00010748342,0.01876514,0.000026054235,0.0011385869],"genre_scores_gemma":[0.98937106,0.0011135913,0.00028289683,0.00021216403,0.00003691467,0.000087205146,0.008672612,0.000007630286,0.00021595508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770457,0.00048881135,0.00060118624,0.0005219669,0.00045028617,0.00023316713],"domain_scores_gemma":[0.98947877,0.0010242236,0.0075019286,0.0003505274,0.0011235226,0.0005209709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018337885,0.00035776172,0.0005996804,0.0033407074,0.00047020032,0.0011323532,0.00056552974,0.0005802286,0.0016487153],"category_scores_gemma":[0.0049750223,0.00029048524,0.001133481,0.004094287,0.00027307158,0.0010007904,0.0009618056,0.00067065214,0.00041137193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015400986,0.000029622615,0.99701476,0.000102548765,0.00013125947,0.00015775127,0.00010501468,0.00004284517,0.000071717885,0.000019833135,0.00060622377,0.0015642204],"study_design_scores_gemma":[0.000009410812,0.000060500894,0.9981717,0.000046710597,0.000086921274,0.00043324966,0.00029858042,0.00016177281,0.000046199653,0.000014478606,0.0006638779,0.0000066416214],"about_ca_topic_score_codex":0.019747408,"about_ca_topic_score_gemma":0.016164092,"teacher_disagreement_score":0.019747408,"about_ca_system_score_codex":0.0012891686,"about_ca_system_score_gemma":0.0010059836,"threshold_uncertainty_score":0.039264917},"labels":[],"label_agreement":null},{"id":"W4406091862","doi":"10.2196/preprints.70167","title":"Developing a SNOMED CT-based value set to document symptoms and diagnoses for adverse drug events (Preprint)","year":2024,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SNOMED CT; Preprint; Medical diagnosis; Medicine; Value (mathematics); Adverse effect; Drug; Medical physics; Computer science; Data science; World Wide Web; Internal medicine; Radiology; Pharmacology; Terminology; Machine learning; Linguistics","score_opus":0.0993774890593277,"score_gpt":0.46328558802218484,"score_spread":0.36390809896285714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406091862","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1625853,0.004593689,0.5876284,0.0067779147,0.00088380056,0.0091123255,0.18125279,0.011393608,0.03577213],"genre_scores_gemma":[0.12365377,0.0011517542,0.75792617,0.0010769471,0.000082558654,0.0023080655,0.11098001,0.00057330437,0.0022474562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923766,0.0021543794,0.0024453027,0.0008654163,0.0019576566,0.00020075444],"domain_scores_gemma":[0.9699093,0.014396286,0.0029101658,0.002716886,0.009478312,0.0005889147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008503544,0.0012016685,0.00069652,0.017723702,0.0011915427,0.003676114,0.0015421449,0.0011210701,0.0044247233],"category_scores_gemma":[0.043394454,0.0005203794,0.0017860084,0.008339374,0.0009869382,0.0034838498,0.0032940095,0.001131379,0.0018984536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008926848,0.0005312671,0.112939134,0.010335267,0.00068855594,0.0040455293,0.009694457,0.016574968,0.026310135,0.043595348,0.13280706,0.64158547],"study_design_scores_gemma":[0.00035564124,0.00064508885,0.10525941,0.012772024,0.0012263,0.0074099167,0.009586699,0.10154186,0.057229213,0.055992045,0.64731926,0.00066248],"about_ca_topic_score_codex":0.0213901,"about_ca_topic_score_gemma":0.03395725,"teacher_disagreement_score":0.0213901,"about_ca_system_score_codex":0.0031126917,"about_ca_system_score_gemma":0.011284503,"threshold_uncertainty_score":0.044971585},"labels":[],"label_agreement":null},{"id":"W4406389311","doi":"10.1002/pds.70102","title":"Masking in Active Comparator Designs in Pharmacovigilance: A Retrospective Bias Analysis on the Spontaneous Reporting of Thiazolidinediones and Cardiovascular Events","year":2025,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa","funders":"","keywords":"Medicine; Pharmacovigilance; Masking (illustration); Pharmacoepidemiology; Pharmacology; Medical prescription; Adverse effect","score_opus":0.18142305255447275,"score_gpt":0.45845024712067745,"score_spread":0.2770271945662047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406389311","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39928102,0.010040958,0.58131295,0.0016870777,0.00035345467,0.0029853017,0.002052402,0.00039751577,0.0018893392],"genre_scores_gemma":[0.92422885,0.00057375635,0.07236289,0.0004332353,0.000094863615,0.0010512073,0.00077042787,0.000034306573,0.00045048332],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.70371336,0.24377961,0.023021167,0.013907291,0.0142043475,0.0013742034],"domain_scores_gemma":[0.40091202,0.44929764,0.09574558,0.042508427,0.0106518855,0.0008843698],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24885073,0.0012150592,0.0014306777,0.0016532652,0.0008194653,0.001960952,0.002218032,0.001900616,0.0023819017],"category_scores_gemma":[0.43183005,0.00094084616,0.010000296,0.002155531,0.0019973638,0.0021618425,0.0022186202,0.0014829314,0.00022123723],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016733358,0.00050783774,0.70955443,0.00557417,0.03631604,0.0007851287,0.002240918,0.05891236,0.002583041,0.031216929,0.0024386,0.13313715],"study_design_scores_gemma":[0.0064329566,0.012148607,0.48783162,0.0041498635,0.057723906,0.0025516304,0.00086848513,0.3206476,0.017663449,0.06980401,0.01946228,0.000715547],"about_ca_topic_score_codex":0.004162155,"about_ca_topic_score_gemma":0.0018652395,"teacher_disagreement_score":0.7511493,"about_ca_system_score_codex":0.0016309648,"about_ca_system_score_gemma":0.003156238,"threshold_uncertainty_score":0.92630076},"labels":[],"label_agreement":null},{"id":"W4406466351","doi":"10.1016/s1553-3212(05)71190-0","title":"10.1016/s1553-3212(05)71190-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Antibiotics; Medicine; Microbiology; Biology","score_opus":0.04906786786812072,"score_gpt":0.34971370448728245,"score_spread":0.3006458366191617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406466351","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036112286,0.00031713807,0.0005260142,0.00039478202,0.00023629116,0.00009776569,0.00066553935,0.00083803065,0.99656326],"genre_scores_gemma":[0.00053609547,0.00014941795,0.00033943725,0.00027527593,0.00006820123,0.000052439824,0.00037973752,0.00013879033,0.9980605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926907,0.000059296824,0.000066474684,0.00022863285,0.00021751066,0.00015898464],"domain_scores_gemma":[0.99702877,0.0007490201,0.00018210469,0.00030652882,0.00058660965,0.0011469803],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012309835,0.0022008806,0.001463643,0.0026827175,0.002042794,0.0033512723,0.0027816657,0.005918872,0.9893527],"category_scores_gemma":[0.0022755102,0.0007792989,0.0014497215,0.0020898688,0.0013382082,0.004465587,0.0034978045,0.0023054169,0.992305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033697375,0.00024844328,0.0009086312,0.0004107485,0.000025967533,0.00022699592,0.000078472534,0.0003913733,0.0012556361,0.0035990016,0.3817272,0.6107906],"study_design_scores_gemma":[0.00006449859,0.00010682932,0.00085235626,0.00027997626,0.0000121123385,0.0003192201,0.00007980647,0.00021098314,0.00027071248,0.00054378633,0.9972377,0.000022041355],"about_ca_topic_score_codex":0.0049224356,"about_ca_topic_score_gemma":0.00418367,"teacher_disagreement_score":0.010647297,"about_ca_system_score_codex":0.0011422264,"about_ca_system_score_gemma":0.0013361406,"threshold_uncertainty_score":0.015186965},"labels":[],"label_agreement":null},{"id":"W4406489663","doi":"10.1111/bcp.16393","title":"Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance","year":2025,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Real world evidence; Medicine; Pharmacology; Risk analysis (engineering); Drug; Internal medicine","score_opus":0.3045487664533782,"score_gpt":0.647155421517782,"score_spread":0.34260665506440385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406489663","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008210289,0.24292181,0.55287147,0.09005393,0.0074385344,0.037277967,0.013230834,0.0022645327,0.045730665],"genre_scores_gemma":[0.16778243,0.056610152,0.6968993,0.02823499,0.006408599,0.03396663,0.0076369885,0.00093081704,0.0015301093],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.3177126,0.5951869,0.049024448,0.007878435,0.028662626,0.0015350771],"domain_scores_gemma":[0.12091628,0.79234266,0.030614503,0.023224965,0.030419469,0.00248211],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5957208,0.0049021454,0.013350669,0.015841257,0.0017218825,0.028240668,0.010324921,0.01126829,0.028741641],"category_scores_gemma":[0.7790916,0.0027774982,0.015852435,0.011442639,0.0046711154,0.01644651,0.013208091,0.011602708,0.0054256697],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008636491,0.0008777003,0.010035918,0.0742773,0.03205592,0.00061779254,0.0014745002,0.02723447,0.0008273196,0.14482,0.06868269,0.63045985],"study_design_scores_gemma":[0.009497067,0.003292519,0.008749685,0.1959257,0.034192365,0.00078115106,0.0010628853,0.03914589,0.0033538416,0.41405028,0.28931904,0.00062957866],"about_ca_topic_score_codex":0.0024367059,"about_ca_topic_score_gemma":0.001998402,"teacher_disagreement_score":0.40427917,"about_ca_system_score_codex":0.009647948,"about_ca_system_score_gemma":0.034737565,"threshold_uncertainty_score":0.49854827},"labels":[],"label_agreement":null},{"id":"W4406544882","doi":"10.1016/s1553-3212(11)70194-7","title":"10.1016/s1553-3212(11)70194-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Apixaban; Warfarin; Medicine; Internal medicine; Atrial fibrillation; Rivaroxaban","score_opus":0.047793719597372664,"score_gpt":0.34901048351336433,"score_spread":0.30121676391599167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406544882","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039607356,0.00042663317,0.00049691,0.0004193602,0.0002638133,0.00010526826,0.0008902554,0.00087565364,0.996126],"genre_scores_gemma":[0.0005831563,0.0002013824,0.00035948222,0.0003402956,0.000085823,0.00006647134,0.00048451073,0.0001445464,0.9977343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992318,0.000056529912,0.00007729516,0.00024654405,0.00022065105,0.00016724264],"domain_scores_gemma":[0.9972119,0.0007727034,0.00020548337,0.0002789158,0.00048243697,0.0010486145],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012925749,0.00277318,0.0018151955,0.0029773745,0.0022951236,0.0034855404,0.0032956365,0.006907534,0.9893037],"category_scores_gemma":[0.0022768767,0.0009400276,0.0016517957,0.002270284,0.0016383639,0.0051976973,0.004052948,0.0026378518,0.99284583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042124957,0.00028180867,0.00092280196,0.0005406336,0.00003278016,0.00029820783,0.00008431501,0.0004930404,0.0014092716,0.0035895293,0.38433257,0.60759383],"study_design_scores_gemma":[0.000095966105,0.00014423252,0.0009386973,0.00038957916,0.000015828346,0.0004315906,0.00008952125,0.00023934247,0.0003343007,0.0006921477,0.9965983,0.000030459842],"about_ca_topic_score_codex":0.004406129,"about_ca_topic_score_gemma":0.004033819,"teacher_disagreement_score":0.010696292,"about_ca_system_score_codex":0.0012351843,"about_ca_system_score_gemma":0.0013262685,"threshold_uncertainty_score":0.015256882},"labels":[],"label_agreement":null},{"id":"W4406554688","doi":"10.1016/s1634-6939(20)30129-0","title":"10.1016/s1634-6939(20)30129-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.04765947722815688,"score_gpt":0.3495944420258986,"score_spread":0.30193496479774173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554688","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003874144,0.0003188074,0.00050573074,0.00037874232,0.00028481887,0.0000988309,0.00064503547,0.0007784914,0.9966022],"genre_scores_gemma":[0.00053452415,0.00016093651,0.00038961536,0.0002855666,0.00008989352,0.000055225042,0.00041412507,0.00015230189,0.99791783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928635,0.00005211353,0.00006633019,0.00021749556,0.000219529,0.00015821749],"domain_scores_gemma":[0.9971866,0.0006771619,0.00015497264,0.00028728595,0.00053412025,0.0011598583],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001123573,0.0022803186,0.0014353764,0.00294849,0.0020052276,0.002949853,0.0027911656,0.0057361964,0.9896355],"category_scores_gemma":[0.0022657681,0.0008112955,0.0015450058,0.0021198047,0.0013322725,0.0043393113,0.0037455736,0.0023254093,0.9916108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034932236,0.0002789235,0.00091252767,0.00043167835,0.000027655013,0.00024885882,0.00007471598,0.00035164287,0.0012735795,0.0033184863,0.37523207,0.6175005],"study_design_scores_gemma":[0.000073179675,0.000117610834,0.0009418083,0.0002809896,0.000012516653,0.00038382554,0.00007447287,0.00019768691,0.00028592176,0.0005550054,0.9970535,0.000023392306],"about_ca_topic_score_codex":0.004392972,"about_ca_topic_score_gemma":0.0038177948,"teacher_disagreement_score":0.010364473,"about_ca_system_score_codex":0.0010265607,"about_ca_system_score_gemma":0.0012328676,"threshold_uncertainty_score":0.01478368},"labels":[],"label_agreement":null},{"id":"W4406652554","doi":"10.1016/b978-0-7020-7605-3.00017-3","title":"10.1016/b978-0-7020-7605-3.00017-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Traditional medicine; Business; Medicine","score_opus":0.060017802342544765,"score_gpt":0.3329234890717606,"score_spread":0.27290568672921584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406652554","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018471791,0.0005525964,0.0010473084,0.00035796108,0.00018789091,0.000052543728,0.00070649886,0.0009866802,0.99592376],"genre_scores_gemma":[0.00041833884,0.00026867134,0.00040911362,0.00013482434,0.000038743518,0.00003190367,0.0003999295,0.0002082427,0.9980901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999491,0.000029004015,0.000033781766,0.00017822336,0.00017693611,0.00009101699],"domain_scores_gemma":[0.99808973,0.00063736277,0.00013211899,0.00024746222,0.00032458664,0.00056877563],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000992748,0.0022101116,0.0015089967,0.0019502967,0.0012566868,0.004440915,0.002925552,0.0043496555,0.9836314],"category_scores_gemma":[0.0017827529,0.00080787146,0.0010408553,0.0019127021,0.0011654989,0.0043185144,0.0033250896,0.0023038841,0.9917828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015384688,0.00013323546,0.00032571494,0.000374689,0.000016246173,0.00011809255,0.00007126345,0.00033221798,0.001968365,0.005093222,0.32305515,0.6683579],"study_design_scores_gemma":[0.000022484806,0.00004908722,0.00045165885,0.00026961358,0.0000076108477,0.0002215745,0.00006386142,0.00012739762,0.00028454556,0.001152292,0.99733657,0.000013350346],"about_ca_topic_score_codex":0.003071323,"about_ca_topic_score_gemma":0.0027073119,"teacher_disagreement_score":0.016368628,"about_ca_system_score_codex":0.0008956792,"about_ca_system_score_gemma":0.00083024515,"threshold_uncertainty_score":0.023347795},"labels":[],"label_agreement":null},{"id":"W4407256171","doi":"10.1097/upj.0000000000000790","title":"Disproportionality Analysis of Hypotension-Related Adverse Drug Reactions Associated With Type 1a Selective Alpha-Blockers in VigiBase","year":2025,"lang":"en","type":"article","venue":"Urology Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Odds ratio; Internal medicine; Confidence interval; Subgroup analysis; Adverse effect; Tamsulosin; Hyperplasia","score_opus":0.04306604844138279,"score_gpt":0.42689962625961897,"score_spread":0.3838335778182362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407256171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720401,0.014589119,0.0037792786,0.00023666467,0.000050356775,0.00026942385,0.007459865,0.00005874908,0.0015164135],"genre_scores_gemma":[0.9949227,0.0011955455,0.0010723871,0.000061879684,0.00006409848,0.00011120501,0.0024310728,0.000012679262,0.00012862294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9774874,0.009583565,0.005554122,0.0032500976,0.00332465,0.0008001971],"domain_scores_gemma":[0.9246187,0.033552047,0.034194265,0.0034022604,0.003292804,0.00093986327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017943105,0.0004369873,0.0015029681,0.011440963,0.00037695884,0.0014653291,0.00071156316,0.00042248188,0.002627212],"category_scores_gemma":[0.050818987,0.00040969922,0.005995568,0.005821342,0.0003808943,0.00073773885,0.0021932328,0.000540677,0.00027176438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011216744,0.000017985813,0.98630446,0.0005669087,0.0030878868,0.00015288946,0.000104483326,0.00026388327,0.00023364698,0.000089754794,0.00024158615,0.007814786],"study_design_scores_gemma":[0.0000619775,0.00032259698,0.9920048,0.00021094276,0.0035607186,0.00088100147,0.00017986847,0.0013964123,0.0002724647,0.00021055846,0.0008766964,0.00002194285],"about_ca_topic_score_codex":0.0027912916,"about_ca_topic_score_gemma":0.0020298306,"teacher_disagreement_score":0.017943105,"about_ca_system_score_codex":0.0006707391,"about_ca_system_score_gemma":0.0007193146,"threshold_uncertainty_score":0.09489334},"labels":[],"label_agreement":null},{"id":"W4407876427","doi":"10.4103/ijcm.ijcm_42_24","title":"A Qualitative Study to Assess Challenges Faced During AEFI Surveillance","year":2025,"lang":"en","type":"article","venue":"Indian Journal of Community Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Qualitative research; Environmental health; Medicine; Sociology; Social science","score_opus":0.3634182212575396,"score_gpt":0.5769689135385385,"score_spread":0.21355069228099893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407876427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637523,0.0012250122,0.0100788865,0.0064,0.0002358887,0.0018952311,0.0008544069,0.000062569175,0.015495697],"genre_scores_gemma":[0.9845339,0.0011638378,0.0055245752,0.0018624595,0.00003740634,0.0016505851,0.00022987262,0.000037058013,0.0049602464],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.986764,0.009926478,0.00038872648,0.0006216273,0.0008349663,0.0014641228],"domain_scores_gemma":[0.9768936,0.015907506,0.0016614143,0.0004962025,0.0029840828,0.0020571495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015266182,0.0005729058,0.0009859354,0.0018669474,0.008598235,0.0041960767,0.0019451671,0.0021563014,0.0049375943],"category_scores_gemma":[0.022204543,0.00064183195,0.0005797217,0.0021876644,0.0065532224,0.005025099,0.0044533554,0.0028134047,0.0006874773],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038338498,0.000099107725,0.0040965034,0.0005026294,0.0000051775287,0.0008236607,0.9858212,0.00006371704,0.00071212655,0.0019260609,0.0012511573,0.0046602474],"study_design_scores_gemma":[0.0000051901175,0.00006537604,0.0010019954,0.00025163678,0.0000027367323,0.00018601323,0.9899103,0.0001352644,0.00015419157,0.0004671166,0.007809318,0.000010872652],"about_ca_topic_score_codex":0.0064371633,"about_ca_topic_score_gemma":0.009152672,"teacher_disagreement_score":0.015266182,"about_ca_system_score_codex":0.006071088,"about_ca_system_score_gemma":0.006580666,"threshold_uncertainty_score":0.08073622},"labels":[],"label_agreement":null},{"id":"W4408121070","doi":"10.63105/pam7","title":"Ezetimiba en Canadá: riesgos de reacciones adversas graves","year":2025,"lang":"es","type":"article","venue":"Panorama actual del medicamento","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.03732062851139806,"score_gpt":0.4145231578262409,"score_spread":0.3772025293148428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408121070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70677835,0.20624198,0.001110054,0.024282765,0.00030770147,0.00021255207,0.020402852,0.00017210725,0.040491637],"genre_scores_gemma":[0.9509007,0.040378656,0.0006043951,0.0021660514,0.00012142975,0.000023915154,0.0023355247,0.00001863509,0.0034507618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989588,0.00010230638,0.000068023604,0.00011682864,0.0005792059,0.00017476846],"domain_scores_gemma":[0.9975038,0.0003110317,0.0008895088,0.000058166836,0.0008173154,0.0004202732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080154574,0.00027775543,0.00044097626,0.0012424754,0.00091080036,0.0012741601,0.00038431442,0.0006479161,0.004963354],"category_scores_gemma":[0.0037823727,0.0001908956,0.00056884746,0.0030001255,0.0005514115,0.0002912462,0.0004966361,0.0014752531,0.00032135687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016369732,0.00014028566,0.8435555,0.0012280835,0.00070576963,0.0007933335,0.00037256128,0.00054139586,0.0007052502,0.0019805187,0.022724597,0.12561573],"study_design_scores_gemma":[0.00019831938,0.00019005153,0.9631281,0.001093548,0.00084838434,0.0015538976,0.0005744075,0.0013633198,0.00048752312,0.00082653016,0.029683542,0.000052385032],"about_ca_topic_score_codex":0.92400074,"about_ca_topic_score_gemma":0.92154366,"teacher_disagreement_score":0.07599926,"about_ca_system_score_codex":0.009342698,"about_ca_system_score_gemma":0.018479632,"threshold_uncertainty_score":0.1528936},"labels":[],"label_agreement":null},{"id":"W4408132489","doi":"10.22541/au.174107914.47596846/v1","title":"Mapping Levothyroxine related Adverse Events: A Disproportionality Analysis of FAERS Individual Case Safety Reports","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Levothyroxine; Medicine; Safety profile; Internal medicine; Thyroid","score_opus":0.11202227250228088,"score_gpt":0.4535615356568489,"score_spread":0.34153926315456806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408132489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777144,0.0018774654,0.010484872,0.00024003063,0.00003406151,0.0011384954,0.0062357998,0.000116694115,0.0021582094],"genre_scores_gemma":[0.9895047,0.00028159207,0.0055784616,0.00008286422,0.000037251863,0.00070962,0.003508699,0.000023976494,0.00027286826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9314448,0.028729552,0.016271645,0.00811007,0.013904597,0.0015392908],"domain_scores_gemma":[0.7849597,0.1091286,0.07780451,0.013403307,0.013556975,0.0011470327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041720327,0.0005977739,0.0011101972,0.013919,0.0005611187,0.0013756322,0.0009334823,0.0005277953,0.0028953655],"category_scores_gemma":[0.14815961,0.0003157426,0.0030093975,0.0058200806,0.0006630878,0.0016355468,0.0035707993,0.0005936176,0.00040272067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014156969,0.00007937607,0.96398365,0.00048485515,0.0019435536,0.0003219272,0.0004524412,0.0010415858,0.00081779103,0.00033416552,0.00074374414,0.028381221],"study_design_scores_gemma":[0.000106676576,0.0009404129,0.9796255,0.0002483666,0.0014408207,0.0020072649,0.0009990396,0.008582117,0.002013903,0.0007206031,0.0032563948,0.000058772],"about_ca_topic_score_codex":0.002030335,"about_ca_topic_score_gemma":0.0016273004,"teacher_disagreement_score":0.041720327,"about_ca_system_score_codex":0.0012345304,"about_ca_system_score_gemma":0.0008802938,"threshold_uncertainty_score":0.22064084},"labels":[],"label_agreement":null},{"id":"W4408557574","doi":"10.3390/antibiotics14030314","title":"ICD-10 Codes to Identify Adverse Drug Events Associated with Antibiotics in Administrative Data","year":2025,"lang":"en","type":"article","venue":"Antibiotics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia; BC Centre for Disease Control","funders":"","keywords":"Medicine; Antibiotics; Medical prescription; Diagnosis code; Intensive care medicine; Confidence interval; Emergency medicine; Adverse effect; Medical emergency; Internal medicine; Pharmacology","score_opus":0.14557156501129803,"score_gpt":0.5046524223868452,"score_spread":0.3590808573755471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408557574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5309338,0.0032368933,0.22655314,0.0021980999,0.0008333206,0.017216604,0.19396411,0.001843549,0.023220455],"genre_scores_gemma":[0.64591587,0.0010905626,0.26225817,0.0007172744,0.00023522072,0.008693152,0.07931268,0.00013390438,0.001643137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98091036,0.0063638375,0.007420681,0.0010128225,0.003592151,0.0007000712],"domain_scores_gemma":[0.93811136,0.025232062,0.022362523,0.0051333075,0.0083163185,0.00084440236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012083382,0.00072680187,0.0008589473,0.009802475,0.0005267431,0.00095376343,0.0012230881,0.0005363168,0.00223749],"category_scores_gemma":[0.0419316,0.00032575338,0.0014007859,0.008266405,0.0005190411,0.0005884248,0.0016371773,0.0012171356,0.0006162587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040739944,0.00035573257,0.92511714,0.0012350996,0.000526099,0.00039706624,0.0009897527,0.002646178,0.00165279,0.002503667,0.013272374,0.0508967],"study_design_scores_gemma":[0.00011894927,0.00025333284,0.96873635,0.00057707826,0.00015302985,0.00081733026,0.0006906686,0.007917218,0.0020602476,0.002673783,0.015924877,0.00007702283],"about_ca_topic_score_codex":0.010798566,"about_ca_topic_score_gemma":0.017855292,"teacher_disagreement_score":0.012083382,"about_ca_system_score_codex":0.0014825552,"about_ca_system_score_gemma":0.003028307,"threshold_uncertainty_score":0.06390381},"labels":[],"label_agreement":null},{"id":"W4408636582","doi":"10.3389/fphar.2025.1555838","title":"The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases","year":2025,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Adverse Event Reporting System; Azacitidine; Pharmacovigilance; Medicine; Adverse effect; MedDRA; Internal medicine; Odds ratio; Oncology; Database; DNA methylation; Biology","score_opus":0.05802066954977816,"score_gpt":0.4406272190561785,"score_spread":0.3826065495064004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408636582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464683,0.006078022,0.0023979465,0.00043458547,0.000024042412,0.0005596555,0.042598218,0.00011681872,0.0013224109],"genre_scores_gemma":[0.9497627,0.0015266462,0.003049893,0.00025303676,0.000048998154,0.00048463023,0.04471754,0.000026171529,0.00013041202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9850867,0.004930492,0.0043776194,0.0026136655,0.002625616,0.0003659597],"domain_scores_gemma":[0.959906,0.0137110865,0.019783469,0.0030346964,0.002886074,0.0006787023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010433392,0.0005294732,0.0013192758,0.0045597767,0.00033340493,0.0017224794,0.00095078297,0.0008767491,0.0014479368],"category_scores_gemma":[0.027428836,0.0003098864,0.0027752037,0.0070322366,0.00035749766,0.0010128745,0.0012667979,0.0007582147,0.00027414004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025999902,0.00018719054,0.97535974,0.0012521911,0.0030123692,0.00043324637,0.0003138468,0.0011259044,0.0004719462,0.0002462839,0.001989798,0.013007504],"study_design_scores_gemma":[0.00040885425,0.00039795245,0.9842964,0.00028666743,0.002744355,0.0010976032,0.00035231726,0.006022425,0.0007005934,0.00022254218,0.003410737,0.00005949381],"about_ca_topic_score_codex":0.008120924,"about_ca_topic_score_gemma":0.0051634572,"teacher_disagreement_score":0.010433392,"about_ca_system_score_codex":0.0013665551,"about_ca_system_score_gemma":0.0018801391,"threshold_uncertainty_score":0.05517769},"labels":[],"label_agreement":null},{"id":"W4408715845","doi":"10.2196/65789","title":"Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study","year":2025,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Incidence (geometry); Adverse effect; Prospective cohort study; Cohort study; Internal medicine; Emergency medicine; Intensive care medicine","score_opus":0.7050401002711952,"score_gpt":0.7161580155389612,"score_spread":0.011117915267765954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408715845","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010675406,0.0004395612,0.0037085486,0.00020826387,0.00012236337,0.9788614,0.0041955886,0.00006876293,0.0017201599],"genre_scores_gemma":[0.009287689,0.00033054064,0.0052688806,0.00019479611,0.000048688766,0.98222995,0.002317227,0.0000080277305,0.00031426104],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9742062,0.014675686,0.0060556494,0.0018727423,0.002023123,0.0011665531],"domain_scores_gemma":[0.9750352,0.003593493,0.0067664194,0.0036663678,0.008965473,0.0019730984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040780794,0.0028251088,0.004063855,0.0033469384,0.003115386,0.0022633711,0.0025552816,0.0027169073,0.014949045],"category_scores_gemma":[0.02351885,0.0014752005,0.003511785,0.0040342687,0.0018336402,0.0028132792,0.0017490716,0.0026985777,0.004493106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30661097,0.0569416,0.18558094,0.06921197,0.005273284,0.0045559504,0.007555907,0.014056305,0.015031769,0.018220378,0.12635164,0.19060929],"study_design_scores_gemma":[0.16935016,0.10808125,0.32675683,0.021021323,0.0035502156,0.002349225,0.0072676595,0.013967173,0.008287096,0.007029074,0.3311969,0.001143063],"about_ca_topic_score_codex":0.0019124518,"about_ca_topic_score_gemma":0.0032446324,"teacher_disagreement_score":0.040780794,"about_ca_system_score_codex":0.0040099276,"about_ca_system_score_gemma":0.018228352,"threshold_uncertainty_score":0.21567208},"labels":[],"label_agreement":null},{"id":"W4408891920","doi":"10.2196/70167","title":"Developing a SNOMED CT–Based Value Set to Document Symptoms and Diagnoses for Adverse Drug Events: Mixed Methods Study","year":2025,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health; Vancouver General Hospital; University of British Columbia; Surrey Memorial Hospital; University of Alberta; University of Victoria; Spinal Cord Injury BC","funders":"","keywords":"SNOMED CT; Medicine; Medical diagnosis; Preprint; Medical physics; Adverse effect; Computer science; Natural language processing; Radiology; Internal medicine; World Wide Web; Terminology","score_opus":0.07117496262961376,"score_gpt":0.5243557526538586,"score_spread":0.45318079002424483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408891920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6730978,0.02144427,0.24430454,0.0015694582,0.00032432124,0.040000312,0.011421073,0.0006214758,0.0072167017],"genre_scores_gemma":[0.5786996,0.0031953352,0.37438315,0.0015599314,0.00015401652,0.033978842,0.0064665503,0.0002545491,0.0013079526],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.954263,0.030140646,0.006265727,0.004092178,0.0047969646,0.00044143226],"domain_scores_gemma":[0.8529315,0.104880586,0.011749323,0.010970242,0.018368248,0.0011000918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.078942925,0.0012567418,0.0010973179,0.0057615326,0.0015597155,0.0037911946,0.0026060245,0.0012313424,0.004338129],"category_scores_gemma":[0.13194154,0.0010957214,0.0047659986,0.0038649088,0.000979969,0.0029351711,0.0030946499,0.0013819127,0.0008199766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008521052,0.0058156378,0.39825547,0.035223633,0.017764442,0.001082005,0.03386125,0.0031801485,0.004798716,0.009184899,0.0077776234,0.47453502],"study_design_scores_gemma":[0.008777738,0.022422643,0.48904002,0.042700104,0.058137286,0.005908843,0.04930688,0.10668716,0.03248466,0.038068097,0.14456344,0.0019031443],"about_ca_topic_score_codex":0.007881489,"about_ca_topic_score_gemma":0.016582917,"teacher_disagreement_score":0.078942925,"about_ca_system_score_codex":0.0032932064,"about_ca_system_score_gemma":0.0054305093,"threshold_uncertainty_score":0.41749507},"labels":[],"label_agreement":null},{"id":"W4408957609","doi":"10.1111/jgs.19457","title":"Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Geriatrics Society","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"Fonds de Recherche du Québec - Santé; Health Canada","keywords":"Medicine; Adverse effect; Clinical trial; Drug; Intensive care medicine; MEDLINE; Pharmacology; Internal medicine","score_opus":0.2166903002480667,"score_gpt":0.5921162661244268,"score_spread":0.3754259658763601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408957609","genre_codex":"protocol","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004146365,0.27386388,0.021288201,0.0045968746,0.0023902075,0.6470854,0.036800448,0.0014406804,0.008387825],"genre_scores_gemma":[0.036763337,0.06649731,0.045063343,0.003929313,0.0005291153,0.8360237,0.008669045,0.00040509313,0.0021197458],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7445271,0.08662754,0.12774704,0.008573842,0.0301243,0.0024000893],"domain_scores_gemma":[0.7390763,0.13120852,0.07959914,0.011070211,0.035115786,0.0039300136],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12213442,0.006923957,0.035615694,0.022930413,0.0032533354,0.009051829,0.008242955,0.006983374,0.020956242],"category_scores_gemma":[0.24656978,0.003498001,0.028472256,0.02332329,0.0050755874,0.009040446,0.0060136346,0.005175965,0.0032458415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086874224,0.000024077972,0.0011890997,0.9636427,0.016654443,0.0001484477,0.00034339522,0.00024641055,0.00016409787,0.00082813,0.0056475983,0.010242867],"study_design_scores_gemma":[0.009343212,0.0006228472,0.008522052,0.8564702,0.061660964,0.00073320215,0.0008431214,0.0017257105,0.0009320491,0.0057513625,0.05302627,0.00036902403],"about_ca_topic_score_codex":0.0056348643,"about_ca_topic_score_gemma":0.011495398,"teacher_disagreement_score":0.87786555,"about_ca_system_score_codex":0.016864674,"about_ca_system_score_gemma":0.032913215,"threshold_uncertainty_score":0.6459162},"labels":[],"label_agreement":null},{"id":"W4409281408","doi":"10.1016/j.biopsych.2025.02.198","title":"8. The Development and Piloting of a Machine Learning Prediction Alerting System for Adverse Events in Psychiatry","year":2025,"lang":"en","type":"article","venue":"Biological Psychiatry","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Waypoint Centre for Mental Health Care; York University; McMaster University; University of Toronto","funders":"","keywords":"Psychology; Adverse effect; Psychiatry; Medicine; Pharmacology","score_opus":0.08361920817749066,"score_gpt":0.4050707204553026,"score_spread":0.321451512277812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409281408","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29218942,0.0013547549,0.49112165,0.0330842,0.0026677675,0.004883082,0.018776748,0.085423596,0.070498854],"genre_scores_gemma":[0.5458747,0.0005192586,0.37485713,0.0047280905,0.00043719742,0.0010703695,0.014847319,0.0008690821,0.05679676],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99895716,0.00022971223,0.00009559898,0.0001532908,0.00043945515,0.00012478701],"domain_scores_gemma":[0.99324775,0.0013592531,0.00032494366,0.00047386816,0.004104399,0.00048988813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030084692,0.00047646,0.00037771027,0.0006513607,0.00050497596,0.00092920114,0.0012608982,0.0016885196,0.012133708],"category_scores_gemma":[0.007387602,0.00031433965,0.0004128172,0.0003252913,0.00017615761,0.0012639596,0.0005722108,0.00092033856,0.008223305],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023350792,0.0013919799,0.056049075,0.00043450465,0.00020214458,0.0010461392,0.0004035463,0.013196426,0.06168364,0.0029699095,0.1426278,0.7176597],"study_design_scores_gemma":[0.001504761,0.0028530606,0.07768624,0.00029152632,0.00035907488,0.001063176,0.00032960525,0.4949871,0.2337461,0.004053035,0.18294723,0.00017916653],"about_ca_topic_score_codex":0.011098558,"about_ca_topic_score_gemma":0.01043128,"teacher_disagreement_score":0.012133708,"about_ca_system_score_codex":0.0005955824,"about_ca_system_score_gemma":0.0021078154,"threshold_uncertainty_score":0.0405913},"labels":[],"label_agreement":null},{"id":"W4409963375","doi":"10.1139/cjpp-2025-0065","title":"Disproportionality analysis of ALK inhibitor-induced hemolytic adverse events: a pharmacovigilance study using the FDA Adverse Event Reporting System Database","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. Food and Drug Administration","keywords":"Pharmacovigilance; Adverse Event Reporting System; Adverse effect; Medicine; Pharmacology; Database; Computer science","score_opus":0.09675433927970234,"score_gpt":0.44403640081048784,"score_spread":0.3472820615307855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409963375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9507629,0.010713508,0.010816669,0.000672014,0.000092171824,0.0011405232,0.023465572,0.00015298658,0.0021837314],"genre_scores_gemma":[0.9804699,0.0012137027,0.0037308014,0.00034631326,0.000085560096,0.00064423995,0.013257287,0.00004883606,0.00020342074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9451317,0.022134768,0.0149971135,0.007859492,0.008632959,0.0012440213],"domain_scores_gemma":[0.91383326,0.033110134,0.036603156,0.008061869,0.007216696,0.0011749476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03307113,0.0006470673,0.0015952537,0.0048470125,0.0005405505,0.0020838412,0.0012031479,0.00067955104,0.0021810918],"category_scores_gemma":[0.061999496,0.0004618924,0.005046872,0.0069652726,0.0004058331,0.0012222007,0.0022636123,0.001087693,0.00031112056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024381734,0.00014512641,0.969956,0.0013607814,0.009744019,0.0002645176,0.00029538074,0.00061187794,0.00033923172,0.00046516026,0.00188744,0.012492307],"study_design_scores_gemma":[0.000493118,0.0010352351,0.9637273,0.00059912493,0.014542593,0.0019754842,0.0005240088,0.007572844,0.0014398855,0.0009305053,0.0070361085,0.00012382257],"about_ca_topic_score_codex":0.004116678,"about_ca_topic_score_gemma":0.0031301705,"teacher_disagreement_score":0.03307113,"about_ca_system_score_codex":0.0012930545,"about_ca_system_score_gemma":0.002186033,"threshold_uncertainty_score":0.17489892},"labels":[],"label_agreement":null},{"id":"W4410318415","doi":"10.2196/67513","title":"Predicting Drug–Side Effect Relationships From Parametric Knowledge Embedded in Biomedical BERT Models: Methodological Study With a Natural Language Processing Approach","year":2025,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Preprint; Computer science; Parametric statistics; Drug; Medicine; Pharmacology; World Wide Web; Mathematics; Statistics","score_opus":0.15044424965768455,"score_gpt":0.4857922108775,"score_spread":0.33534796121981547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410318415","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4320177,0.0011392578,0.5581483,0.0010664857,0.00005632532,0.00024949972,0.0024846506,0.0016215289,0.003216269],"genre_scores_gemma":[0.8576627,0.00031852734,0.13795638,0.00013196323,0.00002776674,0.0001747072,0.0027050823,0.00004777655,0.00097508135],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991928,0.00042229408,0.00005477139,0.00020527809,0.000086371365,0.000038478793],"domain_scores_gemma":[0.993526,0.005513735,0.00027623665,0.00033136288,0.0002934702,0.000059226186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020216424,0.0007201182,0.0002837505,0.0011413618,0.00026317633,0.00079105614,0.000690523,0.0005411508,0.001412343],"category_scores_gemma":[0.0073382226,0.0003321692,0.00091974204,0.0007454324,0.00042186878,0.0014691512,0.000719354,0.001080957,0.00036827778],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081747776,0.00076311006,0.051145222,0.0005001926,0.0004122408,0.0008042753,0.0005184645,0.5044197,0.011490026,0.008925677,0.004183818,0.41601983],"study_design_scores_gemma":[0.000017863458,0.00010778223,0.0032758315,0.000020445897,0.000058181427,0.00011459242,0.00008935325,0.98787594,0.0026444378,0.004826235,0.00095196307,0.000017365683],"about_ca_topic_score_codex":0.0066433344,"about_ca_topic_score_gemma":0.0102389725,"teacher_disagreement_score":0.0066433344,"about_ca_system_score_codex":0.0009651226,"about_ca_system_score_gemma":0.0012048302,"threshold_uncertainty_score":0.013209343},"labels":[],"label_agreement":null},{"id":"W4410966894","doi":"10.1002/bcp.70116","title":"The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study","year":2025,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Univerzita Karlova v Praze","keywords":"Medicine; Diagnosis code; ICD-10; Confidence interval; Adverse effect; Emergency medicine; Internal medicine; Population; Psychiatry; Environmental health","score_opus":0.18322355584218358,"score_gpt":0.5429791913178457,"score_spread":0.3597556354756621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410966894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98444724,0.00061704876,0.0059140604,0.000116902185,0.00009172486,0.0020108658,0.004780276,0.000047433172,0.0019744185],"genre_scores_gemma":[0.97902495,0.00022650165,0.004185313,0.0001821796,0.00005955411,0.0013735204,0.014570326,0.00006569815,0.000312104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9713047,0.012949801,0.0038381221,0.004718222,0.0061303563,0.0010587833],"domain_scores_gemma":[0.8905939,0.047954988,0.021162536,0.018117908,0.0201943,0.001976463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03732889,0.0012802467,0.0010869591,0.003298128,0.000876504,0.0018742755,0.0024610185,0.0017029576,0.001553258],"category_scores_gemma":[0.097148225,0.0008548207,0.002738507,0.0018889874,0.0017134168,0.001433582,0.0025116247,0.0016457794,0.0010223789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010680282,0.00051014085,0.98771244,0.0002195984,0.0006333218,0.00009910657,0.0006699912,0.0006554028,0.00043882438,0.00015235628,0.00096598873,0.0068749418],"study_design_scores_gemma":[0.000307166,0.0006688531,0.9886335,0.00026751356,0.00042728553,0.00060831395,0.00038935264,0.0048066536,0.00083995966,0.00023035657,0.0027684607,0.000052483392],"about_ca_topic_score_codex":0.0036211591,"about_ca_topic_score_gemma":0.0034270429,"teacher_disagreement_score":0.03732889,"about_ca_system_score_codex":0.0012043586,"about_ca_system_score_gemma":0.0023904387,"threshold_uncertainty_score":0.19741637},"labels":[],"label_agreement":null},{"id":"W4411128503","doi":"10.1111/cea.70092","title":"Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study","year":2025,"lang":"en","type":"article","venue":"Clinical & Experimental Allergy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute for Information and Communications Technology Promotion; Information Technology Research Centre; Ministry of Science and ICT, South Korea; Iran Telecommunication Research Center; World Health Organization","keywords":"Anaphylaxis; Medicine; Pharmacovigilance; Drug allergy; Cefuroxime; Drug; Allergy; Internal medicine; Pharmacology; Antibiotics; Immunology","score_opus":0.09018894755204204,"score_gpt":0.5013683411406018,"score_spread":0.41117939358855976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411128503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914254,0.003709819,0.00077924493,0.00025943218,0.000013516321,0.00008856822,0.0031047466,0.000024521947,0.00059483893],"genre_scores_gemma":[0.99723476,0.00048891903,0.0005407461,0.000115003095,0.000019991803,0.000037723545,0.0015070989,0.0000069849384,0.000048859627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98841876,0.0038222892,0.0028555216,0.002476977,0.0019519774,0.00047445856],"domain_scores_gemma":[0.973539,0.007908228,0.014271294,0.001487317,0.0018923177,0.00090193993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008356715,0.00054479897,0.0012394707,0.0038227364,0.00039650808,0.0016557486,0.00090963993,0.00092496484,0.001707704],"category_scores_gemma":[0.023039903,0.00042091252,0.0029472876,0.0059535434,0.00042836458,0.0011092754,0.0020765252,0.0008023798,0.00030820936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042633517,0.000040929033,0.9936907,0.00031289324,0.0014739056,0.00017283692,0.00014385328,0.000118430165,0.00017501457,0.000048392503,0.00028641016,0.003110243],"study_design_scores_gemma":[0.000055193093,0.00022950412,0.9955824,0.00012919544,0.0012485851,0.0007825205,0.00026269373,0.00083288114,0.00016482298,0.000060340728,0.00063491944,0.00001695235],"about_ca_topic_score_codex":0.0049397424,"about_ca_topic_score_gemma":0.0032464988,"teacher_disagreement_score":0.008356715,"about_ca_system_score_codex":0.0008773604,"about_ca_system_score_gemma":0.0010828911,"threshold_uncertainty_score":0.044195116},"labels":[],"label_agreement":null},{"id":"W4411200507","doi":"10.1016/j.jogc.2025.102887","title":"Two Thirds of Community Pharmacies in British Columbia Can Dispense Mifepristone Within 3 Days: A Mystery Caller Survey","year":2025,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Mifepristone; Family medicine; Pharmacy; Pregnancy","score_opus":0.06841412945436,"score_gpt":0.3702391849112518,"score_spread":0.3018250554568918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411200507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096066,0.00059636,0.00009809625,0.0023440616,0.00002206876,0.00006802333,0.0024037114,0.000016183913,0.0034908198],"genre_scores_gemma":[0.9932395,0.00067346543,0.00014337456,0.0021790669,0.000012961839,0.00002686916,0.0007266286,0.000009849437,0.0029882651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863654,0.00017718099,0.00013774387,0.00014098402,0.00051717396,0.0003904085],"domain_scores_gemma":[0.9964412,0.00038815403,0.0013276786,0.00014983093,0.0007609514,0.00093222293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005950371,0.00026341405,0.0003072983,0.00084817817,0.001298653,0.0010567075,0.0010629466,0.0014023527,0.0035611433],"category_scores_gemma":[0.0026028573,0.0005630825,0.00035249034,0.0023934336,0.00044549306,0.0005991337,0.0008793151,0.0016721594,0.0007229263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068580805,0.00012413395,0.9904462,0.000027723505,0.00003623777,0.0002032021,0.0008367435,0.000024422148,0.00023084937,0.00003850522,0.0030645947,0.004898691],"study_design_scores_gemma":[0.0000054952693,0.00001896312,0.99650514,0.000023629258,0.000012755554,0.00010299746,0.0023471965,0.0001109814,0.000027151034,0.000010239528,0.0008273742,0.000008086872],"about_ca_topic_score_codex":0.90199864,"about_ca_topic_score_gemma":0.9510902,"teacher_disagreement_score":0.09800136,"about_ca_system_score_codex":0.004918343,"about_ca_system_score_gemma":0.008279049,"threshold_uncertainty_score":0.19715697},"labels":[],"label_agreement":null},{"id":"W4411299197","doi":"10.1016/j.jcjo.2025.05.021","title":"A real-world population-based study on the association between cataracts and antipsychotics","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Brain and Cognition Discovery Foundation","funders":"Canadian Institutes of Health Research; Alcon; National Natural Science Foundation of China; Life Sciences, University of California, Los Angeles; Foundation Fighting Blindness; Global Alliance for Chronic Diseases; AbbVie; Physicians' Services Incorporated Foundation","keywords":"Quetiapine; Medicine; Odds ratio; Cataracts; Confidence interval; Antipsychotic; Adverse Event Reporting System; Internal medicine; Population; Pharmacovigilance; Adverse effect; Pediatrics; Psychiatry; Schizophrenia (object-oriented programming); Ophthalmology; Environmental health","score_opus":0.12243700354149428,"score_gpt":0.45075941411454534,"score_spread":0.32832241057305106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411299197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938188,0.0013219139,0.00076943444,0.00012990313,0.000012730294,0.00006738353,0.0033546644,0.000009294322,0.00051582657],"genre_scores_gemma":[0.9977168,0.0003902383,0.00044101157,0.000120915785,0.000026494481,0.000037277325,0.0012043882,0.000002365369,0.000060511164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99518186,0.002126007,0.00076323055,0.0010803774,0.00066539814,0.0001831259],"domain_scores_gemma":[0.9854307,0.0038113464,0.008156361,0.0011497921,0.001031634,0.00042012788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031109361,0.00034938063,0.0005247589,0.0017605778,0.0004457212,0.0008389461,0.00041772015,0.00062314415,0.0015170368],"category_scores_gemma":[0.013794522,0.00041838584,0.0007914912,0.0027907155,0.00052083266,0.00082477607,0.00064937695,0.00056374224,0.00023212975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027896743,0.00004436873,0.99663866,0.000082130864,0.0004804778,0.0001059348,0.00006513092,0.00008669331,0.00020377856,0.000036985824,0.00023263787,0.0017442509],"study_design_scores_gemma":[0.000079291276,0.00024786833,0.9975821,0.00003692035,0.00027908216,0.00056862755,0.00015821375,0.00039126643,0.00007678889,0.00007570856,0.00048965035,0.000014651517],"about_ca_topic_score_codex":0.006798407,"about_ca_topic_score_gemma":0.005327539,"teacher_disagreement_score":0.9932016,"about_ca_system_score_codex":0.0005096948,"about_ca_system_score_gemma":0.0005304372,"threshold_uncertainty_score":0.016452372},"labels":[],"label_agreement":null},{"id":"W4411363608","doi":"10.1007/s00228-025-03862-2","title":"Trends in adverse drug reaction reporting in eight selected countries after the implementation of new pharmacovigilance regulation in 2012: a joinpoint regression analysis","year":2025,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"College ter Beoordeling van Geneesmiddelen","keywords":"Pharmacovigilance; Drug; Drug reaction; Pharmacology; Adverse drug reaction; Medicine; Adverse effect","score_opus":0.10941987005096443,"score_gpt":0.5280481886088624,"score_spread":0.41862831855789795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411363608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955491,0.0003047472,0.00078080746,0.00007611127,0.000012554511,0.000038656897,0.0025901387,0.000036142803,0.0006117822],"genre_scores_gemma":[0.99509096,0.00009880044,0.0006394412,0.00003669816,0.000009893767,0.000056141023,0.003789093,0.000017924714,0.00026101916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911103,0.00390378,0.0010031976,0.0019571201,0.0013335159,0.0006920169],"domain_scores_gemma":[0.970909,0.0101047745,0.011658164,0.0017405644,0.0048308037,0.00075671263],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009299498,0.00037590862,0.00077899336,0.002768433,0.0003100463,0.0012837553,0.0007966279,0.0006402361,0.0012570047],"category_scores_gemma":[0.016306264,0.0003659989,0.0016453242,0.004294412,0.0003837071,0.0009972507,0.0010969219,0.0011662346,0.00039871508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030523975,0.000040476374,0.9956254,0.000026625881,0.000297456,0.000064375155,0.0001726054,0.0007259745,0.0000806728,0.0000320426,0.00028712957,0.002342041],"study_design_scores_gemma":[0.000010924208,0.00023254326,0.99528366,0.000011121072,0.00013136402,0.00013775879,0.00039770585,0.003057123,0.00017044148,0.0000141649925,0.00054136006,0.000011791919],"about_ca_topic_score_codex":0.01494491,"about_ca_topic_score_gemma":0.006301647,"teacher_disagreement_score":0.9907005,"about_ca_system_score_codex":0.00079023297,"about_ca_system_score_gemma":0.000646499,"threshold_uncertainty_score":0.049181044},"labels":[],"label_agreement":null},{"id":"W4411639738","doi":"10.1007/s40290-025-00573-y","title":"Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators","year":2025,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; University of Sydney","keywords":"Pharmacology; Medicine; Environmental health; Business","score_opus":0.1384110428210106,"score_gpt":0.4996191888193955,"score_spread":0.3612081459983849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411639738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867214,0.0038377352,0.0010198962,0.0006145209,0.000071595765,0.0009972557,0.0010124082,0.000030833773,0.0056942864],"genre_scores_gemma":[0.994655,0.0014689955,0.0014116775,0.00055790186,0.000041534222,0.0007482612,0.0006713302,0.000037782193,0.0004077089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.91184556,0.04471876,0.019986307,0.00426923,0.01681929,0.0023608373],"domain_scores_gemma":[0.734529,0.15769704,0.06712006,0.007844892,0.02838027,0.004428731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055501137,0.00039491695,0.0013511485,0.0069365883,0.0015848201,0.0043159933,0.0013805999,0.001775843,0.0037146609],"category_scores_gemma":[0.23450053,0.0007908059,0.0026763272,0.0060713356,0.0031971615,0.005766638,0.005873007,0.0018685804,0.00050987845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012969339,0.0013072267,0.8318918,0.0068234922,0.0039616674,0.0003988176,0.050692983,0.0007347676,0.0017647352,0.0020372602,0.0020754177,0.08534239],"study_design_scores_gemma":[0.00090508896,0.0048423377,0.9193374,0.0033590568,0.0027558885,0.0006606684,0.048894074,0.001173956,0.0018157688,0.0011170998,0.01489215,0.0002466349],"about_ca_topic_score_codex":0.009693021,"about_ca_topic_score_gemma":0.008660468,"teacher_disagreement_score":0.055501137,"about_ca_system_score_codex":0.005671376,"about_ca_system_score_gemma":0.005402573,"threshold_uncertainty_score":0.29352158},"labels":[],"label_agreement":null},{"id":"W4411656975","doi":"10.51847/nowhndg4ni","title":"10.51847/nowHNDg4nI","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Antibiotics; Drug reaction; Drug; Adverse effect; Intensive care medicine; Pediatrics; Internal medicine; Pharmacology; Biology; Microbiology","score_opus":0.05363553376830095,"score_gpt":0.36293234739341323,"score_spread":0.3092968136251123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411656975","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006874431,0.002019162,0.0017325652,0.003262102,0.0010198795,0.00015980582,0.0030484686,0.001106314,0.9807773],"genre_scores_gemma":[0.010358262,0.0008911766,0.0016963498,0.001116601,0.00020504979,0.00007148267,0.0014864095,0.00020156316,0.983973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994242,0.00008751866,0.000054797456,0.00015033208,0.00016457049,0.00011857627],"domain_scores_gemma":[0.99868006,0.00024904677,0.00011239515,0.0001498787,0.00034591797,0.00046269872],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00082603446,0.00082003174,0.00049983844,0.001451641,0.0009212238,0.0022043274,0.00082045695,0.0019921958,0.904666],"category_scores_gemma":[0.0011956614,0.00028677698,0.0003441182,0.00096419157,0.00064875773,0.0014766979,0.0015056997,0.001087508,0.8621765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036369823,0.00050026044,0.007263879,0.00036045586,0.000017431163,0.0006894734,0.00015339826,0.00020330846,0.0019799378,0.0034803774,0.21592668,0.76906097],"study_design_scores_gemma":[0.000076377255,0.00010831436,0.0078490395,0.00037713043,0.000014308114,0.0013938299,0.00027339437,0.0003716993,0.00086711795,0.0015990293,0.9870445,0.0000251754],"about_ca_topic_score_codex":0.0043608206,"about_ca_topic_score_gemma":0.0055559836,"teacher_disagreement_score":0.09533399,"about_ca_system_score_codex":0.0011417532,"about_ca_system_score_gemma":0.0010513018,"threshold_uncertainty_score":0.1359824},"labels":[],"label_agreement":null},{"id":"W4411660157","doi":"10.51847/ihhvsm0irt","title":"10.51847/ihHVSM0iRt","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mental illness; Drug; Medicine; Psychiatry; Drug reaction; Adverse effect; Pharmacology; Mental health","score_opus":0.05338846529520993,"score_gpt":0.36284510290497657,"score_spread":0.30945663760976666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411660157","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004822899,0.0006701608,0.0015040416,0.0014255211,0.00060097064,0.00014915738,0.0027933263,0.0017386014,0.9862953],"genre_scores_gemma":[0.010414251,0.00035088,0.0017268546,0.0008695746,0.00020361257,0.00007537331,0.0023210149,0.00028069475,0.9837578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995245,0.000058489633,0.000034088698,0.0001143408,0.00014757099,0.00012104468],"domain_scores_gemma":[0.99890447,0.000188614,0.000072535564,0.00013957151,0.00023965689,0.00045514636],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00069144135,0.00084866805,0.00051769515,0.0016056326,0.0009928931,0.0019760854,0.0009335792,0.0023144148,0.9380342],"category_scores_gemma":[0.0010458102,0.00029983322,0.0004820585,0.0009893803,0.00064354605,0.0010902056,0.0019876105,0.0009434696,0.91303056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053733296,0.00047193802,0.0038014252,0.00025380348,0.000025048,0.000518915,0.00017133632,0.00025957482,0.0034883425,0.004272896,0.19391532,0.7922841],"study_design_scores_gemma":[0.00012173176,0.00020372124,0.0060469187,0.00032036338,0.000026288555,0.00084921415,0.00018512306,0.00040801347,0.0016093797,0.0018018372,0.988399,0.000028319395],"about_ca_topic_score_codex":0.0036316223,"about_ca_topic_score_gemma":0.0028265198,"teacher_disagreement_score":0.061965823,"about_ca_system_score_codex":0.0008383655,"about_ca_system_score_gemma":0.0009509447,"threshold_uncertainty_score":0.088386655},"labels":[],"label_agreement":null},{"id":"W4411715492","doi":"10.1177/02698811251344684","title":"Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database","year":2025,"lang":"en","type":"review","venue":"Journal of Psychopharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Adverse Event Reporting System; Medicine; Azithromycin; Pharmacovigilance; Odds ratio; Food and drug administration; Moxifloxacin; Adverse effect; Internal medicine; Pharmacology; Antibiotics","score_opus":0.09059581851007198,"score_gpt":0.48167806264386626,"score_spread":0.3910822441337943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411715492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00816731,0.98868203,0.0005006582,0.00036374884,0.00006727176,0.000518689,0.0012812882,0.000010895676,0.00040808553],"genre_scores_gemma":[0.090450846,0.9039108,0.0023173888,0.0005877494,0.00018632866,0.001194775,0.0012412757,0.000009990699,0.00010082564],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.97596145,0.005500289,0.012504241,0.002008733,0.0036703441,0.0003550077],"domain_scores_gemma":[0.87497777,0.083367154,0.03132389,0.0018959207,0.0079322895,0.00050295406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017167406,0.0010470169,0.004590082,0.029379912,0.0006216685,0.002159031,0.0017031182,0.0013002624,0.002560771],"category_scores_gemma":[0.06273844,0.0008915344,0.0091429865,0.01935858,0.0009218634,0.0026152025,0.0016804065,0.0008628059,0.00023978333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007940581,0.000093048984,0.040212475,0.78042644,0.022226986,0.0006962308,0.0006458732,0.00025634476,0.00034247627,0.00052648917,0.0022423672,0.15153727],"study_design_scores_gemma":[0.0005022191,0.0008533312,0.114950456,0.6931539,0.14988653,0.005478886,0.0015926574,0.00058951066,0.0008225386,0.0011343603,0.030842068,0.00019358021],"about_ca_topic_score_codex":0.003322169,"about_ca_topic_score_gemma":0.006017666,"teacher_disagreement_score":0.029379912,"about_ca_system_score_codex":0.0024718517,"about_ca_system_score_gemma":0.0054898993,"threshold_uncertainty_score":0.09079099},"labels":[],"label_agreement":null},{"id":"W4412451445","doi":"10.1038/s41598-025-09472-3","title":"Predicting clozapine-induced adverse drug reaction biomarkers using machine learning","year":2025,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Clozapine; Drug reaction; Adverse effect; Drug; Adverse drug reaction; Medicine; Pharmacology; Bioinformatics; Computer science; Schizophrenia (object-oriented programming); Psychiatry; Biology","score_opus":0.08069752969398984,"score_gpt":0.4208029834275179,"score_spread":0.340105453733528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412451445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665418,0.0014364935,0.02937002,0.00030277434,0.000038789134,0.00009380666,0.0010962738,0.00044199266,0.0006780146],"genre_scores_gemma":[0.98579365,0.00021430773,0.012299571,0.00005247356,0.000027044429,0.00002161834,0.0014442491,0.0000054264005,0.00014166889],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991093,0.00038228242,0.00010148487,0.00015930463,0.00017276825,0.000074769465],"domain_scores_gemma":[0.9962057,0.0023487112,0.0006333285,0.00020537259,0.000494436,0.000112451205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002206894,0.0006481008,0.0006133535,0.0017204767,0.00019983524,0.0007201469,0.0004167588,0.00045522695,0.00030799932],"category_scores_gemma":[0.007942201,0.0001299976,0.0006451277,0.00069068035,0.00013875052,0.00040362982,0.00032431216,0.00053731503,0.00018489402],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008983751,0.0004921821,0.56800675,0.00015338942,0.00047490312,0.0003371285,0.00007052231,0.2319638,0.0066318354,0.00023071127,0.0021609142,0.18857938],"study_design_scores_gemma":[0.000025962543,0.0002592858,0.05182848,0.000022159382,0.00008264361,0.0001812544,0.00003915433,0.9431576,0.0034698974,0.0003892553,0.00052548235,0.000018843655],"about_ca_topic_score_codex":0.008013268,"about_ca_topic_score_gemma":0.007784878,"teacher_disagreement_score":0.008013268,"about_ca_system_score_codex":0.00048619282,"about_ca_system_score_gemma":0.00062628667,"threshold_uncertainty_score":0.015933275},"labels":[],"label_agreement":null},{"id":"W4412461971","doi":"10.1515/jbcpp-2025-0084","title":"A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form)","year":2025,"lang":"en","type":"article","venue":"Journal of Basic and Clinical Physiology and Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Causality (physics); Observational study; Government (linguistics); Under-reporting; Medicine; Family medicine; Accounting; Political science; Adverse effect; Pharmacology; Business; Law; Pathology","score_opus":0.11553822340819445,"score_gpt":0.5293874490219851,"score_spread":0.41384922561379067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412461971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654309,0.005324105,0.0077049877,0.0015024556,0.00030866687,0.0073818523,0.0074070804,0.000085714026,0.004854343],"genre_scores_gemma":[0.9868723,0.0005256965,0.0060378863,0.0005534988,0.00005015673,0.003460953,0.0023033062,0.00003303622,0.00016318477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6828595,0.18944308,0.08146968,0.0116682565,0.030822482,0.003736991],"domain_scores_gemma":[0.39612463,0.27392107,0.21250033,0.029875413,0.084790595,0.0027878196],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22222368,0.0005679736,0.0012422682,0.006123672,0.0013419515,0.004077573,0.0015101273,0.0011691772,0.0017633169],"category_scores_gemma":[0.4266388,0.0006238047,0.0025554348,0.009160275,0.0018762274,0.003318833,0.0026196411,0.0010788739,0.00036044003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003991487,0.00024522698,0.95908004,0.0020086572,0.0013975739,0.000116125055,0.005655971,0.0003129238,0.00028228472,0.0009104761,0.0024045832,0.023594618],"study_design_scores_gemma":[0.0007036366,0.0039056286,0.9612852,0.0023640743,0.0014279602,0.00069723633,0.012298253,0.0013296301,0.001305315,0.00062544906,0.0139229875,0.0001346666],"about_ca_topic_score_codex":0.0036793025,"about_ca_topic_score_gemma":0.0028575354,"teacher_disagreement_score":0.7777763,"about_ca_system_score_codex":0.004157892,"about_ca_system_score_gemma":0.0061701904,"threshold_uncertainty_score":0.95913666},"labels":[],"label_agreement":null},{"id":"W4412645354","doi":"10.3389/fpubh.2025.1630412","title":"Sex differences in drug-induced osteoporosis: a pharmacovigilance study based on the FAERS database","year":2025,"lang":"en","type":"article","venue":"Frontiers in Public Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Gansu University of Chinese Medicine","keywords":"Pharmacovigilance; Adverse Event Reporting System; Medicine; MedDRA; Adverse effect; Database; Osteoporosis; Pharmacoepidemiology; Odds ratio; Internal medicine; Pharmacology","score_opus":0.16825760695834666,"score_gpt":0.44704977179729805,"score_spread":0.2787921648389514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412645354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758478,0.001863495,0.00043430418,0.0003104001,0.000013008409,0.00019144872,0.019896414,0.000024748088,0.0014184586],"genre_scores_gemma":[0.98879284,0.00058066065,0.000627687,0.00022841814,0.00002159251,0.00009462375,0.009471349,0.00001189215,0.00017090705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930648,0.001324525,0.0014298692,0.0013720266,0.0024024844,0.0004064248],"domain_scores_gemma":[0.98373425,0.003303337,0.0078790905,0.0014734981,0.0030231753,0.00058663794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004251493,0.0002872005,0.0006781814,0.0027274885,0.0005882512,0.0011573259,0.00079937145,0.00044648896,0.0017341964],"category_scores_gemma":[0.015770486,0.00025163504,0.0011358134,0.0055117956,0.0003234174,0.0005926823,0.0008872506,0.00054595585,0.00023795041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029984044,0.000025618756,0.9954991,0.00007506598,0.00027785078,0.00011316922,0.00013183238,0.000058175076,0.00009879855,0.00004987518,0.0008049415,0.0025657082],"study_design_scores_gemma":[0.000045700963,0.000055014174,0.9971506,0.000042040072,0.00026608966,0.00037683095,0.00015946169,0.0005432149,0.00011890045,0.000025037858,0.001203893,0.000013344357],"about_ca_topic_score_codex":0.15280476,"about_ca_topic_score_gemma":0.12819359,"teacher_disagreement_score":0.15280476,"about_ca_system_score_codex":0.0027985242,"about_ca_system_score_gemma":0.0034945551,"threshold_uncertainty_score":0.30383068},"labels":[],"label_agreement":null},{"id":"W4412689864","doi":"10.1002/bcp.70182","title":"Completeness of spontaneously reported adverse drug reactions in 4 databases","year":2025,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; University of South Australia","keywords":"Database; Completeness (order theory); Adverse Event Reporting System; Medicine; Danish; Adverse drug reaction; Adverse effect; Information retrieval; Computer science; Drug; Pharmacology; Mathematics","score_opus":0.23160756090454496,"score_gpt":0.5484190008536198,"score_spread":0.3168114399490749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412689864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83153343,0.018904459,0.025651438,0.0019295359,0.00024765808,0.004886226,0.10497126,0.00064140075,0.011234702],"genre_scores_gemma":[0.8955392,0.0045625325,0.020002974,0.00047155982,0.0001437492,0.002955905,0.07532186,0.000105333274,0.00089670514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.7972325,0.06655221,0.080126874,0.010691451,0.0428478,0.002549169],"domain_scores_gemma":[0.531533,0.19451603,0.15038778,0.03232424,0.0883339,0.0029050482],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10362185,0.0006935407,0.0016973603,0.01687048,0.00087705493,0.0051522586,0.0023852114,0.00094860326,0.0017847279],"category_scores_gemma":[0.33469462,0.0006885437,0.0027955915,0.01684163,0.0008526637,0.0036197207,0.004558039,0.00070384465,0.00049830286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010450057,0.00010687935,0.92452294,0.0039055923,0.0013036412,0.0002139693,0.002693629,0.0012695342,0.0003818739,0.00080610055,0.0034213644,0.060329538],"study_design_scores_gemma":[0.00022040063,0.0006944993,0.9453577,0.0045804926,0.0013234977,0.0017504125,0.004233329,0.004347931,0.0025944663,0.0010948146,0.033598755,0.00020361209],"about_ca_topic_score_codex":0.014444715,"about_ca_topic_score_gemma":0.008669914,"teacher_disagreement_score":0.89637816,"about_ca_system_score_codex":0.003113207,"about_ca_system_score_gemma":0.008563867,"threshold_uncertainty_score":0.5480113},"labels":[],"label_agreement":null},{"id":"W4412706208","doi":"10.2196/72225","title":"Pharmacoepidemiologic Research Based on Common Data Models: Systematic Review and Bibliometric Analysis","year":2025,"lang":"en","type":"review","venue":"JMIR Medical Informatics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacoepidemiology; Scopus; Observational study; Citation; Medicine; Bibliometrics; MEDLINE; Data science; Computer science; Library science; Political science; Internal medicine","score_opus":0.5703289628451835,"score_gpt":0.637731928899977,"score_spread":0.06740296605479346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412706208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028136367,0.9067849,0.027697869,0.005439064,0.00057840365,0.013860575,0.012011561,0.00041353083,0.0050777323],"genre_scores_gemma":[0.4013432,0.4685974,0.084845155,0.001400515,0.00076718803,0.034160525,0.008422864,0.00014388171,0.00031920642],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.72608733,0.13409477,0.07951078,0.013568375,0.044863466,0.001875294],"domain_scores_gemma":[0.40309423,0.49275535,0.066303074,0.0139902085,0.022363205,0.0014939184],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.14626259,0.0036148247,0.021032741,0.2388936,0.0025000528,0.013884186,0.0043787844,0.002555759,0.0047731716],"category_scores_gemma":[0.4913592,0.0021711725,0.015417123,0.22264811,0.004821505,0.018157076,0.008874437,0.0019323895,0.00042474753],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041986394,0.00013434306,0.0386669,0.7330408,0.054233715,0.00022411135,0.0020131753,0.0033130501,0.00019301743,0.007384952,0.0038507353,0.15652536],"study_design_scores_gemma":[0.0014019441,0.0006973089,0.07172144,0.63602036,0.17953251,0.0011938119,0.0072533623,0.01615764,0.00091203884,0.05184973,0.03271288,0.00054688967],"about_ca_topic_score_codex":0.0066646906,"about_ca_topic_score_gemma":0.00815869,"teacher_disagreement_score":0.8537374,"about_ca_system_score_codex":0.015749197,"about_ca_system_score_gemma":0.032344498,"threshold_uncertainty_score":0.77351975},"labels":[],"label_agreement":null},{"id":"W4412732739","doi":"10.3389/fphar.2025.1630843","title":"Recombinant human growth hormone and brain neoplasm association: a pharmacovigilance and Mendelian randomization analysis based on US FAERS, Japanese JADER, and Canadian CVARD","year":2025,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Mendelian randomization; Medicine; Pharmacology; Oncology; Internal medicine; Adverse effect; Biology; Gene; Genetics; Genotype","score_opus":0.01912587031091526,"score_gpt":0.35638830500234103,"score_spread":0.33726243469142575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412732739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976102,0.0027968546,0.014957462,0.00044387774,0.000048278347,0.00079969724,0.0033460641,0.00016383492,0.0013419902],"genre_scores_gemma":[0.98965293,0.00025980474,0.0078992685,0.00012103874,0.00002239534,0.00028176318,0.0014802035,0.000021156093,0.0002614025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9605495,0.019611329,0.003754809,0.0080192555,0.0064907675,0.001574413],"domain_scores_gemma":[0.9704514,0.014787682,0.009103141,0.0025827673,0.002345909,0.0007291362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02172708,0.0010155699,0.0014869191,0.0048792292,0.0007824383,0.0012325476,0.00121625,0.000748835,0.0023718139],"category_scores_gemma":[0.049729157,0.00045463193,0.004548786,0.0044364957,0.0008544416,0.00064480584,0.0011229204,0.0006253583,0.0001682071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022891944,0.000059298687,0.97876555,0.00017565802,0.0055333064,0.00033401308,0.00017746829,0.001025414,0.00052268687,0.00059614267,0.0005519137,0.009969382],"study_design_scores_gemma":[0.00074532285,0.0011486748,0.95212924,0.00008804579,0.008613348,0.0014622756,0.00029622306,0.031019026,0.0009259952,0.0008685395,0.0026215157,0.00008164116],"about_ca_topic_score_codex":0.09909679,"about_ca_topic_score_gemma":0.049832534,"teacher_disagreement_score":0.9009032,"about_ca_system_score_codex":0.002856686,"about_ca_system_score_gemma":0.0057824557,"threshold_uncertainty_score":0.19703996},"labels":[],"label_agreement":null},{"id":"W4412779253","doi":"10.22541/au.175394925.50330509/v1","title":"The EUROmediCAT network and databases: a resource for pharmacovigilance in pregnancy Short running title: The EUROmediCAT network and databases","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Pharmacovigilance; Database; Resource (disambiguation); Computer science; Medicine; Pharmacology; Computer network; Drug","score_opus":0.15252294235516667,"score_gpt":0.45817390604129776,"score_spread":0.3056509636861311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412779253","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002278749,0.012044998,0.034171466,0.007099108,0.0007649935,0.0006988317,0.90680647,0.015494946,0.020640435],"genre_scores_gemma":[0.020985126,0.012622223,0.056845386,0.0020089357,0.0009441088,0.0016414095,0.8919668,0.0065361755,0.0064498167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891719,0.0032644756,0.0039922264,0.0009998683,0.0022856893,0.00028576184],"domain_scores_gemma":[0.9306569,0.03956261,0.010127148,0.008963475,0.0075242463,0.0031656846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010291744,0.0018768804,0.0023842528,0.014986741,0.0006031328,0.008947662,0.0028799498,0.0029326836,0.07333606],"category_scores_gemma":[0.102310225,0.0012486267,0.0013852695,0.02470871,0.00066170155,0.005415993,0.0047643594,0.0022920836,0.04178644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079242623,0.0000622094,0.0040143295,0.005427781,0.00053690263,0.00029360023,0.00017335503,0.0020370004,0.0006181703,0.02859748,0.86129856,0.09614815],"study_design_scores_gemma":[0.000499547,0.000041588723,0.005994842,0.0033091493,0.00032938062,0.00050849374,0.00010298226,0.003620638,0.0010620087,0.03102017,0.9534301,0.00008101909],"about_ca_topic_score_codex":0.005533115,"about_ca_topic_score_gemma":0.0025473249,"teacher_disagreement_score":0.07333606,"about_ca_system_score_codex":0.002048159,"about_ca_system_score_gemma":0.0064084586,"threshold_uncertainty_score":0.24533355},"labels":[],"label_agreement":null},{"id":"W4412801549","doi":"10.2196/71519","title":"Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server","year":2025,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; MedDRA; Visualization; Usability; Computer science; Medicine; Database; Information retrieval; World Wide Web; Pharmacovigilance; Data mining; Drug; Pharmacology","score_opus":0.11912338669259956,"score_gpt":0.5198591556693626,"score_spread":0.400735768976763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412801549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57459,0.0016213151,0.22021429,0.002364066,0.0005848944,0.006291992,0.017378505,0.16624056,0.010714354],"genre_scores_gemma":[0.55235165,0.0008862645,0.41207382,0.0006071668,0.00017516704,0.0024493441,0.019149285,0.008621321,0.003685959],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99109787,0.0043764515,0.0011757473,0.0011465613,0.001886293,0.0003171558],"domain_scores_gemma":[0.9439553,0.037583467,0.0020398349,0.0048571327,0.009820936,0.0017433526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022016704,0.0016852482,0.0010216647,0.0041840533,0.0006845415,0.004141983,0.0022677202,0.00097313436,0.0053675943],"category_scores_gemma":[0.044970863,0.0008176589,0.0016211964,0.00242197,0.00048894,0.0046907943,0.0035190266,0.001303006,0.001741273],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012209752,0.0034425445,0.1033462,0.005210502,0.0015847669,0.0022749912,0.014126779,0.01329269,0.040546726,0.005015256,0.081749566,0.7172003],"study_design_scores_gemma":[0.0036970552,0.008916625,0.20977394,0.003689773,0.0018654766,0.0036673786,0.010035047,0.47261629,0.0810711,0.01039633,0.19305526,0.0012157882],"about_ca_topic_score_codex":0.0033460762,"about_ca_topic_score_gemma":0.0020061391,"teacher_disagreement_score":0.022016704,"about_ca_system_score_codex":0.0009126829,"about_ca_system_score_gemma":0.0017751753,"threshold_uncertainty_score":0.11643684},"labels":[],"label_agreement":null},{"id":"W4412882697","doi":"10.1007/s40264-025-01588-9","title":"How does the Content and Dissemination of Communications on the Risks of Medicines Affect Prescriber Awareness, Knowledge, and Behaviour: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; University of Sydney","keywords":"Medicine; Affect (linguistics); Knowledge management; Communication","score_opus":0.2535261208218467,"score_gpt":0.5237633475532911,"score_spread":0.2702372267314444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412882697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038184018,0.9935202,0.00036565456,0.00058526377,0.00016518959,0.0007453334,0.00034175662,0.000012458888,0.0004456724],"genre_scores_gemma":[0.043646064,0.95259386,0.001248418,0.0007782057,0.00013625431,0.001264166,0.00020279308,0.000011092487,0.00011911034],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96545225,0.016666649,0.010079521,0.0018451016,0.0053537902,0.0006026591],"domain_scores_gemma":[0.8643211,0.108651936,0.01771724,0.0016937454,0.0069844215,0.00063151994],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028709207,0.0014932454,0.010617836,0.008685604,0.00082060124,0.0041839145,0.0019533378,0.0028200545,0.0028433397],"category_scores_gemma":[0.13388081,0.0014786068,0.011894263,0.0103943655,0.00166512,0.0046322653,0.0019808372,0.0017572324,0.000295648],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028407198,0.00003125893,0.0013993678,0.9477962,0.018514164,0.000052772717,0.00055040274,0.00010095694,0.000102303755,0.00017447889,0.0005160452,0.03047791],"study_design_scores_gemma":[0.00035707268,0.00030019393,0.004954313,0.85594946,0.13005103,0.00017273774,0.0004696381,0.0001376303,0.00026694225,0.00034080725,0.0069495374,0.00005056607],"about_ca_topic_score_codex":0.010769302,"about_ca_topic_score_gemma":0.023800708,"teacher_disagreement_score":0.97129077,"about_ca_system_score_codex":0.0051416694,"about_ca_system_score_gemma":0.018421706,"threshold_uncertainty_score":0.15183061},"labels":[],"label_agreement":null},{"id":"W4413051976","doi":"10.1002/prp2.70164","title":"Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries","year":2025,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; National Health and Medical Research Council; University of South Australia","keywords":"Health care; Medicine; Health professionals; Descriptive statistics; Family medicine; Pharmaceutical industry; Conflict of interest; Adverse effect; Pharmaceutical care; Pharmacovigilance; Business; Pharmacology; Pharmacy; Finance","score_opus":0.28827496316396767,"score_gpt":0.6110109335126671,"score_spread":0.32273597034869944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413051976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9223661,0.017963376,0.0034822193,0.0011520062,0.0001379608,0.0017313447,0.046961077,0.00017562436,0.006030252],"genre_scores_gemma":[0.9516474,0.005302729,0.00334247,0.00049501186,0.0001111778,0.0011874933,0.03753121,0.000053258696,0.00032936022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.80057764,0.062339935,0.07496393,0.0100184195,0.049736276,0.0023637915],"domain_scores_gemma":[0.47239977,0.22085789,0.18815728,0.024072558,0.09029522,0.004217214],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09076765,0.0006876267,0.0023938755,0.02407764,0.0008817762,0.0051560043,0.0023056923,0.0011001277,0.0011602421],"category_scores_gemma":[0.2902689,0.0007588425,0.0029504253,0.025571724,0.0015059821,0.003359234,0.004725722,0.0006301377,0.0003419762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011354262,0.000085617954,0.9615699,0.0032528199,0.0021486336,0.0001598665,0.0036915878,0.0003703127,0.00023777029,0.00028332512,0.0015838523,0.02548088],"study_design_scores_gemma":[0.00012927777,0.00030732751,0.9853507,0.0013009233,0.00083036226,0.0006016102,0.0038159252,0.00062974443,0.0004776261,0.00009822684,0.006379813,0.000078497585],"about_ca_topic_score_codex":0.023004249,"about_ca_topic_score_gemma":0.019151699,"teacher_disagreement_score":0.9092324,"about_ca_system_score_codex":0.0036320344,"about_ca_system_score_gemma":0.00593596,"threshold_uncertainty_score":0.48003095},"labels":[],"label_agreement":null},{"id":"W4413802971","doi":"10.3389/jpps.2025.14917","title":"Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"Government of Jiangsu Province","keywords":"Adverse Event Reporting System; Medicine; Pharmacovigilance; MedDRA; Database; Adverse effect; Odds ratio; Confidence interval; Internal medicine","score_opus":0.1477655184896028,"score_gpt":0.5043642773726585,"score_spread":0.35659875888305576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413802971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691417,0.0053832238,0.0031943694,0.000503449,0.00004350934,0.0013426286,0.01870384,0.000081538485,0.0016056638],"genre_scores_gemma":[0.9816066,0.00097592,0.003001336,0.00027293694,0.000056707413,0.0009293623,0.012969346,0.000019797013,0.00016791552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9670433,0.011729897,0.010066664,0.004324748,0.0062273466,0.00060812273],"domain_scores_gemma":[0.9109755,0.028760433,0.048187494,0.00529618,0.0059514903,0.00082876027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020825954,0.00042168563,0.0009694623,0.0038420984,0.00041373415,0.0016616683,0.00083314814,0.0006581769,0.0016847069],"category_scores_gemma":[0.04728928,0.00033705545,0.0017708738,0.006633649,0.00041392926,0.0013489082,0.0012302534,0.0008037021,0.00039901314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016214016,0.00020784869,0.98432887,0.0007749462,0.0012284528,0.00025225047,0.00023995807,0.00029656055,0.0003209506,0.0001580361,0.0012094622,0.009361361],"study_design_scores_gemma":[0.00032564046,0.00072618097,0.9874697,0.00028850095,0.0016537056,0.0012863196,0.00039355463,0.003718972,0.00067539426,0.00014258492,0.0032767192,0.00004278841],"about_ca_topic_score_codex":0.0023676124,"about_ca_topic_score_gemma":0.0020335345,"teacher_disagreement_score":0.020825954,"about_ca_system_score_codex":0.0012544708,"about_ca_system_score_gemma":0.0016220764,"threshold_uncertainty_score":0.11013949},"labels":[],"label_agreement":null},{"id":"W4414179815","doi":"10.1192/j.eurpsy.2025.455","title":"Guideline concordant screening and monitoring of extrapyramidal symptoms in patients prescribed antipsychotic medication: a systematic review and narrative synthesis","year":2025,"lang":"en","type":"article","venue":"European Psychiatry","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto","funders":"","keywords":"PsycINFO; Guideline; Antipsychotic; Quetiapine; CINAHL; Mental health; MEDLINE; Systematic review; Aripiprazole; Nice","score_opus":0.035003311814155294,"score_gpt":0.3960883745045236,"score_spread":0.36108506269036833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414179815","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026962596,0.97441316,0.0025788685,0.0026792078,0.0007261807,0.012322493,0.0031077827,0.00006120063,0.0014148369],"genre_scores_gemma":[0.038359918,0.9173184,0.015024383,0.0033438532,0.00039545598,0.023200069,0.0018673785,0.000033674303,0.00045692758],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.93807626,0.021622978,0.027623005,0.003397033,0.008426847,0.00085387676],"domain_scores_gemma":[0.8903561,0.06723271,0.024080265,0.002741833,0.014808491,0.0007805718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051532008,0.0020770836,0.010843047,0.019638875,0.0012541692,0.0049888007,0.0038419433,0.0033335832,0.0054866434],"category_scores_gemma":[0.16017275,0.001832533,0.009955585,0.017399535,0.0019419545,0.0058394982,0.0034367775,0.0019686194,0.0006490768],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085604035,0.000008645965,0.00045496295,0.9756581,0.002957759,0.000058881604,0.00036469204,0.00009223066,0.00013839785,0.0003773513,0.0016337693,0.018169511],"study_design_scores_gemma":[0.00012687598,0.00006501212,0.0012401453,0.97136444,0.015083178,0.00013611015,0.00033795784,0.00007650174,0.00013131181,0.00042168173,0.010988624,0.00002812638],"about_ca_topic_score_codex":0.008923487,"about_ca_topic_score_gemma":0.02878658,"teacher_disagreement_score":0.051532008,"about_ca_system_score_codex":0.0075929267,"about_ca_system_score_gemma":0.036343444,"threshold_uncertainty_score":0.27253062},"labels":[],"label_agreement":null},{"id":"W4414253621","doi":"10.3389/fmed.2025.1637091","title":"Utilizing group-based models to identify adverse event patterns after an intervention","year":2025,"lang":"en","type":"article","venue":"Frontiers in Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"Centers for Disease Control and Prevention","keywords":"Intervention (counseling); Psychological intervention; Adverse effect; Event (particle physics); Risk assessment","score_opus":0.09256782980618947,"score_gpt":0.4687174371068804,"score_spread":0.3761496073006909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414253621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81028455,0.00057699846,0.18189158,0.001806461,0.0002569059,0.0011917545,0.0019780195,0.00045001268,0.001563628],"genre_scores_gemma":[0.95951843,0.00028348854,0.03444697,0.00020100447,0.00007526677,0.001266706,0.0019690045,0.0000393864,0.0021998652],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99558,0.0029193412,0.00015057571,0.00079780136,0.00017326548,0.00037896054],"domain_scores_gemma":[0.9765921,0.018247273,0.0025035695,0.0010041107,0.0008617428,0.00079121866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013776201,0.0016028685,0.0017108284,0.0023242955,0.0007689576,0.001631604,0.0019721678,0.001692222,0.0044454243],"category_scores_gemma":[0.030848669,0.00055024045,0.0028324919,0.0013484168,0.00082402583,0.0013385472,0.0019139525,0.0024925962,0.0005397214],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024671373,0.0016728035,0.3564416,0.0002692281,0.0027982453,0.00037799648,0.0014749535,0.56599885,0.00047442858,0.008954705,0.0032348298,0.055835232],"study_design_scores_gemma":[0.00014828608,0.00060401944,0.01611714,0.00004264958,0.00019112919,0.000033653658,0.00027183464,0.97429806,0.00008212598,0.007643779,0.00053792004,0.000029478724],"about_ca_topic_score_codex":0.03903062,"about_ca_topic_score_gemma":0.02407423,"teacher_disagreement_score":0.03903062,"about_ca_system_score_codex":0.0021553126,"about_ca_system_score_gemma":0.0025239738,"threshold_uncertainty_score":0.07760686},"labels":[],"label_agreement":null},{"id":"W4414500736","doi":"10.1371/journal.pone.0331940","title":"Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment","year":2025,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"MacEwan University; Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"Mitacs","keywords":"Standardization; Interoperability; Pipeline (software); Data quality; Pharmacovigilance; Drug; Health data; Resource (disambiguation); Quality (philosophy)","score_opus":0.13420773421696813,"score_gpt":0.4269104410701962,"score_spread":0.2927027068532281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414500736","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13761094,0.017074015,0.65880936,0.024482735,0.0008529867,0.008726353,0.08837244,0.038517382,0.025553765],"genre_scores_gemma":[0.21987572,0.0032614074,0.6985901,0.002875718,0.00028656394,0.0017679805,0.06862938,0.0015139293,0.0031992353],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9457961,0.014093548,0.0058758045,0.0075778207,0.024935877,0.0017208807],"domain_scores_gemma":[0.803884,0.042307463,0.01768533,0.022267222,0.109806955,0.0040489933],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06849499,0.0017167897,0.001913722,0.012475246,0.0030329288,0.0057725157,0.004617166,0.0014561934,0.0040940805],"category_scores_gemma":[0.17752738,0.0010988227,0.00293817,0.01025327,0.0018876807,0.002844109,0.009680619,0.0028151737,0.0020390053],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013225089,0.00033158858,0.18637915,0.005105509,0.0015590715,0.00082481204,0.0045279735,0.014560132,0.018018804,0.008934102,0.11128364,0.64715284],"study_design_scores_gemma":[0.0011277469,0.000889964,0.32581806,0.0056308373,0.0021452133,0.001967649,0.0027144714,0.16588211,0.06390949,0.02394052,0.4050418,0.000932163],"about_ca_topic_score_codex":0.5392439,"about_ca_topic_score_gemma":0.54512423,"teacher_disagreement_score":0.931505,"about_ca_system_score_codex":0.017567186,"about_ca_system_score_gemma":0.09009987,"threshold_uncertainty_score":0.92693925},"labels":[],"label_agreement":null},{"id":"W4414530975","doi":"10.1186/s12913-025-13216-4","title":"Electronic data sources for drug utilization research and healthcare decision-making in Mexico","year":2025,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Instituto Mexicano del Seguro Social; International Society for Pharmacoepidemiology","keywords":"Health informatics; Nursing research; Health administration; Health care; Public health; Health services research; Health economics; Drug Utilization Review; MEDLINE","score_opus":0.4015816953790327,"score_gpt":0.6448482212494892,"score_spread":0.24326652587045644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414530975","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09257499,0.28571698,0.01815441,0.035205867,0.0007693287,0.0070996294,0.51570386,0.0005133793,0.04426157],"genre_scores_gemma":[0.36853608,0.22830331,0.10448992,0.005481089,0.0010150416,0.020990321,0.2682562,0.00021080133,0.0027172498],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96022695,0.020750506,0.011525563,0.001992874,0.004823353,0.0006808265],"domain_scores_gemma":[0.7568975,0.17603575,0.035141993,0.008023461,0.02227885,0.0016223844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044317007,0.00075867295,0.0015858285,0.05240562,0.0016047613,0.0052165934,0.002966557,0.0018763337,0.009382777],"category_scores_gemma":[0.13758548,0.00067910564,0.001416891,0.060601957,0.0011450775,0.0055545084,0.003994901,0.0011995147,0.0008312414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085924275,0.0002974998,0.12284421,0.16384219,0.002332381,0.0015320631,0.009967334,0.0014539837,0.000607518,0.021894105,0.11764164,0.5567278],"study_design_scores_gemma":[0.0004927168,0.00027709664,0.20693178,0.24584101,0.0039189165,0.0009971869,0.019872395,0.0016966854,0.0017691607,0.01053341,0.5073744,0.00029516846],"about_ca_topic_score_codex":0.020484239,"about_ca_topic_score_gemma":0.019726245,"teacher_disagreement_score":0.05240562,"about_ca_system_score_codex":0.0059906677,"about_ca_system_score_gemma":0.015484692,"threshold_uncertainty_score":0.23437351},"labels":[],"label_agreement":null},{"id":"W4414980730","doi":"10.14740/gr2062","title":"Enabling Drug-Induced Liver Injury Surveillance Through Automated Medication Extraction From Clinical Notes: A Medical Information Mart for Intensive Care IV Real-World Large Language Models Validation Study","year":2025,"lang":"en","type":"article","venue":"Gastroenterology Research","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Intensive care; Data extraction; Information extraction; Identification (biology); Recall; Liver injury; Electronic medical record; Extraction (chemistry)","score_opus":0.20978571299538765,"score_gpt":0.57128462922677,"score_spread":0.3614989162313824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414980730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92749083,0.0006127934,0.054155547,0.00068428274,0.00009805675,0.0009323794,0.009574847,0.0051691923,0.001282138],"genre_scores_gemma":[0.86112237,0.0002252291,0.11165569,0.00036306982,0.000049039347,0.0006364416,0.024859058,0.00017738235,0.0009116387],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971855,0.0014247132,0.00036809038,0.0005068498,0.00040520995,0.0001096243],"domain_scores_gemma":[0.99037445,0.005793157,0.0006456961,0.0015158913,0.0014059052,0.0002649911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063407025,0.0010060583,0.00046387044,0.0010547609,0.00036830813,0.0011042594,0.0010772337,0.0007430119,0.0008982076],"category_scores_gemma":[0.017849883,0.0002540728,0.000999505,0.0005634401,0.0003924458,0.0007546847,0.001522112,0.00070109015,0.00078354555],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044621,0.0033471447,0.24540919,0.0022538383,0.0015496971,0.0025860586,0.0024898904,0.15677588,0.05756955,0.0020052257,0.026732972,0.49481848],"study_design_scores_gemma":[0.00067116116,0.0027421305,0.11182279,0.00030619995,0.0004189842,0.001525023,0.0013024082,0.80334115,0.059242003,0.0021644656,0.016271453,0.00019227384],"about_ca_topic_score_codex":0.0069682053,"about_ca_topic_score_gemma":0.006843904,"teacher_disagreement_score":0.0069682053,"about_ca_system_score_codex":0.0011182714,"about_ca_system_score_gemma":0.0016547029,"threshold_uncertainty_score":0.033533216},"labels":[],"label_agreement":null},{"id":"W4415381306","doi":"10.1080/15563650.2025.2570461","title":"Comment on “low risk of adverse events associated with flumazenil administration: a retrospective poison center analysis of acutely poisoned patients”","year":2025,"lang":"en","type":"article","venue":"Clinical Toxicology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; McGill University Health Centre; Université de Sherbrooke","funders":"","keywords":"Flumazenil; Adverse effect; Poison control center; Retrospective cohort study; Poison control; Center (category theory); Occupational safety and health","score_opus":0.07937029293986796,"score_gpt":0.4700280486991922,"score_spread":0.3906577557593242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415381306","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016537503,0.0024378449,0.0003487131,0.9353597,0.058603913,0.000022737626,0.00058814086,0.0001533775,0.00083183],"genre_scores_gemma":[0.0083951885,0.0011716884,0.00035965748,0.92989844,0.058440853,0.0000336213,0.00012928878,0.000049453167,0.0015218941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99070674,0.0029324917,0.0016113184,0.0015307838,0.0025365318,0.000682081],"domain_scores_gemma":[0.951086,0.026545752,0.0061534867,0.001574489,0.012521321,0.002118952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012753626,0.0012103313,0.0016903839,0.0014074389,0.002189617,0.0025880998,0.0038309747,0.023960501,0.0039950246],"category_scores_gemma":[0.075802565,0.0009466615,0.00164945,0.0018865213,0.002910891,0.0028177975,0.001243872,0.02020455,0.0038881649],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016321262,0.000027694869,0.0033588866,0.00019353993,0.00008772685,0.00083276577,0.00014257885,0.00007534897,0.0002569282,0.00048743995,0.99023974,0.00413411],"study_design_scores_gemma":[0.00040289699,0.00040847785,0.02289139,0.001704278,0.00049116404,0.0073753414,0.0009770666,0.0013522665,0.0033191426,0.004640532,0.9560103,0.0004271892],"about_ca_topic_score_codex":0.008622393,"about_ca_topic_score_gemma":0.0076827346,"teacher_disagreement_score":0.023960501,"about_ca_system_score_codex":0.0024462102,"about_ca_system_score_gemma":0.002990937,"threshold_uncertainty_score":0.06744838},"labels":[],"label_agreement":null},{"id":"W4415617558","doi":"10.1002/cpt.70095","title":"Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SNC-Lavalin (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Pharmacovigilance; Pharmacogenomics; Adverse effect; Patient safety; Pharmacogenetics; Population; Health care; Drug reaction","score_opus":0.2948564498869957,"score_gpt":0.5553377293727445,"score_spread":0.2604812794857488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415617558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020908515,0.98829865,0.0031028914,0.006030026,0.0003035297,0.000022177086,0.00005429277,0.00007167576,0.0019076203],"genre_scores_gemma":[0.0025645383,0.9903556,0.0038790775,0.002221814,0.00048276494,0.000023354907,0.000076417295,0.000010172496,0.0003861777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975858,0.0010454791,0.00022910739,0.00018550144,0.0008667831,0.00008730354],"domain_scores_gemma":[0.9924286,0.0053022327,0.00069778366,0.0002234242,0.0011240728,0.00022389046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066609257,0.000993707,0.0020521355,0.0037839368,0.00023160137,0.002789023,0.0016684391,0.0022262523,0.0023557488],"category_scores_gemma":[0.008013646,0.0003261695,0.0018088322,0.0032191665,0.0009796452,0.0024186082,0.001636723,0.0044284933,0.0013066486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040061557,0.000059469094,0.0004305397,0.01585985,0.00046615527,0.00014528727,0.0001285003,0.0007773305,0.00055159297,0.014251672,0.022402551,0.9448869],"study_design_scores_gemma":[0.000049953916,0.00012201085,0.0021217056,0.022752574,0.0007392796,0.0011452055,0.00020231877,0.0009209034,0.0006371308,0.027675213,0.9435701,0.00006348072],"about_ca_topic_score_codex":0.0021927424,"about_ca_topic_score_gemma":0.0023528086,"teacher_disagreement_score":0.0066609257,"about_ca_system_score_codex":0.001825207,"about_ca_system_score_gemma":0.003978083,"threshold_uncertainty_score":0.035226762},"labels":[],"label_agreement":null},{"id":"W4415995292","doi":"10.1186/s12916-025-04420-4","title":"Gaps in the detection of drug-drug interactions between antipsychotic and cardiometabolic medications: a multisource analysis","year":2025,"lang":"en","type":"review","venue":"BMC Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Antipsychotic; Pharmacovigilance; Identification (biology); MEDLINE; Medication adherence; Risk assessment","score_opus":0.14917833836401861,"score_gpt":0.5171677419337466,"score_spread":0.367989403569728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415995292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06606365,0.8942326,0.0043067755,0.0044325716,0.00021019645,0.0007843303,0.027321724,0.00006817438,0.0025798853],"genre_scores_gemma":[0.6485233,0.30872795,0.015657268,0.0036946926,0.00030366477,0.002123396,0.020644795,0.00007387933,0.00025108087],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9062085,0.025192862,0.05015942,0.0063673984,0.010906817,0.0011649774],"domain_scores_gemma":[0.6086063,0.30720347,0.053244665,0.009594856,0.019861419,0.0014892407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06055354,0.0010881516,0.0057933265,0.04688632,0.0009696698,0.003516942,0.002334623,0.0016813091,0.0030611253],"category_scores_gemma":[0.2230523,0.00101346,0.0107114995,0.032288294,0.0012799772,0.0045815147,0.0058081714,0.0011590624,0.00035965844],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011534785,0.000099083016,0.18707438,0.6213854,0.04615682,0.0014739594,0.003272123,0.00082517735,0.0008933892,0.0018794648,0.004905667,0.13088112],"study_design_scores_gemma":[0.0004323889,0.00064434845,0.34115404,0.43738297,0.15099478,0.0032988957,0.005338656,0.0016185638,0.0011647688,0.004449179,0.053251784,0.00026958613],"about_ca_topic_score_codex":0.014051791,"about_ca_topic_score_gemma":0.02665335,"teacher_disagreement_score":0.06055354,"about_ca_system_score_codex":0.003537459,"about_ca_system_score_gemma":0.012815669,"threshold_uncertainty_score":0.3202415},"labels":[],"label_agreement":null},{"id":"W4416276467","doi":"10.37897/rjphp.2025.3-4.4","title":"Materiovigilance: current status, global perspectives and implication for pharmaceutical practice","year":2025,"lang":"","type":"article","venue":"Romanian Journal of Pharmaceutical Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Patient safety; European union; Relevance (law); Health care; Risk management; Medical device; Legislation","score_opus":0.07697359076103555,"score_gpt":0.5358568947007726,"score_spread":0.45888330393973703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416276467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013406168,0.86146516,0.0013170777,0.13021491,0.0010402749,0.000028189204,0.00015482934,0.00006813995,0.0043709376],"genre_scores_gemma":[0.028604828,0.9359561,0.0044246227,0.028123911,0.0021471987,0.00008804919,0.00023402993,0.000034715387,0.0003865195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9822366,0.007554879,0.0031539646,0.0019160145,0.004150227,0.0009882909],"domain_scores_gemma":[0.83960116,0.113741584,0.018590322,0.0030353286,0.01965375,0.0053778915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036385268,0.0007361043,0.001481194,0.008012547,0.0013516853,0.008610633,0.0027726989,0.005060464,0.0060257292],"category_scores_gemma":[0.07765628,0.0005741601,0.0017143184,0.010529747,0.0068743625,0.008779059,0.0046542594,0.0056697764,0.0011171917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018030244,0.00011511942,0.00868101,0.060783204,0.0003428408,0.0008468702,0.0043958668,0.0006801828,0.0005642811,0.057013504,0.083283335,0.7831135],"study_design_scores_gemma":[0.00008330269,0.000297063,0.012616386,0.20405053,0.0007491753,0.0031753134,0.009359099,0.0008677526,0.0006820883,0.053435966,0.7145135,0.00016994153],"about_ca_topic_score_codex":0.008006031,"about_ca_topic_score_gemma":0.007218346,"teacher_disagreement_score":0.036385268,"about_ca_system_score_codex":0.0065450855,"about_ca_system_score_gemma":0.025696905,"threshold_uncertainty_score":0.19242597},"labels":[],"label_agreement":null},{"id":"W4416292676","doi":"10.1080/14740338.2025.2588634","title":"Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Neurocrine Biosciences","keywords":"Pharmacovigilance; Adverse Event Reporting System; Dashboard; Adverse effect; Postmarketing surveillance; Quality (philosophy); Public health; MEDLINE","score_opus":0.22096002355757186,"score_gpt":0.4648317167819514,"score_spread":0.24387169322437954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416292676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59281385,0.024095329,0.16091138,0.14035706,0.0017556377,0.0063253096,0.0059420336,0.0013919863,0.06640746],"genre_scores_gemma":[0.8729217,0.008600466,0.0919564,0.017899038,0.0008149115,0.0022725766,0.0016201675,0.00038462377,0.003530149],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.84277683,0.09815403,0.025936497,0.00499931,0.025954591,0.002178714],"domain_scores_gemma":[0.42968565,0.4600872,0.049747236,0.017713023,0.03985666,0.0029101693],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11727595,0.00092735625,0.0010667025,0.004611349,0.003517106,0.007765803,0.0035680619,0.0058973357,0.0045539388],"category_scores_gemma":[0.32419172,0.0008095248,0.0021803987,0.004812734,0.0025679865,0.0075909654,0.0033041697,0.0043883906,0.0009911804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018177299,0.0022376752,0.32763007,0.009069654,0.0008626003,0.11986412,0.052559342,0.008009371,0.0024641142,0.029439876,0.06085901,0.38518652],"study_design_scores_gemma":[0.00077982194,0.0031236983,0.08624801,0.02604378,0.0023174766,0.1865954,0.062454946,0.035547707,0.016632013,0.033296973,0.5460646,0.0008955918],"about_ca_topic_score_codex":0.010370051,"about_ca_topic_score_gemma":0.011609191,"teacher_disagreement_score":0.88272405,"about_ca_system_score_codex":0.006005306,"about_ca_system_score_gemma":0.010017197,"threshold_uncertainty_score":0.620222},"labels":[],"label_agreement":null},{"id":"W4416411418","doi":"10.1038/s41598-025-24945-1","title":"A disproportionality analysis on proprotein convertase subtilisin/kexin type 9 inhibitors and hypersensitivity and anaphylaxis","year":2025,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of Ottawa","funders":"Charité – Universitätsmedizin Berlin","keywords":"Adverse Event Reporting System; Anaphylaxis; Evolocumab; Alirocumab; Pharmacovigilance; Odds ratio; PCSK9; Proprotein convertase","score_opus":0.04767620807610095,"score_gpt":0.4038387994974918,"score_spread":0.35616259142139084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416411418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479063,0.018846717,0.018462965,0.0011894914,0.00031785766,0.0006909426,0.009536512,0.00011771966,0.002931482],"genre_scores_gemma":[0.994003,0.0009433058,0.0023458053,0.00031610735,0.00015116602,0.00029356297,0.0016863637,0.00003615102,0.00022457395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.88589156,0.06962308,0.014100546,0.014006569,0.012353747,0.0040244637],"domain_scores_gemma":[0.82788694,0.09777738,0.053426106,0.0126249995,0.006389685,0.0018948909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.060117092,0.0011508694,0.0022725533,0.008064394,0.00083108107,0.0020126202,0.0015321041,0.0010141989,0.0031700234],"category_scores_gemma":[0.1219312,0.0008887669,0.014028265,0.0064963433,0.0010153087,0.0018200376,0.00483148,0.0018898058,0.00033133864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019170686,0.000046341367,0.9702057,0.0008066585,0.017598756,0.00023603137,0.00023363977,0.00083903375,0.00026328617,0.00067245204,0.00094431906,0.0062367637],"study_design_scores_gemma":[0.0003047476,0.00081793265,0.9578745,0.0007023343,0.021949394,0.0018499704,0.00044479093,0.009941338,0.00096143945,0.0014394386,0.0035973184,0.00011673455],"about_ca_topic_score_codex":0.0060897702,"about_ca_topic_score_gemma":0.0030000128,"teacher_disagreement_score":0.060117092,"about_ca_system_score_codex":0.0012966075,"about_ca_system_score_gemma":0.0013738314,"threshold_uncertainty_score":0.31793338},"labels":[],"label_agreement":null},{"id":"W4416525820","doi":"10.1016/b978-0-443-29025-1.00014-x","title":"Methods to identify adverse drug interactions and events","year":2025,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Causality (physics); Adverse effect; Drug; Pharmacovigilance; Drug reaction; Odds ratio; MEDLINE; Odds; Systematic review","score_opus":0.08910483149680042,"score_gpt":0.4974156478359909,"score_spread":0.4083108163391905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416525820","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02203102,0.0144638475,0.74544066,0.0042037377,0.0015935691,0.007703418,0.03036031,0.008245957,0.1659575],"genre_scores_gemma":[0.066825405,0.010145442,0.77458096,0.0027190798,0.0005617392,0.006138455,0.011950457,0.0005320858,0.12654634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978624,0.00054317154,0.00035298895,0.00025672195,0.0009186555,0.000066144006],"domain_scores_gemma":[0.99272525,0.0038822726,0.0010963881,0.00051896204,0.001595882,0.00018121529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036755935,0.0010105193,0.00063499575,0.004890346,0.000290235,0.002033155,0.00079484243,0.000592204,0.035876885],"category_scores_gemma":[0.013354759,0.00032367895,0.001279726,0.0017220293,0.00027219485,0.0007889934,0.0010808258,0.0007559068,0.013596378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019092215,0.00016266646,0.009475334,0.0010973596,0.00015891921,0.0001680687,0.00017643104,0.0006118884,0.0020993876,0.006021711,0.039161347,0.9406759],"study_design_scores_gemma":[0.00044204463,0.0009315122,0.057053056,0.0055754986,0.0011669094,0.0055007623,0.0011481406,0.03287433,0.019111335,0.06879705,0.80713266,0.0002666586],"about_ca_topic_score_codex":0.0025166676,"about_ca_topic_score_gemma":0.0048074275,"teacher_disagreement_score":0.035876885,"about_ca_system_score_codex":0.00045905134,"about_ca_system_score_gemma":0.0024284916,"threshold_uncertainty_score":0.12002021},"labels":[],"label_agreement":null},{"id":"W4416636379","doi":"10.1183/13993003.congress-2025.pa5688","title":"Real-world novel adverse drug reactions (ADRs) associated with indacaterol","year":2025,"lang":"","type":"article","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Indacaterol; MedDRA; Pharmacovigilance; Adverse effect; Adverse Event Reporting System; Drug; Clinical trial","score_opus":0.0708309385025243,"score_gpt":0.4198438979338546,"score_spread":0.3490129594313303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416636379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982832,0.004892259,0.005968922,0.00041480898,0.000034878773,0.00039363283,0.0027431168,0.00008998798,0.0026304165],"genre_scores_gemma":[0.99291855,0.00094027666,0.0038540016,0.0001632817,0.000073953124,0.00015031362,0.0017056487,0.000010125941,0.00018386447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9800439,0.010650755,0.003812691,0.0013766115,0.0038802403,0.0002358638],"domain_scores_gemma":[0.92363447,0.038088165,0.03295065,0.0027404523,0.0021897594,0.00039640075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010378398,0.00035221322,0.00060941355,0.001629962,0.00024348508,0.0007755591,0.0003363337,0.00052929024,0.0013964728],"category_scores_gemma":[0.031420443,0.00018329298,0.0008620002,0.001768957,0.0004191957,0.00081984693,0.00062289066,0.0005378723,0.00023033755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001530009,0.0001941811,0.94656557,0.00085377385,0.0005660054,0.0015228397,0.00036418685,0.0011771134,0.001995152,0.00025362248,0.000699694,0.04427778],"study_design_scores_gemma":[0.0001144561,0.0015866254,0.97471535,0.00008587323,0.00037977245,0.01126718,0.0002642717,0.0037286074,0.002626159,0.00044320195,0.004750106,0.000038401588],"about_ca_topic_score_codex":0.00039614804,"about_ca_topic_score_gemma":0.00082053634,"teacher_disagreement_score":0.010378398,"about_ca_system_score_codex":0.00041024951,"about_ca_system_score_gemma":0.0002996666,"threshold_uncertainty_score":0.054886937},"labels":[],"label_agreement":null},{"id":"W4416666723","doi":"10.3390/pharma4040027","title":"Antipsychotic Drugs and Diabetic Ketoacidosis: A Disproportionality Analysis of the FDA Adverse Event Reporting System","year":2025,"lang":"en","type":"article","venue":"Pharmacoepidemiology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Nutrition International; University of Ottawa","funders":"","keywords":"Quetiapine; Pharmacovigilance; Olanzapine; Adverse Event Reporting System; Suspect; Antipsychotic; Adverse effect; Diabetic ketoacidosis; Atypical antipsychotic","score_opus":0.1016492245910644,"score_gpt":0.4834127999650882,"score_spread":0.3817635753740238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416666723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97933334,0.007458371,0.005075585,0.0013143764,0.00007994029,0.000255009,0.0044255224,0.000048969807,0.00200887],"genre_scores_gemma":[0.99658906,0.0005105448,0.0012122294,0.00016597123,0.000083296,0.00007061322,0.0012925698,0.000012231842,0.00006339606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9020968,0.055481933,0.017435728,0.008647204,0.013962129,0.0023762016],"domain_scores_gemma":[0.74184316,0.10778429,0.12437456,0.012102023,0.011921299,0.001974569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053596593,0.00063423486,0.0008852105,0.011808456,0.00062541495,0.0022445503,0.0009772838,0.00077615055,0.0014315029],"category_scores_gemma":[0.13750945,0.00044149297,0.004512493,0.007673057,0.00082010945,0.0024976875,0.0039841393,0.0011440973,0.00025367268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027066216,0.000021607288,0.9937355,0.000098257384,0.0014752017,0.00005601672,0.0000899745,0.00026961722,0.00008542467,0.0001838207,0.00025847508,0.0034553765],"study_design_scores_gemma":[0.00003441677,0.00030402935,0.98971224,0.00020861643,0.001376648,0.000837556,0.0003786365,0.0052780816,0.00032059883,0.0002877905,0.001223683,0.000037745576],"about_ca_topic_score_codex":0.004204972,"about_ca_topic_score_gemma":0.0024393837,"teacher_disagreement_score":0.053596593,"about_ca_system_score_codex":0.0015159408,"about_ca_system_score_gemma":0.0010681842,"threshold_uncertainty_score":0.2834493},"labels":[],"label_agreement":null},{"id":"W4416717861","doi":"10.1097/md.0000000000045802","title":"A real-world analysis of Lomitapide-associated adverse events: Data from FAERS and CVAROD","year":2025,"lang":"en","type":"article","venue":"Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Diarrhea; Odds ratio; Nausea; Abdominal pain; Pharmacovigilance; Vomiting","score_opus":0.15706365218648283,"score_gpt":0.4964052542970888,"score_spread":0.339341602110606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416717861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9002566,0.005845,0.0031571384,0.0004856336,0.00004220113,0.0011001728,0.08704341,0.00014518507,0.0019246899],"genre_scores_gemma":[0.908797,0.0013519414,0.005171462,0.00039137987,0.00008767613,0.0015435709,0.082221985,0.0000503914,0.00038458427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96759486,0.010171531,0.010788912,0.004008559,0.0067019234,0.0007341432],"domain_scores_gemma":[0.8571034,0.05545819,0.064909704,0.009013609,0.01220138,0.0013136899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017225495,0.00057680195,0.0011310246,0.0054222816,0.00039336103,0.0015878864,0.00075117324,0.00093463704,0.0014164627],"category_scores_gemma":[0.06225168,0.00035977145,0.001818066,0.0065245265,0.00053776335,0.00093346054,0.001051034,0.0007686181,0.00044998922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056088106,0.000298477,0.9438023,0.0032706559,0.0035760242,0.0009885072,0.0007268672,0.0026127805,0.0013631854,0.00042267225,0.008114998,0.02921483],"study_design_scores_gemma":[0.0005665832,0.0008654139,0.97730166,0.0004489267,0.0016349817,0.0019013586,0.00049119664,0.0034936187,0.0014174965,0.00025167764,0.011504987,0.00012223552],"about_ca_topic_score_codex":0.0077121337,"about_ca_topic_score_gemma":0.0056134183,"teacher_disagreement_score":0.017225495,"about_ca_system_score_codex":0.001524575,"about_ca_system_score_gemma":0.0016609202,"threshold_uncertainty_score":0.09109819},"labels":[],"label_agreement":null},{"id":"W4416841345","doi":"10.3389/fdsfr.2025.1651090","title":"Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices","year":2025,"lang":"en","type":"article","venue":"Frontiers in Drug Safety and Regulation","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Patient Safety Institute","funders":"University of Oxford; Sanofi; Pfizer","keywords":"Pharmacovigilance; Best practice; Vaccination; Pandemic; Excellence; Health care; Public health; Vaccine safety","score_opus":0.14685375948925397,"score_gpt":0.48055328745986664,"score_spread":0.33369952797061264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416841345","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010952008,0.9655796,0.0031038858,0.023682851,0.0011035574,0.00082031015,0.0019766742,0.000067453315,0.0025704796],"genre_scores_gemma":[0.017251985,0.9545747,0.0137880705,0.008868949,0.0009461141,0.0021687117,0.002075736,0.00004648083,0.0002792477],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.85840285,0.052240353,0.054476906,0.006840827,0.026517434,0.0015217372],"domain_scores_gemma":[0.44495526,0.40739045,0.060055465,0.009133369,0.07578154,0.0026839455],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12279385,0.0015566997,0.0047723837,0.057565864,0.001301217,0.0076020476,0.006135355,0.003450356,0.0031823278],"category_scores_gemma":[0.34667695,0.0020784985,0.0060155615,0.04445876,0.0034054143,0.012053132,0.005491305,0.0046495674,0.00089987804],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001188815,0.00006051923,0.0045101764,0.4728904,0.0015168721,0.00017282201,0.0021788562,0.00048475785,0.00021893864,0.00835217,0.031146998,0.47834858],"study_design_scores_gemma":[0.000041883814,0.00012274174,0.0061635547,0.83688164,0.0022138723,0.00029695188,0.0013765569,0.0003273425,0.00030037892,0.0026317565,0.14956269,0.000080629754],"about_ca_topic_score_codex":0.014385127,"about_ca_topic_score_gemma":0.023805156,"teacher_disagreement_score":0.87720615,"about_ca_system_score_codex":0.011036234,"about_ca_system_score_gemma":0.042651933,"threshold_uncertainty_score":0.6494037},"labels":[],"label_agreement":null},{"id":"W4417023414","doi":"10.1002/bcp.70377","title":"Machine learning methods for predicting adverse drug events: A systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"Mitacs","keywords":"Pharmacovigilance; Random forest; MEDLINE; Logistic regression; Predictive modelling; Adverse effect; Systematic review; Class (philosophy)","score_opus":0.23203149190625977,"score_gpt":0.6195304323002863,"score_spread":0.3874989403940265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417023414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002511752,0.99871266,0.00028985812,0.00018827678,0.00006771186,0.000120811834,0.00023452887,0.000010899092,0.0001240652],"genre_scores_gemma":[0.0041499264,0.99378324,0.0012070383,0.00025498288,0.000082691266,0.0002541834,0.00020347493,0.0000056060585,0.000058723293],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9931164,0.0021774755,0.0026292799,0.00051421387,0.0014521002,0.00011039439],"domain_scores_gemma":[0.9493114,0.04331723,0.0043175025,0.00048747103,0.002375622,0.00019075017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009521501,0.001913395,0.0073648253,0.010763705,0.0004753479,0.0021407695,0.0023179033,0.0018540747,0.0059747486],"category_scores_gemma":[0.047996238,0.0007568446,0.010306729,0.0081005925,0.0006797852,0.0022009623,0.0010784223,0.0014978752,0.0006342775],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018402921,0.000036099806,0.0010924443,0.81899583,0.009407072,0.000065485416,0.00008085228,0.000594577,0.0000793847,0.00037924657,0.00319178,0.16589323],"study_design_scores_gemma":[0.00022453682,0.00023455081,0.0042544957,0.9130611,0.049206506,0.0003388055,0.00009524549,0.0007668551,0.00016031566,0.00086449424,0.030732451,0.000060751077],"about_ca_topic_score_codex":0.00607531,"about_ca_topic_score_gemma":0.013864823,"teacher_disagreement_score":0.010763705,"about_ca_system_score_codex":0.002162396,"about_ca_system_score_gemma":0.0073122657,"threshold_uncertainty_score":0.050355077},"labels":[],"label_agreement":null},{"id":"W4417064044","doi":"10.1097/md.0000000000046304","title":"Systematic analysis of adverse reactions associated with dantrolene treatment: From clinical features to molecular mechanisms","year":2025,"lang":"en","type":"article","venue":"Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Dantrolene; RYR1; Adverse effect; Adverse Event Reporting System; Rhabdomyolysis; Subgroup analysis; Odds ratio","score_opus":0.07184573405049756,"score_gpt":0.47210637210289447,"score_spread":0.4002606380523969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417064044","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23866485,0.715459,0.009096342,0.0014323308,0.00036026325,0.0009460612,0.032224946,0.00010678988,0.0017093851],"genre_scores_gemma":[0.86050296,0.113130845,0.006303654,0.0015116322,0.00028816954,0.0010757593,0.016719146,0.00006078901,0.00040705095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9784842,0.0065273405,0.007982868,0.00344252,0.0032540376,0.0003090119],"domain_scores_gemma":[0.9622404,0.018341267,0.011937355,0.0029486758,0.0042392,0.00029320555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012253609,0.00060997345,0.0026362902,0.004417739,0.0003459204,0.0010578638,0.00075032434,0.00047602467,0.0010800831],"category_scores_gemma":[0.030197015,0.00033739448,0.0054813926,0.0061452924,0.0004131174,0.0006922672,0.001096261,0.0005269696,0.00015818956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034489469,0.00006288422,0.7073218,0.07595445,0.06957532,0.0004436273,0.00043358837,0.00085792394,0.0021610826,0.00065477326,0.0051266663,0.13395895],"study_design_scores_gemma":[0.00059005216,0.000783552,0.8406813,0.017615208,0.10667199,0.0015021727,0.0004789721,0.001656028,0.0024916031,0.0016687663,0.025749767,0.00011060889],"about_ca_topic_score_codex":0.002581076,"about_ca_topic_score_gemma":0.008025607,"teacher_disagreement_score":0.012253609,"about_ca_system_score_codex":0.0007509771,"about_ca_system_score_gemma":0.0019377006,"threshold_uncertainty_score":0.06480408},"labels":[],"label_agreement":null},{"id":"W4417114515","doi":"10.22541/au.176519174.47477285/v1","title":"Infliximab-associated Gastrointestinal Obstruction: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (2004-2024)","year":2025,"lang":"","type":"article","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Pharmacovigilance; Adverse effect; Event (particle physics); Event data; MEDLINE; Adverse drug event; Quarter (Canadian coin)","score_opus":0.059669960063714764,"score_gpt":0.41567955342466,"score_spread":0.35600959336094523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417114515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947968,0.0008055675,0.0004116508,0.0002595232,0.00000931787,0.00005905385,0.0031209039,0.000021080872,0.00051608897],"genre_scores_gemma":[0.99623257,0.00018860813,0.00050846144,0.0001065127,0.000019879208,0.000034290886,0.002807142,0.000003962865,0.000098744975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99232215,0.0031334455,0.0014483966,0.00089436315,0.001713695,0.00048792118],"domain_scores_gemma":[0.9727103,0.003975256,0.019875662,0.0010101176,0.0019197634,0.0005088725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006488869,0.00031260867,0.00045813664,0.0031249926,0.0003495404,0.0011114702,0.0005642136,0.0005003356,0.0006920779],"category_scores_gemma":[0.01527353,0.0002842845,0.00096116855,0.005047657,0.00025567712,0.00052088825,0.00087010296,0.00052701053,0.00018104054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121221834,0.00001607489,0.9976042,0.000026918757,0.00012306975,0.00010086763,0.000059626833,0.00008592383,0.00014601742,0.00001845234,0.00019586344,0.001501785],"study_design_scores_gemma":[0.00001012029,0.000080551166,0.9982085,0.000013179573,0.00010863758,0.00034187594,0.0001030728,0.000565735,0.00014003992,0.00000978981,0.00041438022,0.00000419705],"about_ca_topic_score_codex":0.031455643,"about_ca_topic_score_gemma":0.023534369,"teacher_disagreement_score":0.031455643,"about_ca_system_score_codex":0.0020609647,"about_ca_system_score_gemma":0.0015603475,"threshold_uncertainty_score":0.06254506},"labels":[],"label_agreement":null},{"id":"W4417230705","doi":"10.1515/jbcpp-2025-0120","title":"An overview and comparison of haemovigilance reporting forms across six countries relative to the WHO template","year":2025,"lang":"en","type":"article","venue":"Journal of Basic and Clinical Physiology and Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stakeholder; Data collection; Information system; Qualitative analysis","score_opus":0.21800938391928268,"score_gpt":0.5824384740710674,"score_spread":0.3644290901517847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417230705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9347098,0.007158163,0.010762711,0.0019940424,0.00019700847,0.0036531084,0.030568017,0.0005210369,0.0104362],"genre_scores_gemma":[0.9616863,0.0033400224,0.01817586,0.00054156815,0.000039592793,0.0022949006,0.013108388,0.00012034875,0.0006929887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94165367,0.026391393,0.020130415,0.0027691838,0.0076207113,0.0014346463],"domain_scores_gemma":[0.8064306,0.055639166,0.08665076,0.010808762,0.03821834,0.0022523461],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03930719,0.00045868987,0.00080911606,0.009926844,0.00061236316,0.0023088546,0.0009940948,0.00052897504,0.0013903097],"category_scores_gemma":[0.11767331,0.00043712207,0.0017338952,0.014242751,0.0008549445,0.0018270523,0.001757408,0.0006411664,0.0004461788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009776275,0.00011761965,0.89832354,0.0021588122,0.00027378573,0.00015897541,0.003619366,0.0005685695,0.000605716,0.0007769156,0.0053896396,0.08702941],"study_design_scores_gemma":[0.00006562162,0.0006173344,0.97401255,0.0014720598,0.00026092088,0.00085709454,0.0057907067,0.0008724136,0.0009661133,0.00017802676,0.014848468,0.000058711306],"about_ca_topic_score_codex":0.007331328,"about_ca_topic_score_gemma":0.00479722,"teacher_disagreement_score":0.9606928,"about_ca_system_score_codex":0.0026436914,"about_ca_system_score_gemma":0.005355782,"threshold_uncertainty_score":0.20787877},"labels":[],"label_agreement":null},{"id":"W4417348029","doi":"10.1177/20420986251405091","title":"Evaluating seizures associated with novel antineoplastic agents during breast cancer treatment using the Food and Drug Administration Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"China Primary Health Care Foundation","keywords":"Pharmacovigilance; Adverse Event Reporting System; Vigilance (psychology); Food and drug administration; Adverse effect; Adverse drug event; Breast cancer; Drug reaction; Adverse drug reaction","score_opus":0.08656220519098266,"score_gpt":0.44564625855438,"score_spread":0.3590840533633973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417348029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85466963,0.0056006806,0.004004982,0.0006910732,0.000028368539,0.0011507928,0.12708957,0.00024450905,0.006520397],"genre_scores_gemma":[0.9521246,0.0014152115,0.0035055308,0.00023148707,0.000019938436,0.0003131091,0.04192681,0.00001739776,0.00044578064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99026006,0.0014489501,0.0023093116,0.0013371772,0.004221069,0.00042351842],"domain_scores_gemma":[0.9551272,0.007250015,0.02402976,0.0016021299,0.011078177,0.0009128447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072100754,0.00032303217,0.0005561469,0.0057547083,0.00048411224,0.0011829862,0.00076285744,0.0003074208,0.0010003538],"category_scores_gemma":[0.025335925,0.00015610228,0.0008509106,0.008300562,0.0003388213,0.0004896825,0.00084998395,0.0004249559,0.00016579736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038543716,0.00003129495,0.9758419,0.00051949976,0.0004686788,0.00011549989,0.00019096526,0.00065038557,0.00043854935,0.00018518239,0.0026760972,0.018496582],"study_design_scores_gemma":[0.000039508013,0.00010623266,0.99146277,0.0001077465,0.00029203747,0.00026072704,0.0001859175,0.0019715098,0.00080342405,0.00006747274,0.004675702,0.000026955719],"about_ca_topic_score_codex":0.51369727,"about_ca_topic_score_gemma":0.58892405,"teacher_disagreement_score":0.48630273,"about_ca_system_score_codex":0.007435918,"about_ca_system_score_gemma":0.011603201,"threshold_uncertainty_score":0.97833335},"labels":[],"label_agreement":null},{"id":"W4417465070","doi":"10.30895/2312-7821-2025-535","title":"Open-Access Adverse Drug Reaction Databases: Applicability for Safety Assessment of the Developed Drugs (Review)","year":2025,"lang":"ru","type":"article","venue":"Safety and Risk of Pharmacotherapy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Repurposing; Drug reaction; Variety (cybernetics); Drug repositioning; Selection (genetic algorithm); Adverse drug reaction; MEDLINE","score_opus":0.08910792957440032,"score_gpt":0.5147524120854554,"score_spread":0.4256444825110551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417465070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004709679,0.79002076,0.0098057,0.0057682875,0.0009941157,0.0077201175,0.15907891,0.0012630834,0.020639274],"genre_scores_gemma":[0.04917092,0.7714538,0.054356985,0.004552037,0.0012208498,0.013684291,0.09920226,0.00032496668,0.0060338806],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98495734,0.0047582113,0.0063345144,0.0007045038,0.0029818495,0.0002635407],"domain_scores_gemma":[0.92324746,0.03559152,0.020822044,0.0037611772,0.015494031,0.0010837442],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.016839284,0.00090859353,0.0032565393,0.02101822,0.00032491627,0.0028287568,0.0023496733,0.0015328097,0.02783712],"category_scores_gemma":[0.057672348,0.0005353742,0.0034371156,0.017888127,0.00045689716,0.0028833435,0.0021262183,0.00095107657,0.0043767807],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064501085,0.000073802235,0.0020623629,0.41195062,0.0019034018,0.00017646248,0.0002000446,0.00034282083,0.000642161,0.0033761263,0.06090485,0.51772237],"study_design_scores_gemma":[0.0006155823,0.0003057323,0.013407575,0.22775951,0.0067408844,0.0005728437,0.00024425227,0.00044426302,0.0010659989,0.003368726,0.745371,0.00010367276],"about_ca_topic_score_codex":0.0027647007,"about_ca_topic_score_gemma":0.004513009,"teacher_disagreement_score":0.9976503,"about_ca_system_score_codex":0.0016473548,"about_ca_system_score_gemma":0.008559698,"threshold_uncertainty_score":0.09312445},"labels":[],"label_agreement":null},{"id":"W6893198636","doi":"10.5281/zenodo.14872915","title":"Actualización de seguridad - Revisión de seguridad de HEALTH CANADA encontró un posible vínculo entre el uso de canakinumab y el riesgo de DRESS","year":2025,"lang":"es","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Canakinumab; Euros; Public health","score_opus":0.03762348274980244,"score_gpt":0.38424292009987915,"score_spread":0.3466194373500767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6893198636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46970847,0.23420988,0.040442653,0.08797214,0.005519011,0.0039734496,0.01978831,0.0021365935,0.13624953],"genre_scores_gemma":[0.90613383,0.040651556,0.021487856,0.009603923,0.0006861851,0.00058467634,0.004205081,0.0002465406,0.016400516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96412027,0.009371082,0.0040615923,0.0017429014,0.018859666,0.0018445515],"domain_scores_gemma":[0.88122815,0.01642409,0.014659036,0.004499939,0.079027526,0.004161255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029309904,0.00065281964,0.00095213234,0.00372756,0.0016694282,0.0038946245,0.002191124,0.00069570274,0.0034117394],"category_scores_gemma":[0.05796158,0.000425285,0.0014857018,0.0044812337,0.0017620643,0.0011986546,0.0013101115,0.0017947305,0.0005313962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011540782,0.00032519037,0.28764233,0.005055784,0.00079193915,0.00041844085,0.0026000943,0.0013454916,0.0026612016,0.005464312,0.034272876,0.6582683],"study_design_scores_gemma":[0.00020885596,0.0015409482,0.5843526,0.009241895,0.0016571012,0.001420028,0.0028041792,0.0038638136,0.014480191,0.0017218412,0.37846723,0.0002412921],"about_ca_topic_score_codex":0.7113118,"about_ca_topic_score_gemma":0.66122323,"teacher_disagreement_score":0.28868818,"about_ca_system_score_codex":0.032196403,"about_ca_system_score_gemma":0.07980726,"threshold_uncertainty_score":0.58077663},"labels":[],"label_agreement":null},{"id":"W6901887260","doi":"10.6084/m9.figshare.11870376","title":"Additional file 1 of Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 and Health Canada Regulations","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical study; Public health; Confidentiality; Government (linguistics); MEDLINE; Public policy; Health services research","score_opus":0.501367659243743,"score_gpt":0.5763900667767807,"score_spread":0.07502240753303768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901887260","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020021075,0.000021200778,0.00031781264,0.0004759665,0.0000511307,0.00036447545,0.99126184,0.00023647287,0.007070802],"genre_scores_gemma":[0.02171794,0.000395832,0.00593098,0.003270487,0.00053281756,0.006712389,0.89554334,0.0013004,0.0645958],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951244,0.001125112,0.0011153703,0.0006495266,0.0015221842,0.0004634446],"domain_scores_gemma":[0.8593853,0.09800002,0.011591464,0.0058474117,0.023065118,0.0021106536],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006522061,0.00066321617,0.0008951673,0.0039437898,0.0012022181,0.00200637,0.0016466273,0.0016991405,0.8594611],"category_scores_gemma":[0.11267567,0.00052945904,0.00081127544,0.0058903736,0.0003495389,0.002066766,0.001367368,0.0010551317,0.17272379],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015024879,0.000024438645,0.001027002,0.0005802313,0.000013523384,0.000023188542,0.000027681814,0.0001230415,0.000016788603,0.0008391837,0.9920551,0.005119469],"study_design_scores_gemma":[0.0028263268,0.00020351843,0.028244462,0.0050143804,0.00012736295,0.00037720744,0.00041432973,0.0013040685,0.00046926542,0.00817032,0.95274544,0.00010335898],"about_ca_topic_score_codex":0.024992801,"about_ca_topic_score_gemma":0.030675666,"teacher_disagreement_score":0.99830085,"about_ca_system_score_codex":0.0034563967,"about_ca_system_score_gemma":0.005880079,"threshold_uncertainty_score":0.20046163},"labels":[],"label_agreement":null},{"id":"W6902060446","doi":"10.6084/m9.figshare.26607559.v1","title":"Additional file 1 of Clinical utility of overviews on adverse events of pharmacological interventions","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Adverse effect; Psychological intervention; MEDLINE; Clinical trial; Event (particle physics)","score_opus":0.4889408442659266,"score_gpt":0.5641323406006261,"score_spread":0.07519149633469951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902060446","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000189916,0.000043082164,0.00021733128,0.00018689265,0.000022332748,0.000110282024,0.99712986,0.00015528723,0.0019450791],"genre_scores_gemma":[0.021131312,0.00052971515,0.005763568,0.0019980702,0.00028000414,0.004115084,0.9451075,0.0010295655,0.020045238],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99772686,0.00062793796,0.00065448147,0.00040821717,0.0004043966,0.00017811405],"domain_scores_gemma":[0.87488884,0.104987904,0.0065943524,0.003200199,0.009184464,0.0011443092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003213098,0.00087285193,0.0010865896,0.0035537381,0.0006676507,0.0014992445,0.0013982994,0.0014976799,0.8664836],"category_scores_gemma":[0.083505705,0.00045370462,0.0014128569,0.004711853,0.00023482843,0.0020220985,0.001160167,0.0010908007,0.12375062],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054682116,0.00007659091,0.0039057066,0.0045344853,0.000106866326,0.00006874456,0.00006950914,0.0003702549,0.000038322363,0.0011122719,0.9779001,0.011270317],"study_design_scores_gemma":[0.009332449,0.0004616332,0.048596766,0.012633506,0.00073086936,0.00093232375,0.00065982464,0.0020941126,0.00065997697,0.018480444,0.9052078,0.00021023519],"about_ca_topic_score_codex":0.010641747,"about_ca_topic_score_gemma":0.014041522,"teacher_disagreement_score":0.8664836,"about_ca_system_score_codex":0.0015532648,"about_ca_system_score_gemma":0.0027095373,"threshold_uncertainty_score":0.19044489},"labels":[],"label_agreement":null},{"id":"W6902136187","doi":"10.6084/m9.figshare.26583873.v1","title":"Additional file 1 of Data source profile reporting by studies that use routinely collected health data to explore the effects of drug treatment","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Data source; Health data; Drug treatment; Data collection; Information source (mathematics); MEDLINE","score_opus":0.6180591960231158,"score_gpt":0.5246877531366895,"score_spread":0.09337144288642629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902136187","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010246633,0.000032212156,0.00016258522,0.000053406144,0.000013942193,0.0000704699,0.99900466,0.00012000441,0.0004403789],"genre_scores_gemma":[0.007046311,0.00029120568,0.005746517,0.0010851069,0.00013458903,0.0030106434,0.97629094,0.000769073,0.005625604],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.996924,0.00057840464,0.001154715,0.0006261576,0.00042965307,0.00028713117],"domain_scores_gemma":[0.861572,0.112676926,0.01227714,0.0047324602,0.007203159,0.0015382868],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041911006,0.0015763305,0.0022140583,0.010085144,0.0007523933,0.002525595,0.0016553702,0.0019247925,0.8329138],"category_scores_gemma":[0.085172735,0.00097614195,0.0022504302,0.010081637,0.0004790682,0.002395721,0.0019576047,0.0010509348,0.13232093],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000690848,0.00013316468,0.006923006,0.018036906,0.000433644,0.00009758977,0.00009393121,0.0006795036,0.00016494012,0.0015674205,0.95698947,0.014189617],"study_design_scores_gemma":[0.009233085,0.0004571565,0.04789495,0.0163484,0.0011962701,0.0009224877,0.0005805838,0.0023585963,0.0009894961,0.017463522,0.9022463,0.0003091191],"about_ca_topic_score_codex":0.007044107,"about_ca_topic_score_gemma":0.0120763155,"teacher_disagreement_score":0.9958089,"about_ca_system_score_codex":0.0017701564,"about_ca_system_score_gemma":0.0038178856,"threshold_uncertainty_score":0.23832816},"labels":[],"label_agreement":null},{"id":"W6902199026","doi":"10.6084/m9.figshare.14478957.v1","title":"Additional file 1 of Detection of adverse drug events in e-prescribing and administrative health data: a validation study","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University Health Centre; McGill University","funders":"","keywords":"Adverse effect; Drug; MEDLINE; Health care; Public health; Data collection","score_opus":0.27166375174992347,"score_gpt":0.4727921645870399,"score_spread":0.2011284128371164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902199026","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011879613,0.000013518096,0.00025833645,0.0001767745,0.000018952776,0.00038588204,0.9963331,0.0000808091,0.0015447084],"genre_scores_gemma":[0.037104208,0.00013933785,0.0036306079,0.0010771924,0.00015695185,0.010665319,0.9340189,0.00033543466,0.012872046],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99840075,0.0003892079,0.000467506,0.00028532144,0.00031510298,0.00014200313],"domain_scores_gemma":[0.9526406,0.03333676,0.005200868,0.0021135753,0.005991657,0.0007166456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026474972,0.0005840865,0.0007368189,0.002029587,0.00083181076,0.0009521546,0.0009641507,0.00089108985,0.72437155],"category_scores_gemma":[0.044054262,0.00039946282,0.00073713204,0.003449743,0.00025399675,0.0012439946,0.0007567901,0.0008429394,0.06656584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048104578,0.00026741822,0.011234601,0.0014580864,0.000056605768,0.000075905475,0.00010957556,0.00034607842,0.00006903407,0.0007313454,0.97622347,0.008946874],"study_design_scores_gemma":[0.013733916,0.001226594,0.24966048,0.006476321,0.0003424882,0.0012073022,0.0013697066,0.0032527053,0.00151491,0.0077875806,0.7132067,0.00022136702],"about_ca_topic_score_codex":0.008729566,"about_ca_topic_score_gemma":0.009142555,"teacher_disagreement_score":0.72437155,"about_ca_system_score_codex":0.0012630606,"about_ca_system_score_gemma":0.002252114,"threshold_uncertainty_score":0.3931505},"labels":[],"label_agreement":null},{"id":"W6902216259","doi":"10.6084/m9.figshare.26583873","title":"Additional file 1 of Data source profile reporting by studies that use routinely collected health data to explore the effects of drug treatment","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Data source; Health data; Drug treatment; Data collection; Information source (mathematics); MEDLINE","score_opus":0.6180591960231158,"score_gpt":0.5246877531366895,"score_spread":0.09337144288642629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902216259","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010246633,0.000032212156,0.00016258522,0.000053406144,0.000013942193,0.0000704699,0.99900466,0.00012000441,0.0004403789],"genre_scores_gemma":[0.007046311,0.00029120568,0.005746517,0.0010851069,0.00013458903,0.0030106434,0.97629094,0.000769073,0.005625604],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.996924,0.00057840464,0.001154715,0.0006261576,0.00042965307,0.00028713117],"domain_scores_gemma":[0.861572,0.112676926,0.01227714,0.0047324602,0.007203159,0.0015382868],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041911006,0.0015763305,0.0022140583,0.010085144,0.0007523933,0.002525595,0.0016553702,0.0019247925,0.8329138],"category_scores_gemma":[0.085172735,0.00097614195,0.0022504302,0.010081637,0.0004790682,0.002395721,0.0019576047,0.0010509348,0.13232093],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000690848,0.00013316468,0.006923006,0.018036906,0.000433644,0.00009758977,0.00009393121,0.0006795036,0.00016494012,0.0015674205,0.95698947,0.014189617],"study_design_scores_gemma":[0.009233085,0.0004571565,0.04789495,0.0163484,0.0011962701,0.0009224877,0.0005805838,0.0023585963,0.0009894961,0.017463522,0.9022463,0.0003091191],"about_ca_topic_score_codex":0.007044107,"about_ca_topic_score_gemma":0.0120763155,"teacher_disagreement_score":0.9958089,"about_ca_system_score_codex":0.0017701564,"about_ca_system_score_gemma":0.0038178856,"threshold_uncertainty_score":0.23832816},"labels":[],"label_agreement":null},{"id":"W6902237052","doi":"10.6084/m9.figshare.26607562","title":"Additional file 2 of Clinical utility of overviews on adverse events of pharmacological interventions","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Adverse effect; Psychological intervention; MEDLINE; Clinical trial; Event (particle physics)","score_opus":0.4804156130996516,"score_gpt":0.5634392457966484,"score_spread":0.08302363269699681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902237052","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018107182,0.0000380521,0.0002121522,0.00019677912,0.000024413874,0.000104526946,0.99704283,0.00016743869,0.0020327624],"genre_scores_gemma":[0.019285385,0.0004360191,0.0052101063,0.0020169644,0.00028081177,0.0035681743,0.946336,0.0010704814,0.02179606],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978642,0.00055891083,0.000610739,0.00038822638,0.00039834814,0.00017964379],"domain_scores_gemma":[0.8913286,0.090128444,0.005781027,0.0029955783,0.008640922,0.0011254372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003046537,0.00083328155,0.0011069312,0.0034954818,0.000680412,0.0015904435,0.0014313714,0.0015666569,0.86878896],"category_scores_gemma":[0.07698921,0.00045229017,0.001435215,0.004449632,0.00023867024,0.002042615,0.0011716282,0.001047932,0.120326124],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005400954,0.00007216372,0.0037631737,0.004439988,0.00010146083,0.0000748151,0.00006863913,0.0003649942,0.00004082853,0.0011690797,0.9785351,0.01082968],"study_design_scores_gemma":[0.00790253,0.00035362763,0.040941417,0.010693443,0.0006214864,0.0007638467,0.0006102119,0.0017615458,0.00058843166,0.017697882,0.9178824,0.00018320365],"about_ca_topic_score_codex":0.011096287,"about_ca_topic_score_gemma":0.015068622,"teacher_disagreement_score":0.86878896,"about_ca_system_score_codex":0.001505398,"about_ca_system_score_gemma":0.0026162372,"threshold_uncertainty_score":0.18715656},"labels":[],"label_agreement":null},{"id":"W6902270894","doi":"10.6084/m9.figshare.26574892.v1","title":"Additional file 1 of Medical ID use by international patients with Aspirin-Exacerbated Respiratory Disease","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Disease; MEDLINE; Respiratory disease; Medical record; Respiratory system","score_opus":0.09707351050972518,"score_gpt":0.40307338723780634,"score_spread":0.30599987672808115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902270894","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031612534,0.000013376803,0.000080177575,0.00012628545,0.0000144060505,0.00007085648,0.9967212,0.000060324546,0.0025972335],"genre_scores_gemma":[0.016052498,0.00022653889,0.001154307,0.0010498454,0.00015922761,0.0019647328,0.96047664,0.00024912957,0.018667199],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991122,0.00020094273,0.00019302443,0.00019124562,0.00016697163,0.00013554232],"domain_scores_gemma":[0.98475605,0.009268945,0.0021710857,0.0007050658,0.0026108592,0.00048798375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009987211,0.0005498315,0.0007149323,0.0023056779,0.000594502,0.0008130753,0.0007762323,0.0007373611,0.77862],"category_scores_gemma":[0.019904565,0.00032232617,0.00052270986,0.005129992,0.00015317909,0.0012644299,0.00080966833,0.00065652234,0.10901158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011382409,0.000045215165,0.0032474159,0.0006324113,0.000017511878,0.000025704221,0.00003970088,0.00012641495,0.000022786753,0.00044778432,0.991327,0.003954184],"study_design_scores_gemma":[0.002520936,0.00029717627,0.100369945,0.004416272,0.00013691833,0.0005071767,0.0009904515,0.0013333812,0.0004337376,0.006145097,0.8827459,0.00010303163],"about_ca_topic_score_codex":0.014201903,"about_ca_topic_score_gemma":0.015653998,"teacher_disagreement_score":0.77862,"about_ca_system_score_codex":0.0010089321,"about_ca_system_score_gemma":0.001409057,"threshold_uncertainty_score":0.31577164},"labels":[],"label_agreement":null},{"id":"W6902309029","doi":"10.6084/m9.figshare.26986486","title":"Additional file 2 of Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Primary prevention; Primary care; Systematic review; Fragility; Fragility fracture; MEDLINE","score_opus":0.06075313010151056,"score_gpt":0.37285116140040675,"score_spread":0.3120980312988962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902309029","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025619546,0.00066382875,0.00014521972,0.00029345456,0.000033084838,0.00067732035,0.9966568,0.00009585136,0.001178223],"genre_scores_gemma":[0.032973707,0.007806565,0.010582054,0.0041969125,0.00049367134,0.05746029,0.8558184,0.0009890975,0.029679257],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972602,0.00060864474,0.0011219668,0.0003967833,0.0003793026,0.00023302907],"domain_scores_gemma":[0.9299081,0.058965977,0.0057085315,0.00095487456,0.0039008458,0.00056165777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004394944,0.001554794,0.003998863,0.0073242756,0.00074699864,0.002071486,0.0021176916,0.0017783738,0.7879264],"category_scores_gemma":[0.06991921,0.0008930473,0.0039743213,0.012692591,0.00043700353,0.0035452126,0.0020078812,0.0010711484,0.03885471],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015216605,0.00007835161,0.0031953736,0.510337,0.0015921693,0.00014266418,0.00028916675,0.0006592074,0.00021103148,0.0024538096,0.46623513,0.013284376],"study_design_scores_gemma":[0.040571816,0.0009735813,0.055865634,0.33159938,0.011435425,0.0008772269,0.0013649133,0.002475849,0.00069034874,0.015507671,0.5381837,0.00045439633],"about_ca_topic_score_codex":0.01513763,"about_ca_topic_score_gemma":0.031241933,"teacher_disagreement_score":0.7879264,"about_ca_system_score_codex":0.0025779023,"about_ca_system_score_gemma":0.004830645,"threshold_uncertainty_score":0.30249727},"labels":[],"label_agreement":null},{"id":"W6902342200","doi":"10.6084/m9.figshare.26583879","title":"Additional file 3 of Data source profile reporting by studies that use routinely collected health data to explore the effects of drug treatment","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Data source; Health data; Drug treatment; Data collection; Information source (mathematics); MEDLINE","score_opus":0.6138788188327036,"score_gpt":0.524142030418673,"score_spread":0.08973678841403054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902342200","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010572611,0.000028822516,0.00016459964,0.00005936945,0.000016173255,0.00006674412,0.99891126,0.00015969176,0.00048765074],"genre_scores_gemma":[0.0070060766,0.00025940588,0.0053295353,0.0011224169,0.00014021604,0.0026648121,0.9759856,0.0009492651,0.006542694],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970974,0.0004975061,0.0010724186,0.0005768646,0.00045541118,0.0003005751],"domain_scores_gemma":[0.8750349,0.101269305,0.010903515,0.00441593,0.006913624,0.0014626988],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003965779,0.0017013185,0.0023142365,0.010143115,0.0007641267,0.0027368052,0.0017610053,0.0020411557,0.84595966],"category_scores_gemma":[0.07861941,0.0009768752,0.0025136087,0.009192947,0.0004767946,0.0024516738,0.0020445571,0.0010491997,0.13149418],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074592256,0.00012795547,0.0073333876,0.018831277,0.000481884,0.000118218435,0.00010215996,0.00072573713,0.0001929549,0.0016320702,0.95681,0.012898371],"study_design_scores_gemma":[0.0095546385,0.0003958156,0.04540886,0.016007395,0.001186621,0.00086969096,0.0005694154,0.0024562785,0.0011017513,0.018595288,0.9035387,0.00031536954],"about_ca_topic_score_codex":0.008195449,"about_ca_topic_score_gemma":0.014050925,"teacher_disagreement_score":0.9960342,"about_ca_system_score_codex":0.0018863551,"about_ca_system_score_gemma":0.0038200081,"threshold_uncertainty_score":0.21971977},"labels":[],"label_agreement":null},{"id":"W6920635901","doi":"10.6084/m9.figshare.11870376.v1","title":"Additional file 1 of Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 and Health Canada Regulations","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical study; Public health; Confidentiality; Government (linguistics); MEDLINE; Public policy; Health services research","score_opus":0.501367659243743,"score_gpt":0.5763900667767807,"score_spread":0.07502240753303768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920635901","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020021075,0.000021200778,0.00031781264,0.0004759665,0.0000511307,0.00036447545,0.99126184,0.00023647287,0.007070802],"genre_scores_gemma":[0.02171794,0.000395832,0.00593098,0.003270487,0.00053281756,0.006712389,0.89554334,0.0013004,0.0645958],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951244,0.001125112,0.0011153703,0.0006495266,0.0015221842,0.0004634446],"domain_scores_gemma":[0.8593853,0.09800002,0.011591464,0.0058474117,0.023065118,0.0021106536],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006522061,0.00066321617,0.0008951673,0.0039437898,0.0012022181,0.00200637,0.0016466273,0.0016991405,0.8594611],"category_scores_gemma":[0.11267567,0.00052945904,0.00081127544,0.0058903736,0.0003495389,0.002066766,0.001367368,0.0010551317,0.17272379],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015024879,0.000024438645,0.001027002,0.0005802313,0.000013523384,0.000023188542,0.000027681814,0.0001230415,0.000016788603,0.0008391837,0.9920551,0.005119469],"study_design_scores_gemma":[0.0028263268,0.00020351843,0.028244462,0.0050143804,0.00012736295,0.00037720744,0.00041432973,0.0013040685,0.00046926542,0.00817032,0.95274544,0.00010335898],"about_ca_topic_score_codex":0.024992801,"about_ca_topic_score_gemma":0.030675666,"teacher_disagreement_score":0.9965436,"about_ca_system_score_codex":0.0034563967,"about_ca_system_score_gemma":0.005880079,"threshold_uncertainty_score":0.20046163},"labels":[],"label_agreement":null},{"id":"W6920669391","doi":"10.6084/m9.figshare.17007314.v1","title":"Additional file 1 of Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Drug reaction; Adverse drug reaction; Vigilance (psychology); Adverse effect; MEDLINE; National database","score_opus":0.10741346883382152,"score_gpt":0.39927546434027783,"score_spread":0.2918619955064563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920669391","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017177722,0.000016694225,0.00034500915,0.00016373351,0.000016267799,0.00016072534,0.9968213,0.00020528481,0.0020992875],"genre_scores_gemma":[0.020273682,0.00031436296,0.011957817,0.0015068053,0.0001966451,0.0048233634,0.9410407,0.0016356732,0.018250974],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979506,0.0005577757,0.00044133374,0.00035957337,0.0004921851,0.00019855815],"domain_scores_gemma":[0.9180807,0.06690553,0.003824021,0.00251473,0.007635714,0.0010392624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038064881,0.00072694913,0.000923554,0.0031195856,0.00070029055,0.0017232816,0.0014782379,0.0010535386,0.8816312],"category_scores_gemma":[0.06880555,0.00055969495,0.0012003165,0.0058349743,0.0002508149,0.0017244566,0.0011103209,0.0009451624,0.1173087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036510726,0.000057850775,0.00251196,0.0020949654,0.00005722791,0.000047574955,0.00005275648,0.0005370472,0.000027511749,0.0010494891,0.9840094,0.009189148],"study_design_scores_gemma":[0.009446245,0.00030423747,0.033623166,0.006090108,0.00039096957,0.00051890075,0.0004919267,0.0037495906,0.0005993862,0.014777892,0.9298475,0.00016008386],"about_ca_topic_score_codex":0.028215248,"about_ca_topic_score_gemma":0.04030062,"teacher_disagreement_score":0.9717848,"about_ca_system_score_codex":0.0020936711,"about_ca_system_score_gemma":0.0044350764,"threshold_uncertainty_score":0.16883874},"labels":[],"label_agreement":null},{"id":"W6920837933","doi":"10.6084/m9.figshare.17007314","title":"Additional file 1 of Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Drug reaction; Adverse drug reaction; Vigilance (psychology); Adverse effect; MEDLINE; National database","score_opus":0.10741346883382152,"score_gpt":0.39927546434027783,"score_spread":0.2918619955064563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920837933","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017177722,0.000016694225,0.00034500915,0.00016373351,0.000016267799,0.00016072534,0.9968213,0.00020528481,0.0020992875],"genre_scores_gemma":[0.020273682,0.00031436296,0.011957817,0.0015068053,0.0001966451,0.0048233634,0.9410407,0.0016356732,0.018250974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979506,0.0005577757,0.00044133374,0.00035957337,0.0004921851,0.00019855815],"domain_scores_gemma":[0.9180807,0.06690553,0.003824021,0.00251473,0.007635714,0.0010392624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038064881,0.00072694913,0.000923554,0.0031195856,0.00070029055,0.0017232816,0.0014782379,0.0010535386,0.8816312],"category_scores_gemma":[0.06880555,0.00055969495,0.0012003165,0.0058349743,0.0002508149,0.0017244566,0.0011103209,0.0009451624,0.1173087],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036510726,0.000057850775,0.00251196,0.0020949654,0.00005722791,0.000047574955,0.00005275648,0.0005370472,0.000027511749,0.0010494891,0.9840094,0.009189148],"study_design_scores_gemma":[0.009446245,0.00030423747,0.033623166,0.006090108,0.00039096957,0.00051890075,0.0004919267,0.0037495906,0.0005993862,0.014777892,0.9298475,0.00016008386],"about_ca_topic_score_codex":0.028215248,"about_ca_topic_score_gemma":0.04030062,"teacher_disagreement_score":0.9717848,"about_ca_system_score_codex":0.0020936711,"about_ca_system_score_gemma":0.0044350764,"threshold_uncertainty_score":0.16883874},"labels":[],"label_agreement":null},{"id":"W6920880699","doi":"10.6084/m9.figshare.19802426.v1","title":"Additional file 1 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Table (database); European union; Public health; Risk assessment; MEDLINE","score_opus":0.4780026346208931,"score_gpt":0.5243188584160421,"score_spread":0.04631622379514899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920880699","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016526858,0.000025578473,0.0002722748,0.00007891538,0.000021230611,0.00023209101,0.9985435,0.00011592676,0.0005453726],"genre_scores_gemma":[0.014638841,0.00031429017,0.008324265,0.0010120325,0.00020772222,0.017606769,0.94654477,0.00092699955,0.010424296],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.994484,0.0013052716,0.0019544216,0.0010240915,0.00077571743,0.00045642885],"domain_scores_gemma":[0.84741145,0.124166615,0.010413788,0.007328204,0.00928397,0.0013959917],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008031919,0.0012977349,0.0020779811,0.0078600235,0.0009991318,0.0022849296,0.0019155827,0.0015211492,0.82490945],"category_scores_gemma":[0.122762926,0.0007771738,0.0017479481,0.011361072,0.00046283778,0.0025035655,0.0019189097,0.0012085141,0.08965439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005932808,0.00008534192,0.0041689724,0.011486565,0.00029940024,0.00007923911,0.00012212641,0.0005250513,0.000111023684,0.0017949039,0.9707136,0.010020498],"study_design_scores_gemma":[0.012128152,0.00046010103,0.05048618,0.01830147,0.0012329662,0.00067524385,0.0009205565,0.002597489,0.0008212601,0.019459931,0.892641,0.00027565268],"about_ca_topic_score_codex":0.007715989,"about_ca_topic_score_gemma":0.009788224,"teacher_disagreement_score":0.9919681,"about_ca_system_score_codex":0.001898459,"about_ca_system_score_gemma":0.00407116,"threshold_uncertainty_score":0.24974537},"labels":[],"label_agreement":null},{"id":"W6920909794","doi":"10.6084/m9.figshare.26583879.v1","title":"Additional file 3 of Data source profile reporting by studies that use routinely collected health data to explore the effects of drug treatment","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Data source; Health data; Drug treatment; Data collection; Information source (mathematics); MEDLINE","score_opus":0.6138788188327036,"score_gpt":0.524142030418673,"score_spread":0.08973678841403054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920909794","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010572611,0.000028822516,0.00016459964,0.00005936945,0.000016173255,0.00006674412,0.99891126,0.00015969176,0.00048765074],"genre_scores_gemma":[0.0070060766,0.00025940588,0.0053295353,0.0011224169,0.00014021604,0.0026648121,0.9759856,0.0009492651,0.006542694],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970974,0.0004975061,0.0010724186,0.0005768646,0.00045541118,0.0003005751],"domain_scores_gemma":[0.8750349,0.101269305,0.010903515,0.00441593,0.006913624,0.0014626988],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003965779,0.0017013185,0.0023142365,0.010143115,0.0007641267,0.0027368052,0.0017610053,0.0020411557,0.84595966],"category_scores_gemma":[0.07861941,0.0009768752,0.0025136087,0.009192947,0.0004767946,0.0024516738,0.0020445571,0.0010491997,0.13149418],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074592256,0.00012795547,0.0073333876,0.018831277,0.000481884,0.000118218435,0.00010215996,0.00072573713,0.0001929549,0.0016320702,0.95681,0.012898371],"study_design_scores_gemma":[0.0095546385,0.0003958156,0.04540886,0.016007395,0.001186621,0.00086969096,0.0005694154,0.0024562785,0.0011017513,0.018595288,0.9035387,0.00031536954],"about_ca_topic_score_codex":0.008195449,"about_ca_topic_score_gemma":0.014050925,"teacher_disagreement_score":0.9960342,"about_ca_system_score_codex":0.0018863551,"about_ca_system_score_gemma":0.0038200081,"threshold_uncertainty_score":0.21971977},"labels":[],"label_agreement":null},{"id":"W6920958893","doi":"10.6084/m9.figshare.19802426","title":"Additional file 1 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Table (database); European union; Public health; Risk assessment; MEDLINE","score_opus":0.4780026346208931,"score_gpt":0.5243188584160421,"score_spread":0.04631622379514899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920958893","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016526858,0.000025578473,0.0002722748,0.00007891538,0.000021230611,0.00023209101,0.9985435,0.00011592676,0.0005453726],"genre_scores_gemma":[0.014638841,0.00031429017,0.008324265,0.0010120325,0.00020772222,0.017606769,0.94654477,0.00092699955,0.010424296],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.994484,0.0013052716,0.0019544216,0.0010240915,0.00077571743,0.00045642885],"domain_scores_gemma":[0.84741145,0.124166615,0.010413788,0.007328204,0.00928397,0.0013959917],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008031919,0.0012977349,0.0020779811,0.0078600235,0.0009991318,0.0022849296,0.0019155827,0.0015211492,0.82490945],"category_scores_gemma":[0.122762926,0.0007771738,0.0017479481,0.011361072,0.00046283778,0.0025035655,0.0019189097,0.0012085141,0.08965439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005932808,0.00008534192,0.0041689724,0.011486565,0.00029940024,0.00007923911,0.00012212641,0.0005250513,0.000111023684,0.0017949039,0.9707136,0.010020498],"study_design_scores_gemma":[0.012128152,0.00046010103,0.05048618,0.01830147,0.0012329662,0.00067524385,0.0009205565,0.002597489,0.0008212601,0.019459931,0.892641,0.00027565268],"about_ca_topic_score_codex":0.007715989,"about_ca_topic_score_gemma":0.009788224,"teacher_disagreement_score":0.9919681,"about_ca_system_score_codex":0.001898459,"about_ca_system_score_gemma":0.00407116,"threshold_uncertainty_score":0.24974537},"labels":[],"label_agreement":null},{"id":"W6921048780","doi":"10.6084/m9.figshare.26607562.v1","title":"Additional file 2 of Clinical utility of overviews on adverse events of pharmacological interventions","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Adverse effect; Psychological intervention; MEDLINE; Clinical trial; Event (particle physics)","score_opus":0.4804156130996516,"score_gpt":0.5634392457966484,"score_spread":0.08302363269699681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921048780","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018107182,0.0000380521,0.0002121522,0.00019677912,0.000024413874,0.000104526946,0.99704283,0.00016743869,0.0020327624],"genre_scores_gemma":[0.019285385,0.0004360191,0.0052101063,0.0020169644,0.00028081177,0.0035681743,0.946336,0.0010704814,0.02179606],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978642,0.00055891083,0.000610739,0.00038822638,0.00039834814,0.00017964379],"domain_scores_gemma":[0.8913286,0.090128444,0.005781027,0.0029955783,0.008640922,0.0011254372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003046537,0.00083328155,0.0011069312,0.0034954818,0.000680412,0.0015904435,0.0014313714,0.0015666569,0.86878896],"category_scores_gemma":[0.07698921,0.00045229017,0.001435215,0.004449632,0.00023867024,0.002042615,0.0011716282,0.001047932,0.120326124],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005400954,0.00007216372,0.0037631737,0.004439988,0.00010146083,0.0000748151,0.00006863913,0.0003649942,0.00004082853,0.0011690797,0.9785351,0.01082968],"study_design_scores_gemma":[0.00790253,0.00035362763,0.040941417,0.010693443,0.0006214864,0.0007638467,0.0006102119,0.0017615458,0.00058843166,0.017697882,0.9178824,0.00018320365],"about_ca_topic_score_codex":0.011096287,"about_ca_topic_score_gemma":0.015068622,"teacher_disagreement_score":0.86878896,"about_ca_system_score_codex":0.001505398,"about_ca_system_score_gemma":0.0026162372,"threshold_uncertainty_score":0.18715656},"labels":[],"label_agreement":null},{"id":"W6929682043","doi":"10.48660/08080051","title":"Improving Quantum State Tomography with Mutually Unbiased Bases","year":2008,"lang":"en","type":"other","venue":"PIRSA","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"State (computer science); Quantum; Quantum tomography; Tomography; Mutually unbiased bases; Property (philosophy); Field (mathematics); Quantum state","score_opus":0.06569022198265301,"score_gpt":0.3721390799808237,"score_spread":0.3064488579981707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929682043","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017040115,0.00036079995,0.9761051,0.00076444313,0.00007133909,0.000049422266,0.0002484341,0.00065341155,0.004706973],"genre_scores_gemma":[0.41775882,0.00052049244,0.57201433,0.0007023791,0.0002407326,0.00021609815,0.0010234605,0.00022277782,0.007300871],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99745315,0.0013022191,0.00008735156,0.0003153574,0.0006769587,0.0001649092],"domain_scores_gemma":[0.9946296,0.0032917585,0.00029664542,0.0011892418,0.00046357658,0.0001290861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030465543,0.0010118083,0.0014522176,0.0008241059,0.00073843065,0.0015436934,0.0014209416,0.0015195024,0.004973757],"category_scores_gemma":[0.010549175,0.00065385795,0.0009425024,0.0015858435,0.0014271635,0.0035575563,0.0037809915,0.001712895,0.0010472405],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001000615,0.00023308942,0.0022857212,0.00026471348,0.00030184878,0.00018505527,0.00022462526,0.31261778,0.015514834,0.36543882,0.009131836,0.29280108],"study_design_scores_gemma":[0.00003719493,0.00003460392,0.00024698337,0.000012275499,0.000025869407,0.000059054993,0.000012301809,0.9055692,0.0035334714,0.08891169,0.0015328703,0.000024514724],"about_ca_topic_score_codex":0.002173769,"about_ca_topic_score_gemma":0.003238048,"teacher_disagreement_score":0.004973757,"about_ca_system_score_codex":0.00080725044,"about_ca_system_score_gemma":0.0017326972,"threshold_uncertainty_score":0.016638935},"labels":[],"label_agreement":null},{"id":"W6930123737","doi":"10.5281/zenodo.12352536","title":"ieee standards for electrical engineering pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"IEEE 802.11u; IEEE 802.11w-2009; IEEE floating point; IEEE 802.11b-1999; Power electronics; Electronics; IEEE 802.11r-2008","score_opus":0.08202992533248082,"score_gpt":0.39206227253215953,"score_spread":0.3100323471996787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930123737","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009408932,0.005776045,0.11815799,0.011324704,0.014391198,0.0028184846,0.018804688,0.0128172515,0.8149687],"genre_scores_gemma":[0.016528642,0.015556666,0.09819415,0.0061196894,0.004122168,0.004771822,0.06910216,0.005220302,0.78038436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9809488,0.0026149226,0.0022259478,0.0013126712,0.011986458,0.0009113634],"domain_scores_gemma":[0.9560809,0.0042407196,0.0012003398,0.0061097704,0.03144312,0.00092510757],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008688811,0.0021447234,0.001824071,0.006920951,0.0025271778,0.008872349,0.0045397375,0.00594976,0.3066874],"category_scores_gemma":[0.04011476,0.0010032639,0.0013499175,0.007088111,0.002130282,0.00830987,0.005072841,0.007195668,0.3920899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047014557,0.000105268904,0.0002620059,0.0006709027,0.000012851484,0.000076605866,0.00012808519,0.00093281904,0.00094107795,0.037099548,0.8348426,0.124881096],"study_design_scores_gemma":[0.00001104319,0.000023993878,0.00018881792,0.00043943035,0.0000054143097,0.000098760196,0.000054751472,0.0003367533,0.00035706395,0.007936915,0.990531,0.000016108435],"about_ca_topic_score_codex":0.0037497075,"about_ca_topic_score_gemma":0.0029327774,"teacher_disagreement_score":0.6933126,"about_ca_system_score_codex":0.003286452,"about_ca_system_score_gemma":0.0101208575,"threshold_uncertainty_score":0.98892623},"labels":[],"label_agreement":null},{"id":"W6930503693","doi":"10.5281/zenodo.14153544","title":"PM_035584_B_Oudenaarde","year":2009,"lang":"nl","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boom; Window (computing); Shadow (psychology); Period (music); Quarter (Canadian coin)","score_opus":0.10218443413223602,"score_gpt":0.38092685667746295,"score_spread":0.27874242254522696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930503693","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004246285,0.0003163405,0.00088176463,0.0005746089,0.0012751917,0.0001379798,0.03428668,0.006289662,0.95581305],"genre_scores_gemma":[0.0018420839,0.00021976019,0.0004825162,0.00014635597,0.00016937903,0.00006318323,0.0076480047,0.0027854308,0.9866433],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994943,0.000043930977,0.000024098605,0.000120417906,0.00023181803,0.000085369866],"domain_scores_gemma":[0.9980076,0.00036030638,0.00008829915,0.00032507413,0.00077232753,0.0004464542],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005445713,0.00075032725,0.00078073563,0.001448454,0.0013394272,0.0057040113,0.0013928025,0.001408639,0.94481033],"category_scores_gemma":[0.004422166,0.0006254543,0.00049554114,0.003079286,0.00039613352,0.0018735487,0.0017272885,0.0010488379,0.91352445],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043220647,0.000015362126,0.000095674266,0.00005864827,0.0000013097052,0.000019238876,0.000019666584,0.000025214084,0.0001436186,0.00048481292,0.9752436,0.023849636],"study_design_scores_gemma":[0.000015907248,0.000009562456,0.0005006006,0.000033462242,0.0000012104822,0.000028516277,0.000023393604,0.000036563877,0.00019520205,0.00016439745,0.9989868,0.0000043923937],"about_ca_topic_score_codex":0.010327212,"about_ca_topic_score_gemma":0.009901023,"teacher_disagreement_score":0.05518967,"about_ca_system_score_codex":0.0012907708,"about_ca_system_score_gemma":0.0011055288,"threshold_uncertainty_score":0.078721344},"labels":[],"label_agreement":null},{"id":"W6931598235","doi":"10.5281/zenodo.4554668","title":"I'ts time to recognise the diversity of research careers","year":2021,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Commission","keywords":"Perspective (graphical); Diversity (politics); Marie curie; Curie","score_opus":0.19519950280413936,"score_gpt":0.41569924923688845,"score_spread":0.22049974643274908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931598235","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018362417,0.010807908,0.0039506196,0.45802826,0.066653855,0.00018001975,0.0060591903,0.0018160399,0.45066792],"genre_scores_gemma":[0.014562641,0.011274444,0.007858454,0.092968225,0.01914354,0.00038915954,0.004054014,0.0045857327,0.84516376],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98755544,0.003866531,0.00081336487,0.0010464883,0.0052623325,0.0014557844],"domain_scores_gemma":[0.90620583,0.039130654,0.0049790055,0.01228313,0.022462104,0.014939225],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016913582,0.0006607239,0.001065291,0.004792194,0.0048634512,0.020802267,0.0018527737,0.004580371,0.30457398],"category_scores_gemma":[0.098362766,0.0006974466,0.0007359988,0.008736948,0.0031276527,0.01744621,0.0104687605,0.007932757,0.23144737],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026333242,0.0000072560274,0.00022182164,0.00019006387,0.0000034516702,0.00009779116,0.00089589006,0.000012808352,0.00022693606,0.009872089,0.95102996,0.037415702],"study_design_scores_gemma":[0.0000025402962,0.0000030731665,0.00016646633,0.0001035289,0.0000013089162,0.000107742584,0.0006382271,0.000007458403,0.00004545332,0.0016966428,0.9972205,0.000007055026],"about_ca_topic_score_codex":0.0037063106,"about_ca_topic_score_gemma":0.008632458,"teacher_disagreement_score":0.9830864,"about_ca_system_score_codex":0.0025580006,"about_ca_system_score_gemma":0.0057315864,"threshold_uncertainty_score":0.9919408},"labels":[],"label_agreement":null},{"id":"W6931656993","doi":"10.5281/zenodo.7177903","title":"Figures 34–36 in A New Aquatic Associated Genus of Trichopezinae from the Southern Hemisphere (Diptera: Empidoidea: Brachystomatidae)","year":2022,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Southern Hemisphere; Genus; Scale (ratio); Taxonomy (biology); Southern china","score_opus":0.07713803064126835,"score_gpt":0.34727348967199356,"score_spread":0.2701354590307252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931656993","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16280583,0.012050819,0.029774478,0.0020429536,0.0058364463,0.0011210883,0.022624204,0.003792215,0.75995195],"genre_scores_gemma":[0.5826756,0.011879326,0.07297318,0.00090540247,0.0019025557,0.0007083204,0.030422902,0.00082597067,0.29770675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999137,0.0000089349205,0.00000720222,0.000027366319,0.00002718149,0.000015680243],"domain_scores_gemma":[0.99992204,0.000011023876,0.000019808,0.000008041125,0.000018393474,0.000020797444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009180828,0.00057475246,0.00017563133,0.0019049384,0.000838094,0.00038161463,0.0004000377,0.0005131158,0.059499763],"category_scores_gemma":[0.000208414,0.00014592476,0.00032617757,0.0010911645,0.0005220531,0.0006713952,0.00066625484,0.000610254,0.009013266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058972545,0.00012296262,0.033873275,0.0015114597,0.00008975836,0.0035481963,0.0023776412,0.0006517977,0.029485755,0.008771676,0.2348578,0.68412006],"study_design_scores_gemma":[0.000032025415,0.00007187696,0.10964204,0.00019773604,0.000060970124,0.0040435633,0.0008267116,0.0005184346,0.001217887,0.0012910601,0.8820756,0.000022101889],"about_ca_topic_score_codex":0.0061151977,"about_ca_topic_score_gemma":0.019762978,"teacher_disagreement_score":0.059499763,"about_ca_system_score_codex":0.00037474508,"about_ca_system_score_gemma":0.00040409263,"threshold_uncertainty_score":0.19904655},"labels":[],"label_agreement":null},{"id":"W6939484251","doi":"10.6084/m9.figshare.14478957","title":"Additional file 1 of Detection of adverse drug events in e-prescribing and administrative health data: a validation study","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University Health Centre; McGill University","funders":"","keywords":"Adverse effect; Drug; MEDLINE; Health care; Public health; Data collection","score_opus":0.27166375174992347,"score_gpt":0.4727921645870399,"score_spread":0.2011284128371164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939484251","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011879613,0.000013518096,0.00025833645,0.0001767745,0.000018952776,0.00038588204,0.9963331,0.0000808091,0.0015447084],"genre_scores_gemma":[0.037104208,0.00013933785,0.0036306079,0.0010771924,0.00015695185,0.010665319,0.9340189,0.00033543466,0.012872046],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99840075,0.0003892079,0.000467506,0.00028532144,0.00031510298,0.00014200313],"domain_scores_gemma":[0.9526406,0.03333676,0.005200868,0.0021135753,0.005991657,0.0007166456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026474972,0.0005840865,0.0007368189,0.002029587,0.00083181076,0.0009521546,0.0009641507,0.00089108985,0.72437155],"category_scores_gemma":[0.044054262,0.00039946282,0.00073713204,0.003449743,0.00025399675,0.0012439946,0.0007567901,0.0008429394,0.06656584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048104578,0.00026741822,0.011234601,0.0014580864,0.000056605768,0.000075905475,0.00010957556,0.00034607842,0.00006903407,0.0007313454,0.97622347,0.008946874],"study_design_scores_gemma":[0.013733916,0.001226594,0.24966048,0.006476321,0.0003424882,0.0012073022,0.0013697066,0.0032527053,0.00151491,0.0077875806,0.7132067,0.00022136702],"about_ca_topic_score_codex":0.008729566,"about_ca_topic_score_gemma":0.009142555,"teacher_disagreement_score":0.72437155,"about_ca_system_score_codex":0.0012630606,"about_ca_system_score_gemma":0.002252114,"threshold_uncertainty_score":0.3931505},"labels":[],"label_agreement":null},{"id":"W6939614926","doi":"10.6084/m9.figshare.14478960.v1","title":"Additional file 2 of Detection of adverse drug events in e-prescribing and administrative health data: a validation study","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University Health Centre; McGill University","funders":"","keywords":"Appendix; Adverse effect; Antidepressant; Diagnosis code; Drug","score_opus":0.2653057827778364,"score_gpt":0.4721351631109858,"score_spread":0.2068293803331494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939614926","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010663118,0.0000070054584,0.00020620934,0.00014038951,0.000015181616,0.00039876692,0.9967526,0.00006094792,0.0013527543],"genre_scores_gemma":[0.025236918,0.00007313734,0.0026754173,0.00069444964,0.00010415423,0.008791208,0.9542139,0.0002247201,0.007986052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821424,0.00041518937,0.00050964416,0.0003134408,0.00038325056,0.00016415946],"domain_scores_gemma":[0.965574,0.021059562,0.004214737,0.0025502264,0.005911166,0.0006903321],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002727508,0.00059310696,0.0007372958,0.0020203209,0.0008977678,0.0010368979,0.0012123256,0.00091473083,0.5957326],"category_scores_gemma":[0.041148923,0.00041141408,0.0007002926,0.0039322386,0.00020201865,0.0012044791,0.0007955343,0.0007870353,0.0587016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046392088,0.00021148587,0.0173117,0.00094586116,0.00005039611,0.000077442426,0.000097273514,0.00036908934,0.000055100296,0.00067029113,0.9718388,0.007908652],"study_design_scores_gemma":[0.011148471,0.0008775134,0.319004,0.004379994,0.0002714226,0.0008584469,0.0012476454,0.004366731,0.0011944897,0.005122546,0.6513616,0.0001672494],"about_ca_topic_score_codex":0.013715024,"about_ca_topic_score_gemma":0.013581755,"teacher_disagreement_score":0.5957326,"about_ca_system_score_codex":0.0013833178,"about_ca_system_score_gemma":0.0028520299,"threshold_uncertainty_score":0.57663834},"labels":[],"label_agreement":null},{"id":"W6939882803","doi":"10.71655/uvcibv.gve2p-rde25","title":"LES EFFETS SECONDAIRES DU COTRIMOXAZOLE DANS UNE POPULATION D'IMMUNO-DEPRIMES","year":2025,"lang":"fr","type":"dissertation","venue":"Université Virtuelle de Côte d'Ivoire","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Ile de france; Research methodology; Context (archaeology)","score_opus":0.024651548700117907,"score_gpt":0.34041444267018917,"score_spread":0.31576289397007123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939882803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99023485,0.00567925,0.0018048533,0.00033744657,0.000019724508,0.000110843175,0.0008233345,0.000020770505,0.00096897536],"genre_scores_gemma":[0.9914963,0.0037227338,0.002386142,0.00031550994,0.000028775588,0.00016182836,0.0004841341,0.000008217867,0.0013964407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748814,0.0012631267,0.00022037947,0.0003798453,0.00051670853,0.00013184722],"domain_scores_gemma":[0.9960283,0.0022251252,0.00061964366,0.00034023268,0.00069051003,0.00009611577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046740607,0.00032885035,0.0007124416,0.00085848046,0.0003154468,0.0007828082,0.00043307256,0.00065473345,0.0012490097],"category_scores_gemma":[0.010517934,0.00028061253,0.0008916848,0.0012029662,0.00030300635,0.00028453258,0.00036225683,0.00054405036,0.00020863388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007934106,0.00034188936,0.8531941,0.00076825987,0.001024471,0.00037676952,0.0026346485,0.0011847803,0.008700097,0.000312281,0.0009636321,0.122565016],"study_design_scores_gemma":[0.00029674635,0.006029282,0.976107,0.00024029877,0.0012290354,0.00080925453,0.00068358233,0.0018943874,0.0054817772,0.00017776777,0.0070198537,0.000030939435],"about_ca_topic_score_codex":0.02130619,"about_ca_topic_score_gemma":0.016588401,"teacher_disagreement_score":0.02130619,"about_ca_system_score_codex":0.0006674627,"about_ca_system_score_gemma":0.0010111333,"threshold_uncertainty_score":0.04236436},"labels":[],"label_agreement":null},{"id":"W6949025783","doi":"10.5281/zenodo.14872914","title":"Actualización de seguridad - Revisión de seguridad de HEALTH CANADA encontró un posible vínculo entre el uso de canakinumab y el riesgo de DRESS","year":2025,"lang":"es","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Canakinumab; Euros; Public health","score_opus":0.03762348274980244,"score_gpt":0.38424292009987915,"score_spread":0.3466194373500767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949025783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46970847,0.23420988,0.040442653,0.08797214,0.005519011,0.0039734496,0.01978831,0.0021365935,0.13624953],"genre_scores_gemma":[0.90613383,0.040651556,0.021487856,0.009603923,0.0006861851,0.00058467634,0.004205081,0.0002465406,0.016400516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96412027,0.009371082,0.0040615923,0.0017429014,0.018859666,0.0018445515],"domain_scores_gemma":[0.88122815,0.01642409,0.014659036,0.004499939,0.079027526,0.004161255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029309904,0.00065281964,0.00095213234,0.00372756,0.0016694282,0.0038946245,0.002191124,0.00069570274,0.0034117394],"category_scores_gemma":[0.05796158,0.000425285,0.0014857018,0.0044812337,0.0017620643,0.0011986546,0.0013101115,0.0017947305,0.0005313962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011540782,0.00032519037,0.28764233,0.005055784,0.00079193915,0.00041844085,0.0026000943,0.0013454916,0.0026612016,0.005464312,0.034272876,0.6582683],"study_design_scores_gemma":[0.00020885596,0.0015409482,0.5843526,0.009241895,0.0016571012,0.001420028,0.0028041792,0.0038638136,0.014480191,0.0017218412,0.37846723,0.0002412921],"about_ca_topic_score_codex":0.7113118,"about_ca_topic_score_gemma":0.66122323,"teacher_disagreement_score":0.28868818,"about_ca_system_score_codex":0.032196403,"about_ca_system_score_gemma":0.07980726,"threshold_uncertainty_score":0.58077663},"labels":[],"label_agreement":null},{"id":"W6958259360","doi":"10.6084/m9.figshare.25534302.v2","title":"Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Observational study; Context (archaeology); Pharmacovigilance; Drug; Systematic review; MEDLINE; Pandemic","score_opus":0.154500114516215,"score_gpt":0.4705561393946102,"score_spread":0.31605602487839524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958259360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011746298,0.9978682,0.00007104878,0.00016391359,0.000054920205,0.00020692757,0.00031372087,0.0000043079067,0.00014228298],"genre_scores_gemma":[0.0204338,0.9777117,0.00045496694,0.00054063735,0.00008760347,0.00039658122,0.00027910373,0.0000037566824,0.00009182673],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99275184,0.002053976,0.003254631,0.00044039014,0.0013295797,0.00016955132],"domain_scores_gemma":[0.9691293,0.020832894,0.0070040748,0.00043688426,0.0023538119,0.00024304124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070794914,0.0010833978,0.006076298,0.009426997,0.000492814,0.001843591,0.0011601545,0.0015242638,0.0030799285],"category_scores_gemma":[0.027667644,0.0007561396,0.0076260553,0.008989009,0.00065551733,0.0018110798,0.0011411248,0.0009363952,0.00019351221],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021837694,0.000014783192,0.0014887179,0.96040845,0.00803629,0.000100411766,0.0001127188,0.00006138862,0.00010021412,0.00009819579,0.0009962698,0.028364265],"study_design_scores_gemma":[0.00030549985,0.000353504,0.010680494,0.8878743,0.081861034,0.00089254644,0.0003103044,0.00011417655,0.00020699877,0.00026997447,0.01708203,0.000049073016],"about_ca_topic_score_codex":0.0054989955,"about_ca_topic_score_gemma":0.015787665,"teacher_disagreement_score":0.009426997,"about_ca_system_score_codex":0.0024342777,"about_ca_system_score_gemma":0.0068907347,"threshold_uncertainty_score":0.03744042},"labels":[],"label_agreement":null},{"id":"W6958271102","doi":"10.6084/m9.figshare.25534302.v1","title":"Adverse events related to drug-drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Observational study; Context (archaeology); Pharmacovigilance; Drug; Systematic review; MEDLINE; Pandemic","score_opus":0.15453305321278316,"score_gpt":0.4704584582307465,"score_spread":0.31592540501796335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958271102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011438088,0.997922,0.00006823471,0.00016021027,0.00005224771,0.00019670899,0.0003130098,0.0000041436733,0.0001395666],"genre_scores_gemma":[0.020335775,0.9778391,0.0004505628,0.0005337198,0.00008489213,0.00038012883,0.0002804345,0.0000036021377,0.00009174136],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929582,0.0019705594,0.0032092992,0.0004315299,0.0012649111,0.00016556853],"domain_scores_gemma":[0.9699237,0.020228254,0.0069029387,0.00041151792,0.002291989,0.0002415331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067969873,0.001073364,0.0060023577,0.009419964,0.00048343342,0.0018355917,0.0011593545,0.001518801,0.003114385],"category_scores_gemma":[0.026872905,0.0007329827,0.007416281,0.008946685,0.0006573679,0.0017628135,0.0011374371,0.0009274733,0.00019237932],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021787743,0.000014682769,0.0015107497,0.9609369,0.007988721,0.000102133556,0.00011426782,0.00006112374,0.00009986825,0.00009617013,0.0009915895,0.02786592],"study_design_scores_gemma":[0.00029744068,0.00034614003,0.0110027995,0.8879699,0.08113974,0.0009347407,0.00031139207,0.00010904261,0.00020530092,0.0002653034,0.01736997,0.00004823721],"about_ca_topic_score_codex":0.005694889,"about_ca_topic_score_gemma":0.016191315,"teacher_disagreement_score":0.009419964,"about_ca_system_score_codex":0.0024354174,"about_ca_system_score_gemma":0.0068309195,"threshold_uncertainty_score":0.03594631},"labels":[],"label_agreement":null},{"id":"W6958385085","doi":"10.6084/m9.figshare.26574892","title":"Additional file 1 of Medical ID use by international patients with Aspirin-Exacerbated Respiratory Disease","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Disease; MEDLINE; Respiratory disease; Medical record; Respiratory system","score_opus":0.09707351050972518,"score_gpt":0.40307338723780634,"score_spread":0.30599987672808115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958385085","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031612534,0.000013376803,0.000080177575,0.00012628545,0.0000144060505,0.00007085648,0.9967212,0.000060324546,0.0025972335],"genre_scores_gemma":[0.016052498,0.00022653889,0.001154307,0.0010498454,0.00015922761,0.0019647328,0.96047664,0.00024912957,0.018667199],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991122,0.00020094273,0.00019302443,0.00019124562,0.00016697163,0.00013554232],"domain_scores_gemma":[0.98475605,0.009268945,0.0021710857,0.0007050658,0.0026108592,0.00048798375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009987211,0.0005498315,0.0007149323,0.0023056779,0.000594502,0.0008130753,0.0007762323,0.0007373611,0.77862],"category_scores_gemma":[0.019904565,0.00032232617,0.00052270986,0.005129992,0.00015317909,0.0012644299,0.00080966833,0.00065652234,0.10901158],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011382409,0.000045215165,0.0032474159,0.0006324113,0.000017511878,0.000025704221,0.00003970088,0.00012641495,0.000022786753,0.00044778432,0.991327,0.003954184],"study_design_scores_gemma":[0.002520936,0.00029717627,0.100369945,0.004416272,0.00013691833,0.0005071767,0.0009904515,0.0013333812,0.0004337376,0.006145097,0.8827459,0.00010303163],"about_ca_topic_score_codex":0.014201903,"about_ca_topic_score_gemma":0.015653998,"teacher_disagreement_score":0.77862,"about_ca_system_score_codex":0.0010089321,"about_ca_system_score_gemma":0.001409057,"threshold_uncertainty_score":0.31577164},"labels":[],"label_agreement":null},{"id":"W6976948568","doi":"10.6084/m9.figshare.14478960","title":"Additional file 2 of Detection of adverse drug events in e-prescribing and administrative health data: a validation study","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University Health Centre; McGill University","funders":"","keywords":"Appendix; Adverse effect; Antidepressant; Diagnosis code; Drug","score_opus":0.2653057827778364,"score_gpt":0.4721351631109858,"score_spread":0.2068293803331494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976948568","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010663118,0.0000070054584,0.00020620934,0.00014038951,0.000015181616,0.00039876692,0.9967526,0.00006094792,0.0013527543],"genre_scores_gemma":[0.025236918,0.00007313734,0.0026754173,0.00069444964,0.00010415423,0.008791208,0.9542139,0.0002247201,0.007986052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821424,0.00041518937,0.00050964416,0.0003134408,0.00038325056,0.00016415946],"domain_scores_gemma":[0.965574,0.021059562,0.004214737,0.0025502264,0.005911166,0.0006903321],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002727508,0.00059310696,0.0007372958,0.0020203209,0.0008977678,0.0010368979,0.0012123256,0.00091473083,0.5957326],"category_scores_gemma":[0.041148923,0.00041141408,0.0007002926,0.0039322386,0.00020201865,0.0012044791,0.0007955343,0.0007870353,0.0587016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046392088,0.00021148587,0.0173117,0.00094586116,0.00005039611,0.000077442426,0.000097273514,0.00036908934,0.000055100296,0.00067029113,0.9718388,0.007908652],"study_design_scores_gemma":[0.011148471,0.0008775134,0.319004,0.004379994,0.0002714226,0.0008584469,0.0012476454,0.004366731,0.0011944897,0.005122546,0.6513616,0.0001672494],"about_ca_topic_score_codex":0.013715024,"about_ca_topic_score_gemma":0.013581755,"teacher_disagreement_score":0.5957326,"about_ca_system_score_codex":0.0013833178,"about_ca_system_score_gemma":0.0028520299,"threshold_uncertainty_score":0.57663834},"labels":[],"label_agreement":null},{"id":"W6977237390","doi":"10.6084/m9.figshare.26583876.v1","title":"Additional file 2 of Data source profile reporting by studies that use routinely collected health data to explore the effects of drug treatment","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Data source; Health data; Drug treatment; Data collection; Information source (mathematics); MEDLINE","score_opus":0.6103309054787311,"score_gpt":0.5240271730463227,"score_spread":0.08630373243240841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977237390","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010594779,0.000028674718,0.00016656105,0.000057036927,0.000015314783,0.00006893956,0.998941,0.00014291776,0.00047359447],"genre_scores_gemma":[0.0066692117,0.00024243745,0.0053896704,0.0010669288,0.00013275661,0.0026925846,0.9769882,0.0008446543,0.005973524],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99718297,0.00050008285,0.0010258177,0.0005785014,0.00042567708,0.0002870234],"domain_scores_gemma":[0.8762432,0.10047228,0.010628458,0.004486681,0.006679297,0.0014902005],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039044803,0.0016441443,0.002251289,0.010261835,0.00075514865,0.0026488602,0.0016751622,0.0020434754,0.8394886],"category_scores_gemma":[0.077775076,0.0009950295,0.0023768942,0.009334189,0.0004738211,0.0024126905,0.0019769412,0.0010390893,0.13006806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068921864,0.00013014836,0.0068391743,0.017558696,0.0004270096,0.000112411464,0.000096431344,0.0007364788,0.0001783616,0.0016433698,0.9584596,0.0131291235],"study_design_scores_gemma":[0.008960486,0.00039834084,0.044351343,0.015091137,0.0010866028,0.0008664247,0.00054181874,0.0024747031,0.0010292244,0.018150166,0.90675163,0.0002980988],"about_ca_topic_score_codex":0.0073069413,"about_ca_topic_score_gemma":0.012492245,"teacher_disagreement_score":0.99609554,"about_ca_system_score_codex":0.001762951,"about_ca_system_score_gemma":0.0037792497,"threshold_uncertainty_score":0.2289499},"labels":[],"label_agreement":null},{"id":"W6977538203","doi":"10.6084/m9.figshare.28827025.v1","title":"Additional file 1 of Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Medical prescription; MEDLINE; Prescription drug; Risk assessment","score_opus":0.07768585417127154,"score_gpt":0.40900583002797597,"score_spread":0.3313199758567044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977538203","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050932136,0.00003247835,0.00014212828,0.00005835437,0.0000123527425,0.00006948229,0.9939108,0.00004721149,0.00063393894],"genre_scores_gemma":[0.06978718,0.00020285156,0.0023330543,0.00038870706,0.00008540325,0.0013230977,0.9201961,0.00010738223,0.005576296],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990829,0.00012094137,0.00033235145,0.00024129167,0.00010262153,0.0001197069],"domain_scores_gemma":[0.9868377,0.006083038,0.0038428134,0.00087234564,0.0017911299,0.0005729989],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076420244,0.00065438065,0.0010255362,0.0034427682,0.0006660482,0.00089392124,0.0010748366,0.00064848113,0.4582206],"category_scores_gemma":[0.015454461,0.00052982854,0.0010529722,0.009374794,0.000200474,0.0013017972,0.0007468915,0.00057228195,0.02377351],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012431655,0.00064282236,0.28662542,0.00613884,0.0006011647,0.00063085573,0.00043366165,0.0011378835,0.00040773777,0.0013693821,0.6729937,0.027775409],"study_design_scores_gemma":[0.0027379156,0.0004005356,0.85436887,0.002120339,0.0007218399,0.0016276253,0.0016454055,0.0034464141,0.00055352953,0.0024203754,0.12978211,0.0001750508],"about_ca_topic_score_codex":0.018341357,"about_ca_topic_score_gemma":0.021516351,"teacher_disagreement_score":0.4582206,"about_ca_system_score_codex":0.0008784428,"about_ca_system_score_gemma":0.0018713679,"threshold_uncertainty_score":0.77278256},"labels":[],"label_agreement":null},{"id":"W6979121361","doi":"","title":"Adverse drug reactions in Canada.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.08065252424709893,"score_gpt":0.3617945645567001,"score_spread":0.2811420403096012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6979121361","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18857326,0.30053964,0.0015565848,0.06722731,0.0037950336,0.001203136,0.15320286,0.0009962674,0.282906],"genre_scores_gemma":[0.7804575,0.1383498,0.001780214,0.01839494,0.0007214923,0.0002682931,0.02317438,0.00009394838,0.036759447],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99855155,0.00012491872,0.00021249246,0.00012267291,0.00080207735,0.00018632654],"domain_scores_gemma":[0.99301296,0.00061556394,0.0013569077,0.00006504739,0.0039265356,0.0010229913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057798484,0.0002601242,0.0003533338,0.0022964778,0.001378826,0.0013957508,0.0005567356,0.0006099615,0.01163346],"category_scores_gemma":[0.005753625,0.00019941667,0.0004733002,0.0046945405,0.0003692343,0.00029985153,0.00042772235,0.0008725775,0.0009582662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007292217,0.00016514062,0.33100435,0.0034429228,0.0002757483,0.0019420133,0.0006609362,0.00052772503,0.0008616127,0.0031666174,0.40127784,0.2559459],"study_design_scores_gemma":[0.0001506942,0.00011831948,0.806099,0.002185989,0.00021469458,0.0017448629,0.00078260433,0.00060951407,0.00044835085,0.00041719252,0.18717313,0.000055691966],"about_ca_topic_score_codex":0.9729005,"about_ca_topic_score_gemma":0.97556335,"teacher_disagreement_score":0.02709949,"about_ca_system_score_codex":0.018830072,"about_ca_system_score_gemma":0.0473643,"threshold_uncertainty_score":0.13662243},"labels":[],"label_agreement":null},{"id":"W6979942225","doi":"","title":"Analyzing the Prospective Cross-Section of Pharmacovigilance in Patients Post-Stroke","year":2023,"lang":"en","type":"book-chapter","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Pharmacovigilance; MEDLINE; Data collection; Patient safety; Risk assessment","score_opus":0.04244512098243883,"score_gpt":0.34608725762186465,"score_spread":0.30364213663942585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6979942225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829122,0.0043651015,0.0016476266,0.0009783673,0.00009211615,0.000053123025,0.005737292,0.000028494049,0.0041856943],"genre_scores_gemma":[0.9930997,0.0012196794,0.0007415689,0.00033949313,0.00008731969,0.000042571683,0.0029480828,0.000013468651,0.0015080334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974922,0.0011009407,0.0004674226,0.000386787,0.00033838532,0.00021425915],"domain_scores_gemma":[0.988727,0.006696571,0.00266908,0.0006629713,0.00083229097,0.00041216266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002814387,0.00023022426,0.0005329047,0.0016520284,0.0003588387,0.0009184872,0.00040709376,0.0008610102,0.005984263],"category_scores_gemma":[0.014875935,0.00027980813,0.0015655392,0.003543436,0.0001701587,0.0006330147,0.00065824494,0.00081513094,0.00072559324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019103993,0.000026727685,0.99138874,0.000049536084,0.00052515115,0.00008144602,0.000087802175,0.00009464335,0.00009420166,0.000111503294,0.00089583884,0.0064533777],"study_design_scores_gemma":[0.000012333164,0.00011831919,0.9975599,0.000039020095,0.00028056715,0.00025113038,0.00023380641,0.00043465162,0.00012338923,0.00018584068,0.000752924,0.000008120129],"about_ca_topic_score_codex":0.009544206,"about_ca_topic_score_gemma":0.009943956,"teacher_disagreement_score":0.009544206,"about_ca_system_score_codex":0.00051212753,"about_ca_system_score_gemma":0.0008555872,"threshold_uncertainty_score":0.020019412},"labels":[],"label_agreement":null},{"id":"W6981749362","doi":"","title":"Excellent support 1800681-7208 norton antivirus customer service phone number","year":2016,"lang":"en","type":"other","venue":"OSF Preprints (OSF Preprints)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phone; Service (business); Phone call; Customer service","score_opus":0.05294680939917987,"score_gpt":0.3908208127367954,"score_spread":0.3378740033376155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981749362","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008517368,0.00020080103,0.00060570345,0.00056350906,0.0004550841,0.00012840913,0.0012741707,0.0027511697,0.9931694],"genre_scores_gemma":[0.00051476475,0.00007422126,0.0001702362,0.00010064101,0.000030019806,0.000015083739,0.00042456752,0.00026159344,0.99840885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991334,0.000046557598,0.000022720375,0.00012631962,0.0005354183,0.00013555645],"domain_scores_gemma":[0.9979583,0.000100953104,0.00004937759,0.00014649783,0.0010512625,0.0006936067],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004435253,0.0011534629,0.0007091187,0.0015467848,0.0019679815,0.0034904114,0.001123259,0.0012393986,0.8738905],"category_scores_gemma":[0.0014553928,0.0007544894,0.0005866158,0.0008624085,0.00027800683,0.0015530984,0.0018903365,0.0011787455,0.87029976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003359479,0.00006952762,0.0002590802,0.000040888037,0.0000024914143,0.00005383146,0.000038024562,0.000041815256,0.00078791246,0.0008144895,0.94366777,0.054190625],"study_design_scores_gemma":[0.000013274081,0.00003311402,0.0008288887,0.00003527562,0.000005231925,0.000085028725,0.000084575346,0.00013939597,0.00033607165,0.0001310882,0.9982992,0.000008950295],"about_ca_topic_score_codex":0.016757434,"about_ca_topic_score_gemma":0.053885113,"teacher_disagreement_score":0.12610948,"about_ca_system_score_codex":0.0012138566,"about_ca_system_score_gemma":0.0029747202,"threshold_uncertainty_score":0.17987978},"labels":[],"label_agreement":null},{"id":"W6987008233","doi":"","title":"Risk time-window specification and its impact on the assessment of medication-related adverse events","year":2006,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University","keywords":"Adverse effect; MEDLINE; Product (mathematics)","score_opus":0.04129628092485719,"score_gpt":0.39442234203802645,"score_spread":0.35312606111316924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6987008233","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22177555,0.0051643695,0.75002223,0.0032440932,0.000656038,0.00097181636,0.00515375,0.0028667205,0.010145467],"genre_scores_gemma":[0.7836475,0.0012962772,0.20759235,0.00030616554,0.00019592649,0.0004396299,0.0024812883,0.00029985118,0.0037409742],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9856551,0.010150042,0.0012974668,0.0011138029,0.0014338028,0.00034972807],"domain_scores_gemma":[0.85796815,0.12616517,0.006576337,0.0042651785,0.004005236,0.0010199205],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036397513,0.0009987106,0.0011671998,0.0025508215,0.00035624957,0.0042057172,0.0011979995,0.0012169234,0.0073932093],"category_scores_gemma":[0.12983929,0.0004759963,0.0022485831,0.0017649041,0.00041911876,0.002250817,0.0018828516,0.001713541,0.0008307991],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073098447,0.00049085944,0.25565884,0.0010338891,0.0015237821,0.0012331023,0.00072549994,0.24389893,0.0035272262,0.057964545,0.009860576,0.41677284],"study_design_scores_gemma":[0.00018768627,0.0010326969,0.037570313,0.00034379005,0.0004930235,0.0006996155,0.0003512271,0.928925,0.00239945,0.021875504,0.0060212705,0.000100487276],"about_ca_topic_score_codex":0.009503453,"about_ca_topic_score_gemma":0.0045866542,"teacher_disagreement_score":0.9636025,"about_ca_system_score_codex":0.0009458822,"about_ca_system_score_gemma":0.0027368392,"threshold_uncertainty_score":0.19249076},"labels":[],"label_agreement":null},{"id":"W6995608053","doi":"","title":"Participatory Approaches to Placemaking: Methodological Outlines for Public Spaces in Bergamo (Italy), for Indigenous Communities in Quebec (Canada) and Popular Places in Prerov (Czech Republic)","year":2024,"lang":"en","type":"book-chapter","venue":"Aisberg (University of Bergamo)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Placemaking; Indigenous; Citizen journalism; Participatory action research; Redevelopment; Tourism; Public participation; Traditional knowledge; Sustainability","score_opus":0.5331362031519529,"score_gpt":0.4060327582667622,"score_spread":0.12710344488519065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995608053","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.102178186,0.08579358,0.4139075,0.06262104,0.0016976071,0.041196343,0.0015535301,0.00031829177,0.2907339],"genre_scores_gemma":[0.4475414,0.025268206,0.46481577,0.0025739006,0.00014826684,0.03223633,0.0006467198,0.00020727474,0.026562206],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9605283,0.03228833,0.0012146713,0.0016898823,0.0023503492,0.0019284445],"domain_scores_gemma":[0.97831327,0.015406041,0.0011016534,0.0010918643,0.003034117,0.0010530764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06074105,0.0020077503,0.001259209,0.0107131265,0.028048323,0.027368829,0.005978111,0.0045445003,0.004700723],"category_scores_gemma":[0.021288937,0.0016874374,0.0013547738,0.016714057,0.045854703,0.009140784,0.013775132,0.005277047,0.00059447315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029716619,0.000103950435,0.0017170768,0.0020511304,0.000026205798,0.00077165617,0.5271697,0.0010860226,0.00029941037,0.4085105,0.004424456,0.053810168],"study_design_scores_gemma":[0.000034948935,0.000055715187,0.0031966635,0.004327668,0.000041834577,0.0003253505,0.7062863,0.0006743837,0.00029883813,0.05299163,0.23171008,0.000056607794],"about_ca_topic_score_codex":0.23137344,"about_ca_topic_score_gemma":0.43296677,"teacher_disagreement_score":0.7686266,"about_ca_system_score_codex":0.08375486,"about_ca_system_score_gemma":0.09252398,"threshold_uncertainty_score":0.6076869},"labels":[],"label_agreement":null},{"id":"W6995855927","doi":"","title":"Post-Fire Carbon Dioxide Fluxes in the Western Canadian Boreal Forest: Evidence from Towers, Aircraft and Remote Sensing","year":2003,"lang":"en","type":"article","venue":"NPARC","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boreal; Carbon dioxide; Atmosphere (unit); Carbon dioxide in Earth's atmosphere; Carbon fibers; Carbon cycle","score_opus":0.062397726817453585,"score_gpt":0.36735254323224126,"score_spread":0.30495481641478767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995855927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224406,0.0009486192,0.00015677292,0.00023619396,0.000031200343,0.000023151855,0.00395432,0.0000139441045,0.0023917549],"genre_scores_gemma":[0.99583364,0.0007224599,0.00025502327,0.00012415611,0.000014238308,0.000011571766,0.0022061213,0.0000073135843,0.0008254045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949396,0.000040028448,0.000029350418,0.00009735186,0.00019943994,0.00013985993],"domain_scores_gemma":[0.997294,0.0003103998,0.0005882645,0.00011061187,0.001436714,0.00025992416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063160545,0.00046228422,0.00035574916,0.0008594467,0.0014451796,0.0013656964,0.0011099677,0.00058091275,0.00088692264],"category_scores_gemma":[0.0024398898,0.0002719466,0.00034095682,0.002361101,0.0005858623,0.0006047912,0.00038610815,0.00045847896,0.00013942919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026819482,0.000043649983,0.9917374,0.000055892684,0.00018352512,0.00012703665,0.00039581663,0.00045115477,0.0006142882,0.000052085783,0.0011215318,0.0049494854],"study_design_scores_gemma":[0.000004182508,0.000006894685,0.9991233,0.000009689408,0.00002667866,0.000017338278,0.00025054172,0.00016613609,0.00007955159,0.000007932941,0.00030155343,0.0000062139898],"about_ca_topic_score_codex":0.99050176,"about_ca_topic_score_gemma":0.99398583,"teacher_disagreement_score":0.009498239,"about_ca_system_score_codex":0.0058897706,"about_ca_system_score_gemma":0.008252243,"threshold_uncertainty_score":0.04273349},"labels":[],"label_agreement":null},{"id":"W6995893447","doi":"","title":"Potential role of rivaroxaban in patients with acute coronary syndrome","year":2012,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Dabigatran; Acute coronary syndrome; Aspirin; Apixaban; Warfarin; Stroke (engine)","score_opus":0.19411952194233675,"score_gpt":0.5675320812541951,"score_spread":0.37341255931185835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995893447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6395179,0.2833871,0.0006203097,0.04373008,0.0020588492,0.00014714654,0.0014683723,0.00005466977,0.029015584],"genre_scores_gemma":[0.9370748,0.0521882,0.0008420937,0.0044269464,0.0034014513,0.00006674679,0.00088888383,0.000012418335,0.0010985691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991811,0.00031671184,0.00011235614,0.00008731715,0.00022328475,0.000079254954],"domain_scores_gemma":[0.99722445,0.0011074486,0.00078623195,0.000069859154,0.00037139375,0.00044064538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011366513,0.00040152966,0.0012240957,0.00070222927,0.00036810103,0.0012583775,0.0004352819,0.0010053666,0.0029960675],"category_scores_gemma":[0.007485571,0.00022895854,0.00088017294,0.0012170514,0.00026417561,0.0008988643,0.00040714632,0.0012434609,0.0004580528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038394327,0.00040267888,0.8423614,0.0008819425,0.0005951631,0.0025220062,0.0003032632,0.00031311726,0.0003969883,0.00088947616,0.0095683215,0.13792618],"study_design_scores_gemma":[0.0017774466,0.0014395416,0.96513546,0.0016125676,0.001024508,0.005745717,0.0008927732,0.0016535991,0.00021780045,0.0026404185,0.017768672,0.00009140837],"about_ca_topic_score_codex":0.002621431,"about_ca_topic_score_gemma":0.003661786,"teacher_disagreement_score":0.0029960675,"about_ca_system_score_codex":0.0006246748,"about_ca_system_score_gemma":0.00091881445,"threshold_uncertainty_score":0.010022819},"labels":[],"label_agreement":null},{"id":"W6995915972","doi":"","title":"PPARalpha and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia","year":2013,"lang":"en","type":"article","venue":"MPG.PuRe (Max Planck Society)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Ontario Institute for Cancer Research; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Chronic lymphocytic leukemia; Beta oxidation; Glucocorticoid; Fatty acid; Leukemia; Saturated fatty acid; CD20; Lipid metabolism","score_opus":0.0450899211221319,"score_gpt":0.35895827126240004,"score_spread":0.31386835014026815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995915972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98346186,0.01333588,0.00026814506,0.0006340451,0.000032585078,0.0000075947587,0.00016958792,0.000022986344,0.0020672297],"genre_scores_gemma":[0.99674714,0.0021318046,0.00007911929,0.000087251276,0.000039585215,0.0000049550717,0.00009203355,0.0000030089907,0.00081515126],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998523,0.00005096197,0.000010627035,0.00001887945,0.000034186363,0.00003305682],"domain_scores_gemma":[0.99980706,0.000038054066,0.000095514304,0.000014459984,0.0000134764405,0.00003156719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002785789,0.00014088093,0.00024015534,0.00033509574,0.00016070525,0.00053865905,0.00018146429,0.000260778,0.0021529899],"category_scores_gemma":[0.00033628015,0.00011910374,0.000146193,0.0004186506,0.0002794133,0.0001672786,0.00025465703,0.00037073332,0.0004005943],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013600303,0.00053256075,0.4553855,0.00049296813,0.00034839724,0.005108053,0.0005737568,0.0009706206,0.34548056,0.003123823,0.0033703025,0.17101315],"study_design_scores_gemma":[0.00044729118,0.0018671761,0.9381418,0.0001186085,0.00035996098,0.008105938,0.0009896654,0.0013949737,0.027651755,0.0043420703,0.01654661,0.000034212422],"about_ca_topic_score_codex":0.0010501442,"about_ca_topic_score_gemma":0.0009703781,"teacher_disagreement_score":0.0021529899,"about_ca_system_score_codex":0.00043666954,"about_ca_system_score_gemma":0.00018226057,"threshold_uncertainty_score":0.0072024465},"labels":[],"label_agreement":null},{"id":"W6997064947","doi":"","title":"Three essays on asset pricing and behavioral finance","year":2023,"lang":"en","type":"dissertation","venue":"Mspace (University of Manitoba)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"","keywords":"Portfolio; Earnings; Behavioral economics; Position (finance); Capital asset pricing model; Stock (firearms); Social media; Stock market","score_opus":0.1012520116256838,"score_gpt":0.3813065302371479,"score_spread":0.2800545186114641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6997064947","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020576613,0.10739536,0.023871142,0.51179147,0.17012963,0.00019996666,0.0015079938,0.00044303574,0.16408478],"genre_scores_gemma":[0.18588713,0.0896149,0.014875975,0.11853366,0.26292506,0.00067007693,0.0015251555,0.0005957634,0.32537216],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99873,0.00036816366,0.00010566238,0.00016375192,0.0005198568,0.000112700254],"domain_scores_gemma":[0.98451656,0.010570063,0.00087052333,0.0006430635,0.0022517252,0.0011480262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023546002,0.0010226731,0.00079943886,0.0017862372,0.0013630152,0.0034561157,0.00070933776,0.002321364,0.011597662],"category_scores_gemma":[0.016806861,0.00027186546,0.00096834806,0.0012973122,0.0025529529,0.0030103477,0.0016504807,0.004224497,0.003832906],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080057725,0.0002251817,0.0018652816,0.000384394,0.00004725609,0.00018002753,0.0008918424,0.0007374894,0.00060071476,0.098654814,0.8099379,0.08639503],"study_design_scores_gemma":[0.000030364565,0.00011419168,0.004072527,0.0009082132,0.000023654262,0.00021723716,0.0007304522,0.0010242882,0.00027685997,0.091818884,0.9007345,0.000048805443],"about_ca_topic_score_codex":0.0007916722,"about_ca_topic_score_gemma":0.0007650174,"teacher_disagreement_score":0.011597662,"about_ca_system_score_codex":0.0016102615,"about_ca_system_score_gemma":0.0010627785,"threshold_uncertainty_score":0.038798034},"labels":[],"label_agreement":null},{"id":"W7001011682","doi":"","title":"How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimise bias","year":2019,"lang":"en","type":"article","venue":"eScholarship@McGill (McGill)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Transparency (behavior); Pharmacoepidemiology; Data collection; Protocol (science)","score_opus":0.1463613366742838,"score_gpt":0.40692846937277033,"score_spread":0.2605671326984865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001011682","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014865355,0.0014567978,0.88108134,0.0631667,0.0025762524,0.0022306761,0.0017043717,0.0042646956,0.028653823],"genre_scores_gemma":[0.3755245,0.000954937,0.5939824,0.011848832,0.0028585927,0.0034073333,0.001581463,0.0014038258,0.008438134],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7440633,0.20642476,0.01646579,0.014505247,0.016462578,0.00207833],"domain_scores_gemma":[0.24587083,0.55228186,0.033418294,0.12863085,0.035763703,0.004034494],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24301656,0.0010654442,0.0014323845,0.0041966685,0.0017560283,0.009492655,0.0031723857,0.004310466,0.016639896],"category_scores_gemma":[0.5915444,0.001712326,0.0016514198,0.0030172407,0.003418057,0.018476736,0.0074804816,0.0046325577,0.00411278],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001833183,0.00039333425,0.0381639,0.0015924964,0.0021068149,0.0009656709,0.0062683914,0.047829863,0.0027858946,0.14606544,0.08940511,0.6625899],"study_design_scores_gemma":[0.0007722893,0.0002349046,0.0072807986,0.0013433732,0.00062213995,0.0008245074,0.0013862392,0.14091901,0.0032838795,0.69266313,0.15040667,0.00026305558],"about_ca_topic_score_codex":0.0040121716,"about_ca_topic_score_gemma":0.0038171313,"teacher_disagreement_score":0.75698346,"about_ca_system_score_codex":0.0035595174,"about_ca_system_score_gemma":0.01145933,"threshold_uncertainty_score":0.93349534},"labels":[],"label_agreement":null},{"id":"W7008035280","doi":"","title":"Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Workers in Selected Health Facilities in Abuja","year":2021,"lang":"en","type":"article","venue":"Journals & Books Hosting (International Knowledge Sharing Platform)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse drug reaction; Health care; Drug reaction; Adverse effect; Health professionals; Quarter (Canadian coin); Pharmacovigilance; Drug","score_opus":0.1703487278957798,"score_gpt":0.5035107721768824,"score_spread":0.33316204428110263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7008035280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925023,0.0001405164,0.000022967739,0.00012614309,0.000002920973,0.000020407388,0.000038353697,9.732533e-7,0.00039736356],"genre_scores_gemma":[0.9994336,0.00023177321,0.00008976789,0.000065033244,0.0000037674897,0.000014220664,0.000024576282,2.4930375e-7,0.00013687185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925476,0.00024083034,0.000104896,0.000053861033,0.00020017031,0.000145442],"domain_scores_gemma":[0.9973902,0.00073356146,0.0010964638,0.00006479337,0.00036457478,0.00035044638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013729001,0.00018372764,0.0002945946,0.0008271671,0.00071329455,0.0006493667,0.00031713213,0.0005563837,0.0015223505],"category_scores_gemma":[0.0039757746,0.00028342687,0.00026394904,0.0005300142,0.00041972293,0.0004340889,0.0005270738,0.0004476057,0.00016176577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038003418,0.00024689132,0.98608077,0.00014789995,0.000017886483,0.0003160689,0.0061317184,0.000025965803,0.0004033506,0.000022410728,0.00013348502,0.006435461],"study_design_scores_gemma":[0.00000719678,0.0005471535,0.9805351,0.0001737674,0.000016682761,0.00052244874,0.017428117,0.00013536995,0.00014444537,0.000025305093,0.0004531207,0.000011211133],"about_ca_topic_score_codex":0.007834292,"about_ca_topic_score_gemma":0.009046193,"teacher_disagreement_score":0.007834292,"about_ca_system_score_codex":0.00056308036,"about_ca_system_score_gemma":0.0010619604,"threshold_uncertainty_score":0.015577376},"labels":[],"label_agreement":null},{"id":"W7009294344","doi":"","title":"EFFECTIVENESS OF A REGIONAL REPORTING PROGRAM IN IMPROVING QUALITY OF ADVERSE DRUG REACTION CASE REPORTS","year":2023,"lang":"en","type":"dissertation","venue":"University Library (University of Saskatchewan)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality (philosophy); Adverse drug reaction; Drug reaction; Adverse effect; Health professionals; Data collection; Pharmacovigilance; Program evaluation","score_opus":0.05718829929293107,"score_gpt":0.359627350688505,"score_spread":0.3024390513955739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7009294344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9230141,0.0032003848,0.029540906,0.004612472,0.0002426492,0.01363963,0.0014110293,0.0016563191,0.022682507],"genre_scores_gemma":[0.9192049,0.0016593178,0.071152724,0.000991303,0.00018328223,0.0031160447,0.0013596384,0.00009710236,0.0022357348],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.84137726,0.11477234,0.011354925,0.006944894,0.021750897,0.0037997],"domain_scores_gemma":[0.63029766,0.13700908,0.08038927,0.039786864,0.099940434,0.012576532],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12914596,0.00066526816,0.0008737086,0.0048558526,0.0013066765,0.0034342224,0.0036369404,0.0007502714,0.0019096433],"category_scores_gemma":[0.18122722,0.00080126926,0.001158318,0.004243521,0.0013984392,0.00318543,0.006208926,0.0009310237,0.00047340375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040115123,0.0033386606,0.36997554,0.0023182514,0.00074876146,0.00036513337,0.0064003807,0.006686258,0.00813396,0.0014247383,0.0051754117,0.5914214],"study_design_scores_gemma":[0.00095378526,0.012310107,0.9391063,0.0011837583,0.00065788184,0.00060001906,0.007186313,0.008945491,0.008942147,0.00031333402,0.019545719,0.0002552224],"about_ca_topic_score_codex":0.051811703,"about_ca_topic_score_gemma":0.06794193,"teacher_disagreement_score":0.870854,"about_ca_system_score_codex":0.008152797,"about_ca_system_score_gemma":0.027586767,"threshold_uncertainty_score":0.68299735},"labels":[],"label_agreement":null},{"id":"W7013019901","doi":"","title":"Montreal ballad","year":2008,"lang":"en","type":"other","venue":"University of Debrecen Electronic Archive (University of Debrecen)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ballad; Romance; Power (physics); Broadside; Tower; Register (sociolinguistics)","score_opus":0.028692556954286835,"score_gpt":0.2938838624501459,"score_spread":0.26519130549585906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7013019901","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008270969,0.0032396042,0.0006715279,0.0027468437,0.0011766152,0.000068623536,0.009277002,0.000936855,0.9810558],"genre_scores_gemma":[0.0023686474,0.0007615664,0.00048445354,0.00019428277,0.0000906313,0.000025886242,0.0013079866,0.00031358688,0.9944529],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921083,0.00007359347,0.00002247136,0.00023118277,0.00032817892,0.00013370161],"domain_scores_gemma":[0.99877185,0.000119592274,0.0000667923,0.000101394384,0.00047916584,0.00046126742],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006207438,0.0019455364,0.0007858834,0.00212874,0.0031865204,0.0051077916,0.0013335077,0.0018163206,0.746368],"category_scores_gemma":[0.002441003,0.0006122488,0.00039065265,0.0026337036,0.0008035677,0.0018445171,0.001979747,0.002307527,0.37622306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047838108,0.00002413627,0.00027879342,0.00006904657,0.0000037038963,0.00014657178,0.000037664082,0.00011821655,0.00011207171,0.005384113,0.933121,0.060656756],"study_design_scores_gemma":[0.000010392873,0.000007918811,0.0010343692,0.000039538216,0.0000018910519,0.00006228765,0.000037065434,0.00005280887,0.0000978193,0.00055637455,0.9980925,0.0000069527623],"about_ca_topic_score_codex":0.21138673,"about_ca_topic_score_gemma":0.47672632,"teacher_disagreement_score":0.78861326,"about_ca_system_score_codex":0.005188684,"about_ca_system_score_gemma":0.0059939595,"threshold_uncertainty_score":0.42031264},"labels":[],"label_agreement":null},{"id":"W7015753357","doi":"","title":"Strengths, weaknesses, and opportunities: three tales demonstrating the use, usefulness, and limitations of Canadian post-market data of adverse drug reactions in real-world settings","year":2025,"lang":"en","type":"dissertation","venue":"MacSphere (McMaster University)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CVAR; Drug reaction; Pharmacovigilance; Adverse effect; Disease; Clinical trial; Risk assessment; Drug","score_opus":0.19301226571888194,"score_gpt":0.3451411232064986,"score_spread":0.15212885748761665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7015753357","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017055478,0.0573303,0.048544757,0.78552496,0.016509086,0.0021844776,0.0044558793,0.0010272873,0.067367814],"genre_scores_gemma":[0.21982846,0.13676666,0.3288169,0.20399308,0.009780326,0.004762488,0.005118148,0.0028452468,0.08808866],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.86341625,0.056992464,0.010355107,0.0064745834,0.059520073,0.0032415164],"domain_scores_gemma":[0.5716027,0.12571098,0.015938988,0.043618996,0.22866608,0.014462256],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21322103,0.0016949453,0.0017483525,0.009677768,0.009238618,0.026578492,0.0056327404,0.0038800694,0.0056518796],"category_scores_gemma":[0.37326932,0.00115141,0.0024506676,0.016485956,0.0111566745,0.014974744,0.014341621,0.009731761,0.003006882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032619562,0.00011415009,0.016064277,0.006986766,0.0004996703,0.0004770464,0.058445208,0.00071872654,0.0010968902,0.08332254,0.407222,0.4247265],"study_design_scores_gemma":[0.00006742304,0.00018533584,0.010038711,0.011415604,0.00039872364,0.0006484731,0.030702874,0.0011460917,0.0017682418,0.03695662,0.90631646,0.00035551935],"about_ca_topic_score_codex":0.21250506,"about_ca_topic_score_gemma":0.300707,"teacher_disagreement_score":0.78749496,"about_ca_system_score_codex":0.029271994,"about_ca_system_score_gemma":0.102849536,"threshold_uncertainty_score":0.97023857},"labels":[],"label_agreement":null},{"id":"W7025427285","doi":"","title":"Using information from an indication-based electronic prescribing system to increase pharmacovigilance around antidepressant use for indications besides depression","year":2018,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; McGill University Health Centre; McGill University","keywords":"Antidepressant; Medical prescription; Electronic prescribing; Depression (economics); Hyperparameter; Diagnosis code; Pharmacovigilance","score_opus":0.08244556733087391,"score_gpt":0.40000342291309654,"score_spread":0.3175578555822226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7025427285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7104773,0.005171519,0.19119938,0.029093282,0.0013834983,0.002179731,0.030351339,0.0030228095,0.027121186],"genre_scores_gemma":[0.72488046,0.0028023142,0.25346863,0.0030229844,0.00090134685,0.0006771848,0.012057984,0.00014467808,0.0020443518],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9873985,0.00688042,0.0017525034,0.001112997,0.0026147687,0.00024079248],"domain_scores_gemma":[0.8671868,0.09270455,0.020068517,0.0083232215,0.010322925,0.0013940553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016753742,0.00049768196,0.00082630763,0.005467944,0.00043131172,0.0038146954,0.001007223,0.001203439,0.0036262565],"category_scores_gemma":[0.12828763,0.00042461493,0.0014099053,0.006241031,0.00028139324,0.003013489,0.0016288884,0.0017007735,0.0011955969],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012011251,0.0005751114,0.44306105,0.001473465,0.0010125819,0.00019067373,0.0012571774,0.010454123,0.0027210796,0.003611517,0.022002712,0.5124393],"study_design_scores_gemma":[0.00065781025,0.0030608117,0.62701124,0.0034473613,0.002901938,0.0008675,0.0020924693,0.22380702,0.022028148,0.02306487,0.09050107,0.00055979466],"about_ca_topic_score_codex":0.0024971566,"about_ca_topic_score_gemma":0.0039387224,"teacher_disagreement_score":0.016753742,"about_ca_system_score_codex":0.0009818068,"about_ca_system_score_gemma":0.002375044,"threshold_uncertainty_score":0.08860332},"labels":[],"label_agreement":null},{"id":"W7029320796","doi":"","title":"An introduction to adverse drug reaction reporting systems in different countries","year":2005,"lang":"en","type":"article","venue":"Queensland's institutional digital repository (The University of Queensland)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; MEDLINE; Adverse drug reaction; Medical prescription; Confusion; Health care; Alternative medicine; Drug reaction; Remuneration","score_opus":0.03542863955111849,"score_gpt":0.3272466433514595,"score_spread":0.291818003800341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7029320796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007065182,0.9146864,0.016251516,0.034245096,0.009754824,0.0012678396,0.00395742,0.0008978218,0.011874003],"genre_scores_gemma":[0.053223573,0.8070867,0.09714868,0.019510413,0.008174827,0.0030830945,0.006551756,0.0003443748,0.004876638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9467944,0.024319299,0.019508949,0.0025853324,0.0058103004,0.0009817508],"domain_scores_gemma":[0.8360122,0.09380883,0.031087732,0.0038857192,0.033505112,0.001700374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05245998,0.0012616892,0.00219164,0.0345801,0.001113942,0.006597374,0.0024470668,0.0022046263,0.0057923025],"category_scores_gemma":[0.07835752,0.0014721727,0.0039093164,0.04200684,0.0020979163,0.012028576,0.0033630533,0.0036308318,0.0015221055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031607755,0.00018059777,0.010877722,0.061138365,0.00060909824,0.0004622879,0.0025901357,0.0014538451,0.0015519678,0.013134935,0.0964475,0.81123745],"study_design_scores_gemma":[0.00014246735,0.0008207662,0.07566122,0.086339824,0.0007092545,0.0016811376,0.002229705,0.0009019169,0.0006685952,0.0035701727,0.82706684,0.00020808123],"about_ca_topic_score_codex":0.011035146,"about_ca_topic_score_gemma":0.009197704,"teacher_disagreement_score":0.05245998,"about_ca_system_score_codex":0.0077591334,"about_ca_system_score_gemma":0.008512941,"threshold_uncertainty_score":0.27743822},"labels":[],"label_agreement":null},{"id":"W7034032680","doi":"","title":"Stage Backstage : Solo Exhibition, Donald Browne Gallery, Montreal","year":2014,"lang":"en","type":"other","venue":"University of Hertfordshire Research Archive (University of Hertfordshire)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleofection; Gestational period; Dysgeusia; Hyporeflexia; TSG101; Fusible alloy; Articular cartilage damage","score_opus":0.09316248199124533,"score_gpt":0.378179976779949,"score_spread":0.2850174947887037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7034032680","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012437681,0.011768608,0.0009083713,0.019330084,0.0050623156,0.0002738565,0.0038958357,0.00056527334,0.9457579],"genre_scores_gemma":[0.020130249,0.0025517913,0.00046055476,0.00067980797,0.00024879636,0.000042662876,0.0003707387,0.00020598051,0.97530943],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997161,0.000035734465,0.0000035555026,0.000039808907,0.00011099276,0.00009378859],"domain_scores_gemma":[0.9997099,0.000030551186,0.000007658825,0.000019038896,0.00008469793,0.00014806968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049428747,0.0010873191,0.00020353832,0.000759743,0.008524891,0.002872274,0.0009711051,0.0008888261,0.18628792],"category_scores_gemma":[0.0005881509,0.00044219402,0.00034451226,0.00073363894,0.001521171,0.0009741769,0.0022044217,0.00116863,0.013851079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005383258,0.000029168816,0.00042621055,0.00006686947,0.0000056225035,0.0003024866,0.002147092,0.00010843929,0.00089171284,0.0035925936,0.96768457,0.024691306],"study_design_scores_gemma":[0.0000056607855,0.000007120124,0.0019563274,0.00003345884,0.000001849466,0.000055751945,0.001459432,0.000026214902,0.00018520978,0.0001528483,0.9961085,0.000007644477],"about_ca_topic_score_codex":0.711836,"about_ca_topic_score_gemma":0.9372027,"teacher_disagreement_score":0.711836,"about_ca_system_score_codex":0.008273057,"about_ca_system_score_gemma":0.007820087,"threshold_uncertainty_score":0.6231952},"labels":[],"label_agreement":null},{"id":"W7036445060","doi":"","title":"BioHiTech Global Reports Second Quarter 2021 Financial Results With Record Revenue","year":2021,"lang":"en","type":"other","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Revenue; Payment; Work (physics)","score_opus":0.05139411514186511,"score_gpt":0.39786267626542726,"score_spread":0.34646856112356217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7036445060","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009008456,0.0014277432,0.00070872536,0.010341818,0.0074173766,0.0002044981,0.025167368,0.0025857184,0.95124596],"genre_scores_gemma":[0.0025272167,0.0007608939,0.00036198736,0.002608194,0.0012219166,0.000077731616,0.012905741,0.00045978476,0.9790766],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986206,0.00010474219,0.000054621654,0.0000966037,0.0009114894,0.00021185419],"domain_scores_gemma":[0.99546057,0.0004951384,0.00037448682,0.00019642657,0.0020527642,0.0014206057],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012175268,0.0014450998,0.00070188905,0.002983992,0.0010963546,0.006117569,0.0010044201,0.0033916687,0.548151],"category_scores_gemma":[0.006845933,0.00043275562,0.00078716135,0.0018079998,0.00057728455,0.0018911886,0.0016529119,0.0025558916,0.5658179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034186818,0.000026897287,0.00010832683,0.000027679678,0.0000016226879,0.000019477762,0.0000020949715,0.000038607,0.00006788339,0.00054555095,0.98099697,0.018130751],"study_design_scores_gemma":[0.000049752405,0.000040407398,0.0008401149,0.000068254914,0.0000037914967,0.00004938967,0.00001619977,0.0003317645,0.00021685328,0.0007956389,0.99757904,0.0000088820425],"about_ca_topic_score_codex":0.008708177,"about_ca_topic_score_gemma":0.010394066,"teacher_disagreement_score":0.548151,"about_ca_system_score_codex":0.0016668212,"about_ca_system_score_gemma":0.0043233824,"threshold_uncertainty_score":0.64450777},"labels":[],"label_agreement":null},{"id":"W7042941293","doi":"","title":"Review of National Spontaneous Reporting Schemes: Strengths and Weaknesses","year":2002,"lang":"en","type":"article","venue":"ORCA Online Research @Cardiff (Cardiff University)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Strengths and weaknesses; Developed country; Developing country; Health professionals; Drug reaction; Public health; Health care","score_opus":0.29588637232543374,"score_gpt":0.5172666117677676,"score_spread":0.22138023944233381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7042941293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09089224,0.58304805,0.07495687,0.087564364,0.020419523,0.043052092,0.04677597,0.0015632118,0.051727716],"genre_scores_gemma":[0.46038136,0.2588474,0.15235862,0.037976604,0.004987079,0.044743985,0.034626443,0.0009927023,0.0050857463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.39406165,0.32195416,0.17046382,0.0147963455,0.09487209,0.0038519904],"domain_scores_gemma":[0.11530675,0.41181916,0.11984068,0.055998407,0.29299882,0.004036172],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5621404,0.0012944149,0.0033603625,0.020650676,0.0024385357,0.0070778895,0.0088283,0.00216539,0.004147701],"category_scores_gemma":[0.73584926,0.002178327,0.005740767,0.02734015,0.0040047793,0.00843159,0.006883419,0.002814649,0.0013358225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014047629,0.00025831346,0.106430486,0.18845066,0.004500897,0.00018485003,0.006517577,0.0016851216,0.0003634429,0.010234874,0.057811435,0.6221575],"study_design_scores_gemma":[0.00062496826,0.0011965315,0.20939836,0.33432218,0.0076709394,0.0008912802,0.00667874,0.0025279804,0.0021816147,0.0031394418,0.43099812,0.00036981347],"about_ca_topic_score_codex":0.02687899,"about_ca_topic_score_gemma":0.029318735,"teacher_disagreement_score":0.4378596,"about_ca_system_score_codex":0.017713113,"about_ca_system_score_gemma":0.06316022,"threshold_uncertainty_score":0.53995883},"labels":[],"label_agreement":null},{"id":"W7071077424","doi":"","title":"Should Accreditation Canadaâs Required Organizational Practices and Standards Lead to Prioritization of Clinical Pharmacy Services over Distribution-Related Medication Safety Strategies?","year":2013,"lang":"en","type":"article","venue":"Europe PMC (PubMed Central)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Accreditation; Prioritization; Pharmacy; Lead (geology); Patient safety; Pharmacy practice; Clinical pharmacy; Standardization; MEDLINE; Risk management","score_opus":0.09499480495866397,"score_gpt":0.4410376039140959,"score_spread":0.34604279895543194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071077424","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031054854,0.0037262228,0.00671817,0.9102532,0.0033477112,0.0005470881,0.00068541535,0.0003730749,0.04329435],"genre_scores_gemma":[0.50589293,0.0057304893,0.04635185,0.418326,0.0015560396,0.0009239257,0.0012629771,0.00031855472,0.019637244],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8921234,0.029673835,0.007622251,0.004155815,0.044915613,0.02150901],"domain_scores_gemma":[0.51924455,0.06637121,0.04447842,0.018809762,0.30194095,0.04915509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11864514,0.00064470293,0.00092638173,0.005708186,0.00797846,0.015664663,0.005956888,0.008767112,0.009605536],"category_scores_gemma":[0.2568317,0.00092458376,0.0016803697,0.005959981,0.0069631697,0.0071024317,0.005894038,0.009145316,0.0011395888],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003410441,0.0018431203,0.1499543,0.001964192,0.00043830974,0.00063147314,0.0060536982,0.002531194,0.002679703,0.103537776,0.41121185,0.31881338],"study_design_scores_gemma":[0.00056203036,0.00066681235,0.3530968,0.008482279,0.00040821565,0.0006207704,0.021568622,0.0051218243,0.007246119,0.040392067,0.56118345,0.0006510409],"about_ca_topic_score_codex":0.7547788,"about_ca_topic_score_gemma":0.8509433,"teacher_disagreement_score":0.92304873,"about_ca_system_score_codex":0.07695125,"about_ca_system_score_gemma":0.49434742,"threshold_uncertainty_score":0.627463},"labels":[],"label_agreement":null},{"id":"W7093839229","doi":"","title":"Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis","year":2022,"lang":"en","type":"article","venue":"Utrecht University Repository (Utrecht University)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Interrupted Time Series Analysis; Interrupted time series; Medical prescription; Defined daily dose; Prescription drug","score_opus":0.05254011428094199,"score_gpt":0.3222322857918999,"score_spread":0.2696921715109579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7093839229","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08388484,0.8944637,0.014203194,0.0009998424,0.00075541186,0.00080401864,0.0033807766,0.00019897545,0.0013092564],"genre_scores_gemma":[0.80954343,0.17013937,0.011323188,0.0013461843,0.00052283966,0.0022752844,0.0036850574,0.00016767233,0.0009968665],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97722214,0.015764788,0.0031328157,0.0019981943,0.0014073183,0.00047458647],"domain_scores_gemma":[0.9514886,0.036798365,0.0069767474,0.0028982665,0.0015471019,0.0002909026],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.03480423,0.002124224,0.009706386,0.0028305626,0.000408283,0.0028238897,0.0018339858,0.0020546047,0.0028850976],"category_scores_gemma":[0.064692184,0.0011211551,0.046835728,0.004960623,0.00057357125,0.0012217939,0.0011430456,0.002486285,0.00023690052],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012634547,0.000091310314,0.01662929,0.029602038,0.9243303,0.00010435159,0.000063218955,0.0029955467,0.00021489474,0.0002300064,0.00061434007,0.012490203],"study_design_scores_gemma":[0.0023517732,0.0008377193,0.017620219,0.0035544191,0.9704893,0.00011367287,0.00003336992,0.0026692704,0.00023230034,0.00038264622,0.0016814555,0.000033814893],"about_ca_topic_score_codex":0.0063687917,"about_ca_topic_score_gemma":0.004247044,"teacher_disagreement_score":0.9902936,"about_ca_system_score_codex":0.0017652779,"about_ca_system_score_gemma":0.0015668268,"threshold_uncertainty_score":0.18406451},"labels":[],"label_agreement":null},{"id":"W7095283264","doi":"","title":"RESEARCH Open Access Why the FUSS (Fentanyl Urine Screen","year":2016,"lang":"en","type":"article","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MEDLINE; Urine; Public health; Population; Public access","score_opus":0.5054589339647995,"score_gpt":0.6189729261898026,"score_spread":0.11351399222500314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7095283264","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380644,0.0029632647,0.00041334503,0.016036654,0.00047022305,0.0006351187,0.018379465,0.000044482833,0.022993132],"genre_scores_gemma":[0.98751104,0.0010794478,0.00037619754,0.0046583028,0.000092173774,0.000100924124,0.002144783,0.000019462012,0.00401769],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970143,0.00043138323,0.0002864919,0.00030280394,0.0010971983,0.00086784526],"domain_scores_gemma":[0.9934568,0.00073074794,0.0013554586,0.00033414675,0.0025221808,0.0016006763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014529196,0.00021631707,0.0003435855,0.0007996769,0.0017578405,0.0015501037,0.0009722197,0.0011638829,0.0047514597],"category_scores_gemma":[0.009420427,0.0003184103,0.00051548553,0.0023857595,0.0007742274,0.00068168837,0.0008683495,0.0010208766,0.000460253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006988313,0.000067774534,0.9854305,0.000041487154,0.000044427925,0.00018601447,0.00039674077,0.00002129513,0.000093872804,0.00014262195,0.0077272626,0.0057782093],"study_design_scores_gemma":[0.000019705229,0.00003912001,0.9945615,0.00011320073,0.00003144286,0.00016109088,0.0012138807,0.000097492855,0.000042696684,0.000042078893,0.0036677828,0.000009974731],"about_ca_topic_score_codex":0.96089536,"about_ca_topic_score_gemma":0.9729768,"teacher_disagreement_score":0.99524856,"about_ca_system_score_codex":0.0058910856,"about_ca_system_score_gemma":0.017622318,"threshold_uncertainty_score":0.078669846},"labels":[],"label_agreement":null},{"id":"W7097424247","doi":"","title":"bmjqs-2012-001704","year":2013,"lang":"en","type":"article","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harm; Suspect; Adverse effect; SAFER; Product (mathematics); Number needed to harm; Patient safety; Drug","score_opus":0.13852694936345666,"score_gpt":0.4640693229224217,"score_spread":0.32554237355896504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097424247","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013162615,0.003757665,0.0007757031,0.03557118,0.0060333028,0.002106644,0.1661921,0.0011007754,0.7831464],"genre_scores_gemma":[0.020981617,0.01239559,0.0043943413,0.057354722,0.0107873455,0.003735701,0.09885428,0.0019505798,0.7895459],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941918,0.0018222936,0.0010953044,0.00031936122,0.0019851082,0.00058596395],"domain_scores_gemma":[0.97834253,0.01141428,0.0016395773,0.0014407847,0.0048512355,0.002311608],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0036041546,0.0012852338,0.001959108,0.0055367555,0.0024684654,0.0064712293,0.001759941,0.012905047,0.91311383],"category_scores_gemma":[0.046278384,0.0019330566,0.0022514542,0.006902678,0.001211959,0.004373545,0.004488385,0.004700353,0.625287],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016986529,0.000090334004,0.00031524946,0.0024036206,0.000016737322,0.00009968367,0.000116221694,0.00007196233,0.00006387644,0.004107942,0.9523085,0.040236026],"study_design_scores_gemma":[0.0006997111,0.00004405653,0.000837717,0.0031192012,0.000013973238,0.00008156454,0.000107546875,0.00008609208,0.000039545535,0.0018678939,0.9930795,0.000023214236],"about_ca_topic_score_codex":0.02444269,"about_ca_topic_score_gemma":0.027822496,"teacher_disagreement_score":0.08688617,"about_ca_system_score_codex":0.0055389456,"about_ca_system_score_gemma":0.006840346,"threshold_uncertainty_score":0.12393248},"labels":[],"label_agreement":null},{"id":"W7097543427","doi":"","title":"Reactions","year":2002,"lang":"en","type":"article","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug reaction; Drug; Adverse effect; Adverse drug reaction; Health care; Public health","score_opus":0.25548098732721847,"score_gpt":0.4692597851609602,"score_spread":0.2137787978337417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097543427","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07562552,0.18263572,0.02468732,0.034954164,0.013051331,0.005879664,0.011712193,0.0047322167,0.64672184],"genre_scores_gemma":[0.52627546,0.06458565,0.009382441,0.0635673,0.0033549843,0.001459073,0.009059447,0.00066154916,0.32165405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528015,0.0010475593,0.00051389285,0.00055323844,0.0020400747,0.0005650622],"domain_scores_gemma":[0.9954585,0.000965465,0.00093797967,0.000551783,0.0017391957,0.00034712016],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020445075,0.0010069305,0.0008390453,0.0005925275,0.0010134247,0.0016881998,0.0010353142,0.0021936262,0.0868666],"category_scores_gemma":[0.010954332,0.00026918334,0.0012031003,0.00069251953,0.00047568965,0.0010877361,0.0012729488,0.002551376,0.035305843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031479574,0.0011171753,0.01400162,0.005451846,0.00037495652,0.015252047,0.0007364412,0.00052652665,0.019785797,0.01616929,0.35608858,0.56734776],"study_design_scores_gemma":[0.00033418075,0.0010160892,0.0072748596,0.0016130788,0.00019874386,0.036712714,0.0003694142,0.00027491883,0.012560819,0.0047488967,0.93484896,0.000047342182],"about_ca_topic_score_codex":0.0018635349,"about_ca_topic_score_gemma":0.0016166538,"teacher_disagreement_score":0.9131334,"about_ca_system_score_codex":0.0014013449,"about_ca_system_score_gemma":0.0012488854,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W7098493931","doi":"","title":"Prescription Drugs and Administrative Costs Provincial Drug Plan Officials ’ Views of the Canadian Drug Safety System","year":2016,"lang":"en","type":"article","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Government (linguistics); Context (archaeology); Plan (archaeology); Electronic prescribing; Strengths and weaknesses; Medical prescription; Prescription drug","score_opus":0.09930126512018464,"score_gpt":0.3946386147010507,"score_spread":0.2953373495808661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7098493931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64311093,0.0011925832,0.0008173734,0.16972664,0.00022334432,0.00011604434,0.0010834099,0.000020478454,0.18370923],"genre_scores_gemma":[0.9946802,0.00032321448,0.00017242247,0.0019378247,0.000019353864,0.000008368416,0.000060148857,0.000003864621,0.0027946245],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.98319006,0.003890164,0.00063338736,0.00046379864,0.007339501,0.004483102],"domain_scores_gemma":[0.96109384,0.010832296,0.004267067,0.00079538487,0.015151102,0.007860267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007931902,0.000148247,0.00021351407,0.001964066,0.018143373,0.0091340495,0.0011404303,0.0012291354,0.007024949],"category_scores_gemma":[0.03372272,0.0002555901,0.00027565443,0.0032960908,0.0043501467,0.0015566649,0.0025049795,0.0025791286,0.00017314713],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035486565,0.0001879481,0.36054343,0.0004399975,0.00016049507,0.001737235,0.2365387,0.0032405024,0.0020747455,0.19203196,0.10670982,0.09598034],"study_design_scores_gemma":[0.000053075815,0.00008460623,0.37313533,0.0004883369,0.00009616601,0.00027238292,0.3680383,0.00293135,0.0009247428,0.0056550503,0.24807735,0.00024335882],"about_ca_topic_score_codex":0.9823545,"about_ca_topic_score_gemma":0.98499113,"teacher_disagreement_score":0.88120675,"about_ca_system_score_codex":0.118793234,"about_ca_system_score_gemma":0.14853129,"threshold_uncertainty_score":0.8619093},"labels":[],"label_agreement":null},{"id":"W7103518391","doi":"","title":"Canadaâs Vaccine Vigilance Working Group","year":2014,"lang":"en","type":"article","venue":"PubMed Central","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Vigilance (psychology); Immunization; Immunization program; Public health; Vaccine safety","score_opus":0.06955596043629904,"score_gpt":0.3555475488435037,"score_spread":0.2859915884072047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7103518391","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014562649,0.11886586,0.009541956,0.2596654,0.019111251,0.0045743748,0.07437946,0.0038318962,0.49546713],"genre_scores_gemma":[0.15142877,0.18931864,0.04757487,0.078874305,0.008167418,0.0050275833,0.20658395,0.0016594365,0.31136495],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99213034,0.00076405343,0.0006416406,0.00051914615,0.004821148,0.0011236515],"domain_scores_gemma":[0.9456363,0.002142898,0.002760975,0.0012350552,0.039919462,0.008305361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010079277,0.0010279577,0.00090744294,0.0067173266,0.004557537,0.0050263726,0.0050322204,0.002144957,0.028696535],"category_scores_gemma":[0.027426116,0.0006551326,0.0013850881,0.005351796,0.00094319094,0.002056747,0.0029164543,0.003724521,0.009772513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093953975,0.000055912813,0.0063137515,0.00061896775,0.00004846064,0.00010902293,0.00021434756,0.00010715514,0.0003696209,0.001661272,0.8336375,0.1567701],"study_design_scores_gemma":[0.00004567819,0.00004570538,0.009396533,0.0009684867,0.000074239106,0.00017787953,0.00017207068,0.00015300255,0.00043399015,0.00057607744,0.98793054,0.000025822874],"about_ca_topic_score_codex":0.84650755,"about_ca_topic_score_gemma":0.822714,"teacher_disagreement_score":0.15349245,"about_ca_system_score_codex":0.03524405,"about_ca_system_score_gemma":0.17216814,"threshold_uncertainty_score":0.30879277},"labels":[],"label_agreement":null},{"id":"W7104873159","doi":"10.71781/31538","title":"Impact de la loi de Vanessa sur la déclaration des événements indésirables associés aux médicaments antiplaquettaires","year":2024,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Congenital disease; General practice; Motion study","score_opus":0.026758516301658118,"score_gpt":0.33970163141113857,"score_spread":0.3129431151094805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104873159","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23342425,0.04787981,0.019038223,0.4040166,0.007689308,0.0018327401,0.02400616,0.001193481,0.2609195],"genre_scores_gemma":[0.8258978,0.010897411,0.010727572,0.07401905,0.0012963137,0.0009939082,0.0054258667,0.0002875219,0.070454456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9646913,0.013618787,0.0025751274,0.0023432183,0.011982137,0.004789536],"domain_scores_gemma":[0.87786853,0.032429658,0.023839526,0.006045386,0.044409465,0.015407423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034613486,0.00046930922,0.00072435034,0.0021319005,0.0033357367,0.007080859,0.0025698803,0.0021165241,0.016354796],"category_scores_gemma":[0.09937658,0.00047710675,0.0014920237,0.0019589001,0.0033180572,0.0015542101,0.004323795,0.00453295,0.0018180341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093453587,0.0002768517,0.40494245,0.0030641635,0.0011982226,0.00057145883,0.008289733,0.0013765362,0.0021713402,0.060610805,0.2149102,0.30165374],"study_design_scores_gemma":[0.00018017722,0.0004913121,0.3826923,0.0061752354,0.0008983608,0.0004040758,0.0046419245,0.0014733671,0.0027232466,0.005342012,0.594712,0.00026603643],"about_ca_topic_score_codex":0.6461667,"about_ca_topic_score_gemma":0.71972334,"teacher_disagreement_score":0.6461667,"about_ca_system_score_codex":0.026733318,"about_ca_system_score_gemma":0.082696654,"threshold_uncertainty_score":0.7118342},"labels":[],"label_agreement":null},{"id":"W7104946950","doi":"10.71781/30701","title":"Une étude sur l’évaluation de la causalité des événements indésirables médicamenteux évalués par des professionnels de la santé en milieu hospitalier","year":2025,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Université du Québec à Trois-Rivières; Université Laval","keywords":"Poison control; Context (archaeology); Balance (ability)","score_opus":0.10662115179796954,"score_gpt":0.5100376934115043,"score_spread":0.40341654161353474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104946950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7176609,0.1814528,0.03519041,0.016824134,0.0018288005,0.004000663,0.008108782,0.00026016863,0.0346733],"genre_scores_gemma":[0.93796116,0.030245647,0.016373977,0.0038419901,0.00052476564,0.0019896433,0.0019510632,0.00007676945,0.0070349663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.93823844,0.040060822,0.005383814,0.0036841412,0.011123176,0.0015095149],"domain_scores_gemma":[0.74596786,0.16642326,0.040923323,0.007011422,0.037116922,0.002557136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.066760585,0.0008676424,0.0017203997,0.002865098,0.0015617908,0.0039488096,0.0012341588,0.0015137331,0.0067113643],"category_scores_gemma":[0.16090555,0.0006375843,0.0042063403,0.005296574,0.0015389954,0.002565933,0.0016211702,0.0021867058,0.00076745736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004828188,0.0006445081,0.70240253,0.007885992,0.0073025655,0.00027650798,0.0037766455,0.0009162994,0.0008094041,0.0036769258,0.005619645,0.26186082],"study_design_scores_gemma":[0.0005971122,0.00573494,0.9115006,0.008927514,0.010023369,0.00075133983,0.0032461565,0.002311605,0.0027150358,0.004089813,0.049872197,0.00023022671],"about_ca_topic_score_codex":0.038860355,"about_ca_topic_score_gemma":0.05543726,"teacher_disagreement_score":0.066760585,"about_ca_system_score_codex":0.0058268444,"about_ca_system_score_gemma":0.01131472,"threshold_uncertainty_score":0.35306793},"labels":[],"label_agreement":null},{"id":"W7108476635","doi":"10.2196/75094","title":"Active Surveillance for COVID-19 Vaccine Safety Using Sequential Analysis in Korea: Population-Based Retrospective Observational Study","year":2025,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Observational study; Vaccine safety; Retrospective cohort study; MEDLINE; Vaccination; Public health","score_opus":0.22356643764731582,"score_gpt":0.5127059801418151,"score_spread":0.2891395424944993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108476635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790037,0.00022923364,0.00048532186,0.000025242325,0.0000066847874,0.00005309136,0.0011410206,0.0000061375595,0.00015293804],"genre_scores_gemma":[0.99806017,0.00013050593,0.0003781273,0.000044729026,0.000008236979,0.000057790716,0.0012803624,0.000003034906,0.00003707569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759173,0.0006709727,0.0004988902,0.0007524096,0.00030652646,0.00017945793],"domain_scores_gemma":[0.9946359,0.00059696415,0.0031301035,0.0007123559,0.0005352739,0.0003894535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023596617,0.0005289488,0.00056615274,0.0012202081,0.00040717408,0.00064672885,0.0006421715,0.00045330453,0.000651244],"category_scores_gemma":[0.004439928,0.0006451227,0.0009895755,0.001991792,0.0003773997,0.0007092411,0.0007319985,0.0006156617,0.000153116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012768334,0.000033329863,0.9988691,0.00001891882,0.000119296,0.000038538412,0.00003884834,0.00003059742,0.00011476207,0.000011373543,0.00007545958,0.0005220001],"study_design_scores_gemma":[0.000043280677,0.00038143952,0.9972064,0.000020838626,0.00020458688,0.0004411933,0.00027801268,0.00089270144,0.0001514052,0.000041389354,0.0003246648,0.000014066073],"about_ca_topic_score_codex":0.005014891,"about_ca_topic_score_gemma":0.0054011056,"teacher_disagreement_score":0.005014891,"about_ca_system_score_codex":0.00050060014,"about_ca_system_score_gemma":0.00091499585,"threshold_uncertainty_score":0.012479246},"labels":[],"label_agreement":null},{"id":"W7110891194","doi":"10.1371/journal.pone.0335449.s003","title":"DIMDs reported in FAERS.","year":2025,"lang":"","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Logistic regression; Adverse Event Reporting System; Risk assessment; Quarter (Canadian coin); Food and drug administration; Adverse effect; Risk factor","score_opus":0.21131773673125717,"score_gpt":0.5015481898915302,"score_spread":0.29023045316027296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7110891194","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04351328,0.009194707,0.0025638542,0.005951125,0.0012272213,0.00067214534,0.86761385,0.0036061958,0.065657645],"genre_scores_gemma":[0.44273263,0.01012053,0.008527987,0.010968734,0.0019806365,0.0008075214,0.49315912,0.0008262164,0.030876625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981846,0.00034163293,0.00048411195,0.00027500317,0.00061083323,0.00010381951],"domain_scores_gemma":[0.98391736,0.005774767,0.006964231,0.0013363514,0.0016609875,0.00034630796],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016496503,0.00033183812,0.00042329784,0.0030249804,0.00029489162,0.0011411828,0.00057009317,0.0008203545,0.10851525],"category_scores_gemma":[0.018230356,0.00016425388,0.0009642733,0.0034170893,0.00023470109,0.0008578022,0.000992409,0.00045467593,0.016538637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008939615,0.000055114746,0.16883622,0.00463195,0.0004121952,0.0010253141,0.00018093073,0.0005924998,0.00079697755,0.0025493468,0.65518343,0.1648421],"study_design_scores_gemma":[0.0002077094,0.00022069336,0.35872102,0.0032941361,0.00037606797,0.0056144204,0.0002536408,0.0016885118,0.0016781845,0.0025790536,0.62529105,0.000075562784],"about_ca_topic_score_codex":0.0037527243,"about_ca_topic_score_gemma":0.004542816,"teacher_disagreement_score":0.89148474,"about_ca_system_score_codex":0.00077170524,"about_ca_system_score_gemma":0.00064709387,"threshold_uncertainty_score":0.36301965},"labels":[],"label_agreement":null},{"id":"W7111420190","doi":"10.1371/journal.pone.0335449.s004","title":"Information related to multivariate regression.","year":2025,"lang":"","type":"article","venue":"Figshare","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Logistic regression; Adverse Event Reporting System; Multivariate analysis; Multivariate statistics; Risk assessment; Quarter (Canadian coin); Food and drug administration; MEDLINE","score_opus":0.09102122938446684,"score_gpt":0.46291386302239124,"score_spread":0.3718926336379244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7111420190","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013937352,0.019138701,0.60286564,0.02298809,0.005428093,0.002539891,0.259953,0.030882584,0.04226661],"genre_scores_gemma":[0.280039,0.014562669,0.4270674,0.008369295,0.007975078,0.010644587,0.19947432,0.011412806,0.040454894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9840276,0.010396153,0.0013661914,0.0018308826,0.0020480542,0.00033122016],"domain_scores_gemma":[0.83439404,0.14573446,0.006421022,0.008155574,0.0045994762,0.0006954005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015800089,0.002058056,0.0019471461,0.0050206496,0.00042571226,0.0021981795,0.0023731738,0.001960062,0.16105932],"category_scores_gemma":[0.1341391,0.0010273096,0.0029406673,0.006154704,0.000781107,0.0027254946,0.0026379605,0.0035237966,0.031899694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007483585,0.00021787989,0.030336443,0.0035966851,0.0024560909,0.00034060443,0.00022087643,0.016873758,0.00019011443,0.025688916,0.550348,0.36898234],"study_design_scores_gemma":[0.0006088883,0.0004973344,0.04148179,0.0033400187,0.0012421574,0.0009509888,0.00032086417,0.36237994,0.00096053333,0.20554158,0.38239372,0.00028222668],"about_ca_topic_score_codex":0.0041037314,"about_ca_topic_score_gemma":0.0034818242,"teacher_disagreement_score":0.16105932,"about_ca_system_score_codex":0.0011738072,"about_ca_system_score_gemma":0.0023742206,"threshold_uncertainty_score":0.53879714},"labels":[],"label_agreement":null},{"id":"W7115029826","doi":"","title":"Who is your doctor?: Physician characteristics, use of potentially inappropriate medications, and subsequent risk of adverse drug events","year":2025,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Foundation for Advancement of International Medical Education and Research","keywords":"Adverse effect; Drug; MEDLINE; Event (particle physics); Risk assessment","score_opus":0.05339773774570549,"score_gpt":0.3582638434244992,"score_spread":0.3048661056787937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115029826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435294,0.0022653325,0.00006517966,0.0011731618,0.00003735493,0.000016563492,0.0005869913,0.0000032573794,0.0014992558],"genre_scores_gemma":[0.99814737,0.0008124849,0.000091458176,0.00027628514,0.00004814688,0.000009428046,0.00021901273,0.0000014754007,0.00039428123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992698,0.00021679634,0.00010065462,0.00011449768,0.00017425526,0.00012402392],"domain_scores_gemma":[0.9932854,0.0013812678,0.0038168589,0.00014913708,0.0003685951,0.0009986374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009908845,0.00013555156,0.00026030306,0.0007391671,0.00053750176,0.0009088425,0.0003639405,0.0009937022,0.0037052948],"category_scores_gemma":[0.007476521,0.000284662,0.0005429144,0.0012597361,0.0003216603,0.00072576926,0.00048418515,0.0008343156,0.00053110044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004861636,0.000031625495,0.9986482,0.000016590917,0.000031993433,0.00003025333,0.00007845964,0.000011624289,0.000021978136,0.000012012512,0.0001809146,0.00088769686],"study_design_scores_gemma":[0.0000071197474,0.000057484227,0.99892104,0.000037961574,0.000029112507,0.0001663988,0.00036319214,0.00010901787,0.000017915914,0.000023370081,0.00026424744,0.0000031644406],"about_ca_topic_score_codex":0.017210575,"about_ca_topic_score_gemma":0.026378265,"teacher_disagreement_score":0.017210575,"about_ca_system_score_codex":0.00045422456,"about_ca_system_score_gemma":0.00081910857,"threshold_uncertainty_score":0.034220815},"labels":[],"label_agreement":null},{"id":"W7117130945","doi":"10.1177/20420986251395925","title":"Complex chronic adverse events following immunization: a systemic critique and reform proposal for vaccine pharmacovigilance","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Pharmacovigilance; Adverse effect; Vaccination; Public health; Position paper; Orthostatic vital signs; Pandemic","score_opus":0.0357632173899468,"score_gpt":0.4485094486427596,"score_spread":0.4127462312528128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117130945","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008028791,0.006271207,0.012710111,0.97361666,0.003485034,0.000056844405,0.000025037181,0.00005764153,0.0029746017],"genre_scores_gemma":[0.14956583,0.013342201,0.051268984,0.7470898,0.03464698,0.00075440505,0.000082791,0.00021592247,0.003033138],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8101685,0.120448574,0.01933402,0.013983018,0.032808058,0.0032578604],"domain_scores_gemma":[0.5817866,0.33637685,0.010520104,0.018289136,0.047451142,0.0055761877],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2633604,0.0013072721,0.0030195236,0.0060405866,0.00910727,0.027223857,0.008114164,0.033907585,0.0018273628],"category_scores_gemma":[0.28390035,0.001160826,0.0041191163,0.00319231,0.09447579,0.028509593,0.018960373,0.061024044,0.00096152286],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006169128,0.00004754484,0.0011760427,0.00082849,0.00008928909,0.00041130523,0.013724702,0.00069282507,0.00022940246,0.89227563,0.04747837,0.0429847],"study_design_scores_gemma":[0.00013435828,0.0001604368,0.001014699,0.0042390795,0.00019339439,0.0010668002,0.0061857086,0.002845259,0.00044314077,0.6879716,0.29554656,0.00019897908],"about_ca_topic_score_codex":0.010011982,"about_ca_topic_score_gemma":0.0065550045,"teacher_disagreement_score":0.2633604,"about_ca_system_score_codex":0.023129756,"about_ca_system_score_gemma":0.05873357,"threshold_uncertainty_score":0.90840775},"labels":[],"label_agreement":null},{"id":"W7117408086","doi":"10.1177/09246479251414280","title":"Risk management plans and drug safety in Canada: A cross-sectional study","year":2025,"lang":"en","type":"article","venue":"International Journal of Risk & Safety in Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Risk management; Publication; Risk assessment; Drug; Public health; Information system","score_opus":0.033711286965404215,"score_gpt":0.4326344189214544,"score_spread":0.39892313195605017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117408086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925132,0.001005911,0.00010731532,0.0008119864,0.000012773534,0.00017054963,0.0022439342,0.000008146157,0.003126302],"genre_scores_gemma":[0.99713695,0.0008004692,0.0002266236,0.00035894613,0.0000085840875,0.000053134845,0.00073038996,0.0000054537404,0.00067944627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995862,0.00037818754,0.00040971924,0.00037213133,0.002114073,0.0008638103],"domain_scores_gemma":[0.9865319,0.0022185664,0.004737324,0.000342348,0.0038740353,0.0022958864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029911378,0.00028501503,0.00054370385,0.0020797865,0.003834767,0.0027609945,0.0013512599,0.0008374382,0.005378353],"category_scores_gemma":[0.01032138,0.0007811081,0.00093448884,0.0063588717,0.0013544428,0.0012731138,0.001786522,0.0021834788,0.00029364513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046417692,0.00010300042,0.9959258,0.000056334873,0.000032313146,0.000057215417,0.0013934223,0.000028888875,0.000023295739,0.00008078615,0.0005094883,0.0017431669],"study_design_scores_gemma":[0.000010025351,0.000071921626,0.9928746,0.00010199873,0.000032551296,0.00009037207,0.005285497,0.00021449299,0.00003243014,0.000031832016,0.0012369674,0.000017233131],"about_ca_topic_score_codex":0.9675397,"about_ca_topic_score_gemma":0.96613944,"teacher_disagreement_score":0.032460272,"about_ca_system_score_codex":0.032237705,"about_ca_system_score_gemma":0.045024756,"threshold_uncertainty_score":0.23390204},"labels":[],"label_agreement":null},{"id":"W7117476297","doi":"10.64898/2025.12.25.25343014","title":"Reported Drug Spectrum and Disproportionality Signals for Malignant Neoplasm Progression in FAERS: A Real-World Pharmacovigilance Study","year":2025,"lang":"","type":"article","venue":"medRxiv","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"MedDRA; Pharmacovigilance; Adverse Event Reporting System; Adverse effect; Drug; Odds ratio; Postmarketing surveillance; Pharmacoepidemiology","score_opus":0.09285355331342934,"score_gpt":0.48423069212194314,"score_spread":0.39137713880851377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117476297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942419,0.001771955,0.0011212353,0.00018547938,0.00001471682,0.00007971741,0.0019320872,0.00002512842,0.00062776136],"genre_scores_gemma":[0.99806195,0.00022700307,0.00050276984,0.00006990057,0.00002638202,0.000029638266,0.0010202697,0.0000058549745,0.000056177665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97936535,0.008336103,0.0050308458,0.0037691263,0.0028042188,0.00069431233],"domain_scores_gemma":[0.90277183,0.025500834,0.058619678,0.0064268643,0.005764282,0.0009165493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016697139,0.00047123298,0.00069119496,0.005293256,0.00041323356,0.0021101206,0.00081114133,0.00067596976,0.0015781441],"category_scores_gemma":[0.05451253,0.00039667045,0.0012481884,0.0048558824,0.00057022955,0.0017928111,0.0017582288,0.00059035583,0.00028542485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021856972,0.000026454669,0.9963924,0.00007124182,0.00026752613,0.00009395297,0.00013866795,0.00007554872,0.00014290774,0.00006832258,0.0001433686,0.002361001],"study_design_scores_gemma":[0.00002720539,0.00013903099,0.994282,0.00006608454,0.00037437945,0.0011003235,0.0005052711,0.0018245267,0.00049365073,0.00013738935,0.0010254608,0.000024621233],"about_ca_topic_score_codex":0.0033345355,"about_ca_topic_score_gemma":0.0023209387,"teacher_disagreement_score":0.016697139,"about_ca_system_score_codex":0.0010038414,"about_ca_system_score_gemma":0.0008036175,"threshold_uncertainty_score":0.08830398},"labels":[],"label_agreement":null},{"id":"W7117551031","doi":"10.1093/biomtc/ujaf170","title":"Maximized sequential probability ratio test regression","year":2025,"lang":"en","type":"article","venue":"Biometrics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health","funders":"National Institute of General Medical Sciences; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Poisson regression; Sequential probability ratio test; Poisson distribution; Regression analysis; Regression; Confounding; Conditional probability; Linear regression; Sample size determination","score_opus":0.18732251411507986,"score_gpt":0.4830547194125379,"score_spread":0.29573220529745803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117551031","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010989213,0.0003035772,0.9822484,0.00042498854,0.00016156372,0.0005536315,0.000955886,0.0013520006,0.0030106555],"genre_scores_gemma":[0.3187682,0.00043015665,0.6663259,0.00042623482,0.00037386172,0.0026245709,0.0022160092,0.0008003413,0.008034676],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9647772,0.027337095,0.0010742925,0.0033697719,0.0026453072,0.0007963013],"domain_scores_gemma":[0.8552484,0.12868266,0.0039688433,0.006024834,0.0052848184,0.000790377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032778673,0.0018629247,0.0037155892,0.002012579,0.00056832563,0.0018387624,0.0033356987,0.0016182908,0.028952451],"category_scores_gemma":[0.16387607,0.0007603579,0.0025433179,0.0024730347,0.0018222106,0.002865493,0.0021076389,0.0031237036,0.004116076],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042158924,0.00047076665,0.027089745,0.0015553104,0.001737616,0.0016532462,0.0003721419,0.23297103,0.0025947257,0.17825064,0.023335544,0.5257533],"study_design_scores_gemma":[0.00055397546,0.0010196103,0.0044614263,0.00014626709,0.00024902713,0.0006144459,0.00007570095,0.87165016,0.0028575112,0.10745752,0.010831403,0.0000829847],"about_ca_topic_score_codex":0.0022296093,"about_ca_topic_score_gemma":0.0012311395,"teacher_disagreement_score":0.032778673,"about_ca_system_score_codex":0.0011919212,"about_ca_system_score_gemma":0.002980694,"threshold_uncertainty_score":0.17335224},"labels":[],"label_agreement":null},{"id":"W7118206463","doi":"10.1080/21645515.2025.2600189","title":"Electronic, self-reported active vaccine safety surveillance: A three-country comparison of AusVaxSafety (Australia), CANVAS (Canada) and V-safe (United States)","year":2025,"lang":"en","type":"article","venue":"Human Vaccines & Immunotherapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Vaccine safety; Pandemic; Public health; Public health surveillance; Vaccination; Population; Inclusion (mineral); Disease control","score_opus":0.06206211900780141,"score_gpt":0.4211565337378798,"score_spread":0.3590944147300784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7118206463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94736135,0.023189781,0.0022122234,0.0074519105,0.00076854724,0.0006689325,0.008523702,0.00002904771,0.009794538],"genre_scores_gemma":[0.9867243,0.0060261064,0.001341266,0.0021015413,0.00012677765,0.00029255782,0.0027324848,0.000012358642,0.0006426308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98300236,0.011365266,0.0015460621,0.00083404203,0.0022446867,0.0010075383],"domain_scores_gemma":[0.9595226,0.021183789,0.009648557,0.0010311849,0.0073711704,0.001242832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01757349,0.00031770347,0.0005844262,0.0017412456,0.0005110818,0.0014361584,0.00071172265,0.00079836085,0.0016848801],"category_scores_gemma":[0.050576165,0.00023149783,0.0018188129,0.0025654705,0.0006392925,0.0015143061,0.0013647616,0.0010979155,0.00012215502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047873394,0.0002699345,0.8894709,0.0042156624,0.004529019,0.00012287778,0.0025220304,0.0006417432,0.00018158046,0.0016049463,0.0072588767,0.084395126],"study_design_scores_gemma":[0.0005589729,0.0030986008,0.9639254,0.0062043895,0.0037020324,0.00034253715,0.0054389113,0.0020015996,0.0005365193,0.00050081994,0.013593026,0.00009717986],"about_ca_topic_score_codex":0.07535182,"about_ca_topic_score_gemma":0.10517672,"teacher_disagreement_score":0.92464817,"about_ca_system_score_codex":0.0025607904,"about_ca_system_score_gemma":0.004065598,"threshold_uncertainty_score":0.14982647},"labels":[],"label_agreement":null},{"id":"W7131089401","doi":"10.1097/js9.0000000000003934","title":"A pharmacovigilance study of rituximab-associated adverse events in immune-mediated kidney diseases and transplant-related kidney diseases","year":2025,"lang":"en","type":"article","venue":"International Journal of Surgery","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Adverse effect; Kidney; Acute kidney injury; Kidney disease; MEDLINE","score_opus":0.04562871858152915,"score_gpt":0.3999608556384971,"score_spread":0.3543321370569679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7131089401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908097,0.0033653001,0.0010208944,0.00021211298,0.000012578626,0.00019460163,0.00346969,0.000045433175,0.0008698008],"genre_scores_gemma":[0.99684453,0.00033095098,0.0004574455,0.00015626577,0.000017083736,0.000059598817,0.002026555,0.000006737615,0.000100935205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923189,0.0022245632,0.0014807866,0.0016629397,0.0019688793,0.00034388757],"domain_scores_gemma":[0.9841599,0.0036305033,0.00750368,0.0012225216,0.0027489206,0.0007343389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00711794,0.00034308765,0.0009178,0.0023769566,0.00050286704,0.0012029868,0.0006835952,0.00062213326,0.0008825114],"category_scores_gemma":[0.016511273,0.0002488111,0.0018298981,0.0041861404,0.0002740959,0.0004992787,0.0009516803,0.00053351175,0.00011053262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079400826,0.000059925773,0.9896339,0.00017163643,0.001684882,0.00019025401,0.00022208354,0.00018998384,0.00034526543,0.00008189069,0.00045550358,0.0061707436],"study_design_scores_gemma":[0.00007519978,0.00023076797,0.9961718,0.000039395836,0.0011971749,0.00030101952,0.00009378984,0.0009760602,0.00015236024,0.000047435053,0.00070194516,0.000013060922],"about_ca_topic_score_codex":0.048865657,"about_ca_topic_score_gemma":0.035889026,"teacher_disagreement_score":0.048865657,"about_ca_system_score_codex":0.0028014546,"about_ca_system_score_gemma":0.0036738964,"threshold_uncertainty_score":0.097162426},"labels":[],"label_agreement":null},{"id":"W7132969391","doi":"","title":"Enhancing Drug Safety: Designing Solutions To Meet Prescribers’ Information Needs","year":2025,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Usability; Thematic analysis; Pharmacovigilance; Health informatics; Informatics; Drug; Information needs","score_opus":0.07368904533646023,"score_gpt":0.43320370474732445,"score_spread":0.35951465941086425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132969391","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23306654,0.026686542,0.33686537,0.28506094,0.0017435324,0.0094638625,0.0009014867,0.0024583174,0.103753336],"genre_scores_gemma":[0.32794723,0.01515889,0.6291897,0.01569082,0.00028069064,0.004478461,0.0004705153,0.00020528297,0.0065783337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9583572,0.031148493,0.003136987,0.0012845624,0.004744705,0.0013281009],"domain_scores_gemma":[0.9094469,0.06892278,0.0054390496,0.0037320897,0.009314772,0.0031444868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045519374,0.0010139433,0.00091018534,0.0035508992,0.0040624887,0.008048157,0.002506275,0.004632556,0.0064243604],"category_scores_gemma":[0.091987796,0.0010373361,0.0014106091,0.0024983017,0.0032858083,0.013166944,0.0067514973,0.0041306205,0.0015729953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017202251,0.00096069055,0.011951645,0.02745954,0.0002386304,0.0012697126,0.18791977,0.0014666659,0.007023926,0.02604373,0.034918323,0.70057535],"study_design_scores_gemma":[0.0004917335,0.0013918431,0.012493806,0.028046554,0.00064978405,0.0023301407,0.25937617,0.0054368847,0.008378572,0.09098995,0.5901301,0.00028444943],"about_ca_topic_score_codex":0.0022777282,"about_ca_topic_score_gemma":0.003809744,"teacher_disagreement_score":0.045519374,"about_ca_system_score_codex":0.0046991417,"about_ca_system_score_gemma":0.023173194,"threshold_uncertainty_score":0.24073231},"labels":[],"label_agreement":null},{"id":"W7132980212","doi":"","title":"Therapeutic class-specific signal detection of bradycardia associatedwith propranolol hydrochloride","year":2009,"lang":"en","type":"article","venue":"TSpace","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statistic; Bradycardia; Confidence interval; Adverse drug reaction; Adverse effect; Odds ratio; Statistical significance; Detection theory","score_opus":0.09226586172961211,"score_gpt":0.43269285731994106,"score_spread":0.34042699559032896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132980212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95716876,0.00319835,0.025244473,0.00030621214,0.000086569344,0.0009725779,0.0031495003,0.00026861564,0.009604902],"genre_scores_gemma":[0.9884094,0.0007198587,0.008374292,0.00013543389,0.00003920257,0.00016427512,0.0015960196,0.000016082797,0.00054532517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99180424,0.0021602288,0.0016234342,0.00066406507,0.0034771978,0.00027083466],"domain_scores_gemma":[0.9809229,0.0057102325,0.008370736,0.0010171002,0.0037414096,0.00023762304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005929647,0.00026227284,0.00031818636,0.0015191834,0.00022138726,0.00047037672,0.00036129545,0.00022666615,0.0013824583],"category_scores_gemma":[0.013689169,0.00007190016,0.0005886654,0.0009920307,0.00028478852,0.00021945481,0.00034286123,0.0002901108,0.00023356614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013008923,0.00013276088,0.8634642,0.0009552495,0.00031021997,0.000723265,0.00037650982,0.00047635153,0.012652781,0.0002964668,0.0013960331,0.11791525],"study_design_scores_gemma":[0.000039844163,0.0009611229,0.97045285,0.00010135612,0.0003214659,0.0036035308,0.0002720674,0.0032403306,0.016438065,0.00026277266,0.0042774775,0.000029019911],"about_ca_topic_score_codex":0.002902778,"about_ca_topic_score_gemma":0.004132392,"teacher_disagreement_score":0.005929647,"about_ca_system_score_codex":0.00039071578,"about_ca_system_score_gemma":0.0008890015,"threshold_uncertainty_score":0.031359375},"labels":[],"label_agreement":null},{"id":"W7135497666","doi":"","title":"Does greater pharmacovigilance reporting burden lead to better health outcomes?","year":2025,"lang":"en","type":"dissertation","venue":"Digital Repository (National Repository of Grey Literature)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Context (archaeology); Patient safety; Health care; Work (physics); Lead (geology); Health professionals; Legislature","score_opus":0.05358250289122943,"score_gpt":0.4193349413111234,"score_spread":0.365752438419894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7135497666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5247715,0.054901198,0.012414089,0.3294563,0.001012612,0.0004187657,0.0049010874,0.00018926637,0.07193514],"genre_scores_gemma":[0.9692727,0.014683882,0.0045538354,0.008090435,0.0005256988,0.00013848377,0.00073997845,0.00004087362,0.001954121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9723474,0.014670059,0.002761615,0.002734565,0.005849362,0.0016370941],"domain_scores_gemma":[0.869671,0.053453162,0.0565191,0.005637929,0.012051187,0.0026677116],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04244949,0.00023767493,0.00062196195,0.0025647653,0.0008514188,0.0061365035,0.001504521,0.0015448497,0.0059617804],"category_scores_gemma":[0.14471357,0.00025193414,0.0013603177,0.0054838886,0.0020006285,0.0046883416,0.0024709147,0.0018369439,0.0008591232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004700454,0.00038132985,0.5995061,0.0020754295,0.0010227924,0.00018020779,0.008006291,0.001590059,0.0004982055,0.029889092,0.01239069,0.3439897],"study_design_scores_gemma":[0.00013706309,0.0004507251,0.9187987,0.004814931,0.0008807852,0.00047827355,0.007101425,0.0022643975,0.0012225006,0.018827692,0.044908557,0.000114956],"about_ca_topic_score_codex":0.020378785,"about_ca_topic_score_gemma":0.01131727,"teacher_disagreement_score":0.9575505,"about_ca_system_score_codex":0.00466866,"about_ca_system_score_gemma":0.011711815,"threshold_uncertainty_score":0.22449702},"labels":[],"label_agreement":null},{"id":"W7161563486","doi":"10.55563/clinexprheumatol/xzfkd4","title":"Sex-specific risk profiles of drug-associated joint stiffness and deformity: a FAERS-based pharmacovigilance study with Canadian Vigilance Adverse Reaction Database validation","year":2025,"lang":"en","type":"article","venue":"Clinical and Experimental Rheumatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Adverse effect; Vigilance (psychology); Joint (building); MEDLINE; Risk assessment","score_opus":0.08193014579964089,"score_gpt":0.4293951683497176,"score_spread":0.3474650225500767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161563486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98004204,0.0021268828,0.0015482414,0.00035347417,0.000024873334,0.00041187942,0.012620776,0.000048447437,0.002823359],"genre_scores_gemma":[0.99247724,0.0003860926,0.00078490097,0.00017435831,0.000012416645,0.000081947204,0.0057486887,0.000023314917,0.00031104733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910835,0.000998755,0.0009404912,0.0019496549,0.0040814,0.00094631995],"domain_scores_gemma":[0.984501,0.0016563397,0.004204336,0.0018922652,0.006944009,0.0008019721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008537785,0.00065132376,0.00074583525,0.00280292,0.0014243787,0.0020003696,0.0018456938,0.00069890043,0.0025240292],"category_scores_gemma":[0.025085624,0.00050545053,0.0016029846,0.004654772,0.00095564855,0.0006426454,0.0016771507,0.0008715056,0.00032867637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039066616,0.000031259715,0.9912136,0.000116387084,0.00042277758,0.000103512575,0.0005969542,0.00012277074,0.00019366489,0.0002123385,0.0012936703,0.0053025004],"study_design_scores_gemma":[0.00003238312,0.00006105682,0.9968437,0.000047671554,0.00020226269,0.00021554068,0.00022780598,0.0005789325,0.00011919702,0.000040035087,0.0016108588,0.000020526035],"about_ca_topic_score_codex":0.77932996,"about_ca_topic_score_gemma":0.70163804,"teacher_disagreement_score":0.22067004,"about_ca_system_score_codex":0.010017429,"about_ca_system_score_gemma":0.0152961025,"threshold_uncertainty_score":0.4439392},"labels":[],"label_agreement":null},{"id":"W7161974544","doi":"10.82308/51461","title":"Post-approval drug safety: moving from passive to active pharmacovigilance in Canada","year":2013,"lang":"en","type":"dissertation","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Health care; Transparency (behavior); Mandate; Public health; Context (archaeology); Incentive; Legislature","score_opus":0.03196988136481181,"score_gpt":0.37953132216184177,"score_spread":0.34756144079702994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161974544","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41090778,0.026917825,0.01012155,0.42060974,0.0011423366,0.0015802555,0.0025517398,0.0004677168,0.12570101],"genre_scores_gemma":[0.935365,0.011727244,0.008755509,0.027610429,0.00018832897,0.0001457164,0.0007873734,0.000076600634,0.015343736],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9779701,0.003883898,0.0012737354,0.0018660888,0.010210113,0.0047960375],"domain_scores_gemma":[0.94503075,0.009266261,0.0040071574,0.0015561444,0.025142495,0.014997264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015892962,0.00033207453,0.00045538362,0.00229169,0.0067048445,0.008534282,0.0036392703,0.0023061289,0.0031758694],"category_scores_gemma":[0.03473194,0.00079729874,0.0007761887,0.004067342,0.0033341662,0.0024790412,0.0033792532,0.0035913733,0.00022570688],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011071799,0.0007271828,0.2552325,0.0024296327,0.00030864915,0.0017919199,0.01640859,0.0050095553,0.00359509,0.08497498,0.12337548,0.5050392],"study_design_scores_gemma":[0.0003975578,0.0006494773,0.69777274,0.0018880374,0.00027493518,0.0005556598,0.012691894,0.010750376,0.0026551124,0.0059470655,0.2660976,0.00031958104],"about_ca_topic_score_codex":0.9949351,"about_ca_topic_score_gemma":0.99706453,"teacher_disagreement_score":0.7824187,"about_ca_system_score_codex":0.21758124,"about_ca_system_score_gemma":0.4847068,"threshold_uncertainty_score":0.90749484},"labels":[],"label_agreement":null},{"id":"W7161992113","doi":"10.82308/29219","title":"Risk time-window specification and its impact on the assessment of medication-related adverse events","year":2006,"lang":"en","type":"dissertation","venue":"","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Risk assessment; Risk management; Event (particle physics); MEDLINE","score_opus":0.04794424898400836,"score_gpt":0.45638595427861717,"score_spread":0.4084417052946088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161992113","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2812443,0.002023665,0.7082651,0.001524204,0.00017624436,0.000938688,0.0011068657,0.00076312217,0.003957706],"genre_scores_gemma":[0.8417022,0.00065271446,0.15508069,0.00018142816,0.00007463655,0.00047884314,0.0006799168,0.00009733346,0.0010521814],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.95511794,0.03728611,0.0020186328,0.002065399,0.0027506552,0.00076128583],"domain_scores_gemma":[0.45835856,0.51228637,0.015503801,0.007645702,0.0055649984,0.00064059516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.096322805,0.0013197849,0.0016927755,0.0020631421,0.0005310921,0.004404054,0.0021936775,0.0021244385,0.0018297883],"category_scores_gemma":[0.3026809,0.00079824333,0.0025457891,0.0026776895,0.0011235595,0.0037451766,0.0017614001,0.0031872417,0.00024186821],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031420754,0.0003668226,0.120160244,0.00050482,0.0009869239,0.00097032863,0.0013069594,0.68205464,0.0023365335,0.06343193,0.0018483335,0.12289036],"study_design_scores_gemma":[0.00012094804,0.00057344127,0.012408784,0.00013556561,0.00022474064,0.00027596843,0.00032328596,0.969478,0.0015143218,0.0138278445,0.0010547842,0.000062335894],"about_ca_topic_score_codex":0.010155082,"about_ca_topic_score_gemma":0.0034220777,"teacher_disagreement_score":0.096322805,"about_ca_system_score_codex":0.0015421506,"about_ca_system_score_gemma":0.0028095667,"threshold_uncertainty_score":0.5094098},"labels":[],"label_agreement":null},{"id":"W7162828735","doi":"","title":"Prévention du chemsex : état des lieux des connaissances, attitudes et pratiques des équipes officinales vis-à-vis des usagers du chemsex dans la région Auvergne-Rhône-Alpes","year":2025,"lang":"fr","type":"dissertation","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taboo; Pharmacy; Health care; Intervention (counseling); Harm reduction; Promotion (chess); Quarter (Canadian coin)","score_opus":0.04546928624628752,"score_gpt":0.35719944548463683,"score_spread":0.3117301592383493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7162828735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577855,0.023240909,0.00060270814,0.011510777,0.00010436277,0.000077634635,0.00013024748,0.00002131673,0.0065266285],"genre_scores_gemma":[0.98889405,0.0074301837,0.00082857086,0.0009615546,0.000042242766,0.000051281222,0.0000406106,0.000004342949,0.001747247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963349,0.0023699286,0.00013993471,0.0002336837,0.00057494495,0.00034661964],"domain_scores_gemma":[0.9914334,0.0037094438,0.0025865203,0.0001732373,0.0009041081,0.0011932919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004452275,0.00019168372,0.00022365658,0.00090032833,0.0013168275,0.0017826392,0.00038795554,0.0010348004,0.003037695],"category_scores_gemma":[0.007219683,0.0001944963,0.00021622673,0.0008684331,0.0014129403,0.0013218687,0.0011657409,0.000951867,0.00028519172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028376732,0.0005855979,0.5466132,0.004459453,0.00011650175,0.0022468884,0.1392368,0.00024892748,0.0036350405,0.0048071346,0.0063104164,0.29145625],"study_design_scores_gemma":[0.00003420001,0.0007223204,0.8374639,0.0023021197,0.000045413202,0.001825686,0.104671404,0.00023145838,0.0008871823,0.00039757718,0.051367737,0.000050986448],"about_ca_topic_score_codex":0.038509194,"about_ca_topic_score_gemma":0.04387259,"teacher_disagreement_score":0.038509194,"about_ca_system_score_codex":0.0021699446,"about_ca_system_score_gemma":0.0058491314,"threshold_uncertainty_score":0.07657009},"labels":[],"label_agreement":null},{"id":"W75765592","doi":"10.1177/001857870203700709","title":"Thrombocytopenia Caused by a Protein Pump Inhibitor; Hepatic Failure Associated with the Benzodiazepine Triazolam; Three Cases of Transient Encephalopathy with Paclitaxel; Thalidomide Problems: Hypothyroidism and Venous Thrombosis; Hypertensive Crisis with St. John's Wort","year":2002,"lang":"en","type":"article","venue":"Hospital Pharmacy","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug reaction; Thalidomide; Triazolam; Benzodiazepine; Drug; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.05379096383386908,"score_gpt":0.3080297046447175,"score_spread":0.2542387408108484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W75765592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.941282,0.0047933045,0.0039853454,0.0092273215,0.00057668856,0.0003473679,0.00038344678,0.0003351895,0.039069504],"genre_scores_gemma":[0.9962394,0.00055735535,0.00034101124,0.0012898226,0.000249972,0.000012823031,0.00006712204,0.00001612672,0.0012262083],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99961925,0.00007472834,0.000047940935,0.00006011122,0.00009511571,0.000102850194],"domain_scores_gemma":[0.9988655,0.00034268803,0.00033758482,0.000062901956,0.00007350561,0.00031785556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002892182,0.0010351139,0.00035018814,0.0015066328,0.001844286,0.0005685678,0.0005602521,0.0020010248,0.0021423164],"category_scores_gemma":[0.0028879247,0.00060633424,0.00056373066,0.00093147845,0.0009151363,0.00064796826,0.00052147324,0.0020203365,0.0005809784],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012485476,0.00022348444,0.05639201,0.000074833355,0.00005696155,0.93027955,0.00036446907,0.00024280809,0.0008067729,0.00032422674,0.0044143177,0.006695652],"study_design_scores_gemma":[0.00006497077,0.00035053,0.061100543,0.000039446586,0.00007231064,0.93335766,0.00022803484,0.00059578137,0.001141427,0.00038465712,0.002635874,0.000028711225],"about_ca_topic_score_codex":0.008046136,"about_ca_topic_score_gemma":0.0097188745,"teacher_disagreement_score":0.008046136,"about_ca_system_score_codex":0.0010671696,"about_ca_system_score_gemma":0.00081979576,"threshold_uncertainty_score":0.015998662},"labels":[],"label_agreement":null},{"id":"W849546101","doi":"10.71781/4760","title":"Advances in therapeutic risk management through signal detection and risk minimisation tool analyses","year":2012,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Université de Montréal; Golden Key International Honour Society","keywords":"Humanities; Political science; Gynecology; Philosophy; Medicine","score_opus":0.16400381653289384,"score_gpt":0.5077155720815482,"score_spread":0.3437117555486543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W849546101","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03747563,0.025310429,0.91735363,0.0066650347,0.00038651316,0.0008211658,0.0020587738,0.0020020579,0.007926761],"genre_scores_gemma":[0.28986377,0.015365936,0.6866355,0.0011516181,0.0004518131,0.0010880393,0.0021079993,0.0002536386,0.0030816842],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9813509,0.010402905,0.0016229585,0.0020823444,0.004172626,0.0003682535],"domain_scores_gemma":[0.91153663,0.07018457,0.0061497507,0.003408977,0.008102323,0.0006178376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02699586,0.0022362384,0.0022389712,0.008288706,0.00059045095,0.0057182596,0.002999089,0.0017622188,0.0038668262],"category_scores_gemma":[0.0871725,0.0008679988,0.002659869,0.004609463,0.0013308186,0.0031619393,0.0023876296,0.0025639713,0.0011894426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049345475,0.00039879727,0.040924445,0.0034140556,0.0012427066,0.00014619465,0.000713442,0.027575124,0.0030630932,0.015914997,0.0060440055,0.90006965],"study_design_scores_gemma":[0.0004891995,0.0032200776,0.07038708,0.006513917,0.0029014978,0.0013732067,0.0017396322,0.6875103,0.021977019,0.114302196,0.08891117,0.000674647],"about_ca_topic_score_codex":0.009242387,"about_ca_topic_score_gemma":0.006946387,"teacher_disagreement_score":0.02699586,"about_ca_system_score_codex":0.002699245,"about_ca_system_score_gemma":0.0054813405,"threshold_uncertainty_score":0.1427694},"labels":[],"label_agreement":null},{"id":"W96963580","doi":"10.1186/1710-1492-10-s2-a39","title":"Reconciliation of health records following penicillin allergy testing of hospitalized patients","year":2014,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Penicillin; Medical prescription; Allergy; Penicillin allergy; Antibiotics; Drug allergy; Demographics; Pediatrics; Medical record; Internal medicine; Immunology","score_opus":0.10420657623943255,"score_gpt":0.43593050037938036,"score_spread":0.3317239241399478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W96963580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89268345,0.016006947,0.02122523,0.005590698,0.0011870839,0.0031651133,0.047031492,0.0018837277,0.011226241],"genre_scores_gemma":[0.9063304,0.0041230377,0.037437335,0.0011547916,0.0008233502,0.000911888,0.047863666,0.00017162685,0.0011838335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9644859,0.015032855,0.012155554,0.0023063438,0.0054211393,0.00059826486],"domain_scores_gemma":[0.8438926,0.04759402,0.054491326,0.02336168,0.02853945,0.0021208967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018847903,0.0005745608,0.0012647924,0.014969252,0.0010234261,0.002564481,0.0020202335,0.00085650804,0.0012072725],"category_scores_gemma":[0.08818234,0.00052070734,0.00089653995,0.013073461,0.0004994689,0.002606379,0.001774214,0.000990876,0.0007155437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010612621,0.0002330711,0.823786,0.001303423,0.0005046834,0.0016141762,0.0032247063,0.0010926548,0.0011796458,0.0006418224,0.016698293,0.14866026],"study_design_scores_gemma":[0.0001435928,0.00053241407,0.948261,0.0008360053,0.00047379418,0.0027551209,0.0030558915,0.006779998,0.004993504,0.0008368085,0.031192267,0.0001395907],"about_ca_topic_score_codex":0.0071677985,"about_ca_topic_score_gemma":0.007955448,"teacher_disagreement_score":0.018847903,"about_ca_system_score_codex":0.0018485896,"about_ca_system_score_gemma":0.0034094234,"threshold_uncertainty_score":0.0996784},"labels":[],"label_agreement":null}]}